data_6r1v_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6r1v _Structure_validation_residue.Date_analyzed 2020-01-17 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt . . . . . 0 C--O 1.233 0.197 0 CA-C-O 121.173 0.511 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 29.2 Cg_endo -57.78 115.02 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.899 2.399 . . . . 0.0 112.954 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' ' 6' ' ' GLN . 2.6 pt20 -146.84 168.22 21.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.752 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.592 HG21 ' HB2' ' A' ' 31' ' ' PRO . 46.6 mt -104.18 120.88 49.49 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.39 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 2.4 Cg_endo -83.88 179.68 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.122 2.548 . . . . 0.0 112.321 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -79.1 -25.24 43.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.05 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.38 116.21 8.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 110.259 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -92.89 16.33 12.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.735 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 t -108.54 -29.09 8.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -89.3 174.37 7.87 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.207 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.63 128.67 52.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -80.77 -41.24 23.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.09 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.77 164.09 35.61 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.443 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -107.36 140.88 39.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.899 0.35 . . . . 0.0 110.267 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.4 tp -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.364 0.602 . . . . 0.0 110.113 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.1 mt-10 -120.76 111.88 18.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.638 0.732 . . . . 0.0 111.262 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.8 mt -124.86 93.91 45.1 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.75 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.71 -28.71 87.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.006 2.471 . . . . 0.0 112.283 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.0 -23.19 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.934 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.75 7.3 18.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.905 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 64.68 27.21 13.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.6 mt -106.64 122.28 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.0 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.27 75.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 167.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 67.8 mm-40 -122.0 162.02 39.43 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.68 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 69.0 Cg_endo -77.09 128.05 9.64 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.793 2.328 . . . . 0.0 113.321 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.15 124.93 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.83 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 44' ' ' SER . 62.8 m-85 -93.76 123.26 60.26 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.246 0.545 . . . . 0.0 110.966 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB2' HG21 ' A' ' 7' ' ' ILE . 68.6 Cg_endo -76.14 107.92 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.64 2.227 . . . . 0.0 111.289 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.9 167.22 33.18 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.734 -1.222 . . . . 0.0 112.8 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 88.5 Cg_endo -87.58 31.75 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.889 3.059 . . . . 0.0 112.544 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 62.25 26.88 16.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.202 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -70.32 142.61 89.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.722 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -39.44 -55.52 1.55 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.861 3.04 . . . . 0.0 114.852 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.41 -24.06 67.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -69.4 -39.63 77.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.14 0.495 . . . . 0.0 109.698 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 94.0 mt -80.96 -23.41 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.19 -24.52 63.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -103.86 -22.65 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.674 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -175.3 -156.68 14.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.161 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.454 HG13 ' CE1' ' A' ' 72' ' ' PHE . 28.5 m -92.27 154.58 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 29.6 t -135.51 163.37 30.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.993 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 58' ' ' SER . 31.1 m-85 -74.67 162.34 28.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.49 70.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.931 0.396 . . . . 0.0 110.689 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -137.9 176.14 8.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.666 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.745 0.783 . . . . 0.0 109.305 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -88.33 -22.08 24.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.855 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -76.58 171.97 13.78 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.941 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 66.5 m -154.1 165.32 36.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.948 0.404 . . . . 0.0 110.543 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.51 HD12 ' CG2' ' A' ' 88' ' ' VAL . 15.7 mt -79.43 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.971 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -101.29 -3.06 29.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.584 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -82.66 170.92 14.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.97 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -85.94 -20.76 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -107.69 108.01 19.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.644 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.98 111.66 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 12.2 m -117.31 116.6 27.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.877 0.37 . . . . 0.0 111.014 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.71 121.12 53.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.227 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.04 116.44 22.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.338 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.6 114.31 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.188 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -87.9 84.62 6.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.3 m -68.85 140.37 55.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.534 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.83 150.88 40.52 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.308 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.4 mt -91.98 -43.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -50.72 -43.52 57.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.353 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.5 mtp85 -100.18 124.29 43.79 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.856 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -87.42 -16.62 3.1 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.788 2.326 . . . . 0.0 113.012 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -138.84 73.41 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.184 0.516 . . . . 0.0 110.888 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -119.33 -161.16 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 43.8 mt-30 -60.21 -77.76 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CE1' HG13 ' A' ' 43' ' ' VAL . 3.1 m-85 -84.59 19.02 2.09 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -47.63 78.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -101.96 12.03 37.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -172.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.94 -16.73 64.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.365 0.602 . . . . 0.0 110.337 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -8.88 56.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.787 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.35 1.72 56.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 110.933 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.1 165.56 23.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.111 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 97' ' ' MET . 11.2 pttm -158.08 -170.92 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.896 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.1 ptpt -54.4 -39.14 66.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -117.68 59.78 0.47 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.443 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -84.22 -5.22 59.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.513 ' HE1' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 50.56 85.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.638 0.586 . . . . 0.0 111.694 -177.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 45.5 t -86.66 112.31 22.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.96 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.2 m-85 -100.84 107.93 19.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 12.6 t80 -99.11 102.1 13.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -82.7 88.97 6.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.361 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 52' ' ' LEU . 7.5 p -117.44 124.43 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 111.589 -170.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.24 -57.1 1.13 Allowed Glycine 0 CA--C 1.509 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.718 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -169.11 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.427 0.632 . . . . 0.0 110.223 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.06 154.94 20.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.252 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 m -98.0 100.92 12.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.33 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 51.1 mmt-85 -82.27 112.43 19.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.116 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.721 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.09 128.78 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.607 . . . . 0.0 110.56 177.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.556 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 72.1 m-85 -121.92 151.43 40.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.395 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.59 ' HE3' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -117.67 138.28 52.09 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.674 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 19.3 mmt -80.61 68.35 6.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.263 0.554 . . . . 0.0 110.311 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.92 -38.8 36.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.713 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.579 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 33.4 m -110.27 103.68 12.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.053 0.454 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 97' ' ' MET . 82.8 mt -123.49 126.06 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 7.1 ptm180 -159.77 -175.59 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.526 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 3.3 p30 -136.4 144.79 44.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.794 HG11 HG11 ' A' ' 110' ' ' VAL . 28.7 m -126.41 -169.16 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.787 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.616 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -136.89 160.39 66.48 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.422 -176.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.87 -20.82 30.65 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.645 2.23 . . . . 0.0 112.307 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.1 p -91.7 8.21 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.037 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.448 ' HB2' ' HE2' ' A' ' 104' ' ' LYS . 24.7 t0 -107.71 97.3 7.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.6 m -104.99 16.2 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.222 0.534 . . . . 0.0 110.591 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -104.74 -2.32 25.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.328 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.794 HG11 HG11 ' A' ' 103' ' ' VAL . 13.5 m -96.83 -39.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.979 0.419 . . . . 0.0 110.899 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -86.35 86.96 7.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.462 1.125 . . . . 0.0 108.743 173.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.7 -164.39 1.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.991 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.486 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 7.1 pt-20 -77.7 71.26 4.17 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 111.344 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -86.3 47.88 1.54 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HE2' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -71.64 172.57 9.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.203 -176.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.14 -14.21 36.99 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -92.6 175.21 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 110.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -89.62 -157.32 0.45 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 108.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -104.4 130.62 52.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 110.498 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -96.09 104.02 15.94 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.0 m -88.67 98.22 11.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.469 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -83.13 103.06 12.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.8 mt -96.71 89.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.876 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 m -95.48 101.8 13.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 -175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.8 m -84.06 115.58 22.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -120.33 158.56 26.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.131 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 t70 70.14 98.97 0.06 Allowed 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.91 0.757 . . . . 0.0 110.986 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -86.58 130.02 34.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.619 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -97.16 101.51 13.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.5 -17.16 64.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.573 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -71.16 -27.73 63.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.2 t -133.9 -23.44 1.77 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.79 26.73 8.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.641 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.88 174.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 117.027 0.413 . . . . 0.0 110.963 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -110.83 116.95 32.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.7 -50.95 30.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.149 -170.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.731 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 11.0 mmpt? -95.07 100.41 12.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.158 0.504 . . . . 0.0 111.243 -174.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.415 ' HB2' HG23 ' A' ' 103' ' ' VAL . 68.7 mtm180 -91.9 83.59 5.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.526 ' HD3' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -64.58 129.69 40.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.293 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 11.8 tt -126.67 114.57 38.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 122.234 1.016 . . . . 0.0 110.851 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.627 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 67.4 m-85 -108.12 104.7 14.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.01 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 37.8 t -90.97 93.25 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.703 0.763 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.604 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -88.39 105.14 17.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.661 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.3 m -84.37 142.61 30.03 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.803 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -53.38 114.45 1.5 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 109.873 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.59 HG23 ' HE3' ' A' ' 96' ' ' LYS . 7.3 p -94.28 148.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.351 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.444 -179.745 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 55.2 mtmt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.649 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.9 Cg_endo -57.38 126.67 22.74 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.31 2.673 . . . . 0.0 112.349 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -158.06 162.39 38.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 31' ' ' PRO . 22.6 mt -99.36 123.32 48.87 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.807 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.77 -172.75 1.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.864 2.376 . . . . 0.0 113.008 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -90.92 -14.45 31.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.546 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.45 145.56 25.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.85 0.357 . . . . 0.0 110.628 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -99.55 5.34 46.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.039 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -111.34 9.75 21.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.573 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -110.34 171.96 7.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 111.644 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.51 118.0 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.81 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HB1' ' HG3' ' A' ' 31' ' ' PRO . . . -92.32 -25.07 18.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.233 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.96 177.92 45.21 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.292 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 69.1 m-85 -123.78 136.5 54.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.412 HG21 ' O ' ' A' ' 18' ' ' ILE . 8.1 tp -109.99 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 122.256 1.027 . . . . 0.0 110.085 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -115.2 108.66 16.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.71 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.462 HG12 HG11 ' A' ' 84' ' ' VAL . 25.4 mt -121.34 94.88 48.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.212 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.48 -28.02 70.53 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 122.745 2.297 . . . . 0.0 111.225 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.558 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 34.2 t70 -67.45 -24.94 65.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.572 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -118.01 11.81 13.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.321 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t0 59.39 30.01 19.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.657 0.741 . . . . 0.0 111.063 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.427 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 84.5 mt -97.78 121.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.085 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 2.4 mppt? -145.03 80.73 1.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -154.01 158.82 32.49 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.644 0.259 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 71.1 Cg_endo -75.06 163.52 35.07 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.922 2.414 . . . . 0.0 113.054 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.82 133.41 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.809 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' SER . 68.2 m-85 -106.45 118.87 53.55 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.325 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.519 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 75.1 Cg_endo -85.69 162.8 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.924 2.416 . . . . 0.0 113.224 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.01 -173.75 34.62 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.457 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.75 6.52 4.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.233 2.622 . . . . 0.0 112.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.956 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.646 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 71.1 p -111.61 163.95 16.27 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.414 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 53.8 Cg_exo -38.28 -48.04 2.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.092 3.195 . . . . 0.0 115.361 -173.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -30.14 66.18 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.674 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.5 mp0 -64.93 -43.59 92.25 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.837 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.0 12.08 6.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.91 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.5 ' HA ' ' HZ ' ' A' ' 64' ' ' PHE . 55.2 t-20 -107.77 -47.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.449 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 41' ' ' ARG . 13.3 ptm180 -83.58 -26.0 30.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.278 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.4 -139.86 2.75 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.339 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.525 HG11 HE21 ' A' ' 71' ' ' GLN . 11.6 p -124.57 145.28 32.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.674 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 62.4 m -133.31 -177.39 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -95.82 166.79 11.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.477 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.042 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -149.2 170.48 18.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.141 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -78.18 -23.49 47.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -84.62 -1.47 56.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.34 145.37 51.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -128.04 150.67 49.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.753 0.311 . . . . 0.0 111.032 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.8 mt -80.8 -16.57 53.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.388 0.613 . . . . 0.0 110.221 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.27 -4.33 58.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.632 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.83 164.3 22.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.229 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.592 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.36 -21.85 59.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 177.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.77 145.55 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.0 110.16 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.425 ' HB ' HD21 ' A' ' 121' ' ' LEU . 4.0 mp -125.99 115.05 41.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.839 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -88.99 107.2 18.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.611 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.1 mt -105.02 122.9 58.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.72 126.71 42.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.192 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.7 158.98 20.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.07 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -149.39 93.95 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 m -62.09 148.51 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.5 ' HZ ' ' HA ' ' A' ' 40' ' ' ASN . 88.5 m-85 -118.19 172.21 7.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.662 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.01 -42.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.852 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.89 -4.99 59.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.724 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -117.72 111.14 39.65 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.737 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.58 -10.01 20.15 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.812 2.341 . . . . 0.0 112.347 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -155.64 84.49 1.04 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 110.966 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.416 ' CE2' ' HA ' ' A' ' 63' ' ' THR . 10.2 p90 -108.56 -168.87 1.41 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.525 HE21 HG11 ' A' ' 43' ' ' VAL . 10.0 mm100 -38.33 -69.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' HG23 ' A' ' 43' ' ' VAL . 19.5 m-30 -114.41 78.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.233 -0.292 . . . . 0.0 111.625 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.02 -50.86 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.566 0.698 . . . . 0.0 110.508 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 64.0 t30 -87.17 30.62 0.76 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.157 -172.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.77 -9.54 54.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.371 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -9.62 59.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.033 0.444 . . . . 0.0 111.003 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.16 -6.86 43.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.1 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -79.77 127.14 31.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -111.54 -169.08 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.465 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.04 -44.62 95.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.641 -176.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -99.92 52.94 0.99 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.892 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.4 t -62.96 -21.64 66.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.167 -0.516 . . . . 0.0 111.404 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.461 ' HE3' ' HA ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 50.17 76.01 0.16 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.513 -174.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.8 t -81.46 122.68 36.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.24 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -100.11 99.69 10.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.188 0.518 . . . . 0.0 109.753 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -101.52 109.58 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.423 ' HG2' HG22 ' A' ' 92' ' ' THR . 94.5 mttt -97.21 135.5 39.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.081 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.2 m -141.36 107.95 2.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.85 -102.2 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.352 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' H ' HD21 ' A' ' 90' ' ' ASN . 0.1 OUTLIER -115.26 5.65 14.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.809 0.338 . . . . 0.0 110.868 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HB2' HG23 ' A' ' 88' ' ' VAL . 40.9 mt-10 -102.43 113.63 27.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 87' ' ' LYS . 19.0 m -95.57 97.5 9.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 171.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 93' ' ' ARG . 16.9 mtp85 -93.27 135.88 34.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.192 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -98.68 130.56 45.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 92.7 m-85 -122.63 137.26 54.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.93 0.395 . . . . 0.0 110.611 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.584 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -109.69 131.3 55.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.586 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 22.4 mmt -80.73 76.1 7.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.389 0.614 . . . . 0.0 110.379 -175.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 t -86.97 -12.05 48.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.789 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.7 m -137.11 100.62 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 0.0 110.504 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 97' ' ' MET . 74.4 mt -119.5 122.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.353 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -161.2 -176.73 5.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.905 0.383 . . . . 0.0 110.653 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.618 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 1.1 p30 -131.52 141.02 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 110' ' ' VAL . 35.3 m -121.17 -176.0 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.143 0.497 . . . . 0.0 111.226 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -111.48 157.2 39.85 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.644 -176.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.21 -10.89 14.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.681 2.254 . . . . 0.0 112.643 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -117.16 17.89 14.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.26 129.91 39.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.228 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.89 30.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.63 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.96 -7.15 9.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.688 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 HG13 ' A' ' 103' ' ' VAL . 16.0 m -92.39 -19.11 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.3 0.571 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.458 HD11 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.2 19.97 16.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -116.19 145.14 43.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.388 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 49.34 67.53 0.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.536 0.522 . . . . 0.0 111.375 -174.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.39 89.51 7.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.619 0.724 . . . . 0.0 109.369 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 160.6 28.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.297 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.27 62.08 0.8 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.103 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -59.84 176.64 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.331 0.586 . . . . 0.0 111.178 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -83.04 -170.12 2.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 4.4 mptp? -64.09 112.69 3.11 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.12 131.79 56.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.311 0.577 . . . . 0.0 111.204 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.425 HD21 ' HB ' ' A' ' 57' ' ' ILE . 67.4 mt -86.01 121.22 28.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m -102.88 94.78 5.76 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 24.9 mt -83.84 100.33 10.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.923 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.3 mt -90.54 93.47 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.747 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.3 m -98.25 95.78 7.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.111 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.2 m -78.82 111.92 15.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.606 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.17 178.41 6.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.708 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.21 82.28 0.18 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.566 0.698 . . . . 0.0 110.233 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -83.54 126.45 32.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.529 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -95.48 100.85 12.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.34 -18.07 65.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.481 -174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -74.53 -27.21 60.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.439 HG22 HG12 ' A' ' 135' ' ' VAL . 8.1 t -124.58 -20.33 5.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.783 0.325 . . . . 0.0 111.191 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.67 46.39 6.39 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 133' ' ' THR . 5.6 p -139.76 156.7 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.0 110.355 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -93.76 115.28 27.7 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.05 -40.32 53.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -170.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -104.26 126.9 51.76 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.458 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -103.73 89.2 3.26 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.618 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 51.6 tptt -71.86 123.21 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.1 tt -121.01 124.01 71.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.869 0.842 . . . . 0.0 111.03 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 21.0 m-85 -113.99 108.11 16.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.837 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.9 t -99.52 106.06 18.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.431 0.634 . . . . 0.0 110.088 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.586 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.66 112.08 25.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.268 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.6 m -87.06 139.23 30.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.085 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.82 117.82 6.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.441 0.639 . . . . 0.0 111.291 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.523 HG12 ' HE3' ' A' ' 96' ' ' LYS . 3.3 p -114.11 134.35 57.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.5 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.106 -177.236 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HE3' ' OD1' ' A' ' 53' ' ' ASP . 40.4 mtpt . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HG2' HG22 ' A' ' 88' ' ' VAL . 20.0 Cg_exo -66.21 145.37 78.19 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.004 2.47 . . . . 0.0 112.442 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -123.99 154.21 40.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.097 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.479 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.8 mp -73.64 122.77 88.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.81 167.36 17.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.917 2.411 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -78.85 -12.55 60.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.29 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -99.15 118.82 36.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.673 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -95.53 21.86 7.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.385 -173.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 m -108.33 4.23 24.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.292 0.568 . . . . 0.0 110.322 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 98.5 mttt -102.94 -176.56 3.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.099 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.49 135.22 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.222 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.607 ' HB3' HD11 ' A' ' 52' ' ' LEU . . . -97.53 -35.43 10.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 110.493 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.07 163.29 34.22 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 49.8 m-85 -106.24 134.93 48.59 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 18' ' ' ILE . 8.0 tp -100.33 108.1 22.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.834 0.825 . . . . 0.0 109.782 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 59.0 mt-10 -115.8 111.02 19.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.232 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 46.2 mt -124.42 92.33 48.21 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.722 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -52.82 -34.62 66.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.317 2.678 . . . . 0.0 112.957 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.602 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 5.4 m-20 -58.6 -38.38 77.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.659 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -103.53 8.92 37.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 t70 54.72 38.72 30.58 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.239 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 27' ' ' GLU . 65.5 mt -100.75 127.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.257 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -143.57 29.77 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.826 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 7.0 mm-40 -88.74 149.05 43.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.965 -163.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.76 141.58 24.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.293 1.996 . . . . 0.0 111.795 173.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.87 124.75 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -95.77 108.92 43.36 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.791 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 87.9 Cg_endo -76.69 152.0 32.66 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.744 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.66 -167.78 33.16 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.421 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.44 30.63 0.53 Allowed 'Trans proline' 0 CA--C 1.519 -0.253 0 C-N-CA 123.494 2.796 . . . . 0.0 112.445 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.85 82.9 0.16 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.528 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.21 137.51 24.84 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.048 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.567 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 18.9 Cg_endo -58.7 -27.42 83.28 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.935 2.423 . . . . 0.0 113.381 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 41.8 mt-10 -90.87 -33.62 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -76.63 -30.91 57.08 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.004 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.0 tp -84.89 -5.05 59.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.94 0.876 . . . . 0.0 109.367 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 48.3 t-20 -81.47 -56.05 4.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.283 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -82.8 -26.4 31.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.89 -136.47 3.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.339 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.33 147.35 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 t -130.26 -171.79 2.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.852 0.358 . . . . 0.0 110.181 -175.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -93.1 174.46 7.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.329 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.87 -52.82 8.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -127.99 177.02 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.47 -18.04 52.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -82.43 -2.16 52.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.934 0.397 . . . . 0.0 110.755 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 138.43 57.61 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 38.4 m -122.38 -172.83 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' A' ' 15' ' ' ALA . 65.7 mt -111.95 -18.71 12.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.632 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.413 ' OD1' ' HE3' ' A' ' 4' ' ' LYS . 36.7 t70 -126.52 13.1 7.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.801 0.81 . . . . 0.0 110.184 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 18.8 t70 -81.17 160.83 24.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.239 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -25.53 66.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.826 0.346 . . . . 0.0 110.293 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -108.72 110.71 22.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.789 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 mm -119.2 90.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -92.83 108.73 20.22 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.158 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.9 mt -102.58 121.47 53.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 115.46 27.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.63 167.04 15.95 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.403 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -154.16 153.66 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.453 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 20.0 m -84.91 141.71 30.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 66' ' ' ASP . 45.3 t80 -125.23 107.92 11.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -51.39 -39.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.27 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.447 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 18.8 t70 -73.23 -22.06 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -109.45 129.74 23.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.96 -0.462 . . . . 0.0 111.069 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.72 -5.0 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.976 2.451 . . . . 0.0 113.152 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.91 77.44 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.287 0.565 . . . . 0.0 110.67 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.453 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 30.6 p90 -140.54 -166.97 2.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.804 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.826 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.7 mm100 -43.55 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.075 0.859 . . . . 0.0 112.738 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -106.2 79.66 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.065 0.46 . . . . 0.0 111.002 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -111.48 -52.18 2.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.658 0.742 . . . . 0.0 109.862 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.5 t30 -97.5 19.92 12.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.211 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.21 -16.47 62.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.206 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -9.73 50.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.717 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.26 16.32 11.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.83 147.69 22.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.944 0.402 . . . . 0.0 111.167 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.602 ' HE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -150.59 -172.66 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.407 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' MET . 20.1 ptmt -47.05 -49.78 20.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -171.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.528 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -115.59 59.96 0.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 119.71 -1.233 . . . . 0.0 112.294 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 30.5 m -79.61 -2.44 42.57 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.886 -0.185 . . . . 0.0 111.43 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.499 ' HE2' ' HE2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER 49.7 78.01 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.587 0.554 . . . . 0.0 111.453 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 41.5 t -79.69 112.3 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.722 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -97.86 109.15 21.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.852 0.358 . . . . 0.0 110.084 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -94.07 101.89 13.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.8 tptm -85.63 92.22 8.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.768 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 5' ' ' PRO . 7.3 p -119.47 126.6 75.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.18 0.514 . . . . 0.0 111.091 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.03 -101.02 0.27 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.942 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -125.22 1.85 7.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 0.0 110.273 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.23 132.39 50.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.411 HG21 ' HD3' ' A' ' 87' ' ' LYS . 2.2 m -101.7 87.16 3.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -92.85 128.93 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.137 0.494 . . . . 0.0 110.456 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.44 139.16 32.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.741 -173.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.519 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 77.8 m-85 -122.67 148.88 44.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.784 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -119.16 132.26 55.95 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.641 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 61.6 mtt -82.53 69.67 9.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.379 0.609 . . . . 0.0 110.562 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -75.7 -26.97 58.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.224 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -120.19 108.77 14.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.567 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.31 126.77 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.728 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.544 HH22 ' HB2' ' A' ' 109' ' ' GLU . 25.5 ptt180 -168.1 -177.07 3.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.245 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -120.66 139.96 52.28 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.487 HG23 HG12 ' A' ' 110' ' ' VAL . 31.3 m -129.43 -178.01 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.824 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.518 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -105.55 157.64 34.07 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.271 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -21.49 72.06 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.447 2.098 . . . . 0.0 111.637 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 t -118.8 26.9 9.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.6 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.544 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 19.3 t70 -63.04 152.84 35.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.934 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.16 -14.11 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.926 0.393 . . . . 0.0 111.376 -170.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.544 ' HB2' HH22 ' A' ' 101' ' ' ARG . 43.4 mt-10 -88.44 -29.55 20.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.124 0.488 . . . . 0.0 109.749 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.487 HG12 HG23 ' A' ' 103' ' ' VAL . 22.9 m -79.34 -6.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.391 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 86.0 mt -88.32 3.29 50.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.287 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 7.2 t70 -109.63 -172.51 2.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.349 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.409 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 5.5 pt-20 -130.45 112.26 13.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.14 74.13 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 111.277 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.75 161.29 30.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.282 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.01 6.09 63.6 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -114.43 -179.49 3.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.265 0.555 . . . . 0.0 110.691 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -94.56 -154.74 0.43 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.452 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 9.6 mmtm -64.45 123.91 20.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.88 104.6 16.54 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.719 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.436 HD21 HG11 ' A' ' 84' ' ' VAL . 25.3 tp -78.32 100.76 6.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -93.71 99.48 11.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.002 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.3 mm? -80.5 99.72 8.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.41 110.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.146 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.1 m -110.42 95.3 5.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 -176.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 136' ' ' TRP . 69.2 m -89.7 101.23 13.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -121.8 2.63 10.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.616 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 7.1 t70 -119.86 96.38 5.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.58 130.57 42.17 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.294 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.446 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 50.1 t-20 -97.62 116.87 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.321 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.65 -24.73 62.76 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -72.22 -21.22 61.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -141.2 -34.81 0.48 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.86 2.51 34.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.817 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 133' ' ' THR . 17.2 m -86.73 -174.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.754 0.311 . . . . 0.0 110.89 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 126' ' ' CYS . 54.5 m95 -114.68 126.65 55.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 130' ' ' ASN . 34.7 mm-40 -77.6 -74.72 0.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -175.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.616 ' HG2' ' HB2' ' A' ' 128' ' ' ASP . 22.8 pttm -85.13 131.03 34.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 110.432 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -116.48 97.96 6.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.927 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.596 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -66.18 126.7 29.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 tt -126.21 122.71 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.656 0.741 . . . . 0.0 110.812 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.5 m-85 -108.82 112.13 24.23 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 33.8 t -95.55 96.32 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.473 0.654 . . . . 0.0 109.723 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -96.93 109.89 22.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.332 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 m -81.75 140.38 34.3 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.961 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.59 119.8 8.25 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.455 0.472 . . . . 0.0 110.566 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.582 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 10.0 t -85.89 137.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.94 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.915 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.4 127.31 17.91 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.691 2.261 . . . . 0.0 111.399 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -140.73 127.68 20.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.65 0.738 . . . . 0.0 110.967 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.589 HG13 HD21 ' A' ' 52' ' ' LEU . 7.0 mt -59.95 131.01 89.14 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.14 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.28 160.8 26.1 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.722 2.282 . . . . 0.0 111.407 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 20.1 ptmt -79.23 -15.78 57.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 33.7 t70 -79.99 122.17 26.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 110.727 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -85.12 20.04 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.669 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -126.79 10.26 7.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 93.8 mttt -105.74 174.78 5.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.76 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.88 117.87 52.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.881 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.64 -31.99 23.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.409 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.05 173.21 45.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.259 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 80.8 m-85 -117.13 137.55 52.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.39 114.8 38.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.253 0.549 . . . . 0.0 109.574 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 66.1 mt-10 -117.93 106.16 12.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.426 0.632 . . . . 0.0 111.28 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.94 95.3 48.95 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.93 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.95 -30.36 91.53 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.946 2.431 . . . . 0.0 112.212 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD1' ' HD2' ' A' ' 79' ' ' LYS . 30.4 t0 -66.28 -30.86 71.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.57 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -107.2 3.53 25.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.7 t0 61.73 23.08 13.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.99 0.9 . . . . 0.0 110.583 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 65.2 mt -90.35 106.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.124 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -133.04 83.43 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 31.9 mm-40 -133.8 159.37 72.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.925 -173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.49 148.22 18.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.669 2.246 . . . . 0.0 113.337 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.85 128.09 61.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.075 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' SER . 65.2 m-85 -100.58 117.97 61.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 52.3 Cg_endo -68.19 150.16 76.67 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.866 2.377 . . . . 0.0 112.575 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.07 177.7 27.76 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.427 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 94.6 Cg_endo -79.19 30.99 0.46 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.323 2.682 . . . . 0.0 112.757 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB3' HD22 ' A' ' 39' ' ' LEU . . . 60.22 38.8 19.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.721 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.403 ' HB ' ' OE1' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -53.73 127.21 51.32 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.328 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.36 -59.54 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.994 3.129 . . . . 0.0 114.555 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 41.3 mt-10 -74.42 -35.99 63.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.403 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 23.3 mp0 -69.77 -35.24 74.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.0 110.361 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 34' ' ' ALA . 17.2 tp -84.18 -10.97 57.31 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.839 0.828 . . . . 0.0 109.453 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 52.3 t30 -66.63 -49.69 65.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.778 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -90.79 -23.25 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.386 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.34 -147.07 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.701 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.608 HG21 ' HG2' ' A' ' 71' ' ' GLN . 16.0 m -132.65 152.56 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 5.5 t -137.05 -171.75 3.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.688 0.28 . . . . 0.0 110.402 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -103.09 171.75 7.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.442 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 58' ' ' SER . . . -63.68 -47.63 80.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 110.173 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.29 162.34 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.681 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 9.6 pt-20 -74.26 -17.48 60.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -109.9 30.44 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.623 0.725 . . . . 0.0 109.857 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 7' ' ' ILE . 4.9 tp10 -62.83 146.36 52.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.153 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 37.7 m -120.05 120.14 35.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.102 0.477 . . . . 0.0 111.506 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.895 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.7 mm? -71.22 -17.56 62.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.702 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -92.72 0.88 57.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.524 0.678 . . . . 0.0 110.322 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.9 t70 -83.05 -172.48 4.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.692 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.98 -30.19 18.95 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.84 132.55 56.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.109 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.447 ' HB ' HD21 ' A' ' 121' ' ' LEU . 5.4 mp -135.56 108.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.469 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 20.2 m -101.02 124.69 47.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.998 0.427 . . . . 0.0 111.175 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.57 125.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.818 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.05 127.43 37.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 72' ' ' PHE . . . -139.89 170.71 24.16 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.586 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -169.07 165.28 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.57 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.7 m -75.1 143.16 43.51 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 6.0 t80 -122.06 152.8 39.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.78 0.324 . . . . 0.0 110.635 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -99.43 -47.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.532 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -58.98 -46.03 89.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.965 -174.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -101.77 124.43 40.51 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.6 5.76 6.19 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.805 2.337 . . . . 0.0 110.763 170.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -149.86 80.3 1.38 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.707 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -126.76 -160.25 0.98 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.009 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.608 ' HG2' HG21 ' A' ' 43' ' ' VAL . 1.5 mp0 -59.44 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CD1' ' HA3' ' A' ' 61' ' ' GLY . 22.5 m-30 -91.09 31.66 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.523 HG23 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -63.82 -24.41 67.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 76' ' ' LYS . 64.7 t30 -134.95 36.0 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.723 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 75' ' ' LEU . 3.4 mt -76.89 13.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.589 -0.695 . . . . 0.0 111.271 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 74' ' ' ASN . 16.9 pttp -89.97 -22.09 22.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.227 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.53 21.64 8.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.982 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.85 153.94 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.482 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HD2' ' OD1' ' A' ' 22' ' ' ASP . 4.6 mptt -132.6 -168.16 2.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.0 ptpp? -69.67 -23.94 63.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.855 0.359 . . . . 0.0 111.67 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -121.88 56.34 0.64 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.855 -1.165 . . . . 0.0 112.709 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -81.42 -10.45 59.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.454 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 57.01 90.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.451 0.643 . . . . 0.0 111.344 -174.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.3 t -95.06 109.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.25 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.429 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 73.1 m-85 -94.56 114.35 26.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.446 ' HB2' HD12 ' A' ' 121' ' ' LEU . 9.2 t80 -98.95 104.81 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 18.8 tptp -87.3 83.89 7.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.469 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.895 HG21 ' HG ' ' A' ' 52' ' ' LEU . 7.1 p -113.85 131.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.926 0.393 . . . . 0.0 110.678 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.55 -103.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.61 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -127.54 8.81 6.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.393 0.139 . . . . 0.0 111.227 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.41 158.52 32.55 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 112.159 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -124.63 108.89 12.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -100.14 146.6 26.63 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.186 -0.205 . . . . 0.0 110.591 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.454 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 0.0 OUTLIER -100.85 120.14 39.69 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 94.6 m-85 -112.67 141.28 46.64 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -111.42 133.21 53.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.3 mtt -81.4 63.61 5.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.527 0.679 . . . . 0.0 110.465 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -71.26 -32.27 68.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.462 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 65.3 m -114.26 97.69 6.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 138.7 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.844 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -162.22 -178.45 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.515 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -126.48 140.01 52.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.887 HG23 ' HG3' ' A' ' 139' ' ' ARG . 7.7 m -114.2 147.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -85.77 159.08 55.71 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.623 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . 31.2 Cg_endo -64.79 -22.83 63.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.604 2.203 . . . . 0.0 111.596 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -106.66 8.5 31.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.145 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 11.7 t70 -85.13 142.22 29.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.75 11.07 8.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.951 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.49 -28.27 28.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 0.0 109.505 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.52 -26.42 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.03 9.91 37.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.872 0.368 . . . . 0.0 111.516 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 7.9 t70 -100.93 -175.09 2.78 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.036 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.444 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 4.2 pt-20 -115.22 102.74 10.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.18 0.514 . . . . 0.0 110.477 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -79.52 95.27 5.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.869 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.08 -175.96 3.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.413 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.07 -4.83 84.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.192 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -98.47 -174.31 2.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.81 -158.62 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -64.5 111.82 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 171.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -126.71 151.75 47.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.328 0.585 . . . . 0.0 112.209 -173.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.447 HD21 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -106.98 121.59 44.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.433 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 27.5 m -95.78 98.93 10.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.062 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 8.7 mt -85.03 101.07 12.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.131 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.1 mt -92.01 92.64 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -101.62 101.17 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.317 0.579 . . . . 0.0 111.183 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 76.9 m -84.06 105.07 14.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.874 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -98.8 -27.27 14.01 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.476 ' CG ' ' HD3' ' A' ' 138' ' ' LYS . 16.0 t70 -114.71 100.29 8.14 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.276 0.56 . . . . 0.0 111.14 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -87.14 122.76 31.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.441 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -91.04 107.3 19.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.23 -27.15 67.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.986 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -65.13 -34.74 79.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -173.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.461 HG23 HG13 ' A' ' 135' ' ' VAL . 9.9 t -126.16 -5.6 6.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 110.625 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.93 52.52 14.06 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.931 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 133' ' ' THR . 9.0 p -142.23 150.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 46.6 m95 -92.69 98.0 11.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.707 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 42.7 mt-10 -72.42 -64.87 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 111.101 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.707 ' HD2' ' HB2' ' A' ' 137' ' ' GLU . 8.4 mptt -81.58 109.23 15.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.597 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.887 ' HG3' HG23 ' A' ' 103' ' ' VAL . 11.9 ptt180 -121.38 114.75 21.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.451 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.412 ' HE2' ' CE2' ' A' ' 142' ' ' PHE . 19.9 tptm -83.79 127.35 33.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.671 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.2 tt -120.1 128.44 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.578 0.704 . . . . 0.0 110.975 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.8 m-85 -115.84 116.09 27.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.026 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 41.3 t -98.86 96.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -95.73 116.04 28.3 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.775 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 m -96.34 145.17 25.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.696 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.04 122.56 9.61 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.58 0.55 . . . . 0.0 110.691 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.509 HG21 ' HE3' ' A' ' 96' ' ' LYS . 15.0 p -122.99 150.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.498 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.326 -179.427 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 121.268 0.556 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.66 130.44 24.87 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.051 2.501 . . . . 0.0 113.612 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -143.55 161.33 38.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.088 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 31' ' ' PRO . 3.5 mp -90.89 126.82 54.26 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.71 -175.31 2.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.117 2.545 . . . . 0.0 111.701 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.24 -17.77 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.663 -178.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -90.07 121.51 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.517 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -106.5 16.54 24.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.136 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -102.46 3.48 37.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -122.35 168.6 11.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.846 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.8 t -93.89 119.4 41.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.221 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -94.19 -21.62 18.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.29 164.41 37.17 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.318 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 79.7 m-85 -119.87 144.77 47.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -101.71 108.49 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.812 0.815 . . . . 0.0 109.564 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.78 108.62 17.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.193 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 HG11 ' A' ' 84' ' ' VAL . 41.7 mt -126.42 91.24 48.09 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.096 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.55 -25.75 79.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.942 2.428 . . . . 0.0 112.164 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 33.8 t70 -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.028 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 78' ' ' ALA . . . -110.29 8.31 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.57 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 t70 63.47 27.62 15.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.747 0.784 . . . . 0.0 110.652 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 88.6 mt -104.2 114.62 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.298 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.2 mppt? -142.37 82.1 1.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 11.2 mm-40 -134.02 159.99 70.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.054 -173.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 67.4 Cg_endo -75.17 144.91 30.24 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.918 2.412 . . . . 0.0 113.442 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.81 128.37 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.623 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -97.63 114.6 65.15 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.495 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 86.1 Cg_endo -78.67 142.22 17.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.757 2.305 . . . . 0.0 112.431 -174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.42 -161.43 28.19 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.912 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.51 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 59.8 Cg_endo -88.18 30.02 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.911 3.074 . . . . 0.0 113.312 -175.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.22 56.84 4.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.63 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.38 138.02 95.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.37 -58.62 1.3 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.252 3.302 . . . . 0.0 114.076 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.49 -34.44 76.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.648 0.261 . . . . 0.0 111.696 -176.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -81.2 -36.34 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.426 . . . . 0.0 110.847 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.41 -14.72 59.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.621 0.724 . . . . 0.0 109.575 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -73.91 -42.66 60.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.168 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 12.9 ptm180 -86.13 -40.39 15.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.521 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.88 -157.11 8.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.603 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 72' ' ' PHE . 40.2 t -113.26 142.67 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 t -130.64 -174.73 3.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -93.67 160.05 14.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -29.26 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.445 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -135.78 165.55 25.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 37.6 tt0 -82.8 -32.12 27.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.748 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.47 31.05 0.59 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.119 0.485 . . . . 0.0 111.167 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -85.68 151.41 23.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.801 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 47.1 m -122.93 150.21 43.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.752 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.439 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 93.6 mt -93.02 6.8 46.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.785 0.326 . . . . 0.0 111.746 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -132.68 8.34 4.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.706 0.765 . . . . 0.0 109.547 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.801 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 15.6 t70 -81.71 164.26 21.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.288 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tm0? -67.78 -29.05 68.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.035 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 138.37 53.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.794 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -140.0 117.82 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.858 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -100.23 103.4 14.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.045 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.5 mt -98.31 114.81 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.41 123.77 48.58 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.1 167.63 21.71 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.196 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -139.74 128.86 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.476 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.3 m -52.71 110.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.342 0.591 . . . . 0.0 111.282 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.408 ' HE1' ' HB2' ' A' ' 66' ' ' ASP . 13.8 t80 -80.88 129.48 34.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.93 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.4 mm -75.0 -49.65 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.403 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -74.19 -1.35 20.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.23 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 85.0 mtm180 -130.24 94.38 30.54 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 -13.5 34.5 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.812 2.341 . . . . 0.0 112.515 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -147.33 63.27 1.16 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.445 0.641 . . . . 0.0 110.167 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 9.7 p90 -99.12 -157.79 0.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -43.57 -75.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.506 0.504 . . . . 0.0 112.123 178.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.532 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 22.2 m-30 -100.03 77.17 1.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.84 -52.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 10.7 t30 -88.62 11.94 16.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.047 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -23.16 64.89 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.958 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -70.1 -8.29 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.944 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.72 5.12 41.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.777 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . . . -96.16 135.15 38.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.438 0.637 . . . . 0.0 111.23 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.434 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 3.5 mppt? -108.86 -172.94 2.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -64.21 -30.62 71.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.827 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.82 49.69 0.83 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.246 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.529 ' HG ' ' HB3' ' A' ' 22' ' ' ASP . 6.7 t -66.07 -21.09 66.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.53 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.456 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 53.91 83.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.518 0.675 . . . . 0.0 111.547 -175.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 74.4 t -85.2 125.15 40.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.185 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -106.03 108.42 19.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.276 0.56 . . . . 0.0 110.337 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.75 103.07 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.0 tppp? -86.86 90.69 8.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.983 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 m -117.42 129.12 74.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.78 -88.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.494 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -148.18 11.07 0.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 110.155 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 145.57 41.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 m -109.18 107.11 17.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.372 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -99.74 137.0 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.938 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 0.0 OUTLIER -102.89 139.01 39.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.519 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -133.27 142.52 48.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.023 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -107.63 136.76 46.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.564 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.9 mmt -80.64 70.37 7.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.4 0.619 . . . . 0.0 110.108 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -83.64 -4.69 58.8 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.895 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 20.2 m -144.02 105.82 4.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.093 0.473 . . . . 0.0 110.587 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 97' ' ' MET . 77.3 mt -122.08 123.27 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.924 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -165.23 -166.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.213 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.624 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 4.5 p-10 -142.98 144.97 32.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.637 HG22 ' HE ' ' A' ' 139' ' ' ARG . 11.3 m -132.07 154.17 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.269 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.471 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -97.09 164.86 16.94 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.785 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -67.19 -18.35 50.77 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.473 2.115 . . . . 0.0 111.229 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -103.91 12.86 33.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 110' ' ' VAL . 7.6 t70 -74.63 154.76 38.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.466 ' HA ' HD21 ' A' ' 111' ' ' LEU . 28.5 m -96.11 -15.26 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 -172.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.15 -5.06 55.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.332 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 107' ' ' ASP . 21.8 m -83.6 -17.93 10.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.818 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -112.49 18.5 18.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 178.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.91 167.58 14.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.34 139.44 57.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.804 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.63 143.29 30.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.38 170.0 13.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.588 -166.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.13 51.78 2.87 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.254 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -83.1 177.0 8.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.13 -156.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 19.1 mmtm -60.7 115.45 3.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -106.34 112.04 24.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.979 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.55 105.38 9.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -91.57 93.73 9.09 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.683 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -77.65 99.1 5.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.578 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.51 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.043 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -117.67 89.72 3.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.007 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 64.0 m -73.97 104.82 4.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -110.54 76.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.569 0.7 . . . . 0.0 110.75 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 16.6 t70 -162.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.707 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 131' ' ' GLU . 1.6 t80 61.03 86.67 0.1 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.628 0.58 . . . . 0.0 110.384 -172.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -92.79 97.36 10.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.696 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.471 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 36.4 mt-10 -60.87 -15.74 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.278 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.24 -34.79 78.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.903 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -115.55 -14.99 11.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.436 0.636 . . . . 0.0 109.844 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.11 31.89 50.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.029 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.5 t -134.86 139.33 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -78.14 92.26 4.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 172.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.55 -8.46 59.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 62.9 tttm -121.13 131.15 54.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 19.9 ttp180 -136.57 100.92 4.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.34 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 48.7 tptt -69.1 126.68 30.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.12 124.88 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.772 0.796 . . . . 0.0 111.033 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.564 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 14.6 m-85 -115.66 116.36 27.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.395 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 45.6 t -104.02 103.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.322 0.582 . . . . 0.0 110.103 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.63 114.48 28.2 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.747 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.9 m -89.75 140.14 29.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.07 126.57 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.202 0.525 . . . . 0.0 111.255 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.45 HG11 ' HD3' ' A' ' 96' ' ' LYS . 13.1 p -130.09 160.53 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.229 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.491 -178.13 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 87.8 mttt . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 35.9 Cg_endo -64.19 135.87 49.05 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.974 2.449 . . . . 0.0 112.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -134.41 167.1 21.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.197 0.522 . . . . 0.0 110.519 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.539 HD13 ' HA ' ' A' ' 51' ' ' SER . 43.1 mt -107.02 113.78 62.15 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.73 177.35 3.65 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.92 2.413 . . . . 0.0 112.292 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -74.65 -24.25 58.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 110.134 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.21 100.26 0.77 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.015 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -98.68 20.84 12.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 110.608 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -100.23 -11.86 20.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.284 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -107.33 176.69 5.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.097 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.97 129.53 41.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.727 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.5 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.301 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -155.3 176.08 33.04 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.668 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.507 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 71.9 m-85 -122.7 135.98 54.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.6 tp -98.63 110.05 25.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.807 0.813 . . . . 0.0 109.776 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 85.9 mt-10 -119.17 109.62 16.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.92 89.6 38.15 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.67 -32.73 76.81 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.112 2.541 . . . . 0.0 112.481 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.63 -23.78 64.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -107.89 8.12 28.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.137 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 65.4 17.65 11.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.844 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.557 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 91.2 mt -97.38 131.27 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.985 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 37.0 mtpt -156.41 45.73 0.43 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.486 0.66 . . . . 0.0 109.834 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -106.63 156.87 36.38 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.158 -169.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 57.4 Cg_endo -73.43 148.63 43.28 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 121.91 1.74 . . . . 0.0 112.896 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.82 134.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 44' ' ' SER . 46.5 m-85 -101.08 144.22 28.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.318 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.13 162.52 20.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.411 2.074 . . . . 0.0 110.894 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.24 165.2 13.24 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.093 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.672 ' HG2' ' HG1' ' A' ' 35' ' ' THR . 71.8 Cg_endo -76.66 30.24 0.41 Allowed 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.041 3.161 . . . . 0.0 113.221 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.36 43.39 23.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.763 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.743 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.65 147.24 96.45 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.15 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.622 ' HD2' HG22 ' A' ' 35' ' ' THR . 89.2 Cg_exo -49.04 -53.3 7.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.291 2.66 . . . . 0.0 113.965 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.743 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -71.82 -27.08 62.67 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.761 -178.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.421 ' HG3' ' HB2' ' A' ' 44' ' ' SER . 42.6 tp60 -62.49 -51.91 65.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.995 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.74 -16.83 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.445 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.62 -40.3 66.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.266 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -68.97 -45.12 71.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.051 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.0 -110.19 0.23 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.598 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.3 m -130.71 152.68 37.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.58 0.229 . . . . 0.0 110.679 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 36.9 t -148.18 165.81 29.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.001 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -68.56 162.01 26.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.32 -37.44 25.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -125.61 156.33 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.33 -1.65 58.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.856 0.836 . . . . 0.0 108.772 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -91.14 -19.72 22.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.058 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.71 170.51 16.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.991 0.424 . . . . 0.0 110.532 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.539 ' HA ' HD13 ' A' ' 7' ' ' ILE . 56.1 m -146.94 157.63 43.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.525 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 7' ' ' ILE . 96.0 mt -73.79 -12.09 60.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 111.939 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -113.5 11.16 18.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.879 0.847 . . . . 0.0 109.844 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 4.3 t0 -83.21 156.78 23.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.652 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 115' ' ' LYS . 1.1 tm0? -68.15 -32.75 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.15 120.33 40.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.409 0.623 . . . . 0.0 111.56 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.1 mt -125.75 134.16 67.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 p -132.45 121.14 22.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.06 0.457 . . . . 0.0 112.022 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mt -108.69 128.45 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.02 123.57 33.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.033 0.444 . . . . 0.0 111.283 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 123.94 7.7 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.762 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -70.51 -61.85 1.61 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.505 0.193 . . . . 0.0 110.687 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 m 69.09 122.46 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 O-C-N 124.099 0.875 . . . . 0.0 110.693 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -152.63 138.75 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.3 -37.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.721 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.94 6.94 16.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.339 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -136.39 77.47 47.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.64 3.65 7.66 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.827 2.351 . . . . 0.0 113.338 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -153.19 47.44 0.69 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.973 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -101.5 -175.21 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HG3' ' HG3' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.69 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CZ ' HD13 ' A' ' 123' ' ' LEU . 21.3 m-30 -96.96 81.33 3.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.485 0.66 . . . . 0.0 111.245 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 m -150.4 -41.28 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.174 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -91.08 11.9 21.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.462 0.649 . . . . 0.0 109.388 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.01 -12.53 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.948 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -10.13 58.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.069 0.462 . . . . 0.0 111.257 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . . . -82.13 -9.77 59.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.496 175.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.17 132.06 35.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.068 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 97' ' ' MET . 26.4 mmtp -120.53 -177.74 3.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -61.12 -13.77 19.82 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.42 34.23 2.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.547 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.0 m -82.77 121.86 27.45 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mtp -71.8 108.17 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 110.526 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 63.3 t -89.56 115.94 30.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.668 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.514 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 82.6 m-85 -102.57 121.42 42.35 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.072 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 12.0 t80 -112.81 99.06 7.61 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 5.4 mptt -75.25 102.22 4.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.013 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.85 86.73 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.168 0.509 . . . . 0.0 111.561 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.38 -59.25 3.26 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.308 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -137.35 -37.46 0.63 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 111.392 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -107.97 -179.73 3.98 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 87' ' ' LYS . 6.6 t -132.23 142.57 49.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.397 0.618 . . . . 0.0 109.905 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -100.24 132.2 45.75 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.942 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -99.76 126.48 45.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.942 0.401 . . . . 0.0 110.462 -177.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 83.9 m-85 -125.13 149.94 47.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.38 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.8 tptm -113.17 135.18 54.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.593 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 16.7 mmt -79.9 62.62 4.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -75.62 -8.95 58.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.126 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.537 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 55.9 m -145.21 103.3 3.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.966 -0.459 . . . . 0.0 110.998 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.6 mt -120.59 128.34 76.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.24 177.42 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.637 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -132.16 120.55 22.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -75.24 151.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.51 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -86.51 148.39 46.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.73 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.604 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 32.8 Cg_exo -62.06 -15.68 45.29 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.697 2.265 . . . . 0.0 112.284 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -99.76 -5.66 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.84 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -91.81 133.22 35.83 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.57 24.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -115.89 -28.14 6.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.562 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.18 -22.59 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.475 0.655 . . . . 0.0 110.79 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -99.5 25.53 6.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.467 -173.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.91 175.35 7.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.7 pt-20 -72.21 70.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.397 0.618 . . . . 0.0 112.033 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -86.72 75.46 9.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.569 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -100.11 -179.36 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.31 -2.38 16.29 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.44 -170.71 3.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.34 -0.43 . . . . 0.0 109.946 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.75 -158.51 0.4 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 1.3 mptm? -61.77 104.82 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.05 125.4 49.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.327 0.584 . . . . 0.0 110.54 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.4 tp -91.92 109.72 21.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m -96.28 102.26 14.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.572 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.6 mm? -87.38 100.7 12.93 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.72 89.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.6 m -100.56 99.73 10.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 83.4 m -60.7 125.26 23.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.08 -21.57 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.041 -160.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 13.6 t70 -140.85 108.57 5.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.389 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -101.38 130.08 47.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.57 0.7 . . . . 0.0 109.924 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -80.67 103.27 10.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.274 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -54.95 -26.07 33.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.08 -17.45 58.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.535 ' OG1' HG22 ' A' ' 135' ' ' VAL . 16.5 p -126.68 -37.69 2.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.536 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.85 8.54 51.24 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.939 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.535 HG22 ' OG1' ' A' ' 133' ' ' THR . 30.2 m -98.34 141.51 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 111.34 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 129' ' ' TYR . 60.4 m95 -87.97 86.65 7.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 105' ' ' PRO . 51.2 mt-10 -65.0 -64.19 0.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.961 -175.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 35.6 tttm -85.5 126.48 33.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.09 139.95 51.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 27.0 tttp -87.57 145.08 26.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.126 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.25 125.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.672 0.748 . . . . 0.0 110.936 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.598 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.7 m-85 -111.91 112.71 24.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.891 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 59.3 t -98.15 98.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 109.649 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -98.4 102.87 14.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.201 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.9 m -82.07 139.64 34.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.871 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -57.58 126.01 25.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.492 0.663 . . . . 0.0 110.8 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.05 170.82 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.935 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 3.2 ptmm? . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.715 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.262 0.553 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.33 144.92 69.96 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.6 2.2 . . . . 0.0 112.169 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.79 156.84 47.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.733 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.407 HG13 ' HG ' ' A' ' 52' ' ' LEU . 28.3 mt -107.8 109.6 62.28 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.364 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.658 ' HG2' ' HE3' ' A' ' 13' ' ' LYS . 49.9 Cg_endo -73.35 164.09 36.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.418 2.078 . . . . 0.0 111.579 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -3.22 19.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.706 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 19.3 t70 -69.24 145.63 52.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.272 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 22.5 pttp -118.63 9.73 12.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 111.525 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -95.01 -50.46 5.09 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.056 -0.402 . . . . 0.0 111.35 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.706 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -76.83 162.04 27.96 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -96.85 151.6 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.105 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.36 -32.12 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.66 164.27 25.45 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.994 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 59.1 m-85 -129.73 135.17 48.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.4 tp -104.98 115.23 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.532 0.682 . . . . 0.0 110.154 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -125.17 119.91 29.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.891 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.4 95.03 18.57 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.071 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.93 -22.55 68.51 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.715 2.277 . . . . 0.0 112.115 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.473 ' HB3' ' HG ' ' A' ' 82' ' ' SER . 27.0 t0 -68.5 -33.02 73.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.392 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.56 2.5 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.584 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t0 57.7 36.56 26.73 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.874 0.845 . . . . 0.0 110.313 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.469 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 55.0 mt -102.45 121.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.624 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -147.06 86.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.4 mm-40 -145.26 159.8 47.75 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.617 0.246 . . . . 0.0 111.099 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.2 157.7 45.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.837 2.358 . . . . 0.0 113.447 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.447 ' O ' HG21 ' A' ' 14' ' ' VAL . 93.4 t -110.88 123.34 66.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.716 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' SER . 60.0 m-85 -92.42 110.97 48.3 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.312 0.577 . . . . 0.0 111.467 -175.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.7 Cg_exo -77.61 129.82 10.33 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.223 2.616 . . . . 0.0 111.728 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.03 -173.7 43.68 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.918 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 11' ' ' LYS . 3.3 Cg_exo -78.66 10.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.542 2.828 . . . . 0.0 112.845 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 67.49 29.92 7.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.663 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -68.56 160.24 77.53 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.26 -45.32 22.4 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.697 2.931 . . . . 0.0 114.727 -174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.516 ' OE1' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -71.79 -30.46 65.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.571 -175.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.516 ' HG2' ' OE1' ' A' ' 37' ' ' GLU . 85.2 mm-40 -68.01 -36.84 80.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 0.0 110.339 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -81.92 -0.61 44.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.037 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -108.32 -12.18 15.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.698 0.285 . . . . 0.0 111.001 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.461 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 10.1 ptm180 -95.36 -25.81 16.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.783 0.325 . . . . 0.0 110.576 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.0 -122.59 0.91 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.076 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.702 HG13 ' HG2' ' A' ' 71' ' ' GLN . 7.6 p -122.03 144.22 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 45.0 p -132.29 -168.27 2.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 36.6 m-85 -96.28 165.0 12.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.465 176.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.367 . . . . 0.0 111.446 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.35 168.92 19.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.05 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -67.85 -31.77 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.808 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -88.3 19.95 3.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.034 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 4.6 mm-40 -64.65 158.4 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.031 173.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.784 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 51.8 m -140.04 123.19 16.8 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.134 0.492 . . . . 0.0 111.737 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.51 HD13 ' CG1' ' A' ' 88' ' ' VAL . 30.6 mt -66.22 -26.75 67.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.271 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.55 -19.98 48.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.79 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.784 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 3.5 t70 -72.29 164.53 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.396 -172.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.592 ' HA ' ' HD2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.91 -31.19 61.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.054 -178.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.42 133.98 54.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.684 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.5 mt -133.47 121.7 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.925 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -110.09 107.8 17.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.263 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.497 HD12 HD12 ' A' ' 121' ' ' LEU . 41.1 mt -94.55 111.81 26.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -105.71 123.31 47.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.561 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA3' HG22 ' A' ' 43' ' ' VAL . . . -150.58 175.52 29.57 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.088 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -142.11 156.38 45.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.723 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -71.73 140.96 49.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.361 0.413 . . . . 0.0 111.016 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -100.68 158.53 15.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.357 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.49 -38.14 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -87.9 -5.07 58.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 67' ' ' ARG . 8.6 mmt180 -113.25 115.36 47.62 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 0.0 110.665 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.82 -11.66 5.51 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.961 2.441 . . . . 0.0 113.359 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -160.58 89.07 0.81 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.562 0.696 . . . . 0.0 110.514 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 15.4 p90 -130.69 -151.83 0.48 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.809 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.702 ' HG2' HG13 ' A' ' 43' ' ' VAL . 25.8 mp0 -55.49 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 111.918 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.533 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.6 m-85 -94.88 82.07 3.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.154 0.502 . . . . 0.0 111.198 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 m -110.1 -60.96 1.73 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -95.96 28.12 3.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.656 -176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.8 tp -65.13 -19.0 65.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.418 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -9.61 58.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.62 11.75 23.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.939 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.28 161.39 14.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.349 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -135.27 -176.01 4.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.6 ptmm? -66.52 -13.86 61.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.336 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.66 45.91 1.11 Allowed Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 174.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.473 ' HG ' ' HB3' ' A' ' 22' ' ' ASP . 7.4 t -61.63 -25.33 67.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.09 -0.555 . . . . 0.0 112.117 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.453 ' HE3' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 57.52 89.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.698 0.761 . . . . 0.0 111.518 -175.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.0 t -91.81 125.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.669 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -102.0 104.47 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -97.51 106.07 18.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 49.5 mttp -83.72 125.02 31.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.225 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.51 ' CG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -130.49 101.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.294 0.568 . . . . 0.0 110.144 -177.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.59 -81.72 0.4 Allowed Glycine 0 C--N 1.317 -0.482 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.421 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 -18.62 4.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.349 . . . . 0.0 111.242 -176.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -97.52 152.04 19.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -123.53 99.59 6.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.61 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -93.83 166.35 12.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.734 0.302 . . . . 0.0 110.761 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -127.55 126.64 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.454 0.645 . . . . 0.0 111.894 -170.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.533 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.6 m-85 -116.05 148.22 40.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.454 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.579 ' HB2' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -117.16 129.47 55.98 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 59.5 mtt -79.86 70.33 6.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.402 0.62 . . . . 0.0 110.703 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 t -80.04 -24.93 40.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.556 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 15.0 m -121.03 102.5 8.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.011 0.434 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.7 mt -113.11 129.98 67.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.17 173.94 11.5 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.909 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.505 ' HB3' ' CD ' ' A' ' 140' ' ' LYS . 1.2 p30 -149.36 125.53 10.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.865 168.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG23 HG21 ' A' ' 110' ' ' VAL . 19.0 m -131.38 -177.16 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.398 -169.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.3 mppt? -103.07 145.19 30.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.762 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 136' ' ' TRP . 25.3 Cg_exo -65.62 -12.99 37.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.95 2.433 . . . . 0.0 111.95 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -109.02 16.89 22.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.518 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.09 168.27 19.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.43 -20.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.691 0.281 . . . . 0.0 111.033 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.83 4.84 38.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.265 0.555 . . . . 0.0 110.777 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.467 HG21 HG23 ' A' ' 103' ' ' VAL . 11.3 p -80.12 -20.16 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 12.48 33.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.355 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 157.32 34.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 0.0 110.251 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.563 ' OE1' ' HE2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -92.9 82.73 4.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.541 0.686 . . . . 0.0 112.022 -174.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -77.02 74.23 3.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.563 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.64 174.27 5.95 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.25 -23.1 27.84 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -72.3 158.97 34.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.435 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.493 ' OD1' HG22 ' A' ' 145' ' ' THR . 3.1 p-10 -83.43 -161.71 0.54 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.592 ' HD2' ' HA ' ' A' ' 55' ' ' GLN . 2.4 tptp -46.86 106.31 0.08 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.188 0.305 . . . . 0.0 110.244 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 10.0 pt20 -116.4 135.34 53.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.371 0.605 . . . . 0.0 110.861 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD12 HD12 ' A' ' 59' ' ' ILE . 20.7 tp -101.47 109.86 21.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 m -94.37 101.27 13.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.49 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.9 mm? -80.49 104.55 11.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.727 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.479 HG22 ' HD3' ' A' ' 139' ' ' ARG . 53.3 mt -98.84 100.72 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.6 m -115.6 105.18 12.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.125 0.488 . . . . 0.0 110.833 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.5 m -90.99 94.31 9.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.472 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 9.6 p-10 -105.05 2.45 29.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.672 -166.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.495 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 20.8 t70 -127.66 99.18 5.47 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.246 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 87.2 t80 -97.36 127.19 43.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.446 ' OD1' HG23 ' A' ' 133' ' ' THR . 22.1 t-20 -91.28 111.13 22.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.68 -14.43 62.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -85.7 -29.64 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.446 HG23 ' OD1' ' A' ' 130' ' ' ASN . 10.1 t -124.07 -9.45 7.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.366 0.603 . . . . 0.0 110.663 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.78 54.6 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.727 -0.669 . . . . 0.0 113.062 175.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 133' ' ' THR . 4.7 p -149.23 157.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 67.8 m95 -88.57 117.9 27.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.2 -24.97 25.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 128' ' ' ASP . 21.2 pttp -142.78 154.83 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.548 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.479 ' HD3' HG22 ' A' ' 124' ' ' ILE . 11.8 ttm180 -121.87 112.99 19.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.529 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.505 ' CD ' ' HB3' ' A' ' 102' ' ' ASP . 51.7 tptt -77.14 123.67 26.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.5 tt -127.52 126.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.765 0.793 . . . . 0.0 111.212 -172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.9 m-85 -117.07 112.95 21.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.8 t -94.23 94.68 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -95.96 104.05 15.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.368 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.493 HG22 ' OD1' ' A' ' 118' ' ' ASP . 0.4 OUTLIER -85.1 151.68 23.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -55.58 142.4 33.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 110.865 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' A' ' 96' ' ' LYS . 21.8 t -90.4 144.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.182 -0.913 . . . . 0.0 112.402 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 8.8 mmmm . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.476 0.655 . . . . 0.0 112.349 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 88' ' ' VAL . 55.7 Cg_endo -71.66 146.45 48.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.297 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.31 -175.75 5.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.135 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.595 HG13 ' HG ' ' A' ' 52' ' ' LEU . 25.4 mt -102.08 117.95 60.25 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.716 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.78 168.29 21.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 112.109 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 4.2 mptp? -84.93 -17.11 38.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.379 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.83 125.66 30.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.783 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HB2' HE22 ' A' ' 38' ' ' GLN . 63.4 pttt -105.88 18.86 21.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -94.22 -7.58 41.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.762 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HZ2' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -117.43 -170.03 1.78 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.225 0.536 . . . . 0.0 111.108 -176.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.04 137.7 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.921 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.26 -34.55 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.359 0.599 . . . . 0.0 110.567 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 166.01 39.22 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 75.8 m-85 -107.86 139.3 42.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.266 0.533 . . . . 0.0 110.053 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -101.94 117.48 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 34.9 mt-10 -120.78 113.33 20.01 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.477 0.656 . . . . 0.0 110.907 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 47.9 mt -127.32 94.12 39.34 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.492 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 10.1 Cg_endo -53.19 -42.96 61.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.279 2.653 . . . . 0.0 113.3 -172.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -13.71 61.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.678 0.275 . . . . 0.0 111.737 -176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.51 9.5 23.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.347 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.72 27.77 16.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.203 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.3 mt -96.92 119.99 45.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.329 -175.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 26' ' ' LYS . 24.4 mmmt -141.02 42.7 1.81 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 11.6 mm-40 -102.66 149.7 37.0 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.338 -165.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.39 135.68 13.53 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.771 2.314 . . . . 0.0 112.54 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.45 123.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.206 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.86 121.82 61.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.538 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -79.94 161.13 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.917 2.412 . . . . 0.0 112.256 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.2 -164.35 26.21 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.128 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.93 2.64 8.12 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.682 2.921 . . . . 0.0 113.103 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.96 89.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.882 0.738 . . . . 0.0 110.829 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 p -119.14 157.46 50.81 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.801 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.72 -52.87 6.9 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.695 2.93 . . . . 0.0 114.529 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.43 75.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 111.598 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.585 HE22 ' HB2' ' A' ' 11' ' ' LYS . 37.1 tt0 -72.2 -37.68 69.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.93 0.395 . . . . 0.0 110.472 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.35 -18.06 60.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.98 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -81.7 -28.98 33.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -93.13 -35.79 13.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.673 0.273 . . . . 0.0 111.035 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.422 ' HA2' ' HG3' ' A' ' 71' ' ' GLN . . . -151.39 -137.86 2.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.208 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.25 162.32 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.2 m -131.43 172.32 12.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.905 0.383 . . . . 0.0 111.45 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 31' ' ' PRO . 26.2 m-85 -79.8 166.92 21.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.098 174.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.34 76.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.426 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -144.94 170.05 16.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.034 0.445 . . . . 0.0 110.962 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.09 -25.25 66.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.466 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.93 7.39 18.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 110.999 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.14 148.05 32.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -139.81 123.5 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.946 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.595 ' HG ' HG13 ' A' ' 7' ' ' ILE . 85.4 mt -74.26 -17.39 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.448 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.28 13.59 25.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.45 0.643 . . . . 0.0 110.529 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.45 178.08 4.69 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.561 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.5 pt20 -95.72 -22.21 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.705 0.288 . . . . 0.0 110.667 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.8 105.63 15.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.724 0.773 . . . . 0.0 110.355 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.69 133.92 68.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.746 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 3.0 p -124.69 121.87 35.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.149 0.5 . . . . 0.0 112.06 -173.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -114.07 132.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.1 130.84 45.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.68 126.95 6.82 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.897 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -111.81 76.23 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 m -60.82 134.36 57.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.79 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -145.09 150.75 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.137 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -53.02 -43.24 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 123.713 0.633 . . . . 0.0 112.402 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.84 10.76 3.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.162 -174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -131.21 76.41 76.3 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.15 -28.04 11.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.791 2.327 . . . . 0.0 113.527 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -140.2 73.5 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.475 0.655 . . . . 0.0 110.729 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.451 ' CE1' ' HB ' ' A' ' 73' ' ' THR . 1.4 p90 -132.39 155.09 49.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.538 -0.756 . . . . 0.0 108.972 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 10.3 mm100 16.49 -92.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.735 1.214 . . . . 0.0 114.226 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -116.7 97.11 5.81 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.677 0.275 . . . . 0.0 110.676 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.451 ' HB ' ' CE1' ' A' ' 70' ' ' TYR . 9.1 t -145.49 -39.34 0.24 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.219 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -91.58 26.67 2.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.706 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 125' ' ' THR . 19.6 mt -76.22 3.09 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.619 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -76.12 -21.08 57.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.189 0.518 . . . . 0.0 110.191 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.87 9.69 34.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.133 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.32 23.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.821 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -139.43 179.36 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.919 0.39 . . . . 0.0 111.109 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -66.77 -11.55 55.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.102 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.88 59.85 0.55 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.0 p -74.77 -15.12 60.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.455 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 56.52 88.64 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.866 0.729 . . . . 0.0 111.407 -172.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 56.1 t -88.81 124.56 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.909 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.1 m-85 -107.04 108.54 20.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.615 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 17.0 t80 -93.5 101.39 13.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.6 tptm -84.48 85.51 7.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.668 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' A' ' 5' ' ' PRO . 7.8 p -109.85 125.6 67.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.441 0.638 . . . . 0.0 111.064 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 5' ' ' PRO . . . 63.45 -94.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.494 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.61 11.82 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.668 0.27 . . . . 0.0 111.146 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.8 160.42 26.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.894 0.378 . . . . 0.0 111.005 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 m -124.01 98.01 5.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.081 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HG3' ' HB3' ' A' ' 86' ' ' PHE . 10.4 ptp180 -95.3 132.05 40.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.301 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 0.0 OUTLIER -100.57 140.22 35.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.878 0.371 . . . . 0.0 110.793 -174.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.602 ' OH ' ' HD3' ' A' ' 93' ' ' ARG . 74.5 m-85 -129.31 147.93 51.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.77 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.471 ' HD3' HG13 ' A' ' 147' ' ' VAL . 1.6 tptm -109.54 121.41 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 51.3 mtt -77.75 68.92 3.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 110.238 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -81.43 -11.74 59.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.924 -172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.7 m -135.43 99.4 4.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.991 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.97 128.01 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.4 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 11.6 ptm180 -167.75 179.2 4.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.203 -176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 4.5 p30 -125.12 153.25 43.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.05 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 110' ' ' VAL . 6.1 m -142.61 173.39 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.712 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.761 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -98.43 154.22 37.66 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.069 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.62 -15.5 49.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.623 2.215 . . . . 0.0 111.936 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.7 t -103.76 9.57 37.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.761 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 10.4 t70 -77.21 122.18 24.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.333 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.79 11.38 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.084 0.469 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -81.53 -46.91 13.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 103' ' ' VAL . 33.8 m -86.62 -8.33 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.211 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.0 mt -88.35 -3.78 58.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.103 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.05 160.89 25.66 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.83 106.89 3.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.025 0.441 . . . . 0.0 110.709 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.95 101.96 13.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.979 0.418 . . . . 0.0 111.347 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -169.76 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 173.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.74 -40.56 2.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.326 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -73.86 171.6 13.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.077 0.465 . . . . 0.0 110.766 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.16 -152.58 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.561 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -60.51 113.3 2.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -110.69 126.59 54.69 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.133 0.492 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.9 mt -90.47 116.57 28.5 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.518 HG21 HD13 ' A' ' 141' ' ' ILE . 25.4 m -98.01 102.77 14.62 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.1 mm? -95.78 101.8 13.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.8 97.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.005 0.431 . . . . 0.0 109.885 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.621 HG21 HD13 ' A' ' 75' ' ' LEU . 21.1 p -105.25 107.39 18.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.424 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 m -94.2 92.83 7.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.3 33.72 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.077 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 26.9 t70 -137.47 103.86 5.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -100.08 123.86 44.81 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.833 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -97.86 112.54 24.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.392 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.3 -31.06 70.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.087 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HZ1' ' HB3' ' A' ' 132' ' ' LYS . 5.3 mmmp? -70.8 -22.32 62.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.5 HG22 HG11 ' A' ' 135' ' ' VAL . 8.6 t -130.64 2.06 4.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 58.0 54.66 35.67 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.238 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 133' ' ' THR . 3.3 p -149.95 159.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 70.6 m95 -97.66 101.16 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.87 -66.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.428 -169.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -69.97 88.53 0.58 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.464 0.65 . . . . 0.0 110.568 -176.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.508 ' HG3' HG23 ' A' ' 103' ' ' VAL . 21.2 ptt180 -76.94 73.06 3.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.752 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.611 ' HE2' ' CZ ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -62.67 124.25 20.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.348 -174.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.518 HD13 HG21 ' A' ' 122' ' ' THR . 8.7 tt -114.21 137.88 46.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.592 -168.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.611 ' CZ ' ' HE2' ' A' ' 140' ' ' LYS . 43.7 m-85 -110.44 119.23 38.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.8 t -102.57 102.86 14.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.254 0.549 . . . . 0.0 109.649 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -101.79 111.95 24.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.8 m -86.47 136.47 33.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.023 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.07 120.33 7.31 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.507 0.504 . . . . 0.0 110.833 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.471 HG13 ' HD3' ' A' ' 96' ' ' LYS . 7.1 p -111.19 122.26 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.543 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.298 -173.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt . . . . . 0 C--O 1.233 0.188 0 CA-C-O 121.287 0.565 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.68 135.81 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.634 2.223 . . . . 0.0 111.933 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.537 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 4.1 pt20 -153.16 161.36 42.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.255 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.461 HG21 ' CB ' ' A' ' 31' ' ' PRO . 4.6 mp -93.56 102.46 7.71 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.7 Cg_exo -66.85 165.18 26.79 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 122.805 2.337 . . . . 0.0 112.878 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.877 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -81.33 -22.36 38.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.391 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -74.95 109.95 8.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 41.7 mttp -86.67 9.4 18.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.333 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -110.65 5.73 21.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.24 0.543 . . . . 0.0 110.139 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.608 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 66.1 mttm -92.89 173.0 7.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.766 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.9 t -109.7 117.29 54.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.043 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.63 -26.08 23.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.184 0.516 . . . . 0.0 110.343 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.83 -175.3 43.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.418 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 90.0 m-85 -126.53 140.13 52.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.089 0.444 . . . . 0.0 110.273 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.42 HG21 ' O ' ' A' ' 18' ' ' ILE . 7.2 tp -100.69 110.02 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.571 0.7 . . . . 0.0 109.539 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 42.5 mt-10 -113.34 113.14 24.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.195 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.57 92.07 48.49 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.43 -30.08 91.71 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.953 2.436 . . . . 0.0 112.221 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -70.06 -25.97 63.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.45 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.76 5.71 26.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.3 t0 61.86 20.7 11.68 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.911 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.429 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 68.4 mt -96.71 124.08 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.711 -173.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.429 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 3.9 mppt? -141.16 83.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.574 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 25.2 mm-40 -117.72 151.36 48.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.045 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.19 133.39 14.81 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.939 2.426 . . . . 0.0 111.911 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 43' ' ' VAL . 56.1 t -92.17 118.37 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.842 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.427 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 92.6 m-85 -95.54 114.28 63.6 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 38.2 Cg_endo -64.94 129.58 23.59 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.11 2.54 . . . . 0.0 112.179 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.24 179.43 43.91 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.648 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HG2' HG22 ' A' ' 35' ' ' THR . 62.5 Cg_endo -87.69 33.55 0.41 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.96 3.107 . . . . 0.0 112.451 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.55 32.04 11.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -62.26 138.14 96.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.341 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.95 -48.71 13.85 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.788 2.992 . . . . 0.0 114.109 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.48 -30.06 68.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.821 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.53 -41.49 79.84 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.6 mm? -77.51 -6.08 52.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -83.6 -14.36 52.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -126.32 -36.24 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -154.62 -167.67 16.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.388 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.493 HG13 ' HG2' ' A' ' 71' ' ' GLN . 10.8 m -88.97 153.4 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -139.51 169.01 18.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.62 151.79 26.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.371 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.47 62.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.36 156.93 20.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.0 111.862 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -97.18 -20.95 17.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -72.26 -12.27 61.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -75.08 150.2 38.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.837 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 m -130.86 159.62 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.501 HD12 HG22 ' A' ' 88' ' ' VAL . 84.8 mt -76.3 -20.97 56.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.812 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.92 3.72 36.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 110.246 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.88 156.79 38.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -27.24 65.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.242 0.544 . . . . 0.0 110.685 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.5 110.96 17.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.039 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.48 123.95 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -117.67 116.8 27.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.0 0.428 . . . . 0.0 110.84 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -104.77 122.35 57.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.48 139.28 30.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.37 163.76 32.64 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.378 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -142.75 150.91 40.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.698 0.285 . . . . 0.0 110.36 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 73' ' ' THR . 17.1 m -84.06 150.84 25.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.578 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 9.3 t80 -142.65 151.52 41.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.8 mt -81.82 -47.01 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 111.605 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.81 -43.69 97.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.978 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HD2' ' HB3' ' A' ' 70' ' ' TYR . 1.5 mmt180 -89.35 109.1 28.95 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.34 -11.08 17.54 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.584 2.189 . . . . 0.0 111.524 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -148.13 77.21 1.4 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.823 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.578 ' OH ' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -156.15 158.23 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.574 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 80.0 mt-30 41.44 -107.59 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.705 0.628 . . . . 0.0 112.463 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CD1' HD23 ' A' ' 75' ' ' LEU . 50.6 m-85 -131.69 91.09 2.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.479 ' HA ' HG22 ' A' ' 63' ' ' THR . 2.7 t -120.71 -53.82 2.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.331 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -87.01 18.47 3.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.53 0.681 . . . . 0.0 109.919 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD11 ' HE3' ' A' ' 97' ' ' MET . 28.8 tp -70.06 -7.84 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.671 -178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -8.29 56.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.91 -0.98 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.822 173.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.79 160.61 20.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.283 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -163.5 -169.78 2.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.695 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.5 ptmt -51.1 -36.69 41.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -170.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.56 58.53 0.7 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.314 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.3 m -81.96 -7.95 59.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.469 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 53.33 89.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.567 0.699 . . . . 0.0 111.439 -175.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -90.6 118.36 35.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 90.0 m-85 -103.9 121.26 42.74 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.009 0.433 . . . . 0.0 110.51 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 27.7 t80 -100.68 104.53 15.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.6 tptm -85.73 97.43 10.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.501 HG22 HD12 ' A' ' 52' ' ' LEU . 4.4 p -124.36 120.93 60.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -173.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.02 1.84 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.714 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -172.86 -28.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.979 0.512 . . . . 0.0 110.499 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.2 165.68 15.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.158 0.504 . . . . 0.0 111.565 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 m -123.57 110.74 15.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.616 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 9.1 mmm180 -87.1 132.19 33.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 83' ' ' MET . 0.0 OUTLIER -107.22 123.16 47.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.545 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 87.5 m-85 -118.46 145.39 45.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.485 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.58 ' HE3' HG11 ' A' ' 147' ' ' VAL . 1.3 tppp? -114.43 128.61 56.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.636 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 56.3 mtt -78.22 70.86 4.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.632 0.73 . . . . 0.0 110.636 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -87.09 -6.74 58.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.039 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 49.0 m -140.04 103.86 4.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.347 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 84.3 mt -122.6 130.06 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -158.95 173.31 16.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.883 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.942 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 1.5 p30 -133.03 124.06 26.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.254 0.549 . . . . 0.0 109.9 175.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.79 -172.2 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.953 -171.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.563 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -124.63 152.6 69.27 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.051 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.25 -13.01 33.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.487 2.125 . . . . 0.0 110.974 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -13.13 59.97 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.389 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.536 ' HB2' ' HE3' ' A' ' 104' ' ' LYS . 12.7 t70 -108.99 121.69 45.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.875 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.96 32.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -102.17 -18.47 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.137 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.07 -16.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.239 0.542 . . . . 0.0 111.533 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -98.65 22.04 10.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 111.242 -175.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 10.1 t70 -79.25 -154.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.954 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 39.0 mt-10 -65.52 92.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.05 30.14 4.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.637 0.732 . . . . 0.0 111.492 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.79 153.44 21.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 176.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.33 -21.23 7.32 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -90.12 -170.29 2.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.282 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.49 -164.67 1.21 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -65.03 104.89 0.94 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 110.11 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 13.1 pt20 -100.22 120.18 39.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.296 0.57 . . . . 0.0 110.526 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -85.61 110.32 19.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -94.65 99.64 11.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.555 -175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.1 mt -85.69 108.25 17.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.8 mt -91.46 99.34 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 m -96.52 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.262 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 80.0 m -94.9 93.95 7.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.499 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -113.73 9.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 23.4 t70 -78.95 -79.81 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.619 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 1.0 OUTLIER 62.48 88.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.779 -177.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 48.4 t-20 -85.81 98.04 10.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.0 -3.13 9.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.415 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 93.5 mttt -72.95 -33.02 65.64 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.126 0.489 . . . . 0.0 110.489 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.6 t -128.13 -15.96 4.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.542 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 26.26 45.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.375 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.35 138.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 25.0 m95 -85.09 105.02 15.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.99 -67.75 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.541 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 17.9 tppt? -65.25 117.03 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.411 0.624 . . . . 0.0 110.173 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -124.15 106.22 10.15 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.691 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.942 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 30.4 tttp -86.22 132.98 33.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.628 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.84 123.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.774 0.797 . . . . 0.0 110.607 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 89.4 m-85 -110.56 107.11 16.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.632 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 60.3 t -91.74 98.68 8.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.43 0.633 . . . . 0.0 109.534 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -97.5 97.58 9.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.813 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 7.3 m -73.96 140.67 45.7 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.52 114.77 2.62 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.676 0.75 . . . . 0.0 110.235 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.58 HG11 ' HE3' ' A' ' 96' ' ' LYS . 7.7 p -101.73 125.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.927 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.732 -178.117 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 31.4 mttp . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 31.9 Cg_endo -64.48 115.29 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.291 1.994 . . . . 0.0 109.264 165.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.407 ' HA ' HD23 ' A' ' 52' ' ' LEU . 3.4 pt20 -124.62 143.64 50.61 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.398 0.618 . . . . 0.0 110.98 -172.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 31' ' ' PRO . 9.6 mt -69.12 118.11 58.51 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.245 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.66 174.25 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.381 2.054 . . . . 0.0 111.721 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 9' ' ' LYS . 36.4 mmtm -92.07 36.83 0.98 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.694 0.759 . . . . 0.0 109.997 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' A' ' 13' ' ' LYS . 9.9 t70 -127.2 105.69 8.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.454 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.655 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 32.0 mttp -73.92 -6.86 49.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.324 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.0 t -95.57 -19.56 19.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.995 0.426 . . . . 0.0 110.265 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HG3' ' CG ' ' A' ' 10' ' ' ASP . 56.6 mttp -81.82 176.19 9.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.7 p -112.63 136.63 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.07 -31.29 14.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.372 0.606 . . . . 0.0 110.21 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.15 158.5 31.48 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.093 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -102.87 138.49 39.69 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.872 0.336 . . . . 0.0 110.122 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tp -104.03 120.25 53.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 36.8 mt-10 -128.07 112.06 14.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.548 0.689 . . . . 0.0 110.911 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 43.6 mt -120.91 95.49 48.91 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.446 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.35 -27.07 71.29 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 123.244 2.629 . . . . 0.0 112.402 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 35.2 t70 -67.3 -32.09 72.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.252 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -109.86 5.02 22.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.914 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t0 63.54 22.37 13.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.81 0.814 . . . . 0.0 110.71 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 59.4 mt -79.32 113.48 18.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.291 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -150.69 98.25 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.962 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.659 ' OE2' ' HA ' ' A' ' 70' ' ' TYR . 2.4 mt-10 -169.29 164.47 6.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 O-C-N 123.16 0.287 . . . . 0.0 110.989 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HB3' HG21 ' A' ' 14' ' ' VAL . 21.6 Cg_exo -66.58 148.91 84.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.1 2.534 . . . . 0.0 112.99 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.15 121.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.308 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 44' ' ' SER . 50.6 m-85 -93.44 137.76 23.29 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.26 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HA ' ' HD1' ' A' ' 45' ' ' PHE . 89.5 Cg_endo -92.15 153.52 3.18 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.71 2.273 . . . . 0.0 113.077 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.11 -174.48 25.15 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.861 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.655 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 94.7 Cg_endo -79.98 8.97 3.76 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.574 2.849 . . . . 0.0 113.142 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 61.71 68.82 0.68 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.614 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 33' ' ' PRO . 37.6 p -92.07 161.15 34.03 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.173 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -30.66 26.2 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.086 2.524 . . . . 0.0 112.589 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.43 -43.78 93.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.152 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 39.0 mm-40 -82.16 -40.14 22.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.259 -170.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.2 mm? -70.73 -7.73 46.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.36 0.6 . . . . 0.0 110.577 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -22.75 23.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.487 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 38' ' ' GLN . 7.0 ptm85 -105.14 -13.8 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.221 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . 162.84 -157.18 29.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.386 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.509 HG12 ' CE2' ' A' ' 72' ' ' PHE . 70.2 t -95.44 135.88 28.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.924 0.392 . . . . 0.0 110.05 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.1 m -124.65 170.34 11.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.547 ' HD1' ' HA ' ' A' ' 31' ' ' PRO . 26.8 m-85 -68.66 161.9 27.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.223 174.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.12 -27.87 21.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.577 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 2.2 mm-40 -117.83 145.04 44.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.516 0.674 . . . . 0.0 112.344 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.98 -6.98 59.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -90.27 -5.2 56.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.833 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB3' HD11 ' A' ' 7' ' ' ILE . 2.2 tp10 -48.8 139.44 9.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -143.65 132.42 22.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.68 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.428 HD22 HG13 ' A' ' 7' ' ' ILE . 2.6 mm? -75.98 -11.51 59.97 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.029 0.442 . . . . 0.0 110.813 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -89.17 -9.79 49.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.422 0.63 . . . . 0.0 110.218 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -89.14 170.71 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.495 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 4.7 pt20 -104.13 -0.87 28.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.74 0.305 . . . . 0.0 111.016 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.88 115.65 16.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.43 0.633 . . . . 0.0 109.92 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.21 129.27 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.275 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -108.11 120.78 43.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.344 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.5 mt -111.53 115.77 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.74 116.49 30.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 110.871 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.77 159.99 13.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.929 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -154.76 131.19 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.428 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 2.4 m -65.56 113.01 3.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 41.4 t80 -90.22 128.3 36.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.3 mt -58.97 -37.75 69.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.228 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.468 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 9.3 m-20 -91.95 8.28 38.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.908 0.385 . . . . 0.0 111.372 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 34.2 mtt180 -121.4 97.2 47.4 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.776 0.322 . . . . 0.0 110.985 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.17 -8.35 20.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.614 2.209 . . . . 0.0 111.694 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -154.26 82.3 1.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.659 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.3 p90 -118.37 -164.2 1.01 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.171 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -48.96 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.297 0.373 . . . . 0.0 111.765 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 43' ' ' VAL . 18.8 m-85 -103.21 68.48 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.694 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -92.6 -42.17 9.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.338 0.589 . . . . 0.0 110.355 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.7 t30 -114.24 33.31 5.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.42 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -59.2 -27.21 65.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -177.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -9.92 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.78 -4.74 58.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.124 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -72.18 -174.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 5.9 ptpp? -167.02 -179.0 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.979 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.6 ptpt -53.99 -48.76 70.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.139 -176.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.5 54.99 0.57 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.438 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -73.64 -11.59 60.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.327 -0.436 . . . . 0.0 111.203 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.502 ' HE3' ' HB2' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 54.36 83.84 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.433 0.635 . . . . 0.0 111.801 -176.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.5 t -85.41 111.42 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.827 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -99.8 113.67 26.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 2.1 t80 -102.4 108.21 19.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.593 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.43 92.68 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.974 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 HG23 ' CG ' ' A' ' 91' ' ' GLU . 4.8 m -104.71 117.56 50.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.44 -83.16 0.2 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.572 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -152.74 12.17 0.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.722 0.296 . . . . 0.0 110.823 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.414 ' CG ' HG23 ' A' ' 88' ' ' VAL . 12.6 pt-20 -109.43 140.11 43.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.059 0.456 . . . . 0.0 110.291 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.6 m -100.62 109.71 21.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 16.5 mmt85 -88.7 142.03 28.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.54 173.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.502 ' HB2' ' HE3' ' A' ' 83' ' ' MET . 0.4 OUTLIER -118.67 130.73 56.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.9 0.381 . . . . 0.0 110.542 177.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 81.3 m-85 -127.83 143.85 51.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -107.07 137.32 45.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.743 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.0 mmt -83.87 81.95 8.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 110.14 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -92.2 -36.7 13.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.63 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 6.9 m -109.26 97.04 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.491 HD13 ' HB3' ' A' ' 97' ' ' MET . 75.9 mt -117.68 117.16 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.896 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -168.99 -159.81 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 112.068 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -109.89 153.32 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.818 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.59 ' HB ' ' OD2' ' A' ' 107' ' ' ASP . 10.6 m -135.38 166.48 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 167.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 106' ' ' THR . 0.0 OUTLIER -147.62 161.21 36.38 Favored Pre-proline 0 C--O 1.22 -0.45 0 O-C-N 122.334 -0.229 . . . . 0.0 111.32 -169.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 34.8 Cg_endo -65.08 11.75 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.717 2.278 . . . . 0.0 113.05 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.7 t -129.8 8.79 5.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.59 ' OD2' ' HB ' ' A' ' 103' ' ' VAL . 1.1 p30 -84.2 158.23 21.37 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.536 ' HA ' HD22 ' A' ' 111' ' ' LEU . 29.1 m -112.58 18.73 7.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.198 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 -45.36 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.924 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.81 -11.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.654 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -106.39 12.3 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.703 0.287 . . . . 0.0 111.27 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.6 169.27 9.82 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.519 ' CG ' ' HE3' ' A' ' 115' ' ' LYS . 11.2 pt-20 -92.41 20.25 6.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 52.13 119.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.617 1.167 . . . . 0.0 113.724 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.519 ' HE3' ' CG ' ' A' ' 113' ' ' GLU . 18.9 mmtp -109.48 147.31 33.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.586 -171.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.92 34.27 11.13 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.896 -1.502 . . . . 0.0 115.23 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -122.59 161.89 22.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.837 0.818 . . . . 0.0 112.016 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -93.98 -158.14 0.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -62.09 110.04 1.47 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -116.67 138.81 51.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.26 0.552 . . . . 0.0 112.124 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.4 mt -97.73 112.26 24.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 169.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m -96.26 103.85 15.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.287 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.7 mt -91.11 106.03 18.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.79 100.01 9.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 6.9 m -91.0 107.09 18.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.138 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.8 m -103.89 86.12 2.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -111.18 -2.15 15.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.576 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 36.4 t70 -104.8 94.37 5.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.488 0.661 . . . . 0.0 109.899 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.537 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 92.0 t80 -101.01 124.05 46.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.188 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -91.37 110.28 21.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.7 mt-10 -72.39 -21.65 61.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.847 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 132' ' ' LYS . 43.8 mmtm -72.51 -24.57 61.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.422 HG22 HG13 ' A' ' 135' ' ' VAL . 9.6 t -136.62 4.01 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.304 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.53 48.79 79.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.17 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.422 HG13 HG22 ' A' ' 133' ' ' THR . 4.4 p -137.77 159.22 34.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.537 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 37.6 m95 -100.64 112.74 25.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.576 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 55.8 mt-10 -80.88 -60.02 2.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.932 0.396 . . . . 0.0 111.04 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 47.4 mmtm -88.94 101.52 14.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.177 0.513 . . . . 0.0 110.262 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.526 ' HB2' HG21 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -100.63 105.52 16.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 18.7 tptm -76.63 120.62 22.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.6 tt -118.98 122.55 69.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 122.037 0.922 . . . . 0.0 111.66 -172.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 24.5 m-85 -116.95 106.75 13.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.135 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.0 t -100.76 103.98 15.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.234 0.54 . . . . 0.0 110.259 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.484 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.995 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.7 m -93.59 138.81 31.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -57.83 125.03 21.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.042 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 96' ' ' LYS . 2.7 t -85.75 146.38 6.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.775 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.68 179.024 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.507 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 36.9 Cg_endo -63.09 106.64 0.56 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.15 2.567 . . . . 0.0 112.878 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -120.64 137.9 54.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.776 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.565 ' CD1' ' HG ' ' A' ' 52' ' ' LEU . 4.1 mp -76.5 125.24 87.71 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.71 153.51 54.0 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.116 1.877 . . . . 0.0 110.369 170.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -86.39 14.11 7.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.476 0.655 . . . . 0.0 111.215 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.407 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 27.4 t0 -100.71 102.43 13.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.553 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 24.5 pttm -81.27 0.13 38.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.446 -172.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.2 m -90.32 3.91 52.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 87.5 mttt -103.83 -176.53 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.348 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.79 129.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.049 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.45 -29.93 17.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.78 36.57 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.56 143.32 34.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 117.128 0.464 . . . . 0.0 109.758 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.545 0.688 . . . . 0.0 110.265 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 38.4 mt-10 -115.78 116.54 28.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.922 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.56 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 46.0 mt -133.87 91.62 24.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.52 -34.51 92.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.951 2.434 . . . . 0.0 111.871 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.77 -25.62 68.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.292 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 78' ' ' ALA . . . -114.83 11.37 16.68 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.011 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 58.41 29.67 18.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.773 0.797 . . . . 0.0 110.754 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.629 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 58.9 mt -98.37 118.49 44.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.232 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 5.5 mtmt -150.19 81.91 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.282 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 40.9 mt-10 -149.21 162.47 28.84 Favored Pre-proline 0 N--CA 1.465 0.316 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 60.3 Cg_endo -72.43 148.16 48.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.072 2.515 . . . . 0.0 113.493 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.47 130.59 62.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.016 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 44' ' ' SER . 33.5 m-85 -97.11 137.96 21.25 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.495 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 73.0 Cg_endo -90.15 -172.31 0.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.962 2.441 . . . . 0.0 112.533 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.06 -174.27 16.83 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.453 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.84 12.39 3.02 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.926 3.084 . . . . 0.0 113.081 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.55 74.67 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.193 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.692 HG21 ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -95.83 147.44 33.0 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.087 -176.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.692 ' HD2' HG21 ' A' ' 35' ' ' THR . 81.6 Cg_exo -40.65 -66.83 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.751 2.967 . . . . 0.0 114.46 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -26.63 55.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.762 0.315 . . . . 0.0 111.663 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.553 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 24.8 tp60 -66.54 -37.89 85.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.118 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.6 tp -74.3 -38.7 63.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.772 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -67.93 -9.8 48.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.19 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.59 -28.48 62.82 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 110.415 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.29 -88.7 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.257 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' HA3' ' A' ' 61' ' ' GLY . 34.0 m -137.02 157.84 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 21.9 p -150.72 156.07 40.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.013 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.495 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 21.2 m-85 -70.18 155.13 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.784 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.09 73.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.302 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -152.24 177.7 10.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.434 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.59 -28.2 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 -172.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -76.87 -11.06 59.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.083 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.404 ' OE1' ' HA ' ' A' ' 50' ' ' GLU . 5.1 tp10 -61.24 126.26 26.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 23.5 m -112.39 138.24 49.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.791 0.329 . . . . 0.0 111.441 -173.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.565 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 77.6 mt -67.96 -25.52 65.48 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.57 17.47 23.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.464 0.65 . . . . 0.0 110.355 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.726 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -88.96 -177.21 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.464 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -16.93 58.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.197 0.522 . . . . 0.0 110.08 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.94 142.61 29.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.18 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' HD21 ' A' ' 121' ' ' LEU . 5.3 mp -129.07 105.29 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.727 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.548 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 4.5 m -89.94 113.1 24.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.464 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.0 mt -107.13 111.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.991 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.435 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -96.52 121.93 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA3' HG12 ' A' ' 43' ' ' VAL . . . -121.11 161.22 15.22 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.359 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -123.18 130.32 52.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.611 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 12.0 m -71.15 136.95 48.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.138 -177.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.16 136.63 37.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.328 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.1 mt -90.99 -46.77 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.114 0.483 . . . . 0.0 110.21 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 17.7 t70 -75.18 -39.69 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.399 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -92.34 109.04 35.44 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.92 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 94.1 Cg_endo -83.93 -0.35 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.878 2.385 . . . . 0.0 111.476 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -129.96 71.73 1.46 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.977 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.611 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 10.4 p90 -119.38 -175.41 2.93 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -48.82 -66.69 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.426 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 23.1 m-30 -103.1 31.59 4.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -170.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -49.97 74.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.268 0.556 . . . . 0.0 111.429 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 67.0 t30 -102.51 25.52 8.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.231 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.11 -19.01 64.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.209 0.528 . . . . 0.0 110.901 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -68.87 -20.47 64.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.515 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.52 9.24 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.108 0.48 . . . . 0.0 110.308 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.492 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . . . -89.3 122.71 32.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.066 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 6.3 mmmm -101.58 -164.41 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.283 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -68.5 -21.94 64.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.22 50.88 0.87 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.574 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -70.3 -7.62 43.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.806 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 87.1 mmm 44.66 88.38 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.665 0.745 . . . . 0.0 112.029 -170.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -85.58 124.55 40.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.2 m-85 -109.13 112.99 25.46 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.27 109.56 21.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -91.28 85.51 5.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.706 -175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' ' HG2' ' A' ' 91' ' ' GLU . 11.1 m -111.54 131.04 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.877 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' ASN . . . 59.14 22.1 54.77 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.035 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 29.3 m-80 73.53 14.48 4.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.479 0.711 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 6.2 pt-20 -97.14 179.4 4.93 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -135.28 117.62 15.66 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.428 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 94.5 mtt180 -116.01 133.42 56.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -101.35 131.27 47.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.293 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.545 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 84.2 m-85 -130.76 146.67 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.869 -178.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.806 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.55 132.42 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.532 ' SD ' ' HB1' ' A' ' 144' ' ' ALA . 21.2 mmt -75.53 68.15 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 110.226 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -84.46 -9.58 58.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.431 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 67.4 m -136.84 93.97 2.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.36 0.6 . . . . 0.0 111.183 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.16 118.21 56.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.543 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.9 ptt180 -149.35 165.19 32.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.244 0.545 . . . . 0.0 111.683 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.02 109.12 15.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.933 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.639 HG22 HG11 ' A' ' 110' ' ' VAL . 19.4 m -108.24 168.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.49 0.662 . . . . 0.0 111.683 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HD3' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -138.52 170.38 10.42 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.934 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.77 -26.81 58.77 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.065 1.843 . . . . 0.0 110.175 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -72.64 -12.42 61.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.878 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -91.67 128.8 37.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.477 ' HA ' HD11 ' A' ' 111' ' ' LEU . 17.5 m -113.28 26.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.805 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -109.2 -9.87 15.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.684 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 103' ' ' VAL . 15.9 m -91.62 -8.74 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -112.58 9.94 19.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.666 0.746 . . . . 0.0 109.381 175.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -89.2 160.81 16.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.298 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -50.45 125.93 13.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.489 . . . . 0.0 111.635 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -75.65 129.31 36.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.6 mptt -69.69 157.77 36.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.932 -172.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.04 56.81 1.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.441 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -79.26 -174.35 4.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.023 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.09 -163.78 0.84 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.27 121.63 11.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.92 135.07 54.36 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.158 0.504 . . . . 0.0 110.801 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -92.73 113.98 26.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.536 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.7 m -94.41 92.23 7.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.901 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 27.5 mt -83.47 104.56 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 110.044 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 60' ' ' ALA . 24.3 mt -94.52 101.04 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.074 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -97.11 96.4 8.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.082 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.459 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 62.5 m -96.01 89.25 5.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.93 -14.11 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.17 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 21.1 t70 -110.6 94.77 5.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.561 0.696 . . . . 0.0 109.832 -176.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.582 ' CZ ' ' HA2' ' A' ' 134' ' ' GLY . 94.1 t80 -107.55 124.5 50.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.485 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -90.88 101.96 14.72 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.22 -5.38 17.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.429 -174.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -38.76 68.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.874 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 135' ' ' VAL . 6.9 t -149.81 -26.48 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.582 ' HA2' ' CZ ' ' A' ' 129' ' ' TYR . . . 120.83 36.8 0.75 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.824 -1.179 . . . . 0.0 112.858 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 133' ' ' THR . 93.0 t -104.39 124.05 58.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.459 ' CE3' ' HB3' ' A' ' 126' ' ' CYS . 33.3 m95 -84.86 93.31 8.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.496 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 16.2 mm-40 -60.22 -68.26 0.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.863 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.42 ' HE3' ' C ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -91.76 103.86 16.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 -177.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.446 ' O ' HG21 ' A' ' 103' ' ' VAL . 84.1 mtm180 -105.44 95.65 5.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.925 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.835 ' HD3' ' HE1' ' A' ' 142' ' ' PHE . 2.4 ttmp? -74.54 130.39 39.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.959 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.543 ' CG2' ' HG3' ' A' ' 101' ' ' ARG . 12.8 tt -123.44 120.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.932 0.872 . . . . 0.0 111.025 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.835 ' HE1' ' HD3' ' A' ' 140' ' ' LYS . 8.4 m-85 -106.33 104.07 13.69 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.522 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 61.9 t -98.72 109.61 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.485 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.532 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -104.7 103.34 12.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.524 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -83.85 142.62 30.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.684 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -55.73 133.1 50.65 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.251 -175.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 7.3 p -111.85 160.91 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.259 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.776 -0.63 . . . . 0.0 110.008 -177.065 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 C--O 1.236 0.353 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.71 125.19 15.53 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.695 2.263 . . . . 0.0 112.145 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -147.24 162.2 39.4 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.403 ' N ' HD13 ' A' ' 7' ' ' ILE . 3.4 mp -86.78 127.47 59.98 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 0.0 110.486 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.44 -178.76 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.75 2.3 . . . . 0.0 112.666 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.711 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.4 103.8 7.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.46 -174.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 36.1 mtmm -88.7 13.38 12.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.623 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.8 t -98.26 -11.79 22.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.744 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -105.03 178.18 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 -178.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.99 131.55 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.66 16.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.235 0.541 . . . . 0.0 110.443 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.91 38.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 90.9 m-85 -112.62 138.47 49.36 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.392 0.596 . . . . 0.0 110.858 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.435 HG21 ' O ' ' A' ' 18' ' ' ILE . 7.5 tp -106.78 105.17 18.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 122.167 0.984 . . . . 0.0 109.814 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -111.96 113.5 25.84 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.965 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.3 mt -125.61 95.94 39.41 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.788 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.66 -28.78 77.05 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.796 2.331 . . . . 0.0 111.688 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 27.4 t0 -71.27 -22.24 61.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.039 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.76 5.29 17.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.936 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.8 t70 64.62 24.24 12.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.455 0.645 . . . . 0.0 110.535 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.401 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 81.5 mt -96.23 126.29 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.928 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.4 mppt? -138.77 43.77 2.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 15.9 mm-40 -98.58 154.09 37.66 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.0 Cg_exo -78.5 145.0 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.269 2.646 . . . . 0.0 112.083 175.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.68 115.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -97.29 116.69 65.99 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.881 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 30.1 Cg_endo -63.37 140.67 77.86 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.416 2.077 . . . . 0.0 111.744 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.38 -179.47 41.41 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.356 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.531 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 12.9 Cg_endo -91.82 29.02 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.774 2.983 . . . . 0.0 112.439 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 58.47 50.0 9.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.557 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 p -68.43 150.6 97.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.93 -55.05 4.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.211 2.607 . . . . 0.0 113.099 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.89 -27.06 67.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.377 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -65.97 -46.05 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.327 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -78.53 -4.32 48.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.391 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.58 -18.82 16.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.141 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -102.08 -26.07 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 110.813 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -171.18 35.4 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.08 148.07 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.08 0.44 . . . . 0.0 110.005 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -137.04 -171.95 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 110.693 -174.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 33.3 m-85 -94.94 169.72 9.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.13 84.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 110.436 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -141.82 170.43 15.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.561 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.57 -7.61 54.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.398 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.75 13.54 30.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.644 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 8.0 mm-40 -74.3 169.34 17.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.355 0.598 . . . . 0.0 111.578 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.3 m -138.37 139.9 39.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 96.2 mt -77.45 -13.44 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.632 -176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.77 14.89 23.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.715 0.769 . . . . 0.0 110.103 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' HG12 ' A' ' 57' ' ' ILE . 11.3 t70 -69.29 171.68 8.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.962 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 120' ' ' GLN . 1.1 tm0? -95.62 -26.0 15.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.441 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.447 ' HA ' ' HG3' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -134.09 56.39 1.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.144 0.973 . . . . 0.0 111.106 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.465 HG12 ' HB3' ' A' ' 54' ' ' ASP . 49.9 mt -62.1 127.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.105 -173.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.451 ' HB3' HD13 ' A' ' 124' ' ' ILE . 19.8 m -105.75 109.43 21.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.288 -173.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.01 118.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.034 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.1 133.07 36.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.735 0.302 . . . . 0.0 111.002 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.12 163.91 26.96 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.162 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -139.56 158.77 43.57 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 73' ' ' THR . 21.5 p -102.78 158.58 16.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.899 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -134.57 135.39 42.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.12 -39.92 81.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.154 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.19 -4.31 52.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 51.1 mtt85 -132.72 90.58 32.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.247 0.546 . . . . 0.0 111.422 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.634 ' O ' ' HB ' ' A' ' 73' ' ' THR . 7.6 Cg_exo -73.64 -23.7 16.68 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.624 2.883 . . . . 0.0 113.244 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -124.64 27.1 6.99 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.612 ' CE2' ' HB2' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -92.18 -16.03 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.155 0.979 . . . . 0.0 109.075 177.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 73' ' ' THR . 2.2 mt-30 -164.21 -154.54 0.25 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.292 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 123' ' ' LEU . 19.6 m-85 -74.22 26.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.634 ' HB ' ' O ' ' A' ' 68' ' ' PRO . 21.7 m -60.26 -45.9 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.488 . . . . 0.0 111.028 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -96.43 12.62 30.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.181 0.515 . . . . 0.0 110.675 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.27 -12.6 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.224 0.535 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.28 -12.86 61.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.452 176.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -89.79 -4.6 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.676 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.452 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -75.21 149.64 38.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.234 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 2.6 mppt? -111.12 -169.37 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 174.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.5 ptmm? -76.43 -11.8 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.297 0.57 . . . . 0.0 111.289 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.19 62.18 0.64 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.906 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -81.06 -9.63 59.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.433 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 51.01 83.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.489 0.662 . . . . 0.0 111.82 -174.376 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 80.8 t -85.57 128.8 38.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.939 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -113.57 107.51 15.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -97.54 115.12 27.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.855 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.8 mmtp -93.39 97.33 10.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.237 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.05 130.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.849 0.357 . . . . 0.0 110.547 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.83 30.24 74.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.994 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 68.35 4.49 4.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.313 0.645 . . . . 0.0 111.351 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -92.34 150.63 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.869 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.3 m -109.79 112.64 24.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.829 0.347 . . . . 0.0 110.332 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 146' ' ' GLU . 21.7 mmm180 -105.03 133.22 50.18 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 3.5 mptt -102.35 130.74 49.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 95.8 m-85 -123.35 144.01 49.73 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.793 0.33 . . . . 0.0 110.407 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -113.27 131.56 55.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.8 mmt -74.75 64.38 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.097 0.475 . . . . 0.0 110.663 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -80.22 -13.84 58.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.709 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.8 m -134.1 99.13 4.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.012 0.434 . . . . 0.0 110.258 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 97' ' ' MET . 70.0 mt -117.71 131.42 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.743 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -167.95 -175.29 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.912 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 8.6 p-10 -141.89 125.6 16.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.731 HG21 ' HG3' ' A' ' 139' ' ' ARG . 24.5 m -112.07 173.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.137 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.86 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -122.68 165.04 23.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.68 -16.08 46.17 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.498 2.132 . . . . 0.0 111.746 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 t -109.65 12.94 24.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.342 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 11.8 t70 -93.65 148.47 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.566 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 34.0 m -111.41 0.43 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -170.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.7 -12.79 61.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 110.689 -177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.478 HG12 HG23 ' A' ' 103' ' ' VAL . 22.7 m -94.78 -8.93 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.163 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 4.2 pp -99.15 -9.57 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.758 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -82.67 161.5 22.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.89 128.15 34.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.351 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -85.83 133.97 33.95 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -69.53 160.63 31.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.199 0.523 . . . . 0.0 112.411 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.81 59.93 0.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.327 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.39 176.73 0.76 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.238 0.542 . . . . 0.0 111.016 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -78.76 -155.8 0.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -63.47 103.47 0.52 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 56' ' ' ASN . 18.6 pt20 -101.4 116.6 33.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.33 0.586 . . . . 0.0 109.854 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 tp -84.41 100.91 11.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.2 m -88.95 100.37 13.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.5 mt -87.25 109.04 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.7 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 58' ' ' SER . 22.8 mt -97.84 104.7 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 22.1 m -95.27 97.37 9.81 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.036 0.446 . . . . 0.0 110.185 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 47.9 m -86.96 102.17 14.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.33 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.53 -170.24 3.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.172 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 31.1 t70 57.4 83.95 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.797 0.808 . . . . 0.0 110.637 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.502 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 80.8 t80 -94.65 124.52 38.74 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.081 -174.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -95.67 99.94 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.502 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.0 mt-10 -58.84 -39.92 82.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.819 -171.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -70.52 -14.06 62.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 135' ' ' VAL . 2.1 t -130.98 -7.04 3.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.292 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.82 35.16 72.63 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.623 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 133' ' ' THR . 33.3 m -116.8 155.03 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 117.315 0.557 . . . . 0.0 111.147 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -96.6 100.28 11.86 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.24 -16.93 60.94 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 23.6 ttmm -124.91 86.62 2.58 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.081 0.943 . . . . 0.0 110.928 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.731 ' HG3' HG21 ' A' ' 103' ' ' VAL . 30.1 ptt180 -92.98 86.92 5.58 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.218 172.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.912 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 36.2 tttp -70.25 139.32 52.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.773 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.53 124.5 59.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.932 0.873 . . . . 0.0 111.144 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.58 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 27.4 m-85 -114.48 103.75 11.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.601 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 47.3 t -94.3 96.74 6.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.414 0.626 . . . . 0.0 109.804 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.536 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -93.05 105.91 17.94 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.06 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.7 m -81.35 140.44 34.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.096 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 93' ' ' ARG . 36.4 tt0 -61.27 132.31 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.406 0.622 . . . . 0.0 111.879 -175.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 2.2 t -104.61 170.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.687 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.829 177.387 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.576 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 77.8 Cg_exo -51.36 118.09 4.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.455 2.77 . . . . 0.0 113.258 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.14 168.01 25.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.339 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.533 HG23 ' HB3' ' A' ' 31' ' ' PRO . 3.9 mp -91.66 112.33 53.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.44 165.01 18.72 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.532 2.155 . . . . 0.0 111.818 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -95.97 1.29 52.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.359 0.599 . . . . 0.0 109.835 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.88 109.88 14.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.439 173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -84.66 62.31 7.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.051 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 -29.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.576 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 2.8 mmpt? -54.24 154.59 4.31 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.537 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.37 111.93 32.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 164.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB1' ' HG3' ' A' ' 31' ' ' PRO . . . -76.39 -38.23 56.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.62 165.84 32.63 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.511 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 64.5 m-85 -112.87 132.57 55.24 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -96.74 107.92 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.876 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -112.9 108.15 16.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.887 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 HG12 HG11 ' A' ' 84' ' ' VAL . 23.0 mt -125.4 95.4 41.06 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.233 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.39 -16.2 53.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.797 2.331 . . . . 0.0 112.319 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 38.9 t70 -83.63 -21.67 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.443 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.12 11.24 15.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.329 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.69 19.6 11.88 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.078 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.2 mt -93.57 122.09 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.342 -174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -139.48 49.2 1.82 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.858 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 12.3 mm-40 -116.55 162.52 26.36 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.066 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.34 164.19 14.8 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.903 2.402 . . . . 0.0 113.269 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.14 136.73 59.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.199 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.29 133.49 20.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.761 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 23.9 Cg_exo -67.76 134.17 31.72 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.186 2.591 . . . . 0.0 111.808 168.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.13 144.08 4.1 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.029 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.96 54.44 3.12 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.297 2.665 . . . . 0.0 112.241 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 58.25 42.39 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.776 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.12 127.01 93.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.251 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -52.53 -39.64 74.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.289 2.659 . . . . 0.0 113.299 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.43 -12.52 61.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -101.21 -29.51 12.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.79 -18.24 48.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.123 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -81.96 -15.41 53.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.025 0.44 . . . . 0.0 110.379 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -114.01 -25.02 8.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.875 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.46 -138.05 2.35 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.635 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 72' ' ' PHE . 52.4 t -121.18 138.83 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.815 0.341 . . . . 0.0 110.649 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 t -119.52 169.3 10.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.917 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.761 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 54.7 m-85 -71.84 173.01 8.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.779 0.323 . . . . 0.0 110.361 173.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.14 -61.07 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.517 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.48 115.74 18.63 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 68.32 0.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.742 1.276 . . . . 0.0 111.092 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -146.07 2.6 0.9 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.268 171.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.66 160.52 29.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.146 -175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 41.5 m -141.86 159.45 42.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.506 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.482 ' HG ' HD13 ' A' ' 7' ' ' ILE . 96.5 mt -85.76 -17.11 36.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.406 0.622 . . . . 0.0 109.895 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -86.25 -1.98 57.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.213 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 21.4 t0 -89.57 157.91 17.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.54 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.72 -25.51 26.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.963 0.411 . . . . 0.0 110.292 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.94 115.0 26.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.486 0.66 . . . . 0.0 111.657 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.81 127.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 m -121.95 120.52 34.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.56 126.69 68.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.63 104.48 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.017 0.437 . . . . 0.0 110.68 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.53 166.75 18.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.462 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -155.94 -179.6 8.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 p -117.8 166.98 11.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.303 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 5.1 m-85 -124.16 144.52 49.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.221 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.68 -32.06 28.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.193 0.52 . . . . 0.0 111.206 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -96.97 -6.03 36.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.75 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 10.5 mmt180 -112.8 95.43 33.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.24 -8.36 19.72 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.397 2.065 . . . . 0.0 111.58 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -153.41 83.66 1.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.092 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.441 ' CE2' ' HB ' ' A' ' 73' ' ' THR . 4.7 p90 -142.7 -170.16 3.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.858 ' HG2' ' HB3' ' A' ' 27' ' ' GLU . 77.5 mt-30 -32.81 -69.78 0.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.251 1.02 . . . . 0.0 113.621 -175.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.409 ' CD2' HG12 ' A' ' 43' ' ' VAL . 4.9 m-30 -124.13 111.87 16.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.441 ' HB ' ' CE2' ' A' ' 70' ' ' TYR . 14.9 t -164.59 -40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.379 0.609 . . . . 0.0 110.236 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -96.75 21.08 9.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.712 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.9 tp -65.98 -18.79 65.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -8.71 56.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.893 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.27 -10.64 51.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.94 0.4 . . . . 0.0 110.704 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.521 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -73.29 156.18 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.109 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 97' ' ' MET . 32.8 mttp -129.79 -179.79 5.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.434 -176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -61.71 -28.84 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.114 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.21 42.85 1.72 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.466 -0.873 . . . . 0.0 110.993 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.9 t -57.25 -22.04 38.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.313 0.645 . . . . 0.0 112.048 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.23 87.13 0.06 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.747 0.784 . . . . 0.0 111.49 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.2 t -90.1 136.58 23.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.035 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.8 107.27 14.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.101 0.477 . . . . 0.0 109.926 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -94.7 105.3 17.23 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppp? -84.03 106.65 15.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.604 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 10.6 m -125.4 112.43 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 0.0 111.481 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.08 -94.71 0.18 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.838 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -129.94 8.31 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 110.238 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.87 138.56 40.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.411 ' OG1' ' HE2' ' A' ' 87' ' ' LYS . 43.7 m -107.25 93.19 4.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.578 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD2' ' OE1' ' A' ' 146' ' ' GLU . 12.8 mmt180 -83.07 118.28 23.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.015 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 3.4 mptt -91.82 132.58 36.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 96.1 m-85 -124.7 144.81 50.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.099 0.476 . . . . 0.0 110.961 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.1 OUTLIER -113.52 128.05 56.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.061 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.62 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.1 mmt -78.7 60.43 2.75 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -77.05 -23.71 52.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.441 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.541 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 71.1 m -121.02 102.05 8.08 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 110.874 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.82 121.86 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.524 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -142.71 -172.35 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.471 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.96 141.14 46.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.512 ' HB ' ' OD2' ' A' ' 107' ' ' ASP . 20.8 m -124.14 167.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.045 0.45 . . . . 0.0 111.003 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.934 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.13 163.09 53.68 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.281 -171.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 137' ' ' GLU . 60.2 Cg_endo -72.33 20.94 0.29 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.434 2.089 . . . . 0.0 112.124 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.9 t -156.47 8.87 0.22 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.934 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 2.3 p30 -78.98 176.92 9.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.157 0.503 . . . . 0.0 111.206 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.489 ' HA ' HD12 ' A' ' 111' ' ' LEU . 23.1 m -123.69 24.31 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.235 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.22 5.11 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.82 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.7 m -108.56 -13.95 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.974 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -108.06 1.85 22.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -89.94 174.33 7.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.19 107.3 8.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.579 ' HB3' HE22 ' A' ' 120' ' ' GLN . 56.0 mm-40 -81.83 69.37 8.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.649 0.738 . . . . 0.0 110.564 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -115.04 -165.6 1.04 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.468 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.49 -26.26 24.77 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.275 -0.488 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -125.13 -173.2 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -153.85 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 17.1 mmtm -54.56 123.1 12.07 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 114' ' ' GLN . 12.6 pt20 -117.29 120.09 37.16 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.1 mt -78.18 99.19 6.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.6 m -85.78 96.9 9.89 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.71 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 26.5 mt -94.92 101.37 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.943 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.36 93.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.0 m -93.9 111.27 22.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.144 0.497 . . . . 0.0 110.138 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 58.2 m -95.45 109.5 21.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -136.94 89.22 2.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.994 0.902 . . . . 0.0 110.594 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 9.1 p-10 -153.9 -51.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.194 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.5 83.52 0.1 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.023 0.827 . . . . 0.0 110.772 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 38.4 t-20 -77.84 94.13 4.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.25 -20.76 63.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.144 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.478 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 30.6 mmmt -63.3 -30.47 71.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.492 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 t -129.68 -23.77 2.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.164 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 60.75 1.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.6 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.5 p -159.05 159.67 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -99.05 110.75 23.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 41.8 mt-10 -90.9 -59.83 2.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.709 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 53.2 mmtt -80.81 102.26 9.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.885 0.85 . . . . 0.0 110.987 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.493 ' HB2' HG23 ' A' ' 103' ' ' VAL . 74.1 mtt180 -114.11 102.07 9.82 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.598 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -83.2 122.29 28.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 5.0 tt -118.92 125.36 74.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.59 -172.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.62 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.2 m-85 -109.15 124.54 50.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.534 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.7 t -110.97 109.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.085 0.469 . . . . 0.0 110.318 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.61 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -107.65 120.03 41.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.351 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.6 m -89.86 143.1 27.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.122 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.488 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 31.9 tt0 -61.59 128.59 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.321 0.582 . . . . 0.0 111.239 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.491 HG21 ' HE3' ' A' ' 96' ' ' LYS . 2.3 t -110.92 170.14 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.422 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 148' ' ' LYS . 37.1 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.263 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.1 mtmt . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.851 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 19.0 Cg_endo -58.38 124.12 15.13 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.975 2.45 . . . . 0.0 111.234 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -151.98 175.31 12.64 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.623 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.509 HG23 ' CB ' ' A' ' 31' ' ' PRO . 53.4 mt -113.12 95.23 33.98 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.212 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 23.9 Cg_exo -65.14 164.37 25.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.289 2.659 . . . . 0.0 113.565 -174.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -65.3 -34.1 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.779 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.09 129.44 34.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.368 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -96.88 6.1 49.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.088 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.4 m -101.12 8.45 42.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 65.8 mttm -107.84 175.9 5.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.83 120.49 59.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.614 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.92 -29.37 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.548 . . . . 0.0 110.913 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.99 168.95 42.1 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.238 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 80.0 m-85 -118.05 131.16 56.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -100.63 115.41 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.662 0.744 . . . . 0.0 110.003 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 47.7 mt-10 -123.63 112.39 17.36 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.83 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.447 HD13 HD11 ' A' ' 25' ' ' ILE . 46.3 mt -126.27 94.78 40.26 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.903 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.75 -33.28 96.59 Favored 'Trans proline' 0 CA--C 1.518 -0.314 0 C-N-CA 122.77 2.313 . . . . 0.0 111.505 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HB3' ' HZ1' ' A' ' 79' ' ' LYS . 4.6 m-20 -58.28 -34.45 70.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.37 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -112.35 10.35 19.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.49 30.58 15.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.858 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.447 HD11 HD13 ' A' ' 20' ' ' ILE . 63.1 mt -86.86 133.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.509 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -156.14 57.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.14 0.495 . . . . 0.0 109.745 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -117.81 153.81 50.95 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.656 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -80.16 138.67 12.89 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.818 2.345 . . . . 0.0 112.635 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.93 131.38 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 110.316 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.3 m-85 -101.41 129.22 27.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.795 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 58.8 Cg_endo -71.5 149.81 56.55 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.887 2.391 . . . . 0.0 112.161 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.18 177.89 25.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.047 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.513 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 84.4 Cg_endo -84.63 29.95 0.53 Allowed 'Trans proline' 0 CA--C 1.52 -0.199 0 C-N-CA 123.813 3.009 . . . . 0.0 112.671 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . 60.8 56.34 2.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.042 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 33' ' ' PRO . 1.4 p -76.55 138.22 67.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.67 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -38.47 -66.34 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.49 3.46 . . . . 0.0 114.655 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.59 -35.49 81.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -68.83 -34.4 75.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.731 -174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 pp -87.4 -0.43 56.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.44 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -98.67 -31.57 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.114 175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -70.51 -29.99 66.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.4 -97.48 0.16 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 1.008 ' HB ' ' HG3' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -170.28 153.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 8.4 t -133.37 176.19 8.74 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.362 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 7' ' ' ILE . 73.5 m-85 -89.16 173.62 8.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.96 85.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.767 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.5 mt-10 -134.21 167.41 20.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.153 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 1.4 tm-20 -72.97 -40.08 65.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.141 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -80.49 11.11 3.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.117 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -62.34 146.58 50.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.932 176.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.3 m -141.81 133.27 26.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 111.775 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.25 -2.87 36.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.748 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.03 -13.47 53.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.686 0.755 . . . . 0.0 109.487 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.26 -168.82 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.59 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.69 0.94 9.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.602 0.239 . . . . 0.0 110.452 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -113.16 49.69 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.03 118.27 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.305 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -120.36 124.87 46.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.559 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.2 mt -108.92 136.26 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.38 113.37 26.92 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.942 0.151 . . . . 0.0 110.8 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -105.76 148.21 16.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.678 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -117.16 107.57 14.63 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.173 0.189 . . . . 0.0 110.622 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -65.18 126.63 28.73 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 8.3 t80 -130.97 152.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.65 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.3 mt -90.6 -43.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 4.4 m-20 -76.39 -1.58 27.63 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -122.92 115.58 29.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.67 0.271 . . . . 0.0 110.561 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -90.34 0.57 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.746 2.297 . . . . 0.0 112.032 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -141.74 79.21 1.67 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.564 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.55 -166.62 2.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.364 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 1.008 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 68.8 mm-40 -47.29 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -101.27 28.47 5.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -40.13 85.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.354 0.597 . . . . 0.0 111.053 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 67.0 t30 -111.07 22.99 14.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.476 HD13 ' HE3' ' A' ' 97' ' ' MET . 31.3 tp -69.25 -5.53 23.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.135 0.493 . . . . 0.0 110.998 -176.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.542 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -75.37 -8.23 56.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 110.683 176.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.77 6.57 45.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.347 0.594 . . . . 0.0 110.48 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.95 152.53 21.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.503 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HZ1' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -146.82 -171.5 3.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.117 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -51.96 -22.05 3.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.96 44.83 1.12 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 119.578 -1.296 . . . . 0.0 113.337 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -67.88 142.2 56.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.721 ' HE2' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -91.19 89.85 7.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.101 176.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 57.2 t -85.95 107.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.493 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -100.52 118.85 37.56 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.452 ' C ' ' HG1' ' A' ' 92' ' ' THR . 13.4 t80 -110.51 104.16 12.86 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 1.4 mptm? -81.18 123.1 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.751 -177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 6.6 m -136.95 116.53 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.167 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.05 -95.58 0.2 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.454 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -120.85 -3.41 9.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.537 0.208 . . . . 0.0 110.897 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.42 178.95 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.957 -173.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.452 ' HG1' ' C ' ' A' ' 86' ' ' PHE . 5.1 t -142.4 141.55 32.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -108.53 132.65 53.62 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.721 ' HD3' ' HE2' ' A' ' 83' ' ' MET . 12.1 ptpt -99.3 135.62 40.44 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 86.4 m-85 -122.03 144.36 48.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.703 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.2 tptm -110.04 126.07 53.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.049 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.476 ' HE3' HD13 ' A' ' 75' ' ' LEU . 59.6 mtt -82.07 80.73 8.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.428 0.633 . . . . 0.0 110.588 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 t -89.25 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.153 -173.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.537 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.0 t -144.83 129.17 17.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -141.19 125.47 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.181 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -170.74 -176.62 2.1 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.048 0.218 . . . . 0.0 110.832 172.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.717 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 2.9 p30 -130.24 138.88 50.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.417 . . . . 0.0 110.435 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.8 -179.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.93 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -93.19 154.19 41.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.496 ' HD3' ' HD3' ' A' ' 139' ' ' ARG . 61.0 Cg_endo -72.09 -18.42 27.36 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.317 2.011 . . . . 0.0 111.736 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.7 t -106.63 15.74 25.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.85 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 6.0 t0 -72.58 162.05 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.517 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 -7.25 10.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.71 -29.53 64.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.629 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.22 -9.31 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.915 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 94.1 mt -90.98 10.29 27.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.2 -176.11 3.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.94 132.16 50.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.35 0.595 . . . . 0.0 111.298 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -82.78 120.97 26.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.616 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -84.19 -152.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.693 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.34 55.62 1.16 Allowed Glycine 0 C--N 1.336 0.583 0 O-C-N 123.267 0.354 . . . . 0.0 113.593 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -83.59 147.43 27.74 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -87.36 -157.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -67.06 103.67 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.842 0.353 . . . . 0.0 110.418 -178.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 2.8 pt20 -104.56 136.37 44.24 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.394 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.75 105.8 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.5 m -85.33 100.86 12.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.729 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.6 mt -83.64 99.39 10.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 18.9 mt -91.54 97.22 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 17.4 m -106.9 121.94 45.42 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.804 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 94.2 m -73.54 96.16 2.38 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.201 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 6.4 t70 -110.53 98.36 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.887 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -178.59 -82.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.51 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.613 ' CE1' ' HG2' ' A' ' 131' ' ' GLU . 1.2 t80 58.58 77.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.016 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -83.25 86.28 7.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.269 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.613 ' HG2' ' CE1' ' A' ' 129' ' ' TYR . 27.8 mt-10 -58.79 -22.95 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.764 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -64.83 -27.53 68.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.444 HG22 HG11 ' A' ' 135' ' ' VAL . 4.8 t -121.66 -17.5 7.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.84 0.352 . . . . 0.0 110.445 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 48.64 5.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.239 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 133' ' ' THR . 4.0 p -146.14 158.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.443 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 46.5 m95 -105.34 98.69 8.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.65 -58.51 3.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -85.3 137.12 33.18 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.459 0.647 . . . . 0.0 112.316 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.496 ' HD3' ' HD3' ' A' ' 105' ' ' PRO . 6.5 mpt_? -100.12 111.03 23.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.76 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.717 ' HE3' ' HB3' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -79.03 117.86 20.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.0 tt -120.48 123.48 70.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.913 0.863 . . . . 0.0 111.052 -174.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 11.5 m-85 -108.14 114.65 28.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.048 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 40.2 t -93.95 99.62 9.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.302 0.572 . . . . 0.0 110.02 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -103.83 109.34 21.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.291 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 5.7 m -93.53 143.56 26.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.468 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.01 124.02 14.3 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.685 0.615 . . . . 0.0 111.303 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.488 HG13 ' HD3' ' A' ' 96' ' ' LYS . 6.5 p -111.05 151.6 13.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.585 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.474 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 4.5 ptmm? . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.464 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 53' ' ' ASP . 16.6 mttt . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.192 0.52 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.25 164.44 35.02 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.7 2.267 . . . . 0.0 111.586 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -140.3 130.15 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.009 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.637 HG13 HD21 ' A' ' 52' ' ' LEU . 12.0 mt -63.6 121.98 73.64 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.124 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.33 -179.07 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.965 2.443 . . . . 0.0 112.575 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -81.16 -12.62 59.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.3 0.572 . . . . 0.0 110.554 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.03 113.16 21.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.139 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -91.53 1.46 57.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.223 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 t -98.97 -6.04 29.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.879 0.371 . . . . 0.0 111.377 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -106.3 172.92 6.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.066 0.46 . . . . 0.0 110.884 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.34 125.38 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.609 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.35 -44.98 13.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.381 0.61 . . . . 0.0 109.696 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.88 168.34 36.22 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 68.2 m-85 -107.77 140.84 40.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.138 0.469 . . . . 0.0 110.439 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -105.33 112.71 39.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.855 0.836 . . . . 0.0 109.446 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.589 ' HB3' ' HD2' ' A' ' 26' ' ' LYS . 33.5 mt-10 -122.29 112.58 18.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.528 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.401 HD13 HD13 ' A' ' 25' ' ' ILE . 38.7 mt -127.28 93.95 39.85 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.791 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.51 -28.47 86.72 Favored 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 123.117 2.545 . . . . 0.0 111.808 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 26.9 t70 -67.22 -28.03 67.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.174 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -114.66 12.41 17.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.148 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.5 t70 61.78 26.91 16.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.492 0.663 . . . . 0.0 111.128 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.401 HD13 HD13 ' A' ' 20' ' ' ILE . 80.5 mt -95.99 129.67 45.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.206 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.589 ' HD2' ' HB3' ' A' ' 19' ' ' GLU . 9.2 mmmm -155.26 42.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.468 0.307 . . . . 0.0 111.498 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -124.46 157.47 64.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 36.4 Cg_endo -66.47 149.17 84.62 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.426 2.75 . . . . 0.0 113.52 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.81 138.1 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.214 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -100.33 135.57 20.23 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 121.0 0.428 . . . . 0.0 110.83 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HB2' HG21 ' A' ' 7' ' ' ILE . 73.0 Cg_endo -79.89 128.93 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.729 2.286 . . . . 0.0 111.348 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.661 ' HA3' ' HG2' ' A' ' 38' ' ' GLN . . . -175.82 149.42 9.99 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.676 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' ' 35' ' ' THR . 68.8 Cg_endo -74.46 38.02 0.48 Allowed 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.966 3.111 . . . . 0.0 113.476 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 54.91 36.23 26.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.074 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.494 HG21 ' HG2' ' A' ' 33' ' ' PRO . 6.1 p -76.46 154.16 83.85 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.784 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 77.3 Cg_exo -50.92 -46.71 29.14 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.607 2.871 . . . . 0.0 114.091 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -17.83 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 111.349 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.661 ' HG2' ' HA3' ' A' ' 32' ' ' GLY . 42.4 tp60 -81.41 -46.82 14.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.913 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 96.7 mt -77.89 -1.52 32.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.441 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 65.6 t30 -84.55 -44.19 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.747 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 7.0 ptm180 -75.52 -30.32 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.574 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -179.51 -162.9 29.42 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -85.39 155.73 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 117.491 0.646 . . . . 0.0 110.114 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.546 ' OG ' ' HG3' ' A' ' 38' ' ' GLN . 59.9 m -150.58 179.72 7.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.146 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -73.27 157.85 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.17 76.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.632 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.19 175.99 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.513 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.6 1.9 27.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.88 -17.32 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.49 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.13 154.26 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.733 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.887 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m -141.56 157.95 44.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.833 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.5 mm? -77.08 -23.21 51.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.606 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 15.2 t70 -135.34 70.08 1.44 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.639 1.209 . . . . 0.0 109.108 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.887 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.3 t70 -124.78 162.4 24.37 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.709 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.89 -35.93 82.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.36 131.74 54.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.41 0.624 . . . . 0.0 111.21 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 ' HB ' HD23 ' A' ' 121' ' ' LEU . 47.1 mt -129.2 123.06 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -113.17 109.2 18.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -172.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -107.99 124.35 64.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.09 120.02 33.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.003 0.43 . . . . 0.0 111.08 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.62 118.28 5.54 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.817 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -68.42 -38.62 81.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m 73.01 126.92 0.04 OUTLIER 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.552 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -137.43 142.51 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.22 -39.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.875 173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.63 -46.74 63.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.292 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -107.9 107.12 59.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.711 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.523 ' HA ' HG22 ' A' ' 73' ' ' THR . 96.4 Cg_endo -80.25 -18.89 9.58 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.551 2.168 . . . . 0.0 111.682 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -124.61 70.79 1.13 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.464 0.649 . . . . 0.0 110.896 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -138.48 -177.5 4.88 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 166.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -41.06 -68.41 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -168.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -114.28 96.22 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.24 -174.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 68' ' ' PRO . 1.3 m -156.49 -45.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.641 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -97.91 23.36 8.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.542 0.687 . . . . 0.0 110.247 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -11.5 59.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -71.11 -11.16 60.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.344 . . . . 0.0 111.545 -178.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -89.65 6.86 39.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.497 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -94.05 135.05 35.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.796 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 7.4 mptt -108.51 -170.87 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.617 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 97' ' ' MET . 6.2 ptpp? -65.87 -33.9 76.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.43 54.01 0.57 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.469 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 p -75.02 -15.97 60.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.501 ' HE2' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 54.31 85.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.556 0.693 . . . . 0.0 111.639 -174.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 48.4 t -86.11 113.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.062 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.424 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 89.4 m-85 -98.73 110.43 23.03 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.548 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 34.9 t80 -99.21 102.59 14.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 35.7 mmtp -92.02 81.27 5.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.387 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.833 HG21 ' HG ' ' A' ' 52' ' ' LEU . 5.4 p -93.54 121.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.178 0.513 . . . . 0.0 110.489 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.12 -104.1 0.63 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.731 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 90' ' ' ASN . 6.6 m120 -124.64 9.25 8.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.312 . . . . 0.0 110.718 177.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -100.11 148.58 24.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 110.57 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 93.1 m -117.7 104.34 10.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.188 0.518 . . . . 0.0 111.023 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 58.2 mmt-85 -92.11 135.36 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.986 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.677 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -115.02 130.1 56.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.036 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -130.23 146.88 51.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.72 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.54 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -112.95 135.99 53.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.53 ' SD ' ' HB1' ' A' ' 144' ' ' ALA . 20.8 mmt -79.35 65.44 4.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.528 0.68 . . . . 0.0 110.359 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 t -80.44 -13.75 58.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.551 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.4 m -135.18 90.88 2.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.546 0.689 . . . . 0.0 111.1 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 97' ' ' MET . 73.1 mt -109.07 129.7 63.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.429 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -164.62 -169.64 1.8 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.83 0.347 . . . . 0.0 110.255 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.786 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 3.3 p-10 -145.68 137.37 25.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.548 HG21 ' HD2' ' A' ' 139' ' ' ARG . 21.5 m -120.29 174.13 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.323 -173.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.54 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.2 mppt? -91.6 158.05 41.03 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.827 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.744 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 19.9 Cg_endo -61.7 -24.2 77.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.358 2.039 . . . . 0.0 111.293 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -114.71 29.93 7.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.789 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.29 139.71 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.257 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.1 m -110.87 2.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.738 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -85.92 -36.24 20.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.197 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.1 -10.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.906 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 111' ' ' LEU . 4.2 pp -111.13 -0.13 16.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 111.192 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.84 -159.15 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.441 ' HG3' ' HZ1' ' A' ' 115' ' ' LYS . 9.5 pt-20 -60.98 112.91 2.26 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.458 0.646 . . . . 0.0 111.672 -177.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -85.6 134.18 34.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.518 174.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 12.1 mptt -74.16 174.98 7.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.278 -170.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.81 55.05 1.34 Allowed Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.884 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -69.41 173.54 5.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.329 0.585 . . . . 0.0 110.972 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.4 ' OD1' ' HD3' ' A' ' 119' ' ' LYS . 5.1 t70 -104.54 -149.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.724 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -58.69 114.85 2.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.83 119.84 38.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.259 0.552 . . . . 0.0 111.957 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.524 HD23 ' HB ' ' A' ' 57' ' ' ILE . 14.0 mt -82.38 104.97 13.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -92.63 92.21 7.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.565 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.78 101.12 13.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.997 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 mt -90.92 97.8 7.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.29 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -103.09 101.97 11.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.328 0.585 . . . . 0.0 110.362 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 86.3 m -92.56 101.87 14.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.689 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -120.36 68.44 0.85 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.495 0.664 . . . . 0.0 110.052 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 34.6 t70 -176.26 95.23 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.681 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -102.56 115.94 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -86.69 103.05 14.78 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.89 -27.07 68.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.017 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.563 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -77.53 -18.57 56.86 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.518 -173.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.537 ' OG1' HG11 ' A' ' 135' ' ' VAL . 21.9 p -120.82 -32.3 4.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.62 16.24 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.505 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.537 HG11 ' OG1' ' A' ' 133' ' ' THR . 9.8 p -132.64 154.46 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.578 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.479 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 55.4 m95 -97.71 109.21 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.744 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 44.2 mt-10 -87.93 -63.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -172.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 48.1 tptt -75.57 80.7 2.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.134 0.969 . . . . 0.0 110.348 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.548 ' HD2' HG21 ' A' ' 103' ' ' VAL . 1.5 ptp180 -93.57 108.63 20.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.355 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.786 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 45.6 tptt -80.66 132.77 35.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.334 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -122.71 122.72 66.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.923 0.868 . . . . 0.0 111.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.457 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 13.2 m-85 -110.69 105.32 14.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.687 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 26.2 t -99.35 104.23 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.349 0.595 . . . . 0.0 110.371 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.53 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -100.38 117.76 35.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.368 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.1 m -95.78 144.51 26.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 29.8 tt0 -56.67 135.91 54.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 111.725 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.54 HG21 ' HD3' ' A' ' 96' ' ' LYS . 1.1 t -106.94 172.26 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.55 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.607 176.241 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 7.8 mtmp? . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 18.3 Cg_endo -58.58 134.56 61.71 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.535 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 8.8 pt20 -158.05 176.2 12.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.863 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 31' ' ' PRO . 5.4 mp -96.99 108.88 46.3 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.034 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.4 Cg_exo -68.11 165.03 29.79 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.811 2.341 . . . . 0.0 110.88 170.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -97.02 18.73 14.12 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.909 -171.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 18.3 t70 -86.84 150.07 24.38 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -80.4 -39.72 27.82 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.469 ' HG ' ' NE2' ' A' ' 38' ' ' GLN . 32.7 m -93.49 -22.34 18.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -59.72 150.02 29.07 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.599 0.714 . . . . 0.0 112.443 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -105.9 139.2 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.634 172.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.86 -32.53 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.448 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.16 161.87 26.82 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.485 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 35.7 m-85 -122.88 143.43 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -104.44 118.41 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.252 0.549 . . . . 0.0 109.79 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 26.0 mt-10 -125.81 111.62 15.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 62.1 mt -132.24 109.09 13.75 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 -47.18 15.3 Favored 'Trans proline' 0 N--CA 1.473 0.273 0 C-N-CA 123.157 2.571 . . . . 0.0 113.365 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' HA ' ' A' ' 82' ' ' SER . 20.9 m-20 -62.54 -30.19 71.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -98.18 2.4 48.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.224 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t70 61.55 27.76 17.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.969 0.89 . . . . 0.0 109.887 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 61.0 mt -97.24 129.29 47.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.235 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.532 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 32.5 ttpt -159.86 79.11 0.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 168.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -133.5 157.14 78.75 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.826 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.2 146.88 71.35 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.848 2.365 . . . . 0.0 113.03 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.54 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 76.2 t -106.12 125.44 61.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.712 176.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 61.1 m-85 -93.54 103.44 9.86 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.624 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 3.0 Cg_endo -86.86 155.0 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.355 2.703 . . . . 0.0 112.298 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 34' ' ' ALA . . . 136.77 -151.75 21.04 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.952 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.721 ' HG2' ' HG1' ' A' ' 35' ' ' THR . 78.7 Cg_endo -76.3 19.21 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.249 2.633 . . . . 0.0 113.092 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 32' ' ' GLY . . . 56.87 46.24 20.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.324 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.721 ' HG1' ' HG2' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -54.72 119.7 23.2 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.092 -174.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.32 -38.64 42.81 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.238 2.625 . . . . 0.0 113.066 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.95 -38.4 82.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.311 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.469 ' NE2' ' HG ' ' A' ' 12' ' ' SER . 75.9 mm-40 -90.65 -30.73 16.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.089 0.471 . . . . 0.0 110.4 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.43 -27.99 63.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.975 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -68.28 -24.8 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -80.96 -52.71 7.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.738 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.72 -117.23 1.49 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.06 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.56 142.42 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -128.59 -179.59 5.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.385 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.624 ' CE2' ' HB3' ' A' ' 31' ' ' PRO . 11.9 m-85 -74.61 178.09 5.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.7 -46.79 20.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.68 167.14 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.699 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -80.82 -10.31 59.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.522 0.677 . . . . 0.0 109.951 175.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.83 -23.0 58.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.854 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -84.03 177.86 8.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 112.161 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 70.8 m -137.38 175.13 9.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -172.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.14 -15.95 34.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.432 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -134.9 70.34 1.44 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.283 1.04 . . . . 0.0 109.589 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 14.7 t70 -126.37 160.88 29.18 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.747 171.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -31.54 72.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.64 125.86 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.588 0.708 . . . . 0.0 111.012 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.33 139.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -131.15 116.23 17.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.195 0.521 . . . . 0.0 111.659 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.4 mt -101.09 116.41 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.64 105.07 17.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 111.309 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.64 144.49 15.95 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.301 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -122.81 133.81 54.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.541 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -81.86 113.27 19.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -113.67 109.3 18.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.505 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.7 mm -54.96 -33.98 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.741 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.87 -40.46 76.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 61.1 mtt180 -106.98 108.91 62.74 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.914 0.388 . . . . 0.0 111.068 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 3.3 Cg_exo -77.77 -10.77 16.95 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.196 2.597 . . . . 0.0 112.737 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.68 80.53 1.7 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.425 0.631 . . . . 0.0 111.716 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -132.62 -161.82 1.17 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.751 168.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -49.63 -72.37 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -105.57 31.77 4.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -169.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 m -73.74 -34.86 64.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.04 0.448 . . . . 0.0 111.223 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -116.72 28.0 8.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.277 0.56 . . . . 0.0 110.484 -173.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.22 -21.45 65.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -74.03 -2.05 22.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.302 . . . . 0.0 111.622 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.42 8.2 37.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.62 153.92 20.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -125.82 176.41 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.295 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -61.2 -19.67 61.88 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.89 51.62 0.85 Allowed Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.174 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . 4.0 m -79.28 -4.47 50.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.446 ' HE3' ' HA ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 53.93 82.93 0.08 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.447 0.641 . . . . 0.0 111.244 -175.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.9 t -85.0 113.94 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.967 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 84.3 m-85 -94.26 117.64 30.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.884 0.373 . . . . 0.0 110.052 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -100.44 101.11 11.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 32.4 tptt -83.89 99.14 10.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.864 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 91' ' ' GLU . 4.1 m -116.7 86.96 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.87 -107.04 1.69 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.231 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.14 -11.36 30.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 0.0 110.829 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.839 ' HB2' HG22 ' A' ' 88' ' ' VAL . 38.8 mt-10 -95.11 109.2 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.755 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.0 m -100.57 85.68 2.99 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 93' ' ' ARG . 11.3 ptp180 -93.39 133.73 36.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.525 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.524 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -102.86 139.38 38.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.771 -175.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.545 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.6 m-85 -120.91 148.99 43.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 1.2 tptm -110.49 131.96 54.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.9 mmt -76.68 70.58 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -77.05 -20.62 55.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.669 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 52.5 m -133.53 101.37 5.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 97' ' ' MET . 74.9 mt -116.49 116.54 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.688 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -161.66 -174.39 4.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.53 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.796 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 1.2 p-10 -144.09 134.92 25.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.19 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.7 m -133.77 -175.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.458 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -92.16 160.29 35.7 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.635 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.35 -20.71 31.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 111.445 175.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -98.83 10.54 41.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.882 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.21 115.86 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.802 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.95 2.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 0.0 110.996 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.12 -34.88 18.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.379 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.5 m -77.26 -26.25 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -91.83 20.29 5.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.9 169.37 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.516 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 5.6 pt-20 -66.61 84.8 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.328 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -87.45 37.78 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.652 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -82.52 172.12 13.35 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.639 176.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.91 -7.64 59.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.808 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -91.08 -168.25 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.133 0.492 . . . . 0.0 110.557 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -104.6 -157.78 0.63 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.9 OUTLIER -65.54 107.37 1.68 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -104.97 124.38 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.237 0.541 . . . . 0.0 110.282 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -92.95 98.26 11.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.1 m -84.41 99.11 10.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.258 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 20.0 mt -85.25 106.08 16.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.1 mt -93.52 127.24 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.578 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 30.5 m -136.67 105.21 5.78 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.256 0.551 . . . . 0.0 110.501 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.4 m -99.52 107.39 19.56 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -118.08 -1.46 11.41 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -172.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 137' ' ' GLU . 37.1 t70 -105.71 89.64 3.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.524 0.678 . . . . 0.0 109.919 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.593 ' CE1' ' HA ' ' A' ' 131' ' ' GLU . 92.3 t80 -82.58 124.91 30.59 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.172 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.507 ' OD1' HG23 ' A' ' 133' ' ' THR . 23.1 t-20 -89.29 103.62 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.593 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 40.2 mt-10 -64.09 -23.24 67.25 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -171.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 1.005 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 5.9 mmpt? -78.49 -23.43 46.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.507 HG23 ' OD1' ' A' ' 130' ' ' ASN . 7.7 t -130.06 -30.0 2.03 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.596 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.88 35.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.281 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.453 ' H ' HG22 ' A' ' 133' ' ' THR . 12.8 m -82.8 172.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.47 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 41.9 m95 -117.37 112.11 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.452 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 41.9 mt-10 -77.83 -21.38 51.59 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.796 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -114.98 118.35 33.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.296 0.57 . . . . 0.0 111.036 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -107.13 98.67 8.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.483 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.764 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 47.7 tptt -69.1 128.52 36.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.91 118.49 50.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.989 0.899 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.584 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 15.8 m-85 -109.08 101.59 10.64 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.305 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 38.3 t -95.42 97.09 6.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.403 0.62 . . . . 0.0 110.121 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.544 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -95.91 112.23 24.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.9 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.8 m -90.45 139.34 30.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.88 123.75 15.33 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.564 0.54 . . . . 0.0 110.798 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.524 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 4.0 t -76.8 147.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.644 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt . . . . . 0 C--O 1.248 1.024 0 O-C-N 124.324 1.015 . . . . 0.0 111.236 178.73 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.84 118.33 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.874 2.383 . . . . 0.0 112.126 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -118.96 147.37 44.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.668 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -84.57 121.82 74.91 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.453 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.79 -175.66 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.513 2.142 . . . . 0.0 112.206 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.635 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.73 6.35 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.167 178.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -95.92 103.95 15.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.052 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.486 ' CD ' ' HD3' ' A' ' 33' ' ' PRO . 35.3 mtmm -85.63 12.81 7.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.139 -176.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -106.72 -5.86 18.24 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.203 0.525 . . . . 0.0 109.678 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 30' ' ' TYR . 99.3 mttt -91.37 -177.14 4.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -112.77 138.21 42.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.37 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.72 -29.4 12.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.244 0.545 . . . . 0.0 110.798 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.71 163.51 36.73 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 63.9 m-85 -109.44 135.79 49.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.483 0.642 . . . . 0.0 109.91 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.449 HG21 ' O ' ' A' ' 18' ' ' ILE . 8.1 tp -97.86 108.53 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.772 0.796 . . . . 0.0 109.612 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -114.18 103.7 11.37 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.907 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mt -121.25 92.88 48.76 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.539 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.91 -21.18 68.9 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.052 2.502 . . . . 0.0 111.311 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.498 ' CG ' ' HZ2' ' A' ' 79' ' ' LYS . 24.7 t70 -72.99 -30.14 63.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.888 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.52 10.9 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 63.14 29.25 16.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.769 0.795 . . . . 0.0 110.758 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 27' ' ' GLU . 78.2 mt -102.22 118.74 49.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.5 mppt? -135.82 41.51 2.69 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.681 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 13.1 mm-40 -102.55 154.19 37.64 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.429 -163.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.79 143.45 13.25 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.473 2.116 . . . . 0.0 112.151 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.88 127.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' SER . 57.6 m-85 -100.76 133.71 20.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.493 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -69.26 145.34 59.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.498 2.132 . . . . 0.0 111.841 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . 164.8 162.07 15.08 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.31 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 Cg_endo -88.01 39.86 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.997 3.132 . . . . 0.0 111.545 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.71 35.98 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.47 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.0 152.48 84.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.824 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.53 -57.19 2.49 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.971 3.114 . . . . 0.0 113.818 -175.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.4 mm-40 -59.61 -34.76 73.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.8 mp0 -64.99 -44.21 90.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.287 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.3 -30.92 65.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.44 0.638 . . . . 0.0 110.109 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.08 -39.87 95.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.673 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 28.2 mtp-105 -75.67 -51.61 12.38 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.619 175.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.447 ' C ' ' HG3' ' A' ' 71' ' ' GLN . . . -156.47 -104.91 0.22 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.957 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.92 149.99 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 41.3 t -124.21 157.27 35.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.682 0.277 . . . . 0.0 110.901 -174.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -70.5 178.25 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -66.2 -46.58 76.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 12.8 pt-20 -149.15 -176.47 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.545 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -94.86 -27.37 15.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.151 -171.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -82.8 -9.86 59.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.038 0.447 . . . . 0.0 110.922 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.11 143.04 49.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.042 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 m -121.16 145.13 48.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.752 -171.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -81.84 -10.23 59.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.818 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -100.78 4.02 42.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 110.558 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -95.93 178.41 5.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.519 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.554 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.26 -8.8 28.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.708 0.29 . . . . 0.0 111.301 -177.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.58 107.1 12.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.745 0.783 . . . . 0.0 110.754 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.8 mt -127.58 136.11 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.872 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 36.6 t -132.02 132.71 43.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.382 0.611 . . . . 0.0 110.962 -172.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -115.56 127.97 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.296 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.24 111.61 22.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.042 0.448 . . . . 0.0 111.063 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.99 137.92 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.666 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -148.21 102.09 3.33 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 m -56.37 147.47 21.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.594 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' HB3' ' CG ' ' A' ' 67' ' ' ARG . 69.7 t80 -139.25 148.3 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.3 mt -54.57 -51.52 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.308 -174.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -87.77 40.54 0.94 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.608 -172.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.474 ' CG ' ' HB3' ' A' ' 64' ' ' PHE . 12.8 ptp180 -166.21 88.76 0.86 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.267 0.556 . . . . 0.0 111.416 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.85 -4.53 14.06 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.189 2.593 . . . . 0.0 112.038 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -154.73 83.58 1.1 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.025 -170.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -139.12 -168.19 2.39 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.31 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.681 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 9.2 mm100 -24.1 -75.73 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.882 1.273 . . . . 0.0 113.263 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -117.44 96.47 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 110.786 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.54 -49.74 0.78 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.327 0.584 . . . . 0.0 110.68 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.447 ' OD1' ' HE2' ' A' ' 76' ' ' LYS . 64.2 t30 -87.75 32.74 0.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.489 0.662 . . . . 0.0 110.952 -174.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 75' ' ' LEU . 40.4 mt -72.29 -7.48 49.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.392 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HE2' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -78.4 -11.66 59.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.982 0.42 . . . . 0.0 111.017 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -12.22 49.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.755 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.15 22.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.772 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HZ2' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -157.13 -168.77 2.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.187 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.5 ptmt -46.2 -39.52 9.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.588 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -124.54 57.19 0.68 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.34 -1.409 . . . . 0.0 113.174 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -81.22 -6.94 59.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.727 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 84.2 mmm 47.68 91.63 0.01 OUTLIER 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.838 0.828 . . . . 0.0 112.744 -174.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -85.76 119.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -99.75 107.75 19.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.564 ' HD2' ' HD2' ' A' ' 93' ' ' ARG . 28.8 t80 -90.28 100.51 13.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.8 tppp? -82.86 93.75 7.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.212 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.09 122.03 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.268 0.556 . . . . 0.0 111.011 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.81 -90.48 0.13 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.962 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -139.81 8.47 2.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.0 109.448 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -100.76 131.47 46.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.542 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.8 m -103.67 97.55 7.55 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HD2' ' HD2' ' A' ' 86' ' ' PHE . 9.9 ptp180 -97.35 153.41 18.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.895 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.05 122.29 44.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.186 0.517 . . . . 0.0 111.754 -166.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.509 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.9 m-85 -122.17 138.27 54.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.727 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.88 132.25 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 53.8 mtt -80.9 62.79 5.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.633 0.73 . . . . 0.0 110.175 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -75.93 -12.66 60.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.723 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 37.4 m -132.94 97.84 4.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.311 0.577 . . . . 0.0 110.34 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.92 128.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.341 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.446 ' O ' ' HD2' ' A' ' 140' ' ' LYS . 6.1 ptp180 -161.05 -178.63 6.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.989 0.423 . . . . 0.0 110.536 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.51 143.63 46.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.766 HG21 ' HG3' ' A' ' 139' ' ' ARG . 11.8 m -131.17 170.84 18.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -100.28 146.39 31.9 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.819 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.6 -2.31 2.57 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.938 2.425 . . . . 0.0 112.907 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -126.62 19.49 7.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 1.6 p30 -68.59 166.8 16.37 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.332 0.587 . . . . 0.0 111.143 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.489 ' HA ' HD12 ' A' ' 111' ' ' LEU . 29.0 m -120.54 23.97 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -97.98 -41.82 7.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.158 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -87.25 -7.8 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.908 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 108' ' ' VAL . 2.5 pp -120.0 18.19 12.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.492 . . . . 0.0 110.929 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 32.3 t70 -152.15 138.47 18.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.174 -175.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 115' ' ' LYS . 95.4 mt-10 53.4 65.76 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.795 0.684 . . . . 0.0 111.652 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -88.9 93.28 9.54 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' CE ' ' HB3' ' A' ' 113' ' ' GLU . 8.0 mptt -67.43 163.1 21.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.213 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.38 54.03 2.77 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.806 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -66.21 172.03 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.076 0.465 . . . . 0.0 110.788 172.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.03 -161.07 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 2.3 mppt? -64.72 119.02 9.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.989 0.423 . . . . 0.0 110.057 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.16 138.26 53.12 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.669 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.9 108.33 19.61 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m -92.59 106.12 18.16 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.758 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.7 mt -92.95 103.19 15.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.01 94.26 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -105.25 98.91 8.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.408 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 6.1 p -76.34 96.83 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.319 0.58 . . . . 0.0 109.882 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -125.28 79.26 1.79 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.396 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.758 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 31.5 t70 -168.89 85.72 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.489 ' CE1' ' HA ' ' A' ' 131' ' ' GLU . 70.8 t80 -91.91 125.9 36.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.132 -167.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -97.26 108.55 21.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.489 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 34.6 mt-10 -58.27 -33.72 69.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -71.21 -25.71 62.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.581 HG21 ' H ' ' A' ' 135' ' ' VAL . 2.6 t -125.03 -31.0 3.16 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.837 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.483 ' HA2' ' CE2' ' A' ' 129' ' ' TYR . . . 96.46 4.23 59.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.113 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.581 ' H ' HG21 ' A' ' 133' ' ' THR . 98.5 t -84.67 138.51 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.774 0.321 . . . . 0.0 110.158 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.758 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 45.0 m95 -95.68 105.04 16.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.37 -16.39 56.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.715 -165.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -133.17 130.46 39.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.806 0.336 . . . . 0.0 110.464 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.766 ' HG3' HG21 ' A' ' 103' ' ' VAL . 27.9 ptt180 -111.09 113.6 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.456 0.646 . . . . 0.0 110.181 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.446 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 16.2 tptm -76.33 127.51 33.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.841 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -121.04 127.16 75.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.728 0.775 . . . . 0.0 111.42 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 93.1 m-85 -114.64 108.76 17.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.488 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.6 t -96.68 102.53 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.265 0.555 . . . . 0.0 110.007 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.65 107.97 19.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.336 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.4 m -90.76 144.02 26.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.71 138.44 18.26 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.555 0.534 . . . . 0.0 111.186 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 96' ' ' LYS . 21.5 t -97.05 153.71 3.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.548 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.06 179.394 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.53 130.76 22.53 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.5 2.8 . . . . 0.0 113.524 -174.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.08 169.07 18.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.875 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.4 mp -70.86 122.78 87.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 17.3 Cg_exo -67.52 170.54 13.47 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.747 2.298 . . . . 0.0 112.978 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -79.26 -21.96 45.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.82 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.23 108.56 21.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.022 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 52.6 mtmt -90.63 31.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.745 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -117.17 -20.92 9.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.367 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 19.2 ptpt -90.43 -175.44 4.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.479 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 28' ' ' PRO . 7.8 p -100.94 137.52 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.874 0.369 . . . . 0.0 110.509 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB1' HD13 ' A' ' 52' ' ' LEU . . . -100.81 -40.19 7.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.373 0.606 . . . . 0.0 110.324 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.14 165.45 30.31 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.586 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 47.7 m-85 -115.37 139.25 50.17 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -103.61 115.36 45.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.608 0.718 . . . . 0.0 109.949 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.19 112.67 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.571 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.449 HG12 HG13 ' A' ' 84' ' ' VAL . 43.5 mt -127.93 95.41 34.47 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.142 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.4 -29.61 89.13 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 123.114 2.543 . . . . 0.0 112.047 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.98 -33.19 74.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.47 8.8 21.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 66.68 12.55 8.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.26 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.465 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 62.7 mt -78.21 123.54 35.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.244 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 14.3 mtmm -153.6 84.71 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 119.364 -0.351 . . . . 0.0 110.594 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.596 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 13.1 mm-40 -155.93 163.83 23.42 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 118.0 0.364 . . . . 0.0 111.725 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HB3' HG23 ' A' ' 14' ' ' VAL . 8.2 Cg_exo -72.4 156.89 54.1 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.08 2.52 . . . . 0.0 113.387 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.52 123.6 71.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.623 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.9 123.88 45.79 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.739 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.559 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 19.0 Cg_endo -58.28 129.41 32.73 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.968 2.445 . . . . 0.0 112.228 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.481 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . -172.27 135.12 3.24 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.445 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 Cg_endo -80.68 61.43 8.22 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.309 2.673 . . . . 0.0 112.069 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.02 27.97 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.525 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 7.8 p -79.81 136.62 54.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.187 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 64.1 Cg_exo -52.51 -48.57 21.22 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.471 2.78 . . . . 0.0 113.829 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.623 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 2.2 mp0 -67.42 -23.19 65.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 111.653 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.548 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.9 mp0 -83.06 -26.01 31.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.044 0.45 . . . . 0.0 110.013 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.56 -5.66 55.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.457 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.623 ' ND2' ' HA ' ' A' ' 37' ' ' GLU . 28.4 p30 -97.11 -23.68 16.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -96.0 -20.74 18.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.557 ' HA2' ' NE2' ' A' ' 71' ' ' GLN . . . -168.95 -150.22 6.59 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.84 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.91 142.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.548 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 70.8 m -127.55 -175.58 3.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.246 0.546 . . . . 0.0 112.001 -172.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.79 -178.86 6.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.662 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.71 -50.93 5.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.101 0.477 . . . . 0.0 109.941 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -119.59 -167.58 1.44 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.018 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.47 27.23 9.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -105.41 -28.66 10.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.533 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 58' ' ' SER . 3.0 mp0 -63.79 168.99 4.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.033 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.865 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 56.3 m -147.84 160.14 43.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.396 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.583 ' HB3' HG13 ' A' ' 88' ' ' VAL . 81.9 mt -78.67 2.33 19.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -137.34 11.06 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.916 0.865 . . . . 0.0 109.311 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.865 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 11.9 t70 -79.85 162.26 25.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.605 -175.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.563 ' HA ' ' HD3' ' A' ' 119' ' ' LYS . 1.3 tm0? -63.23 -38.23 90.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.701 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.0 129.64 55.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 110.796 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mt -136.83 116.59 16.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.487 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 17.2 m -113.97 122.13 46.0 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.9 123.92 72.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.19 112.2 23.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.32 159.39 13.73 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.047 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -146.11 136.62 24.05 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.728 ' OG1' ' HA ' ' A' ' 127' ' ' ASP . 2.6 m -51.93 -65.82 0.49 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.374 0.421 . . . . 0.0 111.86 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.558 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 52.7 p90 -170.62 157.83 5.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.909 0.385 . . . . 0.0 110.951 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.2 mm -98.43 -50.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.93 22.61 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.906 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 11.8 mmm180 -115.88 119.54 37.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.365 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.85 -11.26 13.93 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.968 2.445 . . . . 0.0 113.696 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -157.43 90.33 1.1 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.154 0.502 . . . . 0.0 110.783 -169.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 64' ' ' PHE . 11.9 p90 -148.46 -160.27 1.15 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.514 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.596 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -41.66 -79.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.769 0.828 . . . . 0.0 112.739 -175.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -106.48 106.05 16.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 m -147.62 -50.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.26 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -91.99 25.29 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.609 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.465 ' HG ' ' CD1' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -67.24 -17.96 65.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.431 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -75.84 -10.34 59.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.731 0.3 . . . . 0.0 110.808 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.01 -6.3 58.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 110.674 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.85 169.4 18.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.556 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -162.95 -171.29 2.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.731 -178.098 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -49.15 -47.21 45.82 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -113.61 62.08 0.32 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -82.14 -15.94 51.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.445 ' CE ' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 55.15 90.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.675 0.75 . . . . 0.0 111.595 -176.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG21 ' HE2' ' A' ' 97' ' ' MET . 39.7 t -87.98 119.9 36.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.417 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -95.91 106.85 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.465 ' HB2' HD12 ' A' ' 121' ' ' LEU . 3.1 t80 -91.23 94.89 9.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.1 tppp? -81.23 86.39 6.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.452 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 91' ' ' GLU . 5.7 m -90.16 90.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.722 0.772 . . . . 0.0 111.006 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.89 -91.96 0.36 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.032 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.09 -4.84 10.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.659 0.266 . . . . 0.0 111.053 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.667 ' HB2' HG22 ' A' ' 88' ' ' VAL . 32.6 mt-10 -97.66 147.63 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.331 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.2 m -124.81 103.66 8.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.118 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.682 ' HG3' ' HE2' ' A' ' 95' ' ' TYR . 6.6 ptm180 -109.81 139.09 45.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.165 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 3.5 ptmm? -108.34 130.57 55.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 111.962 -172.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.682 ' HE2' ' HG3' ' A' ' 93' ' ' ARG . 61.2 m-85 -116.74 152.24 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.427 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.544 ' HE3' HG12 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -115.73 134.36 55.1 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 20.2 mmt -79.27 63.65 3.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.519 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 t -74.6 -23.81 58.78 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.5 m -129.83 96.12 4.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 111.329 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.47 124.48 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.599 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -137.87 159.98 40.52 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.835 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.39 124.67 51.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.63 HG12 HG12 ' A' ' 110' ' ' VAL . 21.6 m -119.32 131.62 71.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.788 0.804 . . . . 0.0 111.473 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.596 ' HG3' ' HG2' ' A' ' 138' ' ' LYS . 3.2 mppt? -98.35 168.43 9.89 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.03 -11.55 27.87 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.43 2.087 . . . . 0.0 112.266 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t -107.88 8.4 28.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.326 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -94.03 134.45 36.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.317 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.39 4.75 8.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.29 -30.79 71.68 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 110.98 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.63 HG12 HG12 ' A' ' 103' ' ' VAL . 17.0 m -84.67 -6.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.165 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.68 -7.46 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.49 157.96 17.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.69 123.36 18.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -77.18 139.47 39.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.98 -154.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -168.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.8 52.82 1.63 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 123.491 0.494 . . . . 0.0 114.235 -169.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -75.7 150.39 37.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 172.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -90.98 -149.4 0.22 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 32.5 mmtp -60.97 124.38 20.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -137.98 138.85 39.32 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.334 0.588 . . . . 0.0 111.911 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 86' ' ' PHE . 36.8 mt -94.1 103.76 15.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.1 m -88.1 91.1 8.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.793 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 26.1 mt -84.4 99.91 10.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.737 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.7 mt -83.05 78.26 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.9 m -87.81 99.61 12.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.975 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 57.1 m -74.23 94.89 2.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.728 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 35.7 t70 -101.69 1.5 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.346 -172.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.711 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 17.7 t0 -112.5 94.46 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.853 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 32.8 t80 -77.43 -26.98 52.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.155 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.5 t30 49.4 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.743 0.783 . . . . 0.0 111.457 -173.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.467 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 20.4 mt-10 -62.71 -8.63 7.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.808 -174.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 57.1 mmtt -60.37 -35.09 74.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 t -159.41 -3.26 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.19 40.07 7.63 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.424 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.44 117.18 53.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.182 0.515 . . . . 0.0 110.032 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.711 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 27.7 m95 -78.51 96.55 5.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.409 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 46.1 mt-10 -86.29 -61.98 1.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.18 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.596 ' HG2' ' HG3' ' A' ' 104' ' ' LYS . 33.8 mtmm -89.31 119.06 29.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.468 ' HB2' HG22 ' A' ' 103' ' ' VAL . 40.8 mtt85 -100.56 114.71 28.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.494 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -89.01 111.0 21.62 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.3 tt -102.42 127.33 56.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.615 0.721 . . . . 0.0 110.694 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.627 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 89.5 m-85 -108.51 112.73 25.27 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.438 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 44.3 t -101.43 97.33 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.428 0.633 . . . . 0.0 109.776 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.607 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -94.7 113.3 25.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.148 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 m -89.01 141.1 28.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.296 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 5.3 tt0 -61.0 115.38 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.544 HG12 ' HE3' ' A' ' 96' ' ' LYS . 5.1 p -117.19 124.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.573 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.4 -0.809 . . . . 0.0 111.223 -176.487 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 39.4 mtmt . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.888 0.375 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.525 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 13.8 Cg_endo -55.64 124.26 15.84 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.862 2.375 . . . . 0.0 111.277 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -141.1 146.79 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.72 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.5 mp -78.62 129.18 74.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.701 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 163.28 39.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.749 2.299 . . . . 0.0 112.863 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.853 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -70.83 -15.68 62.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.695 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.59 121.88 28.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.745 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 37.7 mmtm -95.2 16.62 16.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.417 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -127.04 26.54 6.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.542 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.457 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 64.4 mttm -118.06 176.03 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.409 0.623 . . . . 0.0 112.045 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.0 t -109.54 111.87 38.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.614 173.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -91.04 -21.42 21.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.02 159.41 31.88 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.901 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 57.9 m-85 -114.81 135.68 53.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -101.86 121.22 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.527 0.68 . . . . 0.0 109.791 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.641 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 37.7 mt-10 -124.26 118.75 27.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.449 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -134.21 96.9 15.32 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -54.01 -35.89 82.47 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.324 2.683 . . . . 0.0 112.999 -176.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.8 -29.84 69.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.796 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.71 2.36 27.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.628 0.251 . . . . 0.0 110.976 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HB3' HD22 ' A' ' 69' ' ' ASN . 30.9 t70 65.56 25.97 11.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.836 0.827 . . . . 0.0 110.084 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.445 HD12 HD11 ' A' ' 20' ' ' ILE . 77.1 mt -91.47 125.4 44.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.954 -177.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.641 ' HD2' ' HG2' ' A' ' 19' ' ' GLU . 7.0 mmmt -151.27 54.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 5.5 mm-40 -121.82 153.66 60.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.611 -166.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.89 134.23 10.6 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.966 2.444 . . . . 0.0 112.807 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.07 135.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.329 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.414 ' HD2' ' HA3' ' A' ' 42' ' ' GLY . 51.2 m-85 -101.46 102.71 23.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.036 0.446 . . . . 0.0 109.857 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.2 Cg_endo -71.14 140.93 38.56 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.972 2.448 . . . . 0.0 112.112 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.15 -171.4 43.37 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.79 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.745 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 27.0 Cg_endo -93.73 34.52 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.012 3.141 . . . . 0.0 112.566 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 60.55 27.73 17.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.431 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.71 HG22 ' HB2' ' A' ' 38' ' ' GLN . 2.6 t -62.67 128.58 91.92 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.894 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.57 -44.89 24.73 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 124.093 3.195 . . . . 0.0 113.928 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 39.4 mt-10 -61.07 -49.37 77.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.71 ' HB2' HG22 ' A' ' 35' ' ' THR . 2.8 mp0 -70.69 -26.37 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 mt -75.33 -10.15 59.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -99.48 -5.68 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.362 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 38' ' ' GLN . 57.4 mtp180 -102.03 -30.7 11.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 30' ' ' TYR . . . -170.05 -170.58 34.61 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.797 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -89.95 150.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 117.63 0.715 . . . . 0.0 109.715 176.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.8 t -137.79 178.91 6.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CD2' ' HG2' ' A' ' 50' ' ' GLU . 58.3 m-85 -84.61 172.65 11.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.81 82.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 0.0 110.775 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -157.31 -179.48 8.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.231 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 14.5 tt0 -76.77 -15.56 59.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.616 -174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -87.56 4.46 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.023 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 6.3 tp10 -56.63 127.56 32.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.87 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.9 m -120.02 121.64 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.895 0.379 . . . . 0.0 110.767 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 52.0 mt -72.73 -16.59 61.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.432 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -98.68 2.63 47.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.218 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.87 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 14.0 t70 -86.77 -178.55 6.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.73 -18.46 23.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -116.8 108.33 15.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.777 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.48 105.49 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 1.1 m -101.17 120.86 40.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.209 -175.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mt -112.98 127.74 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 124.1 39.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.974 0.416 . . . . 0.0 110.937 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.62 173.15 18.2 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.093 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -163.45 179.57 7.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 150.38 20.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.679 0.276 . . . . 0.0 110.967 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.462 ' HE2' ' HB3' ' A' ' 66' ' ' ASP . 40.6 t80 -134.37 152.12 51.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.2 mt -81.45 -53.86 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' HE2' ' A' ' 64' ' ' PHE . 23.0 t70 -64.86 -42.52 94.81 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HE ' ' HB3' ' A' ' 70' ' ' TYR . 22.8 mtp180 -106.98 110.18 63.46 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.605 -175.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.59 -8.73 20.82 Favored 'Trans proline' 0 CA--C 1.516 -0.379 0 C-N-CA 123.188 2.592 . . . . 0.0 112.222 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.421 HD22 ' HB3' ' A' ' 24' ' ' ASP . 17.3 t-20 -161.77 86.29 0.64 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.236 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.45 ' HB3' ' HE ' ' A' ' 67' ' ' ARG . 20.7 p90 -113.16 -150.29 0.46 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 22.0 mp0 -44.48 -56.29 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.358 0.411 . . . . 0.0 111.561 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.478 ' HD2' ' C ' ' A' ' 71' ' ' GLN . 2.5 m-85 -128.12 106.77 9.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -154.91 -64.04 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.974 0.416 . . . . 0.0 110.597 175.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -83.58 21.27 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.53 0.681 . . . . 0.0 110.13 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 75' ' ' LEU . 6.9 tt -60.87 -21.56 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.886 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -9.63 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.129 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.44 -3.28 52.47 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 111.299 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.45 162.47 25.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -135.98 -173.52 3.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.291 -178.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 ptpp? -72.93 11.41 0.69 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.27 46.96 0.43 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 m -83.47 132.41 34.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.84 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 73.2 mmm -79.89 102.48 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.121 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 39.2 t -90.25 132.32 35.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.054 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.542 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 72.4 m-85 -114.28 121.65 44.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -111.17 109.91 20.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.075 0.464 . . . . 0.0 110.14 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 30.3 mmtm -81.43 106.44 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.833 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 HG23 HD11 ' A' ' 52' ' ' LEU . 9.2 p -142.04 132.99 25.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 111.264 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.32 -91.92 0.14 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.405 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -140.46 4.03 1.95 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.43 0.634 . . . . 0.0 109.812 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -110.51 164.57 12.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.391 0.615 . . . . 0.0 111.397 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 m -122.89 92.17 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.995 171.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.418 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 19.5 mmt180 -74.36 121.42 21.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.065 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.589 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.26 131.36 41.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.697 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 89.1 m-85 -127.08 149.08 50.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.84 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -117.53 123.52 46.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.4 mtt -81.82 71.13 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.26 0.552 . . . . 0.0 110.588 -176.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.8 t -83.52 -21.92 32.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.911 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.6 m -118.62 110.37 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -129.93 128.85 65.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.531 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.544 HH21 HG13 ' A' ' 110' ' ' VAL . 28.2 ptt180 -170.42 -175.06 1.81 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.423 ' HB3' ' HZ3' ' A' ' 140' ' ' LYS . 2.7 p30 -126.87 152.2 47.36 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 170.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 110' ' ' VAL . 12.3 m -127.44 126.15 66.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -174.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -73.04 158.32 87.28 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.008 171.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.36 -14.06 18.9 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.729 2.286 . . . . 0.0 112.639 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.439 ' OG1' ' HD3' ' A' ' 104' ' ' LYS . 68.6 p -87.88 -3.41 58.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.039 0.447 . . . . 0.0 111.053 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.526 ' HB2' ' HD2' ' A' ' 104' ' ' LYS . 14.2 t70 -82.74 116.77 22.24 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.87 8.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.09 -39.13 23.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.067 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.544 HG13 HH21 ' A' ' 101' ' ' ARG . 19.6 m -77.84 -23.04 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.373 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.39 -27.1 63.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.784 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.46 97.58 10.55 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.194 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -18.38 109.47 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.896 -1.956 . . . . 0.0 114.448 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.42 ' HB2' HE22 ' A' ' 120' ' ' GLN . 1.7 mp0 -78.52 115.6 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.053 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.57 179.52 5.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.267 173.518 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.27 -16.91 48.66 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.24 178.85 4.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.162 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -89.07 -148.44 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.52 109.01 0.55 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.42 HE22 ' HB2' ' A' ' 114' ' ' GLN . 13.1 pt20 -101.79 118.07 36.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.496 0.665 . . . . 0.0 110.019 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HG ' HD23 ' A' ' 123' ' ' LEU . 20.9 tp -83.5 102.11 11.88 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.1 m -90.7 96.83 10.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.256 -174.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.551 HD23 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mt -90.64 102.67 15.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.814 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.1 mt -95.53 97.15 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.252 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.7 m -96.53 98.26 10.08 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.82 100.68 7.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 128' ' ' ASP . 23.7 t70 -136.0 83.23 2.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.699 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 11.3 t70 166.94 99.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.065 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -87.66 132.42 34.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.527 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 22.7 t-20 -103.94 114.19 28.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.573 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.52 -19.2 46.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 0.0 111.332 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -63.15 -38.14 90.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.166 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.473 HG22 ' OD1' ' A' ' 130' ' ' ASN . 14.2 t -131.85 -11.28 3.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 0.0 111.611 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.43 26.95 26.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.743 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.54 -177.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 117.09 0.445 . . . . 0.0 110.905 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.699 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 58.3 m95 -115.78 104.49 11.71 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 130' ' ' ASN . 43.2 mt-10 -67.86 -58.91 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.953 -172.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HB3' ' CB ' ' A' ' 128' ' ' ASP . 26.7 ttpp -80.97 91.34 6.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.184 0.992 . . . . 0.0 110.582 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -93.99 100.85 12.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.335 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.423 ' HZ3' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -74.82 125.59 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.981 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.93 119.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.987 0.899 . . . . 0.0 111.191 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.479 ' HD2' ' SD ' ' A' ' 97' ' ' MET . 10.4 m-85 -108.67 108.9 19.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.314 175.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 72.0 t -94.22 106.63 18.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.282 0.563 . . . . 0.0 109.956 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -105.14 108.5 20.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.76 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.5 m -79.47 137.26 37.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.418 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 38.0 tt0 -55.6 123.59 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 96' ' ' LYS . 5.7 t -80.81 154.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.417 ' HG2' HG11 ' A' ' 147' ' ' VAL . 10.6 ptpt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.525 -0.75 . . . . 0.0 112.189 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.752 0.311 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.512 ' CB ' ' HB ' ' A' ' 88' ' ' VAL . 36.7 Cg_endo -64.66 124.8 13.77 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.755 2.304 . . . . 0.0 111.532 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -153.18 177.12 11.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.589 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 31' ' ' PRO . 45.9 mt -106.37 105.3 53.82 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.131 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.21 169.68 12.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.675 2.25 . . . . 0.0 112.674 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HZ3' ' CD ' ' A' ' 48' ' ' GLU . 17.4 mtpp -84.96 -21.21 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.787 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.437 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 25.5 t70 -68.89 108.46 3.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.062 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -90.5 19.05 5.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.877 -168.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -112.11 8.35 19.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 35.8 mttp -111.87 178.67 4.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.531 0.681 . . . . 0.0 112.146 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.703 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.614 ' HB3' HD11 ' A' ' 52' ' ' LEU . . . -82.58 -41.85 19.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.286 0.565 . . . . 0.0 110.189 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.97 160.76 33.28 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 38.2 m-85 -102.06 133.47 46.83 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -101.82 114.19 40.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.59 0.709 . . . . 0.0 110.269 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.6 mt-10 -114.95 117.09 29.64 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.042 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 65.0 mt -131.15 94.03 28.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.01 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.36 -16.12 52.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.259 2.64 . . . . 0.0 112.794 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.59 ' HB3' ' HG ' ' A' ' 82' ' ' SER . 33.7 t70 -81.91 -28.43 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.557 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.81 20.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.998 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.41 20.26 10.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.585 0.707 . . . . 0.0 111.21 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 72.0 mt -91.09 114.7 28.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.437 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.8 mppt? -142.79 84.9 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.623 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 4.4 mt-10 -146.41 158.65 46.84 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.782 0.325 . . . . 0.0 111.581 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.0 136.61 16.63 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.907 2.404 . . . . 0.0 112.627 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.64 134.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.146 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' SER . 35.1 m-85 -97.32 121.49 58.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.581 . . . . 0.0 111.13 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HB2' HG22 ' A' ' 7' ' ' ILE . 86.0 Cg_endo -85.92 148.37 9.46 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.334 2.689 . . . . 0.0 112.705 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.91 -169.52 36.56 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.891 172.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.85 13.18 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 123.808 3.006 . . . . 0.0 112.77 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.83 75.57 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.164 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.8 p -97.33 164.53 17.51 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.664 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.34 -37.93 81.78 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.203 1.935 . . . . 0.0 111.339 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.4 mm-40 -59.14 -44.25 92.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.777 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.2 mp0 -59.68 -42.95 94.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.49 -9.58 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.811 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.56 -31.76 12.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.735 0.303 . . . . 0.0 111.155 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.7 ptp180 -87.24 -19.84 27.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.989 0.423 . . . . 0.0 110.614 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.76 -127.26 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.287 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 60' ' ' ALA . 93.9 t -126.92 141.66 45.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.792 ' HB2' ' HB3' ' A' ' 38' ' ' GLN . 41.8 t -119.74 163.65 17.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.214 0.53 . . . . 0.0 110.775 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 7' ' ' ILE . 55.6 m-85 -71.87 159.66 33.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.754 172.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.46 -49.12 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -140.07 166.32 24.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.43 ' CD ' ' HZ3' ' A' ' 9' ' ' LYS . 12.0 tt0 -80.14 -19.83 46.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.28 0.562 . . . . 0.0 110.043 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.04 4.8 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.068 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.24 163.47 23.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.967 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 23.2 t -122.36 177.1 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.614 HD11 ' HB3' ' A' ' 15' ' ' ALA . 85.0 mt -110.17 -16.08 13.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.641 0.257 . . . . 0.0 111.171 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.09 12.11 16.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.893 0.854 . . . . 0.0 109.374 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.967 ' HB2' ' HB3' ' A' ' 51' ' ' SER . 3.1 t70 -79.31 179.18 7.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.413 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -21.85 46.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -131.3 129.24 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.638 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.471 ' HB ' HD21 ' A' ' 121' ' ' LEU . 5.3 mp -129.68 101.75 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.545 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 5.4 m -93.04 125.33 37.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.5 mt -119.13 138.88 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.516 ' O ' HG12 ' A' ' 43' ' ' VAL . . . -117.91 122.35 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.51 166.7 14.32 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.852 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.57 38.02 0.68 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.326 0.563 . . . . 0.0 111.431 -174.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.434 HG21 ' H ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 56.03 -158.75 0.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 -174.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.434 ' H ' HG21 ' A' ' 63' ' ' THR . 47.5 p90 -120.47 178.61 4.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.442 0.639 . . . . 0.0 112.344 -170.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 62.2 mt -128.27 -53.68 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.011 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.42 49.02 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.196 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -142.76 105.49 5.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.161 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.62 -16.5 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.971 1.781 . . . . 0.0 111.601 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -154.78 82.31 1.09 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.749 -176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -122.17 -176.97 3.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.623 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -38.24 -71.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 123' ' ' LEU . 2.5 m-30 -105.66 76.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.765 -0.584 . . . . 0.0 111.446 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.89 -58.36 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.674 0.749 . . . . 0.0 110.259 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -100.34 21.05 13.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.407 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.455 HD22 ' OG1' ' A' ' 125' ' ' THR . 40.8 tp -63.75 -23.18 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.786 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -13.54 62.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.976 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.05 9.72 26.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.662 0.268 . . . . 0.0 111.299 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.482 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -91.67 141.39 28.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.45 . . . . 0.0 111.333 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 82' ' ' SER . 10.6 mptt -109.71 -179.0 3.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.805 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.8 ptpt -57.3 -41.37 79.72 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.49 47.65 1.32 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.719 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.59 ' HG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -66.82 -17.21 64.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.596 0.358 . . . . 0.0 111.895 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.494 ' HE1' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 53.66 86.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.52 0.676 . . . . 0.0 111.727 -174.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -88.37 114.81 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.251 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 76.1 m-85 -101.43 105.4 16.42 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.79 106.93 19.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.7 mmtp -90.91 92.57 8.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.11 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.842 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.8 m -90.67 92.37 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.672 0.748 . . . . 0.0 110.179 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.58 -88.99 0.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.51 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.05 0.28 5.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.151 0.501 . . . . 0.0 110.083 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.842 ' HB2' HG23 ' A' ' 88' ' ' VAL . 9.5 mm-40 -92.18 119.03 31.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.495 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 m -92.54 106.04 18.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.576 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -94.96 136.57 35.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.623 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -114.55 118.85 34.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -177.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 71.9 m-85 -118.03 145.7 44.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.398 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -110.23 138.76 46.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.618 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.8 mmt -81.0 68.06 7.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.141 0.496 . . . . 0.0 110.15 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -75.73 -20.9 58.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.859 -172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 51.0 m -133.03 101.59 5.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.175 0.512 . . . . 0.0 111.17 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 97' ' ' MET . 78.5 mt -119.03 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.266 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -157.97 176.2 12.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.355 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 10.6 p-10 -134.98 128.39 32.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.976 0.417 . . . . 0.0 110.135 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.869 HG13 HG11 ' A' ' 110' ' ' VAL . 31.6 m -129.05 179.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.39 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -102.99 158.0 32.62 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.075 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.75 -15.19 40.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.929 2.419 . . . . 0.0 112.585 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.3 t -96.26 -7.13 36.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.905 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB2' ' HE2' ' A' ' 104' ' ' LYS . 9.9 t0 -84.78 97.94 9.98 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.542 ' HA ' HD22 ' A' ' 111' ' ' LEU . 29.6 m -100.06 8.25 8.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.821 0.343 . . . . 0.0 111.715 -170.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -93.43 -15.47 25.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.869 HG11 HG13 ' A' ' 103' ' ' VAL . 22.5 m -76.44 -23.71 15.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.547 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -97.41 34.54 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.09 0.471 . . . . 0.0 111.064 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -70.16 169.66 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.25 105.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.459 0.647 . . . . 0.0 110.789 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -82.21 45.33 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.466 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 174.57 10.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.33 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.86 13.25 78.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.744 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -110.44 -170.69 1.69 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.082 0.468 . . . . 0.0 110.193 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.73 -163.58 0.86 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.35 110.02 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.11 143.22 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.237 0.541 . . . . 0.0 111.446 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 57' ' ' ILE . 70.6 mt -96.27 125.22 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.316 174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 12.0 m -97.69 92.43 5.88 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.3 mm? -87.45 100.69 12.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.236 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.98 97.84 7.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.455 ' OG1' HD22 ' A' ' 75' ' ' LEU . 2.4 m -102.91 102.11 12.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.963 0.411 . . . . 0.0 109.925 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 20.6 m -85.89 100.4 12.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -115.5 177.55 4.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.342 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.26 83.34 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.739 0.649 . . . . 0.0 111.003 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.688 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -102.91 170.67 7.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.413 0.625 . . . . 0.0 111.919 -172.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -104.9 92.34 4.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.058 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 38.2 mt-10 -44.56 -37.9 3.86 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.36 -29.01 70.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.6 t -126.44 -14.84 5.76 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.509 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.687 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.3 m -75.15 146.48 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 117.437 0.618 . . . . 0.0 110.251 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.688 ' CE3' ' HB3' ' A' ' 129' ' ' TYR . 85.1 m95 -94.14 111.91 23.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -70.6 -53.73 14.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.382 -172.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -90.71 85.09 5.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 0.0 111.405 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 35.7 ptt180 -80.64 79.94 7.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 85.0 tttt -70.15 123.23 21.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.067 -174.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -107.8 125.52 64.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.687 0.756 . . . . 0.0 110.741 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.618 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 37.2 m-85 -109.05 110.83 22.2 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 84.3 t -96.91 103.33 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.405 0.621 . . . . 0.0 109.556 176.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.573 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -101.75 102.37 13.0 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.35 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -87.62 139.5 30.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 7.3 tt0 -55.21 128.61 34.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.941 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 5.9 p -96.48 155.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.128 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.089 -175.263 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' HE2' ' A' ' 17' ' ' TYR . 83.6 mtp . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.528 0.204 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.503 ' NE2' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -156.96 -171.8 3.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.733 177.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.41 136.86 38.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt 54.6 94.69 0.05 OUTLIER Pre-proline 0 C--O 1.233 0.197 0 O-C-N 123.729 0.643 . . . . 0.0 110.674 -169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 29.2 Cg_endo -57.78 115.02 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.899 2.399 . . . . 0.0 112.954 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.503 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 2.6 pt20 -146.84 168.22 21.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.752 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.592 HG21 ' HB2' ' A' ' 31' ' ' PRO . 46.6 mt -104.18 120.88 49.49 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.39 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 2.4 Cg_endo -83.88 179.68 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.122 2.548 . . . . 0.0 112.321 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -79.1 -25.24 43.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.05 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.38 116.21 8.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 110.259 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HA ' ' HE3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -92.89 16.33 12.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.735 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 t -108.54 -29.09 8.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -89.3 174.37 7.87 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.207 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.63 128.67 52.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -80.77 -41.24 23.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.09 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.77 164.09 35.61 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.443 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 72.7 m-85 -107.36 140.88 39.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.899 0.35 . . . . 0.0 110.267 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.4 tp -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.364 0.602 . . . . 0.0 110.113 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.1 mt-10 -120.76 111.88 18.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.638 0.732 . . . . 0.0 111.262 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.8 mt -124.86 93.91 45.1 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.75 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.71 -28.71 87.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.006 2.471 . . . . 0.0 112.283 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.0 -23.19 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.934 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.75 7.3 18.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.905 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 64.68 27.21 13.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.6 mt -106.64 122.28 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.0 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.27 75.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 167.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 67.8 mm-40 -122.0 162.02 39.43 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.68 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 69.0 Cg_endo -77.09 128.05 9.64 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.793 2.328 . . . . 0.0 113.321 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.15 124.93 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.83 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 44' ' ' SER . 62.8 m-85 -93.76 123.26 60.26 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.246 0.545 . . . . 0.0 110.966 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HB2' HG21 ' A' ' 7' ' ' ILE . 68.6 Cg_endo -76.14 107.92 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.64 2.227 . . . . 0.0 111.289 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.9 167.22 33.18 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.734 -1.222 . . . . 0.0 112.8 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.457 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 88.5 Cg_endo -87.58 31.75 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.889 3.059 . . . . 0.0 112.544 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 62.25 26.88 16.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.202 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -70.32 142.61 89.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.722 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -39.44 -55.52 1.55 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.861 3.04 . . . . 0.0 114.852 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.41 -24.06 67.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -69.4 -39.63 77.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.14 0.495 . . . . 0.0 109.698 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 94.0 mt -80.96 -23.41 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.19 -24.52 63.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -103.86 -22.65 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.674 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -175.3 -156.68 14.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.161 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.454 HG13 ' CE1' ' A' ' 72' ' ' PHE . 28.5 m -92.27 154.58 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 29.6 t -135.51 163.37 30.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.993 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 58' ' ' SER . 31.1 m-85 -74.67 162.34 28.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.49 70.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.931 0.396 . . . . 0.0 110.689 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -137.9 176.14 8.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.666 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.745 0.783 . . . . 0.0 109.305 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -88.33 -22.08 24.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.855 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -76.58 171.97 13.78 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.941 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 66.5 m -154.1 165.32 36.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.948 0.404 . . . . 0.0 110.543 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.51 HD12 ' CG2' ' A' ' 88' ' ' VAL . 15.7 mt -79.43 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.971 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -101.29 -3.06 29.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.584 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -82.66 170.92 14.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.97 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -85.94 -20.76 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -107.69 108.01 19.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.644 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.98 111.66 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 12.2 m -117.31 116.6 27.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.877 0.37 . . . . 0.0 111.014 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.71 121.12 53.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.227 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.04 116.44 22.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.338 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.6 114.31 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.188 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -87.9 84.62 6.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.3 m -68.85 140.37 55.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.534 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.83 150.88 40.52 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.308 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.4 mt -91.98 -43.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -50.72 -43.52 57.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.353 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.5 mtp85 -100.18 124.29 43.79 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.856 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -87.42 -16.62 3.1 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.788 2.326 . . . . 0.0 113.012 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -138.84 73.41 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.184 0.516 . . . . 0.0 110.888 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -119.33 -161.16 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 43.8 mt-30 -60.21 -77.76 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CE1' HG13 ' A' ' 43' ' ' VAL . 3.1 m-85 -84.59 19.02 2.09 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -47.63 78.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -101.96 12.03 37.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -172.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.94 -16.73 64.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.365 0.602 . . . . 0.0 110.337 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -8.88 56.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.787 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.35 1.72 56.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 110.933 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.1 165.56 23.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.111 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 97' ' ' MET . 11.2 pttm -158.08 -170.92 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.896 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.674 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.1 ptpt -54.4 -39.14 66.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -117.68 59.78 0.47 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.443 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -84.22 -5.22 59.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.513 ' HE1' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 50.56 85.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.638 0.586 . . . . 0.0 111.694 -177.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 45.5 t -86.66 112.31 22.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.96 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.2 m-85 -100.84 107.93 19.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.525 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 12.6 t80 -99.11 102.1 13.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -82.7 88.97 6.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.361 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 52' ' ' LEU . 7.5 p -117.44 124.43 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 111.589 -170.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.24 -57.1 1.13 Allowed Glycine 0 CA--C 1.509 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.718 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -169.11 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.427 0.632 . . . . 0.0 110.223 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.06 154.94 20.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.252 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 m -98.0 100.92 12.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.33 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 51.1 mmt-85 -82.27 112.43 19.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.116 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.721 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.09 128.78 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.607 . . . . 0.0 110.56 177.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.556 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 72.1 m-85 -121.92 151.43 40.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.395 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.59 ' HE3' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -117.67 138.28 52.09 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.674 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 19.3 mmt -80.61 68.35 6.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.263 0.554 . . . . 0.0 110.311 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.92 -38.8 36.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.713 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.579 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 33.4 m -110.27 103.68 12.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.053 0.454 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.507 HD12 ' HB3' ' A' ' 97' ' ' MET . 82.8 mt -123.49 126.06 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 7.1 ptm180 -159.77 -175.59 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.526 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 3.3 p30 -136.4 144.79 44.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.794 HG11 HG11 ' A' ' 110' ' ' VAL . 28.7 m -126.41 -169.16 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.787 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.616 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -136.89 160.39 66.48 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.422 -176.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.87 -20.82 30.65 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.645 2.23 . . . . 0.0 112.307 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.1 p -91.7 8.21 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.037 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' HB2' ' HE2' ' A' ' 104' ' ' LYS . 24.7 t0 -107.71 97.3 7.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.6 m -104.99 16.2 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.222 0.534 . . . . 0.0 110.591 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -104.74 -2.32 25.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.328 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.794 HG11 HG11 ' A' ' 103' ' ' VAL . 13.5 m -96.83 -39.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.979 0.419 . . . . 0.0 110.899 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -86.35 86.96 7.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.462 1.125 . . . . 0.0 108.743 173.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.7 -164.39 1.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.991 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.486 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 7.1 pt-20 -77.7 71.26 4.17 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 111.344 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -86.3 47.88 1.54 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HE2' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -71.64 172.57 9.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.203 -176.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.14 -14.21 36.99 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -92.6 175.21 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 110.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -89.62 -157.32 0.45 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 108.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -104.4 130.62 52.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 110.498 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -96.09 104.02 15.94 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.0 m -88.67 98.22 11.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.469 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -83.13 103.06 12.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.8 mt -96.71 89.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.876 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 m -95.48 101.8 13.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 -175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.8 m -84.06 115.58 22.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -120.33 158.56 26.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.131 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 t70 70.14 98.97 0.06 Allowed 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.91 0.757 . . . . 0.0 110.986 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -86.58 130.02 34.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.619 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -97.16 101.51 13.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.5 -17.16 64.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.573 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -71.16 -27.73 63.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.2 t -133.9 -23.44 1.77 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.79 26.73 8.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.641 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.88 174.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 117.027 0.413 . . . . 0.0 110.963 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -110.83 116.95 32.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.7 -50.95 30.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.149 -170.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.731 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 11.0 mmpt? -95.07 100.41 12.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.158 0.504 . . . . 0.0 111.243 -174.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.48 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 68.7 mtm180 -91.9 83.59 5.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.526 ' HD3' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -64.58 129.69 40.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.293 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.413 HG23 ' O ' ' A' ' 141' ' ' ILE . 11.8 tt -126.67 114.57 38.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 122.234 1.016 . . . . 0.0 110.851 -173.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.627 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 67.4 m-85 -108.12 104.7 14.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.01 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 37.8 t -90.97 93.25 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.703 0.763 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.604 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -88.39 105.14 17.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.661 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.3 m -84.37 142.61 30.03 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.803 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -53.38 114.45 1.5 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 109.873 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.59 HG23 ' HE3' ' A' ' 96' ' ' LYS . 7.3 p -94.28 148.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.351 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.444 -179.745 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.48 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -104.62 172.64 6.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.022 0.439 . . . . 0.0 110.848 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.75 90.65 8.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 55.2 mtmt -105.43 101.93 34.41 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.843 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.649 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.9 Cg_endo -57.38 126.67 22.74 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.31 2.673 . . . . 0.0 112.349 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -158.06 162.39 38.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 31' ' ' PRO . 22.6 mt -99.36 123.32 48.87 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.807 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.77 -172.75 1.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.864 2.376 . . . . 0.0 113.008 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -90.92 -14.45 31.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.546 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.45 145.56 25.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.85 0.357 . . . . 0.0 110.628 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -99.55 5.34 46.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.039 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -111.34 9.75 21.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.573 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -110.34 171.96 7.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 111.644 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.51 118.0 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.81 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' HB1' ' HG3' ' A' ' 31' ' ' PRO . . . -92.32 -25.07 18.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.233 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.96 177.92 45.21 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.292 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 69.1 m-85 -123.78 136.5 54.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.412 HG21 ' O ' ' A' ' 18' ' ' ILE . 8.1 tp -109.99 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 122.256 1.027 . . . . 0.0 110.085 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -115.2 108.66 16.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.71 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.462 HG12 HG11 ' A' ' 84' ' ' VAL . 25.4 mt -121.34 94.88 48.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.212 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.48 -28.02 70.53 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 122.745 2.297 . . . . 0.0 111.225 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.558 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 34.2 t70 -67.45 -24.94 65.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.572 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -118.01 11.81 13.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.321 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t0 59.39 30.01 19.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.657 0.741 . . . . 0.0 111.063 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.427 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 84.5 mt -97.78 121.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.085 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 2.4 mppt? -145.03 80.73 1.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -154.01 158.82 32.49 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.644 0.259 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 71.1 Cg_endo -75.06 163.52 35.07 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.922 2.414 . . . . 0.0 113.054 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.82 133.41 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.809 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 44' ' ' SER . 68.2 m-85 -106.45 118.87 53.55 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.325 -178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.519 ' HG3' ' HB1' ' A' ' 15' ' ' ALA . 75.1 Cg_endo -85.69 162.8 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.924 2.416 . . . . 0.0 113.224 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.01 -173.75 34.62 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.457 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.75 6.52 4.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.233 2.622 . . . . 0.0 112.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.956 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.646 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 71.1 p -111.61 163.95 16.27 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.414 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.646 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 53.8 Cg_exo -38.28 -48.04 2.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.092 3.195 . . . . 0.0 115.361 -173.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -30.14 66.18 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.674 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.5 mp0 -64.93 -43.59 92.25 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.837 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.0 12.08 6.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.91 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.5 ' HA ' ' HZ ' ' A' ' 64' ' ' PHE . 55.2 t-20 -107.77 -47.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.449 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 41' ' ' ARG . 13.3 ptm180 -83.58 -26.0 30.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.278 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.4 -139.86 2.75 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.339 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.525 HG11 HE21 ' A' ' 71' ' ' GLN . 11.6 p -124.57 145.28 32.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.674 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 62.4 m -133.31 -177.39 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -95.82 166.79 11.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.477 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.042 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -149.2 170.48 18.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.141 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -78.18 -23.49 47.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -84.62 -1.47 56.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.34 145.37 51.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -128.04 150.67 49.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.753 0.311 . . . . 0.0 111.032 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.8 mt -80.8 -16.57 53.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.388 0.613 . . . . 0.0 110.221 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.27 -4.33 58.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.632 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.83 164.3 22.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.229 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.592 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.36 -21.85 59.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 177.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.77 145.55 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.0 110.16 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.425 ' HB ' HD21 ' A' ' 121' ' ' LEU . 4.0 mp -125.99 115.05 41.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.839 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -88.99 107.2 18.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.611 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.1 mt -105.02 122.9 58.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.72 126.71 42.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.192 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.7 158.98 20.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.07 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -149.39 93.95 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 m -62.09 148.51 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.5 ' HZ ' ' HA ' ' A' ' 40' ' ' ASN . 88.5 m-85 -118.19 172.21 7.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.662 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.01 -42.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.852 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.89 -4.99 59.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.724 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -117.72 111.14 39.65 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.737 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.58 -10.01 20.15 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.812 2.341 . . . . 0.0 112.347 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -155.64 84.49 1.04 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 110.966 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.416 ' CE2' ' HA ' ' A' ' 63' ' ' THR . 10.2 p90 -108.56 -168.87 1.41 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.525 HE21 HG11 ' A' ' 43' ' ' VAL . 10.0 mm100 -38.33 -69.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE1' HG23 ' A' ' 43' ' ' VAL . 19.5 m-30 -114.41 78.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.233 -0.292 . . . . 0.0 111.625 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.02 -50.86 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.566 0.698 . . . . 0.0 110.508 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 64.0 t30 -87.17 30.62 0.76 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.157 -172.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.77 -9.54 54.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.371 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -9.62 59.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.033 0.444 . . . . 0.0 111.003 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.16 -6.86 43.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.1 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -79.77 127.14 31.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -111.54 -169.08 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.465 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.04 -44.62 95.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.641 -176.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -99.92 52.94 0.99 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.892 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.4 t -62.96 -21.64 66.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.167 -0.516 . . . . 0.0 111.404 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.461 ' HE3' ' HA ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 50.17 76.01 0.16 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.513 -174.69 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.8 t -81.46 122.68 36.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.24 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -100.11 99.69 10.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.188 0.518 . . . . 0.0 109.753 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -101.52 109.58 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.423 ' HG2' HG22 ' A' ' 92' ' ' THR . 94.5 mttt -97.21 135.5 39.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.081 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.649 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.2 m -141.36 107.95 2.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.85 -102.2 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.352 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' H ' HD21 ' A' ' 90' ' ' ASN . 0.1 OUTLIER -115.26 5.65 14.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.809 0.338 . . . . 0.0 110.868 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HB2' HG23 ' A' ' 88' ' ' VAL . 40.9 mt-10 -102.43 113.63 27.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.423 HG22 ' HG2' ' A' ' 87' ' ' LYS . 19.0 m -95.57 97.5 9.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 171.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 93' ' ' ARG . 16.9 mtp85 -93.27 135.88 34.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.192 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -98.68 130.56 45.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.513 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 92.7 m-85 -122.63 137.26 54.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.93 0.395 . . . . 0.0 110.611 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.584 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -109.69 131.3 55.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.586 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 22.4 mmt -80.73 76.1 7.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.389 0.614 . . . . 0.0 110.379 -175.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 t -86.97 -12.05 48.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.789 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.7 m -137.11 100.62 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 0.0 110.504 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.466 HD12 ' HB3' ' A' ' 97' ' ' MET . 74.4 mt -119.5 122.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.353 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -161.2 -176.73 5.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.905 0.383 . . . . 0.0 110.653 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.618 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 1.1 p30 -131.52 141.02 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 110' ' ' VAL . 35.3 m -121.17 -176.0 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.143 0.497 . . . . 0.0 111.226 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -111.48 157.2 39.85 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.644 -176.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.21 -10.89 14.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.681 2.254 . . . . 0.0 112.643 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -117.16 17.89 14.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.26 129.91 39.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.228 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.89 30.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.63 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.96 -7.15 9.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.688 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG12 HG13 ' A' ' 103' ' ' VAL . 16.0 m -92.39 -19.11 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.3 0.571 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.458 HD11 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.2 19.97 16.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -116.19 145.14 43.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.388 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 49.34 67.53 0.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.536 0.522 . . . . 0.0 111.375 -174.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.39 89.51 7.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.619 0.724 . . . . 0.0 109.369 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 160.6 28.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.297 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.27 62.08 0.8 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.103 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -59.84 176.64 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.331 0.586 . . . . 0.0 111.178 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -83.04 -170.12 2.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 4.4 mptp? -64.09 112.69 3.11 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.12 131.79 56.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.311 0.577 . . . . 0.0 111.204 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.425 HD21 ' HB ' ' A' ' 57' ' ' ILE . 67.4 mt -86.01 121.22 28.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m -102.88 94.78 5.76 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 24.9 mt -83.84 100.33 10.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.923 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.3 mt -90.54 93.47 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.747 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.3 m -98.25 95.78 7.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.111 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.2 m -78.82 111.92 15.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.606 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.17 178.41 6.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.708 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.21 82.28 0.18 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.566 0.698 . . . . 0.0 110.233 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -83.54 126.45 32.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.529 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -95.48 100.85 12.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.34 -18.07 65.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.481 -174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -74.53 -27.21 60.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.439 HG22 HG12 ' A' ' 135' ' ' VAL . 8.1 t -124.58 -20.33 5.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.783 0.325 . . . . 0.0 111.191 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.67 46.39 6.39 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.439 HG12 HG22 ' A' ' 133' ' ' THR . 5.6 p -139.76 156.7 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.0 110.355 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -93.76 115.28 27.7 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.05 -40.32 53.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -170.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -104.26 126.9 51.76 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.458 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -103.73 89.2 3.26 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.618 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 51.6 tptt -71.86 123.21 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.1 tt -121.01 124.01 71.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.869 0.842 . . . . 0.0 111.03 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 21.0 m-85 -113.99 108.11 16.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.837 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.9 t -99.52 106.06 18.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.431 0.634 . . . . 0.0 110.088 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.586 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.66 112.08 25.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.268 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.6 m -87.06 139.23 30.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.085 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.82 117.82 6.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.441 0.639 . . . . 0.0 111.291 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.523 HG12 ' HE3' ' A' ' 96' ' ' LYS . 3.3 p -114.11 134.35 57.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.5 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.106 -177.236 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.84 -170.25 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.428 0.632 . . . . 0.0 110.742 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.35 99.62 7.13 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.118 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HE3' ' OD1' ' A' ' 53' ' ' ASP . 40.4 mtpt -133.12 88.5 36.17 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.571 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HG2' HG22 ' A' ' 88' ' ' VAL . 20.0 Cg_exo -66.21 145.37 78.19 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.004 2.47 . . . . 0.0 112.442 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -123.99 154.21 40.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.097 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.479 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.8 mp -73.64 122.77 88.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.81 167.36 17.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.917 2.411 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -78.85 -12.55 60.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.29 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -99.15 118.82 36.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.673 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -95.53 21.86 7.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.385 -173.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 m -108.33 4.23 24.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.292 0.568 . . . . 0.0 110.322 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 98.5 mttt -102.94 -176.56 3.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.099 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.49 135.22 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.222 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.607 ' HB3' HD11 ' A' ' 52' ' ' LEU . . . -97.53 -35.43 10.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 110.493 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.07 163.29 34.22 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 49.8 m-85 -106.24 134.93 48.59 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 18' ' ' ILE . 8.0 tp -100.33 108.1 22.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.834 0.825 . . . . 0.0 109.782 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.526 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 59.0 mt-10 -115.8 111.02 19.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.232 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 46.2 mt -124.42 92.33 48.21 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.722 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -52.82 -34.62 66.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.317 2.678 . . . . 0.0 112.957 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.602 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 5.4 m-20 -58.6 -38.38 77.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.659 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -103.53 8.92 37.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 t70 54.72 38.72 30.58 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.239 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 27' ' ' GLU . 65.5 mt -100.75 127.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.257 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -143.57 29.77 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.826 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 7.0 mm-40 -88.74 149.05 43.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.965 -163.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.76 141.58 24.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.293 1.996 . . . . 0.0 111.795 173.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.87 124.75 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -95.77 108.92 43.36 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.791 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.544 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 87.9 Cg_endo -76.69 152.0 32.66 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.744 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.66 -167.78 33.16 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.421 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.44 30.63 0.53 Allowed 'Trans proline' 0 CA--C 1.519 -0.253 0 C-N-CA 123.494 2.796 . . . . 0.0 112.445 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.85 82.9 0.16 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.528 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.21 137.51 24.84 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.048 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.567 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 18.9 Cg_endo -58.7 -27.42 83.28 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.935 2.423 . . . . 0.0 113.381 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 41.8 mt-10 -90.87 -33.62 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -76.63 -30.91 57.08 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.004 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.0 tp -84.89 -5.05 59.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.94 0.876 . . . . 0.0 109.367 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 48.3 t-20 -81.47 -56.05 4.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.283 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -82.8 -26.4 31.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.89 -136.47 3.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.339 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.33 147.35 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 t -130.26 -171.79 2.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.852 0.358 . . . . 0.0 110.181 -175.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -93.1 174.46 7.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.329 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.87 -52.82 8.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -127.99 177.02 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.47 -18.04 52.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -82.43 -2.16 52.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.934 0.397 . . . . 0.0 110.755 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 138.43 57.61 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 38.4 m -122.38 -172.83 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' A' ' 15' ' ' ALA . 65.7 mt -111.95 -18.71 12.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.632 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' OD1' ' HE3' ' A' ' 4' ' ' LYS . 36.7 t70 -126.52 13.1 7.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.801 0.81 . . . . 0.0 110.184 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 18.8 t70 -81.17 160.83 24.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.239 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.34 -25.53 66.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.826 0.346 . . . . 0.0 110.293 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -108.72 110.71 22.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.789 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 mm -119.2 90.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -92.83 108.73 20.22 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.158 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.9 mt -102.58 121.47 53.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 115.46 27.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.63 167.04 15.95 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.403 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -154.16 153.66 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.453 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 20.0 m -84.91 141.71 30.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 66' ' ' ASP . 45.3 t80 -125.23 107.92 11.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -51.39 -39.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.27 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.447 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 18.8 t70 -73.23 -22.06 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -109.45 129.74 23.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.96 -0.462 . . . . 0.0 111.069 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.72 -5.0 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.976 2.451 . . . . 0.0 113.152 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.91 77.44 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.287 0.565 . . . . 0.0 110.67 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.453 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 30.6 p90 -140.54 -166.97 2.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.804 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.826 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.7 mm100 -43.55 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.075 0.859 . . . . 0.0 112.738 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -106.2 79.66 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.065 0.46 . . . . 0.0 111.002 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -111.48 -52.18 2.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.658 0.742 . . . . 0.0 109.862 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.5 t30 -97.5 19.92 12.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.211 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.21 -16.47 62.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.206 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -9.73 50.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.717 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.26 16.32 11.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.83 147.69 22.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.944 0.402 . . . . 0.0 111.167 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.602 ' HE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -150.59 -172.66 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.407 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 97' ' ' MET . 20.1 ptmt -47.05 -49.78 20.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -171.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.528 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -115.59 59.96 0.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 119.71 -1.233 . . . . 0.0 112.294 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 30.5 m -79.61 -2.44 42.57 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.886 -0.185 . . . . 0.0 111.43 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.499 ' HE2' ' HE2' ' A' ' 96' ' ' LYS . 0.1 OUTLIER 49.7 78.01 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.587 0.554 . . . . 0.0 111.453 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 41.5 t -79.69 112.3 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.722 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -97.86 109.15 21.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.852 0.358 . . . . 0.0 110.084 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -94.07 101.89 13.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.8 tptm -85.63 92.22 8.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.768 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 5' ' ' PRO . 7.3 p -119.47 126.6 75.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.18 0.514 . . . . 0.0 111.091 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.03 -101.02 0.27 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.942 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -125.22 1.85 7.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 0.0 110.273 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.23 132.39 50.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.411 HG21 ' HD3' ' A' ' 87' ' ' LYS . 2.2 m -101.7 87.16 3.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -92.85 128.93 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.137 0.494 . . . . 0.0 110.456 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.44 139.16 32.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.741 -173.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.519 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 77.8 m-85 -122.67 148.88 44.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.784 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -119.16 132.26 55.95 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.641 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 61.6 mtt -82.53 69.67 9.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.379 0.609 . . . . 0.0 110.562 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -75.7 -26.97 58.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.224 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -120.19 108.77 14.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.567 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.31 126.77 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.728 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.544 HH22 ' HB2' ' A' ' 109' ' ' GLU . 25.5 ptt180 -168.1 -177.07 3.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.245 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -120.66 139.96 52.28 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.487 HG23 HG12 ' A' ' 110' ' ' VAL . 31.3 m -129.43 -178.01 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.824 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.518 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -105.55 157.64 34.07 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.271 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -21.49 72.06 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.447 2.098 . . . . 0.0 111.637 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 t -118.8 26.9 9.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.6 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.544 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 19.3 t70 -63.04 152.84 35.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.934 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.16 -14.11 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.926 0.393 . . . . 0.0 111.376 -170.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.544 ' HB2' HH22 ' A' ' 101' ' ' ARG . 43.4 mt-10 -88.44 -29.55 20.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.124 0.488 . . . . 0.0 109.749 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.487 HG12 HG23 ' A' ' 103' ' ' VAL . 22.9 m -79.34 -6.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.391 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 86.0 mt -88.32 3.29 50.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.287 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 7.2 t70 -109.63 -172.51 2.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.349 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.409 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 5.5 pt-20 -130.45 112.26 13.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.14 74.13 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 111.277 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.75 161.29 30.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.282 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.01 6.09 63.6 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -114.43 -179.49 3.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.265 0.555 . . . . 0.0 110.691 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -94.56 -154.74 0.43 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.452 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 9.6 mmtm -64.45 123.91 20.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.88 104.6 16.54 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.719 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.436 HD21 HG11 ' A' ' 84' ' ' VAL . 25.3 tp -78.32 100.76 6.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -93.71 99.48 11.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.002 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.3 mm? -80.5 99.72 8.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.502 HG22 ' H62' ' A' ' 201' ' ' JPT . 58.7 mt -91.41 110.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.146 -178.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.596 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.1 m -110.42 95.3 5.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 -176.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.495 ' HB3' ' CB ' ' A' ' 136' ' ' TRP . 69.2 m -89.7 101.23 13.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -121.8 2.63 10.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.616 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 7.1 t70 -119.86 96.38 5.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.58 130.57 42.17 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.294 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.446 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 50.1 t-20 -97.62 116.87 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.321 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.65 -24.73 62.76 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -72.22 -21.22 61.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -141.2 -34.81 0.48 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.86 2.51 34.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.817 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 133' ' ' THR . 17.2 m -86.73 -174.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.754 0.311 . . . . 0.0 110.89 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.495 ' CB ' ' HB3' ' A' ' 126' ' ' CYS . 54.5 m95 -114.68 126.65 55.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 130' ' ' ASN . 34.7 mm-40 -77.6 -74.72 0.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -175.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.616 ' HG2' ' HB2' ' A' ' 128' ' ' ASP . 22.8 pttm -85.13 131.03 34.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 110.432 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -116.48 97.96 6.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.927 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.596 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -66.18 126.7 29.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 tt -126.21 122.71 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.656 0.741 . . . . 0.0 110.812 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.5 m-85 -108.82 112.13 24.23 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 33.8 t -95.55 96.32 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.473 0.654 . . . . 0.0 109.723 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -96.93 109.89 22.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.332 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 m -81.75 140.38 34.3 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.961 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.59 119.8 8.25 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.455 0.472 . . . . 0.0 110.566 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.582 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 10.0 t -85.89 137.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.94 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.915 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.502 ' H62' HG22 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtm . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.528 0.204 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -92.27 13.07 20.33 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.951 0.405 . . . . 0.0 110.812 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.87 108.66 5.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.338 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -122.21 94.62 47.85 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.944 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.4 127.31 17.91 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.691 2.261 . . . . 0.0 111.399 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -140.73 127.68 20.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.65 0.738 . . . . 0.0 110.967 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.589 HG13 HD21 ' A' ' 52' ' ' LEU . 7.0 mt -59.95 131.01 89.14 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.14 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.28 160.8 26.1 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.722 2.282 . . . . 0.0 111.407 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 20.1 ptmt -79.23 -15.78 57.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.401 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 33.7 t70 -79.99 122.17 26.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 110.727 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -85.12 20.04 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.669 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -126.79 10.26 7.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 93.8 mttt -105.74 174.78 5.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.76 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.88 117.87 52.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.881 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.64 -31.99 23.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.409 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.05 173.21 45.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.259 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 80.8 m-85 -117.13 137.55 52.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.39 114.8 38.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.253 0.549 . . . . 0.0 109.574 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 66.1 mt-10 -117.93 106.16 12.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.426 0.632 . . . . 0.0 111.28 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.94 95.3 48.95 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.93 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.95 -30.36 91.53 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.946 2.431 . . . . 0.0 112.212 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' OD1' ' HD2' ' A' ' 79' ' ' LYS . 30.4 t0 -66.28 -30.86 71.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.57 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 74' ' ' ASN . . . -107.2 3.53 25.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.7 t0 61.73 23.08 13.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.99 0.9 . . . . 0.0 110.583 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 65.2 mt -90.35 106.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.124 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -133.04 83.43 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 31.9 mm-40 -133.8 159.37 72.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.925 -173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.49 148.22 18.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.669 2.246 . . . . 0.0 113.337 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.85 128.09 61.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.075 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 44' ' ' SER . 65.2 m-85 -100.58 117.97 61.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 52.3 Cg_endo -68.19 150.16 76.67 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.866 2.377 . . . . 0.0 112.575 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.07 177.7 27.76 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.427 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 94.6 Cg_endo -79.19 30.99 0.46 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.323 2.682 . . . . 0.0 112.757 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB3' HD22 ' A' ' 39' ' ' LEU . . . 60.22 38.8 19.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.721 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.403 ' HB ' ' OE1' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -53.73 127.21 51.32 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.328 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.36 -59.54 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.994 3.129 . . . . 0.0 114.555 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 41.3 mt-10 -74.42 -35.99 63.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.403 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 23.3 mp0 -69.77 -35.24 74.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.0 110.361 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 34' ' ' ALA . 17.2 tp -84.18 -10.97 57.31 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.839 0.828 . . . . 0.0 109.453 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.422 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 52.3 t30 -66.63 -49.69 65.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.778 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.45 ' HD2' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -90.79 -23.25 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.386 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.34 -147.07 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.701 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.608 HG21 ' HG2' ' A' ' 71' ' ' GLN . 16.0 m -132.65 152.56 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 5.5 t -137.05 -171.75 3.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.688 0.28 . . . . 0.0 110.402 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -103.09 171.75 7.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.442 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 58' ' ' SER . . . -63.68 -47.63 80.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 110.173 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.29 162.34 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.681 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.413 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 9.6 pt-20 -74.26 -17.48 60.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -109.9 30.44 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.623 0.725 . . . . 0.0 109.857 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 7' ' ' ILE . 4.9 tp10 -62.83 146.36 52.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.153 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 37.7 m -120.05 120.14 35.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.102 0.477 . . . . 0.0 111.506 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.895 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.7 mm? -71.22 -17.56 62.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.702 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -92.72 0.88 57.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.524 0.678 . . . . 0.0 110.322 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.9 t70 -83.05 -172.48 4.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.692 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.98 -30.19 18.95 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.84 132.55 56.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.109 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.447 ' HB ' HD21 ' A' ' 121' ' ' LEU . 5.4 mp -135.56 108.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.469 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 20.2 m -101.02 124.69 47.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.998 0.427 . . . . 0.0 111.175 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.57 125.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.818 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.05 127.43 37.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 72' ' ' PHE . . . -139.89 170.71 24.16 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.586 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -169.07 165.28 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.57 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.7 m -75.1 143.16 43.51 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 6.0 t80 -122.06 152.8 39.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.78 0.324 . . . . 0.0 110.635 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -99.43 -47.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.532 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -58.98 -46.03 89.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.965 -174.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -101.77 124.43 40.51 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.6 5.76 6.19 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.805 2.337 . . . . 0.0 110.763 170.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -149.86 80.3 1.38 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.707 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -126.76 -160.25 0.98 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.009 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.608 ' HG2' HG21 ' A' ' 43' ' ' VAL . 1.5 mp0 -59.44 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.466 ' CD1' ' HA3' ' A' ' 61' ' ' GLY . 22.5 m-30 -91.09 31.66 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.523 HG23 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -63.82 -24.41 67.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.414 ' C ' ' H ' ' A' ' 76' ' ' LYS . 64.7 t30 -134.95 36.0 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.723 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 75' ' ' LEU . 3.4 mt -76.89 13.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.589 -0.695 . . . . 0.0 111.271 177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 74' ' ' ASN . 16.9 pttp -89.97 -22.09 22.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.227 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.53 21.64 8.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.982 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.85 153.94 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.482 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HD2' ' OD1' ' A' ' 22' ' ' ASP . 4.6 mptt -132.6 -168.16 2.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.0 ptpp? -69.67 -23.94 63.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.855 0.359 . . . . 0.0 111.67 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -121.88 56.34 0.64 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.855 -1.165 . . . . 0.0 112.709 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -81.42 -10.45 59.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.454 ' HE1' ' HB3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 57.01 90.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.451 0.643 . . . . 0.0 111.344 -174.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.3 t -95.06 109.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.25 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.429 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 73.1 m-85 -94.56 114.35 26.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.446 ' HB2' HD12 ' A' ' 121' ' ' LEU . 9.2 t80 -98.95 104.81 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 18.8 tptp -87.3 83.89 7.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.469 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.895 HG21 ' HG ' ' A' ' 52' ' ' LEU . 7.1 p -113.85 131.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.926 0.393 . . . . 0.0 110.678 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.55 -103.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.61 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -127.54 8.81 6.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.393 0.139 . . . . 0.0 111.227 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.41 158.52 32.55 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 112.159 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -124.63 108.89 12.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -100.14 146.6 26.63 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.186 -0.205 . . . . 0.0 110.591 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.454 ' HB3' ' HE1' ' A' ' 83' ' ' MET . 0.0 OUTLIER -100.85 120.14 39.69 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 94.6 m-85 -112.67 141.28 46.64 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.549 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -111.42 133.21 53.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.579 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.3 mtt -81.4 63.61 5.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.527 0.679 . . . . 0.0 110.465 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -71.26 -32.27 68.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.462 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 65.3 m -114.26 97.69 6.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 138.7 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.844 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -162.22 -178.45 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.515 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -126.48 140.01 52.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.887 HG23 ' HG3' ' A' ' 139' ' ' ARG . 7.7 m -114.2 147.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.512 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -85.77 159.08 55.71 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.623 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . 31.2 Cg_endo -64.79 -22.83 63.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.604 2.203 . . . . 0.0 111.596 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -106.66 8.5 31.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.145 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 11.7 t70 -85.13 142.22 29.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.75 11.07 8.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.951 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.49 -28.27 28.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 0.0 109.505 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.52 -26.42 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.03 9.91 37.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.872 0.368 . . . . 0.0 111.516 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 7.9 t70 -100.93 -175.09 2.78 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.036 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.444 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 4.2 pt-20 -115.22 102.74 10.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.18 0.514 . . . . 0.0 110.477 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -79.52 95.27 5.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.869 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.08 -175.96 3.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.413 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.07 -4.83 84.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.192 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -98.47 -174.31 2.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.81 -158.62 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -64.5 111.82 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 171.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 120' ' ' GLN . 0.0 OUTLIER -126.71 151.75 47.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.328 0.585 . . . . 0.0 112.209 -173.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.447 HD21 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -106.98 121.59 44.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.433 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.469 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 27.5 m -95.78 98.93 10.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.062 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 8.7 mt -85.03 101.07 12.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.131 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.1 mt -92.01 92.64 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -101.62 101.17 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.317 0.579 . . . . 0.0 111.183 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 76.9 m -84.06 105.07 14.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.874 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -98.8 -27.27 14.01 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.476 ' CG ' ' HD3' ' A' ' 138' ' ' LYS . 16.0 t70 -114.71 100.29 8.14 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.276 0.56 . . . . 0.0 111.14 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -87.14 122.76 31.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.441 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -91.04 107.3 19.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.23 -27.15 67.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.986 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -65.13 -34.74 79.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -173.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.461 HG23 HG13 ' A' ' 135' ' ' VAL . 9.9 t -126.16 -5.6 6.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 110.625 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.93 52.52 14.06 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.931 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.461 HG13 HG23 ' A' ' 133' ' ' THR . 9.0 p -142.23 150.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 46.6 m95 -92.69 98.0 11.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.707 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 42.7 mt-10 -72.42 -64.87 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 111.101 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.707 ' HD2' ' HB2' ' A' ' 137' ' ' GLU . 8.4 mptt -81.58 109.23 15.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.597 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.887 ' HG3' HG23 ' A' ' 103' ' ' VAL . 11.9 ptt180 -121.38 114.75 21.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.451 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.412 ' HE2' ' CE2' ' A' ' 142' ' ' PHE . 19.9 tptm -83.79 127.35 33.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.671 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 15.2 tt -120.1 128.44 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.578 0.704 . . . . 0.0 110.975 -175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.8 m-85 -115.84 116.09 27.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.026 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 41.3 t -98.86 96.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -95.73 116.04 28.3 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.775 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 m -96.34 145.17 25.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.696 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.04 122.56 9.61 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.58 0.55 . . . . 0.0 110.691 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.509 HG21 ' HE3' ' A' ' 96' ' ' LYS . 15.0 p -122.99 150.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.498 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.326 -179.427 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.608 ' SD ' ' HA2' ' A' ' 89' ' ' GLY . 60.9 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -83.01 -177.23 6.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.154 0.502 . . . . 0.0 111.323 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.75 165.48 17.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.574 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt 53.94 93.77 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 123.709 0.631 . . . . 0.0 111.155 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.66 130.44 24.87 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.051 2.501 . . . . 0.0 113.612 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -143.55 161.33 38.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.088 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.475 ' CG2' ' HB2' ' A' ' 31' ' ' PRO . 3.5 mp -90.89 126.82 54.26 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.71 -175.31 2.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.117 2.545 . . . . 0.0 111.701 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.24 -17.77 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.663 -178.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -90.07 121.51 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.517 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -106.5 16.54 24.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.136 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -102.46 3.48 37.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -122.35 168.6 11.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.846 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.8 t -93.89 119.4 41.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.221 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -94.19 -21.62 18.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.29 164.41 37.17 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.318 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 79.7 m-85 -119.87 144.77 47.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -101.71 108.49 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.812 0.815 . . . . 0.0 109.564 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.78 108.62 17.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.193 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 HG12 HG11 ' A' ' 84' ' ' VAL . 41.7 mt -126.42 91.24 48.09 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.096 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -61.55 -25.75 79.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.942 2.428 . . . . 0.0 112.164 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 33.8 t70 -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.028 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 78' ' ' ALA . . . -110.29 8.31 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.57 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 t70 63.47 27.62 15.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.747 0.784 . . . . 0.0 110.652 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 88.6 mt -104.2 114.62 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.298 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.2 mppt? -142.37 82.1 1.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 11.2 mm-40 -134.02 159.99 70.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.054 -173.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 67.4 Cg_endo -75.17 144.91 30.24 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.918 2.412 . . . . 0.0 113.442 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.81 128.37 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.623 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -97.63 114.6 65.15 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.495 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 86.1 Cg_endo -78.67 142.22 17.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.757 2.305 . . . . 0.0 112.431 -174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.42 -161.43 28.19 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.912 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.51 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 59.8 Cg_endo -88.18 30.02 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.911 3.074 . . . . 0.0 113.312 -175.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.22 56.84 4.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.63 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.38 138.02 95.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.37 -58.62 1.3 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.252 3.302 . . . . 0.0 114.076 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.49 -34.44 76.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.648 0.261 . . . . 0.0 111.696 -176.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -81.2 -36.34 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.426 . . . . 0.0 110.847 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.41 -14.72 59.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.621 0.724 . . . . 0.0 109.575 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -73.91 -42.66 60.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.168 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 12.9 ptm180 -86.13 -40.39 15.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.521 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.88 -157.11 8.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.603 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG11 ' CE1' ' A' ' 72' ' ' PHE . 40.2 t -113.26 142.67 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 t -130.64 -174.73 3.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -93.67 160.05 14.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -29.26 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.445 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -135.78 165.55 25.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 37.6 tt0 -82.8 -32.12 27.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.748 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.47 31.05 0.59 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.119 0.485 . . . . 0.0 111.167 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -85.68 151.41 23.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.801 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 47.1 m -122.93 150.21 43.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.752 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.439 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 93.6 mt -93.02 6.8 46.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.785 0.326 . . . . 0.0 111.746 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -132.68 8.34 4.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.706 0.765 . . . . 0.0 109.547 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.801 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 15.6 t70 -81.71 164.26 21.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.288 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tm0? -67.78 -29.05 68.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.035 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 138.37 53.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.794 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -140.0 117.82 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.858 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -100.23 103.4 14.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.045 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.5 mt -98.31 114.81 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.41 123.77 48.58 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.1 167.63 21.71 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.196 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -139.74 128.86 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.476 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.3 m -52.71 110.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.342 0.591 . . . . 0.0 111.282 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.408 ' HE1' ' HB2' ' A' ' 66' ' ' ASP . 13.8 t80 -80.88 129.48 34.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.93 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.4 mm -75.0 -49.65 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.403 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -74.19 -1.35 20.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.23 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 85.0 mtm180 -130.24 94.38 30.54 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 -13.5 34.5 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.812 2.341 . . . . 0.0 112.515 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -147.33 63.27 1.16 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.445 0.641 . . . . 0.0 110.167 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.549 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 9.7 p90 -99.12 -157.79 0.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.496 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -43.57 -75.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.506 0.504 . . . . 0.0 112.123 178.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.532 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 22.2 m-30 -100.03 77.17 1.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.84 -52.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 10.7 t30 -88.62 11.94 16.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.047 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -23.16 64.89 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.958 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -70.1 -8.29 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.944 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.72 5.12 41.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.777 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 23' ' ' ALA . . . -96.16 135.15 38.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.438 0.637 . . . . 0.0 111.23 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.434 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 3.5 mppt? -108.86 -172.94 2.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -64.21 -30.62 71.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.827 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.82 49.69 0.83 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.246 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.529 ' HG ' ' HB3' ' A' ' 22' ' ' ASP . 6.7 t -66.07 -21.09 66.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.53 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.456 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 53.91 83.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.518 0.675 . . . . 0.0 111.547 -175.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 74.4 t -85.2 125.15 40.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.185 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -106.03 108.42 19.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.276 0.56 . . . . 0.0 110.337 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.75 103.07 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.0 tppp? -86.86 90.69 8.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.983 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 m -117.42 129.12 74.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.608 ' HA2' ' SD ' ' A' ' 1' ' ' MET . . . 63.78 -88.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.494 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -148.18 11.07 0.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 110.155 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 145.57 41.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 m -109.18 107.11 17.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.372 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -99.74 137.0 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.938 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 0.0 OUTLIER -102.89 139.01 39.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.519 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -133.27 142.52 48.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.023 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -107.63 136.76 46.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.564 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.9 mmt -80.64 70.37 7.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.4 0.619 . . . . 0.0 110.108 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -83.64 -4.69 58.8 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.895 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.562 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 20.2 m -144.02 105.82 4.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.093 0.473 . . . . 0.0 110.587 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 97' ' ' MET . 77.3 mt -122.08 123.27 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.924 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -165.23 -166.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.213 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.624 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 4.5 p-10 -142.98 144.97 32.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.637 HG22 ' HE ' ' A' ' 139' ' ' ARG . 11.3 m -132.07 154.17 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.269 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.471 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -97.09 164.86 16.94 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.785 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -67.19 -18.35 50.77 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.473 2.115 . . . . 0.0 111.229 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -103.91 12.86 33.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB3' HG12 ' A' ' 110' ' ' VAL . 7.6 t70 -74.63 154.76 38.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.466 ' HA ' HD21 ' A' ' 111' ' ' LEU . 28.5 m -96.11 -15.26 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 -172.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.15 -5.06 55.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.332 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.444 HG12 ' HB3' ' A' ' 107' ' ' ASP . 21.8 m -83.6 -17.93 10.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.818 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -112.49 18.5 18.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 178.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.91 167.58 14.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.34 139.44 57.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.804 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.63 143.29 30.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.38 170.0 13.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.588 -166.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.13 51.78 2.87 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.254 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -83.1 177.0 8.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.13 -156.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.501 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 19.1 mmtm -60.7 115.45 3.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -106.34 112.04 24.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.979 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.55 105.38 9.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -91.57 93.73 9.09 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.683 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -77.65 99.1 5.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.578 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.593 HD12 ' H3 ' ' A' ' 201' ' ' JPT . 51.4 mt -92.51 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.043 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -117.67 89.72 3.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.007 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.723 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 64.0 m -73.97 104.82 4.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -110.54 76.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.569 0.7 . . . . 0.0 110.75 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.554 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 16.6 t70 -162.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.707 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.471 ' CZ ' ' HG2' ' A' ' 131' ' ' GLU . 1.6 t80 61.03 86.67 0.1 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.628 0.58 . . . . 0.0 110.384 -172.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -92.79 97.36 10.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.696 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.471 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 36.4 mt-10 -60.87 -15.74 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.278 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.24 -34.79 78.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.903 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -115.55 -14.99 11.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.436 0.636 . . . . 0.0 109.844 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.11 31.89 50.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.029 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.5 t -134.86 139.33 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.465 ' HB2' ' H1 ' ' A' ' 201' ' ' JPT . 44.1 m95 -78.14 92.26 4.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 172.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.55 -8.46 59.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 62.9 tttm -121.13 131.15 54.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.723 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 19.9 ttp180 -136.57 100.92 4.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.34 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 48.7 tptt -69.1 126.68 30.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.12 124.88 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.772 0.796 . . . . 0.0 111.033 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.564 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 14.6 m-85 -115.66 116.36 27.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.395 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 45.6 t -104.02 103.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.322 0.582 . . . . 0.0 110.103 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.63 114.48 28.2 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.747 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.9 m -89.75 140.14 29.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.07 126.57 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.202 0.525 . . . . 0.0 111.255 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.45 HG11 ' HD3' ' A' ' 96' ' ' LYS . 13.1 p -130.09 160.53 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.229 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.491 -178.13 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.593 ' H3 ' HD12 ' A' ' 124' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.42 173.42 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.131 0.491 . . . . 0.0 110.345 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.48 86.66 7.07 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.629 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 87.8 mttt -137.78 103.85 8.33 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.95 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 35.9 Cg_endo -64.19 135.87 49.05 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.974 2.449 . . . . 0.0 112.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -134.41 167.1 21.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.197 0.522 . . . . 0.0 110.519 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.539 HD13 ' HA ' ' A' ' 51' ' ' SER . 43.1 mt -107.02 113.78 62.15 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.73 177.35 3.65 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.92 2.413 . . . . 0.0 112.292 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -74.65 -24.25 58.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 110.134 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.21 100.26 0.77 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.015 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -98.68 20.84 12.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 110.608 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -100.23 -11.86 20.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.284 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -107.33 176.69 5.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.097 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.97 129.53 41.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.727 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.5 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.301 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -155.3 176.08 33.04 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.668 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 71.9 m-85 -122.7 135.98 54.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.6 tp -98.63 110.05 25.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.807 0.813 . . . . 0.0 109.776 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 85.9 mt-10 -119.17 109.62 16.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.92 89.6 38.15 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.67 -32.73 76.81 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.112 2.541 . . . . 0.0 112.481 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.63 -23.78 64.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -107.89 8.12 28.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.137 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 65.4 17.65 11.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.844 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.557 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 91.2 mt -97.38 131.27 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.985 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.557 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 37.0 mtpt -156.41 45.73 0.43 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.486 0.66 . . . . 0.0 109.834 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -106.63 156.87 36.38 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.158 -169.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 57.4 Cg_endo -73.43 148.63 43.28 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 121.91 1.74 . . . . 0.0 112.896 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.82 134.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.548 ' O ' ' HA ' ' A' ' 44' ' ' SER . 46.5 m-85 -101.08 144.22 28.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.318 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.13 162.52 20.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.411 2.074 . . . . 0.0 110.894 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.24 165.2 13.24 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.093 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.672 ' HG2' ' HG1' ' A' ' 35' ' ' THR . 71.8 Cg_endo -76.66 30.24 0.41 Allowed 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.041 3.161 . . . . 0.0 113.221 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.36 43.39 23.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.763 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.743 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.65 147.24 96.45 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.15 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.622 ' HD2' HG22 ' A' ' 35' ' ' THR . 89.2 Cg_exo -49.04 -53.3 7.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.291 2.66 . . . . 0.0 113.965 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.743 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -71.82 -27.08 62.67 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.761 -178.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.421 ' HG3' ' HB2' ' A' ' 44' ' ' SER . 42.6 tp60 -62.49 -51.91 65.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.995 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.74 -16.83 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.445 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.62 -40.3 66.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.266 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -68.97 -45.12 71.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.051 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.0 -110.19 0.23 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.598 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.3 m -130.71 152.68 37.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.58 0.229 . . . . 0.0 110.679 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 36.9 t -148.18 165.81 29.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.001 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -68.56 162.01 26.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.32 -37.44 25.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -125.61 156.33 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.33 -1.65 58.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.856 0.836 . . . . 0.0 108.772 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -91.14 -19.72 22.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.058 -175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.71 170.51 16.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.991 0.424 . . . . 0.0 110.532 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.539 ' HA ' HD13 ' A' ' 7' ' ' ILE . 56.1 m -146.94 157.63 43.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.525 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 7' ' ' ILE . 96.0 mt -73.79 -12.09 60.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 111.939 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -113.5 11.16 18.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.879 0.847 . . . . 0.0 109.844 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 4.3 t0 -83.21 156.78 23.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.652 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 115' ' ' LYS . 1.1 tm0? -68.15 -32.75 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.15 120.33 40.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.409 0.623 . . . . 0.0 111.56 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.1 mt -125.75 134.16 67.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 p -132.45 121.14 22.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.06 0.457 . . . . 0.0 112.022 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mt -108.69 128.45 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.02 123.57 33.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.033 0.444 . . . . 0.0 111.283 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 123.94 7.7 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.762 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.633 ' HA ' ' H12' ' A' ' 201' ' ' JPT . 3.5 t-160 -70.51 -61.85 1.61 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.505 0.193 . . . . 0.0 110.687 -176.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 m 69.09 122.46 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 O-C-N 124.099 0.875 . . . . 0.0 110.693 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -152.63 138.75 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.3 -37.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.721 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.94 6.94 16.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.339 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -136.39 77.47 47.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.64 3.65 7.66 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.827 2.351 . . . . 0.0 113.338 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -153.19 47.44 0.69 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.973 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -101.5 -175.21 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' HG3' ' HG3' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.69 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' CZ ' HD13 ' A' ' 123' ' ' LEU . 21.3 m-30 -96.96 81.33 3.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.485 0.66 . . . . 0.0 111.245 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 m -150.4 -41.28 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.174 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -91.08 11.9 21.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.462 0.649 . . . . 0.0 109.388 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.01 -12.53 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.948 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -10.13 58.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.069 0.462 . . . . 0.0 111.257 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 23' ' ' ALA . . . -82.13 -9.77 59.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.496 175.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.17 132.06 35.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.068 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 97' ' ' MET . 26.4 mmtp -120.53 -177.74 3.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -61.12 -13.77 19.82 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.42 34.23 2.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.547 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.0 m -82.77 121.86 27.45 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mtp -71.8 108.17 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 110.526 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 63.3 t -89.56 115.94 30.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.668 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.514 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 82.6 m-85 -102.57 121.42 42.35 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.072 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 12.0 t80 -112.81 99.06 7.61 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 5.4 mptt -75.25 102.22 4.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.013 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.85 86.73 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.168 0.509 . . . . 0.0 111.561 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.38 -59.25 3.26 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.308 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -137.35 -37.46 0.63 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 111.392 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -107.97 -179.73 3.98 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 87' ' ' LYS . 6.6 t -132.23 142.57 49.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.397 0.618 . . . . 0.0 109.905 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -100.24 132.2 45.75 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.942 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -99.76 126.48 45.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.942 0.401 . . . . 0.0 110.462 -177.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.569 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 83.9 m-85 -125.13 149.94 47.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.38 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.8 tptm -113.17 135.18 54.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.593 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 16.7 mmt -79.9 62.62 4.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -75.62 -8.95 58.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.126 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.537 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 55.9 m -145.21 103.3 3.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.966 -0.459 . . . . 0.0 110.998 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.6 mt -120.59 128.34 76.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.24 177.42 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.637 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -132.16 120.55 22.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -75.24 151.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.51 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -86.51 148.39 46.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.73 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.604 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 32.8 Cg_exo -62.06 -15.68 45.29 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.697 2.265 . . . . 0.0 112.284 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -99.76 -5.66 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.84 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -91.81 133.22 35.83 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.57 24.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -115.89 -28.14 6.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.562 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.18 -22.59 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.475 0.655 . . . . 0.0 110.79 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.471 HD11 ' N ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -99.5 25.53 6.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.467 -173.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.91 175.35 7.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.7 pt-20 -72.21 70.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.397 0.618 . . . . 0.0 112.033 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -86.72 75.46 9.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.569 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -100.11 -179.36 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.31 -2.38 16.29 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.44 -170.71 3.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.34 -0.43 . . . . 0.0 109.946 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.75 -158.51 0.4 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 1.3 mptm? -61.77 104.82 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.05 125.4 49.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.327 0.584 . . . . 0.0 110.54 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.4 tp -91.92 109.72 21.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m -96.28 102.26 14.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.572 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.6 mm? -87.38 100.7 12.93 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.72 89.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.6 m -100.56 99.73 10.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 83.4 m -60.7 125.26 23.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -112.08 -21.57 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.041 -160.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 13.6 t70 -140.85 108.57 5.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.389 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -101.38 130.08 47.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.57 0.7 . . . . 0.0 109.924 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -80.67 103.27 10.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.274 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -54.95 -26.07 33.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.08 -17.45 58.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.535 ' OG1' HG22 ' A' ' 135' ' ' VAL . 16.5 p -126.68 -37.69 2.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.536 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.85 8.54 51.24 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.939 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.535 HG22 ' OG1' ' A' ' 133' ' ' THR . 30.2 m -98.34 141.51 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 111.34 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 129' ' ' TYR . 60.4 m95 -87.97 86.65 7.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' ' 105' ' ' PRO . 51.2 mt-10 -65.0 -64.19 0.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.961 -175.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 35.6 tttm -85.5 126.48 33.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.09 139.95 51.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.637 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 27.0 tttp -87.57 145.08 26.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.126 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.25 125.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.672 0.748 . . . . 0.0 110.936 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.598 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.7 m-85 -111.91 112.71 24.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.891 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 59.3 t -98.15 98.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 109.649 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -98.4 102.87 14.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.201 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.9 m -82.07 139.64 34.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.871 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -57.58 126.01 25.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.492 0.663 . . . . 0.0 110.8 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.05 170.82 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.935 -176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 3.2 ptmm? . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.715 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.633 ' H12' ' HA ' ' A' ' 62' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.705 0.288 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -88.13 -14.87 37.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.333 0.587 . . . . 0.0 110.693 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.11 135.72 31.21 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.058 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp 43.3 79.76 0.32 Allowed Pre-proline 0 C--O 1.233 0.211 0 O-C-N 123.859 0.724 . . . . 0.0 111.913 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.33 144.92 69.96 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.6 2.2 . . . . 0.0 112.169 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.79 156.84 47.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.733 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.407 HG13 ' HG ' ' A' ' 52' ' ' LEU . 28.3 mt -107.8 109.6 62.28 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.364 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.658 ' HG2' ' HE3' ' A' ' 13' ' ' LYS . 49.9 Cg_endo -73.35 164.09 36.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.418 2.078 . . . . 0.0 111.579 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.19 -3.22 19.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 -177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.706 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 19.3 t70 -69.24 145.63 52.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.272 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 22.5 pttp -118.63 9.73 12.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 111.525 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -95.01 -50.46 5.09 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.056 -0.402 . . . . 0.0 111.35 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.706 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -76.83 162.04 27.96 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -96.85 151.6 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.105 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.36 -32.12 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.66 164.27 25.45 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.994 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 59.1 m-85 -129.73 135.17 48.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.4 tp -104.98 115.23 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.532 0.682 . . . . 0.0 110.154 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -125.17 119.91 29.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.891 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.4 95.03 18.57 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.071 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.93 -22.55 68.51 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.715 2.277 . . . . 0.0 112.115 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.473 ' HB3' ' HG ' ' A' ' 82' ' ' SER . 27.0 t0 -68.5 -33.02 73.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.392 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.56 2.5 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.584 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t0 57.7 36.56 26.73 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.874 0.845 . . . . 0.0 110.313 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.469 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 55.0 mt -102.45 121.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.624 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -147.06 86.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.4 mm-40 -145.26 159.8 47.75 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.617 0.246 . . . . 0.0 111.099 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.2 157.7 45.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.837 2.358 . . . . 0.0 113.447 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.447 ' O ' HG21 ' A' ' 14' ' ' VAL . 93.4 t -110.88 123.34 66.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.716 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 44' ' ' SER . 60.0 m-85 -92.42 110.97 48.3 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.312 0.577 . . . . 0.0 111.467 -175.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.7 Cg_exo -77.61 129.82 10.33 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.223 2.616 . . . . 0.0 111.728 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.03 -173.7 43.68 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.918 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 11' ' ' LYS . 3.3 Cg_exo -78.66 10.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.542 2.828 . . . . 0.0 112.845 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 67.49 29.92 7.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.663 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -68.56 160.24 77.53 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.26 -45.32 22.4 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.697 2.931 . . . . 0.0 114.727 -174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.516 ' OE1' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -71.79 -30.46 65.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.571 -175.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.516 ' HG2' ' OE1' ' A' ' 37' ' ' GLU . 85.2 mm-40 -68.01 -36.84 80.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 0.0 110.339 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -81.92 -0.61 44.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.037 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -108.32 -12.18 15.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.698 0.285 . . . . 0.0 111.001 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.461 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 10.1 ptm180 -95.36 -25.81 16.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.783 0.325 . . . . 0.0 110.576 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.0 -122.59 0.91 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.076 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.702 HG13 ' HG2' ' A' ' 71' ' ' GLN . 7.6 p -122.03 144.22 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 45.0 p -132.29 -168.27 2.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 36.6 m-85 -96.28 165.0 12.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.465 176.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.367 . . . . 0.0 111.446 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.35 168.92 19.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.05 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -67.85 -31.77 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.808 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -88.3 19.95 3.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.034 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 4.6 mm-40 -64.65 158.4 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.031 173.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.784 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 51.8 m -140.04 123.19 16.8 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.134 0.492 . . . . 0.0 111.737 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.51 HD13 ' CG1' ' A' ' 88' ' ' VAL . 30.6 mt -66.22 -26.75 67.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.271 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.55 -19.98 48.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.79 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.784 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 3.5 t70 -72.29 164.53 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.396 -172.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.592 ' HA ' ' HD2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.91 -31.19 61.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.054 -178.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.42 133.98 54.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.684 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.5 mt -133.47 121.7 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.925 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -110.09 107.8 17.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.263 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.497 HD12 HD12 ' A' ' 121' ' ' LEU . 41.1 mt -94.55 111.81 26.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -105.71 123.31 47.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.561 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.455 ' HA3' HG22 ' A' ' 43' ' ' VAL . . . -150.58 175.52 29.57 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.088 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -142.11 156.38 45.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.723 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -71.73 140.96 49.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.361 0.413 . . . . 0.0 111.016 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -100.68 158.53 15.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.357 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.49 -38.14 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -87.9 -5.07 58.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 67' ' ' ARG . 8.6 mmt180 -113.25 115.36 47.62 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 0.0 110.665 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.82 -11.66 5.51 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.961 2.441 . . . . 0.0 113.359 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -160.58 89.07 0.81 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.562 0.696 . . . . 0.0 110.514 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.723 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 15.4 p90 -130.69 -151.83 0.48 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.809 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.702 ' HG2' HG13 ' A' ' 43' ' ' VAL . 25.8 mp0 -55.49 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 111.918 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.533 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.6 m-85 -94.88 82.07 3.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.154 0.502 . . . . 0.0 111.198 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 m -110.1 -60.96 1.73 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -95.96 28.12 3.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.656 -176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.8 tp -65.13 -19.0 65.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.418 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -9.61 58.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.62 11.75 23.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.939 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.28 161.39 14.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.349 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -135.27 -176.01 4.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.6 ptmm? -66.52 -13.86 61.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.336 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.66 45.91 1.11 Allowed Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 174.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.473 ' HG ' ' HB3' ' A' ' 22' ' ' ASP . 7.4 t -61.63 -25.33 67.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.09 -0.555 . . . . 0.0 112.117 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.453 ' HE3' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 57.52 89.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.698 0.761 . . . . 0.0 111.518 -175.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.0 t -91.81 125.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.669 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -102.0 104.47 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -97.51 106.07 18.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 49.5 mttp -83.72 125.02 31.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.225 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.51 ' CG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -130.49 101.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.294 0.568 . . . . 0.0 110.144 -177.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.59 -81.72 0.4 Allowed Glycine 0 C--N 1.317 -0.482 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.421 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 -18.62 4.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.349 . . . . 0.0 111.242 -176.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -97.52 152.04 19.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -123.53 99.59 6.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.61 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -93.83 166.35 12.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.734 0.302 . . . . 0.0 110.761 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -127.55 126.64 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.454 0.645 . . . . 0.0 111.894 -170.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.533 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.6 m-85 -116.05 148.22 40.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.454 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.579 ' HB2' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -117.16 129.47 55.98 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.449 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 59.5 mtt -79.86 70.33 6.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.402 0.62 . . . . 0.0 110.703 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 t -80.04 -24.93 40.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.556 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 15.0 m -121.03 102.5 8.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.011 0.434 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.7 mt -113.11 129.98 67.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.17 173.94 11.5 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.909 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.505 ' HB3' ' CD ' ' A' ' 140' ' ' LYS . 1.2 p30 -149.36 125.53 10.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.865 168.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG23 HG21 ' A' ' 110' ' ' VAL . 19.0 m -131.38 -177.16 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.398 -169.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.3 mppt? -103.07 145.19 30.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.762 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.479 ' HG2' ' O ' ' A' ' 136' ' ' TRP . 25.3 Cg_exo -65.62 -12.99 37.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.95 2.433 . . . . 0.0 111.95 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -109.02 16.89 22.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.518 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.09 168.27 19.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.43 -20.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.691 0.281 . . . . 0.0 111.033 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.83 4.84 38.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.265 0.555 . . . . 0.0 110.777 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.467 HG21 HG23 ' A' ' 103' ' ' VAL . 11.3 p -80.12 -20.16 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.24 12.48 33.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.355 -176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 157.32 34.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 0.0 110.251 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.563 ' OE1' ' HE2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -92.9 82.73 4.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.541 0.686 . . . . 0.0 112.022 -174.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -77.02 74.23 3.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.563 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.64 174.27 5.95 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.25 -23.1 27.84 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -72.3 158.97 34.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.435 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.493 ' OD1' HG22 ' A' ' 145' ' ' THR . 3.1 p-10 -83.43 -161.71 0.54 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.592 ' HD2' ' HA ' ' A' ' 55' ' ' GLN . 2.4 tptp -46.86 106.31 0.08 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.188 0.305 . . . . 0.0 110.244 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 10.0 pt20 -116.4 135.34 53.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.371 0.605 . . . . 0.0 110.861 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD12 HD12 ' A' ' 59' ' ' ILE . 20.7 tp -101.47 109.86 21.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 m -94.37 101.27 13.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.49 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.9 mm? -80.49 104.55 11.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.727 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.479 HG22 ' HD3' ' A' ' 139' ' ' ARG . 53.3 mt -98.84 100.72 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.6 m -115.6 105.18 12.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.125 0.488 . . . . 0.0 110.833 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.5 m -90.99 94.31 9.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.472 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 9.6 p-10 -105.05 2.45 29.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.672 -166.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.495 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 20.8 t70 -127.66 99.18 5.47 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.246 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 87.2 t80 -97.36 127.19 43.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.446 ' OD1' HG23 ' A' ' 133' ' ' THR . 22.1 t-20 -91.28 111.13 22.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.68 -14.43 62.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -85.7 -29.64 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.446 HG23 ' OD1' ' A' ' 130' ' ' ASN . 10.1 t -124.07 -9.45 7.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.366 0.603 . . . . 0.0 110.663 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.78 54.6 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.727 -0.669 . . . . 0.0 113.062 175.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 133' ' ' THR . 4.7 p -149.23 157.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 67.8 m95 -88.57 117.9 27.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.2 -24.97 25.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 128' ' ' ASP . 21.2 pttp -142.78 154.83 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.548 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.479 ' HD3' HG22 ' A' ' 124' ' ' ILE . 11.8 ttm180 -121.87 112.99 19.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.529 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.505 ' CD ' ' HB3' ' A' ' 102' ' ' ASP . 51.7 tptt -77.14 123.67 26.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.5 tt -127.52 126.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.765 0.793 . . . . 0.0 111.212 -172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.527 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.9 m-85 -117.07 112.95 21.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.8 t -94.23 94.68 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -95.96 104.05 15.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.368 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.493 HG22 ' OD1' ' A' ' 118' ' ' ASP . 0.4 OUTLIER -85.1 151.68 23.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -55.58 142.4 33.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 110.865 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' A' ' 96' ' ' LYS . 21.8 t -90.4 144.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.439 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.182 -0.913 . . . . 0.0 112.402 -174.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.941 0.4 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -100.33 4.71 44.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.797 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.18 143.53 9.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.192 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 8.8 mmmm 51.22 91.93 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 O-C-N 123.968 0.792 . . . . 0.0 112.349 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 88' ' ' VAL . 55.7 Cg_endo -71.66 146.45 48.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.297 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.31 -175.75 5.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.135 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.595 HG13 ' HG ' ' A' ' 52' ' ' LEU . 25.4 mt -102.08 117.95 60.25 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.716 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.78 168.29 21.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 112.109 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 4.2 mptp? -84.93 -17.11 38.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.379 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.83 125.66 30.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.783 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HB2' HE22 ' A' ' 38' ' ' GLN . 63.4 pttt -105.88 18.86 21.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -94.22 -7.58 41.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.762 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HZ2' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -117.43 -170.03 1.78 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.225 0.536 . . . . 0.0 111.108 -176.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.04 137.7 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.921 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.26 -34.55 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.359 0.599 . . . . 0.0 110.567 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 166.01 39.22 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.546 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 75.8 m-85 -107.86 139.3 42.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.266 0.533 . . . . 0.0 110.053 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -101.94 117.48 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 34.9 mt-10 -120.78 113.33 20.01 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.477 0.656 . . . . 0.0 110.907 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 47.9 mt -127.32 94.12 39.34 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.492 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 10.1 Cg_endo -53.19 -42.96 61.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.279 2.653 . . . . 0.0 113.3 -172.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -13.71 61.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.678 0.275 . . . . 0.0 111.737 -176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.51 9.5 23.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.347 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.72 27.77 16.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.203 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.3 mt -96.92 119.99 45.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.329 -175.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 26' ' ' LYS . 24.4 mmmt -141.02 42.7 1.81 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 11.6 mm-40 -102.66 149.7 37.0 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.338 -165.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.39 135.68 13.53 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.771 2.314 . . . . 0.0 112.54 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.45 123.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.206 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.86 121.82 61.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.538 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -79.94 161.13 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.917 2.412 . . . . 0.0 112.256 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.2 -164.35 26.21 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.128 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.93 2.64 8.12 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.682 2.921 . . . . 0.0 113.103 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.96 89.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.882 0.738 . . . . 0.0 110.829 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 p -119.14 157.46 50.81 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.801 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.72 -52.87 6.9 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.695 2.93 . . . . 0.0 114.529 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.43 75.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 111.598 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.585 HE22 ' HB2' ' A' ' 11' ' ' LYS . 37.1 tt0 -72.2 -37.68 69.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.93 0.395 . . . . 0.0 110.472 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.35 -18.06 60.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.98 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -81.7 -28.98 33.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -93.13 -35.79 13.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.673 0.273 . . . . 0.0 111.035 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.422 ' HA2' ' HG3' ' A' ' 71' ' ' GLN . . . -151.39 -137.86 2.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.208 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.25 162.32 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.2 m -131.43 172.32 12.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.905 0.383 . . . . 0.0 111.45 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 31' ' ' PRO . 26.2 m-85 -79.8 166.92 21.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.098 174.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.34 76.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.426 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -144.94 170.05 16.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.034 0.445 . . . . 0.0 110.962 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.09 -25.25 66.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.466 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.93 7.39 18.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 110.999 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.14 148.05 32.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -139.81 123.5 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.946 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.595 ' HG ' HG13 ' A' ' 7' ' ' ILE . 85.4 mt -74.26 -17.39 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.448 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.28 13.59 25.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.45 0.643 . . . . 0.0 110.529 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.45 178.08 4.69 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.561 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.5 pt20 -95.72 -22.21 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.705 0.288 . . . . 0.0 110.667 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.8 105.63 15.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.724 0.773 . . . . 0.0 110.355 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.69 133.92 68.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.746 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.405 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 3.0 p -124.69 121.87 35.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.149 0.5 . . . . 0.0 112.06 -173.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -114.07 132.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.1 130.84 45.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.68 126.95 6.82 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.897 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -111.81 76.23 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 m -60.82 134.36 57.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.79 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -145.09 150.75 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.137 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -53.02 -43.24 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 123.713 0.633 . . . . 0.0 112.402 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.84 10.76 3.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.162 -174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -131.21 76.41 76.3 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.15 -28.04 11.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.791 2.327 . . . . 0.0 113.527 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -140.2 73.5 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.475 0.655 . . . . 0.0 110.729 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.451 ' CE1' ' HB ' ' A' ' 73' ' ' THR . 1.4 p90 -132.39 155.09 49.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.538 -0.756 . . . . 0.0 108.972 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.575 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 10.3 mm100 16.49 -92.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.735 1.214 . . . . 0.0 114.226 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -116.7 97.11 5.81 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.677 0.275 . . . . 0.0 110.676 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.451 ' HB ' ' CE1' ' A' ' 70' ' ' TYR . 9.1 t -145.49 -39.34 0.24 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.219 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -91.58 26.67 2.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.706 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.621 HD13 HG21 ' A' ' 125' ' ' THR . 19.6 mt -76.22 3.09 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.619 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -76.12 -21.08 57.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.189 0.518 . . . . 0.0 110.191 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.87 9.69 34.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.133 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.32 23.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.821 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.6 pttt -139.43 179.36 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.919 0.39 . . . . 0.0 111.109 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -66.77 -11.55 55.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.102 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.88 59.85 0.55 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.0 p -74.77 -15.12 60.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.455 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 56.52 88.64 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.866 0.729 . . . . 0.0 111.407 -172.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 56.1 t -88.81 124.56 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.909 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.473 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.1 m-85 -107.04 108.54 20.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.615 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 17.0 t80 -93.5 101.39 13.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.6 tptm -84.48 85.51 7.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.668 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' A' ' 5' ' ' PRO . 7.8 p -109.85 125.6 67.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.441 0.638 . . . . 0.0 111.064 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 5' ' ' PRO . . . 63.45 -94.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.494 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.61 11.82 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.668 0.27 . . . . 0.0 111.146 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.8 160.42 26.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.894 0.378 . . . . 0.0 111.005 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 m -124.01 98.01 5.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.081 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HG3' ' HB3' ' A' ' 86' ' ' PHE . 10.4 ptp180 -95.3 132.05 40.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.301 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HB3' ' HE3' ' A' ' 83' ' ' MET . 0.0 OUTLIER -100.57 140.22 35.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.878 0.371 . . . . 0.0 110.793 -174.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.602 ' OH ' ' HD3' ' A' ' 93' ' ' ARG . 74.5 m-85 -129.31 147.93 51.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.77 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.471 ' HD3' HG13 ' A' ' 147' ' ' VAL . 1.6 tptm -109.54 121.41 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 51.3 mtt -77.75 68.92 3.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 110.238 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -81.43 -11.74 59.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.924 -172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.7 m -135.43 99.4 4.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.991 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.97 128.01 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.4 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.4 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 11.6 ptm180 -167.75 179.2 4.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.203 -176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 4.5 p30 -125.12 153.25 43.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.05 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 110' ' ' VAL . 6.1 m -142.61 173.39 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.712 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.761 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -98.43 154.22 37.66 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.069 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.62 -15.5 49.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.623 2.215 . . . . 0.0 111.936 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.7 t -103.76 9.57 37.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.761 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 10.4 t70 -77.21 122.18 24.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.333 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.79 11.38 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.084 0.469 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -81.53 -46.91 13.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 103' ' ' VAL . 33.8 m -86.62 -8.33 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.211 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.0 mt -88.35 -3.78 58.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.103 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.05 160.89 25.66 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.83 106.89 3.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.025 0.441 . . . . 0.0 110.709 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.95 101.96 13.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.979 0.418 . . . . 0.0 111.347 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -169.76 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 173.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.74 -40.56 2.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.326 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -73.86 171.6 13.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.077 0.465 . . . . 0.0 110.766 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.16 -152.58 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.561 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -60.51 113.3 2.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -110.69 126.59 54.69 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.133 0.492 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.9 mt -90.47 116.57 28.5 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.518 HG21 HD13 ' A' ' 141' ' ' ILE . 25.4 m -98.01 102.77 14.62 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.1 mm? -95.78 101.8 13.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.8 97.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.005 0.431 . . . . 0.0 109.885 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.621 HG21 HD13 ' A' ' 75' ' ' LEU . 21.1 p -105.25 107.39 18.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.424 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 m -94.2 92.83 7.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.3 33.72 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.077 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.467 ' CB ' ' HB2' ' A' ' 138' ' ' LYS . 26.9 t70 -137.47 103.86 5.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -100.08 123.86 44.81 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.833 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -97.86 112.54 24.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.392 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.3 -31.06 70.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.087 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.552 ' HZ1' ' HB3' ' A' ' 132' ' ' LYS . 5.3 mmmp? -70.8 -22.32 62.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.5 HG22 HG11 ' A' ' 135' ' ' VAL . 8.6 t -130.64 2.06 4.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 58.0 54.66 35.67 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.238 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 133' ' ' THR . 3.3 p -149.95 159.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.448 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 70.6 m95 -97.66 101.16 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.87 -66.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.428 -169.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -69.97 88.53 0.58 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.464 0.65 . . . . 0.0 110.568 -176.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.516 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 21.2 ptt180 -76.94 73.06 3.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.752 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.611 ' HE2' ' CZ ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -62.67 124.25 20.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.348 -174.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.518 HD13 HG21 ' A' ' 122' ' ' THR . 8.7 tt -114.21 137.88 46.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.592 -168.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.611 ' CZ ' ' HE2' ' A' ' 140' ' ' LYS . 43.7 m-85 -110.44 119.23 38.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.8 t -102.57 102.86 14.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.254 0.549 . . . . 0.0 109.649 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -101.79 111.95 24.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.8 m -86.47 136.47 33.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.023 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.07 120.33 7.31 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.507 0.504 . . . . 0.0 110.833 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.471 HG13 ' HD3' ' A' ' 96' ' ' LYS . 7.1 p -111.19 122.26 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.543 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.298 -173.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.516 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 70.6 -61.03 0.48 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.706 0.765 . . . . 0.0 110.487 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.98 161.99 13.59 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.221 172.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt 54.22 87.55 0.14 Allowed Pre-proline 0 C--N 1.33 -0.262 0 O-C-N 123.931 0.77 . . . . 0.0 112.197 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.68 135.81 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.634 2.223 . . . . 0.0 111.933 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.537 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 4.1 pt20 -153.16 161.36 42.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.255 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.461 HG21 ' CB ' ' A' ' 31' ' ' PRO . 4.6 mp -93.56 102.46 7.71 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.7 Cg_exo -66.85 165.18 26.79 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 122.805 2.337 . . . . 0.0 112.878 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.877 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -81.33 -22.36 38.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.391 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -74.95 109.95 8.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 41.7 mttp -86.67 9.4 18.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.333 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -110.65 5.73 21.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.24 0.543 . . . . 0.0 110.139 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.608 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 66.1 mttm -92.89 173.0 7.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.766 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.9 t -109.7 117.29 54.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.043 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.63 -26.08 23.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.184 0.516 . . . . 0.0 110.343 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.83 -175.3 43.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.418 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 90.0 m-85 -126.53 140.13 52.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.089 0.444 . . . . 0.0 110.273 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.42 HG21 ' O ' ' A' ' 18' ' ' ILE . 7.2 tp -100.69 110.02 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.571 0.7 . . . . 0.0 109.539 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 42.5 mt-10 -113.34 113.14 24.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.195 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.57 92.07 48.49 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.43 -30.08 91.71 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.953 2.436 . . . . 0.0 112.221 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -70.06 -25.97 63.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.45 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.76 5.71 26.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.3 t0 61.86 20.7 11.68 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.911 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.429 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 68.4 mt -96.71 124.08 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.711 -173.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.429 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 3.9 mppt? -141.16 83.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.574 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 25.2 mm-40 -117.72 151.36 48.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.045 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.19 133.39 14.81 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.939 2.426 . . . . 0.0 111.911 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 43' ' ' VAL . 56.1 t -92.17 118.37 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.842 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.427 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 92.6 m-85 -95.54 114.28 63.6 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 38.2 Cg_endo -64.94 129.58 23.59 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.11 2.54 . . . . 0.0 112.179 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.24 179.43 43.91 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.648 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HG2' HG22 ' A' ' 35' ' ' THR . 62.5 Cg_endo -87.69 33.55 0.41 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.96 3.107 . . . . 0.0 112.451 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.55 32.04 11.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.413 HG22 ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -62.26 138.14 96.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.341 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -46.95 -48.71 13.85 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.788 2.992 . . . . 0.0 114.109 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.48 -30.06 68.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.821 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.53 -41.49 79.84 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.6 mm? -77.51 -6.08 52.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -83.6 -14.36 52.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -126.32 -36.24 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -154.62 -167.67 16.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.388 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.493 HG13 ' HG2' ' A' ' 71' ' ' GLN . 10.8 m -88.97 153.4 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -139.51 169.01 18.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.62 151.79 26.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.371 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.47 62.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.36 156.93 20.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.0 111.862 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -97.18 -20.95 17.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -72.26 -12.27 61.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -75.08 150.2 38.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.837 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 m -130.86 159.62 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.501 HD12 HG22 ' A' ' 88' ' ' VAL . 84.8 mt -76.3 -20.97 56.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.812 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.92 3.72 36.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 110.246 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.88 156.79 38.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -68.87 -27.24 65.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.242 0.544 . . . . 0.0 110.685 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -120.5 110.96 17.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.039 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.48 123.95 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -117.67 116.8 27.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.0 0.428 . . . . 0.0 110.84 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -104.77 122.35 57.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.48 139.28 30.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.37 163.76 32.64 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.378 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -142.75 150.91 40.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.698 0.285 . . . . 0.0 110.36 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 73' ' ' THR . 17.1 m -84.06 150.84 25.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.578 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 9.3 t80 -142.65 151.52 41.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.8 mt -81.82 -47.01 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 111.605 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.81 -43.69 97.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.978 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HD2' ' HB3' ' A' ' 70' ' ' TYR . 1.5 mmt180 -89.35 109.1 28.95 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.34 -11.08 17.54 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.584 2.189 . . . . 0.0 111.524 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -148.13 77.21 1.4 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.823 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.578 ' OH ' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -156.15 158.23 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.574 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 80.0 mt-30 41.44 -107.59 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.705 0.628 . . . . 0.0 112.463 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CD1' HD23 ' A' ' 75' ' ' LEU . 50.6 m-85 -131.69 91.09 2.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.479 ' HA ' HG22 ' A' ' 63' ' ' THR . 2.7 t -120.71 -53.82 2.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.331 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -87.01 18.47 3.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.53 0.681 . . . . 0.0 109.919 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD11 ' HE3' ' A' ' 97' ' ' MET . 28.8 tp -70.06 -7.84 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.671 -178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -8.29 56.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.91 -0.98 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.822 173.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.79 160.61 20.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.283 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -163.5 -169.78 2.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.695 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.5 ptmt -51.1 -36.69 41.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -170.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.56 58.53 0.7 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.314 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.3 m -81.96 -7.95 59.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.469 ' HE2' ' HB3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 53.33 89.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.567 0.699 . . . . 0.0 111.439 -175.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -90.6 118.36 35.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 90.0 m-85 -103.9 121.26 42.74 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.009 0.433 . . . . 0.0 110.51 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 27.7 t80 -100.68 104.53 15.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.6 tptm -85.73 97.43 10.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.501 HG22 HD12 ' A' ' 52' ' ' LEU . 4.4 p -124.36 120.93 60.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -173.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.02 1.84 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.714 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -172.86 -28.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.979 0.512 . . . . 0.0 110.499 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -87.2 165.68 15.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.158 0.504 . . . . 0.0 111.565 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 m -123.57 110.74 15.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.616 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 9.1 mmm180 -87.1 132.19 33.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.469 ' HB3' ' HE2' ' A' ' 83' ' ' MET . 0.0 OUTLIER -107.22 123.16 47.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.545 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 87.5 m-85 -118.46 145.39 45.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.485 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.58 ' HE3' HG11 ' A' ' 147' ' ' VAL . 1.3 tppp? -114.43 128.61 56.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.636 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 56.3 mtt -78.22 70.86 4.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.632 0.73 . . . . 0.0 110.636 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -87.09 -6.74 58.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.039 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 49.0 m -140.04 103.86 4.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.347 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 84.3 mt -122.6 130.06 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -158.95 173.31 16.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.883 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.942 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 1.5 p30 -133.03 124.06 26.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.254 0.549 . . . . 0.0 109.9 175.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.79 -172.2 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.953 -171.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.563 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -124.63 152.6 69.27 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.051 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.25 -13.01 33.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.487 2.125 . . . . 0.0 110.974 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -13.13 59.97 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.389 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.536 ' HB2' ' HE3' ' A' ' 104' ' ' LYS . 12.7 t70 -108.99 121.69 45.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.875 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.96 32.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -102.17 -18.47 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.137 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.07 -16.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.239 0.542 . . . . 0.0 111.533 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.442 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -98.65 22.04 10.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 111.242 -175.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 10.1 t70 -79.25 -154.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.954 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 39.0 mt-10 -65.52 92.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.05 30.14 4.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.637 0.732 . . . . 0.0 111.492 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.79 153.44 21.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 176.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.33 -21.23 7.32 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -90.12 -170.29 2.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.282 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.49 -164.67 1.21 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -65.03 104.89 0.94 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 110.11 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 13.1 pt20 -100.22 120.18 39.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.296 0.57 . . . . 0.0 110.526 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -85.61 110.32 19.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -94.65 99.64 11.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.555 -175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.1 mt -85.69 108.25 17.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.8 mt -91.46 99.34 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 m -96.52 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.262 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 80.0 m -94.9 93.95 7.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.499 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -113.73 9.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 23.4 t70 -78.95 -79.81 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.619 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 1.0 OUTLIER 62.48 88.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.779 -177.471 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 48.4 t-20 -85.81 98.04 10.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.0 -3.13 9.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.415 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 93.5 mttt -72.95 -33.02 65.64 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.126 0.489 . . . . 0.0 110.489 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.6 t -128.13 -15.96 4.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.542 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 26.26 45.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.375 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.35 138.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 25.0 m95 -85.09 105.02 15.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.99 -67.75 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.541 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 17.9 tppt? -65.25 117.03 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.411 0.624 . . . . 0.0 110.173 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -124.15 106.22 10.15 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.691 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.942 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 30.4 tttp -86.22 132.98 33.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.628 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.84 123.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.774 0.797 . . . . 0.0 110.607 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.54 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 89.4 m-85 -110.56 107.11 16.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.632 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 60.3 t -91.74 98.68 8.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.43 0.633 . . . . 0.0 109.534 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -97.5 97.58 9.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.813 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 7.3 m -73.96 140.67 45.7 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.52 114.77 2.62 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.676 0.75 . . . . 0.0 110.235 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.58 HG11 ' HE3' ' A' ' 96' ' ' LYS . 7.7 p -101.73 125.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.927 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.732 -178.117 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.66 -65.03 0.37 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.8 0.809 . . . . 0.0 109.994 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.19 140.37 29.74 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.934 172.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 31.4 mttp -108.49 97.4 22.83 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 31.9 Cg_endo -64.48 115.29 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.291 1.994 . . . . 0.0 109.264 165.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.407 ' HA ' HD23 ' A' ' 52' ' ' LEU . 3.4 pt20 -124.62 143.64 50.61 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.398 0.618 . . . . 0.0 110.98 -172.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 31' ' ' PRO . 9.6 mt -69.12 118.11 58.51 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.245 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.66 174.25 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.381 2.054 . . . . 0.0 111.721 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 9' ' ' LYS . 36.4 mmtm -92.07 36.83 0.98 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.694 0.759 . . . . 0.0 109.997 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' A' ' 13' ' ' LYS . 9.9 t70 -127.2 105.69 8.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.454 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.655 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 32.0 mttp -73.92 -6.86 49.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.324 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.0 t -95.57 -19.56 19.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.995 0.426 . . . . 0.0 110.265 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HG3' ' CG ' ' A' ' 10' ' ' ASP . 56.6 mttp -81.82 176.19 9.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.7 p -112.63 136.63 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.07 -31.29 14.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.372 0.606 . . . . 0.0 110.21 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.15 158.5 31.48 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.093 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -102.87 138.49 39.69 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.872 0.336 . . . . 0.0 110.122 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.3 tp -104.03 120.25 53.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 36.8 mt-10 -128.07 112.06 14.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.548 0.689 . . . . 0.0 110.911 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 43.6 mt -120.91 95.49 48.91 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.446 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.35 -27.07 71.29 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 123.244 2.629 . . . . 0.0 112.402 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 35.2 t70 -67.3 -32.09 72.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.252 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -109.86 5.02 22.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.914 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t0 63.54 22.37 13.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.81 0.814 . . . . 0.0 110.71 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.561 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 59.4 mt -79.32 113.48 18.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.291 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -150.69 98.25 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.962 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.659 ' OE2' ' HA ' ' A' ' 70' ' ' TYR . 2.4 mt-10 -169.29 164.47 6.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 O-C-N 123.16 0.287 . . . . 0.0 110.989 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.47 ' HB3' HG21 ' A' ' 14' ' ' VAL . 21.6 Cg_exo -66.58 148.91 84.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.1 2.534 . . . . 0.0 112.99 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.15 121.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.308 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 44' ' ' SER . 50.6 m-85 -93.44 137.76 23.29 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.26 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HA ' ' HD1' ' A' ' 45' ' ' PHE . 89.5 Cg_endo -92.15 153.52 3.18 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.71 2.273 . . . . 0.0 113.077 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.11 -174.48 25.15 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.861 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.655 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 94.7 Cg_endo -79.98 8.97 3.76 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.574 2.849 . . . . 0.0 113.142 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 45' ' ' PHE . . . 61.71 68.82 0.68 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.614 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.436 HG22 ' HG2' ' A' ' 33' ' ' PRO . 37.6 p -92.07 161.15 34.03 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.173 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -30.66 26.2 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.086 2.524 . . . . 0.0 112.589 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.43 -43.78 93.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.152 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 39.0 mm-40 -82.16 -40.14 22.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.259 -170.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.2 mm? -70.73 -7.73 46.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.36 0.6 . . . . 0.0 110.577 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -22.75 23.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.487 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 38' ' ' GLN . 7.0 ptm85 -105.14 -13.8 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.221 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . 162.84 -157.18 29.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.386 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.509 HG12 ' CE2' ' A' ' 72' ' ' PHE . 70.2 t -95.44 135.88 28.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.924 0.392 . . . . 0.0 110.05 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.1 m -124.65 170.34 11.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.547 ' HD1' ' HA ' ' A' ' 31' ' ' PRO . 26.8 m-85 -68.66 161.9 27.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.223 174.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.12 -27.87 21.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.577 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 2.2 mm-40 -117.83 145.04 44.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.516 0.674 . . . . 0.0 112.344 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.98 -6.98 59.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -90.27 -5.2 56.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.833 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB3' HD11 ' A' ' 7' ' ' ILE . 2.2 tp10 -48.8 139.44 9.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -143.65 132.42 22.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.68 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.428 HD22 HG13 ' A' ' 7' ' ' ILE . 2.6 mm? -75.98 -11.51 59.97 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.029 0.442 . . . . 0.0 110.813 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -89.17 -9.79 49.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.422 0.63 . . . . 0.0 110.218 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -89.14 170.71 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.495 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.54 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 4.7 pt20 -104.13 -0.87 28.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.74 0.305 . . . . 0.0 111.016 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.88 115.65 16.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.43 0.633 . . . . 0.0 109.92 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.21 129.27 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.275 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -108.11 120.78 43.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.344 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.5 mt -111.53 115.77 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' HB3' ' C13' ' A' ' 201' ' ' JPT . . . -97.74 116.49 30.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 110.871 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -110.77 159.99 13.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.929 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -154.76 131.19 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.428 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 2.4 m -65.56 113.01 3.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.478 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 41.4 t80 -90.22 128.3 36.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.3 mt -58.97 -37.75 69.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.228 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.468 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 9.3 m-20 -91.95 8.28 38.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.908 0.385 . . . . 0.0 111.372 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 34.2 mtt180 -121.4 97.2 47.4 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.776 0.322 . . . . 0.0 110.985 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.17 -8.35 20.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.614 2.209 . . . . 0.0 111.694 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -154.26 82.3 1.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.659 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.3 p90 -118.37 -164.2 1.01 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.171 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -48.96 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.297 0.373 . . . . 0.0 111.765 -177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.509 ' CE2' HG12 ' A' ' 43' ' ' VAL . 18.8 m-85 -103.21 68.48 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.694 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -92.6 -42.17 9.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.338 0.589 . . . . 0.0 110.355 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.7 t30 -114.24 33.31 5.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.42 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -59.2 -27.21 65.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -177.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -9.92 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.78 -4.74 58.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.124 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.533 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -72.18 -174.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 5.9 ptpp? -167.02 -179.0 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.979 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.6 ptpt -53.99 -48.76 70.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.139 -176.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.5 54.99 0.57 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.438 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.494 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -73.64 -11.59 60.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.327 -0.436 . . . . 0.0 111.203 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.502 ' HE3' ' HB2' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 54.36 83.84 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.433 0.635 . . . . 0.0 111.801 -176.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.5 t -85.41 111.42 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.827 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -99.8 113.67 26.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.491 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 2.1 t80 -102.4 108.21 19.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.593 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.43 92.68 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.974 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 HG23 ' CG ' ' A' ' 91' ' ' GLU . 4.8 m -104.71 117.56 50.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.44 -83.16 0.2 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.572 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -152.74 12.17 0.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.722 0.296 . . . . 0.0 110.823 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' CG ' HG23 ' A' ' 88' ' ' VAL . 12.6 pt-20 -109.43 140.11 43.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.059 0.456 . . . . 0.0 110.291 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.6 m -100.62 109.71 21.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 16.5 mmt85 -88.7 142.03 28.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.54 173.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.502 ' HB2' ' HE3' ' A' ' 83' ' ' MET . 0.4 OUTLIER -118.67 130.73 56.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.9 0.381 . . . . 0.0 110.542 177.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 81.3 m-85 -127.83 143.85 51.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -107.07 137.32 45.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.743 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.0 mmt -83.87 81.95 8.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 110.14 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -92.2 -36.7 13.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.63 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 6.9 m -109.26 97.04 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.491 HD13 ' HB3' ' A' ' 97' ' ' MET . 75.9 mt -117.68 117.16 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.896 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -168.99 -159.81 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 112.068 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -109.89 153.32 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.818 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.59 ' HB ' ' OD2' ' A' ' 107' ' ' ASP . 10.6 m -135.38 166.48 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 167.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 106' ' ' THR . 0.0 OUTLIER -147.62 161.21 36.38 Favored Pre-proline 0 C--O 1.22 -0.45 0 O-C-N 122.334 -0.229 . . . . 0.0 111.32 -169.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 34.8 Cg_endo -65.08 11.75 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.717 2.278 . . . . 0.0 113.05 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.7 t -129.8 8.79 5.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.59 ' OD2' ' HB ' ' A' ' 103' ' ' VAL . 1.1 p30 -84.2 158.23 21.37 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.536 ' HA ' HD22 ' A' ' 111' ' ' LEU . 29.1 m -112.58 18.73 7.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.198 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 -45.36 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.924 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.81 -11.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.654 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -106.39 12.3 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.703 0.287 . . . . 0.0 111.27 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.6 169.27 9.82 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.519 ' CG ' ' HE3' ' A' ' 115' ' ' LYS . 11.2 pt-20 -92.41 20.25 6.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -175.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 52.13 119.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.617 1.167 . . . . 0.0 113.724 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.519 ' HE3' ' CG ' ' A' ' 113' ' ' GLU . 18.9 mmtp -109.48 147.31 33.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.586 -171.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.92 34.27 11.13 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.896 -1.502 . . . . 0.0 115.23 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -122.59 161.89 22.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.837 0.818 . . . . 0.0 112.016 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -93.98 -158.14 0.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.54 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -62.09 110.04 1.47 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -116.67 138.81 51.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.26 0.552 . . . . 0.0 112.124 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.4 mt -97.73 112.26 24.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 169.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.3 m -96.26 103.85 15.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.287 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.7 mt -91.11 106.03 18.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.79 100.01 9.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 6.9 m -91.0 107.09 18.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.138 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.8 m -103.89 86.12 2.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -111.18 -2.15 15.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.576 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 36.4 t70 -104.8 94.37 5.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.488 0.661 . . . . 0.0 109.899 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.537 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 92.0 t80 -101.01 124.05 46.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.188 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -91.37 110.28 21.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.7 mt-10 -72.39 -21.65 61.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.847 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 132' ' ' LYS . 43.8 mmtm -72.51 -24.57 61.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.422 HG22 HG13 ' A' ' 135' ' ' VAL . 9.6 t -136.62 4.01 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.304 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.53 48.79 79.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.17 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.422 HG13 HG22 ' A' ' 133' ' ' THR . 4.4 p -137.77 159.22 34.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.537 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 37.6 m95 -100.64 112.74 25.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.576 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 55.8 mt-10 -80.88 -60.02 2.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.932 0.396 . . . . 0.0 111.04 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 47.4 mmtm -88.94 101.52 14.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.177 0.513 . . . . 0.0 110.262 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.526 ' HB2' HG21 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -100.63 105.52 16.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 18.7 tptm -76.63 120.62 22.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.6 tt -118.98 122.55 69.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 122.037 0.922 . . . . 0.0 111.66 -172.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 24.5 m-85 -116.95 106.75 13.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.135 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.0 t -100.76 103.98 15.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.234 0.54 . . . . 0.0 110.259 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.484 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.995 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.7 m -93.59 138.81 31.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -57.83 125.03 21.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.042 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 96' ' ' LYS . 2.7 t -85.75 146.38 6.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.775 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.68 179.024 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.405 ' C13' ' HB3' ' A' ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.135 0.493 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -116.98 -174.86 2.67 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.475 -176.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.56 94.41 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.321 0.581 . . . . 0.0 111.804 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -127.64 103.34 22.02 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.106 171.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.507 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 36.9 Cg_endo -63.09 106.64 0.56 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.15 2.567 . . . . 0.0 112.878 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -120.64 137.9 54.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.776 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.565 ' CD1' ' HG ' ' A' ' 52' ' ' LEU . 4.1 mp -76.5 125.24 87.71 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.71 153.51 54.0 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.116 1.877 . . . . 0.0 110.369 170.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -86.39 14.11 7.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.476 0.655 . . . . 0.0 111.215 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.407 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 27.4 t0 -100.71 102.43 13.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.553 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 24.5 pttm -81.27 0.13 38.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.446 -172.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.2 m -90.32 3.91 52.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 87.5 mttt -103.83 -176.53 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.348 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.79 129.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.049 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.45 -29.93 17.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.78 36.57 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.56 143.32 34.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 117.128 0.464 . . . . 0.0 109.758 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.545 0.688 . . . . 0.0 110.265 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 38.4 mt-10 -115.78 116.54 28.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.922 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.56 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 46.0 mt -133.87 91.62 24.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.52 -34.51 92.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.951 2.434 . . . . 0.0 111.871 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.77 -25.62 68.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.292 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' A' ' 78' ' ' ALA . . . -114.83 11.37 16.68 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.011 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 58.41 29.67 18.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.773 0.797 . . . . 0.0 110.754 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.629 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 58.9 mt -98.37 118.49 44.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.232 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.629 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 5.5 mtmt -150.19 81.91 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.282 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 40.9 mt-10 -149.21 162.47 28.84 Favored Pre-proline 0 N--CA 1.465 0.316 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 60.3 Cg_endo -72.43 148.16 48.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.072 2.515 . . . . 0.0 113.493 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.47 130.59 62.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.016 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.545 ' O ' ' HA ' ' A' ' 44' ' ' SER . 33.5 m-85 -97.11 137.96 21.25 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.495 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 73.0 Cg_endo -90.15 -172.31 0.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.962 2.441 . . . . 0.0 112.533 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.06 -174.27 16.83 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.453 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.84 12.39 3.02 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.926 3.084 . . . . 0.0 113.081 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.55 74.67 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.193 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.692 HG21 ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -95.83 147.44 33.0 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.087 -176.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.692 ' HD2' HG21 ' A' ' 35' ' ' THR . 81.6 Cg_exo -40.65 -66.83 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.751 2.967 . . . . 0.0 114.46 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -26.63 55.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.762 0.315 . . . . 0.0 111.663 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.553 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 24.8 tp60 -66.54 -37.89 85.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.118 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.6 tp -74.3 -38.7 63.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.772 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -67.93 -9.8 48.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.19 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.59 -28.48 62.82 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 110.415 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.29 -88.7 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.257 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG12 ' HA3' ' A' ' 61' ' ' GLY . 34.0 m -137.02 157.84 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 21.9 p -150.72 156.07 40.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.013 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.495 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 21.2 m-85 -70.18 155.13 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.784 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.09 73.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.302 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -152.24 177.7 10.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.434 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.59 -28.2 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 -172.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -76.87 -11.06 59.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.083 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.404 ' OE1' ' HA ' ' A' ' 50' ' ' GLU . 5.1 tp10 -61.24 126.26 26.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.726 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 23.5 m -112.39 138.24 49.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.791 0.329 . . . . 0.0 111.441 -173.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.565 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 77.6 mt -67.96 -25.52 65.48 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.57 17.47 23.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.464 0.65 . . . . 0.0 110.355 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.726 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -88.96 -177.21 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.464 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -16.93 58.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.197 0.522 . . . . 0.0 110.08 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.94 142.61 29.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.18 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' HB ' HD21 ' A' ' 121' ' ' LEU . 5.3 mp -129.07 105.29 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.727 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.548 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 4.5 m -89.94 113.1 24.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.464 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.0 mt -107.13 111.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.991 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.435 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -96.52 121.93 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA3' HG12 ' A' ' 43' ' ' VAL . . . -121.11 161.22 15.22 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.359 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -123.18 130.32 52.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.611 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 12.0 m -71.15 136.95 48.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.138 -177.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.16 136.63 37.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.328 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.1 mt -90.99 -46.77 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.114 0.483 . . . . 0.0 110.21 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 17.7 t70 -75.18 -39.69 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.399 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -92.34 109.04 35.44 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.92 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 94.1 Cg_endo -83.93 -0.35 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.878 2.385 . . . . 0.0 111.476 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -129.96 71.73 1.46 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.977 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.611 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 10.4 p90 -119.38 -175.41 2.93 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -48.82 -66.69 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.426 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 23.1 m-30 -103.1 31.59 4.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -170.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -49.97 74.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.268 0.556 . . . . 0.0 111.429 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 67.0 t30 -102.51 25.52 8.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.231 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.11 -19.01 64.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.209 0.528 . . . . 0.0 110.901 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -68.87 -20.47 64.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.515 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.52 9.24 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.108 0.48 . . . . 0.0 110.308 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.492 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . . . -89.3 122.71 32.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.066 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 6.3 mmmm -101.58 -164.41 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.283 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 13.1 ptmm? -68.5 -21.94 64.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.22 50.88 0.87 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.574 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -70.3 -7.62 43.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.806 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 87.1 mmm 44.66 88.38 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.665 0.745 . . . . 0.0 112.029 -170.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -85.58 124.55 40.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.2 m-85 -109.13 112.99 25.46 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.27 109.56 21.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -91.28 85.51 5.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.706 -175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.638 ' O ' ' HG2' ' A' ' 91' ' ' GLU . 11.1 m -111.54 131.04 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.877 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 90' ' ' ASN . . . 59.14 22.1 54.77 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.035 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 29.3 m-80 73.53 14.48 4.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.479 0.711 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 6.2 pt-20 -97.14 179.4 4.93 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -135.28 117.62 15.66 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.428 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 94.5 mtt180 -116.01 133.42 56.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -101.35 131.27 47.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.293 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.545 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 84.2 m-85 -130.76 146.67 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.869 -178.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.806 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.55 132.42 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.532 ' SD ' ' HB1' ' A' ' 144' ' ' ALA . 21.2 mmt -75.53 68.15 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 110.226 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -84.46 -9.58 58.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.431 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 67.4 m -136.84 93.97 2.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.36 0.6 . . . . 0.0 111.183 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.16 118.21 56.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.543 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.9 ptt180 -149.35 165.19 32.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.244 0.545 . . . . 0.0 111.683 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.02 109.12 15.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.933 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.639 HG22 HG11 ' A' ' 110' ' ' VAL . 19.4 m -108.24 168.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.49 0.662 . . . . 0.0 111.683 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HD3' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -138.52 170.38 10.42 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.934 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.77 -26.81 58.77 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.065 1.843 . . . . 0.0 110.175 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -72.64 -12.42 61.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.878 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -91.67 128.8 37.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' HA ' HD11 ' A' ' 111' ' ' LEU . 17.5 m -113.28 26.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.805 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -109.2 -9.87 15.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.684 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.639 HG11 HG22 ' A' ' 103' ' ' VAL . 15.9 m -91.62 -8.74 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -112.58 9.94 19.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.666 0.746 . . . . 0.0 109.381 175.157 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -89.2 160.81 16.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.298 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -50.45 125.93 13.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.489 . . . . 0.0 111.635 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -75.65 129.31 36.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.6 mptt -69.69 157.77 36.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.932 -172.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.04 56.81 1.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.441 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -79.26 -174.35 4.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.023 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.09 -163.78 0.84 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.27 121.63 11.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.92 135.07 54.36 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.158 0.504 . . . . 0.0 110.801 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.409 HD21 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -92.73 113.98 26.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.536 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.7 m -94.41 92.23 7.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.901 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 27.5 mt -83.47 104.56 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 110.044 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 60' ' ' ALA . 24.3 mt -94.52 101.04 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.074 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -97.11 96.4 8.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.082 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.459 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 62.5 m -96.01 89.25 5.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.93 -14.11 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.17 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 21.1 t70 -110.6 94.77 5.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.561 0.696 . . . . 0.0 109.832 -176.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.582 ' CZ ' ' HA2' ' A' ' 134' ' ' GLY . 94.1 t80 -107.55 124.5 50.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.485 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -90.88 101.96 14.72 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.22 -5.38 17.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.429 -174.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -38.76 68.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.874 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 135' ' ' VAL . 6.9 t -149.81 -26.48 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.582 ' HA2' ' CZ ' ' A' ' 129' ' ' TYR . . . 120.83 36.8 0.75 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.824 -1.179 . . . . 0.0 112.858 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.497 HG21 HG23 ' A' ' 133' ' ' THR . 93.0 t -104.39 124.05 58.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.459 ' CE3' ' HB3' ' A' ' 126' ' ' CYS . 33.3 m95 -84.86 93.31 8.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.496 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 16.2 mm-40 -60.22 -68.26 0.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.863 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.42 ' HE3' ' C ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -91.76 103.86 16.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 -177.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.503 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 84.1 mtm180 -105.44 95.65 5.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.925 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.835 ' HD3' ' HE1' ' A' ' 142' ' ' PHE . 2.4 ttmp? -74.54 130.39 39.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.959 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.543 ' CG2' ' HG3' ' A' ' 101' ' ' ARG . 12.8 tt -123.44 120.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.932 0.872 . . . . 0.0 111.025 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.835 ' HE1' ' HD3' ' A' ' 140' ' ' LYS . 8.4 m-85 -106.33 104.07 13.69 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.522 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 61.9 t -98.72 109.61 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.485 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.532 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -104.7 103.34 12.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.524 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -83.85 142.62 30.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.684 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -55.73 133.1 50.65 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.251 -175.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 7.3 p -111.85 160.91 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.259 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.776 -0.63 . . . . 0.0 110.008 -177.065 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.503 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.657 ' SD ' ' HA ' ' A' ' 5' ' ' PRO . 48.5 ttm . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -113.25 5.27 16.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.236 0.541 . . . . 0.0 110.834 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.82 138.89 12.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.122 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 45.97 93.53 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.353 0 O-C-N 124.565 1.165 . . . . 0.0 113.547 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.657 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 32.5 Cg_endo -62.71 125.19 15.53 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.695 2.263 . . . . 0.0 112.145 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -147.24 162.2 39.4 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.403 ' N ' HD13 ' A' ' 7' ' ' ILE . 3.4 mp -86.78 127.47 59.98 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 0.0 110.486 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.44 -178.76 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.75 2.3 . . . . 0.0 112.666 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.711 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.4 103.8 7.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.46 -174.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 36.1 mtmm -88.7 13.38 12.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.623 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.8 t -98.26 -11.79 22.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.744 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -105.03 178.18 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 -178.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.99 131.55 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.66 16.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.235 0.541 . . . . 0.0 110.443 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.91 38.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 90.9 m-85 -112.62 138.47 49.36 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.392 0.596 . . . . 0.0 110.858 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.435 HG21 ' O ' ' A' ' 18' ' ' ILE . 7.5 tp -106.78 105.17 18.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 122.167 0.984 . . . . 0.0 109.814 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -111.96 113.5 25.84 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.965 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.3 mt -125.61 95.94 39.41 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.788 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.66 -28.78 77.05 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.796 2.331 . . . . 0.0 111.688 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 27.4 t0 -71.27 -22.24 61.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.039 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.76 5.29 17.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.936 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.8 t70 64.62 24.24 12.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.455 0.645 . . . . 0.0 110.535 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.401 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 81.5 mt -96.23 126.29 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.928 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.4 mppt? -138.77 43.77 2.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 15.9 mm-40 -98.58 154.09 37.66 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.0 Cg_exo -78.5 145.0 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.269 2.646 . . . . 0.0 112.083 175.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.68 115.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -97.29 116.69 65.99 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.881 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 30.1 Cg_endo -63.37 140.67 77.86 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.416 2.077 . . . . 0.0 111.744 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.38 -179.47 41.41 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.356 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.531 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 12.9 Cg_endo -91.82 29.02 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.774 2.983 . . . . 0.0 112.439 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 45' ' ' PHE . . . 58.47 50.0 9.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.557 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 p -68.43 150.6 97.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.93 -55.05 4.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.211 2.607 . . . . 0.0 113.099 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.89 -27.06 67.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.377 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -65.97 -46.05 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.327 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -78.53 -4.32 48.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.391 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.58 -18.82 16.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.141 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -102.08 -26.07 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 110.813 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -171.18 35.4 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.08 148.07 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.08 0.44 . . . . 0.0 110.005 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -137.04 -171.95 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 110.693 -174.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 33.3 m-85 -94.94 169.72 9.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.13 84.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 110.436 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -141.82 170.43 15.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.561 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.57 -7.61 54.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.398 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.75 13.54 30.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.644 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.419 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 8.0 mm-40 -74.3 169.34 17.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.355 0.598 . . . . 0.0 111.578 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.3 m -138.37 139.9 39.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 96.2 mt -77.45 -13.44 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.632 -176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.77 14.89 23.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.715 0.769 . . . . 0.0 110.103 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' HG12 ' A' ' 57' ' ' ILE . 11.3 t70 -69.29 171.68 8.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.962 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.424 ' O ' ' HG2' ' A' ' 120' ' ' GLN . 1.1 tm0? -95.62 -26.0 15.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.441 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.447 ' HA ' ' HG3' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -134.09 56.39 1.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.144 0.973 . . . . 0.0 111.106 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.465 HG12 ' HB3' ' A' ' 54' ' ' ASP . 49.9 mt -62.1 127.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.105 -173.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.451 ' HB3' HD13 ' A' ' 124' ' ' ILE . 19.8 m -105.75 109.43 21.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.288 -173.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.01 118.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.034 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.1 133.07 36.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.735 0.302 . . . . 0.0 111.002 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.12 163.91 26.96 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.162 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -139.56 158.77 43.57 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 73' ' ' THR . 21.5 p -102.78 158.58 16.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.899 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -134.57 135.39 42.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.12 -39.92 81.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.154 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.19 -4.31 52.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 51.1 mtt85 -132.72 90.58 32.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.247 0.546 . . . . 0.0 111.422 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.634 ' O ' ' HB ' ' A' ' 73' ' ' THR . 7.6 Cg_exo -73.64 -23.7 16.68 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.624 2.883 . . . . 0.0 113.244 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -124.64 27.1 6.99 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.612 ' CE2' ' HB2' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -92.18 -16.03 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.155 0.979 . . . . 0.0 109.075 177.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' C ' ' H ' ' A' ' 73' ' ' THR . 2.2 mt-30 -164.21 -154.54 0.25 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.292 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CE2' HD11 ' A' ' 123' ' ' LEU . 19.6 m-85 -74.22 26.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.634 ' HB ' ' O ' ' A' ' 68' ' ' PRO . 21.7 m -60.26 -45.9 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.488 . . . . 0.0 111.028 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -96.43 12.62 30.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.181 0.515 . . . . 0.0 110.675 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.27 -12.6 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.224 0.535 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.28 -12.86 61.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.452 176.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -89.79 -4.6 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.676 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.452 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -75.21 149.64 38.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.234 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 2.6 mppt? -111.12 -169.37 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 174.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.5 ptmm? -76.43 -11.8 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.297 0.57 . . . . 0.0 111.289 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.19 62.18 0.64 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.906 175.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -81.06 -9.63 59.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.433 ' HE3' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 51.01 83.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.489 0.662 . . . . 0.0 111.82 -174.376 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 80.8 t -85.57 128.8 38.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.939 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -113.57 107.51 15.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -97.54 115.12 27.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.855 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.8 mmtp -93.39 97.33 10.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.237 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.05 130.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.849 0.357 . . . . 0.0 110.547 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.83 30.24 74.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.994 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 68.35 4.49 4.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.313 0.645 . . . . 0.0 111.351 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -92.34 150.63 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.869 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.3 m -109.79 112.64 24.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.829 0.347 . . . . 0.0 110.332 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 146' ' ' GLU . 21.7 mmm180 -105.03 133.22 50.18 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 3.5 mptt -102.35 130.74 49.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 95.8 m-85 -123.35 144.01 49.73 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.793 0.33 . . . . 0.0 110.407 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.536 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -113.27 131.56 55.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.8 mmt -74.75 64.38 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.097 0.475 . . . . 0.0 110.663 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -80.22 -13.84 58.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.709 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.8 m -134.1 99.13 4.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.012 0.434 . . . . 0.0 110.258 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 97' ' ' MET . 70.0 mt -117.71 131.42 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.743 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -167.95 -175.29 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.912 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 8.6 p-10 -141.89 125.6 16.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.731 HG21 ' HG3' ' A' ' 139' ' ' ARG . 24.5 m -112.07 173.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.137 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.86 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -122.68 165.04 23.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.68 -16.08 46.17 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.498 2.132 . . . . 0.0 111.746 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 t -109.65 12.94 24.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.342 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.86 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 11.8 t70 -93.65 148.47 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.566 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 34.0 m -111.41 0.43 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -170.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -72.7 -12.79 61.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 110.689 -177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.478 HG12 HG23 ' A' ' 103' ' ' VAL . 22.7 m -94.78 -8.93 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.163 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 4.2 pp -99.15 -9.57 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.758 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -82.67 161.5 22.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.89 128.15 34.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.351 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -85.83 133.97 33.95 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -69.53 160.63 31.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.199 0.523 . . . . 0.0 112.411 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.81 59.93 0.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.327 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.39 176.73 0.76 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.238 0.542 . . . . 0.0 111.016 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -78.76 -155.8 0.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -63.47 103.47 0.52 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.447 ' HG3' ' HA ' ' A' ' 56' ' ' ASN . 18.6 pt20 -101.4 116.6 33.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.33 0.586 . . . . 0.0 109.854 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 tp -84.41 100.91 11.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.2 m -88.95 100.37 13.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.5 mt -87.25 109.04 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.7 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.451 HD13 ' HB3' ' A' ' 58' ' ' SER . 22.8 mt -97.84 104.7 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 22.1 m -95.27 97.37 9.81 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.036 0.446 . . . . 0.0 110.185 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 47.9 m -86.96 102.17 14.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.33 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.53 -170.24 3.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.172 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 31.1 t70 57.4 83.95 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.797 0.808 . . . . 0.0 110.637 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.502 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 80.8 t80 -94.65 124.52 38.74 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.081 -174.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -95.67 99.94 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.502 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.0 mt-10 -58.84 -39.92 82.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.819 -171.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -70.52 -14.06 62.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.531 HG22 HG22 ' A' ' 135' ' ' VAL . 2.1 t -130.98 -7.04 3.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.292 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.82 35.16 72.63 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.623 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 133' ' ' THR . 33.3 m -116.8 155.03 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 117.315 0.557 . . . . 0.0 111.147 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -96.6 100.28 11.86 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.24 -16.93 60.94 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 23.6 ttmm -124.91 86.62 2.58 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.081 0.943 . . . . 0.0 110.928 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.731 ' HG3' HG21 ' A' ' 103' ' ' VAL . 30.1 ptt180 -92.98 86.92 5.58 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.218 172.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.912 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 36.2 tttp -70.25 139.32 52.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.773 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.53 124.5 59.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.932 0.873 . . . . 0.0 111.144 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.58 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 27.4 m-85 -114.48 103.75 11.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.601 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 47.3 t -94.3 96.74 6.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.414 0.626 . . . . 0.0 109.804 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.536 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -93.05 105.91 17.94 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.06 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.7 m -81.35 140.44 34.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.096 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 93' ' ' ARG . 36.4 tt0 -61.27 132.31 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.406 0.622 . . . . 0.0 111.879 -175.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 2.2 t -104.61 170.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.687 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.5 mtpt . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.829 177.387 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.52 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.917 0.389 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -121.63 -171.3 2.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.314 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.448 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . -109.68 99.55 8.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.998 0.428 . . . . 0.0 110.543 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -106.24 98.62 19.98 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.792 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.576 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 77.8 Cg_exo -51.36 118.09 4.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.455 2.77 . . . . 0.0 113.258 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.14 168.01 25.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.339 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.533 HG23 ' HB3' ' A' ' 31' ' ' PRO . 3.9 mp -91.66 112.33 53.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.44 165.01 18.72 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.532 2.155 . . . . 0.0 111.818 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -95.97 1.29 52.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.359 0.599 . . . . 0.0 109.835 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.88 109.88 14.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.439 173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -84.66 62.31 7.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.051 -174.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 -29.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.576 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 2.8 mmpt? -54.24 154.59 4.31 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.537 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.37 111.93 32.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 164.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB1' ' HG3' ' A' ' 31' ' ' PRO . . . -76.39 -38.23 56.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.62 165.84 32.63 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.511 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 64.5 m-85 -112.87 132.57 55.24 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -96.74 107.92 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.876 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -112.9 108.15 16.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.887 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 HG12 HG11 ' A' ' 84' ' ' VAL . 23.0 mt -125.4 95.4 41.06 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.233 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.39 -16.2 53.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.797 2.331 . . . . 0.0 112.319 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.521 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 38.9 t70 -83.63 -21.67 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.443 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.12 11.24 15.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.329 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.69 19.6 11.88 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.078 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.2 mt -93.57 122.09 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.342 -174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -139.48 49.2 1.82 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.858 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 12.3 mm-40 -116.55 162.52 26.36 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.066 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.34 164.19 14.8 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.903 2.402 . . . . 0.0 113.269 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.14 136.73 59.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.199 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.29 133.49 20.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.761 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 23.9 Cg_exo -67.76 134.17 31.72 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.186 2.591 . . . . 0.0 111.808 168.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.13 144.08 4.1 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.029 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.96 54.44 3.12 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.297 2.665 . . . . 0.0 112.241 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 58.25 42.39 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.776 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.12 127.01 93.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.251 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -52.53 -39.64 74.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.289 2.659 . . . . 0.0 113.299 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.43 -12.52 61.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -101.21 -29.51 12.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.79 -18.24 48.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.123 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -81.96 -15.41 53.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.025 0.44 . . . . 0.0 110.379 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -114.01 -25.02 8.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.875 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.46 -138.05 2.35 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.635 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 72' ' ' PHE . 52.4 t -121.18 138.83 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.815 0.341 . . . . 0.0 110.649 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 t -119.52 169.3 10.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.917 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.761 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 54.7 m-85 -71.84 173.01 8.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.779 0.323 . . . . 0.0 110.361 173.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.14 -61.07 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.517 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.48 115.74 18.63 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 68.32 0.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.742 1.276 . . . . 0.0 111.092 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -146.07 2.6 0.9 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.268 171.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.66 160.52 29.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.146 -175.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 41.5 m -141.86 159.45 42.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.506 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.482 ' HG ' HD13 ' A' ' 7' ' ' ILE . 96.5 mt -85.76 -17.11 36.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.406 0.622 . . . . 0.0 109.895 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -86.25 -1.98 57.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.213 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 21.4 t0 -89.57 157.91 17.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.54 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.72 -25.51 26.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.963 0.411 . . . . 0.0 110.292 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.94 115.0 26.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.486 0.66 . . . . 0.0 111.657 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.81 127.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 m -121.95 120.52 34.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.56 126.69 68.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.63 104.48 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.017 0.437 . . . . 0.0 110.68 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.53 166.75 18.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.462 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -155.94 -179.6 8.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 p -117.8 166.98 11.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.303 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 5.1 m-85 -124.16 144.52 49.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.221 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.68 -32.06 28.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.193 0.52 . . . . 0.0 111.206 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -96.97 -6.03 36.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.75 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 10.5 mmt180 -112.8 95.43 33.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.24 -8.36 19.72 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.397 2.065 . . . . 0.0 111.58 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -153.41 83.66 1.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.092 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.441 ' CE2' ' HB ' ' A' ' 73' ' ' THR . 4.7 p90 -142.7 -170.16 3.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.858 ' HG2' ' HB3' ' A' ' 27' ' ' GLU . 77.5 mt-30 -32.81 -69.78 0.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.251 1.02 . . . . 0.0 113.621 -175.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.409 ' CD2' HG12 ' A' ' 43' ' ' VAL . 4.9 m-30 -124.13 111.87 16.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.441 ' HB ' ' CE2' ' A' ' 70' ' ' TYR . 14.9 t -164.59 -40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.379 0.609 . . . . 0.0 110.236 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -96.75 21.08 9.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.712 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.9 tp -65.98 -18.79 65.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -8.71 56.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.893 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.27 -10.64 51.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.94 0.4 . . . . 0.0 110.704 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -73.29 156.18 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.109 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 97' ' ' MET . 32.8 mttp -129.79 -179.79 5.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.434 -176.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -61.71 -28.84 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.114 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.21 42.85 1.72 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.466 -0.873 . . . . 0.0 110.993 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.9 t -57.25 -22.04 38.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.313 0.645 . . . . 0.0 112.048 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.23 87.13 0.06 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.747 0.784 . . . . 0.0 111.49 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.2 t -90.1 136.58 23.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.035 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.8 107.27 14.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.101 0.477 . . . . 0.0 109.926 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -94.7 105.3 17.23 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppp? -84.03 106.65 15.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.604 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 10.6 m -125.4 112.43 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 0.0 111.481 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.08 -94.71 0.18 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.838 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.423 ' ND2' ' HB1' ' A' ' 3' ' ' ALA . 9.1 p30 -129.94 8.31 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 110.238 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.87 138.56 40.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.411 ' OG1' ' HE2' ' A' ' 87' ' ' LYS . 43.7 m -107.25 93.19 4.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.578 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HD2' ' OE1' ' A' ' 146' ' ' GLU . 12.8 mmt180 -83.07 118.28 23.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.015 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 3.4 mptt -91.82 132.58 36.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 96.1 m-85 -124.7 144.81 50.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.099 0.476 . . . . 0.0 110.961 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.1 OUTLIER -113.52 128.05 56.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.061 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.62 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.1 mmt -78.7 60.43 2.75 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -77.05 -23.71 52.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.441 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.541 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 71.1 m -121.02 102.05 8.08 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 110.874 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.82 121.86 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.524 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -142.71 -172.35 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.471 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.96 141.14 46.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.512 ' HB ' ' OD2' ' A' ' 107' ' ' ASP . 20.8 m -124.14 167.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.045 0.45 . . . . 0.0 111.003 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.934 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.13 163.09 53.68 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.281 -171.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 137' ' ' GLU . 60.2 Cg_endo -72.33 20.94 0.29 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.434 2.089 . . . . 0.0 112.124 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.9 t -156.47 8.87 0.22 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.934 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 2.3 p30 -78.98 176.92 9.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.157 0.503 . . . . 0.0 111.206 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.489 ' HA ' HD12 ' A' ' 111' ' ' LEU . 23.1 m -123.69 24.31 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.235 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.22 5.11 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.82 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.7 m -108.56 -13.95 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.974 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -108.06 1.85 22.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -89.94 174.33 7.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.19 107.3 8.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.579 ' HB3' HE22 ' A' ' 120' ' ' GLN . 56.0 mm-40 -81.83 69.37 8.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.649 0.738 . . . . 0.0 110.564 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -115.04 -165.6 1.04 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.468 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.49 -26.26 24.77 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.275 -0.488 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -125.13 -173.2 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -153.85 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.407 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 17.1 mmtm -54.56 123.1 12.07 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 114' ' ' GLN . 12.6 pt20 -117.29 120.09 37.16 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 28.1 mt -78.18 99.19 6.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.6 m -85.78 96.9 9.89 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.71 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 26.5 mt -94.92 101.37 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.943 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.36 93.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.0 m -93.9 111.27 22.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.144 0.497 . . . . 0.0 110.138 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 58.2 m -95.45 109.5 21.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -136.94 89.22 2.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.994 0.902 . . . . 0.0 110.594 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 9.1 p-10 -153.9 -51.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.194 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.5 83.52 0.1 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.023 0.827 . . . . 0.0 110.772 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.478 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 38.4 t-20 -77.84 94.13 4.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.25 -20.76 63.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.144 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.478 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 30.6 mmmt -63.3 -30.47 71.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.492 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 4.9 t -129.68 -23.77 2.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.164 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 60.75 1.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.6 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 9.5 p -159.05 159.67 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -99.05 110.75 23.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 41.8 mt-10 -90.9 -59.83 2.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.709 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 53.2 mmtt -80.81 102.26 9.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.885 0.85 . . . . 0.0 110.987 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.493 ' HB2' HG23 ' A' ' 103' ' ' VAL . 74.1 mtt180 -114.11 102.07 9.82 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.598 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -83.2 122.29 28.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 5.0 tt -118.92 125.36 74.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.59 -172.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.62 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.2 m-85 -109.15 124.54 50.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.534 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.7 t -110.97 109.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.085 0.469 . . . . 0.0 110.318 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.61 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -107.65 120.03 41.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.351 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.6 m -89.86 143.1 27.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.122 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.488 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 31.9 tt0 -61.59 128.59 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.321 0.582 . . . . 0.0 111.239 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.491 HG21 ' HE3' ' A' ' 96' ' ' LYS . 2.3 t -110.92 170.14 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.422 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 148' ' ' LYS . 37.1 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.263 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HG3' ' HG2' ' A' ' 2' ' ' GLN . 24.9 ptt? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.415 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 82.3 mm-40 73.04 5.07 5.11 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.764 0.826 . . . . 0.0 111.583 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.578 ' HB2' HD21 ' A' ' 90' ' ' ASN . . . -178.81 106.14 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.454 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.1 mtmt -102.41 100.44 15.79 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.851 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 19.0 Cg_endo -58.38 124.12 15.13 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.975 2.45 . . . . 0.0 111.234 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -151.98 175.31 12.64 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.623 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.509 HG23 ' CB ' ' A' ' 31' ' ' PRO . 53.4 mt -113.12 95.23 33.98 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.212 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.514 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 23.9 Cg_exo -65.14 164.37 25.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.289 2.659 . . . . 0.0 113.565 -174.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -65.3 -34.1 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.779 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.09 129.44 34.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.368 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -96.88 6.1 49.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.088 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.4 m -101.12 8.45 42.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 65.8 mttm -107.84 175.9 5.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.83 120.49 59.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.614 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.92 -29.37 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.548 . . . . 0.0 110.913 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.99 168.95 42.1 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.238 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.405 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 80.0 m-85 -118.05 131.16 56.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -100.63 115.41 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.662 0.744 . . . . 0.0 110.003 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 47.7 mt-10 -123.63 112.39 17.36 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.83 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.447 HD13 HD11 ' A' ' 25' ' ' ILE . 46.3 mt -126.27 94.78 40.26 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.903 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.75 -33.28 96.59 Favored 'Trans proline' 0 CA--C 1.518 -0.314 0 C-N-CA 122.77 2.313 . . . . 0.0 111.505 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.475 ' HB3' ' HZ1' ' A' ' 79' ' ' LYS . 4.6 m-20 -58.28 -34.45 70.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.37 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -112.35 10.35 19.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.49 30.58 15.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.858 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.447 HD11 HD13 ' A' ' 20' ' ' ILE . 63.1 mt -86.86 133.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.509 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -156.14 57.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.14 0.495 . . . . 0.0 109.745 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -117.81 153.81 50.95 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.656 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -80.16 138.67 12.89 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.818 2.345 . . . . 0.0 112.635 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.93 131.38 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 110.316 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.3 m-85 -101.41 129.22 27.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.795 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 58.8 Cg_endo -71.5 149.81 56.55 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.887 2.391 . . . . 0.0 112.161 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.18 177.89 25.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.047 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.513 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 84.4 Cg_endo -84.63 29.95 0.53 Allowed 'Trans proline' 0 CA--C 1.52 -0.199 0 C-N-CA 123.813 3.009 . . . . 0.0 112.671 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . 60.8 56.34 2.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.042 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 33' ' ' PRO . 1.4 p -76.55 138.22 67.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.67 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -38.47 -66.34 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.49 3.46 . . . . 0.0 114.655 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.59 -35.49 81.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -68.83 -34.4 75.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.731 -174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 pp -87.4 -0.43 56.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.44 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -98.67 -31.57 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.114 175.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -70.51 -29.99 66.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.4 -97.48 0.16 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 1.008 ' HB ' ' HG3' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -170.28 153.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 8.4 t -133.37 176.19 8.74 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.362 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CE2' HG12 ' A' ' 7' ' ' ILE . 73.5 m-85 -89.16 173.62 8.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.96 85.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.767 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.5 mt-10 -134.21 167.41 20.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.153 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 1.4 tm-20 -72.97 -40.08 65.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.141 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -80.49 11.11 3.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.117 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' HD11 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -62.34 146.58 50.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.932 176.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.3 m -141.81 133.27 26.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 111.775 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.25 -2.87 36.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.748 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.03 -13.47 53.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.686 0.755 . . . . 0.0 109.487 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.26 -168.82 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.59 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.69 0.94 9.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.602 0.239 . . . . 0.0 110.452 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -113.16 49.69 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.03 118.27 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.305 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -120.36 124.87 46.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.559 -175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.2 mt -108.92 136.26 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.38 113.37 26.92 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.942 0.151 . . . . 0.0 110.8 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -105.76 148.21 16.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.678 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.475 ' HB2' ' C12' ' A' ' 201' ' ' JPT . 10.7 t-160 -117.16 107.57 14.63 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.173 0.189 . . . . 0.0 110.622 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -65.18 126.63 28.73 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 8.3 t80 -130.97 152.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.65 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.3 mt -90.6 -43.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 4.4 m-20 -76.39 -1.58 27.63 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -122.92 115.58 29.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.67 0.271 . . . . 0.0 110.561 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -90.34 0.57 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.746 2.297 . . . . 0.0 112.032 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -141.74 79.21 1.67 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.564 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.55 -166.62 2.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.364 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 1.008 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 68.8 mm-40 -47.29 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -101.27 28.47 5.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -40.13 85.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.354 0.597 . . . . 0.0 111.053 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 67.0 t30 -111.07 22.99 14.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.476 HD13 ' HE3' ' A' ' 97' ' ' MET . 31.3 tp -69.25 -5.53 23.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.135 0.493 . . . . 0.0 110.998 -176.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.542 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -75.37 -8.23 56.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 110.683 176.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.77 6.57 45.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.347 0.594 . . . . 0.0 110.48 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.95 152.53 21.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.503 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HZ1' ' HB3' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -146.82 -171.5 3.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.117 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -51.96 -22.05 3.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.96 44.83 1.12 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 119.578 -1.296 . . . . 0.0 113.337 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -67.88 142.2 56.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.721 ' HE2' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -91.19 89.85 7.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.101 176.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 57.2 t -85.95 107.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.493 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -100.52 118.85 37.56 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.452 ' C ' ' HG1' ' A' ' 92' ' ' THR . 13.4 t80 -110.51 104.16 12.86 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 1.4 mptm? -81.18 123.1 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.751 -177.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.851 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 6.6 m -136.95 116.53 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.167 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.05 -95.58 0.2 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.454 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.578 HD21 ' HB2' ' A' ' 3' ' ' ALA . 8.0 p30 -120.85 -3.41 9.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.537 0.208 . . . . 0.0 110.897 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.42 178.95 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.957 -173.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.452 ' HG1' ' C ' ' A' ' 86' ' ' PHE . 5.1 t -142.4 141.55 32.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -108.53 132.65 53.62 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.721 ' HD3' ' HE2' ' A' ' 83' ' ' MET . 12.1 ptpt -99.3 135.62 40.44 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.49 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 86.4 m-85 -122.03 144.36 48.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.703 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.2 tptm -110.04 126.07 53.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.049 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.476 ' HE3' HD13 ' A' ' 75' ' ' LEU . 59.6 mtt -82.07 80.73 8.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.428 0.633 . . . . 0.0 110.588 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.0 t -89.25 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.153 -173.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.537 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.0 t -144.83 129.17 17.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -141.19 125.47 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.181 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -170.74 -176.62 2.1 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.048 0.218 . . . . 0.0 110.832 172.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.717 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 2.9 p30 -130.24 138.88 50.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.417 . . . . 0.0 110.435 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.8 -179.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.93 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -93.19 154.19 41.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.496 ' HD3' ' HD3' ' A' ' 139' ' ' ARG . 61.0 Cg_endo -72.09 -18.42 27.36 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.317 2.011 . . . . 0.0 111.736 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.7 t -106.63 15.74 25.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.85 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 6.0 t0 -72.58 162.05 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.517 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 -7.25 10.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.71 -29.53 64.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.629 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.22 -9.31 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.915 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 94.1 mt -90.98 10.29 27.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.2 -176.11 3.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.94 132.16 50.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.35 0.595 . . . . 0.0 111.298 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -82.78 120.97 26.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.616 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -84.19 -152.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.693 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.34 55.62 1.16 Allowed Glycine 0 C--N 1.336 0.583 0 O-C-N 123.267 0.354 . . . . 0.0 113.593 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -83.59 147.43 27.74 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -87.36 -157.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -67.06 103.67 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.842 0.353 . . . . 0.0 110.418 -178.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 2.8 pt20 -104.56 136.37 44.24 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.394 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.75 105.8 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.5 m -85.33 100.86 12.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.729 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.6 mt -83.64 99.39 10.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 18.9 mt -91.54 97.22 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.451 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 17.4 m -106.9 121.94 45.42 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.804 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 94.2 m -73.54 96.16 2.38 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.201 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 6.4 t70 -110.53 98.36 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.887 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -178.59 -82.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.51 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.613 ' CE1' ' HG2' ' A' ' 131' ' ' GLU . 1.2 t80 58.58 77.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.016 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -83.25 86.28 7.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.269 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.613 ' HG2' ' CE1' ' A' ' 129' ' ' TYR . 27.8 mt-10 -58.79 -22.95 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.764 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -64.83 -27.53 68.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.444 HG22 HG11 ' A' ' 135' ' ' VAL . 4.8 t -121.66 -17.5 7.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.84 0.352 . . . . 0.0 110.445 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 48.64 5.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.239 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 133' ' ' THR . 4.0 p -146.14 158.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.491 ' HB2' ' O4 ' ' A' ' 201' ' ' JPT . 46.5 m95 -105.34 98.69 8.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.65 -58.51 3.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -85.3 137.12 33.18 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.459 0.647 . . . . 0.0 112.316 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.521 HH22 ' C1 ' ' A' ' 201' ' ' JPT . 6.5 mpt_? -100.12 111.03 23.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.76 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.717 ' HE3' ' HB3' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -79.03 117.86 20.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.0 tt -120.48 123.48 70.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.913 0.863 . . . . 0.0 111.052 -174.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 11.5 m-85 -108.14 114.65 28.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.048 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 40.2 t -93.95 99.62 9.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.302 0.572 . . . . 0.0 110.02 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -103.83 109.34 21.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.291 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 5.7 m -93.53 143.56 26.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.468 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -54.01 124.02 14.3 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.685 0.615 . . . . 0.0 111.303 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.488 HG13 ' HD3' ' A' ' 96' ' ' LYS . 6.5 p -111.05 151.6 13.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.585 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.474 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 4.5 ptmm? . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.464 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.521 ' C1 ' HH22 ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.558 0.218 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.02 169.19 9.99 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.0 98.94 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.982 0.801 . . . . 0.0 110.223 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 53' ' ' ASP . 16.6 mttt 54.66 84.73 0.21 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.51 -171.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.25 164.44 35.02 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.7 2.267 . . . . 0.0 111.586 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -140.3 130.15 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.009 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.637 HG13 HD21 ' A' ' 52' ' ' LEU . 12.0 mt -63.6 121.98 73.64 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.124 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.33 -179.07 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.965 2.443 . . . . 0.0 112.575 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -81.16 -12.62 59.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.3 0.572 . . . . 0.0 110.554 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.03 113.16 21.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.139 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -91.53 1.46 57.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.223 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 t -98.97 -6.04 29.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.879 0.371 . . . . 0.0 111.377 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -106.3 172.92 6.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.066 0.46 . . . . 0.0 110.884 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.34 125.38 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.609 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.35 -44.98 13.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.381 0.61 . . . . 0.0 109.696 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.88 168.34 36.22 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 68.2 m-85 -107.77 140.84 40.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.138 0.469 . . . . 0.0 110.439 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -105.33 112.71 39.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.855 0.836 . . . . 0.0 109.446 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.589 ' HB3' ' HD2' ' A' ' 26' ' ' LYS . 33.5 mt-10 -122.29 112.58 18.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.528 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.401 HD13 HD13 ' A' ' 25' ' ' ILE . 38.7 mt -127.28 93.95 39.85 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.791 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.51 -28.47 86.72 Favored 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 123.117 2.545 . . . . 0.0 111.808 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.497 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 26.9 t70 -67.22 -28.03 67.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.174 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -114.66 12.41 17.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.148 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.5 t70 61.78 26.91 16.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.492 0.663 . . . . 0.0 111.128 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.401 HD13 HD13 ' A' ' 20' ' ' ILE . 80.5 mt -95.99 129.67 45.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.206 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.589 ' HD2' ' HB3' ' A' ' 19' ' ' GLU . 9.2 mmmm -155.26 42.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.468 0.307 . . . . 0.0 111.498 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -124.46 157.47 64.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 36.4 Cg_endo -66.47 149.17 84.62 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.426 2.75 . . . . 0.0 113.52 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.81 138.1 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.214 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -100.33 135.57 20.23 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 121.0 0.428 . . . . 0.0 110.83 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HB2' HG21 ' A' ' 7' ' ' ILE . 73.0 Cg_endo -79.89 128.93 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.729 2.286 . . . . 0.0 111.348 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.661 ' HA3' ' HG2' ' A' ' 38' ' ' GLN . . . -175.82 149.42 9.99 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.676 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.494 ' HG2' HG21 ' A' ' 35' ' ' THR . 68.8 Cg_endo -74.46 38.02 0.48 Allowed 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.966 3.111 . . . . 0.0 113.476 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 54.91 36.23 26.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.074 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.494 HG21 ' HG2' ' A' ' 33' ' ' PRO . 6.1 p -76.46 154.16 83.85 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.784 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 77.3 Cg_exo -50.92 -46.71 29.14 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.607 2.871 . . . . 0.0 114.091 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.9 -17.83 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 111.349 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.661 ' HG2' ' HA3' ' A' ' 32' ' ' GLY . 42.4 tp60 -81.41 -46.82 14.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.913 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 96.7 mt -77.89 -1.52 32.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.441 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 65.6 t30 -84.55 -44.19 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.747 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 7.0 ptm180 -75.52 -30.32 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.574 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -179.51 -162.9 29.42 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -85.39 155.73 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 117.491 0.646 . . . . 0.0 110.114 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.546 ' OG ' ' HG3' ' A' ' 38' ' ' GLN . 59.9 m -150.58 179.72 7.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.146 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -73.27 157.85 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.17 76.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.632 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.19 175.99 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.513 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.6 1.9 27.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.88 -17.32 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.49 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -61.13 154.26 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.733 177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.887 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m -141.56 157.95 44.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.833 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.5 mm? -77.08 -23.21 51.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.606 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.46 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 15.2 t70 -135.34 70.08 1.44 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.639 1.209 . . . . 0.0 109.108 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.887 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.3 t70 -124.78 162.4 24.37 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.709 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.89 -35.93 82.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.36 131.74 54.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.41 0.624 . . . . 0.0 111.21 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' HB ' HD23 ' A' ' 121' ' ' LEU . 47.1 mt -129.2 123.06 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -113.17 109.2 18.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -172.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -107.99 124.35 64.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.09 120.02 33.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.003 0.43 . . . . 0.0 111.08 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.62 118.28 5.54 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.817 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -68.42 -38.62 81.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m 73.01 126.92 0.04 OUTLIER 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.552 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -137.43 142.51 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.22 -39.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.875 173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.63 -46.74 63.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.292 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -107.9 107.12 59.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.711 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.523 ' HA ' HG22 ' A' ' 73' ' ' THR . 96.4 Cg_endo -80.25 -18.89 9.58 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.551 2.168 . . . . 0.0 111.682 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -124.61 70.79 1.13 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.464 0.649 . . . . 0.0 110.896 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -138.48 -177.5 4.88 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 166.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -41.06 -68.41 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -168.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -114.28 96.22 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.24 -174.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 68' ' ' PRO . 1.3 m -156.49 -45.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.641 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -97.91 23.36 8.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.542 0.687 . . . . 0.0 110.247 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -11.5 59.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -71.11 -11.16 60.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.344 . . . . 0.0 111.545 -178.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -89.65 6.86 39.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.497 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -94.05 135.05 35.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.796 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 7.4 mptt -108.51 -170.87 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.617 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 97' ' ' MET . 6.2 ptpp? -65.87 -33.9 76.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.43 54.01 0.57 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.469 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 p -75.02 -15.97 60.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.501 ' HE2' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 54.31 85.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.556 0.693 . . . . 0.0 111.639 -174.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 48.4 t -86.11 113.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.062 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 89.4 m-85 -98.73 110.43 23.03 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.548 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 34.9 t80 -99.21 102.59 14.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 35.7 mmtp -92.02 81.27 5.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.387 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.833 HG21 ' HG ' ' A' ' 52' ' ' LEU . 5.4 p -93.54 121.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.178 0.513 . . . . 0.0 110.489 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.12 -104.1 0.63 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.731 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 90' ' ' ASN . 6.6 m120 -124.64 9.25 8.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.312 . . . . 0.0 110.718 177.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -100.11 148.58 24.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 110.57 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 93.1 m -117.7 104.34 10.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.188 0.518 . . . . 0.0 111.023 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 58.2 mmt-85 -92.11 135.36 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.986 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.677 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -115.02 130.1 56.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.036 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -130.23 146.88 51.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.72 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.54 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -112.95 135.99 53.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.702 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.53 ' SD ' ' HB1' ' A' ' 144' ' ' ALA . 20.8 mmt -79.35 65.44 4.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.528 0.68 . . . . 0.0 110.359 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 t -80.44 -13.75 58.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.551 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.4 m -135.18 90.88 2.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.546 0.689 . . . . 0.0 111.1 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 97' ' ' MET . 73.1 mt -109.07 129.7 63.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.429 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -164.62 -169.64 1.8 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.83 0.347 . . . . 0.0 110.255 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.786 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 3.3 p-10 -145.68 137.37 25.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.548 HG21 ' HD2' ' A' ' 139' ' ' ARG . 21.5 m -120.29 174.13 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.323 -173.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.54 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.2 mppt? -91.6 158.05 41.03 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.827 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.744 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 19.9 Cg_endo -61.7 -24.2 77.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.358 2.039 . . . . 0.0 111.293 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -114.71 29.93 7.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.789 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -63.29 139.71 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.257 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.1 m -110.87 2.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.738 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -85.92 -36.24 20.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.197 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.1 -10.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.906 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 111' ' ' LEU . 4.2 pp -111.13 -0.13 16.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 111.192 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.84 -159.15 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.441 ' HG3' ' HZ1' ' A' ' 115' ' ' LYS . 9.5 pt-20 -60.98 112.91 2.26 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.458 0.646 . . . . 0.0 111.672 -177.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -85.6 134.18 34.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.518 174.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 12.1 mptt -74.16 174.98 7.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.278 -170.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.81 55.05 1.34 Allowed Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.884 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -69.41 173.54 5.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.329 0.585 . . . . 0.0 110.972 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.4 ' OD1' ' HD3' ' A' ' 119' ' ' LYS . 5.1 t70 -104.54 -149.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.724 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -58.69 114.85 2.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.83 119.84 38.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.259 0.552 . . . . 0.0 111.957 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.524 HD23 ' HB ' ' A' ' 57' ' ' ILE . 14.0 mt -82.38 104.97 13.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -92.63 92.21 7.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.565 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.7 mt -87.78 101.12 13.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.997 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 mt -90.92 97.8 7.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.29 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -103.09 101.97 11.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.328 0.585 . . . . 0.0 110.362 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 86.3 m -92.56 101.87 14.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.689 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -120.36 68.44 0.85 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.495 0.664 . . . . 0.0 110.052 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 34.6 t70 -176.26 95.23 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.681 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -102.56 115.94 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -86.69 103.05 14.78 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.89 -27.07 68.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.017 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.563 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -77.53 -18.57 56.86 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.518 -173.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.537 ' OG1' HG11 ' A' ' 135' ' ' VAL . 21.9 p -120.82 -32.3 4.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.62 16.24 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.505 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.537 HG11 ' OG1' ' A' ' 133' ' ' THR . 9.8 p -132.64 154.46 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.578 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.705 ' HB2' ' O4 ' ' A' ' 201' ' ' JPT . 55.4 m95 -97.71 109.21 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.744 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 44.2 mt-10 -87.93 -63.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -172.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 48.1 tptt -75.57 80.7 2.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.134 0.969 . . . . 0.0 110.348 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.548 ' HD2' HG21 ' A' ' 103' ' ' VAL . 1.5 ptp180 -93.57 108.63 20.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.355 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.786 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 45.6 tptt -80.66 132.77 35.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.334 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -122.71 122.72 66.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.923 0.868 . . . . 0.0 111.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.457 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 13.2 m-85 -110.69 105.32 14.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.687 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 26.2 t -99.35 104.23 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.349 0.595 . . . . 0.0 110.371 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.53 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -100.38 117.76 35.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.368 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.1 m -95.78 144.51 26.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.724 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 29.8 tt0 -56.67 135.91 54.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 111.725 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.54 HG21 ' HD3' ' A' ' 96' ' ' LYS . 1.1 t -106.94 172.26 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.55 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.607 176.241 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.705 ' O4 ' ' HB2' ' A' ' 136' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -89.24 -164.93 1.22 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.07 0.462 . . . . 0.0 110.863 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.92 90.02 2.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.308 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 7.8 mtmp? -128.92 101.02 20.23 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.795 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 18.3 Cg_endo -58.58 134.56 61.71 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.535 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 8.8 pt20 -158.05 176.2 12.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.863 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 31' ' ' PRO . 5.4 mp -96.99 108.88 46.3 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.034 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.4 Cg_exo -68.11 165.03 29.79 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.811 2.341 . . . . 0.0 110.88 170.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -97.02 18.73 14.12 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.909 -171.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 18.3 t70 -86.84 150.07 24.38 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -80.4 -39.72 27.82 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.469 ' HG ' ' NE2' ' A' ' 38' ' ' GLN . 32.7 m -93.49 -22.34 18.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' C ' ' HD2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -59.72 150.02 29.07 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.599 0.714 . . . . 0.0 112.443 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -105.9 139.2 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.634 172.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.86 -32.53 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.448 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.16 161.87 26.82 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.485 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.487 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 35.7 m-85 -122.88 143.43 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -104.44 118.41 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.252 0.549 . . . . 0.0 109.79 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.563 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 26.0 mt-10 -125.81 111.62 15.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 62.1 mt -132.24 109.09 13.75 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 -47.18 15.3 Favored 'Trans proline' 0 N--CA 1.473 0.273 0 C-N-CA 123.157 2.571 . . . . 0.0 113.365 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.404 ' OD2' ' HA ' ' A' ' 82' ' ' SER . 20.9 m-20 -62.54 -30.19 71.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -98.18 2.4 48.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.224 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t70 61.55 27.76 17.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.969 0.89 . . . . 0.0 109.887 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 61.0 mt -97.24 129.29 47.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.235 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.532 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 32.5 ttpt -159.86 79.11 0.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 168.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -133.5 157.14 78.75 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.826 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.2 146.88 71.35 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.848 2.365 . . . . 0.0 113.03 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.54 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 76.2 t -106.12 125.44 61.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.712 176.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 61.1 m-85 -93.54 103.44 9.86 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.624 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 3.0 Cg_endo -86.86 155.0 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.355 2.703 . . . . 0.0 112.298 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 34' ' ' ALA . . . 136.77 -151.75 21.04 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.952 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.721 ' HG2' ' HG1' ' A' ' 35' ' ' THR . 78.7 Cg_endo -76.3 19.21 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.249 2.633 . . . . 0.0 113.092 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 32' ' ' GLY . . . 56.87 46.24 20.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.324 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.721 ' HG1' ' HG2' ' A' ' 33' ' ' PRO . 0.2 OUTLIER -54.72 119.7 23.2 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.092 -174.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.32 -38.64 42.81 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.238 2.625 . . . . 0.0 113.066 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.95 -38.4 82.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.311 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' NE2' ' HG ' ' A' ' 12' ' ' SER . 75.9 mm-40 -90.65 -30.73 16.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.089 0.471 . . . . 0.0 110.4 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.43 -27.99 63.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.975 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -68.28 -24.8 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.9 mtp-105 -80.96 -52.71 7.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.738 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.72 -117.23 1.49 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.06 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.56 142.42 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -128.59 -179.59 5.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.385 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.624 ' CE2' ' HB3' ' A' ' 31' ' ' PRO . 11.9 m-85 -74.61 178.09 5.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.7 -46.79 20.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.68 167.14 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.699 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -80.82 -10.31 59.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.522 0.677 . . . . 0.0 109.951 175.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.83 -23.0 58.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.854 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -84.03 177.86 8.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 112.161 -172.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 70.8 m -137.38 175.13 9.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -172.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.14 -15.95 34.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.432 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -134.9 70.34 1.44 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.283 1.04 . . . . 0.0 109.589 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 14.7 t70 -126.37 160.88 29.18 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.747 171.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -31.54 72.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.64 125.86 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.588 0.708 . . . . 0.0 111.012 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.33 139.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -131.15 116.23 17.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.195 0.521 . . . . 0.0 111.659 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.4 mt -101.09 116.41 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.64 105.07 17.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 111.309 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.64 144.49 15.95 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.301 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -122.81 133.81 54.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.541 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -81.86 113.27 19.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -113.67 109.3 18.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.505 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.7 mm -54.96 -33.98 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.741 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.87 -40.46 76.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 61.1 mtt180 -106.98 108.91 62.74 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.914 0.388 . . . . 0.0 111.068 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 3.3 Cg_exo -77.77 -10.77 16.95 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.196 2.597 . . . . 0.0 112.737 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.68 80.53 1.7 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.425 0.631 . . . . 0.0 111.716 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -132.62 -161.82 1.17 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.751 168.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -49.63 -72.37 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -105.57 31.77 4.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -169.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 m -73.74 -34.86 64.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.04 0.448 . . . . 0.0 111.223 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -116.72 28.0 8.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.277 0.56 . . . . 0.0 110.484 -173.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.22 -21.45 65.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -74.03 -2.05 22.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.302 . . . . 0.0 111.622 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.42 8.2 37.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.62 153.92 20.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -125.82 176.41 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.295 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -61.2 -19.67 61.88 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.89 51.62 0.85 Allowed Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.174 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . 4.0 m -79.28 -4.47 50.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.446 ' HE3' ' HA ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 53.93 82.93 0.08 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.447 0.641 . . . . 0.0 111.244 -175.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.9 t -85.0 113.94 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.967 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.563 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 84.3 m-85 -94.26 117.64 30.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.884 0.373 . . . . 0.0 110.052 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -100.44 101.11 11.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 32.4 tptt -83.89 99.14 10.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.864 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.839 HG22 ' HB2' ' A' ' 91' ' ' GLU . 4.1 m -116.7 86.96 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.87 -107.04 1.69 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.231 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.14 -11.36 30.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 0.0 110.829 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.839 ' HB2' HG22 ' A' ' 88' ' ' VAL . 38.8 mt-10 -95.11 109.2 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.755 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.0 m -100.57 85.68 2.99 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 93' ' ' ARG . 11.3 ptp180 -93.39 133.73 36.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.525 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -102.86 139.38 38.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.771 -175.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.545 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.6 m-85 -120.91 148.99 43.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 1.2 tptm -110.49 131.96 54.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.9 mmt -76.68 70.58 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -77.05 -20.62 55.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.669 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 52.5 m -133.53 101.37 5.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 97' ' ' MET . 74.9 mt -116.49 116.54 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.688 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -161.66 -174.39 4.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.53 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.796 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 1.2 p-10 -144.09 134.92 25.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.19 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.7 m -133.77 -175.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.458 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -92.16 160.29 35.7 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.635 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.895 ' HA ' ' O2 ' ' A' ' 201' ' ' JPT . 45.5 Cg_endo -70.35 -20.71 31.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 111.445 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -98.83 10.54 41.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.882 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.21 115.86 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.802 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.95 2.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 0.0 110.996 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.12 -34.88 18.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.379 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.5 m -77.26 -26.25 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -91.83 20.29 5.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.9 169.37 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.516 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 5.6 pt-20 -66.61 84.8 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.328 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -87.45 37.78 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.652 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -82.52 172.12 13.35 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.639 176.107 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.91 -7.64 59.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.808 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -91.08 -168.25 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.133 0.492 . . . . 0.0 110.557 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -104.6 -157.78 0.63 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.9 OUTLIER -65.54 107.37 1.68 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -104.97 124.38 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.237 0.541 . . . . 0.0 110.282 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -92.95 98.26 11.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.1 m -84.41 99.11 10.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.258 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 20.0 mt -85.25 106.08 16.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.1 mt -93.52 127.24 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.578 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 30.5 m -136.67 105.21 5.78 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.256 0.551 . . . . 0.0 110.501 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.4 m -99.52 107.39 19.56 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -118.08 -1.46 11.41 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -172.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.452 ' OD2' ' HB2' ' A' ' 137' ' ' GLU . 37.1 t70 -105.71 89.64 3.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.524 0.678 . . . . 0.0 109.919 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.593 ' CE1' ' HA ' ' A' ' 131' ' ' GLU . 92.3 t80 -82.58 124.91 30.59 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.172 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.507 ' OD1' HG23 ' A' ' 133' ' ' THR . 23.1 t-20 -89.29 103.62 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.593 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 40.2 mt-10 -64.09 -23.24 67.25 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -171.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 1.005 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 5.9 mmpt? -78.49 -23.43 46.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.507 HG23 ' OD1' ' A' ' 130' ' ' ASN . 7.7 t -130.06 -30.0 2.03 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.596 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.88 35.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.281 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.453 ' H ' HG22 ' A' ' 133' ' ' THR . 12.8 m -82.8 172.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.47 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 41.9 m95 -117.37 112.11 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.452 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 41.9 mt-10 -77.83 -21.38 51.59 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.796 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -114.98 118.35 33.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.296 0.57 . . . . 0.0 111.036 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -107.13 98.67 8.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.483 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.764 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 47.7 tptt -69.1 128.52 36.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.91 118.49 50.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.989 0.899 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.584 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 15.8 m-85 -109.08 101.59 10.64 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.305 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 38.3 t -95.42 97.09 6.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.403 0.62 . . . . 0.0 110.121 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.544 ' HB3' ' SD ' ' A' ' 97' ' ' MET . . . -95.91 112.23 24.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.9 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.8 m -90.45 139.34 30.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.88 123.75 15.33 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.564 0.54 . . . . 0.0 110.798 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.524 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 4.0 t -76.8 147.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.644 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt . . . . . 0 C--O 1.248 1.024 0 O-C-N 124.324 1.015 . . . . 0.0 111.236 178.73 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.895 ' O2 ' ' HA ' ' A' ' 105' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 17.4 tt0 70.1 6.97 6.01 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.925 0.766 . . . . 0.0 111.13 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.58 142.06 15.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.51 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -119.06 93.2 46.55 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.552 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.84 118.33 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.874 2.383 . . . . 0.0 112.126 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -118.96 147.37 44.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.668 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -84.57 121.82 74.91 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.453 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.79 -175.66 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.513 2.142 . . . . 0.0 112.206 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.635 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.73 6.35 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.167 178.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -95.92 103.95 15.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.052 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.486 ' CD ' ' HD3' ' A' ' 33' ' ' PRO . 35.3 mtmm -85.63 12.81 7.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.139 -176.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -106.72 -5.86 18.24 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.203 0.525 . . . . 0.0 109.678 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 30' ' ' TYR . 99.3 mttt -91.37 -177.14 4.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -112.77 138.21 42.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.37 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.72 -29.4 12.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.244 0.545 . . . . 0.0 110.798 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.71 163.51 36.73 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 63.9 m-85 -109.44 135.79 49.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.483 0.642 . . . . 0.0 109.91 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.449 HG21 ' O ' ' A' ' 18' ' ' ILE . 8.1 tp -97.86 108.53 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.772 0.796 . . . . 0.0 109.612 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -114.18 103.7 11.37 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.907 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mt -121.25 92.88 48.76 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.539 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.91 -21.18 68.9 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.052 2.502 . . . . 0.0 111.311 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.498 ' CG ' ' HZ2' ' A' ' 79' ' ' LYS . 24.7 t70 -72.99 -30.14 63.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.888 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.52 10.9 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 63.14 29.25 16.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.769 0.795 . . . . 0.0 110.758 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 27' ' ' GLU . 78.2 mt -102.22 118.74 49.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.5 mppt? -135.82 41.51 2.69 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.681 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 13.1 mm-40 -102.55 154.19 37.64 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.429 -163.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.79 143.45 13.25 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.473 2.116 . . . . 0.0 112.151 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.88 127.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 44' ' ' SER . 57.6 m-85 -100.76 133.71 20.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.493 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -69.26 145.34 59.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.498 2.132 . . . . 0.0 111.841 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . 164.8 162.07 15.08 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.31 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 Cg_endo -88.01 39.86 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.997 3.132 . . . . 0.0 111.545 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.71 35.98 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.47 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.0 152.48 84.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.824 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.53 -57.19 2.49 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.971 3.114 . . . . 0.0 113.818 -175.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.495 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.4 mm-40 -59.61 -34.76 73.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.8 mp0 -64.99 -44.21 90.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.287 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.3 -30.92 65.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.44 0.638 . . . . 0.0 110.109 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.08 -39.87 95.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.673 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 28.2 mtp-105 -75.67 -51.61 12.38 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.619 175.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.447 ' C ' ' HG3' ' A' ' 71' ' ' GLN . . . -156.47 -104.91 0.22 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.957 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.92 149.99 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 41.3 t -124.21 157.27 35.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.682 0.277 . . . . 0.0 110.901 -174.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -70.5 178.25 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 58' ' ' SER . . . -66.2 -46.58 76.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 12.8 pt-20 -149.15 -176.47 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.545 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -94.86 -27.37 15.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.151 -171.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -82.8 -9.86 59.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.038 0.447 . . . . 0.0 110.922 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.11 143.04 49.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.042 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 m -121.16 145.13 48.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.752 -171.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -81.84 -10.23 59.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.818 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -100.78 4.02 42.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 110.558 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -95.93 178.41 5.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.519 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.554 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.26 -8.8 28.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.708 0.29 . . . . 0.0 111.301 -177.104 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.58 107.1 12.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.745 0.783 . . . . 0.0 110.754 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.8 mt -127.58 136.11 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.872 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' A' ' 46' ' ' ALA . 36.6 t -132.02 132.71 43.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.382 0.611 . . . . 0.0 110.962 -172.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -115.56 127.97 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.296 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.24 111.61 22.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.042 0.448 . . . . 0.0 111.063 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.99 137.92 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.666 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -148.21 102.09 3.33 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 m -56.37 147.47 21.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.594 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' HB3' ' CG ' ' A' ' 67' ' ' ARG . 69.7 t80 -139.25 148.3 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.3 mt -54.57 -51.52 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.308 -174.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -87.77 40.54 0.94 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.608 -172.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.474 ' CG ' ' HB3' ' A' ' 64' ' ' PHE . 12.8 ptp180 -166.21 88.76 0.86 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.267 0.556 . . . . 0.0 111.416 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.85 -4.53 14.06 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.189 2.593 . . . . 0.0 112.038 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -154.73 83.58 1.1 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.025 -170.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -139.12 -168.19 2.39 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.31 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.681 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 9.2 mm100 -24.1 -75.73 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.882 1.273 . . . . 0.0 113.263 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -117.44 96.47 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 110.786 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.54 -49.74 0.78 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.327 0.584 . . . . 0.0 110.68 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' OD1' ' HE2' ' A' ' 76' ' ' LYS . 64.2 t30 -87.75 32.74 0.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.489 0.662 . . . . 0.0 110.952 -174.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 75' ' ' LEU . 40.4 mt -72.29 -7.48 49.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.392 -179.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HE2' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -78.4 -11.66 59.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.982 0.42 . . . . 0.0 111.017 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -12.22 49.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.755 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.15 22.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.772 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HZ2' ' CG ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -157.13 -168.77 2.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.187 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.5 ptmt -46.2 -39.52 9.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.588 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -124.54 57.19 0.68 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.34 -1.409 . . . . 0.0 113.174 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -81.22 -6.94 59.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.727 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 84.2 mmm 47.68 91.63 0.01 OUTLIER 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.838 0.828 . . . . 0.0 112.744 -174.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -85.76 119.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -99.75 107.75 19.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.564 ' HD2' ' HD2' ' A' ' 93' ' ' ARG . 28.8 t80 -90.28 100.51 13.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.8 tppp? -82.86 93.75 7.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.212 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.09 122.03 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.268 0.556 . . . . 0.0 111.011 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.81 -90.48 0.13 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.962 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -139.81 8.47 2.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.0 109.448 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -100.76 131.47 46.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.542 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.8 m -103.67 97.55 7.55 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.564 ' HD2' ' HD2' ' A' ' 86' ' ' PHE . 9.9 ptp180 -97.35 153.41 18.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.895 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.51 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.05 122.29 44.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.186 0.517 . . . . 0.0 111.754 -166.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.509 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.9 m-85 -122.17 138.27 54.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.727 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.88 132.25 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 53.8 mtt -80.9 62.79 5.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.633 0.73 . . . . 0.0 110.175 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -75.93 -12.66 60.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.723 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.547 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 37.4 m -132.94 97.84 4.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.311 0.577 . . . . 0.0 110.34 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.92 128.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.341 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.446 ' O ' ' HD2' ' A' ' 140' ' ' LYS . 6.1 ptp180 -161.05 -178.63 6.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.989 0.423 . . . . 0.0 110.536 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.51 143.63 46.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.766 HG21 ' HG3' ' A' ' 139' ' ' ARG . 11.8 m -131.17 170.84 18.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -100.28 146.39 31.9 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.819 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.6 -2.31 2.57 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.938 2.425 . . . . 0.0 112.907 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -126.62 19.49 7.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 1.6 p30 -68.59 166.8 16.37 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.332 0.587 . . . . 0.0 111.143 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.489 ' HA ' HD12 ' A' ' 111' ' ' LEU . 29.0 m -120.54 23.97 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -97.98 -41.82 7.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.158 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -87.25 -7.8 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.908 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 108' ' ' VAL . 2.5 pp -120.0 18.19 12.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.492 . . . . 0.0 110.929 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 32.3 t70 -152.15 138.47 18.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.174 -175.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 115' ' ' LYS . 95.4 mt-10 53.4 65.76 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.795 0.684 . . . . 0.0 111.652 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -88.9 93.28 9.54 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' CE ' ' HB3' ' A' ' 113' ' ' GLU . 8.0 mptt -67.43 163.1 21.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.213 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.38 54.03 2.77 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.806 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -66.21 172.03 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.076 0.465 . . . . 0.0 110.788 172.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -81.03 -161.07 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 2.3 mppt? -64.72 119.02 9.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.989 0.423 . . . . 0.0 110.057 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.16 138.26 53.12 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.669 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.9 108.33 19.61 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m -92.59 106.12 18.16 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.758 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.7 mt -92.95 103.19 15.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.01 94.26 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -105.25 98.91 8.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.408 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.7 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 6.1 p -76.34 96.83 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.319 0.58 . . . . 0.0 109.882 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -125.28 79.26 1.79 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.396 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.758 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 31.5 t70 -168.89 85.72 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.489 ' CE1' ' HA ' ' A' ' 131' ' ' GLU . 70.8 t80 -91.91 125.9 36.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.132 -167.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -97.26 108.55 21.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.489 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 34.6 mt-10 -58.27 -33.72 69.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -71.21 -25.71 62.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.581 HG21 ' H ' ' A' ' 135' ' ' VAL . 2.6 t -125.03 -31.0 3.16 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.837 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.483 ' HA2' ' CE2' ' A' ' 129' ' ' TYR . . . 96.46 4.23 59.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.113 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.581 ' H ' HG21 ' A' ' 133' ' ' THR . 98.5 t -84.67 138.51 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.774 0.321 . . . . 0.0 110.158 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.758 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 45.0 m95 -95.68 105.04 16.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.37 -16.39 56.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.715 -165.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -133.17 130.46 39.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.806 0.336 . . . . 0.0 110.464 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.766 ' HG3' HG21 ' A' ' 103' ' ' VAL . 27.9 ptt180 -111.09 113.6 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.456 0.646 . . . . 0.0 110.181 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.446 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 16.2 tptm -76.33 127.51 33.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.841 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -121.04 127.16 75.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.728 0.775 . . . . 0.0 111.42 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.476 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 93.1 m-85 -114.64 108.76 17.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.488 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.6 t -96.68 102.53 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.265 0.555 . . . . 0.0 110.007 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.65 107.97 19.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.336 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.4 m -90.76 144.02 26.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.71 138.44 18.26 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.555 0.534 . . . . 0.0 111.186 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 96' ' ' LYS . 21.5 t -97.05 153.71 3.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.548 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.06 179.394 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.646 ' O2 ' ' HD3' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -77.08 -171.25 1.95 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.261 0.553 . . . . 0.0 111.328 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.64 105.27 8.89 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.833 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -128.43 99.12 24.4 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.53 130.76 22.53 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.5 2.8 . . . . 0.0 113.524 -174.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.08 169.07 18.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.875 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 2.4 mp -70.86 122.78 87.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 17.3 Cg_exo -67.52 170.54 13.47 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.747 2.298 . . . . 0.0 112.978 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -79.26 -21.96 45.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.82 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.23 108.56 21.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.022 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 52.6 mtmt -90.63 31.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.745 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -117.17 -20.92 9.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.367 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 19.2 ptpt -90.43 -175.44 4.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.479 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 28' ' ' PRO . 7.8 p -100.94 137.52 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.874 0.369 . . . . 0.0 110.509 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.455 ' HB1' HD13 ' A' ' 52' ' ' LEU . . . -100.81 -40.19 7.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.373 0.606 . . . . 0.0 110.324 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.14 165.45 30.31 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.586 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 47.7 m-85 -115.37 139.25 50.17 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -103.61 115.36 45.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.608 0.718 . . . . 0.0 109.949 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.19 112.67 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.571 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.449 HG12 HG13 ' A' ' 84' ' ' VAL . 43.5 mt -127.93 95.41 34.47 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.142 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.4 -29.61 89.13 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 123.114 2.543 . . . . 0.0 112.047 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.98 -33.19 74.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.47 8.8 21.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 66.68 12.55 8.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.26 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.465 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 62.7 mt -78.21 123.54 35.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.244 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 14.3 mtmm -153.6 84.71 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 119.364 -0.351 . . . . 0.0 110.594 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.596 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 13.1 mm-40 -155.93 163.83 23.42 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 118.0 0.364 . . . . 0.0 111.725 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HB3' HG23 ' A' ' 14' ' ' VAL . 8.2 Cg_exo -72.4 156.89 54.1 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.08 2.52 . . . . 0.0 113.387 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.52 123.6 71.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.623 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.9 123.88 45.79 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.739 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.559 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 19.0 Cg_endo -58.28 129.41 32.73 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.968 2.445 . . . . 0.0 112.228 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . -172.27 135.12 3.24 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.445 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HD3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 Cg_endo -80.68 61.43 8.22 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.309 2.673 . . . . 0.0 112.069 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.02 27.97 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.525 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 7.8 p -79.81 136.62 54.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.187 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 64.1 Cg_exo -52.51 -48.57 21.22 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.471 2.78 . . . . 0.0 113.829 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.623 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 2.2 mp0 -67.42 -23.19 65.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 111.653 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.548 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.9 mp0 -83.06 -26.01 31.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.044 0.45 . . . . 0.0 110.013 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.56 -5.66 55.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.457 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.623 ' ND2' ' HA ' ' A' ' 37' ' ' GLU . 28.4 p30 -97.11 -23.68 16.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -96.0 -20.74 18.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.557 ' HA2' ' NE2' ' A' ' 71' ' ' GLN . . . -168.95 -150.22 6.59 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.84 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.91 142.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.548 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 70.8 m -127.55 -175.58 3.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.246 0.546 . . . . 0.0 112.001 -172.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.79 -178.86 6.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.662 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.71 -50.93 5.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.101 0.477 . . . . 0.0 109.941 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -119.59 -167.58 1.44 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.018 176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.47 27.23 9.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -105.41 -28.66 10.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.533 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 58' ' ' SER . 3.0 mp0 -63.79 168.99 4.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.033 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.865 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 56.3 m -147.84 160.14 43.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.396 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.583 ' HB3' HG13 ' A' ' 88' ' ' VAL . 81.9 mt -78.67 2.33 19.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -137.34 11.06 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.916 0.865 . . . . 0.0 109.311 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.865 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 11.9 t70 -79.85 162.26 25.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.605 -175.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.563 ' HA ' ' HD3' ' A' ' 119' ' ' LYS . 1.3 tm0? -63.23 -38.23 90.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.701 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.0 129.64 55.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 110.796 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mt -136.83 116.59 16.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.487 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 17.2 m -113.97 122.13 46.0 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.9 123.92 72.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.19 112.2 23.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.32 159.39 13.73 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.047 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -146.11 136.62 24.05 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.728 ' OG1' ' HA ' ' A' ' 127' ' ' ASP . 2.6 m -51.93 -65.82 0.49 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.374 0.421 . . . . 0.0 111.86 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.558 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 52.7 p90 -170.62 157.83 5.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.909 0.385 . . . . 0.0 110.951 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.2 mm -98.43 -50.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.93 22.61 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.906 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 11.8 mmm180 -115.88 119.54 37.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.365 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.85 -11.26 13.93 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.968 2.445 . . . . 0.0 113.696 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -157.43 90.33 1.1 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.154 0.502 . . . . 0.0 110.783 -169.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.558 ' OH ' ' HA ' ' A' ' 64' ' ' PHE . 11.9 p90 -148.46 -160.27 1.15 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.514 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.596 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -41.66 -79.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.769 0.828 . . . . 0.0 112.739 -175.698 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -106.48 106.05 16.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 m -147.62 -50.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.26 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -91.99 25.29 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.609 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.465 ' HG ' ' CD1' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -67.24 -17.96 65.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.431 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.4 ' HD2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -75.84 -10.34 59.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.731 0.3 . . . . 0.0 110.808 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.01 -6.3 58.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 110.674 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.85 169.4 18.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.556 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -162.95 -171.29 2.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.731 -178.098 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -49.15 -47.21 45.82 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -113.61 62.08 0.32 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -82.14 -15.94 51.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.445 ' CE ' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 55.15 90.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.675 0.75 . . . . 0.0 111.595 -176.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG21 ' HE2' ' A' ' 97' ' ' MET . 39.7 t -87.98 119.9 36.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.417 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -95.91 106.85 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.465 ' HB2' HD12 ' A' ' 121' ' ' LEU . 3.1 t80 -91.23 94.89 9.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.586 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.1 tppp? -81.23 86.39 6.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.452 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' A' ' 91' ' ' GLU . 5.7 m -90.16 90.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.722 0.772 . . . . 0.0 111.006 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.89 -91.96 0.36 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.032 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.09 -4.84 10.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.659 0.266 . . . . 0.0 111.053 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.667 ' HB2' HG22 ' A' ' 88' ' ' VAL . 32.6 mt-10 -97.66 147.63 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.331 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.2 m -124.81 103.66 8.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.118 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.682 ' HG3' ' HE2' ' A' ' 95' ' ' TYR . 6.6 ptm180 -109.81 139.09 45.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.165 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 147' ' ' VAL . 3.5 ptmm? -108.34 130.57 55.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 111.962 -172.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.682 ' HE2' ' HG3' ' A' ' 93' ' ' ARG . 61.2 m-85 -116.74 152.24 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.427 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.544 ' HE3' HG12 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -115.73 134.36 55.1 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 20.2 mmt -79.27 63.65 3.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.519 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 t -74.6 -23.81 58.78 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.5 m -129.83 96.12 4.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 111.329 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.47 124.48 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.599 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -137.87 159.98 40.52 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.835 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.39 124.67 51.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.63 HG12 HG12 ' A' ' 110' ' ' VAL . 21.6 m -119.32 131.62 71.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.788 0.804 . . . . 0.0 111.473 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.596 ' HG3' ' HG2' ' A' ' 138' ' ' LYS . 3.2 mppt? -98.35 168.43 9.89 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.03 -11.55 27.87 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.43 2.087 . . . . 0.0 112.266 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t -107.88 8.4 28.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.326 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -94.03 134.45 36.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.317 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.39 4.75 8.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.29 -30.79 71.68 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 110.98 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.63 HG12 HG12 ' A' ' 103' ' ' VAL . 17.0 m -84.67 -6.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.165 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.68 -7.46 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.49 157.96 17.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.69 123.36 18.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -77.18 139.47 39.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.98 -154.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -168.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.8 52.82 1.63 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 123.491 0.494 . . . . 0.0 114.235 -169.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -75.7 150.39 37.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 172.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -90.98 -149.4 0.22 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.602 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 32.5 mmtp -60.97 124.38 20.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -137.98 138.85 39.32 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.334 0.588 . . . . 0.0 111.911 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.465 HD12 ' HB2' ' A' ' 86' ' ' PHE . 36.8 mt -94.1 103.76 15.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.1 m -88.1 91.1 8.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.793 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 26.1 mt -84.4 99.91 10.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.737 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.7 mt -83.05 78.26 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.9 m -87.81 99.61 12.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.975 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 57.1 m -74.23 94.89 2.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.728 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 35.7 t70 -101.69 1.5 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.346 -172.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.711 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 17.7 t0 -112.5 94.46 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.853 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 32.8 t80 -77.43 -26.98 52.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.155 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.5 t30 49.4 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.743 0.783 . . . . 0.0 111.457 -173.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.467 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 20.4 mt-10 -62.71 -8.63 7.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.808 -174.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 57.1 mmtt -60.37 -35.09 74.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 t -159.41 -3.26 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.19 40.07 7.63 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.424 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.44 117.18 53.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.182 0.515 . . . . 0.0 110.032 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.711 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 27.7 m95 -78.51 96.55 5.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 46.1 mt-10 -86.29 -61.98 1.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.18 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.596 ' HG2' ' HG3' ' A' ' 104' ' ' LYS . 33.8 mtmm -89.31 119.06 29.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.468 ' HB2' HG22 ' A' ' 103' ' ' VAL . 40.8 mtt85 -100.56 114.71 28.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.494 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -89.01 111.0 21.62 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.3 tt -102.42 127.33 56.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.615 0.721 . . . . 0.0 110.694 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.627 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 89.5 m-85 -108.51 112.73 25.27 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.438 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 44.3 t -101.43 97.33 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.428 0.633 . . . . 0.0 109.776 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.607 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -94.7 113.3 25.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.148 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 m -89.01 141.1 28.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.296 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 5.3 tt0 -61.0 115.38 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.544 HG12 ' HE3' ' A' ' 96' ' ' LYS . 5.1 p -117.19 124.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.573 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.4 -0.809 . . . . 0.0 111.223 -176.487 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.481 ' H4 ' ' H1 ' ' A' ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.53 0.205 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -76.21 -177.35 3.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.03 105.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.438 0.461 . . . . 0.0 109.811 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 39.4 mtmt 59.45 97.52 0.04 OUTLIER Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.867 -167.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.525 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 13.8 Cg_endo -55.64 124.26 15.84 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.862 2.375 . . . . 0.0 111.277 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -141.1 146.79 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.72 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.5 mp -78.62 129.18 74.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.701 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 163.28 39.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.749 2.299 . . . . 0.0 112.863 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.853 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -70.83 -15.68 62.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.695 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.59 121.88 28.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.745 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 37.7 mmtm -95.2 16.62 16.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.417 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -127.04 26.54 6.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.542 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 64.4 mttm -118.06 176.03 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.409 0.623 . . . . 0.0 112.045 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.0 t -109.54 111.87 38.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.614 173.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -91.04 -21.42 21.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.02 159.41 31.88 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.901 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 57.9 m-85 -114.81 135.68 53.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -101.86 121.22 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.527 0.68 . . . . 0.0 109.791 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.641 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 37.7 mt-10 -124.26 118.75 27.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.449 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -134.21 96.9 15.32 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -54.01 -35.89 82.47 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.324 2.683 . . . . 0.0 112.999 -176.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.8 -29.84 69.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.796 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.71 2.36 27.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.628 0.251 . . . . 0.0 110.976 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.421 ' HB3' HD22 ' A' ' 69' ' ' ASN . 30.9 t70 65.56 25.97 11.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.836 0.827 . . . . 0.0 110.084 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.445 HD12 HD11 ' A' ' 20' ' ' ILE . 77.1 mt -91.47 125.4 44.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.954 -177.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.641 ' HD2' ' HG2' ' A' ' 19' ' ' GLU . 7.0 mmmt -151.27 54.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 5.5 mm-40 -121.82 153.66 60.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.611 -166.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.89 134.23 10.6 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.966 2.444 . . . . 0.0 112.807 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.07 135.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.329 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.414 ' HD2' ' HA3' ' A' ' 42' ' ' GLY . 51.2 m-85 -101.46 102.71 23.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.036 0.446 . . . . 0.0 109.857 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.478 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.2 Cg_endo -71.14 140.93 38.56 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.972 2.448 . . . . 0.0 112.112 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.15 -171.4 43.37 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.79 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.745 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 27.0 Cg_endo -93.73 34.52 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.012 3.141 . . . . 0.0 112.566 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 60.55 27.73 17.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.431 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.71 HG22 ' HB2' ' A' ' 38' ' ' GLN . 2.6 t -62.67 128.58 91.92 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.894 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.57 -44.89 24.73 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 124.093 3.195 . . . . 0.0 113.928 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 39.4 mt-10 -61.07 -49.37 77.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.71 ' HB2' HG22 ' A' ' 35' ' ' THR . 2.8 mp0 -70.69 -26.37 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 6.5 mt -75.33 -10.15 59.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -99.48 -5.68 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.362 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 38' ' ' GLN . 57.4 mtp180 -102.03 -30.7 11.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 30' ' ' TYR . . . -170.05 -170.58 34.61 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.797 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -89.95 150.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 117.63 0.715 . . . . 0.0 109.715 176.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.8 t -137.79 178.91 6.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CD2' ' HG2' ' A' ' 50' ' ' GLU . 58.3 m-85 -84.61 172.65 11.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.81 82.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 0.0 110.775 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -157.31 -179.48 8.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.231 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 14.5 tt0 -76.77 -15.56 59.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.616 -174.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -87.56 4.46 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.023 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 6.3 tp10 -56.63 127.56 32.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.87 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.9 m -120.02 121.64 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.895 0.379 . . . . 0.0 110.767 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 52.0 mt -72.73 -16.59 61.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.432 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -98.68 2.63 47.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.218 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.87 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 14.0 t70 -86.77 -178.55 6.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.73 -18.46 23.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -116.8 108.33 15.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.777 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.48 105.49 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 1.1 m -101.17 120.86 40.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.209 -175.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mt -112.98 127.74 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 124.1 39.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.974 0.416 . . . . 0.0 110.937 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.62 173.15 18.2 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.093 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -163.45 179.57 7.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 150.38 20.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.679 0.276 . . . . 0.0 110.967 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.462 ' HE2' ' HB3' ' A' ' 66' ' ' ASP . 40.6 t80 -134.37 152.12 51.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.2 mt -81.45 -53.86 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.462 ' HB3' ' HE2' ' A' ' 64' ' ' PHE . 23.0 t70 -64.86 -42.52 94.81 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HE ' ' HB3' ' A' ' 70' ' ' TYR . 22.8 mtp180 -106.98 110.18 63.46 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.605 -175.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.59 -8.73 20.82 Favored 'Trans proline' 0 CA--C 1.516 -0.379 0 C-N-CA 123.188 2.592 . . . . 0.0 112.222 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.421 HD22 ' HB3' ' A' ' 24' ' ' ASP . 17.3 t-20 -161.77 86.29 0.64 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.236 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.45 ' HB3' ' HE ' ' A' ' 67' ' ' ARG . 20.7 p90 -113.16 -150.29 0.46 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 22.0 mp0 -44.48 -56.29 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.358 0.411 . . . . 0.0 111.561 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.478 ' HD2' ' C ' ' A' ' 71' ' ' GLN . 2.5 m-85 -128.12 106.77 9.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -154.91 -64.04 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.974 0.416 . . . . 0.0 110.597 175.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -83.58 21.27 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.53 0.681 . . . . 0.0 110.13 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 75' ' ' LEU . 6.9 tt -60.87 -21.56 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.886 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -9.63 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.129 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.44 -3.28 52.47 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 111.299 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.45 162.47 25.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -135.98 -173.52 3.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.291 -178.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 ptpp? -72.93 11.41 0.69 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.27 46.96 0.43 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 m -83.47 132.41 34.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.84 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 73.2 mmm -79.89 102.48 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.121 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 39.2 t -90.25 132.32 35.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.054 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.542 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 72.4 m-85 -114.28 121.65 44.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -111.17 109.91 20.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.075 0.464 . . . . 0.0 110.14 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 30.3 mmtm -81.43 106.44 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.833 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 HG23 HD11 ' A' ' 52' ' ' LEU . 9.2 p -142.04 132.99 25.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 111.264 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.32 -91.92 0.14 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.405 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -140.46 4.03 1.95 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.43 0.634 . . . . 0.0 109.812 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -110.51 164.57 12.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.391 0.615 . . . . 0.0 111.397 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 m -122.89 92.17 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.995 171.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.418 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 19.5 mmt180 -74.36 121.42 21.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.065 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.589 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.26 131.36 41.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.697 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 89.1 m-85 -127.08 149.08 50.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.84 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -117.53 123.52 46.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.527 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.4 mtt -81.82 71.13 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.26 0.552 . . . . 0.0 110.588 -176.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.8 t -83.52 -21.92 32.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.911 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.6 m -118.62 110.37 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -129.93 128.85 65.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.531 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.544 HH21 HG13 ' A' ' 110' ' ' VAL . 28.2 ptt180 -170.42 -175.06 1.81 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.423 ' HB3' ' HZ3' ' A' ' 140' ' ' LYS . 2.7 p30 -126.87 152.2 47.36 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 170.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.521 HG22 HG22 ' A' ' 110' ' ' VAL . 12.3 m -127.44 126.15 66.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -174.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.526 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -73.04 158.32 87.28 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.008 171.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.36 -14.06 18.9 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.729 2.286 . . . . 0.0 112.639 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.439 ' OG1' ' HD3' ' A' ' 104' ' ' LYS . 68.6 p -87.88 -3.41 58.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.039 0.447 . . . . 0.0 111.053 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.526 ' HB2' ' HD2' ' A' ' 104' ' ' LYS . 14.2 t70 -82.74 116.77 22.24 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.87 8.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.09 -39.13 23.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.067 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.544 HG13 HH21 ' A' ' 101' ' ' ARG . 19.6 m -77.84 -23.04 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.373 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.39 -27.1 63.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.784 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.46 97.58 10.55 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.194 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -18.38 109.47 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.896 -1.956 . . . . 0.0 114.448 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.42 ' HB2' HE22 ' A' ' 120' ' ' GLN . 1.7 mp0 -78.52 115.6 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.053 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.57 179.52 5.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.267 173.518 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.27 -16.91 48.66 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.24 178.85 4.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.162 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -89.07 -148.44 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.52 109.01 0.55 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.42 HE22 ' HB2' ' A' ' 114' ' ' GLN . 13.1 pt20 -101.79 118.07 36.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.496 0.665 . . . . 0.0 110.019 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HG ' HD23 ' A' ' 123' ' ' LEU . 20.9 tp -83.5 102.11 11.88 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.1 m -90.7 96.83 10.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.256 -174.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.551 HD23 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mt -90.64 102.67 15.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.814 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.1 mt -95.53 97.15 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.252 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.7 m -96.53 98.26 10.08 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.82 100.68 7.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 128' ' ' ASP . 23.7 t70 -136.0 83.23 2.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.699 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 11.3 t70 166.94 99.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.065 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -87.66 132.42 34.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.527 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 22.7 t-20 -103.94 114.19 28.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.573 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.52 -19.2 46.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 0.0 111.332 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -63.15 -38.14 90.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.166 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.473 HG22 ' OD1' ' A' ' 130' ' ' ASN . 14.2 t -131.85 -11.28 3.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 0.0 111.611 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.43 26.95 26.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.743 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.54 -177.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 117.09 0.445 . . . . 0.0 110.905 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.699 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 58.3 m95 -115.78 104.49 11.71 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 130' ' ' ASN . 43.2 mt-10 -67.86 -58.91 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.953 -172.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.488 ' HB3' ' CB ' ' A' ' 128' ' ' ASP . 26.7 ttpp -80.97 91.34 6.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.184 0.992 . . . . 0.0 110.582 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -93.99 100.85 12.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.335 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.423 ' HZ3' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -74.82 125.59 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.981 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.93 119.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.987 0.899 . . . . 0.0 111.191 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.479 ' HD2' ' SD ' ' A' ' 97' ' ' MET . 10.4 m-85 -108.67 108.9 19.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.314 175.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 72.0 t -94.22 106.63 18.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.282 0.563 . . . . 0.0 109.956 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -105.14 108.5 20.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.76 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.5 m -79.47 137.26 37.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.418 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 38.0 tt0 -55.6 123.59 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 96' ' ' LYS . 5.7 t -80.81 154.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.417 ' HG2' HG11 ' A' ' 147' ' ' VAL . 10.6 ptpt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.525 -0.75 . . . . 0.0 112.189 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -98.55 -174.21 2.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.982 0.42 . . . . 0.0 110.822 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.64 132.96 56.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.192 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -126.73 92.02 45.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.267 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.512 ' CB ' ' HB ' ' A' ' 88' ' ' VAL . 36.7 Cg_endo -64.66 124.8 13.77 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.755 2.304 . . . . 0.0 111.532 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -153.18 177.12 11.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.589 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 31' ' ' PRO . 45.9 mt -106.37 105.3 53.82 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.131 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.21 169.68 12.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.675 2.25 . . . . 0.0 112.674 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' HZ3' ' CD ' ' A' ' 48' ' ' GLU . 17.4 mtpp -84.96 -21.21 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.787 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.437 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 25.5 t70 -68.89 108.46 3.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.062 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -90.5 19.05 5.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.877 -168.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -112.11 8.35 19.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 35.8 mttp -111.87 178.67 4.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.531 0.681 . . . . 0.0 112.146 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.703 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.614 ' HB3' HD11 ' A' ' 52' ' ' LEU . . . -82.58 -41.85 19.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.286 0.565 . . . . 0.0 110.189 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.97 160.76 33.28 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 38.2 m-85 -102.06 133.47 46.83 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -101.82 114.19 40.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.59 0.709 . . . . 0.0 110.269 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.6 mt-10 -114.95 117.09 29.64 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.042 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 65.0 mt -131.15 94.03 28.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.01 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.36 -16.12 52.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.259 2.64 . . . . 0.0 112.794 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.59 ' HB3' ' HG ' ' A' ' 82' ' ' SER . 33.7 t70 -81.91 -28.43 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.557 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.81 20.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.998 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.41 20.26 10.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.585 0.707 . . . . 0.0 111.21 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 72.0 mt -91.09 114.7 28.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.437 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.8 mppt? -142.79 84.9 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.623 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 4.4 mt-10 -146.41 158.65 46.84 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.782 0.325 . . . . 0.0 111.581 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.0 136.61 16.63 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.907 2.404 . . . . 0.0 112.627 176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.64 134.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.146 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 44' ' ' SER . 35.1 m-85 -97.32 121.49 58.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.581 . . . . 0.0 111.13 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HB2' HG22 ' A' ' 7' ' ' ILE . 86.0 Cg_endo -85.92 148.37 9.46 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.334 2.689 . . . . 0.0 112.705 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.91 -169.52 36.56 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.891 172.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.85 13.18 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 123.808 3.006 . . . . 0.0 112.77 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.83 75.57 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.164 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.8 p -97.33 164.53 17.51 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.664 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.34 -37.93 81.78 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.203 1.935 . . . . 0.0 111.339 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.4 mm-40 -59.14 -44.25 92.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.777 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.792 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.2 mp0 -59.68 -42.95 94.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.49 -9.58 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.811 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.56 -31.76 12.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.735 0.303 . . . . 0.0 111.155 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.7 ptp180 -87.24 -19.84 27.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.989 0.423 . . . . 0.0 110.614 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.76 -127.26 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.287 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 60' ' ' ALA . 93.9 t -126.92 141.66 45.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.792 ' HB2' ' HB3' ' A' ' 38' ' ' GLN . 41.8 t -119.74 163.65 17.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.214 0.53 . . . . 0.0 110.775 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 7' ' ' ILE . 55.6 m-85 -71.87 159.66 33.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.754 172.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.46 -49.12 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -140.07 166.32 24.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' CD ' ' HZ3' ' A' ' 9' ' ' LYS . 12.0 tt0 -80.14 -19.83 46.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.28 0.562 . . . . 0.0 110.043 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.04 4.8 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.068 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.24 163.47 23.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.967 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 23.2 t -122.36 177.1 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.614 HD11 ' HB3' ' A' ' 15' ' ' ALA . 85.0 mt -110.17 -16.08 13.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.641 0.257 . . . . 0.0 111.171 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.09 12.11 16.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.893 0.854 . . . . 0.0 109.374 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.967 ' HB2' ' HB3' ' A' ' 51' ' ' SER . 3.1 t70 -79.31 179.18 7.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.413 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -21.85 46.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -131.3 129.24 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.638 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.471 ' HB ' HD21 ' A' ' 121' ' ' LEU . 5.3 mp -129.68 101.75 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.545 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 5.4 m -93.04 125.33 37.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.5 mt -119.13 138.88 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.516 ' O ' HG12 ' A' ' 43' ' ' VAL . . . -117.91 122.35 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.51 166.7 14.32 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.852 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.552 ' HB3' ' C12' ' A' ' 201' ' ' JPT . 0.3 OUTLIER -150.57 38.02 0.68 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.326 0.563 . . . . 0.0 111.431 -174.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.434 HG21 ' H ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 56.03 -158.75 0.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 -174.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' H ' HG21 ' A' ' 63' ' ' THR . 47.5 p90 -120.47 178.61 4.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.442 0.639 . . . . 0.0 112.344 -170.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 62.2 mt -128.27 -53.68 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.011 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.42 49.02 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.196 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -142.76 105.49 5.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.161 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.62 -16.5 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.971 1.781 . . . . 0.0 111.601 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -154.78 82.31 1.09 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.749 -176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -122.17 -176.97 3.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.623 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -38.24 -71.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 123' ' ' LEU . 2.5 m-30 -105.66 76.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.765 -0.584 . . . . 0.0 111.446 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.89 -58.36 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.674 0.749 . . . . 0.0 110.259 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -100.34 21.05 13.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.407 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.455 HD22 ' OG1' ' A' ' 125' ' ' THR . 40.8 tp -63.75 -23.18 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.786 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -13.54 62.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.976 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.05 9.72 26.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.662 0.268 . . . . 0.0 111.299 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.482 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -91.67 141.39 28.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.45 . . . . 0.0 111.333 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 82' ' ' SER . 10.6 mptt -109.71 -179.0 3.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.805 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.8 ptpt -57.3 -41.37 79.72 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.49 47.65 1.32 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.719 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.59 ' HG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -66.82 -17.21 64.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.596 0.358 . . . . 0.0 111.895 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.494 ' HE1' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 53.66 86.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.52 0.676 . . . . 0.0 111.727 -174.802 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -88.37 114.81 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.251 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 76.1 m-85 -101.43 105.4 16.42 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.79 106.93 19.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.7 mmtp -90.91 92.57 8.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.11 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.842 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.8 m -90.67 92.37 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.672 0.748 . . . . 0.0 110.179 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.58 -88.99 0.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.51 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.05 0.28 5.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.151 0.501 . . . . 0.0 110.083 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.842 ' HB2' HG23 ' A' ' 88' ' ' VAL . 9.5 mm-40 -92.18 119.03 31.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.495 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 m -92.54 106.04 18.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.576 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -94.96 136.57 35.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.623 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -114.55 118.85 34.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -177.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 71.9 m-85 -118.03 145.7 44.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.398 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -110.23 138.76 46.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.618 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.8 mmt -81.0 68.06 7.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.141 0.496 . . . . 0.0 110.15 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -75.73 -20.9 58.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.859 -172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.55 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 51.0 m -133.03 101.59 5.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.175 0.512 . . . . 0.0 111.17 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 97' ' ' MET . 78.5 mt -119.03 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.266 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -157.97 176.2 12.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.355 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 10.6 p-10 -134.98 128.39 32.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.976 0.417 . . . . 0.0 110.135 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.869 HG13 HG11 ' A' ' 110' ' ' VAL . 31.6 m -129.05 179.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.39 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -102.99 158.0 32.62 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.075 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.75 -15.19 40.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.929 2.419 . . . . 0.0 112.585 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.3 t -96.26 -7.13 36.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.905 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB2' ' HE2' ' A' ' 104' ' ' LYS . 9.9 t0 -84.78 97.94 9.98 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.542 ' HA ' HD22 ' A' ' 111' ' ' LEU . 29.6 m -100.06 8.25 8.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.821 0.343 . . . . 0.0 111.715 -170.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -93.43 -15.47 25.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.869 HG11 HG13 ' A' ' 103' ' ' VAL . 22.5 m -76.44 -23.71 15.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.547 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.542 HD22 ' HA ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -97.41 34.54 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.09 0.471 . . . . 0.0 111.064 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -70.16 169.66 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.25 105.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.459 0.647 . . . . 0.0 110.789 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -82.21 45.33 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.466 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.48 174.57 10.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.33 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.86 13.25 78.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.744 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -110.44 -170.69 1.69 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.082 0.468 . . . . 0.0 110.193 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.73 -163.58 0.86 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -62.35 110.02 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.11 143.22 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.237 0.541 . . . . 0.0 111.446 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.471 HD21 ' HB ' ' A' ' 57' ' ' ILE . 70.6 mt -96.27 125.22 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.316 174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.545 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 12.0 m -97.69 92.43 5.88 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.3 mm? -87.45 100.69 12.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.236 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.98 97.84 7.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.455 ' OG1' HD22 ' A' ' 75' ' ' LEU . 2.4 m -102.91 102.11 12.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.963 0.411 . . . . 0.0 109.925 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 20.6 m -85.89 100.4 12.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -115.5 177.55 4.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.342 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.26 83.34 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.739 0.649 . . . . 0.0 111.003 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.688 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -102.91 170.67 7.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.413 0.625 . . . . 0.0 111.919 -172.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -104.9 92.34 4.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.058 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 38.2 mt-10 -44.56 -37.9 3.86 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.36 -29.01 70.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 8.6 t -126.44 -14.84 5.76 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.509 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.687 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.3 m -75.15 146.48 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 117.437 0.618 . . . . 0.0 110.251 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.688 ' CE3' ' HB3' ' A' ' 129' ' ' TYR . 85.1 m95 -94.14 111.91 23.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -70.6 -53.73 14.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.382 -172.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -90.71 85.09 5.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 0.0 111.405 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.612 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 35.7 ptt180 -80.64 79.94 7.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 85.0 tttt -70.15 123.23 21.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.067 -174.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -107.8 125.52 64.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.687 0.756 . . . . 0.0 110.741 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.618 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 37.2 m-85 -109.05 110.83 22.2 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 84.3 t -96.91 103.33 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.405 0.621 . . . . 0.0 109.556 176.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.573 ' HB1' ' SD ' ' A' ' 97' ' ' MET . . . -101.75 102.37 13.0 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.35 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -87.62 139.5 30.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 7.3 tt0 -55.21 128.61 34.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.941 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 5.9 p -96.48 155.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.128 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.089 -175.263 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' JPT . . . . . 0.612 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.6 mtmt . . . . . 0 C--O 1.233 0.197 0 CA-C-O 121.173 0.511 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 29.2 Cg_endo -57.78 115.02 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.899 2.399 . . . . 0.0 112.954 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -146.84 168.22 21.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.752 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.735 HG23 ' HB2' ' A' ' 31' ' ' PRO . 46.6 mt -104.18 120.88 49.49 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.39 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 2.4 Cg_endo -83.88 179.68 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.122 2.548 . . . . 0.0 112.321 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -79.1 -25.24 43.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.05 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.38 116.21 8.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 110.259 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -92.89 16.33 12.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.735 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 t -108.54 -29.09 8.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -89.3 174.37 7.87 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.207 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.63 128.67 52.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -80.77 -41.24 23.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.09 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.77 164.09 35.61 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.443 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -107.36 140.88 39.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.899 0.35 . . . . 0.0 110.267 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.4 tp -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.364 0.602 . . . . 0.0 110.113 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.1 mt-10 -120.76 111.88 18.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.638 0.732 . . . . 0.0 111.262 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.8 mt -124.86 93.91 45.1 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.75 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.71 -28.71 87.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.006 2.471 . . . . 0.0 112.283 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.0 -23.19 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.934 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.75 7.3 18.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.905 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 64.68 27.21 13.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.6 mt -106.64 122.28 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.0 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.27 75.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 167.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 67.8 mm-40 -122.0 162.02 39.43 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.68 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 69.0 Cg_endo -77.09 128.05 9.64 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.793 2.328 . . . . 0.0 113.321 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.15 124.93 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.83 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 44' ' ' SER . 62.8 m-85 -93.76 123.26 60.26 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.246 0.545 . . . . 0.0 110.966 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.735 ' HB2' HG23 ' A' ' 7' ' ' ILE . 68.6 Cg_endo -76.14 107.92 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.64 2.227 . . . . 0.0 111.289 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.9 167.22 33.18 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.734 -1.222 . . . . 0.0 112.8 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 88.5 Cg_endo -87.58 31.75 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.889 3.059 . . . . 0.0 112.544 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 62.25 26.88 16.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.202 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -70.32 142.61 89.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.722 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -39.44 -55.52 1.55 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.861 3.04 . . . . 0.0 114.852 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.41 -24.06 67.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -69.4 -39.63 77.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.14 0.495 . . . . 0.0 109.698 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 94.0 mt -80.96 -23.41 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.19 -24.52 63.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -103.86 -22.65 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.674 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -175.3 -156.68 14.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.161 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.465 HG11 ' CE1' ' A' ' 72' ' ' PHE . 28.5 m -92.27 154.58 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 29.6 t -135.51 163.37 30.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.993 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 58' ' ' SER . 31.1 m-85 -74.67 162.34 28.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.49 70.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.931 0.396 . . . . 0.0 110.689 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -137.9 176.14 8.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.666 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.745 0.783 . . . . 0.0 109.305 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -88.33 -22.08 24.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.855 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -76.58 171.97 13.78 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.941 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 66.5 m -154.1 165.32 36.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.948 0.404 . . . . 0.0 110.543 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.521 HD13 ' CG2' ' A' ' 88' ' ' VAL . 15.7 mt -79.43 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.971 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -101.29 -3.06 29.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.584 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -82.66 170.92 14.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.97 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -85.94 -20.76 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -107.69 108.01 19.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.644 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.98 111.66 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 12.2 m -117.31 116.6 27.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.877 0.37 . . . . 0.0 111.014 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.71 121.12 53.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.227 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.04 116.44 22.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.338 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.6 114.31 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.188 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -87.9 84.62 6.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.3 m -68.85 140.37 55.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.534 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.83 150.88 40.52 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.308 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.4 mt -91.98 -43.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -50.72 -43.52 57.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.353 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.5 mtp85 -100.18 124.29 43.79 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.856 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -87.42 -16.62 3.1 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.788 2.326 . . . . 0.0 113.012 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -138.84 73.41 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.184 0.516 . . . . 0.0 110.888 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -119.33 -161.16 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 43.8 mt-30 -60.21 -77.76 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' CE1' HG11 ' A' ' 43' ' ' VAL . 3.1 m-85 -84.59 19.02 2.09 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -47.63 78.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -101.96 12.03 37.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -172.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.94 -16.73 64.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.365 0.602 . . . . 0.0 110.337 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -8.88 56.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.787 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.35 1.72 56.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 110.933 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.1 165.56 23.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.111 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 97' ' ' MET . 11.2 pttm -158.08 -170.92 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.896 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.1 ptpt -54.4 -39.14 66.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -117.68 59.78 0.47 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.443 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -84.22 -5.22 59.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.56 85.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.638 0.586 . . . . 0.0 111.694 -177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 45.5 t -86.66 112.31 22.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.96 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.56 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.2 m-85 -100.84 107.93 19.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.551 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 12.6 t80 -99.11 102.1 13.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -82.7 88.97 6.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.361 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 52' ' ' LEU . 7.5 p -117.44 124.43 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 111.589 -170.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.24 -57.1 1.13 Allowed Glycine 0 CA--C 1.509 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.718 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -169.11 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.427 0.632 . . . . 0.0 110.223 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.06 154.94 20.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.252 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 m -98.0 100.92 12.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.33 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 51.1 mmt-85 -82.27 112.43 19.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.116 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.803 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.09 128.78 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.607 . . . . 0.0 110.56 177.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 72.1 m-85 -121.92 151.43 40.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.395 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.601 ' HE3' HG21 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -117.67 138.28 52.09 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.673 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 19.3 mmt -80.61 68.35 6.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.263 0.554 . . . . 0.0 110.311 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.92 -38.8 36.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.713 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.616 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 33.4 m -110.27 103.68 12.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.053 0.454 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.8 mt -123.49 126.06 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.426 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 7.1 ptm180 -159.77 -175.59 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.517 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 3.3 p30 -136.4 144.79 44.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.811 HG11 HG11 ' A' ' 110' ' ' VAL . 28.7 m -126.41 -169.16 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.787 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.615 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -136.89 160.39 66.48 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.422 -176.168 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.87 -20.82 30.65 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.645 2.23 . . . . 0.0 112.307 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.1 p -91.7 8.21 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.037 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.429 ' HB2' ' HE2' ' A' ' 104' ' ' LYS . 24.7 t0 -107.71 97.3 7.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.6 m -104.99 16.2 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.222 0.534 . . . . 0.0 110.591 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -104.74 -2.32 25.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.328 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.811 HG11 HG11 ' A' ' 103' ' ' VAL . 13.5 m -96.83 -39.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.979 0.419 . . . . 0.0 110.899 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.525 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -86.35 86.96 7.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.462 1.125 . . . . 0.0 108.743 173.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.7 -164.39 1.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.991 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.509 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 7.1 pt-20 -77.7 71.26 4.17 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 111.344 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -86.3 47.88 1.54 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.509 ' HE2' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -71.64 172.57 9.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.203 -176.044 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.14 -14.21 36.99 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -92.6 175.21 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 110.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -89.62 -157.32 0.45 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 108.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -104.4 130.62 52.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 110.498 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -96.09 104.02 15.94 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.0 m -88.67 98.22 11.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.469 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -83.13 103.06 12.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.8 mt -96.71 89.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.876 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 m -95.48 101.8 13.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 -175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.8 m -84.06 115.58 22.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -120.33 158.56 26.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.131 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 t70 70.14 98.97 0.06 Allowed 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.91 0.757 . . . . 0.0 110.986 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -86.58 130.02 34.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.619 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -97.16 101.51 13.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.5 -17.16 64.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.573 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -71.16 -27.73 63.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.2 t -133.9 -23.44 1.77 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.79 26.73 8.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.641 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.88 174.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 117.027 0.413 . . . . 0.0 110.963 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -110.83 116.95 32.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.7 -50.95 30.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.149 -170.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.748 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 11.0 mmpt? -95.07 100.41 12.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.158 0.504 . . . . 0.0 111.243 -174.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.433 ' HB2' HG23 ' A' ' 103' ' ' VAL . 68.7 mtm180 -91.9 83.59 5.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.517 ' HD3' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -64.58 129.69 40.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.293 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.67 114.57 38.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 122.234 1.016 . . . . 0.0 110.851 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.647 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 67.4 m-85 -108.12 104.7 14.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.01 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 37.8 t -90.97 93.25 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.703 0.763 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -88.39 105.14 17.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.661 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.3 m -84.37 142.61 30.03 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.803 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -53.38 114.45 1.5 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 109.873 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.601 HG21 ' HE3' ' A' ' 96' ' ' LYS . 7.3 p -94.28 148.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.351 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.444 -179.745 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 55.2 mtmt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.697 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.9 Cg_endo -57.38 126.67 22.74 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.31 2.673 . . . . 0.0 112.349 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -158.06 162.39 38.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 31' ' ' PRO . 22.6 mt -99.36 123.32 48.87 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.807 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.77 -172.75 1.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.864 2.376 . . . . 0.0 113.008 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -90.92 -14.45 31.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.546 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.45 145.56 25.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.85 0.357 . . . . 0.0 110.628 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -99.55 5.34 46.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.039 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -111.34 9.75 21.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.573 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -110.34 171.96 7.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 111.644 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.51 118.0 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.81 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -92.32 -25.07 18.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.233 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.96 177.92 45.21 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.292 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 69.1 m-85 -123.78 136.5 54.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.99 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 122.256 1.027 . . . . 0.0 110.085 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -115.2 108.66 16.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.71 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.487 HG12 HG13 ' A' ' 84' ' ' VAL . 25.4 mt -121.34 94.88 48.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.212 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.48 -28.02 70.53 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 122.745 2.297 . . . . 0.0 111.225 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 34.2 t70 -67.45 -24.94 65.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.572 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -118.01 11.81 13.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.321 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t0 59.39 30.01 19.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.657 0.741 . . . . 0.0 111.063 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.466 HD12 HD12 ' A' ' 20' ' ' ILE . 84.5 mt -97.78 121.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.085 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 2.4 mppt? -145.03 80.73 1.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -154.01 158.82 32.49 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.644 0.259 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 71.1 Cg_endo -75.06 163.52 35.07 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.922 2.414 . . . . 0.0 113.054 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.82 133.41 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.809 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.45 118.87 53.55 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.325 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 75.1 Cg_endo -85.69 162.8 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.924 2.416 . . . . 0.0 113.224 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.01 -173.75 34.62 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.457 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.75 6.52 4.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.233 2.622 . . . . 0.0 112.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.956 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.674 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 71.1 p -111.61 163.95 16.27 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.414 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.674 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 53.8 Cg_exo -38.28 -48.04 2.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.092 3.195 . . . . 0.0 115.361 -173.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -30.14 66.18 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.687 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.5 mp0 -64.93 -43.59 92.25 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.837 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.0 12.08 6.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.91 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HA ' ' HZ ' ' A' ' 64' ' ' PHE . 55.2 t-20 -107.77 -47.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.449 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 41' ' ' ARG . 13.3 ptm180 -83.58 -26.0 30.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.278 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.4 -139.86 2.75 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.339 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG21 ' CE1' ' A' ' 72' ' ' PHE . 11.6 p -124.57 145.28 32.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.687 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 62.4 m -133.31 -177.39 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -95.82 166.79 11.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.477 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.042 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -149.2 170.48 18.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.141 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -78.18 -23.49 47.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -84.62 -1.47 56.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.34 145.37 51.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -128.04 150.67 49.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.753 0.311 . . . . 0.0 111.032 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.8 mt -80.8 -16.57 53.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.388 0.613 . . . . 0.0 110.221 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.27 -4.33 58.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.632 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.83 164.3 22.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.229 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.36 -21.85 59.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 177.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.77 145.55 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.0 110.16 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.435 ' HB ' HD23 ' A' ' 121' ' ' LEU . 4.0 mp -125.99 115.05 41.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.839 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -88.99 107.2 18.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.611 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.1 mt -105.02 122.9 58.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.72 126.71 42.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.192 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.7 158.98 20.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.07 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -149.39 93.95 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 m -62.09 148.51 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.501 ' HZ ' ' HA ' ' A' ' 40' ' ' ASN . 88.5 m-85 -118.19 172.21 7.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.662 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.01 -42.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.852 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.89 -4.99 59.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.724 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -117.72 111.14 39.65 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.737 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.58 -10.01 20.15 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.812 2.341 . . . . 0.0 112.347 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -155.64 84.49 1.04 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 110.966 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 63' ' ' THR . 10.2 p90 -108.56 -168.87 1.41 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -38.33 -69.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CE1' HG21 ' A' ' 43' ' ' VAL . 19.5 m-30 -114.41 78.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.233 -0.292 . . . . 0.0 111.625 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.02 -50.86 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.566 0.698 . . . . 0.0 110.508 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 64.0 t30 -87.17 30.62 0.76 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.157 -172.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.77 -9.54 54.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.371 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -9.62 59.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.033 0.444 . . . . 0.0 111.003 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.16 -6.86 43.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.1 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.572 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -79.77 127.14 31.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -111.54 -169.08 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.465 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.04 -44.62 95.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.641 -176.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -99.92 52.94 0.99 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.892 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.4 t -62.96 -21.64 66.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.167 -0.516 . . . . 0.0 111.404 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.409 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 50.17 76.01 0.16 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.513 -174.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.8 t -81.46 122.68 36.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.24 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -100.11 99.69 10.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.188 0.518 . . . . 0.0 109.753 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -101.52 109.58 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 92' ' ' THR . 94.5 mttt -97.21 135.5 39.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.081 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.2 m -141.36 107.95 2.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.85 -102.2 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.352 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -115.26 5.65 14.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.809 0.338 . . . . 0.0 110.868 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 88' ' ' VAL . 40.9 mt-10 -102.43 113.63 27.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.451 HG23 ' HG2' ' A' ' 87' ' ' LYS . 19.0 m -95.57 97.5 9.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 171.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 93' ' ' ARG . 16.9 mtp85 -93.27 135.88 34.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.192 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -98.68 130.56 45.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 92.7 m-85 -122.63 137.26 54.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.93 0.395 . . . . 0.0 110.611 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.615 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -109.69 131.3 55.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 22.4 mmt -80.73 76.1 7.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.389 0.614 . . . . 0.0 110.379 -175.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 t -86.97 -12.05 48.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.789 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.7 m -137.11 100.62 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 0.0 110.504 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 97' ' ' MET . 74.4 mt -119.5 122.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.353 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -161.2 -176.73 5.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.905 0.383 . . . . 0.0 110.653 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 1.1 p30 -131.52 141.02 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 110' ' ' VAL . 35.3 m -121.17 -176.0 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.143 0.497 . . . . 0.0 111.226 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.502 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -111.48 157.2 39.85 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.644 -176.041 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -60.21 -10.89 14.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.681 2.254 . . . . 0.0 112.643 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -117.16 17.89 14.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.26 129.91 39.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.228 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.89 30.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.63 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.96 -7.15 9.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.688 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 103' ' ' VAL . 16.0 m -92.39 -19.11 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.3 0.571 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.519 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.2 19.97 16.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -116.19 145.14 43.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.388 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 49.34 67.53 0.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.536 0.522 . . . . 0.0 111.375 -174.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -89.39 89.51 7.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.619 0.724 . . . . 0.0 109.369 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 160.6 28.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.297 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.27 62.08 0.8 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.103 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -59.84 176.64 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.331 0.586 . . . . 0.0 111.178 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -83.04 -170.12 2.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 4.4 mptp? -64.09 112.69 3.11 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.12 131.79 56.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.311 0.577 . . . . 0.0 111.204 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.435 HD23 ' HB ' ' A' ' 57' ' ' ILE . 67.4 mt -86.01 121.22 28.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m -102.88 94.78 5.76 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 24.9 mt -83.84 100.33 10.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.923 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.3 mt -90.54 93.47 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.747 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.3 m -98.25 95.78 7.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.111 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.2 m -78.82 111.92 15.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.606 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.17 178.41 6.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.708 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.21 82.28 0.18 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.566 0.698 . . . . 0.0 110.233 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -83.54 126.45 32.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.529 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -95.48 100.85 12.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.34 -18.07 65.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.481 -174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -74.53 -27.21 60.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 135' ' ' VAL . 8.1 t -124.58 -20.33 5.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.783 0.325 . . . . 0.0 111.191 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.67 46.39 6.39 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 133' ' ' THR . 5.6 p -139.76 156.7 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.0 110.355 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -93.76 115.28 27.7 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.05 -40.32 53.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -170.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -104.26 126.9 51.76 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.458 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -103.73 89.2 3.26 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.653 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 51.6 tptt -71.86 123.21 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.1 tt -121.01 124.01 71.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.869 0.842 . . . . 0.0 111.03 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.583 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 21.0 m-85 -113.99 108.11 16.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.837 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.9 t -99.52 106.06 18.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.431 0.634 . . . . 0.0 110.088 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.66 112.08 25.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.268 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.6 m -87.06 139.23 30.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.085 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.82 117.82 6.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.441 0.639 . . . . 0.0 111.291 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.6 HG11 ' HE3' ' A' ' 96' ' ' LYS . 3.3 p -114.11 134.35 57.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.5 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 4.6 ptpp? . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.106 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE3' ' OD1' ' A' ' 53' ' ' ASP . 40.4 mtpt . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HG2' HG22 ' A' ' 88' ' ' VAL . 20.0 Cg_exo -66.21 145.37 78.19 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.004 2.47 . . . . 0.0 112.442 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -123.99 154.21 40.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.097 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.8 mp -73.64 122.77 88.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.81 167.36 17.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.917 2.411 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -78.85 -12.55 60.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.29 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -99.15 118.82 36.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.673 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -95.53 21.86 7.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.385 -173.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 m -108.33 4.23 24.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.292 0.568 . . . . 0.0 110.322 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 98.5 mttt -102.94 -176.56 3.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.099 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.49 135.22 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.222 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.634 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -97.53 -35.43 10.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 110.493 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.07 163.29 34.22 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 49.8 m-85 -106.24 134.93 48.59 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.0 tp -100.33 108.1 22.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.834 0.825 . . . . 0.0 109.782 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 59.0 mt-10 -115.8 111.02 19.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.232 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.408 HG12 HG13 ' A' ' 84' ' ' VAL . 46.2 mt -124.42 92.33 48.21 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.722 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -52.82 -34.62 66.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.317 2.678 . . . . 0.0 112.957 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.602 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 5.4 m-20 -58.6 -38.38 77.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.659 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -103.53 8.92 37.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 t70 54.72 38.72 30.58 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.239 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.537 HG23 ' HG2' ' A' ' 27' ' ' GLU . 65.5 mt -100.75 127.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.257 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -143.57 29.77 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.843 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 7.0 mm-40 -88.74 149.05 43.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.965 -163.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.76 141.58 24.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.293 1.996 . . . . 0.0 111.795 173.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.87 124.75 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -95.77 108.92 43.36 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.791 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.58 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 87.9 Cg_endo -76.69 152.0 32.66 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.744 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.66 -167.78 33.16 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.421 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.44 30.63 0.53 Allowed 'Trans proline' 0 CA--C 1.519 -0.253 0 C-N-CA 123.494 2.796 . . . . 0.0 112.445 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.85 82.9 0.16 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.528 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.21 137.51 24.84 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.048 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.586 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 18.9 Cg_endo -58.7 -27.42 83.28 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.935 2.423 . . . . 0.0 113.381 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 41.8 mt-10 -90.87 -33.62 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -76.63 -30.91 57.08 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.004 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.0 tp -84.89 -5.05 59.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.94 0.876 . . . . 0.0 109.367 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 48.3 t-20 -81.47 -56.05 4.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.283 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -82.8 -26.4 31.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.89 -136.47 3.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.339 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.33 147.35 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 t -130.26 -171.79 2.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.852 0.358 . . . . 0.0 110.181 -175.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -93.1 174.46 7.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.329 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.87 -52.82 8.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -127.99 177.02 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.47 -18.04 52.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -82.43 -2.16 52.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.934 0.397 . . . . 0.0 110.755 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 138.43 57.61 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 38.4 m -122.38 -172.83 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.634 HD11 ' HB1' ' A' ' 15' ' ' ALA . 65.7 mt -111.95 -18.71 12.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.632 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 4' ' ' LYS . 36.7 t70 -126.52 13.1 7.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.801 0.81 . . . . 0.0 110.184 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 18.8 t70 -81.17 160.83 24.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.239 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -66.34 -25.53 66.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.826 0.346 . . . . 0.0 110.293 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -108.72 110.71 22.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.789 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 mm -119.2 90.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -92.83 108.73 20.22 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.158 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.9 mt -102.58 121.47 53.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 115.46 27.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 72' ' ' PHE . . . -123.63 167.04 15.95 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.403 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -154.16 153.66 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.463 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 20.0 m -84.91 141.71 30.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CE2' ' HB3' ' A' ' 66' ' ' ASP . 45.3 t80 -125.23 107.92 11.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -51.39 -39.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.27 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.464 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 18.8 t70 -73.23 -22.06 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -109.45 129.74 23.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.96 -0.462 . . . . 0.0 111.069 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.72 -5.0 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.976 2.451 . . . . 0.0 113.152 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -143.91 77.44 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.287 0.565 . . . . 0.0 110.67 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 30.6 p90 -140.54 -166.97 2.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.804 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.843 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 13.2 mm-40 -43.55 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.075 0.859 . . . . 0.0 112.738 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.402 ' CD2' ' HA3' ' A' ' 61' ' ' GLY . 23.8 m-85 -106.2 79.66 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.065 0.46 . . . . 0.0 111.002 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -111.48 -52.18 2.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.658 0.742 . . . . 0.0 109.862 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.5 t30 -97.5 19.92 12.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.211 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.21 -16.47 62.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.206 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -9.73 50.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.717 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.26 16.32 11.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.83 147.69 22.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.944 0.402 . . . . 0.0 111.167 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.602 ' HE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -150.59 -172.66 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.407 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 97' ' ' MET . 20.1 ptmt -47.05 -49.78 20.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -171.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -115.59 59.96 0.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 119.71 -1.233 . . . . 0.0 112.294 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 30.5 m -79.61 -2.44 42.57 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.886 -0.185 . . . . 0.0 111.43 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 49.7 78.01 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.587 0.554 . . . . 0.0 111.453 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 41.5 t -79.69 112.3 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.722 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -97.86 109.15 21.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.852 0.358 . . . . 0.0 110.084 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -94.07 101.89 13.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.8 tptm -85.63 92.22 8.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.768 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 5' ' ' PRO . 7.3 p -119.47 126.6 75.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.18 0.514 . . . . 0.0 111.091 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.03 -101.02 0.27 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.942 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -125.22 1.85 7.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 0.0 110.273 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.23 132.39 50.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -101.7 87.16 3.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -92.85 128.93 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.137 0.494 . . . . 0.0 110.456 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.44 139.16 32.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.741 -173.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 77.8 m-85 -122.67 148.88 44.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.784 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.599 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -119.16 132.26 55.95 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.66 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 61.6 mtt -82.53 69.67 9.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.379 0.609 . . . . 0.0 110.562 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -75.7 -26.97 58.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.224 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.613 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -120.19 108.77 14.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.567 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.31 126.77 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.728 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.565 HH22 ' HB2' ' A' ' 109' ' ' GLU . 25.5 ptt180 -168.1 -177.07 3.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.245 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -120.66 139.96 52.28 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 110' ' ' VAL . 31.3 m -129.43 -178.01 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.824 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -105.55 157.64 34.07 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.271 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -21.49 72.06 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.447 2.098 . . . . 0.0 111.637 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 t -118.8 26.9 9.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.6 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 19.3 t70 -63.04 152.84 35.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.934 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.16 -14.11 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.926 0.393 . . . . 0.0 111.376 -170.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.565 ' HB2' HH22 ' A' ' 101' ' ' ARG . 43.4 mt-10 -88.44 -29.55 20.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.124 0.488 . . . . 0.0 109.749 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 103' ' ' VAL . 22.9 m -79.34 -6.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.391 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 86.0 mt -88.32 3.29 50.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.287 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -109.63 -172.51 2.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.349 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.45 112.26 13.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.14 74.13 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 111.277 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.75 161.29 30.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.282 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.01 6.09 63.6 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -114.43 -179.49 3.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.265 0.555 . . . . 0.0 110.691 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -94.56 -154.74 0.43 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 9.6 mmtm -64.45 123.91 20.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.88 104.6 16.54 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.719 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 144' ' ' ALA . 25.3 tp -78.32 100.76 6.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -93.71 99.48 11.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.002 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.3 mm? -80.5 99.72 8.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.41 110.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.146 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.1 m -110.42 95.3 5.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 -176.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.505 ' HB3' ' CB ' ' A' ' 136' ' ' TRP . 69.2 m -89.7 101.23 13.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -121.8 2.63 10.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.665 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 7.1 t70 -119.86 96.38 5.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.58 130.57 42.17 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.294 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 50.1 t-20 -97.62 116.87 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.321 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.65 -24.73 62.76 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -72.22 -21.22 61.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.522 HG23 HG22 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -141.2 -34.81 0.48 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.86 2.51 34.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.817 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 133' ' ' THR . 17.2 m -86.73 -174.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.754 0.311 . . . . 0.0 110.89 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 126' ' ' CYS . 54.5 m95 -114.68 126.65 55.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 130' ' ' ASN . 34.7 mm-40 -77.6 -74.72 0.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -175.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.665 ' HG2' ' HB2' ' A' ' 128' ' ' ASP . 22.8 pttm -85.13 131.03 34.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 110.432 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -116.48 97.96 6.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.927 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -66.18 126.7 29.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 tt -126.21 122.71 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.656 0.741 . . . . 0.0 110.812 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.574 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.5 m-85 -108.82 112.13 24.23 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 33.8 t -95.55 96.32 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.473 0.654 . . . . 0.0 109.723 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -96.93 109.89 22.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.332 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 m -81.75 140.38 34.3 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.961 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.59 119.8 8.25 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.455 0.472 . . . . 0.0 110.566 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.599 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 10.0 t -85.89 137.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.94 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.915 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.4 127.31 17.91 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.691 2.261 . . . . 0.0 111.399 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -140.73 127.68 20.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.65 0.738 . . . . 0.0 110.967 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.615 HG13 HD21 ' A' ' 52' ' ' LEU . 7.0 mt -59.95 131.01 89.14 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.14 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.28 160.8 26.1 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.722 2.282 . . . . 0.0 111.407 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 20.1 ptmt -79.23 -15.78 57.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 33.7 t70 -79.99 122.17 26.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 110.727 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -85.12 20.04 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.669 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -126.79 10.26 7.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.565 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 93.8 mttt -105.74 174.78 5.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.76 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.88 117.87 52.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.881 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.64 -31.99 23.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.409 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.05 173.21 45.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.259 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 80.8 m-85 -117.13 137.55 52.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.39 114.8 38.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.253 0.549 . . . . 0.0 109.574 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 66.1 mt-10 -117.93 106.16 12.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.426 0.632 . . . . 0.0 111.28 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.94 95.3 48.95 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.93 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HG3' ' HE2' ' A' ' 85' ' ' TYR . 18.6 Cg_endo -59.95 -30.36 91.53 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.946 2.431 . . . . 0.0 112.212 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.473 ' OD1' ' HD2' ' A' ' 79' ' ' LYS . 30.4 t0 -66.28 -30.86 71.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.57 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 74' ' ' ASN . . . -107.2 3.53 25.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.7 t0 61.73 23.08 13.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.99 0.9 . . . . 0.0 110.583 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 65.2 mt -90.35 106.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.124 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -133.04 83.43 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.554 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 31.9 mm-40 -133.8 159.37 72.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.925 -173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.49 148.22 18.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.669 2.246 . . . . 0.0 113.337 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.85 128.09 61.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.075 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' SER . 65.2 m-85 -100.58 117.97 61.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 52.3 Cg_endo -68.19 150.16 76.67 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.866 2.377 . . . . 0.0 112.575 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.07 177.7 27.76 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.427 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 94.6 Cg_endo -79.19 30.99 0.46 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.323 2.682 . . . . 0.0 112.757 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HB1' HD22 ' A' ' 39' ' ' LEU . . . 60.22 38.8 19.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.721 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.414 ' HB ' ' OE1' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -53.73 127.21 51.32 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.328 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.36 -59.54 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.994 3.129 . . . . 0.0 114.555 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 41.3 mt-10 -74.42 -35.99 63.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 23.3 mp0 -69.77 -35.24 74.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.0 110.361 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.427 HD22 ' HB1' ' A' ' 34' ' ' ALA . 17.2 tp -84.18 -10.97 57.31 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.839 0.828 . . . . 0.0 109.453 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 52.3 t30 -66.63 -49.69 65.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.778 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -90.79 -23.25 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.386 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.34 -147.07 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.701 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 71' ' ' GLN . 16.0 m -132.65 152.56 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 5.5 t -137.05 -171.75 3.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.688 0.28 . . . . 0.0 110.402 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -103.09 171.75 7.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.442 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' SER . . . -63.68 -47.63 80.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 110.173 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.29 162.34 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.681 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 9.6 pt-20 -74.26 -17.48 60.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -109.9 30.44 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.623 0.725 . . . . 0.0 109.857 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' HD12 ' A' ' 7' ' ' ILE . 4.9 tp10 -62.83 146.36 52.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.153 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 37.7 m -120.05 120.14 35.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.102 0.477 . . . . 0.0 111.506 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.917 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.7 mm? -71.22 -17.56 62.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.702 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -92.72 0.88 57.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.524 0.678 . . . . 0.0 110.322 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.9 t70 -83.05 -172.48 4.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.692 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.98 -30.19 18.95 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.84 132.55 56.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.109 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.464 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.4 mp -135.56 108.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 20.2 m -101.02 124.69 47.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.998 0.427 . . . . 0.0 111.175 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.57 125.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.818 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.05 127.43 37.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 72' ' ' PHE . . . -139.89 170.71 24.16 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.586 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -169.07 165.28 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.583 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.7 m -75.1 143.16 43.51 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 6.0 t80 -122.06 152.8 39.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.78 0.324 . . . . 0.0 110.635 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -99.43 -47.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.545 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -58.98 -46.03 89.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.965 -174.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -101.77 124.43 40.51 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.6 5.76 6.19 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.805 2.337 . . . . 0.0 110.763 170.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -149.86 80.3 1.38 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.707 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -126.76 -160.25 0.98 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.009 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.613 ' HG2' HG22 ' A' ' 43' ' ' VAL . 1.5 mp0 -59.44 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.478 ' CD1' ' HA3' ' A' ' 61' ' ' GLY . 22.5 m-30 -91.09 31.66 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.526 HG23 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -63.82 -24.41 67.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.4 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 64.7 t30 -134.95 36.0 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.723 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.89 13.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.589 -0.695 . . . . 0.0 111.271 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -89.97 -22.09 22.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.227 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.53 21.64 8.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.982 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.85 153.94 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.482 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HD2' ' OD1' ' A' ' 22' ' ' ASP . 4.6 mptt -132.6 -168.16 2.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.0 ptpp? -69.67 -23.94 63.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.855 0.359 . . . . 0.0 111.67 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -121.88 56.34 0.64 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.855 -1.165 . . . . 0.0 112.709 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -81.42 -10.45 59.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 57.01 90.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.451 0.643 . . . . 0.0 111.344 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.3 t -95.06 109.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.25 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 73.1 m-85 -94.56 114.35 26.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 121' ' ' LEU . 9.2 t80 -98.95 104.81 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 18.8 tptp -87.3 83.89 7.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.469 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.917 HG21 ' HG ' ' A' ' 52' ' ' LEU . 7.1 p -113.85 131.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.926 0.393 . . . . 0.0 110.678 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.55 -103.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.61 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -127.54 8.81 6.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.393 0.139 . . . . 0.0 111.227 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.41 158.52 32.55 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 112.159 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -124.63 108.89 12.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 97.9 mtt180 -100.14 146.6 26.63 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.186 -0.205 . . . . 0.0 110.591 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 120.14 39.69 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.571 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 94.6 m-85 -112.67 141.28 46.64 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -111.42 133.21 53.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.695 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.3 mtt -81.4 63.61 5.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.527 0.679 . . . . 0.0 110.465 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -71.26 -32.27 68.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.462 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 65.3 m -114.26 97.69 6.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 138.7 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.844 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -162.22 -178.45 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.515 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -126.48 140.01 52.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.888 HG23 ' HG3' ' A' ' 139' ' ' ARG . 7.7 m -114.2 147.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -85.77 159.08 55.71 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.623 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . 31.2 Cg_endo -64.79 -22.83 63.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.604 2.203 . . . . 0.0 111.596 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -106.66 8.5 31.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.145 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 11.7 t70 -85.13 142.22 29.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.75 11.07 8.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.951 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.49 -28.27 28.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 0.0 109.505 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.52 -26.42 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.03 9.91 37.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.872 0.368 . . . . 0.0 111.516 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 7.9 t70 -100.93 -175.09 2.78 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.036 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.406 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 4.2 pt-20 -115.22 102.74 10.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.18 0.514 . . . . 0.0 110.477 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -79.52 95.27 5.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.869 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.502 ' H ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.08 -175.96 3.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.413 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.07 -4.83 84.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.192 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -98.47 -174.31 2.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.81 -158.62 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -64.5 111.82 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 171.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.71 151.75 47.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.328 0.585 . . . . 0.0 112.209 -173.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -106.98 121.59 44.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.433 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 27.5 m -95.78 98.93 10.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.062 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 8.7 mt -85.03 101.07 12.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.131 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.1 mt -92.01 92.64 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -101.62 101.17 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.317 0.579 . . . . 0.0 111.183 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 76.9 m -84.06 105.07 14.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.874 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -98.8 -27.27 14.01 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.485 ' CG ' ' HD3' ' A' ' 138' ' ' LYS . 16.0 t70 -114.71 100.29 8.14 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.276 0.56 . . . . 0.0 111.14 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -87.14 122.76 31.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.441 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -91.04 107.3 19.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.23 -27.15 67.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.986 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -65.13 -34.74 79.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -173.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.506 HG23 HG12 ' A' ' 135' ' ' VAL . 9.9 t -126.16 -5.6 6.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 110.625 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.93 52.52 14.06 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.931 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.506 HG12 HG23 ' A' ' 133' ' ' THR . 9.0 p -142.23 150.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 46.6 m95 -92.69 98.0 11.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.741 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 42.7 mt-10 -72.42 -64.87 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 111.101 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.741 ' HD2' ' HB2' ' A' ' 137' ' ' GLU . 8.4 mptt -81.58 109.23 15.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.597 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.888 ' HG3' HG23 ' A' ' 103' ' ' VAL . 11.9 ptt180 -121.38 114.75 21.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.451 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.414 ' HE2' ' CE2' ' A' ' 142' ' ' PHE . 19.9 tptm -83.79 127.35 33.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.671 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.2 tt -120.1 128.44 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.578 0.704 . . . . 0.0 110.975 -175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.8 m-85 -115.84 116.09 27.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.026 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 41.3 t -98.86 96.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -95.73 116.04 28.3 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.775 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 m -96.34 145.17 25.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.696 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.04 122.56 9.61 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.58 0.55 . . . . 0.0 110.691 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.542 HG21 ' HE3' ' A' ' 96' ' ' LYS . 15.0 p -122.99 150.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.498 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 148' ' ' LYS . 14.9 ptpt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.326 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 121.268 0.556 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.66 130.44 24.87 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.051 2.501 . . . . 0.0 113.612 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -143.55 161.33 38.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.088 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 31' ' ' PRO . 3.5 mp -90.89 126.82 54.26 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.71 -175.31 2.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.117 2.545 . . . . 0.0 111.701 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.24 -17.77 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.663 -178.42 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -90.07 121.51 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.517 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -106.5 16.54 24.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.136 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -102.46 3.48 37.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -122.35 168.6 11.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.846 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.8 t -93.89 119.4 41.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.221 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -94.19 -21.62 18.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.29 164.41 37.17 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.318 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 79.7 m-85 -119.87 144.77 47.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -101.71 108.49 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.812 0.815 . . . . 0.0 109.564 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.78 108.62 17.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.193 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.431 HG12 HG13 ' A' ' 84' ' ' VAL . 41.7 mt -126.42 91.24 48.09 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.096 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 21.5 Cg_endo -61.55 -25.75 79.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.942 2.428 . . . . 0.0 112.164 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.562 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 33.8 t70 -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.028 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -110.29 8.31 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.57 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 t70 63.47 27.62 15.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.747 0.784 . . . . 0.0 110.652 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 88.6 mt -104.2 114.62 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.298 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.2 mppt? -142.37 82.1 1.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 11.2 mm-40 -134.02 159.99 70.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.054 -173.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 67.4 Cg_endo -75.17 144.91 30.24 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.918 2.412 . . . . 0.0 113.442 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.81 128.37 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.623 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -97.63 114.6 65.15 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HB2' HG23 ' A' ' 7' ' ' ILE . 86.1 Cg_endo -78.67 142.22 17.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.757 2.305 . . . . 0.0 112.431 -174.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.42 -161.43 28.19 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.912 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 59.8 Cg_endo -88.18 30.02 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.911 3.074 . . . . 0.0 113.312 -175.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.22 56.84 4.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.63 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.38 138.02 95.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.37 -58.62 1.3 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.252 3.302 . . . . 0.0 114.076 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.49 -34.44 76.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.648 0.261 . . . . 0.0 111.696 -176.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -81.2 -36.34 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.426 . . . . 0.0 110.847 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.41 -14.72 59.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.621 0.724 . . . . 0.0 109.575 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -73.91 -42.66 60.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.168 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 41' ' ' ARG . 12.9 ptm180 -86.13 -40.39 15.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.521 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.88 -157.11 8.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.603 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 HE21 ' A' ' 71' ' ' GLN . 40.2 t -113.26 142.67 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 t -130.64 -174.73 3.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -93.67 160.05 14.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -29.26 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.445 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -135.78 165.55 25.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 37.6 tt0 -82.8 -32.12 27.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.748 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.47 31.05 0.59 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.119 0.485 . . . . 0.0 111.167 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -85.68 151.41 23.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.838 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 47.1 m -122.93 150.21 43.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.752 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 93.6 mt -93.02 6.8 46.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.785 0.326 . . . . 0.0 111.746 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -132.68 8.34 4.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.706 0.765 . . . . 0.0 109.547 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.838 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 15.6 t70 -81.71 164.26 21.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.288 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tm0? -67.78 -29.05 68.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.035 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 138.37 53.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.794 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -140.0 117.82 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.858 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -100.23 103.4 14.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.045 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.5 mt -98.31 114.81 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.41 123.77 48.58 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.1 167.63 21.71 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.196 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -139.74 128.86 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.491 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.3 m -52.71 110.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.342 0.591 . . . . 0.0 111.282 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 66' ' ' ASP . 13.8 t80 -80.88 129.48 34.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.93 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.4 mm -75.0 -49.65 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.403 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.43 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -74.19 -1.35 20.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.23 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 85.0 mtm180 -130.24 94.38 30.54 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 -13.5 34.5 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.812 2.341 . . . . 0.0 112.515 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -147.33 63.27 1.16 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.445 0.641 . . . . 0.0 110.167 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 9.7 p90 -99.12 -157.79 0.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -43.57 -75.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.506 0.504 . . . . 0.0 112.123 178.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.541 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 22.2 m-30 -100.03 77.17 1.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.84 -52.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.554 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 10.7 t30 -88.62 11.94 16.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.047 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -23.16 64.89 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.958 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -70.1 -8.29 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.944 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.72 5.12 41.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.777 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . . . -96.16 135.15 38.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.438 0.637 . . . . 0.0 111.23 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' SER . 3.5 mppt? -108.86 -172.94 2.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -64.21 -30.62 71.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.827 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.82 49.69 0.83 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.246 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 6.7 t -66.07 -21.09 66.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.53 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 53.91 83.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.518 0.675 . . . . 0.0 111.547 -175.016 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 74.4 t -85.2 125.15 40.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.185 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -106.03 108.42 19.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.276 0.56 . . . . 0.0 110.337 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.75 103.07 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.0 tppp? -86.86 90.69 8.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.983 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 m -117.42 129.12 74.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.78 -88.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.494 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -148.18 11.07 0.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 110.155 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 145.57 41.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 m -109.18 107.11 17.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.372 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -99.74 137.0 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.938 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.413 ' HB3' ' CE ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -102.89 139.01 39.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.519 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -133.27 142.52 48.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.023 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -107.63 136.76 46.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.9 mmt -80.64 70.37 7.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.4 0.619 . . . . 0.0 110.108 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -83.64 -4.69 58.8 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.895 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 20.2 m -144.02 105.82 4.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.093 0.473 . . . . 0.0 110.587 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 97' ' ' MET . 77.3 mt -122.08 123.27 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.924 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -165.23 -166.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.213 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.666 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 4.5 p-10 -142.98 144.97 32.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.691 HG23 ' HE ' ' A' ' 139' ' ' ARG . 11.3 m -132.07 154.17 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.269 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -97.09 164.86 16.94 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.785 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -67.19 -18.35 50.77 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.473 2.115 . . . . 0.0 111.229 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -103.91 12.86 33.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' HG13 ' A' ' 110' ' ' VAL . 7.6 t70 -74.63 154.76 38.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.432 ' HA ' HD21 ' A' ' 111' ' ' LEU . 28.5 m -96.11 -15.26 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 -172.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.15 -5.06 55.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.332 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 107' ' ' ASP . 21.8 m -83.6 -17.93 10.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.818 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -112.49 18.5 18.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 178.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.91 167.58 14.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.34 139.44 57.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.804 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.63 143.29 30.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.38 170.0 13.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.588 -166.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.13 51.78 2.87 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.254 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -83.1 177.0 8.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.13 -156.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 19.1 mmtm -60.7 115.45 3.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -106.34 112.04 24.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.979 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.55 105.38 9.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -91.57 93.73 9.09 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.683 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -77.65 99.1 5.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.578 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.51 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.043 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -117.67 89.72 3.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.007 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 64.0 m -73.97 104.82 4.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -110.54 76.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.569 0.7 . . . . 0.0 110.75 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 16.6 t70 -162.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.707 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.484 ' CZ ' ' HG2' ' A' ' 131' ' ' GLU . 1.6 t80 61.03 86.67 0.1 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.628 0.58 . . . . 0.0 110.384 -172.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -92.79 97.36 10.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.696 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.484 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 36.4 mt-10 -60.87 -15.74 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.278 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.24 -34.79 78.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.903 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -115.55 -14.99 11.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.436 0.636 . . . . 0.0 109.844 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.11 31.89 50.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.029 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.5 t -134.86 139.33 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 44.1 m95 -78.14 92.26 4.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 172.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.55 -8.46 59.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 62.9 tttm -121.13 131.15 54.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 19.9 ttp180 -136.57 100.92 4.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.34 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.666 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 48.7 tptt -69.1 126.68 30.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.12 124.88 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.772 0.796 . . . . 0.0 111.033 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 14.6 m-85 -115.66 116.36 27.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.395 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 45.6 t -104.02 103.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.322 0.582 . . . . 0.0 110.103 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.63 114.48 28.2 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.747 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.9 m -89.75 140.14 29.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.07 126.57 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.202 0.525 . . . . 0.0 111.255 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.461 HG11 ' HD3' ' A' ' 96' ' ' LYS . 13.1 p -130.09 160.53 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.229 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.491 -178.13 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 87.8 mttt . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 35.9 Cg_endo -64.19 135.87 49.05 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.974 2.449 . . . . 0.0 112.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -134.41 167.1 21.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.197 0.522 . . . . 0.0 110.519 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 51' ' ' SER . 43.1 mt -107.02 113.78 62.15 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.73 177.35 3.65 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.92 2.413 . . . . 0.0 112.292 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -74.65 -24.25 58.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 110.134 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.21 100.26 0.77 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.015 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -98.68 20.84 12.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 110.608 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -100.23 -11.86 20.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.284 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -107.33 176.69 5.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.097 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.97 129.53 41.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.727 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.5 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.301 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -155.3 176.08 33.04 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.668 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 71.9 m-85 -122.7 135.98 54.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.6 tp -98.63 110.05 25.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.807 0.813 . . . . 0.0 109.776 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 85.9 mt-10 -119.17 109.62 16.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.92 89.6 38.15 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.67 -32.73 76.81 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.112 2.541 . . . . 0.0 112.481 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.63 -23.78 64.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -107.89 8.12 28.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.137 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 65.4 17.65 11.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.844 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 91.2 mt -97.38 131.27 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.985 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 37.0 mtpt -156.41 45.73 0.43 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.486 0.66 . . . . 0.0 109.834 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -106.63 156.87 36.38 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.158 -169.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 57.4 Cg_endo -73.43 148.63 43.28 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 121.91 1.74 . . . . 0.0 112.896 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.82 134.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 44' ' ' SER . 46.5 m-85 -101.08 144.22 28.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.318 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.13 162.52 20.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.411 2.074 . . . . 0.0 110.894 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.24 165.2 13.24 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.093 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.66 30.24 0.41 Allowed 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.041 3.161 . . . . 0.0 113.221 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.36 43.39 23.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.763 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.759 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.65 147.24 96.45 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.15 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.637 ' HD2' HG22 ' A' ' 35' ' ' THR . 89.2 Cg_exo -49.04 -53.3 7.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.291 2.66 . . . . 0.0 113.965 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.759 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -71.82 -27.08 62.67 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.761 -178.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 44' ' ' SER . 42.6 tp60 -62.49 -51.91 65.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.995 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.74 -16.83 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.445 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.62 -40.3 66.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.266 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -68.97 -45.12 71.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.051 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.0 -110.19 0.23 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.598 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.3 m -130.71 152.68 37.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.58 0.229 . . . . 0.0 110.679 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 36.9 t -148.18 165.81 29.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.001 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -68.56 162.01 26.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.32 -37.44 25.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HB3' ' H ' ' A' ' 49' ' ' ASN . 21.2 mm-40 -125.61 156.33 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.33 -1.65 58.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.856 0.836 . . . . 0.0 108.772 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.436 ' H ' ' HB3' ' A' ' 47' ' ' GLU . 27.0 t-20 -91.14 -19.72 22.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.058 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.71 170.51 16.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.991 0.424 . . . . 0.0 110.532 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.535 ' HA ' HD12 ' A' ' 7' ' ' ILE . 56.1 m -146.94 157.63 43.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.525 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HG ' HG13 ' A' ' 7' ' ' ILE . 96.0 mt -73.79 -12.09 60.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 111.939 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -113.5 11.16 18.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.879 0.847 . . . . 0.0 109.844 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 4.3 t0 -83.21 156.78 23.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.652 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 115' ' ' LYS . 1.1 tm0? -68.15 -32.75 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.15 120.33 40.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.409 0.623 . . . . 0.0 111.56 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.1 mt -125.75 134.16 67.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 p -132.45 121.14 22.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.06 0.457 . . . . 0.0 112.022 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mt -108.69 128.45 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.02 123.57 33.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.033 0.444 . . . . 0.0 111.283 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 123.94 7.7 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.762 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -70.51 -61.85 1.61 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.505 0.193 . . . . 0.0 110.687 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 m 69.09 122.46 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 O-C-N 124.099 0.875 . . . . 0.0 110.693 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -152.63 138.75 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.3 -37.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.721 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.94 6.94 16.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.339 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -136.39 77.47 47.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.64 3.65 7.66 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.827 2.351 . . . . 0.0 113.338 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -153.19 47.44 0.69 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.973 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -101.5 -175.21 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HG3' ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.69 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 21.3 m-30 -96.96 81.33 3.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.485 0.66 . . . . 0.0 111.245 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 m -150.4 -41.28 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.174 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -91.08 11.9 21.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.462 0.649 . . . . 0.0 109.388 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.01 -12.53 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.948 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -10.13 58.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.069 0.462 . . . . 0.0 111.257 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -82.13 -9.77 59.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.496 175.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.17 132.06 35.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.068 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' MET . 26.4 mmtp -120.53 -177.74 3.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -61.12 -13.77 19.82 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.42 34.23 2.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.547 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.0 m -82.77 121.86 27.45 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mtp -71.8 108.17 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 110.526 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 63.3 t -89.56 115.94 30.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.668 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 82.6 m-85 -102.57 121.42 42.35 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.072 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 12.0 t80 -112.81 99.06 7.61 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 5.4 mptt -75.25 102.22 4.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.013 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.85 86.73 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.168 0.509 . . . . 0.0 111.561 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.38 -59.25 3.26 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.308 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -137.35 -37.46 0.63 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 111.392 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -107.97 -179.73 3.98 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 6.6 t -132.23 142.57 49.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.397 0.618 . . . . 0.0 109.905 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -100.24 132.2 45.75 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.942 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -99.76 126.48 45.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.942 0.401 . . . . 0.0 110.462 -177.05 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 83.9 m-85 -125.13 149.94 47.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.38 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.8 tptm -113.17 135.18 54.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.604 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 16.7 mmt -79.9 62.62 4.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -75.62 -8.95 58.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.126 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.573 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 55.9 m -145.21 103.3 3.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.966 -0.459 . . . . 0.0 110.998 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.6 mt -120.59 128.34 76.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.24 177.42 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -132.16 120.55 22.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -75.24 151.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.51 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -86.51 148.39 46.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.73 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.628 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 32.8 Cg_exo -62.06 -15.68 45.29 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.697 2.265 . . . . 0.0 112.284 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -99.76 -5.66 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.84 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -91.81 133.22 35.83 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.57 24.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -115.89 -28.14 6.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.562 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.18 -22.59 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.475 0.655 . . . . 0.0 110.79 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.499 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -99.5 25.53 6.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.467 -173.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.91 175.35 7.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.552 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.7 pt-20 -72.21 70.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.397 0.618 . . . . 0.0 112.033 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -86.72 75.46 9.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.569 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -100.11 -179.36 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.31 -2.38 16.29 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.44 -170.71 3.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.34 -0.43 . . . . 0.0 109.946 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.75 -158.51 0.4 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 1.3 mptm? -61.77 104.82 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.05 125.4 49.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.327 0.584 . . . . 0.0 110.54 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.4 tp -91.92 109.72 21.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m -96.28 102.26 14.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.572 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.6 mm? -87.38 100.7 12.93 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.72 89.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.6 m -100.56 99.73 10.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 83.4 m -60.7 125.26 23.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.425 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 8.8 t70 -112.08 -21.57 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.041 -160.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 13.6 t70 -140.85 108.57 5.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.389 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -101.38 130.08 47.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.57 0.7 . . . . 0.0 109.924 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -80.67 103.27 10.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.274 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -54.95 -26.07 33.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.08 -17.45 58.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.554 ' OG1' HG22 ' A' ' 135' ' ' VAL . 16.5 p -126.68 -37.69 2.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.536 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.85 8.54 51.24 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.939 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.554 HG22 ' OG1' ' A' ' 133' ' ' THR . 30.2 m -98.34 141.51 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 111.34 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 129' ' ' TYR . 60.4 m95 -87.97 86.65 7.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 105' ' ' PRO . 51.2 mt-10 -65.0 -64.19 0.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.961 -175.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 35.6 tttm -85.5 126.48 33.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -129.09 139.95 51.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.64 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 27.0 tttp -87.57 145.08 26.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.126 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.25 125.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.672 0.748 . . . . 0.0 110.936 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.7 m-85 -111.91 112.71 24.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.891 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 59.3 t -98.15 98.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 109.649 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -98.4 102.87 14.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.201 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.9 m -82.07 139.64 34.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.871 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -57.58 126.01 25.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.492 0.663 . . . . 0.0 110.8 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 148' ' ' LYS . 11.9 p -114.05 170.82 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.935 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.2 ptmm? . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.715 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.262 0.553 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.33 144.92 69.96 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.6 2.2 . . . . 0.0 112.169 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.79 156.84 47.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.733 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.421 HG23 ' CB ' ' A' ' 31' ' ' PRO . 28.3 mt -107.8 109.6 62.28 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.364 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.689 ' HG2' ' HE3' ' A' ' 13' ' ' LYS . 49.9 Cg_endo -73.35 164.09 36.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.418 2.078 . . . . 0.0 111.579 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.19 -3.22 19.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 -177.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.714 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 19.3 t70 -69.24 145.63 52.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.272 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 22.5 pttp -118.63 9.73 12.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 111.525 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -95.01 -50.46 5.09 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.056 -0.402 . . . . 0.0 111.35 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.714 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -76.83 162.04 27.96 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -96.85 151.6 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.105 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.36 -32.12 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.66 164.27 25.45 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.994 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 59.1 m-85 -129.73 135.17 48.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -104.98 115.23 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.532 0.682 . . . . 0.0 110.154 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -125.17 119.91 29.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.891 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.4 95.03 18.57 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.071 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.93 -22.55 68.51 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.715 2.277 . . . . 0.0 112.115 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 82' ' ' SER . 27.0 t0 -68.5 -33.02 73.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.392 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.56 2.5 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.584 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t0 57.7 36.56 26.73 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.874 0.845 . . . . 0.0 110.313 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 55.0 mt -102.45 121.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.624 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -147.06 86.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.4 mm-40 -145.26 159.8 47.75 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.617 0.246 . . . . 0.0 111.099 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.2 157.7 45.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.837 2.358 . . . . 0.0 113.447 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 14' ' ' VAL . 93.4 t -110.88 123.34 66.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.716 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 44' ' ' SER . 60.0 m-85 -92.42 110.97 48.3 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.312 0.577 . . . . 0.0 111.467 -175.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.7 Cg_exo -77.61 129.82 10.33 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.223 2.616 . . . . 0.0 111.728 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.03 -173.7 43.68 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.918 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 11' ' ' LYS . 3.3 Cg_exo -78.66 10.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.542 2.828 . . . . 0.0 112.845 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 67.49 29.92 7.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.663 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -68.56 160.24 77.53 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.26 -45.32 22.4 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.697 2.931 . . . . 0.0 114.727 -174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.517 ' OE1' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -71.79 -30.46 65.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.571 -175.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HG2' ' OE1' ' A' ' 37' ' ' GLU . 85.2 mm-40 -68.01 -36.84 80.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 0.0 110.339 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -81.92 -0.61 44.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.037 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -108.32 -12.18 15.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.698 0.285 . . . . 0.0 111.001 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 10.1 ptm180 -95.36 -25.81 16.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.783 0.325 . . . . 0.0 110.576 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.0 -122.59 0.91 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.076 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 ' HG2' ' A' ' 71' ' ' GLN . 7.6 p -122.03 144.22 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 45.0 p -132.29 -168.27 2.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.456 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 36.6 m-85 -96.28 165.0 12.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.465 176.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.367 . . . . 0.0 111.446 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.35 168.92 19.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.05 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -67.85 -31.77 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.808 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -88.3 19.95 3.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.034 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 4.6 mm-40 -64.65 158.4 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.031 173.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.816 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 51.8 m -140.04 123.19 16.8 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.134 0.492 . . . . 0.0 111.737 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' CG1' ' A' ' 88' ' ' VAL . 30.6 mt -66.22 -26.75 67.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.271 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.55 -19.98 48.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.79 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.816 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 3.5 t70 -72.29 164.53 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.396 -172.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.61 ' HA ' ' HD2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.91 -31.19 61.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.054 -178.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.42 133.98 54.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.684 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.5 mt -133.47 121.7 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.925 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -110.09 107.8 17.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.263 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 121' ' ' LEU . 41.1 mt -94.55 111.81 26.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -105.71 123.31 47.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.561 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.477 ' HA3' HG23 ' A' ' 43' ' ' VAL . . . -150.58 175.52 29.57 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.088 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -142.11 156.38 45.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.733 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -71.73 140.96 49.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.361 0.413 . . . . 0.0 111.016 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -100.68 158.53 15.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.357 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.49 -38.14 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -87.9 -5.07 58.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 67' ' ' ARG . 8.6 mmt180 -113.25 115.36 47.62 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 0.0 110.665 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.82 -11.66 5.51 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.961 2.441 . . . . 0.0 113.359 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -160.58 89.07 0.81 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.562 0.696 . . . . 0.0 110.514 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.733 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 15.4 p90 -130.69 -151.83 0.48 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.809 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.697 ' HG2' HG12 ' A' ' 43' ' ' VAL . 25.8 mp0 -55.49 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 111.918 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.6 m-85 -94.88 82.07 3.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.154 0.502 . . . . 0.0 111.198 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 m -110.1 -60.96 1.73 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -95.96 28.12 3.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.656 -176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.8 tp -65.13 -19.0 65.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.418 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -9.61 58.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.62 11.75 23.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.939 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.28 161.39 14.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.349 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -135.27 -176.01 4.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.6 ptmm? -66.52 -13.86 61.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.336 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.66 45.91 1.11 Allowed Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 174.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.4 t -61.63 -25.33 67.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.09 -0.555 . . . . 0.0 112.117 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.52 89.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.698 0.761 . . . . 0.0 111.518 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.0 t -91.81 125.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.669 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -102.0 104.47 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -97.51 106.07 18.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 49.5 mttp -83.72 125.02 31.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.225 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -130.49 101.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.294 0.568 . . . . 0.0 110.144 -177.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.59 -81.72 0.4 Allowed Glycine 0 C--N 1.317 -0.482 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.421 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 -18.62 4.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.349 . . . . 0.0 111.242 -176.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -97.52 152.04 19.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -123.53 99.59 6.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.61 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -93.83 166.35 12.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.734 0.302 . . . . 0.0 110.761 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.564 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -127.55 126.64 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.454 0.645 . . . . 0.0 111.894 -170.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.6 m-85 -116.05 148.22 40.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.454 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.614 ' HB2' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -117.16 129.47 55.98 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 59.5 mtt -79.86 70.33 6.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.402 0.62 . . . . 0.0 110.703 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 t -80.04 -24.93 40.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.587 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 15.0 m -121.03 102.5 8.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.011 0.434 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.7 mt -113.11 129.98 67.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.17 173.94 11.5 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.909 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 140' ' ' LYS . 1.2 p30 -149.36 125.53 10.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.865 168.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 110' ' ' VAL . 19.0 m -131.38 -177.16 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.398 -169.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.3 mppt? -103.07 145.19 30.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.762 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 136' ' ' TRP . 25.3 Cg_exo -65.62 -12.99 37.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.95 2.433 . . . . 0.0 111.95 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -109.02 16.89 22.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.518 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.09 168.27 19.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.43 -20.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.691 0.281 . . . . 0.0 111.033 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.83 4.84 38.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.265 0.555 . . . . 0.0 110.777 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.461 HG23 HG21 ' A' ' 103' ' ' VAL . 11.3 p -80.12 -20.16 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -104.24 12.48 33.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.355 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 157.32 34.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 0.0 110.251 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.571 ' OE1' ' HE2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -92.9 82.73 4.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.541 0.686 . . . . 0.0 112.022 -174.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -77.02 74.23 3.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.571 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.64 174.27 5.95 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.25 -23.1 27.84 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -72.3 158.97 34.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.435 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.462 ' OD1' HG22 ' A' ' 145' ' ' THR . 3.1 p-10 -83.43 -161.71 0.54 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 55' ' ' GLN . 2.4 tptp -46.86 106.31 0.08 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.188 0.305 . . . . 0.0 110.244 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 10.0 pt20 -116.4 135.34 53.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.371 0.605 . . . . 0.0 110.861 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 59' ' ' ILE . 20.7 tp -101.47 109.86 21.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 m -94.37 101.27 13.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.49 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.9 mm? -80.49 104.55 11.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.727 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.473 HG23 ' HD3' ' A' ' 139' ' ' ARG . 53.3 mt -98.84 100.72 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.6 m -115.6 105.18 12.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.125 0.488 . . . . 0.0 110.833 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.5 m -90.99 94.31 9.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.453 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 9.6 p-10 -105.05 2.45 29.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.672 -166.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.5 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 20.8 t70 -127.66 99.18 5.47 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.246 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 87.2 t80 -97.36 127.19 43.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 133' ' ' THR . 22.1 t-20 -91.28 111.13 22.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.68 -14.43 62.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -85.7 -29.64 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 135' ' ' VAL . 10.1 t -124.07 -9.45 7.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.366 0.603 . . . . 0.0 110.663 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.78 54.6 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.727 -0.669 . . . . 0.0 113.062 175.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.474 HG12 HG23 ' A' ' 133' ' ' THR . 4.7 p -149.23 157.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 67.8 m95 -88.57 117.9 27.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.2 -24.97 25.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 128' ' ' ASP . 21.2 pttp -142.78 154.83 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.548 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HD3' HG23 ' A' ' 124' ' ' ILE . 11.8 ttm180 -121.87 112.99 19.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.529 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.515 ' CD ' ' HB3' ' A' ' 102' ' ' ASP . 51.7 tptt -77.14 123.67 26.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.41 HD12 HH11 ' A' ' 139' ' ' ARG . 11.5 tt -127.52 126.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.765 0.793 . . . . 0.0 111.212 -172.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.9 m-85 -117.07 112.95 21.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.8 t -94.23 94.68 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -95.96 104.05 15.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.368 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 0.4 OUTLIER -85.1 151.68 23.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 7.4 tp10 -55.58 142.4 33.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 110.865 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 96' ' ' LYS . 21.8 t -90.4 144.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.182 -0.913 . . . . 0.0 112.402 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 8.8 mmmm . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.476 0.655 . . . . 0.0 112.349 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 88' ' ' VAL . 55.7 Cg_endo -71.66 146.45 48.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.297 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.31 -175.75 5.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.135 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.597 HG13 ' HG ' ' A' ' 52' ' ' LEU . 25.4 mt -102.08 117.95 60.25 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.716 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.78 168.29 21.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 112.109 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 4.2 mptp? -84.93 -17.11 38.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.379 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.83 125.66 30.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.783 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -105.88 18.86 21.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -94.22 -7.58 41.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.762 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -170.03 1.78 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.225 0.536 . . . . 0.0 111.108 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.04 137.7 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.921 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.26 -34.55 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.359 0.599 . . . . 0.0 110.567 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 166.01 39.22 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 75.8 m-85 -107.86 139.3 42.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.266 0.533 . . . . 0.0 110.053 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 25' ' ' ILE . 8.4 tp -101.94 117.48 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 34.9 mt-10 -120.78 113.33 20.01 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.477 0.656 . . . . 0.0 110.907 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 47.9 mt -127.32 94.12 39.34 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.492 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 10.1 Cg_endo -53.19 -42.96 61.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.279 2.653 . . . . 0.0 113.3 -172.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -13.71 61.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.678 0.275 . . . . 0.0 111.737 -176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.51 9.5 23.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.347 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.72 27.77 16.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.203 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.3 mt -96.92 119.99 45.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.329 -175.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 26' ' ' LYS . 24.4 mmmt -141.02 42.7 1.81 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.607 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 11.6 mm-40 -102.66 149.7 37.0 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.338 -165.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.39 135.68 13.53 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.771 2.314 . . . . 0.0 112.54 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.45 123.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.206 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.86 121.82 61.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -79.94 161.13 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.917 2.412 . . . . 0.0 112.256 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.2 -164.35 26.21 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.128 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.93 2.64 8.12 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.682 2.921 . . . . 0.0 113.103 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.96 89.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.882 0.738 . . . . 0.0 110.829 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 p -119.14 157.46 50.81 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.801 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.72 -52.87 6.9 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.695 2.93 . . . . 0.0 114.529 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.43 75.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 111.598 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -72.2 -37.68 69.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.93 0.395 . . . . 0.0 110.472 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.35 -18.06 60.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.98 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -81.7 -28.98 33.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -93.13 -35.79 13.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.673 0.273 . . . . 0.0 111.035 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' HG3' ' A' ' 71' ' ' GLN . . . -151.39 -137.86 2.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.208 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.25 162.32 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.2 m -131.43 172.32 12.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.905 0.383 . . . . 0.0 111.45 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.8 166.92 21.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.098 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.34 76.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.426 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -144.94 170.05 16.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.034 0.445 . . . . 0.0 110.962 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.09 -25.25 66.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.466 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.93 7.39 18.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 110.999 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.14 148.05 32.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -139.81 123.5 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.946 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.597 ' HG ' HG13 ' A' ' 7' ' ' ILE . 85.4 mt -74.26 -17.39 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.448 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.28 13.59 25.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.45 0.643 . . . . 0.0 110.529 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.45 178.08 4.69 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.5 pt20 -95.72 -22.21 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.705 0.288 . . . . 0.0 110.667 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -106.8 105.63 15.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.724 0.773 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.69 133.92 68.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.746 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 3.0 p -124.69 121.87 35.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.149 0.5 . . . . 0.0 112.06 -173.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -114.07 132.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.1 130.84 45.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.68 126.95 6.82 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.897 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -111.81 76.23 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 m -60.82 134.36 57.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.79 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -145.09 150.75 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.137 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -53.02 -43.24 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 123.713 0.633 . . . . 0.0 112.402 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.84 10.76 3.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.162 -174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -131.21 76.41 76.3 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.15 -28.04 11.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.791 2.327 . . . . 0.0 113.527 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.2 73.5 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.475 0.655 . . . . 0.0 110.729 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.463 ' CE1' ' HB ' ' A' ' 73' ' ' THR . 1.4 p90 -132.39 155.09 49.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.538 -0.756 . . . . 0.0 108.972 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.607 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 67.9 mm-40 16.49 -92.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.735 1.214 . . . . 0.0 114.226 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -116.7 97.11 5.81 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.677 0.275 . . . . 0.0 110.676 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.463 ' HB ' ' CE1' ' A' ' 70' ' ' TYR . 9.1 t -145.49 -39.34 0.24 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.219 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -91.58 26.67 2.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.706 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 125' ' ' THR . 19.6 mt -76.22 3.09 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.619 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -76.12 -21.08 57.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.189 0.518 . . . . 0.0 110.191 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.87 9.69 34.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.133 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.32 23.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.821 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 82' ' ' SER . 38.6 pttt -139.43 179.36 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.919 0.39 . . . . 0.0 111.109 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -66.77 -11.55 55.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.102 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.88 59.85 0.55 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 79' ' ' LYS . 6.0 p -74.77 -15.12 60.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.52 88.64 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.866 0.729 . . . . 0.0 111.407 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 56.1 t -88.81 124.56 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.909 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.1 m-85 -107.04 108.54 20.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.647 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 17.0 t80 -93.5 101.39 13.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.6 tptm -84.48 85.51 7.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.668 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 5' ' ' PRO . 7.8 p -109.85 125.6 67.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.441 0.638 . . . . 0.0 111.064 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 5' ' ' PRO . . . 63.45 -94.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.494 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.61 11.82 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.668 0.27 . . . . 0.0 111.146 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.8 160.42 26.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.894 0.378 . . . . 0.0 111.005 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 m -124.01 98.01 5.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.081 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.647 ' HG3' ' HB3' ' A' ' 86' ' ' PHE . 10.4 ptp180 -95.3 132.05 40.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.301 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -100.57 140.22 35.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.878 0.371 . . . . 0.0 110.793 -174.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.617 ' OH ' ' HD3' ' A' ' 93' ' ' ARG . 74.5 m-85 -129.31 147.93 51.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.77 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HD3' HG11 ' A' ' 147' ' ' VAL . 1.6 tptm -109.54 121.41 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 51.3 mtt -77.75 68.92 3.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 110.238 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -81.43 -11.74 59.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.924 -172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.7 m -135.43 99.4 4.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.991 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.97 128.01 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.4 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -167.75 179.2 4.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.203 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 4.5 p30 -125.12 153.25 43.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.05 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 110' ' ' VAL . 6.1 m -142.61 173.39 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.712 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.767 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -98.43 154.22 37.66 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.069 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.62 -15.5 49.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.623 2.215 . . . . 0.0 111.936 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.7 t -103.76 9.57 37.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.767 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 10.4 t70 -77.21 122.18 24.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.333 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.79 11.38 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.084 0.469 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -81.53 -46.91 13.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 103' ' ' VAL . 33.8 m -86.62 -8.33 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.211 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.0 mt -88.35 -3.78 58.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.103 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.05 160.89 25.66 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.83 106.89 3.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.025 0.441 . . . . 0.0 110.709 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.95 101.96 13.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.979 0.418 . . . . 0.0 111.347 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -169.76 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 173.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.74 -40.56 2.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.326 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -73.86 171.6 13.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.077 0.465 . . . . 0.0 110.766 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.16 -152.58 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.567 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -60.51 113.3 2.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -110.69 126.59 54.69 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.133 0.492 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 121' ' ' LEU . 23.9 mt -90.47 116.57 28.5 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.579 HG23 HD11 ' A' ' 141' ' ' ILE . 25.4 m -98.01 102.77 14.62 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.1 mm? -95.78 101.8 13.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.8 97.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.005 0.431 . . . . 0.0 109.885 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.651 HG21 HD12 ' A' ' 75' ' ' LEU . 21.1 p -105.25 107.39 18.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.424 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 m -94.2 92.83 7.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.3 33.72 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.077 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 26.9 t70 -137.47 103.86 5.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -100.08 123.86 44.81 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.833 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -97.86 112.54 24.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.392 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.3 -31.06 70.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.087 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mmmp? -70.8 -22.32 62.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.588 HG23 HG12 ' A' ' 135' ' ' VAL . 8.6 t -130.64 2.06 4.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 58.0 54.66 35.67 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.238 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 133' ' ' THR . 3.3 p -149.95 159.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.472 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 70.6 m95 -97.66 101.16 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.87 -66.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.428 -169.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -69.97 88.53 0.58 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.464 0.65 . . . . 0.0 110.568 -176.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.54 ' HG3' HG23 ' A' ' 103' ' ' VAL . 21.2 ptt180 -76.94 73.06 3.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.752 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HE2' ' CZ ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -62.67 124.25 20.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.348 -174.327 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.579 HD11 HG23 ' A' ' 122' ' ' THR . 8.7 tt -114.21 137.88 46.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.592 -168.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.614 ' CZ ' ' HE2' ' A' ' 140' ' ' LYS . 43.7 m-85 -110.44 119.23 38.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.8 t -102.57 102.86 14.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.254 0.549 . . . . 0.0 109.649 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -101.79 111.95 24.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.8 m -86.47 136.47 33.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.023 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.07 120.33 7.31 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.507 0.504 . . . . 0.0 110.833 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.509 HG11 ' HD3' ' A' ' 96' ' ' LYS . 7.1 p -111.19 122.26 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.543 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.298 -173.995 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt . . . . . 0 C--O 1.233 0.188 0 CA-C-O 121.287 0.565 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.68 135.81 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.634 2.223 . . . . 0.0 111.933 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.542 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 12.3 pt20 -153.16 161.36 42.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.255 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.477 HG23 ' CB ' ' A' ' 31' ' ' PRO . 4.6 mp -93.56 102.46 7.71 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.7 Cg_exo -66.85 165.18 26.79 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 122.805 2.337 . . . . 0.0 112.878 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.966 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -81.33 -22.36 38.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.391 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -74.95 109.95 8.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 41.7 mttp -86.67 9.4 18.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.333 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -110.65 5.73 21.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.24 0.543 . . . . 0.0 110.139 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.634 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 66.1 mttm -92.89 173.0 7.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.766 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.9 t -109.7 117.29 54.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.043 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.63 -26.08 23.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.184 0.516 . . . . 0.0 110.343 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.83 -175.3 43.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.418 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 90.0 m-85 -126.53 140.13 52.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.089 0.444 . . . . 0.0 110.273 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.2 tp -100.69 110.02 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.571 0.7 . . . . 0.0 109.539 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 42.5 mt-10 -113.34 113.14 24.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.195 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.57 92.07 48.49 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.43 -30.08 91.71 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.953 2.436 . . . . 0.0 112.221 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -70.06 -25.97 63.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.45 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.76 5.71 26.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.3 t0 61.86 20.7 11.68 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.911 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.428 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 68.4 mt -96.71 124.08 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.711 -173.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 3.9 mppt? -141.16 83.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.571 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 25.2 mm-40 -117.72 151.36 48.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.045 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.19 133.39 14.81 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.939 2.426 . . . . 0.0 111.911 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HA ' HG23 ' A' ' 43' ' ' VAL . 56.1 t -92.17 118.37 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.842 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.427 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 92.6 m-85 -95.54 114.28 63.6 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 38.2 Cg_endo -64.94 129.58 23.59 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.11 2.54 . . . . 0.0 112.179 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.24 179.43 43.91 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.648 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HG2' HG23 ' A' ' 35' ' ' THR . 62.5 Cg_endo -87.69 33.55 0.41 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.96 3.107 . . . . 0.0 112.451 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.55 32.04 11.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -62.26 138.14 96.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.341 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 85.4 Cg_exo -46.95 -48.71 13.85 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.788 2.992 . . . . 0.0 114.109 -172.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.48 -30.06 68.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.821 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.53 -41.49 79.84 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.6 mm? -77.51 -6.08 52.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -83.6 -14.36 52.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -126.32 -36.24 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -154.62 -167.67 16.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.388 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 ' HG2' ' A' ' 71' ' ' GLN . 10.8 m -88.97 153.4 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -139.51 169.01 18.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.62 151.79 26.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.371 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.47 62.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.36 156.93 20.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.0 111.862 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -97.18 -20.95 17.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -72.26 -12.27 61.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -75.08 150.2 38.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.837 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 m -130.86 159.62 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 88' ' ' VAL . 84.8 mt -76.3 -20.97 56.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.812 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.92 3.72 36.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 110.246 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.88 156.79 38.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -68.87 -27.24 65.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.242 0.544 . . . . 0.0 110.685 -176.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -120.5 110.96 17.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.039 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.48 123.95 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -117.67 116.8 27.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.0 0.428 . . . . 0.0 110.84 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -104.77 122.35 57.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.48 139.28 30.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.37 163.76 32.64 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.378 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -142.75 150.91 40.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.698 0.285 . . . . 0.0 110.36 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 ' HA ' ' A' ' 73' ' ' THR . 17.1 m -84.06 150.84 25.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.596 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 9.3 t80 -142.65 151.52 41.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.8 mt -81.82 -47.01 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 111.605 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.81 -43.69 97.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.978 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 70' ' ' TYR . 1.5 mmt180 -89.35 109.1 28.95 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.34 -11.08 17.54 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.584 2.189 . . . . 0.0 111.524 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -148.13 77.21 1.4 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.823 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.596 ' OH ' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -156.15 158.23 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.571 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 80.0 mt-30 41.44 -107.59 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.705 0.628 . . . . 0.0 112.463 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 75' ' ' LEU . 50.6 m-85 -131.69 91.09 2.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 63' ' ' THR . 2.7 t -120.71 -53.82 2.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.331 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 73' ' ' THR . 63.9 t30 -87.01 18.47 3.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.53 0.681 . . . . 0.0 109.919 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 72' ' ' PHE . 28.8 tp -70.06 -7.84 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.671 -178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -8.29 56.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.91 -0.98 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.822 173.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.79 160.61 20.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.283 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -163.5 -169.78 2.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.695 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.5 ptmt -51.1 -36.69 41.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -170.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.56 58.53 0.7 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.314 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.3 m -81.96 -7.95 59.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.33 89.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.567 0.699 . . . . 0.0 111.439 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -90.6 118.36 35.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 90.0 m-85 -103.9 121.26 42.74 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.009 0.433 . . . . 0.0 110.51 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 27.7 t80 -100.68 104.53 15.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.6 tptm -85.73 97.43 10.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.562 HG21 HD13 ' A' ' 52' ' ' LEU . 4.4 p -124.36 120.93 60.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -173.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.02 1.84 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.714 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -172.86 -28.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.979 0.512 . . . . 0.0 110.499 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 9.4 pt-20 -87.2 165.68 15.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.158 0.504 . . . . 0.0 111.565 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 m -123.57 110.74 15.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.616 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 9.1 mmm180 -87.1 132.19 33.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -107.22 123.16 47.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.57 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 87.5 m-85 -118.46 145.39 45.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.485 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.647 ' HE3' HG11 ' A' ' 147' ' ' VAL . 1.3 tppp? -114.43 128.61 56.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 56.3 mtt -78.22 70.86 4.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.632 0.73 . . . . 0.0 110.636 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -87.09 -6.74 58.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.039 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.596 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 49.0 m -140.04 103.86 4.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.347 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 97' ' ' MET . 84.3 mt -122.6 130.06 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -158.95 173.31 16.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.883 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.929 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 1.5 p30 -133.03 124.06 26.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.254 0.549 . . . . 0.0 109.9 175.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.79 -172.2 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.953 -171.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.558 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -124.63 152.6 69.27 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.051 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.25 -13.01 33.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.487 2.125 . . . . 0.0 110.974 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -13.13 59.97 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.389 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.55 ' HB2' ' HE3' ' A' ' 104' ' ' LYS . 12.7 t70 -108.99 121.69 45.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.875 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.96 32.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -102.17 -18.47 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.137 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.07 -16.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.239 0.542 . . . . 0.0 111.533 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.508 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -98.65 22.04 10.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 111.242 -175.131 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 10.1 t70 -79.25 -154.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.954 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 39.0 mt-10 -65.52 92.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.05 30.14 4.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.637 0.732 . . . . 0.0 111.492 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.79 153.44 21.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 176.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.33 -21.23 7.32 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -90.12 -170.29 2.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.282 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.49 -164.67 1.21 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -65.03 104.89 0.94 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 110.11 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 13.1 pt20 -100.22 120.18 39.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.296 0.57 . . . . 0.0 110.526 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -85.61 110.32 19.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -94.65 99.64 11.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.555 -175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.1 mt -85.69 108.25 17.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.8 mt -91.46 99.34 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 m -96.52 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.262 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 80.0 m -94.9 93.95 7.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.499 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -113.73 9.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 23.4 t70 -78.95 -79.81 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.619 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 1.0 OUTLIER 62.48 88.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.779 -177.471 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 48.4 t-20 -85.81 98.04 10.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.4 ' HG2' ' CE2' ' A' ' 129' ' ' TYR . 44.1 mt-10 -68.0 -3.13 9.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 93.5 mttt -72.95 -33.02 65.64 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.126 0.489 . . . . 0.0 110.489 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.6 t -128.13 -15.96 4.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.542 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 26.26 45.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.375 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.35 138.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 25.0 m95 -85.09 105.02 15.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.99 -67.75 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 17.9 tppt? -65.25 117.03 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.411 0.624 . . . . 0.0 110.173 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -124.15 106.22 10.15 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.691 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 30.4 tttp -86.22 132.98 33.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.628 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.84 123.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.774 0.797 . . . . 0.0 110.607 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 89.4 m-85 -110.56 107.11 16.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.632 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 60.3 t -91.74 98.68 8.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.43 0.633 . . . . 0.0 109.534 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -97.5 97.58 9.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.813 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 7.3 m -73.96 140.67 45.7 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.52 114.77 2.62 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.676 0.75 . . . . 0.0 110.235 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.647 HG11 ' HE3' ' A' ' 96' ' ' LYS . 7.7 p -101.73 125.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.927 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 148' ' ' LYS . 10.3 ptpt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.732 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 31.4 mttp . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 31.9 Cg_endo -64.48 115.29 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.291 1.994 . . . . 0.0 109.264 165.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.421 ' HA ' HD23 ' A' ' 52' ' ' LEU . 14.4 pt20 -124.62 143.64 50.61 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.398 0.618 . . . . 0.0 110.98 -172.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.626 HG23 ' HB2' ' A' ' 31' ' ' PRO . 9.6 mt -69.12 118.11 58.51 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.245 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.66 174.25 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.381 2.054 . . . . 0.0 111.721 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 36.4 mmtm -92.07 36.83 0.98 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.694 0.759 . . . . 0.0 109.997 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 13' ' ' LYS . 9.9 t70 -127.2 105.69 8.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.454 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.659 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 32.0 mttp -73.92 -6.86 49.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.324 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.0 t -95.57 -19.56 19.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.995 0.426 . . . . 0.0 110.265 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HG3' ' CG ' ' A' ' 10' ' ' ASP . 56.6 mttp -81.82 176.19 9.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.7 p -112.63 136.63 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.07 -31.29 14.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.372 0.606 . . . . 0.0 110.21 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.15 158.5 31.48 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.093 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -102.87 138.49 39.69 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.872 0.336 . . . . 0.0 110.122 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 84' ' ' VAL . 9.3 tp -104.03 120.25 53.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 36.8 mt-10 -128.07 112.06 14.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.548 0.689 . . . . 0.0 110.911 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.597 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 43.6 mt -120.91 95.49 48.91 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.446 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.35 -27.07 71.29 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 123.244 2.629 . . . . 0.0 112.402 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 35.2 t70 -67.3 -32.09 72.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.252 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -109.86 5.02 22.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.914 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t0 63.54 22.37 13.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.81 0.814 . . . . 0.0 110.71 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.597 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 59.4 mt -79.32 113.48 18.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.291 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -150.69 98.25 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.962 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.683 ' OE2' ' HA ' ' A' ' 70' ' ' TYR . 2.4 mt-10 -169.29 164.47 6.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 O-C-N 123.16 0.287 . . . . 0.0 110.989 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HB3' HG21 ' A' ' 14' ' ' VAL . 21.6 Cg_exo -66.58 148.91 84.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.1 2.534 . . . . 0.0 112.99 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.15 121.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.308 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 44' ' ' SER . 50.6 m-85 -93.44 137.76 23.29 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.26 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -92.15 153.52 3.18 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.71 2.273 . . . . 0.0 113.077 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.11 -174.48 25.15 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.861 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.659 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 94.7 Cg_endo -79.98 8.97 3.76 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.574 2.849 . . . . 0.0 113.142 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 61.71 68.82 0.68 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.614 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 33' ' ' PRO . 37.6 p -92.07 161.15 34.03 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.173 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -30.66 26.2 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.086 2.524 . . . . 0.0 112.589 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.43 -43.78 93.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.152 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.504 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 39.0 mm-40 -82.16 -40.14 22.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.259 -170.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.2 mm? -70.73 -7.73 46.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.36 0.6 . . . . 0.0 110.577 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -22.75 23.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.487 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 38' ' ' GLN . 7.0 ptm85 -105.14 -13.8 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.221 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . 162.84 -157.18 29.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.386 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 72' ' ' PHE . 70.2 t -95.44 135.88 28.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.924 0.392 . . . . 0.0 110.05 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.1 m -124.65 170.34 11.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HD1' ' HA ' ' A' ' 31' ' ' PRO . 26.8 m-85 -68.66 161.9 27.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.223 174.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.12 -27.87 21.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.577 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 2.2 mm-40 -117.83 145.04 44.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.516 0.674 . . . . 0.0 112.344 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.98 -6.98 59.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -90.27 -5.2 56.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.833 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.554 ' HB3' HD13 ' A' ' 7' ' ' ILE . 2.2 tp10 -48.8 139.44 9.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -143.65 132.42 22.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.68 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.434 HD21 HG13 ' A' ' 7' ' ' ILE . 2.6 mm? -75.98 -11.51 59.97 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.029 0.442 . . . . 0.0 110.813 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -89.17 -9.79 49.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.422 0.63 . . . . 0.0 110.218 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -89.14 170.71 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.495 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.554 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 4.7 pt20 -104.13 -0.87 28.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.74 0.305 . . . . 0.0 111.016 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -131.88 115.65 16.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.43 0.633 . . . . 0.0 109.92 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.21 129.27 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.275 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -108.11 120.78 43.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.344 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.5 mt -111.53 115.77 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.74 116.49 30.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 110.871 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' HA2' HG13 ' A' ' 43' ' ' VAL . . . -110.77 159.99 13.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.929 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -154.76 131.19 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 2.4 m -65.56 113.01 3.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 41.4 t80 -90.22 128.3 36.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.3 mt -58.97 -37.75 69.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.228 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.465 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 9.3 m-20 -91.95 8.28 38.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.908 0.385 . . . . 0.0 111.372 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 34.2 mtt180 -121.4 97.2 47.4 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.776 0.322 . . . . 0.0 110.985 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.17 -8.35 20.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.614 2.209 . . . . 0.0 111.694 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -154.26 82.3 1.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.683 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.3 p90 -118.37 -164.2 1.01 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.171 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 27' ' ' GLU . 24.6 mp0 -48.96 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.297 0.373 . . . . 0.0 111.765 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.521 ' CE2' HG11 ' A' ' 43' ' ' VAL . 18.8 m-85 -103.21 68.48 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.694 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -92.6 -42.17 9.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.338 0.589 . . . . 0.0 110.355 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.7 t30 -114.24 33.31 5.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.42 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -59.2 -27.21 65.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -177.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -9.92 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.78 -4.74 58.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.124 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.539 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -72.18 -174.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 5.9 ptpp? -167.02 -179.0 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.979 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.6 ptpt -53.99 -48.76 70.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.139 -176.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.5 54.99 0.57 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.438 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -73.64 -11.59 60.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.327 -0.436 . . . . 0.0 111.203 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 54.36 83.84 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.433 0.635 . . . . 0.0 111.801 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.5 t -85.41 111.42 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.827 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -99.8 113.67 26.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.519 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 2.1 t80 -102.4 108.21 19.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.593 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.43 92.68 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.974 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 91' ' ' GLU . 4.8 m -104.71 117.56 50.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.44 -83.16 0.2 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.572 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -152.74 12.17 0.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.722 0.296 . . . . 0.0 110.823 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.422 ' CG ' HG23 ' A' ' 88' ' ' VAL . 12.6 pt-20 -109.43 140.11 43.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.059 0.456 . . . . 0.0 110.291 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.6 m -100.62 109.71 21.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 16.5 mmt85 -88.7 142.03 28.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.54 173.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -118.67 130.73 56.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.9 0.381 . . . . 0.0 110.542 177.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 81.3 m-85 -127.83 143.85 51.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -107.07 137.32 45.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.743 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.0 mmt -83.87 81.95 8.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 110.14 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -92.2 -36.7 13.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.63 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.61 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 6.9 m -109.26 97.04 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 97' ' ' MET . 75.9 mt -117.68 117.16 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.896 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -168.99 -159.81 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 112.068 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -109.89 153.32 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.818 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 139' ' ' ARG . 10.6 m -135.38 166.48 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 167.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 106' ' ' THR . 0.0 OUTLIER -147.62 161.21 36.38 Favored Pre-proline 0 C--O 1.22 -0.45 0 O-C-N 122.334 -0.229 . . . . 0.0 111.32 -169.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 34.8 Cg_endo -65.08 11.75 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.717 2.278 . . . . 0.0 113.05 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.456 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.7 t -129.8 8.79 5.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.599 ' OD2' ' HB ' ' A' ' 103' ' ' VAL . 1.1 p30 -84.2 158.23 21.37 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 111' ' ' LEU . 29.1 m -112.58 18.73 7.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.198 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 -45.36 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.924 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.81 -11.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.654 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -106.39 12.3 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.703 0.287 . . . . 0.0 111.27 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.6 169.27 9.82 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.534 ' CG ' ' HE3' ' A' ' 115' ' ' LYS . 11.2 pt-20 -92.41 20.25 6.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 52.13 119.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.617 1.167 . . . . 0.0 113.724 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HE3' ' CG ' ' A' ' 113' ' ' GLU . 18.9 mmtp -109.48 147.31 33.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.586 -171.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.92 34.27 11.13 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.896 -1.502 . . . . 0.0 115.23 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -122.59 161.89 22.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.837 0.818 . . . . 0.0 112.016 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -93.98 -158.14 0.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -62.09 110.04 1.47 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -116.67 138.81 51.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.26 0.552 . . . . 0.0 112.124 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 121' ' ' LEU . 22.4 mt -97.73 112.26 24.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 169.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.42 HG23 HG22 ' A' ' 143' ' ' VAL . 13.3 m -96.26 103.85 15.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.287 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.7 mt -91.11 106.03 18.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.79 100.01 9.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 6.9 m -91.0 107.09 18.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.138 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.8 m -103.89 86.12 2.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -111.18 -2.15 15.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.574 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 36.4 t70 -104.8 94.37 5.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.488 0.661 . . . . 0.0 109.899 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 92.0 t80 -101.01 124.05 46.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.188 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -91.37 110.28 21.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.438 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.7 mt-10 -72.39 -21.65 61.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.847 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -72.51 -24.57 61.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.456 HG23 HG12 ' A' ' 135' ' ' VAL . 9.6 t -136.62 4.01 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.304 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.53 48.79 79.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.17 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 133' ' ' THR . 4.4 p -137.77 159.22 34.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.543 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 37.6 m95 -100.64 112.74 25.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 55.8 mt-10 -80.88 -60.02 2.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.932 0.396 . . . . 0.0 111.04 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 47.4 mmtm -88.94 101.52 14.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.177 0.513 . . . . 0.0 110.262 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -100.63 105.52 16.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 18.7 tptm -76.63 120.62 22.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.6 tt -118.98 122.55 69.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 122.037 0.922 . . . . 0.0 111.66 -172.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 24.5 m-85 -116.95 106.75 13.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.135 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.0 t -100.76 103.98 15.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.234 0.54 . . . . 0.0 110.259 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.494 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.995 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.7 m -93.59 138.81 31.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -57.83 125.03 21.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.042 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.519 HG21 ' HD3' ' A' ' 96' ' ' LYS . 2.7 t -85.75 146.38 6.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.775 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.68 179.024 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.51 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 36.9 Cg_endo -63.09 106.64 0.56 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.15 2.567 . . . . 0.0 112.878 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -120.64 137.9 54.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.776 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 52' ' ' LEU . 4.1 mp -76.5 125.24 87.71 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.71 153.51 54.0 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.116 1.877 . . . . 0.0 110.369 170.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -86.39 14.11 7.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.476 0.655 . . . . 0.0 111.215 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 27.4 t0 -100.71 102.43 13.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.549 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 24.5 pttm -81.27 0.13 38.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.446 -172.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.2 m -90.32 3.91 52.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 87.5 mttt -103.83 -176.53 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.348 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.79 129.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.049 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.45 -29.93 17.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.78 36.57 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.56 143.32 34.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 117.128 0.464 . . . . 0.0 109.758 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.545 0.688 . . . . 0.0 110.265 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 38.4 mt-10 -115.78 116.54 28.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.922 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.591 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 46.0 mt -133.87 91.62 24.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.52 -34.51 92.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.951 2.434 . . . . 0.0 111.871 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.77 -25.62 68.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.292 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -114.83 11.37 16.68 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.011 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 58.41 29.67 18.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.773 0.797 . . . . 0.0 110.754 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.632 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 58.9 mt -98.37 118.49 44.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.232 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 5.5 mtmt -150.19 81.91 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.282 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.424 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 40.9 mt-10 -149.21 162.47 28.84 Favored Pre-proline 0 N--CA 1.465 0.316 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 60.3 Cg_endo -72.43 148.16 48.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.072 2.515 . . . . 0.0 113.493 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.47 130.59 62.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.016 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 44' ' ' SER . 33.5 m-85 -97.11 137.96 21.25 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 73.0 Cg_endo -90.15 -172.31 0.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.962 2.441 . . . . 0.0 112.533 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.06 -174.27 16.83 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.453 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.84 12.39 3.02 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.926 3.084 . . . . 0.0 113.081 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.55 74.67 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.193 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.705 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -95.83 147.44 33.0 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.087 -176.692 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.705 ' HD2' HG22 ' A' ' 35' ' ' THR . 81.6 Cg_exo -40.65 -66.83 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.751 2.967 . . . . 0.0 114.46 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -26.63 55.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.762 0.315 . . . . 0.0 111.663 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.549 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 24.8 tp60 -66.54 -37.89 85.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.118 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.6 tp -74.3 -38.7 63.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.772 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -67.93 -9.8 48.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.19 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.59 -28.48 62.82 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 110.415 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.29 -88.7 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.257 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.443 HG12 ' HA3' ' A' ' 61' ' ' GLY . 34.0 m -137.02 157.84 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 21.9 p -150.72 156.07 40.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.013 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 21.2 m-85 -70.18 155.13 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.784 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.09 73.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.302 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -152.24 177.7 10.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.434 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.59 -28.2 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 -172.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -76.87 -11.06 59.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.083 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 50' ' ' GLU . 5.1 tp10 -61.24 126.26 26.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.747 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 23.5 m -112.39 138.24 49.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.791 0.329 . . . . 0.0 111.441 -173.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.661 ' HG ' HD11 ' A' ' 7' ' ' ILE . 77.6 mt -67.96 -25.52 65.48 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.57 17.47 23.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.464 0.65 . . . . 0.0 110.355 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -88.96 -177.21 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.464 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -16.93 58.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.197 0.522 . . . . 0.0 110.08 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.94 142.61 29.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.18 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.3 mp -129.07 105.29 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.727 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.562 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 4.5 m -89.94 113.1 24.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.464 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 ' CE1' ' A' ' 45' ' ' PHE . 57.0 mt -107.13 111.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.991 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -96.52 121.93 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.443 ' HA3' HG12 ' A' ' 43' ' ' VAL . . . -121.11 161.22 15.22 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.359 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -123.18 130.32 52.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.608 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 12.0 m -71.15 136.95 48.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.138 -177.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.16 136.63 37.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.328 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.1 mt -90.99 -46.77 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.114 0.483 . . . . 0.0 110.21 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.455 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 17.7 t70 -75.18 -39.69 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.399 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -92.34 109.04 35.44 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.92 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 94.1 Cg_endo -83.93 -0.35 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.878 2.385 . . . . 0.0 111.476 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -129.96 71.73 1.46 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.977 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.608 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 10.4 p90 -119.38 -175.41 2.93 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 1.4 mp0 -48.82 -66.69 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -173.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CZ ' HD22 ' A' ' 123' ' ' LEU . 23.1 m-30 -103.1 31.59 4.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -170.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -49.97 74.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.268 0.556 . . . . 0.0 111.429 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 67.0 t30 -102.51 25.52 8.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.231 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.11 -19.01 64.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.209 0.528 . . . . 0.0 110.901 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -68.87 -20.47 64.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.515 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.52 9.24 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.108 0.48 . . . . 0.0 110.308 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . . . -89.3 122.71 32.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.066 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 6.3 mmmm -101.58 -164.41 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.283 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -68.5 -21.94 64.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.22 50.88 0.87 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.574 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -70.3 -7.62 43.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.8 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 87.1 mmm 44.66 88.38 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.665 0.745 . . . . 0.0 112.029 -170.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -85.58 124.55 40.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.2 m-85 -109.13 112.99 25.46 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.27 109.56 21.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 5.3 tptp -91.28 85.51 5.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.706 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.652 ' O ' ' HG2' ' A' ' 91' ' ' GLU . 11.1 m -111.54 131.04 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.877 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 90' ' ' ASN . . . 59.14 22.1 54.77 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.035 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 29.3 m-80 73.53 14.48 4.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.479 0.711 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 6.2 pt-20 -97.14 179.4 4.93 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -135.28 117.62 15.66 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 94.5 mtt180 -116.01 133.42 56.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -101.35 131.27 47.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.293 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 84.2 m-85 -130.76 146.67 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.869 -178.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.8 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.55 132.42 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 21.2 mmt -75.53 68.15 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 110.226 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -84.46 -9.58 58.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.431 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 67.4 m -136.84 93.97 2.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.36 0.6 . . . . 0.0 111.183 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.16 118.21 56.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.562 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.9 ptt180 -149.35 165.19 32.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.244 0.545 . . . . 0.0 111.683 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.02 109.12 15.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.933 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.658 HG21 HG11 ' A' ' 110' ' ' VAL . 19.4 m -108.24 168.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.49 0.662 . . . . 0.0 111.683 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HD3' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -138.52 170.38 10.42 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.934 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.77 -26.81 58.77 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.065 1.843 . . . . 0.0 110.175 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -72.64 -12.42 61.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.878 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -91.67 128.8 37.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HA ' HD11 ' A' ' 111' ' ' LEU . 17.5 m -113.28 26.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.805 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -109.2 -9.87 15.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.684 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.658 HG11 HG21 ' A' ' 103' ' ' VAL . 15.9 m -91.62 -8.74 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -112.58 9.94 19.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.666 0.746 . . . . 0.0 109.381 175.157 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -89.2 160.81 16.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.298 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -50.45 125.93 13.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.489 . . . . 0.0 111.635 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -75.65 129.31 36.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.6 mptt -69.69 157.77 36.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.932 -172.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.04 56.81 1.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.441 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -79.26 -174.35 4.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.023 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.09 -163.78 0.84 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.27 121.63 11.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.92 135.07 54.36 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.158 0.504 . . . . 0.0 110.801 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -92.73 113.98 26.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.536 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.7 m -94.41 92.23 7.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.901 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 27.5 mt -83.47 104.56 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 110.044 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 60' ' ' ALA . 24.3 mt -94.52 101.04 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.074 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -97.11 96.4 8.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.082 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.482 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 62.5 m -96.01 89.25 5.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.93 -14.11 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.17 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.516 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 21.1 t70 -110.6 94.77 5.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.561 0.696 . . . . 0.0 109.832 -176.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 134' ' ' GLY . 94.1 t80 -107.55 124.5 50.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.485 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -90.88 101.96 14.72 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.22 -5.38 17.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.429 -174.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -38.76 68.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.874 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 135' ' ' VAL . 6.9 t -149.81 -26.48 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 129' ' ' TYR . . . 120.83 36.8 0.75 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.824 -1.179 . . . . 0.0 112.858 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.532 HG23 HG23 ' A' ' 133' ' ' THR . 93.0 t -104.39 124.05 58.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CE3' ' HB3' ' A' ' 126' ' ' CYS . 33.3 m95 -84.86 93.31 8.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.516 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 16.2 mm-40 -60.22 -68.26 0.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.863 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -91.76 103.86 16.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 -177.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.46 ' O ' HG22 ' A' ' 103' ' ' VAL . 84.1 mtm180 -105.44 95.65 5.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.925 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.836 ' HD3' ' HE1' ' A' ' 142' ' ' PHE . 2.4 ttmp? -74.54 130.39 39.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.959 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.562 ' CG2' ' HG3' ' A' ' 101' ' ' ARG . 12.8 tt -123.44 120.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.932 0.872 . . . . 0.0 111.025 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.836 ' HE1' ' HD3' ' A' ' 140' ' ' LYS . 8.4 m-85 -106.33 104.07 13.69 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.522 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 61.9 t -98.72 109.61 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.485 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.545 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.7 103.34 12.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.524 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -83.85 142.62 30.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.684 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -55.73 133.1 50.65 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.251 -175.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 7.3 p -111.85 160.91 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.259 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 147' ' ' VAL . 21.9 mmmt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.776 -0.63 . . . . 0.0 110.008 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 56.5 mtpt . . . . . 0 C--O 1.236 0.353 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 32.5 Cg_endo -62.71 125.19 15.53 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.695 2.263 . . . . 0.0 112.145 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -147.24 162.2 39.4 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' CD1' ' HG ' ' A' ' 52' ' ' LEU . 3.4 mp -86.78 127.47 59.98 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 0.0 110.486 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.44 -178.76 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.75 2.3 . . . . 0.0 112.666 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.711 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.4 103.8 7.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.46 -174.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.575 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 36.1 mtmm -88.7 13.38 12.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.623 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.8 t -98.26 -11.79 22.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.744 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -105.03 178.18 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 -178.434 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.99 131.55 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.66 16.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.235 0.541 . . . . 0.0 110.443 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.91 38.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 90.9 m-85 -112.62 138.47 49.36 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.392 0.596 . . . . 0.0 110.858 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.5 tp -106.78 105.17 18.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 122.167 0.984 . . . . 0.0 109.814 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -111.96 113.5 25.84 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.965 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.3 mt -125.61 95.94 39.41 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.788 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.66 -28.78 77.05 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.796 2.331 . . . . 0.0 111.688 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.469 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 27.4 t0 -71.27 -22.24 61.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.039 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.76 5.29 17.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.936 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.8 t70 64.62 24.24 12.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.455 0.645 . . . . 0.0 110.535 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.5 mt -96.23 126.29 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.928 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.4 mppt? -138.77 43.77 2.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 15.9 mm-40 -98.58 154.09 37.66 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.0 Cg_exo -78.5 145.0 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.269 2.646 . . . . 0.0 112.083 175.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.68 115.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -97.29 116.69 65.99 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.881 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 30.1 Cg_endo -63.37 140.67 77.86 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.416 2.077 . . . . 0.0 111.744 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.38 -179.47 41.41 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.356 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.575 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 12.9 Cg_endo -91.82 29.02 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.774 2.983 . . . . 0.0 112.439 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 58.47 50.0 9.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.557 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 p -68.43 150.6 97.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.93 -55.05 4.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.211 2.607 . . . . 0.0 113.099 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.89 -27.06 67.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.377 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -65.97 -46.05 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.327 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -78.53 -4.32 48.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.391 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.58 -18.82 16.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.141 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -102.08 -26.07 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 110.813 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -171.18 35.4 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.08 148.07 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.08 0.44 . . . . 0.0 110.005 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -137.04 -171.95 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 110.693 -174.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 33.3 m-85 -94.94 169.72 9.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.13 84.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 110.436 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -141.82 170.43 15.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.561 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.57 -7.61 54.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.398 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.75 13.54 30.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.644 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 8.0 mm-40 -74.3 169.34 17.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.355 0.598 . . . . 0.0 111.578 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.3 m -138.37 139.9 39.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 96.2 mt -77.45 -13.44 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.632 -176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.77 14.89 23.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.715 0.769 . . . . 0.0 110.103 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HB3' HG12 ' A' ' 57' ' ' ILE . 11.3 t70 -69.29 171.68 8.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.962 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 120' ' ' GLN . 1.1 tm0? -95.62 -26.0 15.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.441 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.495 ' HA ' ' HG3' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -134.09 56.39 1.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.144 0.973 . . . . 0.0 111.106 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 54' ' ' ASP . 49.9 mt -62.1 127.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.105 -173.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -105.75 109.43 21.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.288 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.01 118.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.034 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.1 133.07 36.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.735 0.302 . . . . 0.0 111.002 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.12 163.91 26.96 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.162 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -139.56 158.77 43.57 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 73' ' ' THR . 21.5 p -102.78 158.58 16.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.899 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.626 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -134.57 135.39 42.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.262 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.12 -39.92 81.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.154 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.19 -4.31 52.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 51.1 mtt85 -132.72 90.58 32.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.247 0.546 . . . . 0.0 111.422 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.644 ' O ' ' HB ' ' A' ' 73' ' ' THR . 7.6 Cg_exo -73.64 -23.7 16.68 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.624 2.883 . . . . 0.0 113.244 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -124.64 27.1 6.99 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.626 ' CE2' ' HB2' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -92.18 -16.03 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.155 0.979 . . . . 0.0 109.075 177.486 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HB3' ' H ' ' A' ' 72' ' ' PHE . 2.2 mt-30 -164.21 -154.54 0.25 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.292 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CE2' HD13 ' A' ' 123' ' ' LEU . 19.6 m-85 -74.22 26.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 68' ' ' PRO . 21.7 m -60.26 -45.9 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.488 . . . . 0.0 111.028 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -96.43 12.62 30.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.181 0.515 . . . . 0.0 110.675 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.27 -12.6 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.224 0.535 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.28 -12.86 61.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.452 176.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -89.79 -4.6 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.676 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -75.21 149.64 38.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.234 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 2.6 mppt? -111.12 -169.37 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 174.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.5 ptmm? -76.43 -11.8 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.297 0.57 . . . . 0.0 111.289 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.19 62.18 0.64 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.906 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -81.06 -9.63 59.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 51.01 83.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.489 0.662 . . . . 0.0 111.82 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 80.8 t -85.57 128.8 38.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.939 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -113.57 107.51 15.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -97.54 115.12 27.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.855 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.8 mmtp -93.39 97.33 10.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.237 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.05 130.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.849 0.357 . . . . 0.0 110.547 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.83 30.24 74.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.994 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 68.35 4.49 4.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.313 0.645 . . . . 0.0 111.351 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -92.34 150.63 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.869 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.3 m -109.79 112.64 24.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.829 0.347 . . . . 0.0 110.332 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 146' ' ' GLU . 21.7 mmm180 -105.03 133.22 50.18 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 3.5 mptt -102.35 130.74 49.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 95.8 m-85 -123.35 144.01 49.73 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.793 0.33 . . . . 0.0 110.407 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.55 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -113.27 131.56 55.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.8 mmt -74.75 64.38 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.097 0.475 . . . . 0.0 110.663 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -80.22 -13.84 58.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.709 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.612 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.8 m -134.1 99.13 4.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.012 0.434 . . . . 0.0 110.258 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 97' ' ' MET . 70.0 mt -117.71 131.42 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.743 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.413 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 15.0 ptm180 -167.95 -175.29 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 171.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.93 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 8.6 p-10 -141.89 125.6 16.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' A' ' 139' ' ' ARG . 24.5 m -112.07 173.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.137 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.857 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -122.68 165.04 23.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.68 -16.08 46.17 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.498 2.132 . . . . 0.0 111.746 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 t -109.65 12.94 24.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.342 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.857 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 11.8 t70 -93.65 148.47 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 34.0 m -111.41 0.43 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -170.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.413 ' HG3' ' NH2' ' A' ' 101' ' ' ARG . 26.8 mm-40 -72.7 -12.79 61.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 110.689 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 103' ' ' VAL . 22.7 m -94.78 -8.93 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.163 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 4.2 pp -99.15 -9.57 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.758 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -82.67 161.5 22.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.89 128.15 34.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.351 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -85.83 133.97 33.95 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -69.53 160.63 31.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.199 0.523 . . . . 0.0 112.411 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.81 59.93 0.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.327 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.39 176.73 0.76 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.238 0.542 . . . . 0.0 111.016 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -78.76 -155.8 0.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -63.47 103.47 0.52 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.495 ' HG3' ' HA ' ' A' ' 56' ' ' ASN . 18.6 pt20 -101.4 116.6 33.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.33 0.586 . . . . 0.0 109.854 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 tp -84.41 100.91 11.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.2 m -88.95 100.37 13.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.5 mt -87.25 109.04 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.7 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.8 mt -97.84 104.7 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 22.1 m -95.27 97.37 9.81 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.036 0.446 . . . . 0.0 110.185 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 47.9 m -86.96 102.17 14.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.33 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.53 -170.24 3.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.172 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 31.1 t70 57.4 83.95 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.797 0.808 . . . . 0.0 110.637 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 80.8 t80 -94.65 124.52 38.74 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.081 -174.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -95.67 99.94 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.506 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.0 mt-10 -58.84 -39.92 82.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.819 -171.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -70.52 -14.06 62.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.635 HG23 HG22 ' A' ' 135' ' ' VAL . 2.1 t -130.98 -7.04 3.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.292 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.82 35.16 72.63 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.623 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 133' ' ' THR . 33.3 m -116.8 155.03 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 117.315 0.557 . . . . 0.0 111.147 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -96.6 100.28 11.86 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.24 -16.93 60.94 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 23.6 ttmm -124.91 86.62 2.58 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.081 0.943 . . . . 0.0 110.928 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.726 ' HG3' HG23 ' A' ' 103' ' ' VAL . 30.1 ptt180 -92.98 86.92 5.58 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.218 172.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.93 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 36.2 tttp -70.25 139.32 52.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.773 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.53 124.5 59.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.932 0.873 . . . . 0.0 111.144 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.585 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 27.4 m-85 -114.48 103.75 11.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.601 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 47.3 t -94.3 96.74 6.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.414 0.626 . . . . 0.0 109.804 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.548 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -93.05 105.91 17.94 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.06 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.7 m -81.35 140.44 34.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.096 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 93' ' ' ARG . 36.4 tt0 -61.27 132.31 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.406 0.622 . . . . 0.0 111.879 -175.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 2.2 t -104.61 170.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.687 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 147' ' ' VAL . 40.5 mtpt . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.829 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.601 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 77.8 Cg_exo -51.36 118.09 4.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.455 2.77 . . . . 0.0 113.258 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.14 168.01 25.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.339 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.557 HG23 ' HB3' ' A' ' 31' ' ' PRO . 3.9 mp -91.66 112.33 53.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.44 165.01 18.72 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.532 2.155 . . . . 0.0 111.818 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.647 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -95.97 1.29 52.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.359 0.599 . . . . 0.0 109.835 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.88 109.88 14.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.439 173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 22.7 mttm -84.66 62.31 7.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.051 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 -29.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.576 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 2.8 mmpt? -54.24 154.59 4.31 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.537 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.37 111.93 32.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 164.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -76.39 -38.23 56.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.62 165.84 32.63 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.511 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 64.5 m-85 -112.87 132.57 55.24 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -96.74 107.92 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.876 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -112.9 108.15 16.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.887 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG12 HG13 ' A' ' 84' ' ' VAL . 23.0 mt -125.4 95.4 41.06 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.233 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.39 -16.2 53.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.797 2.331 . . . . 0.0 112.319 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 38.9 t70 -83.63 -21.67 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.443 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.12 11.24 15.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.329 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.69 19.6 11.88 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.078 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 20' ' ' ILE . 74.2 mt -93.57 122.09 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.342 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -139.48 49.2 1.82 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.897 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 12.3 mm-40 -116.55 162.52 26.36 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.066 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 90.9 Cg_endo -83.34 164.19 14.8 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.903 2.402 . . . . 0.0 113.269 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.14 136.73 59.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.199 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.29 133.49 20.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.793 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 23.9 Cg_exo -67.76 134.17 31.72 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.186 2.591 . . . . 0.0 111.808 168.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.13 144.08 4.1 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.029 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 60.3 Cg_endo -73.96 54.44 3.12 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.297 2.665 . . . . 0.0 112.241 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 58.25 42.39 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.776 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -69.12 127.01 93.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.251 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 65.1 Cg_exo -52.53 -39.64 74.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.289 2.659 . . . . 0.0 113.299 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.43 -12.52 61.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -101.21 -29.51 12.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.79 -18.24 48.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.123 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -81.96 -15.41 53.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.025 0.44 . . . . 0.0 110.379 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -114.01 -25.02 8.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.875 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.46 -138.05 2.35 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.635 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 72' ' ' PHE . 52.4 t -121.18 138.83 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.815 0.341 . . . . 0.0 110.649 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 t -119.52 169.3 10.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.917 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.793 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 54.7 m-85 -71.84 173.01 8.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.779 0.323 . . . . 0.0 110.361 173.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.14 -61.07 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.517 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.48 115.74 18.63 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 68.32 0.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.742 1.276 . . . . 0.0 111.092 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -146.07 2.6 0.9 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.268 171.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -76.66 160.52 29.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.146 -175.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 41.5 m -141.86 159.45 42.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.506 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' A' ' 7' ' ' ILE . 96.5 mt -85.76 -17.11 36.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.406 0.622 . . . . 0.0 109.895 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -86.25 -1.98 57.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.213 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 21.4 t0 -89.57 157.91 17.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.54 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.72 -25.51 26.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.963 0.411 . . . . 0.0 110.292 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.94 115.0 26.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.486 0.66 . . . . 0.0 111.657 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.81 127.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 m -121.95 120.52 34.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.56 126.69 68.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.4 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -94.63 104.48 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.017 0.437 . . . . 0.0 110.68 -176.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' HG13 ' A' ' 43' ' ' VAL . . . -101.53 166.75 18.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.462 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -155.94 -179.6 8.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 p -117.8 166.98 11.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.303 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 5.1 m-85 -124.16 144.52 49.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.221 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.68 -32.06 28.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.193 0.52 . . . . 0.0 111.206 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -96.97 -6.03 36.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.75 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 10.5 mmt180 -112.8 95.43 33.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.24 -8.36 19.72 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.397 2.065 . . . . 0.0 111.58 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -153.41 83.66 1.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.092 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CE2' ' HB ' ' A' ' 73' ' ' THR . 4.7 p90 -142.7 -170.16 3.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.897 ' HG2' ' HB3' ' A' ' 27' ' ' GLU . 77.5 mt-30 -32.81 -69.78 0.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.251 1.02 . . . . 0.0 113.621 -175.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 43' ' ' VAL . 4.9 m-30 -124.13 111.87 16.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.453 ' HB ' ' CE2' ' A' ' 70' ' ' TYR . 14.9 t -164.59 -40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.379 0.609 . . . . 0.0 110.236 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -96.75 21.08 9.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.712 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.9 tp -65.98 -18.79 65.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -8.71 56.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.893 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.27 -10.64 51.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.94 0.4 . . . . 0.0 110.704 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.537 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -73.29 156.18 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.109 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 97' ' ' MET . 32.8 mttp -129.79 -179.79 5.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.434 -176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -61.71 -28.84 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.114 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.21 42.85 1.72 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.466 -0.873 . . . . 0.0 110.993 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.516 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.9 t -57.25 -22.04 38.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.313 0.645 . . . . 0.0 112.048 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.23 87.13 0.06 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.747 0.784 . . . . 0.0 111.49 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.2 t -90.1 136.58 23.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.035 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.8 107.27 14.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.101 0.477 . . . . 0.0 109.926 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -94.7 105.3 17.23 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppp? -84.03 106.65 15.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.604 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 10.6 m -125.4 112.43 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 0.0 111.481 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.08 -94.71 0.18 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.838 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -129.94 8.31 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 110.238 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.87 138.56 40.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.427 ' OG1' ' HE2' ' A' ' 87' ' ' LYS . 43.7 m -107.25 93.19 4.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.578 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 146' ' ' GLU . 12.8 mmt180 -83.07 118.28 23.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.015 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.644 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 3.4 mptt -91.82 132.58 36.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 96.1 m-85 -124.7 144.81 50.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.099 0.476 . . . . 0.0 110.961 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.1 OUTLIER -113.52 128.05 56.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.061 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.632 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.1 mmt -78.7 60.43 2.75 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -77.05 -23.71 52.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.441 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.579 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 71.1 m -121.02 102.05 8.08 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 110.874 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.82 121.86 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.524 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -142.71 -172.35 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.471 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.96 141.14 46.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 139' ' ' ARG . 20.8 m -124.14 167.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.045 0.45 . . . . 0.0 111.003 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.959 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.13 163.09 53.68 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.281 -171.626 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 137' ' ' GLU . 60.2 Cg_endo -72.33 20.94 0.29 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.434 2.089 . . . . 0.0 112.124 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.9 t -156.47 8.87 0.22 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.959 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 2.3 p30 -78.98 176.92 9.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.157 0.503 . . . . 0.0 111.206 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.521 ' HA ' HD11 ' A' ' 111' ' ' LEU . 23.1 m -123.69 24.31 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.235 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.22 5.11 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.82 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.7 m -108.56 -13.95 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.974 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -108.06 1.85 22.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -89.94 174.33 7.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.19 107.3 8.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -81.83 69.37 8.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.649 0.738 . . . . 0.0 110.564 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -115.04 -165.6 1.04 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.468 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.49 -26.26 24.77 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.275 -0.488 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -125.13 -173.2 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -153.85 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 17.1 mmtm -54.56 123.1 12.07 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HB2' HG13 ' A' ' 143' ' ' VAL . 3.9 pt20 -117.29 120.09 37.16 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 121' ' ' LEU . 28.1 mt -78.18 99.19 6.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.6 m -85.78 96.9 9.89 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.71 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 26.5 mt -94.92 101.37 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.943 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.36 93.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.0 m -93.9 111.27 22.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.144 0.497 . . . . 0.0 110.138 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 58.2 m -95.45 109.5 21.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -136.94 89.22 2.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.994 0.902 . . . . 0.0 110.594 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 9.1 p-10 -153.9 -51.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.194 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.5 83.52 0.1 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.023 0.827 . . . . 0.0 110.772 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 38.4 t-20 -77.84 94.13 4.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.25 -20.76 63.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.144 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 30.6 mmmt -63.3 -30.47 71.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.492 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 135' ' ' VAL . 4.9 t -129.68 -23.77 2.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 60.75 1.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.6 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 133' ' ' THR . 9.5 p -159.05 159.67 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -99.05 110.75 23.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 41.8 mt-10 -90.9 -59.83 2.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.709 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 53.2 mmtt -80.81 102.26 9.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.885 0.85 . . . . 0.0 110.987 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.549 ' HB2' HG23 ' A' ' 103' ' ' VAL . 74.1 mtt180 -114.11 102.07 9.82 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.598 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -83.2 122.29 28.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 5.0 tt -118.92 125.36 74.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.59 -172.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.632 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.2 m-85 -109.15 124.54 50.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.534 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.7 t -110.97 109.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.085 0.469 . . . . 0.0 110.318 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.62 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -107.65 120.03 41.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.351 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.6 m -89.86 143.1 27.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.122 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.496 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 31.9 tt0 -61.59 128.59 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.321 0.582 . . . . 0.0 111.239 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 148' ' ' LYS . 2.3 t -110.92 170.14 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.422 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.48 ' H ' HG12 ' A' ' 147' ' ' VAL . 37.1 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.263 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.1 mtmt . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.878 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 19.0 Cg_endo -58.38 124.12 15.13 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.975 2.45 . . . . 0.0 111.234 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -151.98 175.31 12.64 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.623 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.527 HG23 ' CB ' ' A' ' 31' ' ' PRO . 53.4 mt -113.12 95.23 33.98 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.212 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 23.9 Cg_exo -65.14 164.37 25.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.289 2.659 . . . . 0.0 113.565 -174.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -65.3 -34.1 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.779 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.09 129.44 34.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.368 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -96.88 6.1 49.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.088 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.4 m -101.12 8.45 42.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 65.8 mttm -107.84 175.9 5.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.83 120.49 59.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.614 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.92 -29.37 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.548 . . . . 0.0 110.913 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.99 168.95 42.1 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.238 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 80.0 m-85 -118.05 131.16 56.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -100.63 115.41 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.662 0.744 . . . . 0.0 110.003 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 47.7 mt-10 -123.63 112.39 17.36 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.83 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 25' ' ' ILE . 46.3 mt -126.27 94.78 40.26 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.903 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.75 -33.28 96.59 Favored 'Trans proline' 0 CA--C 1.518 -0.314 0 C-N-CA 122.77 2.313 . . . . 0.0 111.505 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.28 -34.45 70.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.37 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -112.35 10.35 19.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.49 30.58 15.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.858 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 20' ' ' ILE . 63.1 mt -86.86 133.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -156.14 57.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.14 0.495 . . . . 0.0 109.745 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -117.81 153.81 50.95 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.656 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -80.16 138.67 12.89 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.818 2.345 . . . . 0.0 112.635 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.93 131.38 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 110.316 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.3 m-85 -101.41 129.22 27.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.795 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 58.8 Cg_endo -71.5 149.81 56.55 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.887 2.391 . . . . 0.0 112.161 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.18 177.89 25.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.047 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 84.4 Cg_endo -84.63 29.95 0.53 Allowed 'Trans proline' 0 CA--C 1.52 -0.199 0 C-N-CA 123.813 3.009 . . . . 0.0 112.671 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . 60.8 56.34 2.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.042 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.52 HG23 ' HG2' ' A' ' 33' ' ' PRO . 1.4 p -76.55 138.22 67.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.67 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -38.47 -66.34 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.49 3.46 . . . . 0.0 114.655 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.59 -35.49 81.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -68.83 -34.4 75.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.731 -174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 pp -87.4 -0.43 56.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.44 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -98.67 -31.57 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.114 175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -70.51 -29.99 66.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.4 -97.48 0.16 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.031 ' HB ' ' HG3' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -170.28 153.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.703 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 8.4 t -133.37 176.19 8.74 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.362 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 73.5 m-85 -89.16 173.62 8.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.96 85.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.767 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.5 mt-10 -134.21 167.41 20.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.153 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 1.4 tm-20 -72.97 -40.08 65.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.141 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -80.49 11.11 3.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.117 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -62.34 146.58 50.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.932 176.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.3 m -141.81 133.27 26.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 111.775 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.25 -2.87 36.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.748 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.03 -13.47 53.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.686 0.755 . . . . 0.0 109.487 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.26 -168.82 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.59 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -121.69 0.94 9.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.602 0.239 . . . . 0.0 110.452 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -113.16 49.69 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.03 118.27 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.305 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' HD11 ' A' ' 124' ' ' ILE . 15.5 m -120.36 124.87 46.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.559 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.2 mt -108.92 136.26 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.38 113.37 26.92 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.942 0.151 . . . . 0.0 110.8 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -105.76 148.21 16.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.678 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -117.16 107.57 14.63 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.173 0.189 . . . . 0.0 110.622 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -65.18 126.63 28.73 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 8.3 t80 -130.97 152.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.65 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.3 mt -90.6 -43.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 4.4 m-20 -76.39 -1.58 27.63 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -122.92 115.58 29.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.67 0.271 . . . . 0.0 110.561 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -90.34 0.57 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.746 2.297 . . . . 0.0 112.032 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -141.74 79.21 1.67 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.564 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.55 -166.62 2.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.364 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 1.031 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 68.8 mm-40 -47.29 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -101.27 28.47 5.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -40.13 85.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.354 0.597 . . . . 0.0 111.053 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.55 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 67.0 t30 -111.07 22.99 14.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.25 -5.53 23.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.135 0.493 . . . . 0.0 110.998 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.55 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -75.37 -8.23 56.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 110.683 176.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.77 6.57 45.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.347 0.594 . . . . 0.0 110.48 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.95 152.53 21.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.503 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 -171.5 3.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -51.96 -22.05 3.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.96 44.83 1.12 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 119.578 -1.296 . . . . 0.0 113.337 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -67.88 142.2 56.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.647 ' HE1' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -91.19 89.85 7.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.101 176.3 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 57.2 t -85.95 107.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.493 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -100.52 118.85 37.56 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -110.51 104.16 12.86 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 1.4 mptm? -81.18 123.1 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.751 -177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.878 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 6.6 m -136.95 116.53 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.167 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.05 -95.58 0.2 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.454 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -120.85 -3.41 9.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.537 0.208 . . . . 0.0 110.897 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.42 178.95 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.957 -173.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -142.4 141.55 32.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 146' ' ' GLU . 18.3 mmm180 -108.53 132.65 53.62 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.647 ' HD3' ' HE1' ' A' ' 83' ' ' MET . 12.1 ptpt -99.3 135.62 40.44 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 86.4 m-85 -122.03 144.36 48.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.703 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.2 tptm -110.04 126.07 53.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.049 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.486 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 59.6 mtt -82.07 80.73 8.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.428 0.633 . . . . 0.0 110.588 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 98' ' ' THR . 2.0 t -89.25 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.153 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.0 t -144.83 129.17 17.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -141.19 125.47 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.181 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -170.74 -176.62 2.1 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.048 0.218 . . . . 0.0 110.832 172.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.731 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 2.9 p30 -130.24 138.88 50.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.417 . . . . 0.0 110.435 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.8 -179.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.93 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -93.19 154.19 41.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HD3' ' A' ' 139' ' ' ARG . 61.0 Cg_endo -72.09 -18.42 27.36 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.317 2.011 . . . . 0.0 111.736 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.7 t -106.63 15.74 25.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.85 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.415 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 6.0 t0 -72.58 162.05 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.517 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 -7.25 10.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.71 -29.53 64.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.629 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.22 -9.31 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.915 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 94.1 mt -90.98 10.29 27.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.2 -176.11 3.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.94 132.16 50.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.35 0.595 . . . . 0.0 111.298 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -82.78 120.97 26.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.616 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -84.19 -152.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.693 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.34 55.62 1.16 Allowed Glycine 0 C--N 1.336 0.583 0 O-C-N 123.267 0.354 . . . . 0.0 113.593 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -83.59 147.43 27.74 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -87.36 -157.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -67.06 103.67 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.842 0.353 . . . . 0.0 110.418 -178.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 12.5 pt20 -104.56 136.37 44.24 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.394 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.75 105.8 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.5 m -85.33 100.86 12.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.729 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.6 mt -83.64 99.39 10.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 58' ' ' SER . 18.9 mt -91.54 97.22 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 17.4 m -106.9 121.94 45.42 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.804 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 94.2 m -73.54 96.16 2.38 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.201 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 6.4 t70 -110.53 98.36 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.887 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -178.59 -82.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.51 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.63 ' CE1' ' HG2' ' A' ' 131' ' ' GLU . 1.2 t80 58.58 77.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.016 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -83.25 86.28 7.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.269 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.63 ' HG2' ' CE1' ' A' ' 129' ' ' TYR . 27.8 mt-10 -58.79 -22.95 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.764 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -64.83 -27.53 68.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.485 HG23 HG12 ' A' ' 135' ' ' VAL . 4.8 t -121.66 -17.5 7.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.84 0.352 . . . . 0.0 110.445 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 48.64 5.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.239 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.485 HG12 HG23 ' A' ' 133' ' ' THR . 4.0 p -146.14 158.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 46.5 m95 -105.34 98.69 8.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.65 -58.51 3.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -85.3 137.12 33.18 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.459 0.647 . . . . 0.0 112.316 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HD3' ' HD3' ' A' ' 105' ' ' PRO . 6.5 mpt_? -100.12 111.03 23.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.76 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -79.03 117.86 20.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.0 tt -120.48 123.48 70.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.913 0.863 . . . . 0.0 111.052 -174.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 11.5 m-85 -108.14 114.65 28.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.048 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 40.2 t -93.95 99.62 9.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.302 0.572 . . . . 0.0 110.02 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -103.83 109.34 21.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.291 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 5.7 m -93.53 143.56 26.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.468 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 93' ' ' ARG . 34.0 tt0 -54.01 124.02 14.3 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.685 0.615 . . . . 0.0 111.303 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.525 HG11 ' HD3' ' A' ' 96' ' ' LYS . 6.5 p -111.05 151.6 13.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.585 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 4.5 ptmm? . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.464 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 53' ' ' ASP . 16.6 mttt . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.192 0.52 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 88' ' ' VAL . 11.1 Cg_exo -70.25 164.44 35.02 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.7 2.267 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -140.3 130.15 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.009 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.702 HG13 HD21 ' A' ' 52' ' ' LEU . 12.0 mt -63.6 121.98 73.64 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.124 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.33 -179.07 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.965 2.443 . . . . 0.0 112.575 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -81.16 -12.62 59.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.3 0.572 . . . . 0.0 110.554 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.03 113.16 21.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.139 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -91.53 1.46 57.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.223 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 t -98.97 -6.04 29.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.879 0.371 . . . . 0.0 111.377 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -106.3 172.92 6.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.066 0.46 . . . . 0.0 110.884 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.34 125.38 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.609 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.35 -44.98 13.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.381 0.61 . . . . 0.0 109.696 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.88 168.34 36.22 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 68.2 m-85 -107.77 140.84 40.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.138 0.469 . . . . 0.0 110.439 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -105.33 112.71 39.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.855 0.836 . . . . 0.0 109.446 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HB3' ' HD2' ' A' ' 26' ' ' LYS . 33.5 mt-10 -122.29 112.58 18.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.528 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 25' ' ' ILE . 38.7 mt -127.28 93.95 39.85 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.791 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.51 -28.47 86.72 Favored 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 123.117 2.545 . . . . 0.0 111.808 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 26.9 t70 -67.22 -28.03 67.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.174 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -114.66 12.41 17.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.148 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.5 t70 61.78 26.91 16.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.492 0.663 . . . . 0.0 111.128 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 20' ' ' ILE . 80.5 mt -95.99 129.67 45.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.206 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.596 ' HD2' ' HB3' ' A' ' 19' ' ' GLU . 9.2 mmmm -155.26 42.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.468 0.307 . . . . 0.0 111.498 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -124.46 157.47 64.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 36.4 Cg_endo -66.47 149.17 84.62 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.426 2.75 . . . . 0.0 113.52 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.81 138.1 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.214 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -100.33 135.57 20.23 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 121.0 0.428 . . . . 0.0 110.83 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.0 Cg_endo -79.89 128.93 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.729 2.286 . . . . 0.0 111.348 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.673 ' HA3' ' HG2' ' A' ' 38' ' ' GLN . . . -175.82 149.42 9.99 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.676 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.483 ' HG2' HG23 ' A' ' 35' ' ' THR . 68.8 Cg_endo -74.46 38.02 0.48 Allowed 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.966 3.111 . . . . 0.0 113.476 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 54.91 36.23 26.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.074 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 33' ' ' PRO . 6.1 p -76.46 154.16 83.85 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.784 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 77.3 Cg_exo -50.92 -46.71 29.14 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.607 2.871 . . . . 0.0 114.091 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -75.9 -17.83 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 111.349 -177.66 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.673 ' HG2' ' HA3' ' A' ' 32' ' ' GLY . 42.4 tp60 -81.41 -46.82 14.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.913 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 96.7 mt -77.89 -1.52 32.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.441 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 65.6 t30 -84.55 -44.19 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.747 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 7.0 ptm180 -75.52 -30.32 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.574 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -179.51 -162.9 29.42 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -85.39 155.73 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 117.491 0.646 . . . . 0.0 110.114 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.562 ' OG ' ' HG3' ' A' ' 38' ' ' GLN . 59.9 m -150.58 179.72 7.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.146 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -73.27 157.85 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.17 76.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.632 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.19 175.99 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.513 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.6 1.9 27.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.88 -17.32 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.49 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 58' ' ' SER . 1.3 mp0 -61.13 154.26 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.733 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m -141.56 157.95 44.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.88 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.5 mm? -77.08 -23.21 51.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.606 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 15.2 t70 -135.34 70.08 1.44 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.639 1.209 . . . . 0.0 109.108 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.895 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.3 t70 -124.78 162.4 24.37 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.709 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.89 -35.93 82.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.36 131.74 54.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.41 0.624 . . . . 0.0 111.21 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 121' ' ' LEU . 47.1 mt -129.2 123.06 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.417 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 1.1 m -113.17 109.2 18.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -107.99 124.35 64.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.09 120.02 33.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.003 0.43 . . . . 0.0 111.08 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.62 118.28 5.54 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.817 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -68.42 -38.62 81.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m 73.01 126.92 0.04 OUTLIER 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.552 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -137.43 142.51 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.22 -39.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.875 173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.63 -46.74 63.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.292 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -107.9 107.12 59.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.711 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.558 ' HA ' HG21 ' A' ' 73' ' ' THR . 96.4 Cg_endo -80.25 -18.89 9.58 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.551 2.168 . . . . 0.0 111.682 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -124.61 70.79 1.13 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.464 0.649 . . . . 0.0 110.896 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.444 ' HE1' ' HG1' ' A' ' 73' ' ' THR . 3.7 p90 -138.48 -177.5 4.88 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 166.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -41.06 -68.41 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -168.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -114.28 96.22 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.24 -174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 68' ' ' PRO . 1.3 m -156.49 -45.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.641 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -97.91 23.36 8.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.542 0.687 . . . . 0.0 110.247 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -11.5 59.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -71.11 -11.16 60.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.344 . . . . 0.0 111.545 -178.748 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -89.65 6.86 39.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -94.05 135.05 35.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.796 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 7.4 mptt -108.51 -170.87 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.617 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 97' ' ' MET . 6.2 ptpp? -65.87 -33.9 76.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.43 54.01 0.57 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.469 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 p -75.02 -15.97 60.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.425 ' HG2' ' HE3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 54.31 85.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.556 0.693 . . . . 0.0 111.639 -174.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 48.4 t -86.11 113.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.062 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 89.4 m-85 -98.73 110.43 23.03 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 34.9 t80 -99.21 102.59 14.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 35.7 mmtp -92.02 81.27 5.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.387 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.88 HG21 ' HG ' ' A' ' 52' ' ' LEU . 5.4 p -93.54 121.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.178 0.513 . . . . 0.0 110.489 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.12 -104.1 0.63 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.731 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -124.64 9.25 8.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.312 . . . . 0.0 110.718 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -100.11 148.58 24.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 110.57 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 93.1 m -117.7 104.34 10.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.188 0.518 . . . . 0.0 111.023 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 58.2 mmt-85 -92.11 135.36 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.986 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -115.02 130.1 56.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.036 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -130.23 146.88 51.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.72 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -112.95 135.99 53.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.702 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 20.8 mmt -79.35 65.44 4.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.528 0.68 . . . . 0.0 110.359 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 t -80.44 -13.75 58.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.551 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.4 m -135.18 90.88 2.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.546 0.689 . . . . 0.0 111.1 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 97' ' ' MET . 73.1 mt -109.07 129.7 63.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.429 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -164.62 -169.64 1.8 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.83 0.347 . . . . 0.0 110.255 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.819 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 3.3 p-10 -145.68 137.37 25.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.56 HG23 ' HD2' ' A' ' 139' ' ' ARG . 21.5 m -120.29 174.13 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.323 -173.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.526 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.2 mppt? -91.6 158.05 41.03 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.827 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.737 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 19.9 Cg_endo -61.7 -24.2 77.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.358 2.039 . . . . 0.0 111.293 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -114.71 29.93 7.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.789 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 17.9 t70 -63.29 139.71 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.257 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.1 m -110.87 2.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.738 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -85.92 -36.24 20.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.197 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.1 -10.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.906 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 pp -111.13 -0.13 16.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 111.192 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.84 -159.15 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 9.5 pt-20 -60.98 112.91 2.26 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.458 0.646 . . . . 0.0 111.672 -177.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -85.6 134.18 34.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.518 174.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 12.1 mptt -74.16 174.98 7.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.278 -170.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.81 55.05 1.34 Allowed Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.884 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -69.41 173.54 5.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.329 0.585 . . . . 0.0 110.972 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.411 ' OD1' ' HD3' ' A' ' 119' ' ' LYS . 5.1 t70 -104.54 -149.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -58.69 114.85 2.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.83 119.84 38.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.259 0.552 . . . . 0.0 111.957 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 57' ' ' ILE . 14.0 mt -82.38 104.97 13.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -92.63 92.21 7.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.565 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 16.7 mt -87.78 101.12 13.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 mt -90.92 97.8 7.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.29 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -103.09 101.97 11.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.328 0.585 . . . . 0.0 110.362 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 86.3 m -92.56 101.87 14.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.689 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -120.36 68.44 0.85 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.495 0.664 . . . . 0.0 110.052 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 34.6 t70 -176.26 95.23 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.681 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -102.56 115.94 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -86.69 103.05 14.78 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.89 -27.07 68.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.017 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -77.53 -18.57 56.86 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.518 -173.404 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 135' ' ' VAL . 21.9 p -120.82 -32.3 4.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.62 16.24 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.505 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.535 HG12 ' OG1' ' A' ' 133' ' ' THR . 9.8 p -132.64 154.46 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.578 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.499 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 55.4 m95 -97.71 109.21 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.737 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 44.2 mt-10 -87.93 -63.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -172.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 48.1 tptt -75.57 80.7 2.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.134 0.969 . . . . 0.0 110.348 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HD2' HG23 ' A' ' 103' ' ' VAL . 1.5 ptp180 -93.57 108.63 20.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.355 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.819 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 45.6 tptt -80.66 132.77 35.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.334 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -122.71 122.72 66.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.923 0.868 . . . . 0.0 111.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.459 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 13.2 m-85 -110.69 105.32 14.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.687 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 26.2 t -99.35 104.23 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.349 0.595 . . . . 0.0 110.371 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.536 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -100.38 117.76 35.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.368 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.1 m -95.78 144.51 26.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 29.8 tt0 -56.67 135.91 54.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 111.725 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.626 HG21 ' HD3' ' A' ' 96' ' ' LYS . 1.1 t -106.94 172.26 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.55 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 147' ' ' VAL . 30.4 mmmt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.607 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 7.8 mtmp? . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 18.3 Cg_endo -58.58 134.56 61.71 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.547 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 8.8 pt20 -158.05 176.2 12.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.863 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 31' ' ' PRO . 5.4 mp -96.99 108.88 46.3 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.034 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.4 Cg_exo -68.11 165.03 29.79 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.811 2.341 . . . . 0.0 110.88 170.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -97.02 18.73 14.12 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.909 -171.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 18.3 t70 -86.84 150.07 24.38 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' GLN . 34.8 mmtp -80.4 -39.72 27.82 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 m -93.49 -22.34 18.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -59.72 150.02 29.07 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.599 0.714 . . . . 0.0 112.443 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -105.9 139.2 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.634 172.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.86 -32.53 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.448 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.16 161.87 26.82 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.485 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 35.7 m-85 -122.88 143.43 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -104.44 118.41 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.252 0.549 . . . . 0.0 109.79 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 26.0 mt-10 -125.81 111.62 15.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 62.1 mt -132.24 109.09 13.75 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 -47.18 15.3 Favored 'Trans proline' 0 N--CA 1.473 0.273 0 C-N-CA 123.157 2.571 . . . . 0.0 113.365 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -62.54 -30.19 71.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -98.18 2.4 48.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.224 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t70 61.55 27.76 17.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.969 0.89 . . . . 0.0 109.887 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 61.0 mt -97.24 129.29 47.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.235 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 32.5 ttpt -159.86 79.11 0.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 168.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.403 ' HB3' HE21 ' A' ' 71' ' ' GLN . 62.2 mm-40 -133.5 157.14 78.75 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.826 -173.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.2 146.88 71.35 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.848 2.365 . . . . 0.0 113.03 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.531 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 76.2 t -106.12 125.44 61.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.712 176.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 61.1 m-85 -93.54 103.44 9.86 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.627 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 3.0 Cg_endo -86.86 155.0 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.355 2.703 . . . . 0.0 112.298 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.77 -151.75 21.04 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.952 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.582 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 78.7 Cg_endo -76.3 19.21 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.249 2.633 . . . . 0.0 113.092 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 56.87 46.24 20.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.324 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.72 119.7 23.2 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.092 -174.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.32 -38.64 42.81 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.238 2.625 . . . . 0.0 113.066 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.95 -38.4 82.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.311 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 75.9 mm-40 -90.65 -30.73 16.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.089 0.471 . . . . 0.0 110.4 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.43 -27.99 63.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.975 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -68.28 -24.8 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 41' ' ' ARG . 15.9 mtp-105 -80.96 -52.71 7.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.738 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.72 -117.23 1.49 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.06 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.56 142.42 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -128.59 -179.59 5.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.385 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 31' ' ' PRO . 11.9 m-85 -74.61 178.09 5.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.7 -46.79 20.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.68 167.14 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.699 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -80.82 -10.31 59.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.522 0.677 . . . . 0.0 109.951 175.308 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.83 -23.0 58.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.854 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 9.5 pt-20 -84.03 177.86 8.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 112.161 -172.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.509 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 70.8 m -137.38 175.13 9.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -172.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.14 -15.95 34.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.432 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -134.9 70.34 1.44 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.283 1.04 . . . . 0.0 109.589 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 14.7 t70 -126.37 160.88 29.18 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.747 171.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -63.84 -31.54 72.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.64 125.86 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.588 0.708 . . . . 0.0 111.012 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.33 139.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -131.15 116.23 17.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.195 0.521 . . . . 0.0 111.659 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.4 mt -101.09 116.41 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.64 105.07 17.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 111.309 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.64 144.49 15.95 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.301 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -122.81 133.81 54.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.552 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -81.86 113.27 19.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -113.67 109.3 18.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.505 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.7 mm -54.96 -33.98 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.741 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.87 -40.46 76.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 61.1 mtt180 -106.98 108.91 62.74 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.914 0.388 . . . . 0.0 111.068 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 3.3 Cg_exo -77.77 -10.77 16.95 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.196 2.597 . . . . 0.0 112.737 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.68 80.53 1.7 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.425 0.631 . . . . 0.0 111.716 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.552 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -132.62 -161.82 1.17 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.751 168.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 27' ' ' GLU . 25.6 mp0 -49.63 -72.37 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -105.57 31.77 4.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -169.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 m -73.74 -34.86 64.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.04 0.448 . . . . 0.0 111.223 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -116.72 28.0 8.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.277 0.56 . . . . 0.0 110.484 -173.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.22 -21.45 65.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -74.03 -2.05 22.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.302 . . . . 0.0 111.622 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.42 8.2 37.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.62 153.92 20.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -125.82 176.41 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.295 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -61.2 -19.67 61.88 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.89 51.62 0.85 Allowed Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.174 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 m -79.28 -4.47 50.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 53.93 82.93 0.08 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.447 0.641 . . . . 0.0 111.244 -175.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.9 t -85.0 113.94 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.967 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.577 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 84.3 m-85 -94.26 117.64 30.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.884 0.373 . . . . 0.0 110.052 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.408 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 10.6 t80 -100.44 101.11 11.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 32.4 tptt -83.89 99.14 10.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.864 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.871 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.1 m -116.7 86.96 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.87 -107.04 1.69 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.231 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.14 -11.36 30.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 0.0 110.829 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.871 ' HB2' HG23 ' A' ' 88' ' ' VAL . 38.8 mt-10 -95.11 109.2 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.755 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.0 m -100.57 85.68 2.99 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 93' ' ' ARG . 11.3 ptp180 -93.39 133.73 36.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.525 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -102.86 139.38 38.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.771 -175.346 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.6 m-85 -120.91 148.99 43.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 1.2 tptm -110.49 131.96 54.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.9 mmt -76.68 70.58 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -77.05 -20.62 55.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.669 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 52.5 m -133.53 101.37 5.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 97' ' ' MET . 74.9 mt -116.49 116.54 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.688 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -161.66 -174.39 4.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.53 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.799 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 1.2 p-10 -144.09 134.92 25.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.19 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.7 m -133.77 -175.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.458 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -92.16 160.29 35.7 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.635 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.35 -20.71 31.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 111.445 175.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -98.83 10.54 41.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.882 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.21 115.86 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.802 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.95 2.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 0.0 110.996 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.12 -34.88 18.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.379 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.5 m -77.26 -26.25 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -91.83 20.29 5.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.9 169.37 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.516 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 5.6 pt-20 -66.61 84.8 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.328 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -87.45 37.78 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.652 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -82.52 172.12 13.35 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.639 176.107 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.91 -7.64 59.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.808 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -91.08 -168.25 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.133 0.492 . . . . 0.0 110.557 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -104.6 -157.78 0.63 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.9 OUTLIER -65.54 107.37 1.68 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -104.97 124.38 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.237 0.541 . . . . 0.0 110.282 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -92.95 98.26 11.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.1 m -84.41 99.11 10.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.258 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 20.0 mt -85.25 106.08 16.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.1 mt -93.52 127.24 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.578 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 30.5 m -136.67 105.21 5.78 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.256 0.551 . . . . 0.0 110.501 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.4 m -99.52 107.39 19.56 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -118.08 -1.46 11.41 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -172.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 137' ' ' GLU . 37.1 t70 -105.71 89.64 3.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.524 0.678 . . . . 0.0 109.919 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' A' ' 131' ' ' GLU . 92.3 t80 -82.58 124.91 30.59 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.172 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.514 ' OD1' HG22 ' A' ' 133' ' ' THR . 23.1 t-20 -89.29 103.62 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.595 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 40.2 mt-10 -64.09 -23.24 67.25 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -171.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 1.011 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 5.9 mmpt? -78.49 -23.43 46.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.514 HG22 ' OD1' ' A' ' 130' ' ' ASN . 7.7 t -130.06 -30.0 2.03 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.596 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.88 35.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.281 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.511 ' H ' HG23 ' A' ' 133' ' ' THR . 12.8 m -82.8 172.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 41.9 m95 -117.37 112.11 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.465 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 41.9 mt-10 -77.83 -21.38 51.59 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.799 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -114.98 118.35 33.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.296 0.57 . . . . 0.0 111.036 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -107.13 98.67 8.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.483 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 47.7 tptt -69.1 128.52 36.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.91 118.49 50.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.989 0.899 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 15.8 m-85 -109.08 101.59 10.64 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.305 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 38.3 t -95.42 97.09 6.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.403 0.62 . . . . 0.0 110.121 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.557 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -95.91 112.23 24.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.9 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.8 m -90.45 139.34 30.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.88 123.75 15.33 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.564 0.54 . . . . 0.0 110.798 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.553 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 4.0 t -76.8 147.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.644 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt . . . . . 0 C--O 1.248 1.024 0 O-C-N 124.324 1.015 . . . . 0.0 111.236 178.73 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 68.8 mmtt . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.84 118.33 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.874 2.383 . . . . 0.0 112.126 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -118.96 147.37 44.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.668 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.405 HG23 ' HB3' ' A' ' 31' ' ' PRO . 22.4 mt -84.57 121.82 74.91 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.453 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.79 -175.66 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.513 2.142 . . . . 0.0 112.206 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.667 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.73 6.35 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.167 178.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -95.92 103.95 15.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.052 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' CD ' ' HD3' ' A' ' 33' ' ' PRO . 35.3 mtmm -85.63 12.81 7.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.139 -176.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -106.72 -5.86 18.24 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.203 0.525 . . . . 0.0 109.678 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 99.3 mttt -91.37 -177.14 4.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -112.77 138.21 42.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.37 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.72 -29.4 12.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.244 0.545 . . . . 0.0 110.798 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.71 163.51 36.73 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 63.9 m-85 -109.44 135.79 49.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.483 0.642 . . . . 0.0 109.91 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.1 tp -97.86 108.53 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.772 0.796 . . . . 0.0 109.612 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -114.18 103.7 11.37 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.907 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mt -121.25 92.88 48.76 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.539 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.91 -21.18 68.9 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.052 2.502 . . . . 0.0 111.311 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.99 -30.14 63.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.888 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.52 10.9 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 63.14 29.25 16.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.769 0.795 . . . . 0.0 110.758 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.53 HG23 ' HG2' ' A' ' 27' ' ' GLU . 78.2 mt -102.22 118.74 49.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.5 mppt? -135.82 41.51 2.69 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.727 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 13.1 mm-40 -102.55 154.19 37.64 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.429 -163.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.79 143.45 13.25 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.473 2.116 . . . . 0.0 112.151 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.88 127.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 44' ' ' SER . 57.6 m-85 -100.76 133.71 20.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.493 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -69.26 145.34 59.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.498 2.132 . . . . 0.0 111.841 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . 164.8 162.07 15.08 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.31 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.743 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 Cg_endo -88.01 39.86 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.997 3.132 . . . . 0.0 111.545 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.71 35.98 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.47 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.403 ' OG1' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -76.0 152.48 84.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.824 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.53 -57.19 2.49 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.971 3.114 . . . . 0.0 113.818 -175.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.4 mm-40 -59.61 -34.76 73.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.8 mp0 -64.99 -44.21 90.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.287 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.3 -30.92 65.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.44 0.638 . . . . 0.0 110.109 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.08 -39.87 95.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.673 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 28.2 mtp-105 -75.67 -51.61 12.38 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.619 175.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' C ' ' HG3' ' A' ' 71' ' ' GLN . . . -156.47 -104.91 0.22 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.957 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.92 149.99 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 41.3 t -124.21 157.27 35.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.682 0.277 . . . . 0.0 110.901 -174.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -70.5 178.25 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 58' ' ' SER . . . -66.2 -46.58 76.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.743 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 12.8 pt-20 -149.15 -176.47 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.545 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -94.86 -27.37 15.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.151 -171.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -82.8 -9.86 59.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.038 0.447 . . . . 0.0 110.922 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.11 143.04 49.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.042 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 m -121.16 145.13 48.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.752 -171.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -81.84 -10.23 59.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.818 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -100.78 4.02 42.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 110.558 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -95.93 178.41 5.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.519 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.55 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 4.7 pp0? -97.26 -8.8 28.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.708 0.29 . . . . 0.0 111.301 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -119.58 107.1 12.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.745 0.783 . . . . 0.0 110.754 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.8 mt -127.58 136.11 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.872 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 36.6 t -132.02 132.71 43.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.382 0.611 . . . . 0.0 110.962 -172.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -115.56 127.97 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.296 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.24 111.61 22.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.042 0.448 . . . . 0.0 111.063 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.99 137.92 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.666 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -148.21 102.09 3.33 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 m -56.37 147.47 21.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.594 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.48 ' HB3' ' CG ' ' A' ' 67' ' ' ARG . 69.7 t80 -139.25 148.3 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.3 mt -54.57 -51.52 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.308 -174.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -87.77 40.54 0.94 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.608 -172.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.48 ' CG ' ' HB3' ' A' ' 64' ' ' PHE . 12.8 ptp180 -166.21 88.76 0.86 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.267 0.556 . . . . 0.0 111.416 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.85 -4.53 14.06 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.189 2.593 . . . . 0.0 112.038 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -154.73 83.58 1.1 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.025 -170.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -139.12 -168.19 2.39 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.31 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.727 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 56.1 mm-40 -24.1 -75.73 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.882 1.273 . . . . 0.0 113.263 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -117.44 96.47 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 110.786 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.54 -49.74 0.78 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.327 0.584 . . . . 0.0 110.68 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.467 ' OD1' ' HE2' ' A' ' 76' ' ' LYS . 64.2 t30 -87.75 32.74 0.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.489 0.662 . . . . 0.0 110.952 -174.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.29 -7.48 49.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.392 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.467 ' HE2' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -78.4 -11.66 59.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.982 0.42 . . . . 0.0 111.017 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -12.22 49.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.755 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.15 22.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.772 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -157.13 -168.77 2.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.187 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.5 ptmt -46.2 -39.52 9.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.633 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -124.54 57.19 0.68 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.34 -1.409 . . . . 0.0 113.174 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -81.22 -6.94 59.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.736 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 84.2 mmm 47.68 91.63 0.01 OUTLIER 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.838 0.828 . . . . 0.0 112.744 -174.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -85.76 119.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -99.75 107.75 19.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.569 ' HD2' ' HD2' ' A' ' 93' ' ' ARG . 28.8 t80 -90.28 100.51 13.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.8 tppp? -82.86 93.75 7.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.212 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.09 122.03 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.268 0.556 . . . . 0.0 111.011 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.81 -90.48 0.13 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.962 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -139.81 8.47 2.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.0 109.448 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -100.76 131.47 46.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.542 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.8 m -103.67 97.55 7.55 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.569 ' HD2' ' HD2' ' A' ' 86' ' ' PHE . 9.9 ptp180 -97.35 153.41 18.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.895 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.05 122.29 44.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.186 0.517 . . . . 0.0 111.754 -166.2 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.9 m-85 -122.17 138.27 54.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.736 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.88 132.25 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.665 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 53.8 mtt -80.9 62.79 5.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.633 0.73 . . . . 0.0 110.175 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -75.93 -12.66 60.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.723 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 37.4 m -132.94 97.84 4.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.311 0.577 . . . . 0.0 110.34 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.92 128.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.341 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' A' ' 140' ' ' LYS . 6.1 ptp180 -161.05 -178.63 6.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.989 0.423 . . . . 0.0 110.536 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.51 143.63 46.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.795 HG23 ' HG3' ' A' ' 139' ' ' ARG . 11.8 m -131.17 170.84 18.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.624 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -100.28 146.39 31.9 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.819 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 139' ' ' ARG . 38.3 Cg_exo -61.6 -2.31 2.57 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.938 2.425 . . . . 0.0 112.907 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -126.62 19.49 7.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.624 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 1.6 p30 -68.59 166.8 16.37 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.332 0.587 . . . . 0.0 111.143 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.474 ' HA ' HD11 ' A' ' 111' ' ' LEU . 29.0 m -120.54 23.97 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -97.98 -41.82 7.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.158 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -87.25 -7.8 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.908 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 108' ' ' VAL . 2.5 pp -120.0 18.19 12.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.492 . . . . 0.0 110.929 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 32.3 t70 -152.15 138.47 18.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.174 -175.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.415 ' HB3' ' CE ' ' A' ' 115' ' ' LYS . 95.4 mt-10 53.4 65.76 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.795 0.684 . . . . 0.0 111.652 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -88.9 93.28 9.54 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' CE ' ' HB3' ' A' ' 113' ' ' GLU . 8.0 mptt -67.43 163.1 21.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.213 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.38 54.03 2.77 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.806 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -66.21 172.03 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.076 0.465 . . . . 0.0 110.788 172.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 3.2 t70 -81.03 -161.07 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 2.3 mppt? -64.72 119.02 9.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.989 0.423 . . . . 0.0 110.057 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.16 138.26 53.12 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.669 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.9 108.33 19.61 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m -92.59 106.12 18.16 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.758 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.7 mt -92.95 103.19 15.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.01 94.26 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -105.25 98.91 8.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.408 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.725 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 6.1 p -76.34 96.83 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.319 0.58 . . . . 0.0 109.882 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -125.28 79.26 1.79 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.396 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.784 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 31.5 t70 -168.89 85.72 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.492 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 70.8 t80 -91.91 125.9 36.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.132 -167.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -97.26 108.55 21.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.486 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 34.6 mt-10 -58.27 -33.72 69.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -71.21 -25.71 62.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 135' ' ' VAL . 2.6 t -125.03 -31.0 3.16 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.837 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.492 ' HA2' ' CE2' ' A' ' 129' ' ' TYR . . . 96.46 4.23 59.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.113 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.647 ' H ' HG23 ' A' ' 133' ' ' THR . 98.5 t -84.67 138.51 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.774 0.321 . . . . 0.0 110.158 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.784 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 45.0 m95 -95.68 105.04 16.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.37 -16.39 56.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.715 -165.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 128' ' ' ASP . 4.6 tppp? -133.17 130.46 39.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.806 0.336 . . . . 0.0 110.464 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.795 ' HG3' HG23 ' A' ' 103' ' ' VAL . 27.9 ptt180 -111.09 113.6 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.456 0.646 . . . . 0.0 110.181 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 16.2 tptm -76.33 127.51 33.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.841 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -121.04 127.16 75.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.728 0.775 . . . . 0.0 111.42 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 93.1 m-85 -114.64 108.76 17.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.488 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.6 t -96.68 102.53 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.265 0.555 . . . . 0.0 110.007 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.65 107.97 19.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.336 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.4 m -90.76 144.02 26.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.71 138.44 18.26 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.555 0.534 . . . . 0.0 111.186 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 96' ' ' LYS . 21.5 t -97.05 153.71 3.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.548 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.06 179.394 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.53 130.76 22.53 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.5 2.8 . . . . 0.0 113.524 -174.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -144.08 169.07 18.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.875 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.433 HG23 ' HB3' ' A' ' 31' ' ' PRO . 2.4 mp -70.86 122.78 87.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 17.3 Cg_exo -67.52 170.54 13.47 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.747 2.298 . . . . 0.0 112.978 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -79.26 -21.96 45.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.82 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.23 108.56 21.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.022 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 52.6 mtmt -90.63 31.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.745 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -117.17 -20.92 9.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.367 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 19.2 ptpt -90.43 -175.44 4.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.479 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.8 p -100.94 137.52 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.874 0.369 . . . . 0.0 110.509 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -100.81 -40.19 7.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.373 0.606 . . . . 0.0 110.324 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.14 165.45 30.31 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.607 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 47.7 m-85 -115.37 139.25 50.17 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -103.61 115.36 45.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.608 0.718 . . . . 0.0 109.949 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.19 112.67 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.571 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.466 HG12 HG13 ' A' ' 84' ' ' VAL . 43.5 mt -127.93 95.41 34.47 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.142 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.4 -29.61 89.13 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 123.114 2.543 . . . . 0.0 112.047 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.98 -33.19 74.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.47 8.8 21.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 66.68 12.55 8.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.26 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.479 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 62.7 mt -78.21 123.54 35.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.244 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 14.3 mtmm -153.6 84.71 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 119.364 -0.351 . . . . 0.0 110.594 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.1 mm-40 -155.93 163.83 23.42 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 118.0 0.364 . . . . 0.0 111.725 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 14' ' ' VAL . 8.2 Cg_exo -72.4 156.89 54.1 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.08 2.52 . . . . 0.0 113.387 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.52 123.6 71.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.623 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.9 123.88 45.79 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.739 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 19.0 Cg_endo -58.28 129.41 32.73 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.968 2.445 . . . . 0.0 112.228 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . -172.27 135.12 3.24 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.445 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.486 ' HD3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 Cg_endo -80.68 61.43 8.22 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.309 2.673 . . . . 0.0 112.069 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.02 27.97 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.525 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 7.8 p -79.81 136.62 54.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.187 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 64.1 Cg_exo -52.51 -48.57 21.22 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.471 2.78 . . . . 0.0 113.829 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.628 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 2.2 mp0 -67.42 -23.19 65.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 111.653 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.565 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.9 mp0 -83.06 -26.01 31.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.044 0.45 . . . . 0.0 110.013 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.56 -5.66 55.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.457 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' A' ' 37' ' ' GLU . 28.4 p30 -97.11 -23.68 16.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -96.0 -20.74 18.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA2' ' NE2' ' A' ' 71' ' ' GLN . . . -168.95 -150.22 6.59 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.84 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.91 142.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.565 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 70.8 m -127.55 -175.58 3.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.246 0.546 . . . . 0.0 112.001 -172.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.79 -178.86 6.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.662 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.71 -50.93 5.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.101 0.477 . . . . 0.0 109.941 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HB2' ' OE2' ' A' ' 50' ' ' GLU . 35.7 mt-10 -119.59 -167.58 1.44 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.018 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.47 27.23 9.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -105.41 -28.66 10.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.533 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 58' ' ' SER . 3.0 mp0 -63.79 168.99 4.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.033 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.878 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 56.3 m -147.84 160.14 43.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.396 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HB3' HG11 ' A' ' 88' ' ' VAL . 81.9 mt -78.67 2.33 19.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -137.34 11.06 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.916 0.865 . . . . 0.0 109.311 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.878 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 11.9 t70 -79.85 162.26 25.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.605 -175.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.584 ' HA ' ' HD3' ' A' ' 119' ' ' LYS . 1.3 tm0? -63.23 -38.23 90.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.701 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.0 129.64 55.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 110.796 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.43 ' HB ' HD23 ' A' ' 121' ' ' LEU . 36.7 mt -136.83 116.59 16.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.518 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 17.2 m -113.97 122.13 46.0 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.9 123.92 72.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.19 112.2 23.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.32 159.39 13.73 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.047 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -146.11 136.62 24.05 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.747 ' OG1' ' HA ' ' A' ' 127' ' ' ASP . 2.6 m -51.93 -65.82 0.49 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.374 0.421 . . . . 0.0 111.86 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 52.7 p90 -170.62 157.83 5.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.909 0.385 . . . . 0.0 110.951 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.2 mm -98.43 -50.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.93 22.61 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.906 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 11.8 mmm180 -115.88 119.54 37.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.365 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.85 -11.26 13.93 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.968 2.445 . . . . 0.0 113.696 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -157.43 90.33 1.1 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.154 0.502 . . . . 0.0 110.783 -169.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.577 ' OH ' ' HA ' ' A' ' 64' ' ' PHE . 11.9 p90 -148.46 -160.27 1.15 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.514 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.606 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -41.66 -79.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.769 0.828 . . . . 0.0 112.739 -175.698 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -106.48 106.05 16.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 m -147.62 -50.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.26 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -91.99 25.29 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.609 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.479 ' HG ' ' CD1' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -67.24 -17.96 65.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.431 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -75.84 -10.34 59.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.731 0.3 . . . . 0.0 110.808 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.01 -6.3 58.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 110.674 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.85 169.4 18.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.556 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -162.95 -171.29 2.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.731 -178.098 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -49.15 -47.21 45.82 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -113.61 62.08 0.32 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -82.14 -15.94 51.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.472 ' CE ' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 55.15 90.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.675 0.75 . . . . 0.0 111.595 -176.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 20' ' ' ILE . 39.7 t -87.98 119.9 36.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.417 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -95.91 106.85 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 121' ' ' LEU . 3.1 t80 -91.23 94.89 9.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.1 tppp? -81.23 86.39 6.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.452 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 91' ' ' GLU . 5.7 m -90.16 90.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.722 0.772 . . . . 0.0 111.006 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.89 -91.96 0.36 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.032 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.09 -4.84 10.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.659 0.266 . . . . 0.0 111.053 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.69 ' HB2' HG23 ' A' ' 88' ' ' VAL . 32.6 mt-10 -97.66 147.63 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.331 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.2 m -124.81 103.66 8.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.118 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.692 ' HG3' ' HE2' ' A' ' 95' ' ' TYR . 6.6 ptm180 -109.81 139.09 45.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.165 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HB2' ' CE ' ' A' ' 83' ' ' MET . 3.5 ptmm? -108.34 130.57 55.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 111.962 -172.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.692 ' HE2' ' HG3' ' A' ' 93' ' ' ARG . 61.2 m-85 -116.74 152.24 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.427 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.566 ' HE3' HG11 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -115.73 134.36 55.1 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.639 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 20.2 mmt -79.27 63.65 3.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.519 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 t -74.6 -23.81 58.78 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.603 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.5 m -129.83 96.12 4.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 111.329 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.47 124.48 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.599 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -137.87 159.98 40.52 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.835 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.39 124.67 51.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.64 HG11 HG13 ' A' ' 110' ' ' VAL . 21.6 m -119.32 131.62 71.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.788 0.804 . . . . 0.0 111.473 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.618 ' HG3' ' HG2' ' A' ' 138' ' ' LYS . 3.2 mppt? -98.35 168.43 9.89 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.03 -11.55 27.87 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.43 2.087 . . . . 0.0 112.266 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t -107.88 8.4 28.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.326 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 12.7 t0 -94.03 134.45 36.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.317 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.39 4.75 8.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.29 -30.79 71.68 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 110.98 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.64 HG13 HG11 ' A' ' 103' ' ' VAL . 17.0 m -84.67 -6.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.165 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.68 -7.46 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.49 157.96 17.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.69 123.36 18.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -77.18 139.47 39.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.98 -154.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -168.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.8 52.82 1.63 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 123.491 0.494 . . . . 0.0 114.235 -169.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -75.7 150.39 37.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 172.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -90.98 -149.4 0.22 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.637 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 32.5 mmtp -60.97 124.38 20.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -137.98 138.85 39.32 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.334 0.588 . . . . 0.0 111.911 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 86' ' ' PHE . 36.8 mt -94.1 103.76 15.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.1 m -88.1 91.1 8.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.793 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 26.1 mt -84.4 99.91 10.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.737 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.7 mt -83.05 78.26 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.9 m -87.81 99.61 12.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.975 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 57.1 m -74.23 94.89 2.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.747 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 35.7 t70 -101.69 1.5 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.346 -172.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.727 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 17.7 t0 -112.5 94.46 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.853 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 32.8 t80 -77.43 -26.98 52.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.155 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.5 t30 49.4 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.743 0.783 . . . . 0.0 111.457 -173.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.472 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 20.4 mt-10 -62.71 -8.63 7.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.808 -174.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 57.1 mmtt -60.37 -35.09 74.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 t -159.41 -3.26 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.19 40.07 7.63 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.424 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.44 117.18 53.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.182 0.515 . . . . 0.0 110.032 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.727 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 27.7 m95 -78.51 96.55 5.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 46.1 mt-10 -86.29 -61.98 1.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.18 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.618 ' HG2' ' HG3' ' A' ' 104' ' ' LYS . 33.8 mtmm -89.31 119.06 29.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.475 ' HB2' HG23 ' A' ' 103' ' ' VAL . 40.8 mtt85 -100.56 114.71 28.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.494 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -89.01 111.0 21.62 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.3 tt -102.42 127.33 56.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.615 0.721 . . . . 0.0 110.694 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.639 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 89.5 m-85 -108.51 112.73 25.27 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.438 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 44.3 t -101.43 97.33 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.428 0.633 . . . . 0.0 109.776 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.616 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -94.7 113.3 25.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.148 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 m -89.01 141.1 28.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.296 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 5.3 tt0 -61.0 115.38 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.566 HG11 ' HE3' ' A' ' 96' ' ' LYS . 5.1 p -117.19 124.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.573 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.4 -0.809 . . . . 0.0 111.223 -176.487 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 39.4 mtmt . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.888 0.375 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 13.8 Cg_endo -55.64 124.26 15.84 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.862 2.375 . . . . 0.0 111.277 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -141.1 146.79 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.72 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.5 mp -78.62 129.18 74.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.701 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 163.28 39.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.749 2.299 . . . . 0.0 112.863 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.934 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -70.83 -15.68 62.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.695 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.59 121.88 28.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.753 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 37.7 mmtm -95.2 16.62 16.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.417 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -127.04 26.54 6.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.542 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 64.4 mttm -118.06 176.03 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.409 0.623 . . . . 0.0 112.045 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.0 t -109.54 111.87 38.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.614 173.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -91.04 -21.42 21.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.02 159.41 31.88 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.901 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 57.9 m-85 -114.81 135.68 53.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -101.86 121.22 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.527 0.68 . . . . 0.0 109.791 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.648 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 37.7 mt-10 -124.26 118.75 27.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.449 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -134.21 96.9 15.32 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -54.01 -35.89 82.47 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.324 2.683 . . . . 0.0 112.999 -176.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.8 -29.84 69.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.796 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.71 2.36 27.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.628 0.251 . . . . 0.0 110.976 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HB3' HD21 ' A' ' 69' ' ' ASN . 30.9 t70 65.56 25.97 11.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.836 0.827 . . . . 0.0 110.084 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 20' ' ' ILE . 77.1 mt -91.47 125.4 44.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.954 -177.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.648 ' HD2' ' HG2' ' A' ' 19' ' ' GLU . 7.0 mmmt -151.27 54.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 5.5 mm-40 -121.82 153.66 60.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.611 -166.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.89 134.23 10.6 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.966 2.444 . . . . 0.0 112.807 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.07 135.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.329 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.41 ' HD2' ' HA3' ' A' ' 42' ' ' GLY . 51.2 m-85 -101.46 102.71 23.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.036 0.446 . . . . 0.0 109.857 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.2 Cg_endo -71.14 140.93 38.56 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.972 2.448 . . . . 0.0 112.112 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.15 -171.4 43.37 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.79 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.753 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 27.0 Cg_endo -93.73 34.52 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.012 3.141 . . . . 0.0 112.566 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 60.55 27.73 17.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.431 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.729 HG23 ' HB2' ' A' ' 38' ' ' GLN . 2.6 t -62.67 128.58 91.92 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.894 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.57 -44.89 24.73 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 124.093 3.195 . . . . 0.0 113.928 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 39.4 mt-10 -61.07 -49.37 77.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.729 ' HB2' HG23 ' A' ' 35' ' ' THR . 2.8 mp0 -70.69 -26.37 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 39' ' ' LEU . 6.5 mt -75.33 -10.15 59.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 176.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -99.48 -5.68 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.362 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' GLN . 57.4 mtp180 -102.03 -30.7 11.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 30' ' ' TYR . . . -170.05 -170.58 34.61 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.797 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -89.95 150.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 117.63 0.715 . . . . 0.0 109.715 176.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.8 t -137.79 178.91 6.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CD2' ' HG2' ' A' ' 50' ' ' GLU . 58.3 m-85 -84.61 172.65 11.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.81 82.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 0.0 110.775 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -157.31 -179.48 8.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.231 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 14.5 tt0 -76.77 -15.56 59.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.616 -174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -87.56 4.46 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.023 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 6.3 tp10 -56.63 127.56 32.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.909 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.9 m -120.02 121.64 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.895 0.379 . . . . 0.0 110.767 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 52.0 mt -72.73 -16.59 61.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.432 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -98.68 2.63 47.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.218 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.909 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 14.0 t70 -86.77 -178.55 6.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.73 -18.46 23.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -116.8 108.33 15.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.777 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.48 105.49 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.406 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 1.1 m -101.17 120.86 40.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.209 -175.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mt -112.98 127.74 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 124.1 39.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.974 0.416 . . . . 0.0 110.937 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.62 173.15 18.2 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.093 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -163.45 179.57 7.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 150.38 20.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.679 0.276 . . . . 0.0 110.967 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.477 ' HE2' ' HB3' ' A' ' 66' ' ' ASP . 40.6 t80 -134.37 152.12 51.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.2 mt -81.45 -53.86 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' HE2' ' A' ' 64' ' ' PHE . 23.0 t70 -64.86 -42.52 94.81 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' A' ' 70' ' ' TYR . 22.8 mtp180 -106.98 110.18 63.46 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.605 -175.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.59 -8.73 20.82 Favored 'Trans proline' 0 CA--C 1.516 -0.379 0 C-N-CA 123.188 2.592 . . . . 0.0 112.222 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.443 HD21 ' HB3' ' A' ' 24' ' ' ASP . 17.3 t-20 -161.77 86.29 0.64 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.236 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.475 ' HB3' ' HE ' ' A' ' 67' ' ' ARG . 20.7 p90 -113.16 -150.29 0.46 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 22.0 mp0 -44.48 -56.29 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.358 0.411 . . . . 0.0 111.561 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' HD2' ' C ' ' A' ' 71' ' ' GLN . 2.5 m-85 -128.12 106.77 9.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.91 -64.04 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.974 0.416 . . . . 0.0 110.597 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -83.58 21.27 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.53 0.681 . . . . 0.0 110.13 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 75' ' ' LEU . 6.9 tt -60.87 -21.56 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.886 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -9.63 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.129 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.44 -3.28 52.47 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 111.299 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.45 162.47 25.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -135.98 -173.52 3.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.291 -178.321 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 ptpp? -72.93 11.41 0.69 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.27 46.96 0.43 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 m -83.47 132.41 34.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.853 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 73.2 mmm -79.89 102.48 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.121 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 39.2 t -90.25 132.32 35.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.054 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 72.4 m-85 -114.28 121.65 44.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -111.17 109.91 20.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.075 0.464 . . . . 0.0 110.14 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 30.3 mmtm -81.43 106.44 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.833 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 52' ' ' LEU . 9.2 p -142.04 132.99 25.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 111.264 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.32 -91.92 0.14 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.405 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -140.46 4.03 1.95 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.43 0.634 . . . . 0.0 109.812 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -110.51 164.57 12.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.391 0.615 . . . . 0.0 111.397 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 m -122.89 92.17 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.995 171.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 19.5 mmt180 -74.36 121.42 21.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.065 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.26 131.36 41.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.697 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 89.1 m-85 -127.08 149.08 50.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.853 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -117.53 123.52 46.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.4 mtt -81.82 71.13 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.26 0.552 . . . . 0.0 110.588 -176.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.8 t -83.52 -21.92 32.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.911 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.6 m -118.62 110.37 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -129.93 128.85 65.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.531 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.582 HH21 HG13 ' A' ' 110' ' ' VAL . 28.2 ptt180 -170.42 -175.06 1.81 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . 2.7 p30 -126.87 152.2 47.36 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 170.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 110' ' ' VAL . 12.3 m -127.44 126.15 66.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -174.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.563 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -73.04 158.32 87.28 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.008 171.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.36 -14.06 18.9 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.729 2.286 . . . . 0.0 112.639 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 104' ' ' LYS . 68.6 p -87.88 -3.41 58.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.039 0.447 . . . . 0.0 111.053 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.563 ' HB2' ' HD2' ' A' ' 104' ' ' LYS . 14.2 t70 -82.74 116.77 22.24 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.87 8.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.09 -39.13 23.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.067 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG13 HH21 ' A' ' 101' ' ' ARG . 19.6 m -77.84 -23.04 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.373 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.39 -27.1 63.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.784 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.46 97.58 10.55 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.194 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -18.38 109.47 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.896 -1.956 . . . . 0.0 114.448 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.52 115.6 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.053 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.57 179.52 5.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.267 173.518 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.27 -16.91 48.66 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.24 178.85 4.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.162 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -89.07 -148.44 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.52 109.01 0.55 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.79 118.07 36.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.496 0.665 . . . . 0.0 110.019 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HG ' HD21 ' A' ' 123' ' ' LEU . 20.9 tp -83.5 102.11 11.88 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.1 m -90.7 96.83 10.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.256 -174.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.59 HD21 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mt -90.64 102.67 15.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.814 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.1 mt -95.53 97.15 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.252 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.7 m -96.53 98.26 10.08 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.82 100.68 7.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 128' ' ' ASP . 23.7 t70 -136.0 83.23 2.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.725 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 11.3 t70 166.94 99.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.065 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -87.66 132.42 34.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 22.7 t-20 -103.94 114.19 28.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.573 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.52 -19.2 46.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 0.0 111.332 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -63.15 -38.14 90.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.166 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.485 HG22 ' OD1' ' A' ' 130' ' ' ASN . 14.2 t -131.85 -11.28 3.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 0.0 111.611 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.43 26.95 26.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.743 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.54 -177.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 117.09 0.445 . . . . 0.0 110.905 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.725 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 58.3 m95 -115.78 104.49 11.71 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 130' ' ' ASN . 43.2 mt-10 -67.86 -58.91 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.953 -172.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 128' ' ' ASP . 26.7 ttpp -80.97 91.34 6.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.184 0.992 . . . . 0.0 110.582 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -93.99 100.85 12.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.335 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -74.82 125.59 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.981 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.93 119.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.987 0.899 . . . . 0.0 111.191 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HD2' ' SD ' ' A' ' 97' ' ' MET . 10.4 m-85 -108.67 108.9 19.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.314 175.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 72.0 t -94.22 106.63 18.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.282 0.563 . . . . 0.0 109.956 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.509 ' HB2' ' HG2' ' A' ' 97' ' ' MET . . . -105.14 108.5 20.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.76 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.5 m -79.47 137.26 37.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.433 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 38.0 tt0 -55.6 123.59 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 96' ' ' LYS . 5.7 t -80.81 154.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.41 ' HG2' HG12 ' A' ' 147' ' ' VAL . 10.6 ptpt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.525 -0.75 . . . . 0.0 112.189 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 92.9 mttt . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.752 0.311 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.519 ' CB ' ' HB ' ' A' ' 88' ' ' VAL . 36.7 Cg_endo -64.66 124.8 13.77 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.755 2.304 . . . . 0.0 111.532 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -153.18 177.12 11.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.589 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 31' ' ' PRO . 45.9 mt -106.37 105.3 53.82 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.131 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.21 169.68 12.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.675 2.25 . . . . 0.0 112.674 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 17.4 mtpp -84.96 -21.21 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.787 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.44 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 25.5 t70 -68.89 108.46 3.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.062 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 29.9 mttp -90.5 19.05 5.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.877 -168.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -112.11 8.35 19.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 35.8 mttp -111.87 178.67 4.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.531 0.681 . . . . 0.0 112.146 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.703 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -82.58 -41.85 19.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.286 0.565 . . . . 0.0 110.189 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.97 160.76 33.28 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 38.2 m-85 -102.06 133.47 46.83 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -101.82 114.19 40.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.59 0.709 . . . . 0.0 110.269 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.6 mt-10 -114.95 117.09 29.64 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.042 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 65.0 mt -131.15 94.03 28.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.01 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.36 -16.12 52.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.259 2.64 . . . . 0.0 112.794 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB3' ' OG ' ' A' ' 82' ' ' SER . 33.7 t70 -81.91 -28.43 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.557 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.81 20.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.998 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.41 20.26 10.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.585 0.707 . . . . 0.0 111.21 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 72.0 mt -91.09 114.7 28.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.437 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.8 mppt? -142.79 84.9 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.637 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 4.4 mt-10 -146.41 158.65 46.84 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.782 0.325 . . . . 0.0 111.581 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 73.6 Cg_endo -77.0 136.61 16.63 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.907 2.404 . . . . 0.0 112.627 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.64 134.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.146 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' SER . 35.1 m-85 -97.32 121.49 58.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.581 . . . . 0.0 111.13 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.584 ' HB2' HG23 ' A' ' 7' ' ' ILE . 86.0 Cg_endo -85.92 148.37 9.46 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.334 2.689 . . . . 0.0 112.705 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.91 -169.52 36.56 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.891 172.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 35' ' ' THR . 81.7 Cg_endo -76.85 13.18 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 123.808 3.006 . . . . 0.0 112.77 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.83 75.57 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.164 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 33' ' ' PRO . 72.8 p -97.33 164.53 17.51 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.664 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.34 -37.93 81.78 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.203 1.935 . . . . 0.0 111.339 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.4 mm-40 -59.14 -44.25 92.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.777 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.817 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.2 mp0 -59.68 -42.95 94.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.49 -9.58 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.811 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.56 -31.76 12.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.735 0.303 . . . . 0.0 111.155 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.7 ptp180 -87.24 -19.84 27.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.989 0.423 . . . . 0.0 110.614 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.76 -127.26 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.287 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 60' ' ' ALA . 93.9 t -126.92 141.66 45.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.817 ' HB2' ' HB3' ' A' ' 38' ' ' GLN . 41.8 t -119.74 163.65 17.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.214 0.53 . . . . 0.0 110.775 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 7' ' ' ILE . 55.6 m-85 -71.87 159.66 33.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.754 172.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.46 -49.12 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -140.07 166.32 24.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.14 -19.83 46.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.28 0.562 . . . . 0.0 110.043 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -80.04 4.8 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.068 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.24 163.47 23.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.992 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 23.2 t -122.36 177.1 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 15' ' ' ALA . 85.0 mt -110.17 -16.08 13.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.641 0.257 . . . . 0.0 111.171 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.09 12.11 16.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.893 0.854 . . . . 0.0 109.374 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.992 ' HB2' ' HB3' ' A' ' 51' ' ' SER . 3.1 t70 -79.31 179.18 7.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.413 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -21.85 46.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -131.3 129.24 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.638 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.3 mp -129.68 101.75 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.549 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 5.4 m -93.04 125.33 37.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.5 mt -119.13 138.88 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.527 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.91 122.35 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.51 166.7 14.32 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.852 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.57 38.02 0.68 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.326 0.563 . . . . 0.0 111.431 -174.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 56.03 -158.75 0.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 -174.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.453 ' H ' HG22 ' A' ' 63' ' ' THR . 47.5 p90 -120.47 178.61 4.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.442 0.639 . . . . 0.0 112.344 -170.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 62.2 mt -128.27 -53.68 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.011 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.42 49.02 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.196 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 16.9 mmt180 -142.76 105.49 5.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.161 -175.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.62 -16.5 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.971 1.781 . . . . 0.0 111.601 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -154.78 82.31 1.09 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.749 -176.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -122.17 -176.97 3.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.637 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -38.24 -71.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 2.5 m-30 -105.66 76.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.765 -0.584 . . . . 0.0 111.446 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.89 -58.36 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.674 0.749 . . . . 0.0 110.259 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -100.34 21.05 13.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.407 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.475 HD23 ' OG1' ' A' ' 125' ' ' THR . 40.8 tp -63.75 -23.18 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.786 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -13.54 62.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.976 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.05 9.72 26.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.662 0.268 . . . . 0.0 111.299 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.491 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -91.67 141.39 28.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.45 . . . . 0.0 111.333 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 82' ' ' SER . 10.6 mptt -109.71 -179.0 3.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.805 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.8 ptpt -57.3 -41.37 79.72 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.49 47.65 1.32 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.719 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.552 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -66.82 -17.21 64.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.596 0.358 . . . . 0.0 111.895 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.66 86.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.52 0.676 . . . . 0.0 111.727 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -88.37 114.81 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.251 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 76.1 m-85 -101.43 105.4 16.42 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.79 106.93 19.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.7 mmtp -90.91 92.57 8.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.11 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.8 m -90.67 92.37 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.672 0.748 . . . . 0.0 110.179 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.58 -88.99 0.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.51 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.05 0.28 5.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.151 0.501 . . . . 0.0 110.083 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.864 ' HB2' HG23 ' A' ' 88' ' ' VAL . 9.5 mm-40 -92.18 119.03 31.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.495 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 m -92.54 106.04 18.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.576 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -94.96 136.57 35.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -114.55 118.85 34.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -177.19 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.583 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 71.9 m-85 -118.03 145.7 44.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.398 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -110.23 138.76 46.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.8 mmt -81.0 68.06 7.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.141 0.496 . . . . 0.0 110.15 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -75.73 -20.9 58.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.859 -172.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 51.0 m -133.03 101.59 5.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.175 0.512 . . . . 0.0 111.17 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 97' ' ' MET . 78.5 mt -119.03 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.266 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -157.97 176.2 12.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.355 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 10.6 p-10 -134.98 128.39 32.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.976 0.417 . . . . 0.0 110.135 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.902 HG11 HG11 ' A' ' 110' ' ' VAL . 31.6 m -129.05 179.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.39 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -102.99 158.0 32.62 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.075 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 139' ' ' ARG . 19.8 Cg_endo -61.75 -15.19 40.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.929 2.419 . . . . 0.0 112.585 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.3 t -96.26 -7.13 36.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.905 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.78 97.94 9.98 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.635 ' HA ' HD21 ' A' ' 111' ' ' LEU . 29.6 m -100.06 8.25 8.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.821 0.343 . . . . 0.0 111.715 -170.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -93.43 -15.47 25.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.902 HG11 HG11 ' A' ' 103' ' ' VAL . 22.5 m -76.44 -23.71 15.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.547 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -97.41 34.54 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.09 0.471 . . . . 0.0 111.064 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -70.16 169.66 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.25 105.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.459 0.647 . . . . 0.0 110.789 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -82.21 45.33 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.466 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -77.48 174.57 10.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.33 175.538 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.86 13.25 78.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.744 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -110.44 -170.69 1.69 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.082 0.468 . . . . 0.0 110.193 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.73 -163.58 0.86 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -62.35 110.02 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.11 143.22 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.237 0.541 . . . . 0.0 111.446 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.494 HD23 ' HB ' ' A' ' 57' ' ' ILE . 70.6 mt -96.27 125.22 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.316 174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 12.0 m -97.69 92.43 5.88 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.3 mm? -87.45 100.69 12.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.236 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.98 97.84 7.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.475 ' OG1' HD23 ' A' ' 75' ' ' LEU . 2.4 m -102.91 102.11 12.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.963 0.411 . . . . 0.0 109.925 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 20.6 m -85.89 100.4 12.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -115.5 177.55 4.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.342 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.26 83.34 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.739 0.649 . . . . 0.0 111.003 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.697 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -102.91 170.67 7.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.413 0.625 . . . . 0.0 111.919 -172.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -104.9 92.34 4.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.058 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 38.2 mt-10 -44.56 -37.9 3.86 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.36 -29.01 70.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 135' ' ' VAL . 8.6 t -126.44 -14.84 5.76 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.509 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.687 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 133' ' ' THR . 16.3 m -75.15 146.48 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 117.437 0.618 . . . . 0.0 110.251 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.697 ' CE3' ' HB3' ' A' ' 129' ' ' TYR . 85.1 m95 -94.14 111.91 23.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -70.6 -53.73 14.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.382 -172.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -90.71 85.09 5.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 0.0 111.405 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 35.7 ptt180 -80.64 79.94 7.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 85.0 tttt -70.15 123.23 21.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.067 -174.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -107.8 125.52 64.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.687 0.756 . . . . 0.0 110.741 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.2 m-85 -109.05 110.83 22.2 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 84.3 t -96.91 103.33 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.405 0.621 . . . . 0.0 109.556 176.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -101.75 102.37 13.0 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.35 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -87.62 139.5 30.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 7.3 tt0 -55.21 128.61 34.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.941 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 5.9 p -96.48 155.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.128 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.089 -175.263 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' HE2' ' A' ' 17' ' ' TYR . 83.6 mtp . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.528 0.204 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' NE2' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -156.96 -171.8 3.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.733 177.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.41 136.86 38.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.6 mtmt 54.6 94.69 0.05 OUTLIER Pre-proline 0 C--O 1.233 0.197 0 O-C-N 123.729 0.643 . . . . 0.0 110.674 -169.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 29.2 Cg_endo -57.78 115.02 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.899 2.399 . . . . 0.0 112.954 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.515 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 13.0 pt20 -146.84 168.22 21.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.752 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.735 HG23 ' HB2' ' A' ' 31' ' ' PRO . 46.6 mt -104.18 120.88 49.49 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.39 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 2.4 Cg_endo -83.88 179.68 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.122 2.548 . . . . 0.0 112.321 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -79.1 -25.24 43.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.05 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.38 116.21 8.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 110.259 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -92.89 16.33 12.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.735 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 t -108.54 -29.09 8.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -89.3 174.37 7.87 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.207 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.63 128.67 52.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -80.77 -41.24 23.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.09 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.77 164.09 35.61 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.443 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 72.7 m-85 -107.36 140.88 39.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.899 0.35 . . . . 0.0 110.267 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.4 tp -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.364 0.602 . . . . 0.0 110.113 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.1 mt-10 -120.76 111.88 18.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.638 0.732 . . . . 0.0 111.262 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.8 mt -124.86 93.91 45.1 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.75 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.71 -28.71 87.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.006 2.471 . . . . 0.0 112.283 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.0 -23.19 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.934 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.75 7.3 18.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.905 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 64.68 27.21 13.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.6 mt -106.64 122.28 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.0 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.27 75.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 167.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 67.8 mm-40 -122.0 162.02 39.43 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.68 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 69.0 Cg_endo -77.09 128.05 9.64 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.793 2.328 . . . . 0.0 113.321 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.15 124.93 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.83 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 44' ' ' SER . 62.8 m-85 -93.76 123.26 60.26 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.246 0.545 . . . . 0.0 110.966 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.735 ' HB2' HG23 ' A' ' 7' ' ' ILE . 68.6 Cg_endo -76.14 107.92 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.64 2.227 . . . . 0.0 111.289 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.9 167.22 33.18 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.734 -1.222 . . . . 0.0 112.8 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 88.5 Cg_endo -87.58 31.75 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.889 3.059 . . . . 0.0 112.544 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 62.25 26.88 16.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.202 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -70.32 142.61 89.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.722 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -39.44 -55.52 1.55 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.861 3.04 . . . . 0.0 114.852 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.41 -24.06 67.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -69.4 -39.63 77.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.14 0.495 . . . . 0.0 109.698 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 94.0 mt -80.96 -23.41 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.19 -24.52 63.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -103.86 -22.65 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.674 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -175.3 -156.68 14.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.161 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.465 HG11 ' CE1' ' A' ' 72' ' ' PHE . 28.5 m -92.27 154.58 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 29.6 t -135.51 163.37 30.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.993 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 58' ' ' SER . 31.1 m-85 -74.67 162.34 28.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.49 70.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.931 0.396 . . . . 0.0 110.689 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -137.9 176.14 8.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.666 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.745 0.783 . . . . 0.0 109.305 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -88.33 -22.08 24.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.855 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -76.58 171.97 13.78 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.941 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 66.5 m -154.1 165.32 36.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.948 0.404 . . . . 0.0 110.543 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.521 HD13 ' CG2' ' A' ' 88' ' ' VAL . 15.7 mt -79.43 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.971 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -101.29 -3.06 29.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.584 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -82.66 170.92 14.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.97 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -85.94 -20.76 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -107.69 108.01 19.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.644 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.98 111.66 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 12.2 m -117.31 116.6 27.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.877 0.37 . . . . 0.0 111.014 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.71 121.12 53.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.227 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.04 116.44 22.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.338 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.6 114.31 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.188 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -87.9 84.62 6.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.3 m -68.85 140.37 55.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.534 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.83 150.88 40.52 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.308 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.4 mt -91.98 -43.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -50.72 -43.52 57.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.353 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.5 mtp85 -100.18 124.29 43.79 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.856 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -87.42 -16.62 3.1 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.788 2.326 . . . . 0.0 113.012 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -138.84 73.41 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.184 0.516 . . . . 0.0 110.888 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -119.33 -161.16 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 43.8 mt-30 -60.21 -77.76 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' CE1' HG11 ' A' ' 43' ' ' VAL . 3.1 m-85 -84.59 19.02 2.09 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -47.63 78.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -101.96 12.03 37.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -172.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.94 -16.73 64.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.365 0.602 . . . . 0.0 110.337 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -8.88 56.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.787 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.35 1.72 56.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 110.933 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.1 165.56 23.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.111 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 97' ' ' MET . 11.2 pttm -158.08 -170.92 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.896 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.1 ptpt -54.4 -39.14 66.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -117.68 59.78 0.47 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.443 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -84.22 -5.22 59.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.56 85.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.638 0.586 . . . . 0.0 111.694 -177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 45.5 t -86.66 112.31 22.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.96 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.56 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.2 m-85 -100.84 107.93 19.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.551 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 12.6 t80 -99.11 102.1 13.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -82.7 88.97 6.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.361 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 52' ' ' LEU . 7.5 p -117.44 124.43 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 111.589 -170.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.24 -57.1 1.13 Allowed Glycine 0 CA--C 1.509 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.718 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -169.11 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.427 0.632 . . . . 0.0 110.223 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.06 154.94 20.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.252 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 m -98.0 100.92 12.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.33 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 51.1 mmt-85 -82.27 112.43 19.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.116 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.803 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.09 128.78 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.607 . . . . 0.0 110.56 177.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 72.1 m-85 -121.92 151.43 40.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.395 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.601 ' HE3' HG21 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -117.67 138.28 52.09 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.673 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 19.3 mmt -80.61 68.35 6.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.263 0.554 . . . . 0.0 110.311 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.92 -38.8 36.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.713 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.616 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 33.4 m -110.27 103.68 12.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.053 0.454 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.8 mt -123.49 126.06 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.426 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 7.1 ptm180 -159.77 -175.59 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.517 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 3.3 p30 -136.4 144.79 44.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.811 HG11 HG11 ' A' ' 110' ' ' VAL . 28.7 m -126.41 -169.16 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.787 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.615 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -136.89 160.39 66.48 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.422 -176.168 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.87 -20.82 30.65 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.645 2.23 . . . . 0.0 112.307 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.1 p -91.7 8.21 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.037 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.429 ' HB2' ' HE2' ' A' ' 104' ' ' LYS . 24.7 t0 -107.71 97.3 7.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.6 m -104.99 16.2 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.222 0.534 . . . . 0.0 110.591 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -104.74 -2.32 25.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.328 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.811 HG11 HG11 ' A' ' 103' ' ' VAL . 13.5 m -96.83 -39.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.979 0.419 . . . . 0.0 110.899 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -86.35 86.96 7.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.462 1.125 . . . . 0.0 108.743 173.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.7 -164.39 1.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.991 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.509 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 7.1 pt-20 -77.7 71.26 4.17 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 111.344 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -86.3 47.88 1.54 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.509 ' HE2' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -71.64 172.57 9.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.203 -176.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.14 -14.21 36.99 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -92.6 175.21 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 110.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -89.62 -157.32 0.45 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 108.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -104.4 130.62 52.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 110.498 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -96.09 104.02 15.94 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.0 m -88.67 98.22 11.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.469 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -83.13 103.06 12.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.8 mt -96.71 89.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.876 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 m -95.48 101.8 13.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 -175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.8 m -84.06 115.58 22.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -120.33 158.56 26.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.131 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 t70 70.14 98.97 0.06 Allowed 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.91 0.757 . . . . 0.0 110.986 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -86.58 130.02 34.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.619 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -97.16 101.51 13.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.5 -17.16 64.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.573 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -71.16 -27.73 63.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.2 t -133.9 -23.44 1.77 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.79 26.73 8.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.641 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.88 174.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 117.027 0.413 . . . . 0.0 110.963 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -110.83 116.95 32.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.7 -50.95 30.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.149 -170.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.748 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 11.0 mmpt? -95.07 100.41 12.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.158 0.504 . . . . 0.0 111.243 -174.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.503 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 68.7 mtm180 -91.9 83.59 5.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.517 ' HD3' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -64.58 129.69 40.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.293 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.67 114.57 38.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 122.234 1.016 . . . . 0.0 110.851 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.647 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 67.4 m-85 -108.12 104.7 14.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.01 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 37.8 t -90.97 93.25 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.703 0.763 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -88.39 105.14 17.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.661 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.3 m -84.37 142.61 30.03 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.803 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -53.38 114.45 1.5 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 109.873 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.601 HG21 ' HE3' ' A' ' 96' ' ' LYS . 7.3 p -94.28 148.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.351 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.444 -179.745 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.503 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -104.62 172.64 6.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.022 0.439 . . . . 0.0 110.848 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.75 90.65 8.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 55.2 mtmt -105.43 101.93 34.41 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.843 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.697 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.9 Cg_endo -57.38 126.67 22.74 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.31 2.673 . . . . 0.0 112.349 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -158.06 162.39 38.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 31' ' ' PRO . 22.6 mt -99.36 123.32 48.87 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.807 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.77 -172.75 1.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.864 2.376 . . . . 0.0 113.008 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -90.92 -14.45 31.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.546 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.45 145.56 25.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.85 0.357 . . . . 0.0 110.628 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -99.55 5.34 46.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.039 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -111.34 9.75 21.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.573 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -110.34 171.96 7.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 111.644 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.51 118.0 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.81 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -92.32 -25.07 18.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.233 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.96 177.92 45.21 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.292 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 69.1 m-85 -123.78 136.5 54.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.99 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 122.256 1.027 . . . . 0.0 110.085 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -115.2 108.66 16.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.71 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.487 HG12 HG13 ' A' ' 84' ' ' VAL . 25.4 mt -121.34 94.88 48.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.212 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.48 -28.02 70.53 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 122.745 2.297 . . . . 0.0 111.225 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 34.2 t70 -67.45 -24.94 65.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.572 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -118.01 11.81 13.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.321 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t0 59.39 30.01 19.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.657 0.741 . . . . 0.0 111.063 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.466 HD12 HD12 ' A' ' 20' ' ' ILE . 84.5 mt -97.78 121.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.085 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 2.4 mppt? -145.03 80.73 1.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -154.01 158.82 32.49 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.644 0.259 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 71.1 Cg_endo -75.06 163.52 35.07 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.922 2.414 . . . . 0.0 113.054 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.82 133.41 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.809 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.45 118.87 53.55 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.325 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 75.1 Cg_endo -85.69 162.8 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.924 2.416 . . . . 0.0 113.224 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.01 -173.75 34.62 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.457 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.75 6.52 4.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.233 2.622 . . . . 0.0 112.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.956 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.674 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 71.1 p -111.61 163.95 16.27 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.414 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.674 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 53.8 Cg_exo -38.28 -48.04 2.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.092 3.195 . . . . 0.0 115.361 -173.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -30.14 66.18 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.687 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.5 mp0 -64.93 -43.59 92.25 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.837 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.0 12.08 6.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.91 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HA ' ' HZ ' ' A' ' 64' ' ' PHE . 55.2 t-20 -107.77 -47.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.449 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 41' ' ' ARG . 13.3 ptm180 -83.58 -26.0 30.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.278 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.4 -139.86 2.75 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.339 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG21 ' CE1' ' A' ' 72' ' ' PHE . 11.6 p -124.57 145.28 32.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.687 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 62.4 m -133.31 -177.39 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -95.82 166.79 11.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.477 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.042 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -149.2 170.48 18.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.141 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -78.18 -23.49 47.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -84.62 -1.47 56.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.34 145.37 51.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -128.04 150.67 49.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.753 0.311 . . . . 0.0 111.032 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.8 mt -80.8 -16.57 53.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.388 0.613 . . . . 0.0 110.221 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.27 -4.33 58.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.632 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.83 164.3 22.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.229 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.36 -21.85 59.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 177.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.77 145.55 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.0 110.16 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' HB ' HD23 ' A' ' 121' ' ' LEU . 4.0 mp -125.99 115.05 41.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.839 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -88.99 107.2 18.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.611 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.1 mt -105.02 122.9 58.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.72 126.71 42.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.192 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.7 158.98 20.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.07 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -149.39 93.95 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 m -62.09 148.51 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.501 ' HZ ' ' HA ' ' A' ' 40' ' ' ASN . 88.5 m-85 -118.19 172.21 7.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.662 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.01 -42.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.852 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.89 -4.99 59.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.724 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -117.72 111.14 39.65 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.737 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.58 -10.01 20.15 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.812 2.341 . . . . 0.0 112.347 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -155.64 84.49 1.04 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 110.966 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 63' ' ' THR . 10.2 p90 -108.56 -168.87 1.41 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -38.33 -69.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CE1' HG21 ' A' ' 43' ' ' VAL . 19.5 m-30 -114.41 78.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.233 -0.292 . . . . 0.0 111.625 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.02 -50.86 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.566 0.698 . . . . 0.0 110.508 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 64.0 t30 -87.17 30.62 0.76 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.157 -172.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.77 -9.54 54.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.371 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -9.62 59.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.033 0.444 . . . . 0.0 111.003 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.16 -6.86 43.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.1 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.572 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -79.77 127.14 31.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -111.54 -169.08 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.465 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.04 -44.62 95.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.641 -176.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -99.92 52.94 0.99 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.892 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.4 t -62.96 -21.64 66.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.167 -0.516 . . . . 0.0 111.404 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.409 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 50.17 76.01 0.16 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.513 -174.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.8 t -81.46 122.68 36.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.24 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -100.11 99.69 10.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.188 0.518 . . . . 0.0 109.753 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -101.52 109.58 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 92' ' ' THR . 94.5 mttt -97.21 135.5 39.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.081 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.2 m -141.36 107.95 2.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.85 -102.2 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.352 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -115.26 5.65 14.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.809 0.338 . . . . 0.0 110.868 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 88' ' ' VAL . 40.9 mt-10 -102.43 113.63 27.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.451 HG23 ' HG2' ' A' ' 87' ' ' LYS . 19.0 m -95.57 97.5 9.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 171.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 93' ' ' ARG . 16.9 mtp85 -93.27 135.88 34.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.192 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -98.68 130.56 45.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 92.7 m-85 -122.63 137.26 54.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.93 0.395 . . . . 0.0 110.611 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.615 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -109.69 131.3 55.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 22.4 mmt -80.73 76.1 7.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.389 0.614 . . . . 0.0 110.379 -175.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 t -86.97 -12.05 48.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.789 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.7 m -137.11 100.62 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 0.0 110.504 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 97' ' ' MET . 74.4 mt -119.5 122.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.353 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -161.2 -176.73 5.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.905 0.383 . . . . 0.0 110.653 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 1.1 p30 -131.52 141.02 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 110' ' ' VAL . 35.3 m -121.17 -176.0 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.143 0.497 . . . . 0.0 111.226 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.502 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -111.48 157.2 39.85 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.644 -176.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -60.21 -10.89 14.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.681 2.254 . . . . 0.0 112.643 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -117.16 17.89 14.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.26 129.91 39.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.228 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.89 30.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.63 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.96 -7.15 9.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.688 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 103' ' ' VAL . 16.0 m -92.39 -19.11 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.3 0.571 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.519 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.2 19.97 16.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -116.19 145.14 43.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.388 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 49.34 67.53 0.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.536 0.522 . . . . 0.0 111.375 -174.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -89.39 89.51 7.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.619 0.724 . . . . 0.0 109.369 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 160.6 28.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.297 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.27 62.08 0.8 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.103 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -59.84 176.64 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.331 0.586 . . . . 0.0 111.178 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -83.04 -170.12 2.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 4.4 mptp? -64.09 112.69 3.11 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.12 131.79 56.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.311 0.577 . . . . 0.0 111.204 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.435 HD23 ' HB ' ' A' ' 57' ' ' ILE . 67.4 mt -86.01 121.22 28.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m -102.88 94.78 5.76 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 24.9 mt -83.84 100.33 10.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.923 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.3 mt -90.54 93.47 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.747 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.3 m -98.25 95.78 7.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.111 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.2 m -78.82 111.92 15.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.606 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.17 178.41 6.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.708 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.21 82.28 0.18 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.566 0.698 . . . . 0.0 110.233 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -83.54 126.45 32.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.529 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -95.48 100.85 12.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.34 -18.07 65.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.481 -174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -74.53 -27.21 60.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 135' ' ' VAL . 8.1 t -124.58 -20.33 5.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.783 0.325 . . . . 0.0 111.191 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.67 46.39 6.39 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 133' ' ' THR . 5.6 p -139.76 156.7 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.0 110.355 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -93.76 115.28 27.7 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.05 -40.32 53.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -170.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -104.26 126.9 51.76 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.458 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -103.73 89.2 3.26 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.653 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 51.6 tptt -71.86 123.21 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.1 tt -121.01 124.01 71.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.869 0.842 . . . . 0.0 111.03 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.583 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 21.0 m-85 -113.99 108.11 16.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.837 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.9 t -99.52 106.06 18.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.431 0.634 . . . . 0.0 110.088 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.66 112.08 25.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.268 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.6 m -87.06 139.23 30.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.085 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.82 117.82 6.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.441 0.639 . . . . 0.0 111.291 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.6 HG11 ' HE3' ' A' ' 96' ' ' LYS . 3.3 p -114.11 134.35 57.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.5 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 4.6 ptpp? . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.106 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.84 -170.25 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.428 0.632 . . . . 0.0 110.742 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.35 99.62 7.13 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.118 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE3' ' OD1' ' A' ' 53' ' ' ASP . 40.4 mtpt -133.12 88.5 36.17 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.571 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HG2' HG22 ' A' ' 88' ' ' VAL . 20.0 Cg_exo -66.21 145.37 78.19 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.004 2.47 . . . . 0.0 112.442 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -123.99 154.21 40.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.097 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.8 mp -73.64 122.77 88.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.81 167.36 17.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.917 2.411 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -78.85 -12.55 60.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.29 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -99.15 118.82 36.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.673 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -95.53 21.86 7.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.385 -173.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 m -108.33 4.23 24.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.292 0.568 . . . . 0.0 110.322 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 98.5 mttt -102.94 -176.56 3.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.099 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.49 135.22 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.222 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.634 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -97.53 -35.43 10.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 110.493 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.07 163.29 34.22 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 49.8 m-85 -106.24 134.93 48.59 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.0 tp -100.33 108.1 22.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.834 0.825 . . . . 0.0 109.782 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 59.0 mt-10 -115.8 111.02 19.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.232 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG12 HG13 ' A' ' 84' ' ' VAL . 46.2 mt -124.42 92.33 48.21 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.722 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -52.82 -34.62 66.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.317 2.678 . . . . 0.0 112.957 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.602 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 5.4 m-20 -58.6 -38.38 77.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.659 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -103.53 8.92 37.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 t70 54.72 38.72 30.58 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.239 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.537 HG23 ' HG2' ' A' ' 27' ' ' GLU . 65.5 mt -100.75 127.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.257 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -143.57 29.77 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.843 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 7.0 mm-40 -88.74 149.05 43.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.965 -163.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.76 141.58 24.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.293 1.996 . . . . 0.0 111.795 173.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.87 124.75 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -95.77 108.92 43.36 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.791 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.58 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 87.9 Cg_endo -76.69 152.0 32.66 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.744 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.66 -167.78 33.16 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.421 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.44 30.63 0.53 Allowed 'Trans proline' 0 CA--C 1.519 -0.253 0 C-N-CA 123.494 2.796 . . . . 0.0 112.445 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.85 82.9 0.16 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.528 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.21 137.51 24.84 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.048 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.586 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 18.9 Cg_endo -58.7 -27.42 83.28 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.935 2.423 . . . . 0.0 113.381 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 41.8 mt-10 -90.87 -33.62 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -76.63 -30.91 57.08 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.004 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.0 tp -84.89 -5.05 59.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.94 0.876 . . . . 0.0 109.367 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 48.3 t-20 -81.47 -56.05 4.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.283 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -82.8 -26.4 31.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.89 -136.47 3.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.339 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -140.33 147.35 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 t -130.26 -171.79 2.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.852 0.358 . . . . 0.0 110.181 -175.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -93.1 174.46 7.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.329 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.87 -52.82 8.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -127.99 177.02 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.47 -18.04 52.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -82.43 -2.16 52.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.934 0.397 . . . . 0.0 110.755 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 138.43 57.61 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 38.4 m -122.38 -172.83 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.634 HD11 ' HB1' ' A' ' 15' ' ' ALA . 65.7 mt -111.95 -18.71 12.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.632 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 4' ' ' LYS . 36.7 t70 -126.52 13.1 7.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.801 0.81 . . . . 0.0 110.184 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 18.8 t70 -81.17 160.83 24.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.239 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -66.34 -25.53 66.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.826 0.346 . . . . 0.0 110.293 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -108.72 110.71 22.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.789 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 mm -119.2 90.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -92.83 108.73 20.22 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.158 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.9 mt -102.58 121.47 53.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 115.46 27.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 72' ' ' PHE . . . -123.63 167.04 15.95 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.403 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -154.16 153.66 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.463 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 20.0 m -84.91 141.71 30.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CE2' ' HB3' ' A' ' 66' ' ' ASP . 45.3 t80 -125.23 107.92 11.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -51.39 -39.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.27 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.464 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 18.8 t70 -73.23 -22.06 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -109.45 129.74 23.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.96 -0.462 . . . . 0.0 111.069 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.72 -5.0 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.976 2.451 . . . . 0.0 113.152 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -143.91 77.44 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.287 0.565 . . . . 0.0 110.67 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 30.6 p90 -140.54 -166.97 2.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.804 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.843 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 13.2 mm-40 -43.55 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.075 0.859 . . . . 0.0 112.738 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.402 ' CD2' ' HA3' ' A' ' 61' ' ' GLY . 23.8 m-85 -106.2 79.66 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.065 0.46 . . . . 0.0 111.002 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -111.48 -52.18 2.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.658 0.742 . . . . 0.0 109.862 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.5 t30 -97.5 19.92 12.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.211 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.21 -16.47 62.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.206 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -9.73 50.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.717 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.26 16.32 11.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.83 147.69 22.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.944 0.402 . . . . 0.0 111.167 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.602 ' HE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -150.59 -172.66 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.407 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 97' ' ' MET . 20.1 ptmt -47.05 -49.78 20.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -171.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -115.59 59.96 0.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 119.71 -1.233 . . . . 0.0 112.294 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 30.5 m -79.61 -2.44 42.57 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.886 -0.185 . . . . 0.0 111.43 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 49.7 78.01 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.587 0.554 . . . . 0.0 111.453 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 41.5 t -79.69 112.3 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.722 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -97.86 109.15 21.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.852 0.358 . . . . 0.0 110.084 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -94.07 101.89 13.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.8 tptm -85.63 92.22 8.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.768 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 5' ' ' PRO . 7.3 p -119.47 126.6 75.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.18 0.514 . . . . 0.0 111.091 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.03 -101.02 0.27 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.942 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -125.22 1.85 7.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 0.0 110.273 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.23 132.39 50.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -101.7 87.16 3.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -92.85 128.93 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.137 0.494 . . . . 0.0 110.456 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.44 139.16 32.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.741 -173.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 77.8 m-85 -122.67 148.88 44.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.784 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.599 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -119.16 132.26 55.95 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.66 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 61.6 mtt -82.53 69.67 9.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.379 0.609 . . . . 0.0 110.562 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -75.7 -26.97 58.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.224 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.613 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -120.19 108.77 14.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.567 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.31 126.77 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.728 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.565 HH22 ' HB2' ' A' ' 109' ' ' GLU . 25.5 ptt180 -168.1 -177.07 3.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.245 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -120.66 139.96 52.28 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 110' ' ' VAL . 31.3 m -129.43 -178.01 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.824 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -105.55 157.64 34.07 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.271 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -21.49 72.06 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.447 2.098 . . . . 0.0 111.637 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 t -118.8 26.9 9.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.6 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 19.3 t70 -63.04 152.84 35.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.934 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.16 -14.11 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.926 0.393 . . . . 0.0 111.376 -170.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.565 ' HB2' HH22 ' A' ' 101' ' ' ARG . 43.4 mt-10 -88.44 -29.55 20.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.124 0.488 . . . . 0.0 109.749 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 103' ' ' VAL . 22.9 m -79.34 -6.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.391 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 86.0 mt -88.32 3.29 50.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.287 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -109.63 -172.51 2.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.349 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.45 112.26 13.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.14 74.13 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 111.277 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.75 161.29 30.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.282 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.01 6.09 63.6 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -114.43 -179.49 3.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.265 0.555 . . . . 0.0 110.691 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -94.56 -154.74 0.43 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 9.6 mmtm -64.45 123.91 20.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.88 104.6 16.54 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.719 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 144' ' ' ALA . 25.3 tp -78.32 100.76 6.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -93.71 99.48 11.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.002 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.3 mm? -80.5 99.72 8.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.41 110.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.146 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.1 m -110.42 95.3 5.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 -176.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.505 ' HB3' ' CB ' ' A' ' 136' ' ' TRP . 69.2 m -89.7 101.23 13.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -121.8 2.63 10.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.665 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 7.1 t70 -119.86 96.38 5.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.58 130.57 42.17 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.294 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 50.1 t-20 -97.62 116.87 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.321 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.65 -24.73 62.76 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -72.22 -21.22 61.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.522 HG23 HG22 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -141.2 -34.81 0.48 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.86 2.51 34.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.817 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 133' ' ' THR . 17.2 m -86.73 -174.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.754 0.311 . . . . 0.0 110.89 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 126' ' ' CYS . 54.5 m95 -114.68 126.65 55.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 130' ' ' ASN . 34.7 mm-40 -77.6 -74.72 0.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -175.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.665 ' HG2' ' HB2' ' A' ' 128' ' ' ASP . 22.8 pttm -85.13 131.03 34.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 110.432 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -116.48 97.96 6.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.927 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -66.18 126.7 29.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 tt -126.21 122.71 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.656 0.741 . . . . 0.0 110.812 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.574 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.5 m-85 -108.82 112.13 24.23 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 33.8 t -95.55 96.32 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.473 0.654 . . . . 0.0 109.723 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -96.93 109.89 22.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.332 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 m -81.75 140.38 34.3 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.961 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.59 119.8 8.25 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.455 0.472 . . . . 0.0 110.566 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.599 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 10.0 t -85.89 137.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.94 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.915 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtm . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.528 0.204 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -92.27 13.07 20.33 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.951 0.405 . . . . 0.0 110.812 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.87 108.66 5.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.338 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -122.21 94.62 47.85 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.944 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.4 127.31 17.91 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.691 2.261 . . . . 0.0 111.399 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -140.73 127.68 20.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.65 0.738 . . . . 0.0 110.967 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.615 HG13 HD21 ' A' ' 52' ' ' LEU . 7.0 mt -59.95 131.01 89.14 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.14 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.28 160.8 26.1 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.722 2.282 . . . . 0.0 111.407 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 20.1 ptmt -79.23 -15.78 57.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 33.7 t70 -79.99 122.17 26.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 110.727 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -85.12 20.04 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.669 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -126.79 10.26 7.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.565 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 93.8 mttt -105.74 174.78 5.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.76 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.88 117.87 52.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.881 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.64 -31.99 23.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.409 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.05 173.21 45.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.259 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 80.8 m-85 -117.13 137.55 52.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.39 114.8 38.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.253 0.549 . . . . 0.0 109.574 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 66.1 mt-10 -117.93 106.16 12.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.426 0.632 . . . . 0.0 111.28 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.94 95.3 48.95 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.93 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HG3' ' HE2' ' A' ' 85' ' ' TYR . 18.6 Cg_endo -59.95 -30.36 91.53 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.946 2.431 . . . . 0.0 112.212 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.473 ' OD1' ' HD2' ' A' ' 79' ' ' LYS . 30.4 t0 -66.28 -30.86 71.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.57 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 74' ' ' ASN . . . -107.2 3.53 25.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.7 t0 61.73 23.08 13.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.99 0.9 . . . . 0.0 110.583 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 65.2 mt -90.35 106.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.124 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -133.04 83.43 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.554 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 31.9 mm-40 -133.8 159.37 72.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.925 -173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.49 148.22 18.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.669 2.246 . . . . 0.0 113.337 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.85 128.09 61.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.075 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' SER . 65.2 m-85 -100.58 117.97 61.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 52.3 Cg_endo -68.19 150.16 76.67 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.866 2.377 . . . . 0.0 112.575 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.07 177.7 27.76 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.427 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 94.6 Cg_endo -79.19 30.99 0.46 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.323 2.682 . . . . 0.0 112.757 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HB1' HD22 ' A' ' 39' ' ' LEU . . . 60.22 38.8 19.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.721 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.414 ' HB ' ' OE1' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -53.73 127.21 51.32 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.328 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.36 -59.54 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.994 3.129 . . . . 0.0 114.555 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 41.3 mt-10 -74.42 -35.99 63.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 23.3 mp0 -69.77 -35.24 74.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.0 110.361 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.427 HD22 ' HB1' ' A' ' 34' ' ' ALA . 17.2 tp -84.18 -10.97 57.31 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.839 0.828 . . . . 0.0 109.453 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 52.3 t30 -66.63 -49.69 65.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.778 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -90.79 -23.25 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.386 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.34 -147.07 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.701 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 71' ' ' GLN . 16.0 m -132.65 152.56 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 5.5 t -137.05 -171.75 3.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.688 0.28 . . . . 0.0 110.402 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -103.09 171.75 7.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.442 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' SER . . . -63.68 -47.63 80.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 110.173 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.29 162.34 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.681 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 9.6 pt-20 -74.26 -17.48 60.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -109.9 30.44 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.623 0.725 . . . . 0.0 109.857 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' HD12 ' A' ' 7' ' ' ILE . 4.9 tp10 -62.83 146.36 52.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.153 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 37.7 m -120.05 120.14 35.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.102 0.477 . . . . 0.0 111.506 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.917 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.7 mm? -71.22 -17.56 62.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.702 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -92.72 0.88 57.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.524 0.678 . . . . 0.0 110.322 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.9 t70 -83.05 -172.48 4.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.692 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.98 -30.19 18.95 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.84 132.55 56.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.109 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.464 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.4 mp -135.56 108.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 20.2 m -101.02 124.69 47.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.998 0.427 . . . . 0.0 111.175 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.57 125.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.818 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.05 127.43 37.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 72' ' ' PHE . . . -139.89 170.71 24.16 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.586 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -169.07 165.28 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.583 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.7 m -75.1 143.16 43.51 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 6.0 t80 -122.06 152.8 39.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.78 0.324 . . . . 0.0 110.635 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -99.43 -47.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.545 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -58.98 -46.03 89.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.965 -174.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -101.77 124.43 40.51 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.6 5.76 6.19 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.805 2.337 . . . . 0.0 110.763 170.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -149.86 80.3 1.38 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.707 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -126.76 -160.25 0.98 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.009 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.613 ' HG2' HG22 ' A' ' 43' ' ' VAL . 1.5 mp0 -59.44 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.478 ' CD1' ' HA3' ' A' ' 61' ' ' GLY . 22.5 m-30 -91.09 31.66 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.526 HG23 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -63.82 -24.41 67.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.4 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 64.7 t30 -134.95 36.0 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.723 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.89 13.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.589 -0.695 . . . . 0.0 111.271 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -89.97 -22.09 22.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.227 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.53 21.64 8.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.982 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.85 153.94 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.482 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HD2' ' OD1' ' A' ' 22' ' ' ASP . 4.6 mptt -132.6 -168.16 2.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.0 ptpp? -69.67 -23.94 63.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.855 0.359 . . . . 0.0 111.67 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -121.88 56.34 0.64 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.855 -1.165 . . . . 0.0 112.709 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -81.42 -10.45 59.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 57.01 90.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.451 0.643 . . . . 0.0 111.344 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.3 t -95.06 109.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.25 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 73.1 m-85 -94.56 114.35 26.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 121' ' ' LEU . 9.2 t80 -98.95 104.81 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 18.8 tptp -87.3 83.89 7.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.469 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.917 HG21 ' HG ' ' A' ' 52' ' ' LEU . 7.1 p -113.85 131.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.926 0.393 . . . . 0.0 110.678 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.55 -103.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.61 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -127.54 8.81 6.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.393 0.139 . . . . 0.0 111.227 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.41 158.52 32.55 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 112.159 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -124.63 108.89 12.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 97.9 mtt180 -100.14 146.6 26.63 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.186 -0.205 . . . . 0.0 110.591 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 120.14 39.69 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.571 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 94.6 m-85 -112.67 141.28 46.64 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -111.42 133.21 53.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.3 mtt -81.4 63.61 5.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.527 0.679 . . . . 0.0 110.465 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -71.26 -32.27 68.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.462 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 65.3 m -114.26 97.69 6.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 138.7 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.844 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -162.22 -178.45 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.515 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -126.48 140.01 52.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.888 HG23 ' HG3' ' A' ' 139' ' ' ARG . 7.7 m -114.2 147.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -85.77 159.08 55.71 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.623 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . 31.2 Cg_endo -64.79 -22.83 63.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.604 2.203 . . . . 0.0 111.596 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -106.66 8.5 31.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.145 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 11.7 t70 -85.13 142.22 29.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.75 11.07 8.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.951 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.49 -28.27 28.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 0.0 109.505 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.52 -26.42 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.03 9.91 37.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.872 0.368 . . . . 0.0 111.516 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 7.9 t70 -100.93 -175.09 2.78 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.036 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.406 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 4.2 pt-20 -115.22 102.74 10.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.18 0.514 . . . . 0.0 110.477 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -79.52 95.27 5.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.869 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.502 ' H ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.08 -175.96 3.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.413 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.07 -4.83 84.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.192 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -98.47 -174.31 2.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.81 -158.62 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -64.5 111.82 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 171.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.71 151.75 47.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.328 0.585 . . . . 0.0 112.209 -173.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -106.98 121.59 44.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.433 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 27.5 m -95.78 98.93 10.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.062 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 8.7 mt -85.03 101.07 12.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.131 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.1 mt -92.01 92.64 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -101.62 101.17 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.317 0.579 . . . . 0.0 111.183 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 76.9 m -84.06 105.07 14.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.874 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -98.8 -27.27 14.01 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.485 ' CG ' ' HD3' ' A' ' 138' ' ' LYS . 16.0 t70 -114.71 100.29 8.14 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.276 0.56 . . . . 0.0 111.14 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -87.14 122.76 31.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.441 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -91.04 107.3 19.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.23 -27.15 67.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.986 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -65.13 -34.74 79.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -173.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.506 HG23 HG12 ' A' ' 135' ' ' VAL . 9.9 t -126.16 -5.6 6.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 110.625 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.93 52.52 14.06 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.931 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.506 HG12 HG23 ' A' ' 133' ' ' THR . 9.0 p -142.23 150.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 46.6 m95 -92.69 98.0 11.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.741 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 42.7 mt-10 -72.42 -64.87 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 111.101 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.741 ' HD2' ' HB2' ' A' ' 137' ' ' GLU . 8.4 mptt -81.58 109.23 15.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.597 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.888 ' HG3' HG23 ' A' ' 103' ' ' VAL . 11.9 ptt180 -121.38 114.75 21.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.451 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.414 ' HE2' ' CE2' ' A' ' 142' ' ' PHE . 19.9 tptm -83.79 127.35 33.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.671 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.2 tt -120.1 128.44 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.578 0.704 . . . . 0.0 110.975 -175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.8 m-85 -115.84 116.09 27.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.026 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 41.3 t -98.86 96.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -95.73 116.04 28.3 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.775 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 m -96.34 145.17 25.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.696 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.04 122.56 9.61 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.58 0.55 . . . . 0.0 110.691 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.542 HG21 ' HE3' ' A' ' 96' ' ' LYS . 15.0 p -122.99 150.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.498 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 148' ' ' LYS . 14.9 ptpt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.326 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.608 ' SD ' ' HA2' ' A' ' 89' ' ' GLY . 60.9 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -83.01 -177.23 6.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.154 0.502 . . . . 0.0 111.323 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.75 165.48 17.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.574 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt 53.94 93.77 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 123.709 0.631 . . . . 0.0 111.155 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.66 130.44 24.87 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.051 2.501 . . . . 0.0 113.612 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -143.55 161.33 38.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.088 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 31' ' ' PRO . 3.5 mp -90.89 126.82 54.26 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.71 -175.31 2.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.117 2.545 . . . . 0.0 111.701 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.24 -17.77 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.663 -178.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -90.07 121.51 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.517 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -106.5 16.54 24.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.136 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -102.46 3.48 37.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -122.35 168.6 11.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.846 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.8 t -93.89 119.4 41.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.221 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -94.19 -21.62 18.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.29 164.41 37.17 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.318 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 79.7 m-85 -119.87 144.77 47.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -101.71 108.49 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.812 0.815 . . . . 0.0 109.564 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.78 108.62 17.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.193 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.431 HG12 HG13 ' A' ' 84' ' ' VAL . 41.7 mt -126.42 91.24 48.09 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.096 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 21.5 Cg_endo -61.55 -25.75 79.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.942 2.428 . . . . 0.0 112.164 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.562 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 33.8 t70 -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.028 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -110.29 8.31 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.57 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 t70 63.47 27.62 15.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.747 0.784 . . . . 0.0 110.652 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 88.6 mt -104.2 114.62 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.298 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.2 mppt? -142.37 82.1 1.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 11.2 mm-40 -134.02 159.99 70.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.054 -173.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 67.4 Cg_endo -75.17 144.91 30.24 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.918 2.412 . . . . 0.0 113.442 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.81 128.37 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.623 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -97.63 114.6 65.15 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HB2' HG23 ' A' ' 7' ' ' ILE . 86.1 Cg_endo -78.67 142.22 17.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.757 2.305 . . . . 0.0 112.431 -174.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.42 -161.43 28.19 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.912 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 59.8 Cg_endo -88.18 30.02 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.911 3.074 . . . . 0.0 113.312 -175.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.22 56.84 4.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.63 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.38 138.02 95.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.37 -58.62 1.3 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.252 3.302 . . . . 0.0 114.076 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.49 -34.44 76.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.648 0.261 . . . . 0.0 111.696 -176.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 9.4 tp60 -81.2 -36.34 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.426 . . . . 0.0 110.847 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.41 -14.72 59.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.621 0.724 . . . . 0.0 109.575 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -73.91 -42.66 60.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.168 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 41' ' ' ARG . 12.9 ptm180 -86.13 -40.39 15.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.521 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.88 -157.11 8.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.603 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 HE21 ' A' ' 71' ' ' GLN . 40.2 t -113.26 142.67 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 t -130.64 -174.73 3.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -93.67 160.05 14.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -29.26 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.445 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -135.78 165.55 25.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 37.6 tt0 -82.8 -32.12 27.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.748 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.47 31.05 0.59 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.119 0.485 . . . . 0.0 111.167 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -85.68 151.41 23.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.838 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 47.1 m -122.93 150.21 43.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.752 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 93.6 mt -93.02 6.8 46.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.785 0.326 . . . . 0.0 111.746 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -132.68 8.34 4.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.706 0.765 . . . . 0.0 109.547 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.838 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 15.6 t70 -81.71 164.26 21.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.288 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tm0? -67.78 -29.05 68.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.035 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 138.37 53.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.794 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -140.0 117.82 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.858 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -100.23 103.4 14.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.045 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.5 mt -98.31 114.81 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.41 123.77 48.58 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.1 167.63 21.71 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.196 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -139.74 128.86 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.491 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.3 m -52.71 110.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.342 0.591 . . . . 0.0 111.282 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 66' ' ' ASP . 13.8 t80 -80.88 129.48 34.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.93 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.4 mm -75.0 -49.65 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.403 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.43 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -74.19 -1.35 20.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.23 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 85.0 mtm180 -130.24 94.38 30.54 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 -13.5 34.5 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.812 2.341 . . . . 0.0 112.515 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -147.33 63.27 1.16 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.445 0.641 . . . . 0.0 110.167 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 9.7 p90 -99.12 -157.79 0.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -43.57 -75.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.506 0.504 . . . . 0.0 112.123 178.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.541 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 22.2 m-30 -100.03 77.17 1.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.84 -52.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.554 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 10.7 t30 -88.62 11.94 16.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.047 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -23.16 64.89 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.958 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -70.1 -8.29 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.944 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.72 5.12 41.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.777 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . . . -96.16 135.15 38.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.438 0.637 . . . . 0.0 111.23 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' SER . 3.5 mppt? -108.86 -172.94 2.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -64.21 -30.62 71.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.827 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.82 49.69 0.83 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.246 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 6.7 t -66.07 -21.09 66.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.53 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 53.91 83.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.518 0.675 . . . . 0.0 111.547 -175.016 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 74.4 t -85.2 125.15 40.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.185 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -106.03 108.42 19.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.276 0.56 . . . . 0.0 110.337 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.75 103.07 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.0 tppp? -86.86 90.69 8.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.983 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 m -117.42 129.12 74.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.608 ' HA2' ' SD ' ' A' ' 1' ' ' MET . . . 63.78 -88.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.494 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -148.18 11.07 0.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 110.155 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 145.57 41.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 m -109.18 107.11 17.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.372 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -99.74 137.0 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.938 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.413 ' HB3' ' CE ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -102.89 139.01 39.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.519 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -133.27 142.52 48.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.023 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -107.63 136.76 46.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.9 mmt -80.64 70.37 7.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.4 0.619 . . . . 0.0 110.108 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -83.64 -4.69 58.8 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.895 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 20.2 m -144.02 105.82 4.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.093 0.473 . . . . 0.0 110.587 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 97' ' ' MET . 77.3 mt -122.08 123.27 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.924 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -165.23 -166.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.213 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.666 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 4.5 p-10 -142.98 144.97 32.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.691 HG23 ' HE ' ' A' ' 139' ' ' ARG . 11.3 m -132.07 154.17 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.269 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -97.09 164.86 16.94 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.785 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -67.19 -18.35 50.77 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.473 2.115 . . . . 0.0 111.229 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -103.91 12.86 33.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' HG13 ' A' ' 110' ' ' VAL . 7.6 t70 -74.63 154.76 38.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.432 ' HA ' HD21 ' A' ' 111' ' ' LEU . 28.5 m -96.11 -15.26 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 -172.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.15 -5.06 55.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.332 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 107' ' ' ASP . 21.8 m -83.6 -17.93 10.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.818 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -112.49 18.5 18.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 178.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.91 167.58 14.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.34 139.44 57.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.804 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.63 143.29 30.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.38 170.0 13.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.588 -166.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.13 51.78 2.87 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.254 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -83.1 177.0 8.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.13 -156.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 19.1 mmtm -60.7 115.45 3.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -106.34 112.04 24.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.979 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.55 105.38 9.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -91.57 93.73 9.09 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.683 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -77.65 99.1 5.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.578 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.51 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.043 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -117.67 89.72 3.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.007 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 64.0 m -73.97 104.82 4.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -110.54 76.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.569 0.7 . . . . 0.0 110.75 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 16.6 t70 -162.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.707 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.484 ' CZ ' ' HG2' ' A' ' 131' ' ' GLU . 1.6 t80 61.03 86.67 0.1 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.628 0.58 . . . . 0.0 110.384 -172.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -92.79 97.36 10.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.696 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.484 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 36.4 mt-10 -60.87 -15.74 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.278 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.24 -34.79 78.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.903 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -115.55 -14.99 11.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.436 0.636 . . . . 0.0 109.844 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.11 31.89 50.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.029 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.5 t -134.86 139.33 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 44.1 m95 -78.14 92.26 4.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 172.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.55 -8.46 59.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 62.9 tttm -121.13 131.15 54.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 19.9 ttp180 -136.57 100.92 4.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.34 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.666 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 48.7 tptt -69.1 126.68 30.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.12 124.88 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.772 0.796 . . . . 0.0 111.033 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 14.6 m-85 -115.66 116.36 27.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.395 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 45.6 t -104.02 103.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.322 0.582 . . . . 0.0 110.103 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.63 114.48 28.2 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.747 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.9 m -89.75 140.14 29.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.07 126.57 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.202 0.525 . . . . 0.0 111.255 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.461 HG11 ' HD3' ' A' ' 96' ' ' LYS . 13.1 p -130.09 160.53 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.229 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.491 -178.13 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.42 173.42 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.131 0.491 . . . . 0.0 110.345 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.48 86.66 7.07 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.629 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 87.8 mttt -137.78 103.85 8.33 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.95 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 35.9 Cg_endo -64.19 135.87 49.05 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.974 2.449 . . . . 0.0 112.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -134.41 167.1 21.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.197 0.522 . . . . 0.0 110.519 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 51' ' ' SER . 43.1 mt -107.02 113.78 62.15 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.73 177.35 3.65 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.92 2.413 . . . . 0.0 112.292 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -74.65 -24.25 58.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 110.134 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.21 100.26 0.77 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.015 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -98.68 20.84 12.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 110.608 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -100.23 -11.86 20.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.284 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -107.33 176.69 5.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.097 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.97 129.53 41.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.727 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.5 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.301 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -155.3 176.08 33.04 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.668 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 71.9 m-85 -122.7 135.98 54.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.6 tp -98.63 110.05 25.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.807 0.813 . . . . 0.0 109.776 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 85.9 mt-10 -119.17 109.62 16.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.92 89.6 38.15 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.67 -32.73 76.81 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.112 2.541 . . . . 0.0 112.481 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.63 -23.78 64.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -107.89 8.12 28.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.137 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 65.4 17.65 11.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.844 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 91.2 mt -97.38 131.27 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.985 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 37.0 mtpt -156.41 45.73 0.43 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.486 0.66 . . . . 0.0 109.834 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -106.63 156.87 36.38 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.158 -169.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 57.4 Cg_endo -73.43 148.63 43.28 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 121.91 1.74 . . . . 0.0 112.896 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.82 134.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 44' ' ' SER . 46.5 m-85 -101.08 144.22 28.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.318 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.13 162.52 20.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.411 2.074 . . . . 0.0 110.894 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.24 165.2 13.24 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.093 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.66 30.24 0.41 Allowed 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.041 3.161 . . . . 0.0 113.221 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.36 43.39 23.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.763 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.759 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.65 147.24 96.45 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.15 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.637 ' HD2' HG22 ' A' ' 35' ' ' THR . 89.2 Cg_exo -49.04 -53.3 7.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.291 2.66 . . . . 0.0 113.965 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.759 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -71.82 -27.08 62.67 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.761 -178.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 44' ' ' SER . 42.6 tp60 -62.49 -51.91 65.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.995 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.74 -16.83 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.445 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.62 -40.3 66.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.266 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -68.97 -45.12 71.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.051 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.0 -110.19 0.23 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.598 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.3 m -130.71 152.68 37.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.58 0.229 . . . . 0.0 110.679 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 36.9 t -148.18 165.81 29.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.001 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -68.56 162.01 26.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.32 -37.44 25.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HB3' ' H ' ' A' ' 49' ' ' ASN . 21.2 mm-40 -125.61 156.33 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.33 -1.65 58.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.856 0.836 . . . . 0.0 108.772 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.436 ' H ' ' HB3' ' A' ' 47' ' ' GLU . 27.0 t-20 -91.14 -19.72 22.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.058 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.71 170.51 16.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.991 0.424 . . . . 0.0 110.532 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.535 ' HA ' HD12 ' A' ' 7' ' ' ILE . 56.1 m -146.94 157.63 43.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.525 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HG ' HG13 ' A' ' 7' ' ' ILE . 96.0 mt -73.79 -12.09 60.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 111.939 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -113.5 11.16 18.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.879 0.847 . . . . 0.0 109.844 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 4.3 t0 -83.21 156.78 23.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.652 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 115' ' ' LYS . 1.1 tm0? -68.15 -32.75 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.15 120.33 40.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.409 0.623 . . . . 0.0 111.56 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.1 mt -125.75 134.16 67.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 p -132.45 121.14 22.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.06 0.457 . . . . 0.0 112.022 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mt -108.69 128.45 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.02 123.57 33.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.033 0.444 . . . . 0.0 111.283 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 123.94 7.7 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.762 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.47 ' HA ' ' C12' ' A' ' 201' ' ' JPT . 3.5 t-160 -70.51 -61.85 1.61 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.505 0.193 . . . . 0.0 110.687 -176.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 m 69.09 122.46 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 O-C-N 124.099 0.875 . . . . 0.0 110.693 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -152.63 138.75 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.3 -37.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.721 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.94 6.94 16.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.339 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -136.39 77.47 47.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.64 3.65 7.66 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.827 2.351 . . . . 0.0 113.338 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -153.19 47.44 0.69 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.973 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -101.5 -175.21 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HG3' ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.69 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 21.3 m-30 -96.96 81.33 3.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.485 0.66 . . . . 0.0 111.245 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 m -150.4 -41.28 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.174 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -91.08 11.9 21.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.462 0.649 . . . . 0.0 109.388 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.01 -12.53 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.948 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -10.13 58.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.069 0.462 . . . . 0.0 111.257 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -82.13 -9.77 59.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.496 175.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.17 132.06 35.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.068 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' MET . 26.4 mmtp -120.53 -177.74 3.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -61.12 -13.77 19.82 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.42 34.23 2.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.547 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.0 m -82.77 121.86 27.45 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mtp -71.8 108.17 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 110.526 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 63.3 t -89.56 115.94 30.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.668 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 82.6 m-85 -102.57 121.42 42.35 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.072 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 12.0 t80 -112.81 99.06 7.61 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 5.4 mptt -75.25 102.22 4.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.013 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.85 86.73 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.168 0.509 . . . . 0.0 111.561 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.38 -59.25 3.26 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.308 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -137.35 -37.46 0.63 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 111.392 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -107.97 -179.73 3.98 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 6.6 t -132.23 142.57 49.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.397 0.618 . . . . 0.0 109.905 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -100.24 132.2 45.75 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.942 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -99.76 126.48 45.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.942 0.401 . . . . 0.0 110.462 -177.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 83.9 m-85 -125.13 149.94 47.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.38 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.8 tptm -113.17 135.18 54.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.604 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 16.7 mmt -79.9 62.62 4.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -75.62 -8.95 58.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.126 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.573 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 55.9 m -145.21 103.3 3.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.966 -0.459 . . . . 0.0 110.998 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.6 mt -120.59 128.34 76.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.24 177.42 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -132.16 120.55 22.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -75.24 151.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.51 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -86.51 148.39 46.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.73 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.628 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 32.8 Cg_exo -62.06 -15.68 45.29 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.697 2.265 . . . . 0.0 112.284 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -99.76 -5.66 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.84 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -91.81 133.22 35.83 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.57 24.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -115.89 -28.14 6.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.562 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.18 -22.59 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.475 0.655 . . . . 0.0 110.79 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.499 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -99.5 25.53 6.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.467 -173.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.91 175.35 7.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.552 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.7 pt-20 -72.21 70.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.397 0.618 . . . . 0.0 112.033 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -86.72 75.46 9.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.569 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -100.11 -179.36 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.31 -2.38 16.29 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.44 -170.71 3.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.34 -0.43 . . . . 0.0 109.946 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.75 -158.51 0.4 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 1.3 mptm? -61.77 104.82 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.05 125.4 49.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.327 0.584 . . . . 0.0 110.54 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.4 tp -91.92 109.72 21.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m -96.28 102.26 14.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.572 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.6 mm? -87.38 100.7 12.93 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.72 89.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.6 m -100.56 99.73 10.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 83.4 m -60.7 125.26 23.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.425 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 8.8 t70 -112.08 -21.57 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.041 -160.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 13.6 t70 -140.85 108.57 5.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.389 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -101.38 130.08 47.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.57 0.7 . . . . 0.0 109.924 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -80.67 103.27 10.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.274 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -54.95 -26.07 33.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.08 -17.45 58.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.554 ' OG1' HG22 ' A' ' 135' ' ' VAL . 16.5 p -126.68 -37.69 2.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.536 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.85 8.54 51.24 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.939 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.554 HG22 ' OG1' ' A' ' 133' ' ' THR . 30.2 m -98.34 141.51 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 111.34 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 129' ' ' TYR . 60.4 m95 -87.97 86.65 7.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 105' ' ' PRO . 51.2 mt-10 -65.0 -64.19 0.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.961 -175.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 35.6 tttm -85.5 126.48 33.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -129.09 139.95 51.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.64 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 27.0 tttp -87.57 145.08 26.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.126 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.25 125.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.672 0.748 . . . . 0.0 110.936 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.7 m-85 -111.91 112.71 24.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.891 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 59.3 t -98.15 98.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 109.649 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -98.4 102.87 14.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.201 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.9 m -82.07 139.64 34.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.871 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -57.58 126.01 25.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.492 0.663 . . . . 0.0 110.8 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 148' ' ' LYS . 11.9 p -114.05 170.82 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.935 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.2 ptmm? . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.715 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.47 ' C12' ' HA ' ' A' ' 62' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.705 0.288 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -88.13 -14.87 37.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.333 0.587 . . . . 0.0 110.693 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.11 135.72 31.21 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.058 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp 43.3 79.76 0.32 Allowed Pre-proline 0 C--O 1.233 0.211 0 O-C-N 123.859 0.724 . . . . 0.0 111.913 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.33 144.92 69.96 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.6 2.2 . . . . 0.0 112.169 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.79 156.84 47.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.733 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.421 HG23 ' CB ' ' A' ' 31' ' ' PRO . 28.3 mt -107.8 109.6 62.28 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.364 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.689 ' HG2' ' HE3' ' A' ' 13' ' ' LYS . 49.9 Cg_endo -73.35 164.09 36.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.418 2.078 . . . . 0.0 111.579 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.19 -3.22 19.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 -177.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.714 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 19.3 t70 -69.24 145.63 52.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.272 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 22.5 pttp -118.63 9.73 12.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 111.525 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -95.01 -50.46 5.09 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.056 -0.402 . . . . 0.0 111.35 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.714 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -76.83 162.04 27.96 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -96.85 151.6 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.105 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.36 -32.12 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.66 164.27 25.45 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.994 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 59.1 m-85 -129.73 135.17 48.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -104.98 115.23 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.532 0.682 . . . . 0.0 110.154 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -125.17 119.91 29.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.891 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.4 95.03 18.57 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.071 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.93 -22.55 68.51 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.715 2.277 . . . . 0.0 112.115 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 82' ' ' SER . 27.0 t0 -68.5 -33.02 73.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.392 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.56 2.5 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.584 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t0 57.7 36.56 26.73 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.874 0.845 . . . . 0.0 110.313 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 55.0 mt -102.45 121.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.624 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -147.06 86.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.4 mm-40 -145.26 159.8 47.75 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.617 0.246 . . . . 0.0 111.099 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.2 157.7 45.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.837 2.358 . . . . 0.0 113.447 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 14' ' ' VAL . 93.4 t -110.88 123.34 66.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.716 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 44' ' ' SER . 60.0 m-85 -92.42 110.97 48.3 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.312 0.577 . . . . 0.0 111.467 -175.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.7 Cg_exo -77.61 129.82 10.33 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.223 2.616 . . . . 0.0 111.728 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.03 -173.7 43.68 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.918 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 11' ' ' LYS . 3.3 Cg_exo -78.66 10.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.542 2.828 . . . . 0.0 112.845 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 67.49 29.92 7.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.663 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -68.56 160.24 77.53 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.26 -45.32 22.4 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.697 2.931 . . . . 0.0 114.727 -174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.517 ' OE1' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -71.79 -30.46 65.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.571 -175.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HG2' ' OE1' ' A' ' 37' ' ' GLU . 85.2 mm-40 -68.01 -36.84 80.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 0.0 110.339 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -81.92 -0.61 44.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.037 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -108.32 -12.18 15.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.698 0.285 . . . . 0.0 111.001 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 10.1 ptm180 -95.36 -25.81 16.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.783 0.325 . . . . 0.0 110.576 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.0 -122.59 0.91 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.076 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 ' HG2' ' A' ' 71' ' ' GLN . 7.6 p -122.03 144.22 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 45.0 p -132.29 -168.27 2.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.456 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 36.6 m-85 -96.28 165.0 12.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.465 176.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.367 . . . . 0.0 111.446 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.35 168.92 19.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.05 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -67.85 -31.77 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.808 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -88.3 19.95 3.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.034 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 4.6 mm-40 -64.65 158.4 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.031 173.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.816 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 51.8 m -140.04 123.19 16.8 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.134 0.492 . . . . 0.0 111.737 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' CG1' ' A' ' 88' ' ' VAL . 30.6 mt -66.22 -26.75 67.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.271 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.55 -19.98 48.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.79 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.816 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 3.5 t70 -72.29 164.53 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.396 -172.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.61 ' HA ' ' HD2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.91 -31.19 61.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.054 -178.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.42 133.98 54.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.684 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.5 mt -133.47 121.7 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.925 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -110.09 107.8 17.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.263 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 121' ' ' LEU . 41.1 mt -94.55 111.81 26.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -105.71 123.31 47.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.561 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.477 ' HA3' HG23 ' A' ' 43' ' ' VAL . . . -150.58 175.52 29.57 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.088 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -142.11 156.38 45.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.733 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -71.73 140.96 49.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.361 0.413 . . . . 0.0 111.016 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -100.68 158.53 15.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.357 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.49 -38.14 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -87.9 -5.07 58.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 67' ' ' ARG . 8.6 mmt180 -113.25 115.36 47.62 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 0.0 110.665 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.82 -11.66 5.51 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.961 2.441 . . . . 0.0 113.359 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -160.58 89.07 0.81 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.562 0.696 . . . . 0.0 110.514 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.733 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 15.4 p90 -130.69 -151.83 0.48 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.809 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.697 ' HG2' HG12 ' A' ' 43' ' ' VAL . 25.8 mp0 -55.49 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 111.918 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.6 m-85 -94.88 82.07 3.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.154 0.502 . . . . 0.0 111.198 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 m -110.1 -60.96 1.73 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -95.96 28.12 3.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.656 -176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.8 tp -65.13 -19.0 65.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.418 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -9.61 58.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.62 11.75 23.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.939 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.28 161.39 14.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.349 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -135.27 -176.01 4.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.6 ptmm? -66.52 -13.86 61.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.336 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.66 45.91 1.11 Allowed Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 174.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.4 t -61.63 -25.33 67.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.09 -0.555 . . . . 0.0 112.117 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.52 89.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.698 0.761 . . . . 0.0 111.518 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.0 t -91.81 125.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.669 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -102.0 104.47 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -97.51 106.07 18.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 49.5 mttp -83.72 125.02 31.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.225 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -130.49 101.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.294 0.568 . . . . 0.0 110.144 -177.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.59 -81.72 0.4 Allowed Glycine 0 C--N 1.317 -0.482 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.421 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 -18.62 4.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.349 . . . . 0.0 111.242 -176.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -97.52 152.04 19.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -123.53 99.59 6.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.61 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -93.83 166.35 12.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.734 0.302 . . . . 0.0 110.761 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.564 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -127.55 126.64 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.454 0.645 . . . . 0.0 111.894 -170.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.6 m-85 -116.05 148.22 40.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.454 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.614 ' HB2' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -117.16 129.47 55.98 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 59.5 mtt -79.86 70.33 6.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.402 0.62 . . . . 0.0 110.703 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 t -80.04 -24.93 40.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.587 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 15.0 m -121.03 102.5 8.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.011 0.434 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.7 mt -113.11 129.98 67.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.17 173.94 11.5 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.909 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 140' ' ' LYS . 1.2 p30 -149.36 125.53 10.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.865 168.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 110' ' ' VAL . 19.0 m -131.38 -177.16 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.398 -169.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.3 mppt? -103.07 145.19 30.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.762 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 136' ' ' TRP . 25.3 Cg_exo -65.62 -12.99 37.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.95 2.433 . . . . 0.0 111.95 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -109.02 16.89 22.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.518 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.09 168.27 19.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.43 -20.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.691 0.281 . . . . 0.0 111.033 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.83 4.84 38.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.265 0.555 . . . . 0.0 110.777 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.461 HG23 HG21 ' A' ' 103' ' ' VAL . 11.3 p -80.12 -20.16 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -104.24 12.48 33.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.355 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 157.32 34.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 0.0 110.251 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.571 ' OE1' ' HE2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -92.9 82.73 4.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.541 0.686 . . . . 0.0 112.022 -174.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -77.02 74.23 3.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.571 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.64 174.27 5.95 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.25 -23.1 27.84 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -72.3 158.97 34.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.435 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.462 ' OD1' HG22 ' A' ' 145' ' ' THR . 3.1 p-10 -83.43 -161.71 0.54 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 55' ' ' GLN . 2.4 tptp -46.86 106.31 0.08 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.188 0.305 . . . . 0.0 110.244 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 10.0 pt20 -116.4 135.34 53.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.371 0.605 . . . . 0.0 110.861 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 59' ' ' ILE . 20.7 tp -101.47 109.86 21.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 m -94.37 101.27 13.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.49 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.9 mm? -80.49 104.55 11.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.727 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.473 HG23 ' HD3' ' A' ' 139' ' ' ARG . 53.3 mt -98.84 100.72 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.6 m -115.6 105.18 12.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.125 0.488 . . . . 0.0 110.833 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.5 m -90.99 94.31 9.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.453 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 9.6 p-10 -105.05 2.45 29.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.672 -166.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.5 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 20.8 t70 -127.66 99.18 5.47 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.246 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 87.2 t80 -97.36 127.19 43.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 133' ' ' THR . 22.1 t-20 -91.28 111.13 22.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.68 -14.43 62.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -85.7 -29.64 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 135' ' ' VAL . 10.1 t -124.07 -9.45 7.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.366 0.603 . . . . 0.0 110.663 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.78 54.6 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.727 -0.669 . . . . 0.0 113.062 175.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.474 HG12 HG23 ' A' ' 133' ' ' THR . 4.7 p -149.23 157.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 67.8 m95 -88.57 117.9 27.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.2 -24.97 25.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 128' ' ' ASP . 21.2 pttp -142.78 154.83 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.548 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HD3' HG23 ' A' ' 124' ' ' ILE . 11.8 ttm180 -121.87 112.99 19.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.529 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.515 ' CD ' ' HB3' ' A' ' 102' ' ' ASP . 51.7 tptt -77.14 123.67 26.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.41 HD12 HH11 ' A' ' 139' ' ' ARG . 11.5 tt -127.52 126.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.765 0.793 . . . . 0.0 111.212 -172.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.9 m-85 -117.07 112.95 21.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.8 t -94.23 94.68 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -95.96 104.05 15.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.368 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 0.4 OUTLIER -85.1 151.68 23.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 7.4 tp10 -55.58 142.4 33.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 110.865 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 96' ' ' LYS . 21.8 t -90.4 144.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.182 -0.913 . . . . 0.0 112.402 -174.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.941 0.4 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -100.33 4.71 44.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.797 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.18 143.53 9.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.192 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 8.8 mmmm 51.22 91.93 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 O-C-N 123.968 0.792 . . . . 0.0 112.349 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 88' ' ' VAL . 55.7 Cg_endo -71.66 146.45 48.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.297 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.31 -175.75 5.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.135 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.597 HG13 ' HG ' ' A' ' 52' ' ' LEU . 25.4 mt -102.08 117.95 60.25 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.716 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.78 168.29 21.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 112.109 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 4.2 mptp? -84.93 -17.11 38.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.379 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.83 125.66 30.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.783 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -105.88 18.86 21.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -94.22 -7.58 41.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.762 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -170.03 1.78 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.225 0.536 . . . . 0.0 111.108 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.04 137.7 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.921 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.26 -34.55 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.359 0.599 . . . . 0.0 110.567 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 166.01 39.22 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 75.8 m-85 -107.86 139.3 42.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.266 0.533 . . . . 0.0 110.053 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 25' ' ' ILE . 8.4 tp -101.94 117.48 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 34.9 mt-10 -120.78 113.33 20.01 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.477 0.656 . . . . 0.0 110.907 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 47.9 mt -127.32 94.12 39.34 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.492 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 10.1 Cg_endo -53.19 -42.96 61.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.279 2.653 . . . . 0.0 113.3 -172.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -13.71 61.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.678 0.275 . . . . 0.0 111.737 -176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.51 9.5 23.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.347 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.72 27.77 16.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.203 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.3 mt -96.92 119.99 45.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.329 -175.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 26' ' ' LYS . 24.4 mmmt -141.02 42.7 1.81 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.607 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 11.6 mm-40 -102.66 149.7 37.0 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.338 -165.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.39 135.68 13.53 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.771 2.314 . . . . 0.0 112.54 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.45 123.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.206 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.86 121.82 61.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -79.94 161.13 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.917 2.412 . . . . 0.0 112.256 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.2 -164.35 26.21 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.128 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.93 2.64 8.12 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.682 2.921 . . . . 0.0 113.103 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.96 89.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.882 0.738 . . . . 0.0 110.829 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 p -119.14 157.46 50.81 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.801 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.72 -52.87 6.9 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.695 2.93 . . . . 0.0 114.529 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.43 75.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 111.598 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -72.2 -37.68 69.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.93 0.395 . . . . 0.0 110.472 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.35 -18.06 60.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.98 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -81.7 -28.98 33.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -93.13 -35.79 13.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.673 0.273 . . . . 0.0 111.035 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' HG3' ' A' ' 71' ' ' GLN . . . -151.39 -137.86 2.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.208 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.25 162.32 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.2 m -131.43 172.32 12.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.905 0.383 . . . . 0.0 111.45 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.8 166.92 21.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.098 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.34 76.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.426 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -144.94 170.05 16.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.034 0.445 . . . . 0.0 110.962 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.09 -25.25 66.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.466 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.93 7.39 18.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 110.999 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.14 148.05 32.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -139.81 123.5 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.946 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.597 ' HG ' HG13 ' A' ' 7' ' ' ILE . 85.4 mt -74.26 -17.39 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.448 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.28 13.59 25.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.45 0.643 . . . . 0.0 110.529 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.45 178.08 4.69 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.5 pt20 -95.72 -22.21 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.705 0.288 . . . . 0.0 110.667 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -106.8 105.63 15.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.724 0.773 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.69 133.92 68.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.746 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 3.0 p -124.69 121.87 35.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.149 0.5 . . . . 0.0 112.06 -173.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -114.07 132.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.1 130.84 45.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.68 126.95 6.82 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.897 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -111.81 76.23 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 m -60.82 134.36 57.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.79 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -145.09 150.75 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.137 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -53.02 -43.24 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 123.713 0.633 . . . . 0.0 112.402 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.84 10.76 3.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.162 -174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -131.21 76.41 76.3 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.15 -28.04 11.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.791 2.327 . . . . 0.0 113.527 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -140.2 73.5 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.475 0.655 . . . . 0.0 110.729 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.463 ' CE1' ' HB ' ' A' ' 73' ' ' THR . 1.4 p90 -132.39 155.09 49.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.538 -0.756 . . . . 0.0 108.972 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.607 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 67.9 mm-40 16.49 -92.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.735 1.214 . . . . 0.0 114.226 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -116.7 97.11 5.81 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.677 0.275 . . . . 0.0 110.676 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.463 ' HB ' ' CE1' ' A' ' 70' ' ' TYR . 9.1 t -145.49 -39.34 0.24 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.219 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -91.58 26.67 2.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.706 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 125' ' ' THR . 19.6 mt -76.22 3.09 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.619 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -76.12 -21.08 57.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.189 0.518 . . . . 0.0 110.191 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.87 9.69 34.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.133 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.32 23.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.821 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 82' ' ' SER . 38.6 pttt -139.43 179.36 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.919 0.39 . . . . 0.0 111.109 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -66.77 -11.55 55.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.102 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.88 59.85 0.55 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 79' ' ' LYS . 6.0 p -74.77 -15.12 60.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.52 88.64 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.866 0.729 . . . . 0.0 111.407 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 56.1 t -88.81 124.56 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.909 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.1 m-85 -107.04 108.54 20.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.647 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 17.0 t80 -93.5 101.39 13.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.6 tptm -84.48 85.51 7.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.668 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 5' ' ' PRO . 7.8 p -109.85 125.6 67.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.441 0.638 . . . . 0.0 111.064 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 5' ' ' PRO . . . 63.45 -94.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.494 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.61 11.82 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.668 0.27 . . . . 0.0 111.146 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.8 160.42 26.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.894 0.378 . . . . 0.0 111.005 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 m -124.01 98.01 5.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.081 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.647 ' HG3' ' HB3' ' A' ' 86' ' ' PHE . 10.4 ptp180 -95.3 132.05 40.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.301 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -100.57 140.22 35.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.878 0.371 . . . . 0.0 110.793 -174.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.617 ' OH ' ' HD3' ' A' ' 93' ' ' ARG . 74.5 m-85 -129.31 147.93 51.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.77 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HD3' HG11 ' A' ' 147' ' ' VAL . 1.6 tptm -109.54 121.41 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 51.3 mtt -77.75 68.92 3.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 110.238 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -81.43 -11.74 59.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.924 -172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.7 m -135.43 99.4 4.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.991 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.97 128.01 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.4 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -167.75 179.2 4.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.203 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 4.5 p30 -125.12 153.25 43.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.05 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 110' ' ' VAL . 6.1 m -142.61 173.39 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.712 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.767 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -98.43 154.22 37.66 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.069 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.62 -15.5 49.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.623 2.215 . . . . 0.0 111.936 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.7 t -103.76 9.57 37.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.767 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 10.4 t70 -77.21 122.18 24.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.333 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.79 11.38 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.084 0.469 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -81.53 -46.91 13.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 103' ' ' VAL . 33.8 m -86.62 -8.33 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.211 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.0 mt -88.35 -3.78 58.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.103 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.05 160.89 25.66 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.83 106.89 3.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.025 0.441 . . . . 0.0 110.709 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.95 101.96 13.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.979 0.418 . . . . 0.0 111.347 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -169.76 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 173.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.74 -40.56 2.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.326 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -73.86 171.6 13.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.077 0.465 . . . . 0.0 110.766 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.16 -152.58 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.567 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -60.51 113.3 2.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -110.69 126.59 54.69 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.133 0.492 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 121' ' ' LEU . 23.9 mt -90.47 116.57 28.5 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.579 HG23 HD11 ' A' ' 141' ' ' ILE . 25.4 m -98.01 102.77 14.62 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.1 mm? -95.78 101.8 13.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.8 97.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.005 0.431 . . . . 0.0 109.885 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.651 HG21 HD12 ' A' ' 75' ' ' LEU . 21.1 p -105.25 107.39 18.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.424 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 m -94.2 92.83 7.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.3 33.72 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.077 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 26.9 t70 -137.47 103.86 5.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -100.08 123.86 44.81 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.833 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -97.86 112.54 24.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.392 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.3 -31.06 70.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.087 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mmmp? -70.8 -22.32 62.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.588 HG23 HG12 ' A' ' 135' ' ' VAL . 8.6 t -130.64 2.06 4.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 58.0 54.66 35.67 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.238 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 133' ' ' THR . 3.3 p -149.95 159.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.472 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 70.6 m95 -97.66 101.16 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.87 -66.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.428 -169.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -69.97 88.53 0.58 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.464 0.65 . . . . 0.0 110.568 -176.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.54 ' HG3' HG23 ' A' ' 103' ' ' VAL . 21.2 ptt180 -76.94 73.06 3.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.752 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HE2' ' CZ ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -62.67 124.25 20.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.348 -174.327 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.579 HD11 HG23 ' A' ' 122' ' ' THR . 8.7 tt -114.21 137.88 46.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.592 -168.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.614 ' CZ ' ' HE2' ' A' ' 140' ' ' LYS . 43.7 m-85 -110.44 119.23 38.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.8 t -102.57 102.86 14.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.254 0.549 . . . . 0.0 109.649 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -101.79 111.95 24.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.8 m -86.47 136.47 33.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.023 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.07 120.33 7.31 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.507 0.504 . . . . 0.0 110.833 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.509 HG11 ' HD3' ' A' ' 96' ' ' LYS . 7.1 p -111.19 122.26 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.543 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.298 -173.995 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.516 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 70.6 -61.03 0.48 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.706 0.765 . . . . 0.0 110.487 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.98 161.99 13.59 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.221 172.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt 54.22 87.55 0.14 Allowed Pre-proline 0 C--N 1.33 -0.262 0 O-C-N 123.931 0.77 . . . . 0.0 112.197 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.68 135.81 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.634 2.223 . . . . 0.0 111.933 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.542 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 12.3 pt20 -153.16 161.36 42.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.255 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.477 HG23 ' CB ' ' A' ' 31' ' ' PRO . 4.6 mp -93.56 102.46 7.71 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.7 Cg_exo -66.85 165.18 26.79 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 122.805 2.337 . . . . 0.0 112.878 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.966 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -81.33 -22.36 38.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.391 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -74.95 109.95 8.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 41.7 mttp -86.67 9.4 18.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.333 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -110.65 5.73 21.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.24 0.543 . . . . 0.0 110.139 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.634 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 66.1 mttm -92.89 173.0 7.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.766 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.9 t -109.7 117.29 54.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.043 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.63 -26.08 23.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.184 0.516 . . . . 0.0 110.343 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.83 -175.3 43.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.418 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 90.0 m-85 -126.53 140.13 52.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.089 0.444 . . . . 0.0 110.273 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.2 tp -100.69 110.02 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.571 0.7 . . . . 0.0 109.539 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 42.5 mt-10 -113.34 113.14 24.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.195 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.57 92.07 48.49 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.43 -30.08 91.71 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.953 2.436 . . . . 0.0 112.221 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -70.06 -25.97 63.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.45 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.76 5.71 26.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.3 t0 61.86 20.7 11.68 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.911 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.428 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 68.4 mt -96.71 124.08 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.711 -173.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 3.9 mppt? -141.16 83.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.571 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 25.2 mm-40 -117.72 151.36 48.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.045 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.19 133.39 14.81 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.939 2.426 . . . . 0.0 111.911 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HA ' HG23 ' A' ' 43' ' ' VAL . 56.1 t -92.17 118.37 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.842 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.427 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 92.6 m-85 -95.54 114.28 63.6 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 38.2 Cg_endo -64.94 129.58 23.59 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.11 2.54 . . . . 0.0 112.179 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.24 179.43 43.91 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.648 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HG2' HG23 ' A' ' 35' ' ' THR . 62.5 Cg_endo -87.69 33.55 0.41 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.96 3.107 . . . . 0.0 112.451 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.55 32.04 11.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -62.26 138.14 96.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.341 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 85.4 Cg_exo -46.95 -48.71 13.85 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.788 2.992 . . . . 0.0 114.109 -172.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.48 -30.06 68.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.821 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.53 -41.49 79.84 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.6 mm? -77.51 -6.08 52.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -83.6 -14.36 52.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -126.32 -36.24 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -154.62 -167.67 16.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.388 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 ' HG2' ' A' ' 71' ' ' GLN . 10.8 m -88.97 153.4 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -139.51 169.01 18.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.62 151.79 26.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.371 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.47 62.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.36 156.93 20.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.0 111.862 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -97.18 -20.95 17.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -72.26 -12.27 61.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -75.08 150.2 38.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.837 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 m -130.86 159.62 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 88' ' ' VAL . 84.8 mt -76.3 -20.97 56.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.812 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.92 3.72 36.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 110.246 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.88 156.79 38.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -68.87 -27.24 65.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.242 0.544 . . . . 0.0 110.685 -176.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -120.5 110.96 17.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.039 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.48 123.95 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -117.67 116.8 27.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.0 0.428 . . . . 0.0 110.84 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -104.77 122.35 57.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.48 139.28 30.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.37 163.76 32.64 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.378 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -142.75 150.91 40.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.698 0.285 . . . . 0.0 110.36 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 ' HA ' ' A' ' 73' ' ' THR . 17.1 m -84.06 150.84 25.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.596 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 9.3 t80 -142.65 151.52 41.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.8 mt -81.82 -47.01 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 111.605 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.81 -43.69 97.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.978 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 70' ' ' TYR . 1.5 mmt180 -89.35 109.1 28.95 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.34 -11.08 17.54 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.584 2.189 . . . . 0.0 111.524 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -148.13 77.21 1.4 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.823 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.596 ' OH ' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -156.15 158.23 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.571 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 80.0 mt-30 41.44 -107.59 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.705 0.628 . . . . 0.0 112.463 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 75' ' ' LEU . 50.6 m-85 -131.69 91.09 2.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 63' ' ' THR . 2.7 t -120.71 -53.82 2.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.331 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 73' ' ' THR . 63.9 t30 -87.01 18.47 3.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.53 0.681 . . . . 0.0 109.919 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 72' ' ' PHE . 28.8 tp -70.06 -7.84 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.671 -178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -8.29 56.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.91 -0.98 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.822 173.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.79 160.61 20.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.283 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -163.5 -169.78 2.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.695 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.5 ptmt -51.1 -36.69 41.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -170.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.56 58.53 0.7 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.314 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.3 m -81.96 -7.95 59.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.33 89.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.567 0.699 . . . . 0.0 111.439 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -90.6 118.36 35.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 90.0 m-85 -103.9 121.26 42.74 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.009 0.433 . . . . 0.0 110.51 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 27.7 t80 -100.68 104.53 15.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.6 tptm -85.73 97.43 10.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG21 HD13 ' A' ' 52' ' ' LEU . 4.4 p -124.36 120.93 60.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -173.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.02 1.84 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.714 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -172.86 -28.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.979 0.512 . . . . 0.0 110.499 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 9.4 pt-20 -87.2 165.68 15.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.158 0.504 . . . . 0.0 111.565 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 m -123.57 110.74 15.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.616 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 9.1 mmm180 -87.1 132.19 33.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -107.22 123.16 47.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.57 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 87.5 m-85 -118.46 145.39 45.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.485 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.647 ' HE3' HG11 ' A' ' 147' ' ' VAL . 1.3 tppp? -114.43 128.61 56.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 56.3 mtt -78.22 70.86 4.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.632 0.73 . . . . 0.0 110.636 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -87.09 -6.74 58.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.039 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.596 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 49.0 m -140.04 103.86 4.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.347 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 97' ' ' MET . 84.3 mt -122.6 130.06 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -158.95 173.31 16.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.883 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.929 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 1.5 p30 -133.03 124.06 26.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.254 0.549 . . . . 0.0 109.9 175.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.79 -172.2 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.953 -171.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.558 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -124.63 152.6 69.27 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.051 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.25 -13.01 33.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.487 2.125 . . . . 0.0 110.974 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -13.13 59.97 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.389 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.55 ' HB2' ' HE3' ' A' ' 104' ' ' LYS . 12.7 t70 -108.99 121.69 45.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.875 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.96 32.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -102.17 -18.47 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.137 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.07 -16.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.239 0.542 . . . . 0.0 111.533 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.508 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -98.65 22.04 10.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 111.242 -175.131 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 10.1 t70 -79.25 -154.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.954 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 39.0 mt-10 -65.52 92.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.05 30.14 4.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.637 0.732 . . . . 0.0 111.492 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.79 153.44 21.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 176.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.33 -21.23 7.32 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -90.12 -170.29 2.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.282 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.49 -164.67 1.21 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -65.03 104.89 0.94 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 110.11 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 13.1 pt20 -100.22 120.18 39.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.296 0.57 . . . . 0.0 110.526 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -85.61 110.32 19.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -94.65 99.64 11.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.555 -175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.1 mt -85.69 108.25 17.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.8 mt -91.46 99.34 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 m -96.52 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.262 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 80.0 m -94.9 93.95 7.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.499 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -113.73 9.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 23.4 t70 -78.95 -79.81 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.619 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 1.0 OUTLIER 62.48 88.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.779 -177.471 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 48.4 t-20 -85.81 98.04 10.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.4 ' HG2' ' CE2' ' A' ' 129' ' ' TYR . 44.1 mt-10 -68.0 -3.13 9.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 93.5 mttt -72.95 -33.02 65.64 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.126 0.489 . . . . 0.0 110.489 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.6 t -128.13 -15.96 4.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.542 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 26.26 45.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.375 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.35 138.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 25.0 m95 -85.09 105.02 15.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.99 -67.75 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 17.9 tppt? -65.25 117.03 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.411 0.624 . . . . 0.0 110.173 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -124.15 106.22 10.15 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.691 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 30.4 tttp -86.22 132.98 33.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.628 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.84 123.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.774 0.797 . . . . 0.0 110.607 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 89.4 m-85 -110.56 107.11 16.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.632 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 60.3 t -91.74 98.68 8.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.43 0.633 . . . . 0.0 109.534 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -97.5 97.58 9.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.813 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 7.3 m -73.96 140.67 45.7 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.52 114.77 2.62 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.676 0.75 . . . . 0.0 110.235 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.647 HG11 ' HE3' ' A' ' 96' ' ' LYS . 7.7 p -101.73 125.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.927 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 148' ' ' LYS . 10.3 ptpt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.732 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.66 -65.03 0.37 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.8 0.809 . . . . 0.0 109.994 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.19 140.37 29.74 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.934 172.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 31.4 mttp -108.49 97.4 22.83 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 31.9 Cg_endo -64.48 115.29 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.291 1.994 . . . . 0.0 109.264 165.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.421 ' HA ' HD23 ' A' ' 52' ' ' LEU . 14.4 pt20 -124.62 143.64 50.61 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.398 0.618 . . . . 0.0 110.98 -172.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.626 HG23 ' HB2' ' A' ' 31' ' ' PRO . 9.6 mt -69.12 118.11 58.51 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.245 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.66 174.25 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.381 2.054 . . . . 0.0 111.721 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 36.4 mmtm -92.07 36.83 0.98 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.694 0.759 . . . . 0.0 109.997 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 13' ' ' LYS . 9.9 t70 -127.2 105.69 8.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.454 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.659 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 32.0 mttp -73.92 -6.86 49.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.324 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.0 t -95.57 -19.56 19.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.995 0.426 . . . . 0.0 110.265 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HG3' ' CG ' ' A' ' 10' ' ' ASP . 56.6 mttp -81.82 176.19 9.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.7 p -112.63 136.63 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.07 -31.29 14.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.372 0.606 . . . . 0.0 110.21 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.15 158.5 31.48 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.093 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -102.87 138.49 39.69 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.872 0.336 . . . . 0.0 110.122 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 84' ' ' VAL . 9.3 tp -104.03 120.25 53.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 36.8 mt-10 -128.07 112.06 14.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.548 0.689 . . . . 0.0 110.911 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.597 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 43.6 mt -120.91 95.49 48.91 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.446 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.35 -27.07 71.29 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 123.244 2.629 . . . . 0.0 112.402 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 35.2 t70 -67.3 -32.09 72.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.252 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -109.86 5.02 22.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.914 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t0 63.54 22.37 13.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.81 0.814 . . . . 0.0 110.71 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.597 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 59.4 mt -79.32 113.48 18.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.291 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -150.69 98.25 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.962 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.683 ' OE2' ' HA ' ' A' ' 70' ' ' TYR . 2.4 mt-10 -169.29 164.47 6.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 O-C-N 123.16 0.287 . . . . 0.0 110.989 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HB3' HG21 ' A' ' 14' ' ' VAL . 21.6 Cg_exo -66.58 148.91 84.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.1 2.534 . . . . 0.0 112.99 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.15 121.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.308 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 44' ' ' SER . 50.6 m-85 -93.44 137.76 23.29 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.26 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -92.15 153.52 3.18 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.71 2.273 . . . . 0.0 113.077 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.11 -174.48 25.15 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.861 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.659 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 94.7 Cg_endo -79.98 8.97 3.76 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.574 2.849 . . . . 0.0 113.142 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 61.71 68.82 0.68 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.614 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 33' ' ' PRO . 37.6 p -92.07 161.15 34.03 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.173 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -30.66 26.2 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.086 2.524 . . . . 0.0 112.589 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.43 -43.78 93.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.152 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.504 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 39.0 mm-40 -82.16 -40.14 22.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.259 -170.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.2 mm? -70.73 -7.73 46.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.36 0.6 . . . . 0.0 110.577 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -22.75 23.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.487 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 38' ' ' GLN . 7.0 ptm85 -105.14 -13.8 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.221 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . 162.84 -157.18 29.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.386 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 72' ' ' PHE . 70.2 t -95.44 135.88 28.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.924 0.392 . . . . 0.0 110.05 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.1 m -124.65 170.34 11.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HD1' ' HA ' ' A' ' 31' ' ' PRO . 26.8 m-85 -68.66 161.9 27.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.223 174.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.12 -27.87 21.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.577 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 2.2 mm-40 -117.83 145.04 44.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.516 0.674 . . . . 0.0 112.344 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.98 -6.98 59.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -90.27 -5.2 56.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.833 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.554 ' HB3' HD13 ' A' ' 7' ' ' ILE . 2.2 tp10 -48.8 139.44 9.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -143.65 132.42 22.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.68 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.434 HD21 HG13 ' A' ' 7' ' ' ILE . 2.6 mm? -75.98 -11.51 59.97 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.029 0.442 . . . . 0.0 110.813 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -89.17 -9.79 49.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.422 0.63 . . . . 0.0 110.218 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -89.14 170.71 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.495 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.554 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 4.7 pt20 -104.13 -0.87 28.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.74 0.305 . . . . 0.0 111.016 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -131.88 115.65 16.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.43 0.633 . . . . 0.0 109.92 177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.21 129.27 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.275 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -108.11 120.78 43.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.344 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.5 mt -111.53 115.77 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.414 ' HB1' ' C13' ' A' ' 201' ' ' JPT . . . -97.74 116.49 30.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 110.871 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' HA2' HG13 ' A' ' 43' ' ' VAL . . . -110.77 159.99 13.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.929 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -154.76 131.19 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 2.4 m -65.56 113.01 3.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 41.4 t80 -90.22 128.3 36.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.3 mt -58.97 -37.75 69.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.228 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.465 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 9.3 m-20 -91.95 8.28 38.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.908 0.385 . . . . 0.0 111.372 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 34.2 mtt180 -121.4 97.2 47.4 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.776 0.322 . . . . 0.0 110.985 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.17 -8.35 20.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.614 2.209 . . . . 0.0 111.694 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -154.26 82.3 1.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.683 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.3 p90 -118.37 -164.2 1.01 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.171 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 27' ' ' GLU . 24.6 mp0 -48.96 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.297 0.373 . . . . 0.0 111.765 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.521 ' CE2' HG11 ' A' ' 43' ' ' VAL . 18.8 m-85 -103.21 68.48 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.694 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -92.6 -42.17 9.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.338 0.589 . . . . 0.0 110.355 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.7 t30 -114.24 33.31 5.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.42 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -59.2 -27.21 65.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -177.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -9.92 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.78 -4.74 58.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.124 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.539 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -72.18 -174.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 5.9 ptpp? -167.02 -179.0 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.979 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.6 ptpt -53.99 -48.76 70.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.139 -176.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.5 54.99 0.57 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.438 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -73.64 -11.59 60.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.327 -0.436 . . . . 0.0 111.203 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 54.36 83.84 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.433 0.635 . . . . 0.0 111.801 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.5 t -85.41 111.42 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.827 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -99.8 113.67 26.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.519 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 2.1 t80 -102.4 108.21 19.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.593 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.43 92.68 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.974 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 91' ' ' GLU . 4.8 m -104.71 117.56 50.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.44 -83.16 0.2 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.572 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -152.74 12.17 0.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.722 0.296 . . . . 0.0 110.823 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' CG ' HG23 ' A' ' 88' ' ' VAL . 12.6 pt-20 -109.43 140.11 43.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.059 0.456 . . . . 0.0 110.291 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.6 m -100.62 109.71 21.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 16.5 mmt85 -88.7 142.03 28.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.54 173.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -118.67 130.73 56.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.9 0.381 . . . . 0.0 110.542 177.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 81.3 m-85 -127.83 143.85 51.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -107.07 137.32 45.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.743 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.0 mmt -83.87 81.95 8.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 110.14 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -92.2 -36.7 13.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.63 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.61 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 6.9 m -109.26 97.04 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 97' ' ' MET . 75.9 mt -117.68 117.16 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.896 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -168.99 -159.81 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 112.068 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -109.89 153.32 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.818 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 139' ' ' ARG . 10.6 m -135.38 166.48 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 167.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 106' ' ' THR . 0.0 OUTLIER -147.62 161.21 36.38 Favored Pre-proline 0 C--O 1.22 -0.45 0 O-C-N 122.334 -0.229 . . . . 0.0 111.32 -169.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 34.8 Cg_endo -65.08 11.75 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.717 2.278 . . . . 0.0 113.05 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.456 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.7 t -129.8 8.79 5.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.599 ' OD2' ' HB ' ' A' ' 103' ' ' VAL . 1.1 p30 -84.2 158.23 21.37 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 111' ' ' LEU . 29.1 m -112.58 18.73 7.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.198 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 -45.36 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.924 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.81 -11.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.654 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -106.39 12.3 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.703 0.287 . . . . 0.0 111.27 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.6 169.27 9.82 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.534 ' CG ' ' HE3' ' A' ' 115' ' ' LYS . 11.2 pt-20 -92.41 20.25 6.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -175.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 52.13 119.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.617 1.167 . . . . 0.0 113.724 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HE3' ' CG ' ' A' ' 113' ' ' GLU . 18.9 mmtp -109.48 147.31 33.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.586 -171.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.92 34.27 11.13 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.896 -1.502 . . . . 0.0 115.23 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -122.59 161.89 22.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.837 0.818 . . . . 0.0 112.016 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -93.98 -158.14 0.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -62.09 110.04 1.47 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -116.67 138.81 51.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.26 0.552 . . . . 0.0 112.124 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 121' ' ' LEU . 22.4 mt -97.73 112.26 24.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 169.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.42 HG23 HG22 ' A' ' 143' ' ' VAL . 13.3 m -96.26 103.85 15.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.287 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.7 mt -91.11 106.03 18.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.79 100.01 9.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 6.9 m -91.0 107.09 18.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.138 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.8 m -103.89 86.12 2.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -111.18 -2.15 15.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.574 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 36.4 t70 -104.8 94.37 5.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.488 0.661 . . . . 0.0 109.899 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 92.0 t80 -101.01 124.05 46.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.188 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -91.37 110.28 21.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.438 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.7 mt-10 -72.39 -21.65 61.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.847 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -72.51 -24.57 61.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.456 HG23 HG12 ' A' ' 135' ' ' VAL . 9.6 t -136.62 4.01 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.304 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.53 48.79 79.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.17 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 133' ' ' THR . 4.4 p -137.77 159.22 34.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.543 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 37.6 m95 -100.64 112.74 25.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 55.8 mt-10 -80.88 -60.02 2.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.932 0.396 . . . . 0.0 111.04 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 47.4 mmtm -88.94 101.52 14.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.177 0.513 . . . . 0.0 110.262 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -100.63 105.52 16.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 18.7 tptm -76.63 120.62 22.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.6 tt -118.98 122.55 69.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 122.037 0.922 . . . . 0.0 111.66 -172.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 24.5 m-85 -116.95 106.75 13.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.135 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.0 t -100.76 103.98 15.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.234 0.54 . . . . 0.0 110.259 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.494 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.995 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.7 m -93.59 138.81 31.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -57.83 125.03 21.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.042 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG21 ' HD3' ' A' ' 96' ' ' LYS . 2.7 t -85.75 146.38 6.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.775 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.68 179.024 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.414 ' C13' ' HB1' ' A' ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.135 0.493 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -116.98 -174.86 2.67 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.475 -176.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.56 94.41 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.321 0.581 . . . . 0.0 111.804 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -127.64 103.34 22.02 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.106 171.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.51 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 36.9 Cg_endo -63.09 106.64 0.56 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.15 2.567 . . . . 0.0 112.878 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -120.64 137.9 54.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.776 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 52' ' ' LEU . 4.1 mp -76.5 125.24 87.71 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.71 153.51 54.0 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.116 1.877 . . . . 0.0 110.369 170.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -86.39 14.11 7.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.476 0.655 . . . . 0.0 111.215 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 27.4 t0 -100.71 102.43 13.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.549 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 24.5 pttm -81.27 0.13 38.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.446 -172.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.2 m -90.32 3.91 52.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 87.5 mttt -103.83 -176.53 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.348 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.79 129.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.049 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.45 -29.93 17.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.78 36.57 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.56 143.32 34.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 117.128 0.464 . . . . 0.0 109.758 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.545 0.688 . . . . 0.0 110.265 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 38.4 mt-10 -115.78 116.54 28.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.922 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.591 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 46.0 mt -133.87 91.62 24.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.52 -34.51 92.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.951 2.434 . . . . 0.0 111.871 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.77 -25.62 68.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.292 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -114.83 11.37 16.68 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.011 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 58.41 29.67 18.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.773 0.797 . . . . 0.0 110.754 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.632 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 58.9 mt -98.37 118.49 44.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.232 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 5.5 mtmt -150.19 81.91 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.282 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.424 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 40.9 mt-10 -149.21 162.47 28.84 Favored Pre-proline 0 N--CA 1.465 0.316 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 60.3 Cg_endo -72.43 148.16 48.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.072 2.515 . . . . 0.0 113.493 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.47 130.59 62.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.016 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 44' ' ' SER . 33.5 m-85 -97.11 137.96 21.25 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 73.0 Cg_endo -90.15 -172.31 0.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.962 2.441 . . . . 0.0 112.533 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.06 -174.27 16.83 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.453 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.84 12.39 3.02 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.926 3.084 . . . . 0.0 113.081 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.55 74.67 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.193 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.705 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -95.83 147.44 33.0 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.087 -176.692 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.705 ' HD2' HG22 ' A' ' 35' ' ' THR . 81.6 Cg_exo -40.65 -66.83 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.751 2.967 . . . . 0.0 114.46 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -26.63 55.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.762 0.315 . . . . 0.0 111.663 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.549 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 24.8 tp60 -66.54 -37.89 85.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.118 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.6 tp -74.3 -38.7 63.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.772 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -67.93 -9.8 48.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.19 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.59 -28.48 62.82 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 110.415 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.29 -88.7 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.257 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.443 HG12 ' HA3' ' A' ' 61' ' ' GLY . 34.0 m -137.02 157.84 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 21.9 p -150.72 156.07 40.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.013 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 21.2 m-85 -70.18 155.13 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.784 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.09 73.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.302 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -152.24 177.7 10.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.434 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.59 -28.2 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 -172.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -76.87 -11.06 59.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.083 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 50' ' ' GLU . 5.1 tp10 -61.24 126.26 26.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.747 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 23.5 m -112.39 138.24 49.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.791 0.329 . . . . 0.0 111.441 -173.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.661 ' HG ' HD11 ' A' ' 7' ' ' ILE . 77.6 mt -67.96 -25.52 65.48 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.57 17.47 23.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.464 0.65 . . . . 0.0 110.355 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -88.96 -177.21 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.464 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -16.93 58.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.197 0.522 . . . . 0.0 110.08 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.94 142.61 29.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.18 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.3 mp -129.07 105.29 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.727 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.562 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 4.5 m -89.94 113.1 24.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.464 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 ' CE1' ' A' ' 45' ' ' PHE . 57.0 mt -107.13 111.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.991 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -96.52 121.93 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.443 ' HA3' HG12 ' A' ' 43' ' ' VAL . . . -121.11 161.22 15.22 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.359 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -123.18 130.32 52.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.608 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 12.0 m -71.15 136.95 48.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.138 -177.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.16 136.63 37.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.328 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.1 mt -90.99 -46.77 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.114 0.483 . . . . 0.0 110.21 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.455 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 17.7 t70 -75.18 -39.69 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.399 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -92.34 109.04 35.44 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.92 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 94.1 Cg_endo -83.93 -0.35 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.878 2.385 . . . . 0.0 111.476 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -129.96 71.73 1.46 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.977 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.608 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 10.4 p90 -119.38 -175.41 2.93 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 1.4 mp0 -48.82 -66.69 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -173.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CZ ' HD22 ' A' ' 123' ' ' LEU . 23.1 m-30 -103.1 31.59 4.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -170.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -49.97 74.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.268 0.556 . . . . 0.0 111.429 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 67.0 t30 -102.51 25.52 8.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.231 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.11 -19.01 64.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.209 0.528 . . . . 0.0 110.901 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -68.87 -20.47 64.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.515 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.52 9.24 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.108 0.48 . . . . 0.0 110.308 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . . . -89.3 122.71 32.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.066 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 6.3 mmmm -101.58 -164.41 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.283 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -68.5 -21.94 64.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.22 50.88 0.87 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.574 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -70.3 -7.62 43.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.8 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 87.1 mmm 44.66 88.38 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.665 0.745 . . . . 0.0 112.029 -170.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -85.58 124.55 40.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.2 m-85 -109.13 112.99 25.46 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.27 109.56 21.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 5.3 tptp -91.28 85.51 5.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.706 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.652 ' O ' ' HG2' ' A' ' 91' ' ' GLU . 11.1 m -111.54 131.04 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.877 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 90' ' ' ASN . . . 59.14 22.1 54.77 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.035 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 29.3 m-80 73.53 14.48 4.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.479 0.711 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 6.2 pt-20 -97.14 179.4 4.93 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -135.28 117.62 15.66 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 94.5 mtt180 -116.01 133.42 56.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -101.35 131.27 47.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.293 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 84.2 m-85 -130.76 146.67 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.869 -178.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.8 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.55 132.42 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 21.2 mmt -75.53 68.15 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 110.226 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -84.46 -9.58 58.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.431 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 67.4 m -136.84 93.97 2.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.36 0.6 . . . . 0.0 111.183 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.16 118.21 56.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.562 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.9 ptt180 -149.35 165.19 32.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.244 0.545 . . . . 0.0 111.683 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.02 109.12 15.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.933 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.658 HG21 HG11 ' A' ' 110' ' ' VAL . 19.4 m -108.24 168.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.49 0.662 . . . . 0.0 111.683 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HD3' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -138.52 170.38 10.42 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.934 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.77 -26.81 58.77 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.065 1.843 . . . . 0.0 110.175 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -72.64 -12.42 61.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.878 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -91.67 128.8 37.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HA ' HD11 ' A' ' 111' ' ' LEU . 17.5 m -113.28 26.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.805 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -109.2 -9.87 15.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.684 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.658 HG11 HG21 ' A' ' 103' ' ' VAL . 15.9 m -91.62 -8.74 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -112.58 9.94 19.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.666 0.746 . . . . 0.0 109.381 175.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -89.2 160.81 16.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.298 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -50.45 125.93 13.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.489 . . . . 0.0 111.635 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -75.65 129.31 36.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.6 mptt -69.69 157.77 36.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.932 -172.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.04 56.81 1.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.441 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -79.26 -174.35 4.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.023 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.09 -163.78 0.84 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.27 121.63 11.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.92 135.07 54.36 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.158 0.504 . . . . 0.0 110.801 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -92.73 113.98 26.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.536 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.7 m -94.41 92.23 7.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.901 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 27.5 mt -83.47 104.56 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 110.044 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 60' ' ' ALA . 24.3 mt -94.52 101.04 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.074 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -97.11 96.4 8.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.082 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.482 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 62.5 m -96.01 89.25 5.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.93 -14.11 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.17 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.516 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 21.1 t70 -110.6 94.77 5.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.561 0.696 . . . . 0.0 109.832 -176.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 134' ' ' GLY . 94.1 t80 -107.55 124.5 50.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.485 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -90.88 101.96 14.72 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.22 -5.38 17.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.429 -174.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -38.76 68.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.874 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 135' ' ' VAL . 6.9 t -149.81 -26.48 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 129' ' ' TYR . . . 120.83 36.8 0.75 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.824 -1.179 . . . . 0.0 112.858 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.532 HG23 HG23 ' A' ' 133' ' ' THR . 93.0 t -104.39 124.05 58.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CE3' ' HB3' ' A' ' 126' ' ' CYS . 33.3 m95 -84.86 93.31 8.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.516 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 16.2 mm-40 -60.22 -68.26 0.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.863 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -91.76 103.86 16.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 -177.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.503 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 84.1 mtm180 -105.44 95.65 5.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.925 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.836 ' HD3' ' HE1' ' A' ' 142' ' ' PHE . 2.4 ttmp? -74.54 130.39 39.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.959 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.562 ' CG2' ' HG3' ' A' ' 101' ' ' ARG . 12.8 tt -123.44 120.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.932 0.872 . . . . 0.0 111.025 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.836 ' HE1' ' HD3' ' A' ' 140' ' ' LYS . 8.4 m-85 -106.33 104.07 13.69 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.522 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 61.9 t -98.72 109.61 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.485 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.545 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.7 103.34 12.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.524 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -83.85 142.62 30.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.684 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -55.73 133.1 50.65 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.251 -175.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 7.3 p -111.85 160.91 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.259 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 147' ' ' VAL . 21.9 mmmt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.776 -0.63 . . . . 0.0 110.008 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.503 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.674 ' SD ' ' HA ' ' A' ' 5' ' ' PRO . 48.5 ttm . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -113.25 5.27 16.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.236 0.541 . . . . 0.0 110.834 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.82 138.89 12.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.122 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 56.5 mtpt 45.97 93.53 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.353 0 O-C-N 124.565 1.165 . . . . 0.0 113.547 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 32.5 Cg_endo -62.71 125.19 15.53 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.695 2.263 . . . . 0.0 112.145 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -147.24 162.2 39.4 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' CD1' ' HG ' ' A' ' 52' ' ' LEU . 3.4 mp -86.78 127.47 59.98 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 0.0 110.486 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.44 -178.76 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.75 2.3 . . . . 0.0 112.666 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.711 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.4 103.8 7.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.46 -174.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.575 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 36.1 mtmm -88.7 13.38 12.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.623 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.8 t -98.26 -11.79 22.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.744 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -105.03 178.18 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 -178.434 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.99 131.55 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.66 16.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.235 0.541 . . . . 0.0 110.443 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.91 38.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 90.9 m-85 -112.62 138.47 49.36 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.392 0.596 . . . . 0.0 110.858 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.5 tp -106.78 105.17 18.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 122.167 0.984 . . . . 0.0 109.814 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -111.96 113.5 25.84 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.965 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.3 mt -125.61 95.94 39.41 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.788 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.66 -28.78 77.05 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.796 2.331 . . . . 0.0 111.688 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.469 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 27.4 t0 -71.27 -22.24 61.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.039 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.76 5.29 17.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.936 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.8 t70 64.62 24.24 12.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.455 0.645 . . . . 0.0 110.535 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.5 mt -96.23 126.29 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.928 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.4 mppt? -138.77 43.77 2.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 15.9 mm-40 -98.58 154.09 37.66 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.0 Cg_exo -78.5 145.0 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.269 2.646 . . . . 0.0 112.083 175.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.68 115.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -97.29 116.69 65.99 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.881 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 30.1 Cg_endo -63.37 140.67 77.86 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.416 2.077 . . . . 0.0 111.744 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.38 -179.47 41.41 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.356 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.575 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 12.9 Cg_endo -91.82 29.02 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.774 2.983 . . . . 0.0 112.439 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 58.47 50.0 9.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.557 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 p -68.43 150.6 97.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.93 -55.05 4.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.211 2.607 . . . . 0.0 113.099 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.89 -27.06 67.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.377 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -65.97 -46.05 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.327 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -78.53 -4.32 48.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.391 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.58 -18.82 16.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.141 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -102.08 -26.07 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 110.813 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -171.18 35.4 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.08 148.07 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.08 0.44 . . . . 0.0 110.005 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -137.04 -171.95 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 110.693 -174.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 33.3 m-85 -94.94 169.72 9.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.13 84.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 110.436 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -141.82 170.43 15.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.561 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.57 -7.61 54.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.398 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.75 13.54 30.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.644 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 8.0 mm-40 -74.3 169.34 17.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.355 0.598 . . . . 0.0 111.578 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.3 m -138.37 139.9 39.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 96.2 mt -77.45 -13.44 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.632 -176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.77 14.89 23.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.715 0.769 . . . . 0.0 110.103 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HB3' HG12 ' A' ' 57' ' ' ILE . 11.3 t70 -69.29 171.68 8.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.962 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 120' ' ' GLN . 1.1 tm0? -95.62 -26.0 15.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.441 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.495 ' HA ' ' HG3' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -134.09 56.39 1.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.144 0.973 . . . . 0.0 111.106 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 54' ' ' ASP . 49.9 mt -62.1 127.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.105 -173.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -105.75 109.43 21.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.288 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.01 118.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.034 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.1 133.07 36.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.735 0.302 . . . . 0.0 111.002 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.12 163.91 26.96 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.162 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -139.56 158.77 43.57 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 73' ' ' THR . 21.5 p -102.78 158.58 16.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.899 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.626 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -134.57 135.39 42.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.262 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.12 -39.92 81.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.154 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.19 -4.31 52.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 51.1 mtt85 -132.72 90.58 32.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.247 0.546 . . . . 0.0 111.422 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.644 ' O ' ' HB ' ' A' ' 73' ' ' THR . 7.6 Cg_exo -73.64 -23.7 16.68 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.624 2.883 . . . . 0.0 113.244 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -124.64 27.1 6.99 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.626 ' CE2' ' HB2' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -92.18 -16.03 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.155 0.979 . . . . 0.0 109.075 177.486 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HB3' ' H ' ' A' ' 72' ' ' PHE . 2.2 mt-30 -164.21 -154.54 0.25 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.292 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CE2' HD13 ' A' ' 123' ' ' LEU . 19.6 m-85 -74.22 26.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 68' ' ' PRO . 21.7 m -60.26 -45.9 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.488 . . . . 0.0 111.028 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -96.43 12.62 30.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.181 0.515 . . . . 0.0 110.675 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.27 -12.6 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.224 0.535 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.28 -12.86 61.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.452 176.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -89.79 -4.6 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.676 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -75.21 149.64 38.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.234 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 2.6 mppt? -111.12 -169.37 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 174.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.5 ptmm? -76.43 -11.8 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.297 0.57 . . . . 0.0 111.289 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.19 62.18 0.64 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.906 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -81.06 -9.63 59.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 51.01 83.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.489 0.662 . . . . 0.0 111.82 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 80.8 t -85.57 128.8 38.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.939 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -113.57 107.51 15.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -97.54 115.12 27.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.855 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.8 mmtp -93.39 97.33 10.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.237 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.05 130.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.849 0.357 . . . . 0.0 110.547 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.83 30.24 74.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.994 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 68.35 4.49 4.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.313 0.645 . . . . 0.0 111.351 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -92.34 150.63 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.869 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.3 m -109.79 112.64 24.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.829 0.347 . . . . 0.0 110.332 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 146' ' ' GLU . 21.7 mmm180 -105.03 133.22 50.18 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 3.5 mptt -102.35 130.74 49.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 95.8 m-85 -123.35 144.01 49.73 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.793 0.33 . . . . 0.0 110.407 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.55 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -113.27 131.56 55.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.8 mmt -74.75 64.38 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.097 0.475 . . . . 0.0 110.663 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -80.22 -13.84 58.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.709 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.612 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.8 m -134.1 99.13 4.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.012 0.434 . . . . 0.0 110.258 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 97' ' ' MET . 70.0 mt -117.71 131.42 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.743 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.413 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 15.0 ptm180 -167.95 -175.29 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 171.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.93 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 8.6 p-10 -141.89 125.6 16.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' A' ' 139' ' ' ARG . 24.5 m -112.07 173.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.137 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.857 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -122.68 165.04 23.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.68 -16.08 46.17 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.498 2.132 . . . . 0.0 111.746 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 t -109.65 12.94 24.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.342 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.857 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 11.8 t70 -93.65 148.47 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 34.0 m -111.41 0.43 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -170.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.413 ' HG3' ' NH2' ' A' ' 101' ' ' ARG . 26.8 mm-40 -72.7 -12.79 61.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 110.689 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 103' ' ' VAL . 22.7 m -94.78 -8.93 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.163 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 4.2 pp -99.15 -9.57 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.758 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -82.67 161.5 22.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.89 128.15 34.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.351 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -85.83 133.97 33.95 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -69.53 160.63 31.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.199 0.523 . . . . 0.0 112.411 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.81 59.93 0.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.327 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.39 176.73 0.76 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.238 0.542 . . . . 0.0 111.016 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -78.76 -155.8 0.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -63.47 103.47 0.52 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.495 ' HG3' ' HA ' ' A' ' 56' ' ' ASN . 18.6 pt20 -101.4 116.6 33.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.33 0.586 . . . . 0.0 109.854 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 tp -84.41 100.91 11.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.2 m -88.95 100.37 13.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.5 mt -87.25 109.04 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.7 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.8 mt -97.84 104.7 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 22.1 m -95.27 97.37 9.81 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.036 0.446 . . . . 0.0 110.185 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 47.9 m -86.96 102.17 14.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.33 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.53 -170.24 3.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.172 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 31.1 t70 57.4 83.95 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.797 0.808 . . . . 0.0 110.637 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 80.8 t80 -94.65 124.52 38.74 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.081 -174.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -95.67 99.94 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.506 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.0 mt-10 -58.84 -39.92 82.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.819 -171.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -70.52 -14.06 62.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.635 HG23 HG22 ' A' ' 135' ' ' VAL . 2.1 t -130.98 -7.04 3.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.292 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.82 35.16 72.63 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.623 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 133' ' ' THR . 33.3 m -116.8 155.03 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 117.315 0.557 . . . . 0.0 111.147 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -96.6 100.28 11.86 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.24 -16.93 60.94 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 23.6 ttmm -124.91 86.62 2.58 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.081 0.943 . . . . 0.0 110.928 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.726 ' HG3' HG23 ' A' ' 103' ' ' VAL . 30.1 ptt180 -92.98 86.92 5.58 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.218 172.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.93 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 36.2 tttp -70.25 139.32 52.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.773 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.53 124.5 59.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.932 0.873 . . . . 0.0 111.144 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.585 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 27.4 m-85 -114.48 103.75 11.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.601 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 47.3 t -94.3 96.74 6.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.414 0.626 . . . . 0.0 109.804 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.548 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -93.05 105.91 17.94 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.06 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.7 m -81.35 140.44 34.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.096 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 93' ' ' ARG . 36.4 tt0 -61.27 132.31 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.406 0.622 . . . . 0.0 111.879 -175.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 2.2 t -104.61 170.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.687 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 147' ' ' VAL . 40.5 mtpt . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.829 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.52 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.917 0.389 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -121.63 -171.3 2.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.314 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . -109.68 99.55 8.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.998 0.428 . . . . 0.0 110.543 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -106.24 98.62 19.98 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.792 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.601 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 77.8 Cg_exo -51.36 118.09 4.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.455 2.77 . . . . 0.0 113.258 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.14 168.01 25.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.339 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.557 HG23 ' HB3' ' A' ' 31' ' ' PRO . 3.9 mp -91.66 112.33 53.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.44 165.01 18.72 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.532 2.155 . . . . 0.0 111.818 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.647 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -95.97 1.29 52.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.359 0.599 . . . . 0.0 109.835 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.88 109.88 14.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.439 173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 22.7 mttm -84.66 62.31 7.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.051 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 -29.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.576 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 2.8 mmpt? -54.24 154.59 4.31 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.537 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.37 111.93 32.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 164.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -76.39 -38.23 56.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.62 165.84 32.63 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.511 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 64.5 m-85 -112.87 132.57 55.24 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -96.74 107.92 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.876 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -112.9 108.15 16.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.887 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG12 HG13 ' A' ' 84' ' ' VAL . 23.0 mt -125.4 95.4 41.06 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.233 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.39 -16.2 53.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.797 2.331 . . . . 0.0 112.319 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 38.9 t70 -83.63 -21.67 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.443 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.12 11.24 15.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.329 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.69 19.6 11.88 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.078 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 20' ' ' ILE . 74.2 mt -93.57 122.09 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.342 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -139.48 49.2 1.82 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.897 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 12.3 mm-40 -116.55 162.52 26.36 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.066 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 90.9 Cg_endo -83.34 164.19 14.8 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.903 2.402 . . . . 0.0 113.269 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.14 136.73 59.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.199 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.29 133.49 20.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.793 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 23.9 Cg_exo -67.76 134.17 31.72 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.186 2.591 . . . . 0.0 111.808 168.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.13 144.08 4.1 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.029 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 60.3 Cg_endo -73.96 54.44 3.12 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.297 2.665 . . . . 0.0 112.241 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 58.25 42.39 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.776 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -69.12 127.01 93.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.251 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 65.1 Cg_exo -52.53 -39.64 74.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.289 2.659 . . . . 0.0 113.299 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.43 -12.52 61.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -101.21 -29.51 12.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.79 -18.24 48.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.123 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -81.96 -15.41 53.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.025 0.44 . . . . 0.0 110.379 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -114.01 -25.02 8.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.875 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.46 -138.05 2.35 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.635 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 72' ' ' PHE . 52.4 t -121.18 138.83 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.815 0.341 . . . . 0.0 110.649 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 t -119.52 169.3 10.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.917 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.793 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 54.7 m-85 -71.84 173.01 8.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.779 0.323 . . . . 0.0 110.361 173.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.14 -61.07 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.517 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.48 115.74 18.63 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 68.32 0.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.742 1.276 . . . . 0.0 111.092 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -146.07 2.6 0.9 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.268 171.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -76.66 160.52 29.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.146 -175.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 41.5 m -141.86 159.45 42.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.506 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' A' ' 7' ' ' ILE . 96.5 mt -85.76 -17.11 36.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.406 0.622 . . . . 0.0 109.895 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -86.25 -1.98 57.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.213 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 21.4 t0 -89.57 157.91 17.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.54 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.72 -25.51 26.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.963 0.411 . . . . 0.0 110.292 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.94 115.0 26.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.486 0.66 . . . . 0.0 111.657 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.81 127.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 m -121.95 120.52 34.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.56 126.69 68.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.4 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -94.63 104.48 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.017 0.437 . . . . 0.0 110.68 -176.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' HG13 ' A' ' 43' ' ' VAL . . . -101.53 166.75 18.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.462 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -155.94 -179.6 8.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 p -117.8 166.98 11.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.303 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 5.1 m-85 -124.16 144.52 49.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.221 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.68 -32.06 28.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.193 0.52 . . . . 0.0 111.206 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -96.97 -6.03 36.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.75 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 10.5 mmt180 -112.8 95.43 33.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.24 -8.36 19.72 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.397 2.065 . . . . 0.0 111.58 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -153.41 83.66 1.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.092 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CE2' ' HB ' ' A' ' 73' ' ' THR . 4.7 p90 -142.7 -170.16 3.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.897 ' HG2' ' HB3' ' A' ' 27' ' ' GLU . 77.5 mt-30 -32.81 -69.78 0.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.251 1.02 . . . . 0.0 113.621 -175.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 43' ' ' VAL . 4.9 m-30 -124.13 111.87 16.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.453 ' HB ' ' CE2' ' A' ' 70' ' ' TYR . 14.9 t -164.59 -40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.379 0.609 . . . . 0.0 110.236 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -96.75 21.08 9.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.712 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.9 tp -65.98 -18.79 65.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -8.71 56.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.893 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.27 -10.64 51.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.94 0.4 . . . . 0.0 110.704 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.537 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -73.29 156.18 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.109 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 97' ' ' MET . 32.8 mttp -129.79 -179.79 5.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.434 -176.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -61.71 -28.84 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.114 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.21 42.85 1.72 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.466 -0.873 . . . . 0.0 110.993 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.516 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.9 t -57.25 -22.04 38.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.313 0.645 . . . . 0.0 112.048 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.23 87.13 0.06 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.747 0.784 . . . . 0.0 111.49 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.2 t -90.1 136.58 23.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.035 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.8 107.27 14.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.101 0.477 . . . . 0.0 109.926 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -94.7 105.3 17.23 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppp? -84.03 106.65 15.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.604 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 10.6 m -125.4 112.43 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 0.0 111.481 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.08 -94.71 0.18 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.838 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -129.94 8.31 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 110.238 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.87 138.56 40.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.427 ' OG1' ' HE2' ' A' ' 87' ' ' LYS . 43.7 m -107.25 93.19 4.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.578 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 146' ' ' GLU . 12.8 mmt180 -83.07 118.28 23.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.015 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.644 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 3.4 mptt -91.82 132.58 36.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 96.1 m-85 -124.7 144.81 50.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.099 0.476 . . . . 0.0 110.961 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.1 OUTLIER -113.52 128.05 56.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.061 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.632 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.1 mmt -78.7 60.43 2.75 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -77.05 -23.71 52.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.441 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.579 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 71.1 m -121.02 102.05 8.08 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 110.874 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.82 121.86 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.524 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -142.71 -172.35 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.471 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.96 141.14 46.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 139' ' ' ARG . 20.8 m -124.14 167.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.045 0.45 . . . . 0.0 111.003 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.959 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.13 163.09 53.68 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.281 -171.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 137' ' ' GLU . 60.2 Cg_endo -72.33 20.94 0.29 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.434 2.089 . . . . 0.0 112.124 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.9 t -156.47 8.87 0.22 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.959 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 2.3 p30 -78.98 176.92 9.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.157 0.503 . . . . 0.0 111.206 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.521 ' HA ' HD11 ' A' ' 111' ' ' LEU . 23.1 m -123.69 24.31 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.235 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.22 5.11 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.82 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.7 m -108.56 -13.95 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.974 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -108.06 1.85 22.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -89.94 174.33 7.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.19 107.3 8.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -81.83 69.37 8.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.649 0.738 . . . . 0.0 110.564 -176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -115.04 -165.6 1.04 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.468 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.49 -26.26 24.77 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.275 -0.488 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -125.13 -173.2 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -153.85 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 17.1 mmtm -54.56 123.1 12.07 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.471 ' HB2' HG13 ' A' ' 143' ' ' VAL . 3.9 pt20 -117.29 120.09 37.16 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 121' ' ' LEU . 28.1 mt -78.18 99.19 6.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.6 m -85.78 96.9 9.89 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.71 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 26.5 mt -94.92 101.37 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.943 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.36 93.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.0 m -93.9 111.27 22.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.144 0.497 . . . . 0.0 110.138 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 58.2 m -95.45 109.5 21.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -136.94 89.22 2.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.994 0.902 . . . . 0.0 110.594 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 9.1 p-10 -153.9 -51.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.194 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.5 83.52 0.1 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.023 0.827 . . . . 0.0 110.772 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 38.4 t-20 -77.84 94.13 4.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.25 -20.76 63.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.144 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 30.6 mmmt -63.3 -30.47 71.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.492 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 135' ' ' VAL . 4.9 t -129.68 -23.77 2.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 60.75 1.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.6 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 133' ' ' THR . 9.5 p -159.05 159.67 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -99.05 110.75 23.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 41.8 mt-10 -90.9 -59.83 2.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.709 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 53.2 mmtt -80.81 102.26 9.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.885 0.85 . . . . 0.0 110.987 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.549 ' HB2' HG23 ' A' ' 103' ' ' VAL . 74.1 mtt180 -114.11 102.07 9.82 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.598 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -83.2 122.29 28.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 5.0 tt -118.92 125.36 74.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.59 -172.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.632 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.2 m-85 -109.15 124.54 50.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.534 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.7 t -110.97 109.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.085 0.469 . . . . 0.0 110.318 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.62 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -107.65 120.03 41.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.351 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.6 m -89.86 143.1 27.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.122 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.496 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 31.9 tt0 -61.59 128.59 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.321 0.582 . . . . 0.0 111.239 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 148' ' ' LYS . 2.3 t -110.92 170.14 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.422 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.48 ' H ' HG12 ' A' ' 147' ' ' VAL . 37.1 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.263 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG3' ' HG2' ' A' ' 2' ' ' GLN . 24.9 ptt? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 82.3 mm-40 73.04 5.07 5.11 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.764 0.826 . . . . 0.0 111.583 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.81 106.14 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.454 -178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.1 mtmt -102.41 100.44 15.79 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.878 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 19.0 Cg_endo -58.38 124.12 15.13 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.975 2.45 . . . . 0.0 111.234 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -151.98 175.31 12.64 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.623 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.527 HG23 ' CB ' ' A' ' 31' ' ' PRO . 53.4 mt -113.12 95.23 33.98 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.212 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 23.9 Cg_exo -65.14 164.37 25.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.289 2.659 . . . . 0.0 113.565 -174.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -65.3 -34.1 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.779 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.09 129.44 34.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.368 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -96.88 6.1 49.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.088 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.4 m -101.12 8.45 42.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 65.8 mttm -107.84 175.9 5.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.83 120.49 59.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.614 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.92 -29.37 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.548 . . . . 0.0 110.913 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.99 168.95 42.1 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.238 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 80.0 m-85 -118.05 131.16 56.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -100.63 115.41 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.662 0.744 . . . . 0.0 110.003 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 47.7 mt-10 -123.63 112.39 17.36 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.83 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 25' ' ' ILE . 46.3 mt -126.27 94.78 40.26 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.903 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.75 -33.28 96.59 Favored 'Trans proline' 0 CA--C 1.518 -0.314 0 C-N-CA 122.77 2.313 . . . . 0.0 111.505 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.28 -34.45 70.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.37 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -112.35 10.35 19.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.49 30.58 15.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.858 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 20' ' ' ILE . 63.1 mt -86.86 133.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -156.14 57.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.14 0.495 . . . . 0.0 109.745 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -117.81 153.81 50.95 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.656 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -80.16 138.67 12.89 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.818 2.345 . . . . 0.0 112.635 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.93 131.38 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 110.316 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.3 m-85 -101.41 129.22 27.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.795 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 58.8 Cg_endo -71.5 149.81 56.55 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.887 2.391 . . . . 0.0 112.161 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.18 177.89 25.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.047 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 84.4 Cg_endo -84.63 29.95 0.53 Allowed 'Trans proline' 0 CA--C 1.52 -0.199 0 C-N-CA 123.813 3.009 . . . . 0.0 112.671 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . 60.8 56.34 2.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.042 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.52 HG23 ' HG2' ' A' ' 33' ' ' PRO . 1.4 p -76.55 138.22 67.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.67 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -38.47 -66.34 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.49 3.46 . . . . 0.0 114.655 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.59 -35.49 81.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -68.83 -34.4 75.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.731 -174.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 pp -87.4 -0.43 56.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.44 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -98.67 -31.57 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.114 175.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -70.51 -29.99 66.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.4 -97.48 0.16 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.031 ' HB ' ' HG3' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -170.28 153.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 8.4 t -133.37 176.19 8.74 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.362 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 73.5 m-85 -89.16 173.62 8.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.96 85.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.767 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.5 mt-10 -134.21 167.41 20.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.153 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 1.4 tm-20 -72.97 -40.08 65.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.141 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -80.49 11.11 3.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.117 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -62.34 146.58 50.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.932 176.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.3 m -141.81 133.27 26.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 111.775 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.25 -2.87 36.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.748 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.03 -13.47 53.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.686 0.755 . . . . 0.0 109.487 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.26 -168.82 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.59 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -121.69 0.94 9.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.602 0.239 . . . . 0.0 110.452 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -113.16 49.69 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.03 118.27 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.305 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' HD11 ' A' ' 124' ' ' ILE . 15.5 m -120.36 124.87 46.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.559 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.2 mt -108.92 136.26 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.38 113.37 26.92 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.942 0.151 . . . . 0.0 110.8 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -105.76 148.21 16.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.678 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.473 ' HB2' ' C12' ' A' ' 201' ' ' JPT . 10.7 t-160 -117.16 107.57 14.63 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.173 0.189 . . . . 0.0 110.622 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -65.18 126.63 28.73 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 8.3 t80 -130.97 152.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.65 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.3 mt -90.6 -43.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 4.4 m-20 -76.39 -1.58 27.63 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -122.92 115.58 29.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.67 0.271 . . . . 0.0 110.561 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -90.34 0.57 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.746 2.297 . . . . 0.0 112.032 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -141.74 79.21 1.67 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.564 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.55 -166.62 2.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.364 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 1.031 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 68.8 mm-40 -47.29 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -101.27 28.47 5.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -40.13 85.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.354 0.597 . . . . 0.0 111.053 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.55 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 67.0 t30 -111.07 22.99 14.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.25 -5.53 23.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.135 0.493 . . . . 0.0 110.998 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.55 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -75.37 -8.23 56.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 110.683 176.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.77 6.57 45.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.347 0.594 . . . . 0.0 110.48 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.95 152.53 21.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.503 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 -171.5 3.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -51.96 -22.05 3.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.96 44.83 1.12 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 119.578 -1.296 . . . . 0.0 113.337 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -67.88 142.2 56.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.647 ' HE1' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -91.19 89.85 7.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.101 176.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 57.2 t -85.95 107.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.493 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -100.52 118.85 37.56 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -110.51 104.16 12.86 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 1.4 mptm? -81.18 123.1 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.751 -177.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.878 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 6.6 m -136.95 116.53 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.167 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.05 -95.58 0.2 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.454 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -120.85 -3.41 9.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.537 0.208 . . . . 0.0 110.897 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.42 178.95 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.957 -173.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -142.4 141.55 32.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 146' ' ' GLU . 18.3 mmm180 -108.53 132.65 53.62 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.647 ' HD3' ' HE1' ' A' ' 83' ' ' MET . 12.1 ptpt -99.3 135.62 40.44 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 86.4 m-85 -122.03 144.36 48.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.703 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.2 tptm -110.04 126.07 53.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.049 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.486 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 59.6 mtt -82.07 80.73 8.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.428 0.633 . . . . 0.0 110.588 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 98' ' ' THR . 2.0 t -89.25 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.153 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.0 t -144.83 129.17 17.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -141.19 125.47 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.181 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -170.74 -176.62 2.1 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.048 0.218 . . . . 0.0 110.832 172.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.731 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 2.9 p30 -130.24 138.88 50.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.417 . . . . 0.0 110.435 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.8 -179.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.93 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -93.19 154.19 41.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HD3' ' A' ' 139' ' ' ARG . 61.0 Cg_endo -72.09 -18.42 27.36 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.317 2.011 . . . . 0.0 111.736 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.7 t -106.63 15.74 25.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.85 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.415 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 6.0 t0 -72.58 162.05 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.517 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 -7.25 10.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.71 -29.53 64.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.629 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.22 -9.31 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.915 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 94.1 mt -90.98 10.29 27.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.2 -176.11 3.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.94 132.16 50.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.35 0.595 . . . . 0.0 111.298 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -82.78 120.97 26.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.616 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -84.19 -152.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.693 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.34 55.62 1.16 Allowed Glycine 0 C--N 1.336 0.583 0 O-C-N 123.267 0.354 . . . . 0.0 113.593 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -83.59 147.43 27.74 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -87.36 -157.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -67.06 103.67 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.842 0.353 . . . . 0.0 110.418 -178.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 12.5 pt20 -104.56 136.37 44.24 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.394 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.75 105.8 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.5 m -85.33 100.86 12.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.729 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.6 mt -83.64 99.39 10.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 58' ' ' SER . 18.9 mt -91.54 97.22 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 17.4 m -106.9 121.94 45.42 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.804 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 94.2 m -73.54 96.16 2.38 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.201 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 6.4 t70 -110.53 98.36 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.887 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -178.59 -82.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.51 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.63 ' CE1' ' HG2' ' A' ' 131' ' ' GLU . 1.2 t80 58.58 77.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.016 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -83.25 86.28 7.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.269 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.63 ' HG2' ' CE1' ' A' ' 129' ' ' TYR . 27.8 mt-10 -58.79 -22.95 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.764 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -64.83 -27.53 68.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.485 HG23 HG12 ' A' ' 135' ' ' VAL . 4.8 t -121.66 -17.5 7.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.84 0.352 . . . . 0.0 110.445 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 48.64 5.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.239 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.485 HG12 HG23 ' A' ' 133' ' ' THR . 4.0 p -146.14 158.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.501 ' HB2' ' O4 ' ' A' ' 201' ' ' JPT . 46.5 m95 -105.34 98.69 8.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.65 -58.51 3.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -85.3 137.12 33.18 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.459 0.647 . . . . 0.0 112.316 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HD3' ' HD3' ' A' ' 105' ' ' PRO . 6.5 mpt_? -100.12 111.03 23.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.76 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -79.03 117.86 20.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.0 tt -120.48 123.48 70.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.913 0.863 . . . . 0.0 111.052 -174.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 11.5 m-85 -108.14 114.65 28.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.048 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 40.2 t -93.95 99.62 9.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.302 0.572 . . . . 0.0 110.02 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -103.83 109.34 21.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.291 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 5.7 m -93.53 143.56 26.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.468 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 93' ' ' ARG . 34.0 tt0 -54.01 124.02 14.3 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.685 0.615 . . . . 0.0 111.303 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.525 HG11 ' HD3' ' A' ' 96' ' ' LYS . 6.5 p -111.05 151.6 13.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.585 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 4.5 ptmm? . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.464 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.501 ' O4 ' ' HB2' ' A' ' 136' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.558 0.218 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.02 169.19 9.99 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.0 98.94 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.982 0.801 . . . . 0.0 110.223 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 53' ' ' ASP . 16.6 mttt 54.66 84.73 0.21 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.51 -171.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 88' ' ' VAL . 11.1 Cg_exo -70.25 164.44 35.02 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.7 2.267 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -140.3 130.15 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.009 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.702 HG13 HD21 ' A' ' 52' ' ' LEU . 12.0 mt -63.6 121.98 73.64 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.124 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.33 -179.07 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.965 2.443 . . . . 0.0 112.575 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -81.16 -12.62 59.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.3 0.572 . . . . 0.0 110.554 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.03 113.16 21.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.139 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -91.53 1.46 57.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.223 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 t -98.97 -6.04 29.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.879 0.371 . . . . 0.0 111.377 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -106.3 172.92 6.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.066 0.46 . . . . 0.0 110.884 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.34 125.38 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.609 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.35 -44.98 13.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.381 0.61 . . . . 0.0 109.696 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.88 168.34 36.22 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 68.2 m-85 -107.77 140.84 40.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.138 0.469 . . . . 0.0 110.439 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -105.33 112.71 39.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.855 0.836 . . . . 0.0 109.446 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HB3' ' HD2' ' A' ' 26' ' ' LYS . 33.5 mt-10 -122.29 112.58 18.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.528 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 25' ' ' ILE . 38.7 mt -127.28 93.95 39.85 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.791 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.51 -28.47 86.72 Favored 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 123.117 2.545 . . . . 0.0 111.808 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 26.9 t70 -67.22 -28.03 67.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.174 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -114.66 12.41 17.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.148 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.5 t70 61.78 26.91 16.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.492 0.663 . . . . 0.0 111.128 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 20' ' ' ILE . 80.5 mt -95.99 129.67 45.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.206 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.596 ' HD2' ' HB3' ' A' ' 19' ' ' GLU . 9.2 mmmm -155.26 42.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.468 0.307 . . . . 0.0 111.498 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -124.46 157.47 64.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 36.4 Cg_endo -66.47 149.17 84.62 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.426 2.75 . . . . 0.0 113.52 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.81 138.1 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.214 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -100.33 135.57 20.23 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 121.0 0.428 . . . . 0.0 110.83 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.0 Cg_endo -79.89 128.93 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.729 2.286 . . . . 0.0 111.348 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.673 ' HA3' ' HG2' ' A' ' 38' ' ' GLN . . . -175.82 149.42 9.99 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.676 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.483 ' HG2' HG23 ' A' ' 35' ' ' THR . 68.8 Cg_endo -74.46 38.02 0.48 Allowed 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.966 3.111 . . . . 0.0 113.476 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 54.91 36.23 26.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.074 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 33' ' ' PRO . 6.1 p -76.46 154.16 83.85 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.784 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 77.3 Cg_exo -50.92 -46.71 29.14 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.607 2.871 . . . . 0.0 114.091 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -75.9 -17.83 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 111.349 -177.66 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.673 ' HG2' ' HA3' ' A' ' 32' ' ' GLY . 42.4 tp60 -81.41 -46.82 14.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.913 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 96.7 mt -77.89 -1.52 32.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.441 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 65.6 t30 -84.55 -44.19 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.747 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 7.0 ptm180 -75.52 -30.32 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.574 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -179.51 -162.9 29.42 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -85.39 155.73 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 117.491 0.646 . . . . 0.0 110.114 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.562 ' OG ' ' HG3' ' A' ' 38' ' ' GLN . 59.9 m -150.58 179.72 7.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.146 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -73.27 157.85 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.17 76.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.632 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.19 175.99 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.513 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.6 1.9 27.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.88 -17.32 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.49 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 58' ' ' SER . 1.3 mp0 -61.13 154.26 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.733 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m -141.56 157.95 44.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.88 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.5 mm? -77.08 -23.21 51.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.606 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 15.2 t70 -135.34 70.08 1.44 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.639 1.209 . . . . 0.0 109.108 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.895 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.3 t70 -124.78 162.4 24.37 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.709 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.89 -35.93 82.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.36 131.74 54.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.41 0.624 . . . . 0.0 111.21 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 121' ' ' LEU . 47.1 mt -129.2 123.06 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.417 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 1.1 m -113.17 109.2 18.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -107.99 124.35 64.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.09 120.02 33.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.003 0.43 . . . . 0.0 111.08 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.62 118.28 5.54 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.817 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -68.42 -38.62 81.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m 73.01 126.92 0.04 OUTLIER 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.552 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -137.43 142.51 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.22 -39.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.875 173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.63 -46.74 63.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.292 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -107.9 107.12 59.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.711 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.558 ' HA ' HG21 ' A' ' 73' ' ' THR . 96.4 Cg_endo -80.25 -18.89 9.58 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.551 2.168 . . . . 0.0 111.682 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -124.61 70.79 1.13 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.464 0.649 . . . . 0.0 110.896 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.444 ' HE1' ' HG1' ' A' ' 73' ' ' THR . 3.7 p90 -138.48 -177.5 4.88 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 166.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -41.06 -68.41 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -168.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -114.28 96.22 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.24 -174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 68' ' ' PRO . 1.3 m -156.49 -45.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.641 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -97.91 23.36 8.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.542 0.687 . . . . 0.0 110.247 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -11.5 59.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -71.11 -11.16 60.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.344 . . . . 0.0 111.545 -178.748 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -89.65 6.86 39.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -94.05 135.05 35.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.796 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 7.4 mptt -108.51 -170.87 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.617 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 97' ' ' MET . 6.2 ptpp? -65.87 -33.9 76.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.43 54.01 0.57 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.469 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 p -75.02 -15.97 60.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.425 ' HG2' ' HE3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 54.31 85.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.556 0.693 . . . . 0.0 111.639 -174.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 48.4 t -86.11 113.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.062 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 89.4 m-85 -98.73 110.43 23.03 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 34.9 t80 -99.21 102.59 14.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 35.7 mmtp -92.02 81.27 5.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.387 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.88 HG21 ' HG ' ' A' ' 52' ' ' LEU . 5.4 p -93.54 121.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.178 0.513 . . . . 0.0 110.489 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.12 -104.1 0.63 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.731 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 90' ' ' ASN . 6.6 m120 -124.64 9.25 8.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.312 . . . . 0.0 110.718 177.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -100.11 148.58 24.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 110.57 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 93.1 m -117.7 104.34 10.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.188 0.518 . . . . 0.0 111.023 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 58.2 mmt-85 -92.11 135.36 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.986 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -115.02 130.1 56.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.036 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -130.23 146.88 51.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.72 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -112.95 135.99 53.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.702 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 20.8 mmt -79.35 65.44 4.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.528 0.68 . . . . 0.0 110.359 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 t -80.44 -13.75 58.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.551 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.4 m -135.18 90.88 2.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.546 0.689 . . . . 0.0 111.1 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 97' ' ' MET . 73.1 mt -109.07 129.7 63.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.429 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -164.62 -169.64 1.8 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.83 0.347 . . . . 0.0 110.255 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.819 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 3.3 p-10 -145.68 137.37 25.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.56 HG23 ' HD2' ' A' ' 139' ' ' ARG . 21.5 m -120.29 174.13 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.323 -173.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.526 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.2 mppt? -91.6 158.05 41.03 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.827 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.737 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 19.9 Cg_endo -61.7 -24.2 77.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.358 2.039 . . . . 0.0 111.293 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -114.71 29.93 7.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.789 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 17.9 t70 -63.29 139.71 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.257 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.1 m -110.87 2.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.738 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -85.92 -36.24 20.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.197 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.1 -10.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.906 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 pp -111.13 -0.13 16.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 111.192 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.84 -159.15 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 9.5 pt-20 -60.98 112.91 2.26 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.458 0.646 . . . . 0.0 111.672 -177.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -85.6 134.18 34.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.518 174.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 12.1 mptt -74.16 174.98 7.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.278 -170.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.81 55.05 1.34 Allowed Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.884 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -69.41 173.54 5.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.329 0.585 . . . . 0.0 110.972 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.411 ' OD1' ' HD3' ' A' ' 119' ' ' LYS . 5.1 t70 -104.54 -149.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -58.69 114.85 2.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.83 119.84 38.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.259 0.552 . . . . 0.0 111.957 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 57' ' ' ILE . 14.0 mt -82.38 104.97 13.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -92.63 92.21 7.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.565 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 16.7 mt -87.78 101.12 13.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 mt -90.92 97.8 7.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.29 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -103.09 101.97 11.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.328 0.585 . . . . 0.0 110.362 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 86.3 m -92.56 101.87 14.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.689 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -120.36 68.44 0.85 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.495 0.664 . . . . 0.0 110.052 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 34.6 t70 -176.26 95.23 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.681 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -102.56 115.94 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -86.69 103.05 14.78 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.89 -27.07 68.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.017 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -77.53 -18.57 56.86 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.518 -173.404 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 135' ' ' VAL . 21.9 p -120.82 -32.3 4.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.62 16.24 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.505 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.535 HG12 ' OG1' ' A' ' 133' ' ' THR . 9.8 p -132.64 154.46 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.578 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.718 ' HB2' ' O4 ' ' A' ' 201' ' ' JPT . 55.4 m95 -97.71 109.21 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.737 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 44.2 mt-10 -87.93 -63.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -172.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 48.1 tptt -75.57 80.7 2.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.134 0.969 . . . . 0.0 110.348 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HD2' HG23 ' A' ' 103' ' ' VAL . 1.5 ptp180 -93.57 108.63 20.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.355 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.819 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 45.6 tptt -80.66 132.77 35.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.334 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -122.71 122.72 66.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.923 0.868 . . . . 0.0 111.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.459 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 13.2 m-85 -110.69 105.32 14.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.687 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 26.2 t -99.35 104.23 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.349 0.595 . . . . 0.0 110.371 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.536 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -100.38 117.76 35.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.368 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.1 m -95.78 144.51 26.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 29.8 tt0 -56.67 135.91 54.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 111.725 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.626 HG21 ' HD3' ' A' ' 96' ' ' LYS . 1.1 t -106.94 172.26 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.55 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 147' ' ' VAL . 30.4 mmmt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.607 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.718 ' O4 ' ' HB2' ' A' ' 136' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -89.24 -164.93 1.22 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.07 0.462 . . . . 0.0 110.863 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.92 90.02 2.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.308 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 7.8 mtmp? -128.92 101.02 20.23 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.795 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 18.3 Cg_endo -58.58 134.56 61.71 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.547 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 8.8 pt20 -158.05 176.2 12.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.863 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 31' ' ' PRO . 5.4 mp -96.99 108.88 46.3 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.034 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.4 Cg_exo -68.11 165.03 29.79 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.811 2.341 . . . . 0.0 110.88 170.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -97.02 18.73 14.12 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.909 -171.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 18.3 t70 -86.84 150.07 24.38 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' GLN . 34.8 mmtp -80.4 -39.72 27.82 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 m -93.49 -22.34 18.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -59.72 150.02 29.07 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.599 0.714 . . . . 0.0 112.443 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -105.9 139.2 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.634 172.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.86 -32.53 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.448 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.16 161.87 26.82 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.485 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 35.7 m-85 -122.88 143.43 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -104.44 118.41 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.252 0.549 . . . . 0.0 109.79 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 26.0 mt-10 -125.81 111.62 15.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 62.1 mt -132.24 109.09 13.75 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 -47.18 15.3 Favored 'Trans proline' 0 N--CA 1.473 0.273 0 C-N-CA 123.157 2.571 . . . . 0.0 113.365 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -62.54 -30.19 71.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -98.18 2.4 48.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.224 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t70 61.55 27.76 17.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.969 0.89 . . . . 0.0 109.887 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 61.0 mt -97.24 129.29 47.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.235 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 32.5 ttpt -159.86 79.11 0.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 168.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.403 ' HB3' HE21 ' A' ' 71' ' ' GLN . 62.2 mm-40 -133.5 157.14 78.75 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.826 -173.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.2 146.88 71.35 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.848 2.365 . . . . 0.0 113.03 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.531 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 76.2 t -106.12 125.44 61.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.712 176.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 61.1 m-85 -93.54 103.44 9.86 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.627 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 3.0 Cg_endo -86.86 155.0 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.355 2.703 . . . . 0.0 112.298 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.77 -151.75 21.04 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.952 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.582 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 78.7 Cg_endo -76.3 19.21 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.249 2.633 . . . . 0.0 113.092 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 56.87 46.24 20.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.324 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.72 119.7 23.2 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.092 -174.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.32 -38.64 42.81 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.238 2.625 . . . . 0.0 113.066 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.95 -38.4 82.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.311 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 75.9 mm-40 -90.65 -30.73 16.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.089 0.471 . . . . 0.0 110.4 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.43 -27.99 63.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.975 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -68.28 -24.8 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 41' ' ' ARG . 15.9 mtp-105 -80.96 -52.71 7.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.738 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.72 -117.23 1.49 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.06 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.56 142.42 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -128.59 -179.59 5.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.385 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 31' ' ' PRO . 11.9 m-85 -74.61 178.09 5.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.7 -46.79 20.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.68 167.14 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.699 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -80.82 -10.31 59.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.522 0.677 . . . . 0.0 109.951 175.308 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.83 -23.0 58.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.854 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 9.5 pt-20 -84.03 177.86 8.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 112.161 -172.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.509 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 70.8 m -137.38 175.13 9.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -172.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.14 -15.95 34.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.432 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -134.9 70.34 1.44 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.283 1.04 . . . . 0.0 109.589 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 14.7 t70 -126.37 160.88 29.18 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.747 171.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -63.84 -31.54 72.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.64 125.86 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.588 0.708 . . . . 0.0 111.012 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.33 139.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -131.15 116.23 17.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.195 0.521 . . . . 0.0 111.659 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.4 mt -101.09 116.41 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.64 105.07 17.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 111.309 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.64 144.49 15.95 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.301 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -122.81 133.81 54.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.552 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -81.86 113.27 19.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -113.67 109.3 18.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.505 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.7 mm -54.96 -33.98 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.741 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.87 -40.46 76.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 61.1 mtt180 -106.98 108.91 62.74 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.914 0.388 . . . . 0.0 111.068 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 3.3 Cg_exo -77.77 -10.77 16.95 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.196 2.597 . . . . 0.0 112.737 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.68 80.53 1.7 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.425 0.631 . . . . 0.0 111.716 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.552 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -132.62 -161.82 1.17 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.751 168.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 27' ' ' GLU . 25.6 mp0 -49.63 -72.37 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -105.57 31.77 4.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -169.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 m -73.74 -34.86 64.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.04 0.448 . . . . 0.0 111.223 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -116.72 28.0 8.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.277 0.56 . . . . 0.0 110.484 -173.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.22 -21.45 65.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -74.03 -2.05 22.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.302 . . . . 0.0 111.622 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.42 8.2 37.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.62 153.92 20.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -125.82 176.41 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.295 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -61.2 -19.67 61.88 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.89 51.62 0.85 Allowed Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.174 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 m -79.28 -4.47 50.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 53.93 82.93 0.08 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.447 0.641 . . . . 0.0 111.244 -175.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.9 t -85.0 113.94 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.967 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.577 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 84.3 m-85 -94.26 117.64 30.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.884 0.373 . . . . 0.0 110.052 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.408 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 10.6 t80 -100.44 101.11 11.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 32.4 tptt -83.89 99.14 10.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.864 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.871 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.1 m -116.7 86.96 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.87 -107.04 1.69 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.231 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.14 -11.36 30.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 0.0 110.829 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.871 ' HB2' HG23 ' A' ' 88' ' ' VAL . 38.8 mt-10 -95.11 109.2 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.755 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.0 m -100.57 85.68 2.99 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 93' ' ' ARG . 11.3 ptp180 -93.39 133.73 36.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.525 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -102.86 139.38 38.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.771 -175.346 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.6 m-85 -120.91 148.99 43.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 1.2 tptm -110.49 131.96 54.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.9 mmt -76.68 70.58 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -77.05 -20.62 55.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.669 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 52.5 m -133.53 101.37 5.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 97' ' ' MET . 74.9 mt -116.49 116.54 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.688 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -161.66 -174.39 4.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.53 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.799 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 1.2 p-10 -144.09 134.92 25.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.19 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.7 m -133.77 -175.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.458 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -92.16 160.29 35.7 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.635 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.872 ' HA ' ' O2 ' ' A' ' 201' ' ' JPT . 45.5 Cg_endo -70.35 -20.71 31.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 111.445 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -98.83 10.54 41.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.882 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.21 115.86 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.802 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.95 2.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 0.0 110.996 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.12 -34.88 18.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.379 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.5 m -77.26 -26.25 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -91.83 20.29 5.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.9 169.37 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.516 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 5.6 pt-20 -66.61 84.8 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.328 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -87.45 37.78 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.652 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -82.52 172.12 13.35 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.639 176.107 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.91 -7.64 59.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.808 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -91.08 -168.25 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.133 0.492 . . . . 0.0 110.557 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -104.6 -157.78 0.63 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.9 OUTLIER -65.54 107.37 1.68 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -104.97 124.38 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.237 0.541 . . . . 0.0 110.282 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -92.95 98.26 11.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.1 m -84.41 99.11 10.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.258 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 20.0 mt -85.25 106.08 16.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.1 mt -93.52 127.24 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.578 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 30.5 m -136.67 105.21 5.78 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.256 0.551 . . . . 0.0 110.501 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.4 m -99.52 107.39 19.56 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -118.08 -1.46 11.41 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -172.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 137' ' ' GLU . 37.1 t70 -105.71 89.64 3.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.524 0.678 . . . . 0.0 109.919 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' A' ' 131' ' ' GLU . 92.3 t80 -82.58 124.91 30.59 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.172 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.514 ' OD1' HG22 ' A' ' 133' ' ' THR . 23.1 t-20 -89.29 103.62 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.595 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 40.2 mt-10 -64.09 -23.24 67.25 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -171.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 1.011 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 5.9 mmpt? -78.49 -23.43 46.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.514 HG22 ' OD1' ' A' ' 130' ' ' ASN . 7.7 t -130.06 -30.0 2.03 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.596 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.88 35.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.281 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.511 ' H ' HG23 ' A' ' 133' ' ' THR . 12.8 m -82.8 172.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 41.9 m95 -117.37 112.11 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.465 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 41.9 mt-10 -77.83 -21.38 51.59 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.799 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -114.98 118.35 33.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.296 0.57 . . . . 0.0 111.036 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -107.13 98.67 8.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.483 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 47.7 tptt -69.1 128.52 36.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.91 118.49 50.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.989 0.899 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 15.8 m-85 -109.08 101.59 10.64 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.305 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 38.3 t -95.42 97.09 6.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.403 0.62 . . . . 0.0 110.121 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.557 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -95.91 112.23 24.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.9 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.8 m -90.45 139.34 30.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.88 123.75 15.33 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.564 0.54 . . . . 0.0 110.798 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.553 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 4.0 t -76.8 147.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.644 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt . . . . . 0 C--O 1.248 1.024 0 O-C-N 124.324 1.015 . . . . 0.0 111.236 178.73 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.872 ' O2 ' ' HA ' ' A' ' 105' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 17.4 tt0 70.1 6.97 6.01 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.925 0.766 . . . . 0.0 111.13 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.58 142.06 15.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.51 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 68.8 mmtt -119.06 93.2 46.55 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.552 172.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.84 118.33 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.874 2.383 . . . . 0.0 112.126 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -118.96 147.37 44.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.668 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.405 HG23 ' HB3' ' A' ' 31' ' ' PRO . 22.4 mt -84.57 121.82 74.91 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.453 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.79 -175.66 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.513 2.142 . . . . 0.0 112.206 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.667 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.73 6.35 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.167 178.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -95.92 103.95 15.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.052 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' CD ' ' HD3' ' A' ' 33' ' ' PRO . 35.3 mtmm -85.63 12.81 7.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.139 -176.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -106.72 -5.86 18.24 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.203 0.525 . . . . 0.0 109.678 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 99.3 mttt -91.37 -177.14 4.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -112.77 138.21 42.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.37 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.72 -29.4 12.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.244 0.545 . . . . 0.0 110.798 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.71 163.51 36.73 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 63.9 m-85 -109.44 135.79 49.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.483 0.642 . . . . 0.0 109.91 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.1 tp -97.86 108.53 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.772 0.796 . . . . 0.0 109.612 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -114.18 103.7 11.37 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.907 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mt -121.25 92.88 48.76 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.539 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.91 -21.18 68.9 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.052 2.502 . . . . 0.0 111.311 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.99 -30.14 63.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.888 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.52 10.9 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 63.14 29.25 16.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.769 0.795 . . . . 0.0 110.758 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.53 HG23 ' HG2' ' A' ' 27' ' ' GLU . 78.2 mt -102.22 118.74 49.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.5 mppt? -135.82 41.51 2.69 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.727 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 13.1 mm-40 -102.55 154.19 37.64 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.429 -163.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.79 143.45 13.25 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.473 2.116 . . . . 0.0 112.151 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.88 127.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 44' ' ' SER . 57.6 m-85 -100.76 133.71 20.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.493 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -69.26 145.34 59.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.498 2.132 . . . . 0.0 111.841 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . 164.8 162.07 15.08 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.31 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.743 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 Cg_endo -88.01 39.86 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.997 3.132 . . . . 0.0 111.545 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.71 35.98 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.47 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.403 ' OG1' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -76.0 152.48 84.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.824 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.53 -57.19 2.49 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.971 3.114 . . . . 0.0 113.818 -175.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.4 mm-40 -59.61 -34.76 73.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.8 mp0 -64.99 -44.21 90.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.287 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.3 -30.92 65.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.44 0.638 . . . . 0.0 110.109 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.08 -39.87 95.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.673 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 28.2 mtp-105 -75.67 -51.61 12.38 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.619 175.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' C ' ' HG3' ' A' ' 71' ' ' GLN . . . -156.47 -104.91 0.22 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.957 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.92 149.99 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 41.3 t -124.21 157.27 35.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.682 0.277 . . . . 0.0 110.901 -174.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -70.5 178.25 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 58' ' ' SER . . . -66.2 -46.58 76.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.743 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 12.8 pt-20 -149.15 -176.47 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.545 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -94.86 -27.37 15.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.151 -171.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -82.8 -9.86 59.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.038 0.447 . . . . 0.0 110.922 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.11 143.04 49.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.042 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 m -121.16 145.13 48.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.752 -171.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -81.84 -10.23 59.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.818 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -100.78 4.02 42.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 110.558 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -95.93 178.41 5.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.519 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.55 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 4.7 pp0? -97.26 -8.8 28.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.708 0.29 . . . . 0.0 111.301 -177.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -119.58 107.1 12.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.745 0.783 . . . . 0.0 110.754 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.8 mt -127.58 136.11 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.872 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 36.6 t -132.02 132.71 43.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.382 0.611 . . . . 0.0 110.962 -172.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -115.56 127.97 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.296 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.24 111.61 22.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.042 0.448 . . . . 0.0 111.063 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.99 137.92 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.666 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -148.21 102.09 3.33 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 m -56.37 147.47 21.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.594 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.48 ' HB3' ' CG ' ' A' ' 67' ' ' ARG . 69.7 t80 -139.25 148.3 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.3 mt -54.57 -51.52 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.308 -174.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -87.77 40.54 0.94 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.608 -172.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' CG ' ' HB3' ' A' ' 64' ' ' PHE . 12.8 ptp180 -166.21 88.76 0.86 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.267 0.556 . . . . 0.0 111.416 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.85 -4.53 14.06 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.189 2.593 . . . . 0.0 112.038 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -154.73 83.58 1.1 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.025 -170.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -139.12 -168.19 2.39 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.31 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.727 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 56.1 mm-40 -24.1 -75.73 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.882 1.273 . . . . 0.0 113.263 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -117.44 96.47 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 110.786 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.54 -49.74 0.78 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.327 0.584 . . . . 0.0 110.68 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.467 ' OD1' ' HE2' ' A' ' 76' ' ' LYS . 64.2 t30 -87.75 32.74 0.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.489 0.662 . . . . 0.0 110.952 -174.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.29 -7.48 49.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.392 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.467 ' HE2' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -78.4 -11.66 59.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.982 0.42 . . . . 0.0 111.017 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -12.22 49.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.755 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.15 22.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.772 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -157.13 -168.77 2.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.187 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.5 ptmt -46.2 -39.52 9.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.633 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -124.54 57.19 0.68 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.34 -1.409 . . . . 0.0 113.174 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -81.22 -6.94 59.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.736 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 84.2 mmm 47.68 91.63 0.01 OUTLIER 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.838 0.828 . . . . 0.0 112.744 -174.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -85.76 119.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -99.75 107.75 19.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.569 ' HD2' ' HD2' ' A' ' 93' ' ' ARG . 28.8 t80 -90.28 100.51 13.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.8 tppp? -82.86 93.75 7.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.212 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.09 122.03 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.268 0.556 . . . . 0.0 111.011 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.81 -90.48 0.13 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.962 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -139.81 8.47 2.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.0 109.448 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -100.76 131.47 46.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.542 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.8 m -103.67 97.55 7.55 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.569 ' HD2' ' HD2' ' A' ' 86' ' ' PHE . 9.9 ptp180 -97.35 153.41 18.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.895 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.05 122.29 44.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.186 0.517 . . . . 0.0 111.754 -166.2 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.9 m-85 -122.17 138.27 54.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.736 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.88 132.25 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.665 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 53.8 mtt -80.9 62.79 5.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.633 0.73 . . . . 0.0 110.175 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -75.93 -12.66 60.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.723 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 37.4 m -132.94 97.84 4.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.311 0.577 . . . . 0.0 110.34 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.92 128.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.341 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' A' ' 140' ' ' LYS . 6.1 ptp180 -161.05 -178.63 6.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.989 0.423 . . . . 0.0 110.536 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.51 143.63 46.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.795 HG23 ' HG3' ' A' ' 139' ' ' ARG . 11.8 m -131.17 170.84 18.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.624 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -100.28 146.39 31.9 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.819 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 139' ' ' ARG . 38.3 Cg_exo -61.6 -2.31 2.57 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.938 2.425 . . . . 0.0 112.907 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -126.62 19.49 7.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.624 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 1.6 p30 -68.59 166.8 16.37 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.332 0.587 . . . . 0.0 111.143 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.474 ' HA ' HD11 ' A' ' 111' ' ' LEU . 29.0 m -120.54 23.97 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -97.98 -41.82 7.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.158 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -87.25 -7.8 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.908 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 108' ' ' VAL . 2.5 pp -120.0 18.19 12.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.492 . . . . 0.0 110.929 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 32.3 t70 -152.15 138.47 18.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.174 -175.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.415 ' HB3' ' CE ' ' A' ' 115' ' ' LYS . 95.4 mt-10 53.4 65.76 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.795 0.684 . . . . 0.0 111.652 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -88.9 93.28 9.54 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' CE ' ' HB3' ' A' ' 113' ' ' GLU . 8.0 mptt -67.43 163.1 21.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.213 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.38 54.03 2.77 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.806 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -66.21 172.03 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.076 0.465 . . . . 0.0 110.788 172.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 3.2 t70 -81.03 -161.07 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 2.3 mppt? -64.72 119.02 9.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.989 0.423 . . . . 0.0 110.057 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.16 138.26 53.12 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.669 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.9 108.33 19.61 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m -92.59 106.12 18.16 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.758 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.7 mt -92.95 103.19 15.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.01 94.26 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -105.25 98.91 8.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.408 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.725 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 6.1 p -76.34 96.83 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.319 0.58 . . . . 0.0 109.882 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -125.28 79.26 1.79 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.396 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.784 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 31.5 t70 -168.89 85.72 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.492 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 70.8 t80 -91.91 125.9 36.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.132 -167.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -97.26 108.55 21.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.486 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 34.6 mt-10 -58.27 -33.72 69.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -71.21 -25.71 62.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 135' ' ' VAL . 2.6 t -125.03 -31.0 3.16 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.837 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' HA2' ' CE2' ' A' ' 129' ' ' TYR . . . 96.46 4.23 59.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.113 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.647 ' H ' HG23 ' A' ' 133' ' ' THR . 98.5 t -84.67 138.51 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.774 0.321 . . . . 0.0 110.158 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.784 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 45.0 m95 -95.68 105.04 16.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.37 -16.39 56.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.715 -165.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 128' ' ' ASP . 4.6 tppp? -133.17 130.46 39.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.806 0.336 . . . . 0.0 110.464 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.795 ' HG3' HG23 ' A' ' 103' ' ' VAL . 27.9 ptt180 -111.09 113.6 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.456 0.646 . . . . 0.0 110.181 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 16.2 tptm -76.33 127.51 33.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.841 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -121.04 127.16 75.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.728 0.775 . . . . 0.0 111.42 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 93.1 m-85 -114.64 108.76 17.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.488 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.6 t -96.68 102.53 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.265 0.555 . . . . 0.0 110.007 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.65 107.97 19.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.336 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.4 m -90.76 144.02 26.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.71 138.44 18.26 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.555 0.534 . . . . 0.0 111.186 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 96' ' ' LYS . 21.5 t -97.05 153.71 3.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.548 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.06 179.394 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.665 ' O2 ' ' HD3' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -77.08 -171.25 1.95 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.261 0.553 . . . . 0.0 111.328 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.64 105.27 8.89 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.833 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -128.43 99.12 24.4 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.53 130.76 22.53 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.5 2.8 . . . . 0.0 113.524 -174.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -144.08 169.07 18.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.875 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.433 HG23 ' HB3' ' A' ' 31' ' ' PRO . 2.4 mp -70.86 122.78 87.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 17.3 Cg_exo -67.52 170.54 13.47 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.747 2.298 . . . . 0.0 112.978 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -79.26 -21.96 45.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.82 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.23 108.56 21.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.022 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 52.6 mtmt -90.63 31.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.745 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -117.17 -20.92 9.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.367 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 19.2 ptpt -90.43 -175.44 4.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.479 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.8 p -100.94 137.52 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.874 0.369 . . . . 0.0 110.509 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -100.81 -40.19 7.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.373 0.606 . . . . 0.0 110.324 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.14 165.45 30.31 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.607 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 47.7 m-85 -115.37 139.25 50.17 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -103.61 115.36 45.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.608 0.718 . . . . 0.0 109.949 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.19 112.67 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.571 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.466 HG12 HG13 ' A' ' 84' ' ' VAL . 43.5 mt -127.93 95.41 34.47 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.142 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.4 -29.61 89.13 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 123.114 2.543 . . . . 0.0 112.047 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.98 -33.19 74.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.47 8.8 21.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 66.68 12.55 8.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.26 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.479 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 62.7 mt -78.21 123.54 35.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.244 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 14.3 mtmm -153.6 84.71 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 119.364 -0.351 . . . . 0.0 110.594 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.1 mm-40 -155.93 163.83 23.42 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 118.0 0.364 . . . . 0.0 111.725 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 14' ' ' VAL . 8.2 Cg_exo -72.4 156.89 54.1 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.08 2.52 . . . . 0.0 113.387 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.52 123.6 71.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.623 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.9 123.88 45.79 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.739 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 19.0 Cg_endo -58.28 129.41 32.73 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.968 2.445 . . . . 0.0 112.228 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . -172.27 135.12 3.24 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.445 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.486 ' HD3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 Cg_endo -80.68 61.43 8.22 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.309 2.673 . . . . 0.0 112.069 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.02 27.97 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.525 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 7.8 p -79.81 136.62 54.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.187 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 64.1 Cg_exo -52.51 -48.57 21.22 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.471 2.78 . . . . 0.0 113.829 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.628 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 2.2 mp0 -67.42 -23.19 65.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 111.653 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.565 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.9 mp0 -83.06 -26.01 31.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.044 0.45 . . . . 0.0 110.013 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.56 -5.66 55.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.457 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' A' ' 37' ' ' GLU . 28.4 p30 -97.11 -23.68 16.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -96.0 -20.74 18.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA2' ' NE2' ' A' ' 71' ' ' GLN . . . -168.95 -150.22 6.59 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.84 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.91 142.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.565 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 70.8 m -127.55 -175.58 3.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.246 0.546 . . . . 0.0 112.001 -172.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.79 -178.86 6.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.662 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.71 -50.93 5.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.101 0.477 . . . . 0.0 109.941 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HB2' ' OE2' ' A' ' 50' ' ' GLU . 35.7 mt-10 -119.59 -167.58 1.44 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.018 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.47 27.23 9.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -105.41 -28.66 10.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.533 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 58' ' ' SER . 3.0 mp0 -63.79 168.99 4.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.033 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.878 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 56.3 m -147.84 160.14 43.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.396 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HB3' HG11 ' A' ' 88' ' ' VAL . 81.9 mt -78.67 2.33 19.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -137.34 11.06 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.916 0.865 . . . . 0.0 109.311 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.878 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 11.9 t70 -79.85 162.26 25.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.605 -175.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.584 ' HA ' ' HD3' ' A' ' 119' ' ' LYS . 1.3 tm0? -63.23 -38.23 90.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.701 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.0 129.64 55.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 110.796 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.43 ' HB ' HD23 ' A' ' 121' ' ' LEU . 36.7 mt -136.83 116.59 16.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.518 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 17.2 m -113.97 122.13 46.0 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.9 123.92 72.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.19 112.2 23.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.32 159.39 13.73 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.047 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -146.11 136.62 24.05 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.747 ' OG1' ' HA ' ' A' ' 127' ' ' ASP . 2.6 m -51.93 -65.82 0.49 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.374 0.421 . . . . 0.0 111.86 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 52.7 p90 -170.62 157.83 5.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.909 0.385 . . . . 0.0 110.951 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.2 mm -98.43 -50.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.93 22.61 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.906 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 11.8 mmm180 -115.88 119.54 37.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.365 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.85 -11.26 13.93 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.968 2.445 . . . . 0.0 113.696 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -157.43 90.33 1.1 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.154 0.502 . . . . 0.0 110.783 -169.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.577 ' OH ' ' HA ' ' A' ' 64' ' ' PHE . 11.9 p90 -148.46 -160.27 1.15 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.514 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.606 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -41.66 -79.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.769 0.828 . . . . 0.0 112.739 -175.698 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -106.48 106.05 16.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 m -147.62 -50.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.26 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -91.99 25.29 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.609 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.479 ' HG ' ' CD1' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -67.24 -17.96 65.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.431 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -75.84 -10.34 59.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.731 0.3 . . . . 0.0 110.808 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.01 -6.3 58.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 110.674 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.85 169.4 18.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.556 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -162.95 -171.29 2.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.731 -178.098 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -49.15 -47.21 45.82 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -113.61 62.08 0.32 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -82.14 -15.94 51.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.472 ' CE ' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 55.15 90.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.675 0.75 . . . . 0.0 111.595 -176.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 20' ' ' ILE . 39.7 t -87.98 119.9 36.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.417 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -95.91 106.85 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 121' ' ' LEU . 3.1 t80 -91.23 94.89 9.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.1 tppp? -81.23 86.39 6.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.452 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 91' ' ' GLU . 5.7 m -90.16 90.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.722 0.772 . . . . 0.0 111.006 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.89 -91.96 0.36 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.032 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.09 -4.84 10.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.659 0.266 . . . . 0.0 111.053 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.69 ' HB2' HG23 ' A' ' 88' ' ' VAL . 32.6 mt-10 -97.66 147.63 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.331 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.2 m -124.81 103.66 8.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.118 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.692 ' HG3' ' HE2' ' A' ' 95' ' ' TYR . 6.6 ptm180 -109.81 139.09 45.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.165 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HB2' ' CE ' ' A' ' 83' ' ' MET . 3.5 ptmm? -108.34 130.57 55.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 111.962 -172.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.692 ' HE2' ' HG3' ' A' ' 93' ' ' ARG . 61.2 m-85 -116.74 152.24 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.427 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.566 ' HE3' HG11 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -115.73 134.36 55.1 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.639 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 20.2 mmt -79.27 63.65 3.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.519 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 t -74.6 -23.81 58.78 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.603 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.5 m -129.83 96.12 4.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 111.329 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.47 124.48 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.599 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -137.87 159.98 40.52 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.835 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.39 124.67 51.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.64 HG11 HG13 ' A' ' 110' ' ' VAL . 21.6 m -119.32 131.62 71.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.788 0.804 . . . . 0.0 111.473 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.618 ' HG3' ' HG2' ' A' ' 138' ' ' LYS . 3.2 mppt? -98.35 168.43 9.89 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.03 -11.55 27.87 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.43 2.087 . . . . 0.0 112.266 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t -107.88 8.4 28.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.326 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 12.7 t0 -94.03 134.45 36.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.317 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.39 4.75 8.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.29 -30.79 71.68 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 110.98 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.64 HG13 HG11 ' A' ' 103' ' ' VAL . 17.0 m -84.67 -6.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.165 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.68 -7.46 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.49 157.96 17.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.69 123.36 18.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -77.18 139.47 39.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.98 -154.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -168.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.8 52.82 1.63 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 123.491 0.494 . . . . 0.0 114.235 -169.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -75.7 150.39 37.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 172.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -90.98 -149.4 0.22 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.637 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 32.5 mmtp -60.97 124.38 20.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -137.98 138.85 39.32 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.334 0.588 . . . . 0.0 111.911 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 86' ' ' PHE . 36.8 mt -94.1 103.76 15.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.1 m -88.1 91.1 8.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.793 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 26.1 mt -84.4 99.91 10.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.737 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.7 mt -83.05 78.26 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.9 m -87.81 99.61 12.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.975 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 57.1 m -74.23 94.89 2.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.747 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 35.7 t70 -101.69 1.5 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.346 -172.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.727 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 17.7 t0 -112.5 94.46 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.853 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 32.8 t80 -77.43 -26.98 52.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.155 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.5 t30 49.4 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.743 0.783 . . . . 0.0 111.457 -173.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.472 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 20.4 mt-10 -62.71 -8.63 7.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.808 -174.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 57.1 mmtt -60.37 -35.09 74.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 t -159.41 -3.26 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.19 40.07 7.63 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.424 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.44 117.18 53.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.182 0.515 . . . . 0.0 110.032 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.727 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 27.7 m95 -78.51 96.55 5.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 46.1 mt-10 -86.29 -61.98 1.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.18 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.618 ' HG2' ' HG3' ' A' ' 104' ' ' LYS . 33.8 mtmm -89.31 119.06 29.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.475 ' HB2' HG23 ' A' ' 103' ' ' VAL . 40.8 mtt85 -100.56 114.71 28.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.494 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -89.01 111.0 21.62 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.3 tt -102.42 127.33 56.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.615 0.721 . . . . 0.0 110.694 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.639 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 89.5 m-85 -108.51 112.73 25.27 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.438 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 44.3 t -101.43 97.33 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.428 0.633 . . . . 0.0 109.776 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.616 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -94.7 113.3 25.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.148 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 m -89.01 141.1 28.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.296 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 5.3 tt0 -61.0 115.38 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.566 HG11 ' HE3' ' A' ' 96' ' ' LYS . 5.1 p -117.19 124.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.573 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.4 -0.809 . . . . 0.0 111.223 -176.487 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.432 ' C5 ' ' HE ' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.53 0.205 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -76.21 -177.35 3.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.03 105.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.438 0.461 . . . . 0.0 109.811 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 39.4 mtmt 59.45 97.52 0.04 OUTLIER Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.867 -167.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 13.8 Cg_endo -55.64 124.26 15.84 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.862 2.375 . . . . 0.0 111.277 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -141.1 146.79 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.72 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.5 mp -78.62 129.18 74.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.701 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 163.28 39.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.749 2.299 . . . . 0.0 112.863 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.934 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -70.83 -15.68 62.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.695 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.59 121.88 28.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.753 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 37.7 mmtm -95.2 16.62 16.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.417 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -127.04 26.54 6.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.542 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 64.4 mttm -118.06 176.03 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.409 0.623 . . . . 0.0 112.045 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.0 t -109.54 111.87 38.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.614 173.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -91.04 -21.42 21.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.02 159.41 31.88 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.901 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 57.9 m-85 -114.81 135.68 53.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -101.86 121.22 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.527 0.68 . . . . 0.0 109.791 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.648 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 37.7 mt-10 -124.26 118.75 27.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.449 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -134.21 96.9 15.32 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -54.01 -35.89 82.47 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.324 2.683 . . . . 0.0 112.999 -176.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.8 -29.84 69.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.796 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.71 2.36 27.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.628 0.251 . . . . 0.0 110.976 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HB3' HD21 ' A' ' 69' ' ' ASN . 30.9 t70 65.56 25.97 11.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.836 0.827 . . . . 0.0 110.084 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 20' ' ' ILE . 77.1 mt -91.47 125.4 44.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.954 -177.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.648 ' HD2' ' HG2' ' A' ' 19' ' ' GLU . 7.0 mmmt -151.27 54.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 5.5 mm-40 -121.82 153.66 60.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.611 -166.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.89 134.23 10.6 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.966 2.444 . . . . 0.0 112.807 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.07 135.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.329 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.41 ' HD2' ' HA3' ' A' ' 42' ' ' GLY . 51.2 m-85 -101.46 102.71 23.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.036 0.446 . . . . 0.0 109.857 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.2 Cg_endo -71.14 140.93 38.56 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.972 2.448 . . . . 0.0 112.112 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.15 -171.4 43.37 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.79 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.753 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 27.0 Cg_endo -93.73 34.52 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.012 3.141 . . . . 0.0 112.566 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 60.55 27.73 17.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.431 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.729 HG23 ' HB2' ' A' ' 38' ' ' GLN . 2.6 t -62.67 128.58 91.92 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.894 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.57 -44.89 24.73 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 124.093 3.195 . . . . 0.0 113.928 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 39.4 mt-10 -61.07 -49.37 77.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.729 ' HB2' HG23 ' A' ' 35' ' ' THR . 2.8 mp0 -70.69 -26.37 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 39' ' ' LEU . 6.5 mt -75.33 -10.15 59.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 176.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -99.48 -5.68 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.362 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' GLN . 57.4 mtp180 -102.03 -30.7 11.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 30' ' ' TYR . . . -170.05 -170.58 34.61 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.797 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -89.95 150.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 117.63 0.715 . . . . 0.0 109.715 176.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.8 t -137.79 178.91 6.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CD2' ' HG2' ' A' ' 50' ' ' GLU . 58.3 m-85 -84.61 172.65 11.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.81 82.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 0.0 110.775 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -157.31 -179.48 8.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.231 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 14.5 tt0 -76.77 -15.56 59.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.616 -174.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -87.56 4.46 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.023 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 6.3 tp10 -56.63 127.56 32.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.909 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.9 m -120.02 121.64 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.895 0.379 . . . . 0.0 110.767 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 52.0 mt -72.73 -16.59 61.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.432 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -98.68 2.63 47.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.218 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.909 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 14.0 t70 -86.77 -178.55 6.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.73 -18.46 23.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -116.8 108.33 15.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.777 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.48 105.49 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.406 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 1.1 m -101.17 120.86 40.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.209 -175.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mt -112.98 127.74 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 124.1 39.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.974 0.416 . . . . 0.0 110.937 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.62 173.15 18.2 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.093 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -163.45 179.57 7.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 150.38 20.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.679 0.276 . . . . 0.0 110.967 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.477 ' HE2' ' HB3' ' A' ' 66' ' ' ASP . 40.6 t80 -134.37 152.12 51.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.2 mt -81.45 -53.86 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' HE2' ' A' ' 64' ' ' PHE . 23.0 t70 -64.86 -42.52 94.81 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' A' ' 70' ' ' TYR . 22.8 mtp180 -106.98 110.18 63.46 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.605 -175.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.59 -8.73 20.82 Favored 'Trans proline' 0 CA--C 1.516 -0.379 0 C-N-CA 123.188 2.592 . . . . 0.0 112.222 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.443 HD21 ' HB3' ' A' ' 24' ' ' ASP . 17.3 t-20 -161.77 86.29 0.64 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.236 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.475 ' HB3' ' HE ' ' A' ' 67' ' ' ARG . 20.7 p90 -113.16 -150.29 0.46 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 22.0 mp0 -44.48 -56.29 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.358 0.411 . . . . 0.0 111.561 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.474 ' HD2' ' C ' ' A' ' 71' ' ' GLN . 2.5 m-85 -128.12 106.77 9.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.91 -64.04 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.974 0.416 . . . . 0.0 110.597 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -83.58 21.27 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.53 0.681 . . . . 0.0 110.13 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 75' ' ' LEU . 6.9 tt -60.87 -21.56 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.886 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -9.63 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.129 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.44 -3.28 52.47 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 111.299 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.45 162.47 25.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -135.98 -173.52 3.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.291 -178.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 ptpp? -72.93 11.41 0.69 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.27 46.96 0.43 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 m -83.47 132.41 34.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.853 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 73.2 mmm -79.89 102.48 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.121 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 39.2 t -90.25 132.32 35.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.054 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 72.4 m-85 -114.28 121.65 44.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -111.17 109.91 20.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.075 0.464 . . . . 0.0 110.14 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 30.3 mmtm -81.43 106.44 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.833 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 52' ' ' LEU . 9.2 p -142.04 132.99 25.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 111.264 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.32 -91.92 0.14 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.405 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -140.46 4.03 1.95 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.43 0.634 . . . . 0.0 109.812 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -110.51 164.57 12.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.391 0.615 . . . . 0.0 111.397 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 m -122.89 92.17 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.995 171.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 19.5 mmt180 -74.36 121.42 21.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.065 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.26 131.36 41.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.697 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 89.1 m-85 -127.08 149.08 50.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.853 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -117.53 123.52 46.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.4 mtt -81.82 71.13 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.26 0.552 . . . . 0.0 110.588 -176.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.8 t -83.52 -21.92 32.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.911 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.6 m -118.62 110.37 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -129.93 128.85 65.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.531 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.582 HH21 HG13 ' A' ' 110' ' ' VAL . 28.2 ptt180 -170.42 -175.06 1.81 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . 2.7 p30 -126.87 152.2 47.36 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 170.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 110' ' ' VAL . 12.3 m -127.44 126.15 66.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -174.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.563 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -73.04 158.32 87.28 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.008 171.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.36 -14.06 18.9 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.729 2.286 . . . . 0.0 112.639 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 104' ' ' LYS . 68.6 p -87.88 -3.41 58.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.039 0.447 . . . . 0.0 111.053 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.563 ' HB2' ' HD2' ' A' ' 104' ' ' LYS . 14.2 t70 -82.74 116.77 22.24 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.87 8.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.09 -39.13 23.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.067 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.582 HG13 HH21 ' A' ' 101' ' ' ARG . 19.6 m -77.84 -23.04 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.373 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.39 -27.1 63.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.784 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.46 97.58 10.55 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.194 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -18.38 109.47 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.896 -1.956 . . . . 0.0 114.448 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -78.52 115.6 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.053 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.57 179.52 5.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.267 173.518 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.27 -16.91 48.66 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.24 178.85 4.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.162 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -89.07 -148.44 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.52 109.01 0.55 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.79 118.07 36.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.496 0.665 . . . . 0.0 110.019 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HG ' HD21 ' A' ' 123' ' ' LEU . 20.9 tp -83.5 102.11 11.88 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.1 m -90.7 96.83 10.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.256 -174.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.59 HD21 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mt -90.64 102.67 15.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.814 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.1 mt -95.53 97.15 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.252 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.7 m -96.53 98.26 10.08 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.82 100.68 7.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 128' ' ' ASP . 23.7 t70 -136.0 83.23 2.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.725 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 11.3 t70 166.94 99.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.065 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -87.66 132.42 34.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 22.7 t-20 -103.94 114.19 28.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.573 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.52 -19.2 46.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 0.0 111.332 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -63.15 -38.14 90.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.166 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.485 HG22 ' OD1' ' A' ' 130' ' ' ASN . 14.2 t -131.85 -11.28 3.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 0.0 111.611 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.43 26.95 26.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.743 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.54 -177.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 117.09 0.445 . . . . 0.0 110.905 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.725 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 58.3 m95 -115.78 104.49 11.71 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 130' ' ' ASN . 43.2 mt-10 -67.86 -58.91 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.953 -172.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 128' ' ' ASP . 26.7 ttpp -80.97 91.34 6.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.184 0.992 . . . . 0.0 110.582 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -93.99 100.85 12.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.335 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -74.82 125.59 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.981 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.93 119.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.987 0.899 . . . . 0.0 111.191 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HD2' ' SD ' ' A' ' 97' ' ' MET . 10.4 m-85 -108.67 108.9 19.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.314 175.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 72.0 t -94.22 106.63 18.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.282 0.563 . . . . 0.0 109.956 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.509 ' HB2' ' HG2' ' A' ' 97' ' ' MET . . . -105.14 108.5 20.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.76 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.5 m -79.47 137.26 37.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.433 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 38.0 tt0 -55.6 123.59 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 96' ' ' LYS . 5.7 t -80.81 154.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.41 ' HG2' HG12 ' A' ' 147' ' ' VAL . 10.6 ptpt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.525 -0.75 . . . . 0.0 112.189 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -98.55 -174.21 2.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.982 0.42 . . . . 0.0 110.822 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.64 132.96 56.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.192 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 92.9 mttt -126.73 92.02 45.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.267 174.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.519 ' CB ' ' HB ' ' A' ' 88' ' ' VAL . 36.7 Cg_endo -64.66 124.8 13.77 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.755 2.304 . . . . 0.0 111.532 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -153.18 177.12 11.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.589 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 31' ' ' PRO . 45.9 mt -106.37 105.3 53.82 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.131 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.21 169.68 12.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.675 2.25 . . . . 0.0 112.674 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 17.4 mtpp -84.96 -21.21 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.787 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.44 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 25.5 t70 -68.89 108.46 3.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.062 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 29.9 mttp -90.5 19.05 5.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.877 -168.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -112.11 8.35 19.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 35.8 mttp -111.87 178.67 4.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.531 0.681 . . . . 0.0 112.146 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.703 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -82.58 -41.85 19.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.286 0.565 . . . . 0.0 110.189 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.97 160.76 33.28 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 38.2 m-85 -102.06 133.47 46.83 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -101.82 114.19 40.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.59 0.709 . . . . 0.0 110.269 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.6 mt-10 -114.95 117.09 29.64 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.042 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 65.0 mt -131.15 94.03 28.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.01 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.36 -16.12 52.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.259 2.64 . . . . 0.0 112.794 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB3' ' OG ' ' A' ' 82' ' ' SER . 33.7 t70 -81.91 -28.43 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.557 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.81 20.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.998 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.41 20.26 10.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.585 0.707 . . . . 0.0 111.21 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 72.0 mt -91.09 114.7 28.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.437 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.8 mppt? -142.79 84.9 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.637 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 4.4 mt-10 -146.41 158.65 46.84 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.782 0.325 . . . . 0.0 111.581 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 73.6 Cg_endo -77.0 136.61 16.63 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.907 2.404 . . . . 0.0 112.627 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.64 134.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.146 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' SER . 35.1 m-85 -97.32 121.49 58.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.581 . . . . 0.0 111.13 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.584 ' HB2' HG23 ' A' ' 7' ' ' ILE . 86.0 Cg_endo -85.92 148.37 9.46 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.334 2.689 . . . . 0.0 112.705 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.91 -169.52 36.56 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.891 172.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 35' ' ' THR . 81.7 Cg_endo -76.85 13.18 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 123.808 3.006 . . . . 0.0 112.77 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.83 75.57 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.164 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 33' ' ' PRO . 72.8 p -97.33 164.53 17.51 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.664 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.34 -37.93 81.78 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.203 1.935 . . . . 0.0 111.339 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.4 mm-40 -59.14 -44.25 92.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.777 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.817 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.2 mp0 -59.68 -42.95 94.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.49 -9.58 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.811 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.56 -31.76 12.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.735 0.303 . . . . 0.0 111.155 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.7 ptp180 -87.24 -19.84 27.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.989 0.423 . . . . 0.0 110.614 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.76 -127.26 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.287 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 60' ' ' ALA . 93.9 t -126.92 141.66 45.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.817 ' HB2' ' HB3' ' A' ' 38' ' ' GLN . 41.8 t -119.74 163.65 17.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.214 0.53 . . . . 0.0 110.775 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 7' ' ' ILE . 55.6 m-85 -71.87 159.66 33.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.754 172.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.46 -49.12 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -140.07 166.32 24.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.14 -19.83 46.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.28 0.562 . . . . 0.0 110.043 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -80.04 4.8 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.068 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.24 163.47 23.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.992 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 23.2 t -122.36 177.1 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 15' ' ' ALA . 85.0 mt -110.17 -16.08 13.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.641 0.257 . . . . 0.0 111.171 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.09 12.11 16.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.893 0.854 . . . . 0.0 109.374 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.992 ' HB2' ' HB3' ' A' ' 51' ' ' SER . 3.1 t70 -79.31 179.18 7.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.413 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -21.85 46.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -131.3 129.24 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.638 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.3 mp -129.68 101.75 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.549 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 5.4 m -93.04 125.33 37.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.5 mt -119.13 138.88 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.527 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.91 122.35 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.51 166.7 14.32 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.852 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.564 ' HB3' ' C12' ' A' ' 201' ' ' JPT . 0.3 OUTLIER -150.57 38.02 0.68 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.326 0.563 . . . . 0.0 111.431 -174.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 56.03 -158.75 0.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 -174.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.453 ' H ' HG22 ' A' ' 63' ' ' THR . 47.5 p90 -120.47 178.61 4.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.442 0.639 . . . . 0.0 112.344 -170.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 62.2 mt -128.27 -53.68 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.011 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.42 49.02 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.196 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 16.9 mmt180 -142.76 105.49 5.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.161 -175.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.62 -16.5 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.971 1.781 . . . . 0.0 111.601 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -154.78 82.31 1.09 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.749 -176.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -122.17 -176.97 3.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.637 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -38.24 -71.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 2.5 m-30 -105.66 76.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.765 -0.584 . . . . 0.0 111.446 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.89 -58.36 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.674 0.749 . . . . 0.0 110.259 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -100.34 21.05 13.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.407 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.475 HD23 ' OG1' ' A' ' 125' ' ' THR . 40.8 tp -63.75 -23.18 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.786 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -13.54 62.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.976 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.05 9.72 26.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.662 0.268 . . . . 0.0 111.299 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.491 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -91.67 141.39 28.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.45 . . . . 0.0 111.333 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 82' ' ' SER . 10.6 mptt -109.71 -179.0 3.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.805 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.8 ptpt -57.3 -41.37 79.72 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.49 47.65 1.32 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.719 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.552 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -66.82 -17.21 64.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.596 0.358 . . . . 0.0 111.895 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.66 86.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.52 0.676 . . . . 0.0 111.727 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -88.37 114.81 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.251 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 76.1 m-85 -101.43 105.4 16.42 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.79 106.93 19.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.7 mmtp -90.91 92.57 8.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.11 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.8 m -90.67 92.37 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.672 0.748 . . . . 0.0 110.179 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.58 -88.99 0.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.51 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.05 0.28 5.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.151 0.501 . . . . 0.0 110.083 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.864 ' HB2' HG23 ' A' ' 88' ' ' VAL . 9.5 mm-40 -92.18 119.03 31.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.495 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 m -92.54 106.04 18.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.576 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -94.96 136.57 35.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -114.55 118.85 34.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -177.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.583 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 71.9 m-85 -118.03 145.7 44.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.398 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -110.23 138.76 46.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.8 mmt -81.0 68.06 7.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.141 0.496 . . . . 0.0 110.15 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -75.73 -20.9 58.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.859 -172.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 51.0 m -133.03 101.59 5.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.175 0.512 . . . . 0.0 111.17 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 97' ' ' MET . 78.5 mt -119.03 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.266 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -157.97 176.2 12.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.355 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 10.6 p-10 -134.98 128.39 32.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.976 0.417 . . . . 0.0 110.135 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.902 HG11 HG11 ' A' ' 110' ' ' VAL . 31.6 m -129.05 179.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.39 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -102.99 158.0 32.62 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.075 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 139' ' ' ARG . 19.8 Cg_endo -61.75 -15.19 40.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.929 2.419 . . . . 0.0 112.585 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.3 t -96.26 -7.13 36.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.905 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.78 97.94 9.98 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.635 ' HA ' HD21 ' A' ' 111' ' ' LEU . 29.6 m -100.06 8.25 8.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.821 0.343 . . . . 0.0 111.715 -170.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -93.43 -15.47 25.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.902 HG11 HG11 ' A' ' 103' ' ' VAL . 22.5 m -76.44 -23.71 15.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.547 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -97.41 34.54 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.09 0.471 . . . . 0.0 111.064 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -70.16 169.66 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.25 105.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.459 0.647 . . . . 0.0 110.789 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -82.21 45.33 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.466 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -77.48 174.57 10.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.33 175.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.86 13.25 78.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.744 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -110.44 -170.69 1.69 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.082 0.468 . . . . 0.0 110.193 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.73 -163.58 0.86 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -62.35 110.02 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.11 143.22 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.237 0.541 . . . . 0.0 111.446 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.494 HD23 ' HB ' ' A' ' 57' ' ' ILE . 70.6 mt -96.27 125.22 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.316 174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 12.0 m -97.69 92.43 5.88 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.3 mm? -87.45 100.69 12.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.236 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.98 97.84 7.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.475 ' OG1' HD23 ' A' ' 75' ' ' LEU . 2.4 m -102.91 102.11 12.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.963 0.411 . . . . 0.0 109.925 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 20.6 m -85.89 100.4 12.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -115.5 177.55 4.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.342 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.26 83.34 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.739 0.649 . . . . 0.0 111.003 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.697 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -102.91 170.67 7.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.413 0.625 . . . . 0.0 111.919 -172.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -104.9 92.34 4.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.058 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 38.2 mt-10 -44.56 -37.9 3.86 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.36 -29.01 70.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 135' ' ' VAL . 8.6 t -126.44 -14.84 5.76 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.509 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.687 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 133' ' ' THR . 16.3 m -75.15 146.48 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 117.437 0.618 . . . . 0.0 110.251 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.697 ' CE3' ' HB3' ' A' ' 129' ' ' TYR . 85.1 m95 -94.14 111.91 23.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -70.6 -53.73 14.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.382 -172.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -90.71 85.09 5.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 0.0 111.405 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.612 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 35.7 ptt180 -80.64 79.94 7.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 85.0 tttt -70.15 123.23 21.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.067 -174.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -107.8 125.52 64.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.687 0.756 . . . . 0.0 110.741 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.2 m-85 -109.05 110.83 22.2 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 84.3 t -96.91 103.33 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.405 0.621 . . . . 0.0 109.556 176.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -101.75 102.37 13.0 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.35 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -87.62 139.5 30.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 7.3 tt0 -55.21 128.61 34.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.941 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 5.9 p -96.48 155.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.128 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.089 -175.263 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' JPT . . . . . 0.612 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.6 mtmt . . . . . 0 C--O 1.233 0.197 0 CA-C-O 121.173 0.511 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 29.2 Cg_endo -57.78 115.02 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.899 2.399 . . . . 0.0 112.954 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.407 ' HB3' HE21 ' A' ' 6' ' ' GLN . 2.6 pt20 -146.84 168.22 21.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.752 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.735 HG23 ' HB2' ' A' ' 31' ' ' PRO . 46.6 mt -104.18 120.88 49.49 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.39 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 2.4 Cg_endo -83.88 179.68 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.122 2.548 . . . . 0.0 112.321 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -79.1 -25.24 43.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.05 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.38 116.21 8.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 110.259 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -92.89 16.33 12.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.735 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 t -108.54 -29.09 8.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -89.3 174.37 7.87 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.207 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.63 128.67 52.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -80.77 -41.24 23.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.09 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.77 164.09 35.61 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.443 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -107.36 140.88 39.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.899 0.35 . . . . 0.0 110.267 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.4 tp -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.364 0.602 . . . . 0.0 110.113 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.1 mt-10 -120.76 111.88 18.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.638 0.732 . . . . 0.0 111.262 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.8 mt -124.86 93.91 45.1 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.75 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.71 -28.71 87.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.006 2.471 . . . . 0.0 112.283 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.0 -23.19 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.934 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.75 7.3 18.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.905 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 64.68 27.21 13.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.6 mt -106.64 122.28 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.0 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.27 75.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 167.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 67.8 mm-40 -122.0 162.02 39.43 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.68 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 69.0 Cg_endo -77.09 128.05 9.64 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.793 2.328 . . . . 0.0 113.321 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.15 124.93 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.83 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 44' ' ' SER . 62.8 m-85 -93.76 123.26 60.26 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.246 0.545 . . . . 0.0 110.966 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.735 ' HB2' HG23 ' A' ' 7' ' ' ILE . 68.6 Cg_endo -76.14 107.92 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.64 2.227 . . . . 0.0 111.289 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.9 167.22 33.18 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.734 -1.222 . . . . 0.0 112.8 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 88.5 Cg_endo -87.58 31.75 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.889 3.059 . . . . 0.0 112.544 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 62.25 26.88 16.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.202 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -70.32 142.61 89.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.722 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -39.44 -55.52 1.55 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.861 3.04 . . . . 0.0 114.852 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.41 -24.06 67.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -69.4 -39.63 77.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.14 0.495 . . . . 0.0 109.698 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 94.0 mt -80.96 -23.41 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.19 -24.52 63.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -103.86 -22.65 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.674 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -175.3 -156.68 14.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.161 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.465 HG11 ' CE1' ' A' ' 72' ' ' PHE . 28.5 m -92.27 154.58 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 29.6 t -135.51 163.37 30.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.993 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 58' ' ' SER . 31.1 m-85 -74.67 162.34 28.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.49 70.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.931 0.396 . . . . 0.0 110.689 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -137.9 176.14 8.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.666 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.745 0.783 . . . . 0.0 109.305 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -88.33 -22.08 24.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.855 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -76.58 171.97 13.78 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.941 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 66.5 m -154.1 165.32 36.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.948 0.404 . . . . 0.0 110.543 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.521 HD13 ' CG2' ' A' ' 88' ' ' VAL . 15.7 mt -79.43 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.971 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -101.29 -3.06 29.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.584 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -82.66 170.92 14.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.97 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -85.94 -20.76 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -107.69 108.01 19.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.644 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.98 111.66 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 12.2 m -117.31 116.6 27.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.877 0.37 . . . . 0.0 111.014 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.71 121.12 53.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.227 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.04 116.44 22.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.338 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.6 114.31 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.188 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -87.9 84.62 6.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.3 m -68.85 140.37 55.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.534 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.83 150.88 40.52 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.308 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.4 mt -91.98 -43.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -50.72 -43.52 57.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.353 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.5 mtp85 -100.18 124.29 43.79 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.856 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -87.42 -16.62 3.1 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.788 2.326 . . . . 0.0 113.012 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -138.84 73.41 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.184 0.516 . . . . 0.0 110.888 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -119.33 -161.16 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 43.8 mt-30 -60.21 -77.76 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' CE1' HG11 ' A' ' 43' ' ' VAL . 3.1 m-85 -84.59 19.02 2.09 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -47.63 78.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -101.96 12.03 37.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -172.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.94 -16.73 64.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.365 0.602 . . . . 0.0 110.337 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -8.88 56.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.787 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.35 1.72 56.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 110.933 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.1 165.56 23.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.111 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 97' ' ' MET . 11.2 pttm -158.08 -170.92 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.896 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.1 ptpt -54.4 -39.14 66.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -117.68 59.78 0.47 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.443 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -84.22 -5.22 59.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.56 85.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.638 0.586 . . . . 0.0 111.694 -177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 45.5 t -86.66 112.31 22.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.96 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.56 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.2 m-85 -100.84 107.93 19.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.551 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 12.6 t80 -99.11 102.1 13.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -82.7 88.97 6.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.361 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 52' ' ' LEU . 7.5 p -117.44 124.43 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 111.589 -170.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.24 -57.1 1.13 Allowed Glycine 0 CA--C 1.509 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.718 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -169.11 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.427 0.632 . . . . 0.0 110.223 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.06 154.94 20.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.252 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 m -98.0 100.92 12.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.33 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 51.1 mmt-85 -82.27 112.43 19.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.116 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.803 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.09 128.78 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.607 . . . . 0.0 110.56 177.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 72.1 m-85 -121.92 151.43 40.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.395 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.601 ' HE3' HG21 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -117.67 138.28 52.09 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.673 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 19.3 mmt -80.61 68.35 6.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.263 0.554 . . . . 0.0 110.311 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.92 -38.8 36.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.713 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.616 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 33.4 m -110.27 103.68 12.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.053 0.454 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.8 mt -123.49 126.06 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.426 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 7.1 ptm180 -159.77 -175.59 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.517 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 3.3 p30 -136.4 144.79 44.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.811 HG11 HG11 ' A' ' 110' ' ' VAL . 28.7 m -126.41 -169.16 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.787 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.615 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -136.89 160.39 66.48 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.422 -176.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.87 -20.82 30.65 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.645 2.23 . . . . 0.0 112.307 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.1 p -91.7 8.21 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.037 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.429 ' HB2' ' HE2' ' A' ' 104' ' ' LYS . 24.7 t0 -107.71 97.3 7.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.6 m -104.99 16.2 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.222 0.534 . . . . 0.0 110.591 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -104.74 -2.32 25.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.328 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.811 HG11 HG11 ' A' ' 103' ' ' VAL . 13.5 m -96.83 -39.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.979 0.419 . . . . 0.0 110.899 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.525 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -86.35 86.96 7.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.462 1.125 . . . . 0.0 108.743 173.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.7 -164.39 1.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.991 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.509 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 7.1 pt-20 -77.7 71.26 4.17 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 111.344 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -86.3 47.88 1.54 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.509 ' HE2' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -71.64 172.57 9.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.203 -176.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.14 -14.21 36.99 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -92.6 175.21 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 110.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -89.62 -157.32 0.45 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 108.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -104.4 130.62 52.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 110.498 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -96.09 104.02 15.94 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.0 m -88.67 98.22 11.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.469 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -83.13 103.06 12.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.8 mt -96.71 89.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.876 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 m -95.48 101.8 13.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 -175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.8 m -84.06 115.58 22.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -120.33 158.56 26.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.131 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 t70 70.14 98.97 0.06 Allowed 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.91 0.757 . . . . 0.0 110.986 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -86.58 130.02 34.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.619 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -97.16 101.51 13.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.5 -17.16 64.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.573 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -71.16 -27.73 63.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.2 t -133.9 -23.44 1.77 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.79 26.73 8.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.641 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.88 174.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 117.027 0.413 . . . . 0.0 110.963 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -110.83 116.95 32.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.7 -50.95 30.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.149 -170.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.748 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 11.0 mmpt? -95.07 100.41 12.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.158 0.504 . . . . 0.0 111.243 -174.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.433 ' HB2' HG23 ' A' ' 103' ' ' VAL . 68.7 mtm180 -91.9 83.59 5.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.517 ' HD3' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -64.58 129.69 40.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.293 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.67 114.57 38.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 122.234 1.016 . . . . 0.0 110.851 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.647 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 67.4 m-85 -108.12 104.7 14.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.01 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 37.8 t -90.97 93.25 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.703 0.763 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -88.39 105.14 17.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.661 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.3 m -84.37 142.61 30.03 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.803 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -53.38 114.45 1.5 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 109.873 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.601 HG21 ' HE3' ' A' ' 96' ' ' LYS . 7.3 p -94.28 148.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.351 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.444 -179.745 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 55.2 mtmt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.697 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.9 Cg_endo -57.38 126.67 22.74 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.31 2.673 . . . . 0.0 112.349 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -158.06 162.39 38.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 31' ' ' PRO . 22.6 mt -99.36 123.32 48.87 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.807 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.77 -172.75 1.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.864 2.376 . . . . 0.0 113.008 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -90.92 -14.45 31.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.546 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.45 145.56 25.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.85 0.357 . . . . 0.0 110.628 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -99.55 5.34 46.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.039 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -111.34 9.75 21.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.573 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -110.34 171.96 7.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 111.644 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.51 118.0 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.81 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -92.32 -25.07 18.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.233 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.96 177.92 45.21 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.292 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 69.1 m-85 -123.78 136.5 54.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.99 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 122.256 1.027 . . . . 0.0 110.085 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -115.2 108.66 16.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.71 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.487 HG12 HG13 ' A' ' 84' ' ' VAL . 25.4 mt -121.34 94.88 48.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.212 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.48 -28.02 70.53 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 122.745 2.297 . . . . 0.0 111.225 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 34.2 t70 -67.45 -24.94 65.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.572 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -118.01 11.81 13.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.321 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t0 59.39 30.01 19.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.657 0.741 . . . . 0.0 111.063 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.466 HD12 HD12 ' A' ' 20' ' ' ILE . 84.5 mt -97.78 121.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.085 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 2.4 mppt? -145.03 80.73 1.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HB3' HE22 ' A' ' 71' ' ' GLN . 14.4 mm-40 -154.01 158.82 32.49 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.644 0.259 . . . . 0.0 111.517 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 71.1 Cg_endo -75.06 163.52 35.07 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.922 2.414 . . . . 0.0 113.054 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.82 133.41 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.809 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.45 118.87 53.55 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.325 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 75.1 Cg_endo -85.69 162.8 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.924 2.416 . . . . 0.0 113.224 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.01 -173.75 34.62 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.457 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.75 6.52 4.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.233 2.622 . . . . 0.0 112.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.956 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.674 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 71.1 p -111.61 163.95 16.27 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.414 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.674 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 53.8 Cg_exo -38.28 -48.04 2.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.092 3.195 . . . . 0.0 115.361 -173.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -30.14 66.18 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.687 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.5 mp0 -64.93 -43.59 92.25 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.837 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.0 12.08 6.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.91 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HA ' ' HZ ' ' A' ' 64' ' ' PHE . 55.2 t-20 -107.77 -47.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.449 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 41' ' ' ARG . 13.3 ptm180 -83.58 -26.0 30.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.278 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.4 -139.86 2.75 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.339 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.554 HG12 HE21 ' A' ' 71' ' ' GLN . 11.6 p -124.57 145.28 32.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.687 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 62.4 m -133.31 -177.39 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -95.82 166.79 11.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.477 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.042 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -149.2 170.48 18.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.141 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -78.18 -23.49 47.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -84.62 -1.47 56.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.34 145.37 51.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -128.04 150.67 49.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.753 0.311 . . . . 0.0 111.032 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.8 mt -80.8 -16.57 53.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.388 0.613 . . . . 0.0 110.221 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.27 -4.33 58.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.632 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.83 164.3 22.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.229 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.36 -21.85 59.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 177.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.77 145.55 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.0 110.16 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.435 ' HB ' HD23 ' A' ' 121' ' ' LEU . 4.0 mp -125.99 115.05 41.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.839 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -88.99 107.2 18.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.611 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.1 mt -105.02 122.9 58.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.72 126.71 42.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.192 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.7 158.98 20.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.07 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -149.39 93.95 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 m -62.09 148.51 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.501 ' HZ ' ' HA ' ' A' ' 40' ' ' ASN . 88.5 m-85 -118.19 172.21 7.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.662 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.01 -42.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.852 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.89 -4.99 59.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.724 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -117.72 111.14 39.65 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.737 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.58 -10.01 20.15 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.812 2.341 . . . . 0.0 112.347 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -155.64 84.49 1.04 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 110.966 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 63' ' ' THR . 10.2 p90 -108.56 -168.87 1.41 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.554 HE21 HG12 ' A' ' 43' ' ' VAL . 10.0 mm100 -38.33 -69.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CE1' HG21 ' A' ' 43' ' ' VAL . 19.5 m-30 -114.41 78.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.233 -0.292 . . . . 0.0 111.625 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.02 -50.86 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.566 0.698 . . . . 0.0 110.508 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 64.0 t30 -87.17 30.62 0.76 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.157 -172.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.77 -9.54 54.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.371 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -9.62 59.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.033 0.444 . . . . 0.0 111.003 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.16 -6.86 43.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.1 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.572 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -79.77 127.14 31.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -111.54 -169.08 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.465 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.04 -44.62 95.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.641 -176.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -99.92 52.94 0.99 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.892 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.4 t -62.96 -21.64 66.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.167 -0.516 . . . . 0.0 111.404 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.409 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 50.17 76.01 0.16 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.513 -174.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.8 t -81.46 122.68 36.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.24 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -100.11 99.69 10.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.188 0.518 . . . . 0.0 109.753 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -101.52 109.58 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 92' ' ' THR . 94.5 mttt -97.21 135.5 39.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.081 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.2 m -141.36 107.95 2.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.85 -102.2 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.352 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.525 HD22 ' H ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -115.26 5.65 14.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.809 0.338 . . . . 0.0 110.868 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 88' ' ' VAL . 40.9 mt-10 -102.43 113.63 27.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.451 HG23 ' HG2' ' A' ' 87' ' ' LYS . 19.0 m -95.57 97.5 9.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 171.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 93' ' ' ARG . 16.9 mtp85 -93.27 135.88 34.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.192 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -98.68 130.56 45.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 92.7 m-85 -122.63 137.26 54.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.93 0.395 . . . . 0.0 110.611 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.615 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -109.69 131.3 55.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 22.4 mmt -80.73 76.1 7.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.389 0.614 . . . . 0.0 110.379 -175.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 t -86.97 -12.05 48.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.789 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.7 m -137.11 100.62 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 0.0 110.504 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 97' ' ' MET . 74.4 mt -119.5 122.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.353 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -161.2 -176.73 5.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.905 0.383 . . . . 0.0 110.653 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 1.1 p30 -131.52 141.02 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 110' ' ' VAL . 35.3 m -121.17 -176.0 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.143 0.497 . . . . 0.0 111.226 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.502 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -111.48 157.2 39.85 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.644 -176.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -60.21 -10.89 14.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.681 2.254 . . . . 0.0 112.643 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -117.16 17.89 14.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.26 129.91 39.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.228 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.89 30.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.63 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.96 -7.15 9.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.688 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 103' ' ' VAL . 16.0 m -92.39 -19.11 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.3 0.571 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.519 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.2 19.97 16.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -116.19 145.14 43.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.388 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 49.34 67.53 0.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.536 0.522 . . . . 0.0 111.375 -174.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.39 89.51 7.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.619 0.724 . . . . 0.0 109.369 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 160.6 28.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.297 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.27 62.08 0.8 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.103 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -59.84 176.64 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.331 0.586 . . . . 0.0 111.178 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -83.04 -170.12 2.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 4.4 mptp? -64.09 112.69 3.11 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.12 131.79 56.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.311 0.577 . . . . 0.0 111.204 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.435 HD23 ' HB ' ' A' ' 57' ' ' ILE . 67.4 mt -86.01 121.22 28.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m -102.88 94.78 5.76 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 24.9 mt -83.84 100.33 10.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.923 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.3 mt -90.54 93.47 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.747 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.3 m -98.25 95.78 7.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.111 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.2 m -78.82 111.92 15.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.606 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.17 178.41 6.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.708 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.21 82.28 0.18 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.566 0.698 . . . . 0.0 110.233 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -83.54 126.45 32.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.529 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -95.48 100.85 12.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.34 -18.07 65.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.481 -174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -74.53 -27.21 60.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 135' ' ' VAL . 8.1 t -124.58 -20.33 5.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.783 0.325 . . . . 0.0 111.191 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.67 46.39 6.39 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 133' ' ' THR . 5.6 p -139.76 156.7 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.0 110.355 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -93.76 115.28 27.7 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.05 -40.32 53.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -170.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -104.26 126.9 51.76 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.458 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -103.73 89.2 3.26 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.653 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 51.6 tptt -71.86 123.21 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.1 tt -121.01 124.01 71.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.869 0.842 . . . . 0.0 111.03 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.583 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 21.0 m-85 -113.99 108.11 16.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.837 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.9 t -99.52 106.06 18.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.431 0.634 . . . . 0.0 110.088 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.66 112.08 25.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.268 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.6 m -87.06 139.23 30.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.085 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.82 117.82 6.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.441 0.639 . . . . 0.0 111.291 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.6 HG11 ' HE3' ' A' ' 96' ' ' LYS . 3.3 p -114.11 134.35 57.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.5 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 4.6 ptpp? . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.106 -177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE3' ' OD1' ' A' ' 53' ' ' ASP . 40.4 mtpt . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HG2' HG22 ' A' ' 88' ' ' VAL . 20.0 Cg_exo -66.21 145.37 78.19 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.004 2.47 . . . . 0.0 112.442 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -123.99 154.21 40.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.097 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.8 mp -73.64 122.77 88.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.81 167.36 17.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.917 2.411 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -78.85 -12.55 60.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.29 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -99.15 118.82 36.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.673 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -95.53 21.86 7.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.385 -173.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 m -108.33 4.23 24.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.292 0.568 . . . . 0.0 110.322 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 98.5 mttt -102.94 -176.56 3.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.099 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.49 135.22 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.222 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.634 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -97.53 -35.43 10.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 110.493 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.07 163.29 34.22 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 49.8 m-85 -106.24 134.93 48.59 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.0 tp -100.33 108.1 22.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.834 0.825 . . . . 0.0 109.782 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 59.0 mt-10 -115.8 111.02 19.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.232 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.408 HG12 HG13 ' A' ' 84' ' ' VAL . 46.2 mt -124.42 92.33 48.21 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.722 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -52.82 -34.62 66.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.317 2.678 . . . . 0.0 112.957 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.602 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 5.4 m-20 -58.6 -38.38 77.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.659 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -103.53 8.92 37.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 t70 54.72 38.72 30.58 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.239 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.537 HG23 ' HG2' ' A' ' 27' ' ' GLU . 65.5 mt -100.75 127.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.257 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -143.57 29.77 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.843 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 7.0 mm-40 -88.74 149.05 43.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.965 -163.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.76 141.58 24.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.293 1.996 . . . . 0.0 111.795 173.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.87 124.75 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -95.77 108.92 43.36 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.791 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.58 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 87.9 Cg_endo -76.69 152.0 32.66 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.744 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.66 -167.78 33.16 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.421 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.44 30.63 0.53 Allowed 'Trans proline' 0 CA--C 1.519 -0.253 0 C-N-CA 123.494 2.796 . . . . 0.0 112.445 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.85 82.9 0.16 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.528 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.21 137.51 24.84 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.048 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.586 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 18.9 Cg_endo -58.7 -27.42 83.28 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.935 2.423 . . . . 0.0 113.381 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 41.8 mt-10 -90.87 -33.62 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -76.63 -30.91 57.08 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.004 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.0 tp -84.89 -5.05 59.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.94 0.876 . . . . 0.0 109.367 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 48.3 t-20 -81.47 -56.05 4.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.283 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -82.8 -26.4 31.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.89 -136.47 3.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.339 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.45 HG12 HE21 ' A' ' 71' ' ' GLN . 14.8 p -140.33 147.35 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 t -130.26 -171.79 2.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.852 0.358 . . . . 0.0 110.181 -175.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -93.1 174.46 7.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.329 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.87 -52.82 8.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -127.99 177.02 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.47 -18.04 52.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -82.43 -2.16 52.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.934 0.397 . . . . 0.0 110.755 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 138.43 57.61 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 38.4 m -122.38 -172.83 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.634 HD11 ' HB1' ' A' ' 15' ' ' ALA . 65.7 mt -111.95 -18.71 12.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.632 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 4' ' ' LYS . 36.7 t70 -126.52 13.1 7.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.801 0.81 . . . . 0.0 110.184 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 18.8 t70 -81.17 160.83 24.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.239 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -66.34 -25.53 66.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.826 0.346 . . . . 0.0 110.293 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -108.72 110.71 22.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.789 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 mm -119.2 90.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -92.83 108.73 20.22 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.158 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.9 mt -102.58 121.47 53.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 115.46 27.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 72' ' ' PHE . . . -123.63 167.04 15.95 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.403 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -154.16 153.66 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.463 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 20.0 m -84.91 141.71 30.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CE2' ' HB3' ' A' ' 66' ' ' ASP . 45.3 t80 -125.23 107.92 11.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -51.39 -39.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.27 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.464 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 18.8 t70 -73.23 -22.06 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -109.45 129.74 23.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.96 -0.462 . . . . 0.0 111.069 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.72 -5.0 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.976 2.451 . . . . 0.0 113.152 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.91 77.44 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.287 0.565 . . . . 0.0 110.67 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 30.6 p90 -140.54 -166.97 2.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.804 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.843 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.7 mm100 -43.55 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.075 0.859 . . . . 0.0 112.738 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.402 ' CD2' ' HA3' ' A' ' 61' ' ' GLY . 23.8 m-85 -106.2 79.66 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.065 0.46 . . . . 0.0 111.002 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -111.48 -52.18 2.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.658 0.742 . . . . 0.0 109.862 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.5 t30 -97.5 19.92 12.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.211 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.21 -16.47 62.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.206 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -9.73 50.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.717 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.26 16.32 11.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.83 147.69 22.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.944 0.402 . . . . 0.0 111.167 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.602 ' HE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -150.59 -172.66 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.407 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 97' ' ' MET . 20.1 ptmt -47.05 -49.78 20.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -171.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -115.59 59.96 0.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 119.71 -1.233 . . . . 0.0 112.294 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 30.5 m -79.61 -2.44 42.57 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.886 -0.185 . . . . 0.0 111.43 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 49.7 78.01 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.587 0.554 . . . . 0.0 111.453 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 41.5 t -79.69 112.3 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.722 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -97.86 109.15 21.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.852 0.358 . . . . 0.0 110.084 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -94.07 101.89 13.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.8 tptm -85.63 92.22 8.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.768 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 5' ' ' PRO . 7.3 p -119.47 126.6 75.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.18 0.514 . . . . 0.0 111.091 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.03 -101.02 0.27 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.942 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -125.22 1.85 7.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 0.0 110.273 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.23 132.39 50.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -101.7 87.16 3.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -92.85 128.93 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.137 0.494 . . . . 0.0 110.456 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.44 139.16 32.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.741 -173.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 77.8 m-85 -122.67 148.88 44.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.784 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.599 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -119.16 132.26 55.95 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.66 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 61.6 mtt -82.53 69.67 9.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.379 0.609 . . . . 0.0 110.562 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -75.7 -26.97 58.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.224 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.613 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -120.19 108.77 14.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.567 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.31 126.77 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.728 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.565 HH22 ' HB2' ' A' ' 109' ' ' GLU . 25.5 ptt180 -168.1 -177.07 3.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.245 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -120.66 139.96 52.28 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 110' ' ' VAL . 31.3 m -129.43 -178.01 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.824 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -105.55 157.64 34.07 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.271 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -21.49 72.06 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.447 2.098 . . . . 0.0 111.637 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 t -118.8 26.9 9.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.6 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 19.3 t70 -63.04 152.84 35.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.934 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.16 -14.11 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.926 0.393 . . . . 0.0 111.376 -170.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.565 ' HB2' HH22 ' A' ' 101' ' ' ARG . 43.4 mt-10 -88.44 -29.55 20.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.124 0.488 . . . . 0.0 109.749 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 103' ' ' VAL . 22.9 m -79.34 -6.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.391 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 86.0 mt -88.32 3.29 50.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.287 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -109.63 -172.51 2.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.349 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.45 112.26 13.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.14 74.13 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 111.277 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.75 161.29 30.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.282 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.01 6.09 63.6 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -114.43 -179.49 3.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.265 0.555 . . . . 0.0 110.691 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -94.56 -154.74 0.43 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 9.6 mmtm -64.45 123.91 20.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.88 104.6 16.54 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.719 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 144' ' ' ALA . 25.3 tp -78.32 100.76 6.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -93.71 99.48 11.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.002 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.3 mm? -80.5 99.72 8.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.41 110.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.146 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.1 m -110.42 95.3 5.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 -176.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.505 ' HB3' ' CB ' ' A' ' 136' ' ' TRP . 69.2 m -89.7 101.23 13.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -121.8 2.63 10.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.665 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 7.1 t70 -119.86 96.38 5.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.58 130.57 42.17 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.294 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 50.1 t-20 -97.62 116.87 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.321 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.65 -24.73 62.76 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -72.22 -21.22 61.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.522 HG23 HG22 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -141.2 -34.81 0.48 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.86 2.51 34.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.817 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 133' ' ' THR . 17.2 m -86.73 -174.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.754 0.311 . . . . 0.0 110.89 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 126' ' ' CYS . 54.5 m95 -114.68 126.65 55.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 130' ' ' ASN . 34.7 mm-40 -77.6 -74.72 0.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -175.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.665 ' HG2' ' HB2' ' A' ' 128' ' ' ASP . 22.8 pttm -85.13 131.03 34.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 110.432 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -116.48 97.96 6.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.927 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -66.18 126.7 29.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 tt -126.21 122.71 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.656 0.741 . . . . 0.0 110.812 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.574 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.5 m-85 -108.82 112.13 24.23 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 33.8 t -95.55 96.32 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.473 0.654 . . . . 0.0 109.723 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -96.93 109.89 22.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.332 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 m -81.75 140.38 34.3 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.961 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.59 119.8 8.25 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.455 0.472 . . . . 0.0 110.566 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.599 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 10.0 t -85.89 137.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.94 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.915 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm . . . . . 0 C--O 1.235 0.291 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.4 127.31 17.91 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.691 2.261 . . . . 0.0 111.399 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -140.73 127.68 20.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.65 0.738 . . . . 0.0 110.967 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.615 HG13 HD21 ' A' ' 52' ' ' LEU . 7.0 mt -59.95 131.01 89.14 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.14 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.28 160.8 26.1 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.722 2.282 . . . . 0.0 111.407 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 20.1 ptmt -79.23 -15.78 57.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 33.7 t70 -79.99 122.17 26.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 110.727 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -85.12 20.04 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.669 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -126.79 10.26 7.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.565 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 93.8 mttt -105.74 174.78 5.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.76 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.88 117.87 52.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.881 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.64 -31.99 23.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.409 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.05 173.21 45.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.259 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 80.8 m-85 -117.13 137.55 52.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.39 114.8 38.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.253 0.549 . . . . 0.0 109.574 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 66.1 mt-10 -117.93 106.16 12.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.426 0.632 . . . . 0.0 111.28 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.94 95.3 48.95 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.93 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HG3' ' HE2' ' A' ' 85' ' ' TYR . 18.6 Cg_endo -59.95 -30.36 91.53 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.946 2.431 . . . . 0.0 112.212 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.473 ' OD1' ' HD2' ' A' ' 79' ' ' LYS . 30.4 t0 -66.28 -30.86 71.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.57 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 74' ' ' ASN . . . -107.2 3.53 25.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.7 t0 61.73 23.08 13.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.99 0.9 . . . . 0.0 110.583 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 65.2 mt -90.35 106.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.124 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -133.04 83.43 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.554 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 31.9 mm-40 -133.8 159.37 72.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.925 -173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.49 148.22 18.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.669 2.246 . . . . 0.0 113.337 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.85 128.09 61.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.075 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' SER . 65.2 m-85 -100.58 117.97 61.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 52.3 Cg_endo -68.19 150.16 76.67 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.866 2.377 . . . . 0.0 112.575 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.07 177.7 27.76 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.427 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 94.6 Cg_endo -79.19 30.99 0.46 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.323 2.682 . . . . 0.0 112.757 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HB1' HD22 ' A' ' 39' ' ' LEU . . . 60.22 38.8 19.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.721 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.414 ' HB ' ' OE1' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -53.73 127.21 51.32 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.328 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.36 -59.54 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.994 3.129 . . . . 0.0 114.555 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 41.3 mt-10 -74.42 -35.99 63.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.414 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 23.3 mp0 -69.77 -35.24 74.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.0 110.361 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.427 HD22 ' HB1' ' A' ' 34' ' ' ALA . 17.2 tp -84.18 -10.97 57.31 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.839 0.828 . . . . 0.0 109.453 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 52.3 t30 -66.63 -49.69 65.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.778 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -90.79 -23.25 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.386 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.34 -147.07 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.701 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 71' ' ' GLN . 16.0 m -132.65 152.56 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 5.5 t -137.05 -171.75 3.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.688 0.28 . . . . 0.0 110.402 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -103.09 171.75 7.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.442 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' SER . . . -63.68 -47.63 80.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 110.173 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.29 162.34 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.681 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 9.6 pt-20 -74.26 -17.48 60.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -109.9 30.44 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.623 0.725 . . . . 0.0 109.857 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' HD12 ' A' ' 7' ' ' ILE . 4.9 tp10 -62.83 146.36 52.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.153 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 37.7 m -120.05 120.14 35.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.102 0.477 . . . . 0.0 111.506 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.917 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.7 mm? -71.22 -17.56 62.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.702 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -92.72 0.88 57.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.524 0.678 . . . . 0.0 110.322 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.9 t70 -83.05 -172.48 4.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.692 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.98 -30.19 18.95 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.84 132.55 56.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.109 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.464 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.4 mp -135.56 108.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 20.2 m -101.02 124.69 47.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.998 0.427 . . . . 0.0 111.175 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.57 125.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.818 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.05 127.43 37.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 72' ' ' PHE . . . -139.89 170.71 24.16 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.586 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -169.07 165.28 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.583 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.7 m -75.1 143.16 43.51 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 6.0 t80 -122.06 152.8 39.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.78 0.324 . . . . 0.0 110.635 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -99.43 -47.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.545 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -58.98 -46.03 89.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.965 -174.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -101.77 124.43 40.51 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.6 5.76 6.19 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.805 2.337 . . . . 0.0 110.763 170.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -149.86 80.3 1.38 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.707 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -126.76 -160.25 0.98 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.009 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.613 ' HG2' HG22 ' A' ' 43' ' ' VAL . 1.5 mp0 -59.44 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.478 ' CD1' ' HA3' ' A' ' 61' ' ' GLY . 22.5 m-30 -91.09 31.66 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.526 HG23 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -63.82 -24.41 67.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.4 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 64.7 t30 -134.95 36.0 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.723 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.89 13.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.589 -0.695 . . . . 0.0 111.271 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -89.97 -22.09 22.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.227 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.53 21.64 8.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.982 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.85 153.94 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.482 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HD2' ' OD1' ' A' ' 22' ' ' ASP . 4.6 mptt -132.6 -168.16 2.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.0 ptpp? -69.67 -23.94 63.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.855 0.359 . . . . 0.0 111.67 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -121.88 56.34 0.64 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.855 -1.165 . . . . 0.0 112.709 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -81.42 -10.45 59.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 57.01 90.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.451 0.643 . . . . 0.0 111.344 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.3 t -95.06 109.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.25 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 73.1 m-85 -94.56 114.35 26.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 121' ' ' LEU . 9.2 t80 -98.95 104.81 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 18.8 tptp -87.3 83.89 7.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.469 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.917 HG21 ' HG ' ' A' ' 52' ' ' LEU . 7.1 p -113.85 131.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.926 0.393 . . . . 0.0 110.678 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.55 -103.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.61 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -127.54 8.81 6.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.393 0.139 . . . . 0.0 111.227 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.41 158.52 32.55 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 112.159 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -124.63 108.89 12.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 97.9 mtt180 -100.14 146.6 26.63 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.186 -0.205 . . . . 0.0 110.591 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 120.14 39.69 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.571 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 94.6 m-85 -112.67 141.28 46.64 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -111.42 133.21 53.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.3 mtt -81.4 63.61 5.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.527 0.679 . . . . 0.0 110.465 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -71.26 -32.27 68.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.462 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 65.3 m -114.26 97.69 6.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 138.7 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.844 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -162.22 -178.45 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.515 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -126.48 140.01 52.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.888 HG23 ' HG3' ' A' ' 139' ' ' ARG . 7.7 m -114.2 147.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -85.77 159.08 55.71 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.623 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . 31.2 Cg_endo -64.79 -22.83 63.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.604 2.203 . . . . 0.0 111.596 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -106.66 8.5 31.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.145 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 11.7 t70 -85.13 142.22 29.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.75 11.07 8.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.951 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.49 -28.27 28.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 0.0 109.505 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.52 -26.42 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.03 9.91 37.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.872 0.368 . . . . 0.0 111.516 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 7.9 t70 -100.93 -175.09 2.78 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.036 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.406 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 4.2 pt-20 -115.22 102.74 10.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.18 0.514 . . . . 0.0 110.477 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -79.52 95.27 5.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.869 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.502 ' H ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.08 -175.96 3.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.413 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.07 -4.83 84.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.192 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -98.47 -174.31 2.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.81 -158.62 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -64.5 111.82 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 171.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.71 151.75 47.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.328 0.585 . . . . 0.0 112.209 -173.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -106.98 121.59 44.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.433 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 27.5 m -95.78 98.93 10.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.062 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 8.7 mt -85.03 101.07 12.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.131 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.1 mt -92.01 92.64 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -101.62 101.17 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.317 0.579 . . . . 0.0 111.183 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 76.9 m -84.06 105.07 14.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.874 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -98.8 -27.27 14.01 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.485 ' CG ' ' HD3' ' A' ' 138' ' ' LYS . 16.0 t70 -114.71 100.29 8.14 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.276 0.56 . . . . 0.0 111.14 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -87.14 122.76 31.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.441 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -91.04 107.3 19.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.23 -27.15 67.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.986 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -65.13 -34.74 79.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -173.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.506 HG23 HG12 ' A' ' 135' ' ' VAL . 9.9 t -126.16 -5.6 6.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 110.625 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.93 52.52 14.06 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.931 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.506 HG12 HG23 ' A' ' 133' ' ' THR . 9.0 p -142.23 150.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 46.6 m95 -92.69 98.0 11.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.741 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 42.7 mt-10 -72.42 -64.87 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 111.101 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.741 ' HD2' ' HB2' ' A' ' 137' ' ' GLU . 8.4 mptt -81.58 109.23 15.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.597 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.888 ' HG3' HG23 ' A' ' 103' ' ' VAL . 11.9 ptt180 -121.38 114.75 21.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.451 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.414 ' HE2' ' CE2' ' A' ' 142' ' ' PHE . 19.9 tptm -83.79 127.35 33.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.671 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.2 tt -120.1 128.44 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.578 0.704 . . . . 0.0 110.975 -175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.8 m-85 -115.84 116.09 27.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.026 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 41.3 t -98.86 96.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -95.73 116.04 28.3 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.775 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 m -96.34 145.17 25.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.696 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.04 122.56 9.61 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.58 0.55 . . . . 0.0 110.691 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.542 HG21 ' HE3' ' A' ' 96' ' ' LYS . 15.0 p -122.99 150.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.498 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 148' ' ' LYS . 14.9 ptpt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.326 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt . . . . . 0 N--CA 1.453 -0.291 0 CA-C-O 121.268 0.556 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.66 130.44 24.87 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.051 2.501 . . . . 0.0 113.612 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -143.55 161.33 38.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.088 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 31' ' ' PRO . 3.5 mp -90.89 126.82 54.26 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.71 -175.31 2.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.117 2.545 . . . . 0.0 111.701 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.24 -17.77 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.663 -178.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -90.07 121.51 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.517 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -106.5 16.54 24.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.136 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -102.46 3.48 37.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -122.35 168.6 11.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.846 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.8 t -93.89 119.4 41.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.221 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -94.19 -21.62 18.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.29 164.41 37.17 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.318 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 79.7 m-85 -119.87 144.77 47.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -101.71 108.49 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.812 0.815 . . . . 0.0 109.564 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.78 108.62 17.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.193 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.431 HG12 HG13 ' A' ' 84' ' ' VAL . 41.7 mt -126.42 91.24 48.09 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.096 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 21.5 Cg_endo -61.55 -25.75 79.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.942 2.428 . . . . 0.0 112.164 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.562 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 33.8 t70 -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.028 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -110.29 8.31 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.57 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 t70 63.47 27.62 15.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.747 0.784 . . . . 0.0 110.652 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 88.6 mt -104.2 114.62 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.298 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.2 mppt? -142.37 82.1 1.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 11.2 mm-40 -134.02 159.99 70.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.054 -173.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 67.4 Cg_endo -75.17 144.91 30.24 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.918 2.412 . . . . 0.0 113.442 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.81 128.37 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.623 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -97.63 114.6 65.15 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HB2' HG23 ' A' ' 7' ' ' ILE . 86.1 Cg_endo -78.67 142.22 17.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.757 2.305 . . . . 0.0 112.431 -174.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.42 -161.43 28.19 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.912 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 59.8 Cg_endo -88.18 30.02 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.911 3.074 . . . . 0.0 113.312 -175.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.22 56.84 4.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.63 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.38 138.02 95.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.37 -58.62 1.3 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.252 3.302 . . . . 0.0 114.076 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.49 -34.44 76.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.648 0.261 . . . . 0.0 111.696 -176.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -81.2 -36.34 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.426 . . . . 0.0 110.847 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.41 -14.72 59.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.621 0.724 . . . . 0.0 109.575 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -73.91 -42.66 60.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.168 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 41' ' ' ARG . 12.9 ptm180 -86.13 -40.39 15.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.521 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.88 -157.11 8.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.603 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 HE21 ' A' ' 71' ' ' GLN . 40.2 t -113.26 142.67 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 t -130.64 -174.73 3.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -93.67 160.05 14.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -29.26 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.445 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -135.78 165.55 25.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 37.6 tt0 -82.8 -32.12 27.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.748 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.47 31.05 0.59 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.119 0.485 . . . . 0.0 111.167 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -85.68 151.41 23.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.838 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 47.1 m -122.93 150.21 43.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.752 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 93.6 mt -93.02 6.8 46.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.785 0.326 . . . . 0.0 111.746 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -132.68 8.34 4.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.706 0.765 . . . . 0.0 109.547 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.838 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 15.6 t70 -81.71 164.26 21.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.288 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tm0? -67.78 -29.05 68.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.035 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 138.37 53.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.794 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -140.0 117.82 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.858 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -100.23 103.4 14.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.045 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.5 mt -98.31 114.81 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.41 123.77 48.58 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.1 167.63 21.71 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.196 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -139.74 128.86 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.491 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.3 m -52.71 110.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.342 0.591 . . . . 0.0 111.282 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 66' ' ' ASP . 13.8 t80 -80.88 129.48 34.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.93 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.4 mm -75.0 -49.65 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.403 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.43 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -74.19 -1.35 20.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.23 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 85.0 mtm180 -130.24 94.38 30.54 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 -13.5 34.5 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.812 2.341 . . . . 0.0 112.515 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -147.33 63.27 1.16 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.445 0.641 . . . . 0.0 110.167 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 9.7 p90 -99.12 -157.79 0.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -43.57 -75.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.506 0.504 . . . . 0.0 112.123 178.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.541 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 22.2 m-30 -100.03 77.17 1.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.84 -52.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.554 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 10.7 t30 -88.62 11.94 16.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.047 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -23.16 64.89 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.958 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -70.1 -8.29 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.944 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.72 5.12 41.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.777 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . . . -96.16 135.15 38.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.438 0.637 . . . . 0.0 111.23 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' SER . 3.5 mppt? -108.86 -172.94 2.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -64.21 -30.62 71.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.827 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.82 49.69 0.83 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.246 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 6.7 t -66.07 -21.09 66.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.53 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 53.91 83.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.518 0.675 . . . . 0.0 111.547 -175.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 74.4 t -85.2 125.15 40.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.185 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -106.03 108.42 19.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.276 0.56 . . . . 0.0 110.337 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.75 103.07 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.0 tppp? -86.86 90.69 8.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.983 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 m -117.42 129.12 74.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.78 -88.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.494 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -148.18 11.07 0.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 110.155 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 145.57 41.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 m -109.18 107.11 17.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.372 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -99.74 137.0 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.938 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.413 ' HB3' ' CE ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -102.89 139.01 39.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.519 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -133.27 142.52 48.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.023 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -107.63 136.76 46.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.9 mmt -80.64 70.37 7.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.4 0.619 . . . . 0.0 110.108 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -83.64 -4.69 58.8 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.895 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 20.2 m -144.02 105.82 4.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.093 0.473 . . . . 0.0 110.587 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 97' ' ' MET . 77.3 mt -122.08 123.27 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.924 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -165.23 -166.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.213 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.666 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 4.5 p-10 -142.98 144.97 32.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.691 HG23 ' HE ' ' A' ' 139' ' ' ARG . 11.3 m -132.07 154.17 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.269 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -97.09 164.86 16.94 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.785 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -67.19 -18.35 50.77 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.473 2.115 . . . . 0.0 111.229 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -103.91 12.86 33.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' HG13 ' A' ' 110' ' ' VAL . 7.6 t70 -74.63 154.76 38.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.432 ' HA ' HD21 ' A' ' 111' ' ' LEU . 28.5 m -96.11 -15.26 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 -172.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.15 -5.06 55.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.332 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 107' ' ' ASP . 21.8 m -83.6 -17.93 10.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.818 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -112.49 18.5 18.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 178.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.91 167.58 14.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.34 139.44 57.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.804 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.63 143.29 30.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.38 170.0 13.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.588 -166.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.13 51.78 2.87 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.254 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -83.1 177.0 8.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.13 -156.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 19.1 mmtm -60.7 115.45 3.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -106.34 112.04 24.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.979 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.55 105.38 9.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -91.57 93.73 9.09 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.683 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -77.65 99.1 5.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.578 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.51 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.043 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -117.67 89.72 3.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.007 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 64.0 m -73.97 104.82 4.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -110.54 76.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.569 0.7 . . . . 0.0 110.75 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 16.6 t70 -162.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.707 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.484 ' CZ ' ' HG2' ' A' ' 131' ' ' GLU . 1.6 t80 61.03 86.67 0.1 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.628 0.58 . . . . 0.0 110.384 -172.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -92.79 97.36 10.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.696 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.484 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 36.4 mt-10 -60.87 -15.74 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.278 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.24 -34.79 78.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.903 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -115.55 -14.99 11.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.436 0.636 . . . . 0.0 109.844 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.11 31.89 50.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.029 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.5 t -134.86 139.33 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 44.1 m95 -78.14 92.26 4.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 172.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.55 -8.46 59.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 62.9 tttm -121.13 131.15 54.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 19.9 ttp180 -136.57 100.92 4.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.34 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.666 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 48.7 tptt -69.1 126.68 30.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.12 124.88 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.772 0.796 . . . . 0.0 111.033 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 14.6 m-85 -115.66 116.36 27.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.395 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 45.6 t -104.02 103.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.322 0.582 . . . . 0.0 110.103 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.63 114.48 28.2 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.747 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.9 m -89.75 140.14 29.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.07 126.57 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.202 0.525 . . . . 0.0 111.255 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.461 HG11 ' HD3' ' A' ' 96' ' ' LYS . 13.1 p -130.09 160.53 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.229 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.491 -178.13 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 87.8 mttt . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 109.95 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 35.9 Cg_endo -64.19 135.87 49.05 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.974 2.449 . . . . 0.0 112.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -134.41 167.1 21.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.197 0.522 . . . . 0.0 110.519 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 51' ' ' SER . 43.1 mt -107.02 113.78 62.15 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.73 177.35 3.65 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.92 2.413 . . . . 0.0 112.292 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -74.65 -24.25 58.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 110.134 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.21 100.26 0.77 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.015 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -98.68 20.84 12.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 110.608 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -100.23 -11.86 20.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.284 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -107.33 176.69 5.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.097 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.97 129.53 41.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.727 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.5 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.301 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -155.3 176.08 33.04 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.668 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 71.9 m-85 -122.7 135.98 54.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.6 tp -98.63 110.05 25.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.807 0.813 . . . . 0.0 109.776 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 85.9 mt-10 -119.17 109.62 16.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.92 89.6 38.15 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.67 -32.73 76.81 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.112 2.541 . . . . 0.0 112.481 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.63 -23.78 64.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -107.89 8.12 28.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.137 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 65.4 17.65 11.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.844 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 91.2 mt -97.38 131.27 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.985 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 37.0 mtpt -156.41 45.73 0.43 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.486 0.66 . . . . 0.0 109.834 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -106.63 156.87 36.38 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.158 -169.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 57.4 Cg_endo -73.43 148.63 43.28 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 121.91 1.74 . . . . 0.0 112.896 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.82 134.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 44' ' ' SER . 46.5 m-85 -101.08 144.22 28.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.318 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.13 162.52 20.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.411 2.074 . . . . 0.0 110.894 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.24 165.2 13.24 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.093 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.66 30.24 0.41 Allowed 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.041 3.161 . . . . 0.0 113.221 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.36 43.39 23.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.763 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.759 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.65 147.24 96.45 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.15 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.637 ' HD2' HG22 ' A' ' 35' ' ' THR . 89.2 Cg_exo -49.04 -53.3 7.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.291 2.66 . . . . 0.0 113.965 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.759 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -71.82 -27.08 62.67 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.761 -178.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 44' ' ' SER . 42.6 tp60 -62.49 -51.91 65.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.995 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.74 -16.83 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.445 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.62 -40.3 66.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.266 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -68.97 -45.12 71.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.051 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.0 -110.19 0.23 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.598 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.3 m -130.71 152.68 37.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.58 0.229 . . . . 0.0 110.679 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 36.9 t -148.18 165.81 29.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.001 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -68.56 162.01 26.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.32 -37.44 25.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HB3' ' H ' ' A' ' 49' ' ' ASN . 21.2 mm-40 -125.61 156.33 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.33 -1.65 58.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.856 0.836 . . . . 0.0 108.772 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.436 ' H ' ' HB3' ' A' ' 47' ' ' GLU . 27.0 t-20 -91.14 -19.72 22.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.058 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.71 170.51 16.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.991 0.424 . . . . 0.0 110.532 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.535 ' HA ' HD12 ' A' ' 7' ' ' ILE . 56.1 m -146.94 157.63 43.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.525 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HG ' HG13 ' A' ' 7' ' ' ILE . 96.0 mt -73.79 -12.09 60.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 111.939 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -113.5 11.16 18.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.879 0.847 . . . . 0.0 109.844 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 4.3 t0 -83.21 156.78 23.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.652 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 115' ' ' LYS . 1.1 tm0? -68.15 -32.75 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.15 120.33 40.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.409 0.623 . . . . 0.0 111.56 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.1 mt -125.75 134.16 67.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 p -132.45 121.14 22.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.06 0.457 . . . . 0.0 112.022 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mt -108.69 128.45 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.02 123.57 33.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.033 0.444 . . . . 0.0 111.283 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 123.94 7.7 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.762 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -70.51 -61.85 1.61 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.505 0.193 . . . . 0.0 110.687 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 m 69.09 122.46 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 O-C-N 124.099 0.875 . . . . 0.0 110.693 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -152.63 138.75 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.3 -37.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.721 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.94 6.94 16.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.339 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -136.39 77.47 47.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.64 3.65 7.66 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.827 2.351 . . . . 0.0 113.338 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -153.19 47.44 0.69 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.973 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -101.5 -175.21 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HG3' ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.69 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 21.3 m-30 -96.96 81.33 3.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.485 0.66 . . . . 0.0 111.245 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 m -150.4 -41.28 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.174 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -91.08 11.9 21.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.462 0.649 . . . . 0.0 109.388 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.01 -12.53 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.948 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -10.13 58.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.069 0.462 . . . . 0.0 111.257 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -82.13 -9.77 59.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.496 175.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.17 132.06 35.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.068 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' MET . 26.4 mmtp -120.53 -177.74 3.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -61.12 -13.77 19.82 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.42 34.23 2.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.547 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.0 m -82.77 121.86 27.45 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mtp -71.8 108.17 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 110.526 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 63.3 t -89.56 115.94 30.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.668 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 82.6 m-85 -102.57 121.42 42.35 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.072 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 12.0 t80 -112.81 99.06 7.61 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 5.4 mptt -75.25 102.22 4.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.013 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.85 86.73 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.168 0.509 . . . . 0.0 111.561 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.38 -59.25 3.26 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.308 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -137.35 -37.46 0.63 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 111.392 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -107.97 -179.73 3.98 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 6.6 t -132.23 142.57 49.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.397 0.618 . . . . 0.0 109.905 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -100.24 132.2 45.75 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.942 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -99.76 126.48 45.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.942 0.401 . . . . 0.0 110.462 -177.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 83.9 m-85 -125.13 149.94 47.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.38 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.8 tptm -113.17 135.18 54.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.604 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 16.7 mmt -79.9 62.62 4.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -75.62 -8.95 58.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.126 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.573 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 55.9 m -145.21 103.3 3.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.966 -0.459 . . . . 0.0 110.998 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.6 mt -120.59 128.34 76.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.24 177.42 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -132.16 120.55 22.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -75.24 151.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.51 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -86.51 148.39 46.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.73 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.628 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 32.8 Cg_exo -62.06 -15.68 45.29 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.697 2.265 . . . . 0.0 112.284 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -99.76 -5.66 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.84 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -91.81 133.22 35.83 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.57 24.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -115.89 -28.14 6.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.562 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.18 -22.59 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.475 0.655 . . . . 0.0 110.79 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.499 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -99.5 25.53 6.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.467 -173.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.91 175.35 7.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.552 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.7 pt-20 -72.21 70.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.397 0.618 . . . . 0.0 112.033 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -86.72 75.46 9.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.569 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -100.11 -179.36 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.31 -2.38 16.29 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.44 -170.71 3.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.34 -0.43 . . . . 0.0 109.946 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.75 -158.51 0.4 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 1.3 mptm? -61.77 104.82 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.05 125.4 49.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.327 0.584 . . . . 0.0 110.54 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.4 tp -91.92 109.72 21.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m -96.28 102.26 14.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.572 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.6 mm? -87.38 100.7 12.93 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.72 89.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.6 m -100.56 99.73 10.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 83.4 m -60.7 125.26 23.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.425 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 8.8 t70 -112.08 -21.57 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.041 -160.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 13.6 t70 -140.85 108.57 5.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.389 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -101.38 130.08 47.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.57 0.7 . . . . 0.0 109.924 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -80.67 103.27 10.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.274 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -54.95 -26.07 33.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.08 -17.45 58.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.554 ' OG1' HG22 ' A' ' 135' ' ' VAL . 16.5 p -126.68 -37.69 2.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.536 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.85 8.54 51.24 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.939 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.554 HG22 ' OG1' ' A' ' 133' ' ' THR . 30.2 m -98.34 141.51 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 111.34 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 129' ' ' TYR . 60.4 m95 -87.97 86.65 7.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 105' ' ' PRO . 51.2 mt-10 -65.0 -64.19 0.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.961 -175.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 35.6 tttm -85.5 126.48 33.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -129.09 139.95 51.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.64 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 27.0 tttp -87.57 145.08 26.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.126 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.25 125.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.672 0.748 . . . . 0.0 110.936 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.7 m-85 -111.91 112.71 24.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.891 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 59.3 t -98.15 98.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 109.649 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -98.4 102.87 14.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.201 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.9 m -82.07 139.64 34.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.871 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -57.58 126.01 25.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.492 0.663 . . . . 0.0 110.8 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 148' ' ' LYS . 11.9 p -114.05 170.82 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.935 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.2 ptmm? . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.715 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp . . . . . 0 C--O 1.233 0.211 0 CA-C-O 121.262 0.553 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.33 144.92 69.96 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.6 2.2 . . . . 0.0 112.169 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.79 156.84 47.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.733 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.421 HG23 ' CB ' ' A' ' 31' ' ' PRO . 28.3 mt -107.8 109.6 62.28 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.364 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.689 ' HG2' ' HE3' ' A' ' 13' ' ' LYS . 49.9 Cg_endo -73.35 164.09 36.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.418 2.078 . . . . 0.0 111.579 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.19 -3.22 19.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 -177.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.714 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 19.3 t70 -69.24 145.63 52.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.272 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 22.5 pttp -118.63 9.73 12.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 111.525 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -95.01 -50.46 5.09 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.056 -0.402 . . . . 0.0 111.35 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.714 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -76.83 162.04 27.96 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -96.85 151.6 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.105 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.36 -32.12 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.66 164.27 25.45 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.994 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 59.1 m-85 -129.73 135.17 48.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -104.98 115.23 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.532 0.682 . . . . 0.0 110.154 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -125.17 119.91 29.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.891 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.4 95.03 18.57 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.071 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.93 -22.55 68.51 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.715 2.277 . . . . 0.0 112.115 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 82' ' ' SER . 27.0 t0 -68.5 -33.02 73.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.392 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.56 2.5 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.584 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t0 57.7 36.56 26.73 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.874 0.845 . . . . 0.0 110.313 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 55.0 mt -102.45 121.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.624 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -147.06 86.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.4 mm-40 -145.26 159.8 47.75 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.617 0.246 . . . . 0.0 111.099 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.2 157.7 45.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.837 2.358 . . . . 0.0 113.447 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 14' ' ' VAL . 93.4 t -110.88 123.34 66.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.716 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 44' ' ' SER . 60.0 m-85 -92.42 110.97 48.3 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.312 0.577 . . . . 0.0 111.467 -175.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.7 Cg_exo -77.61 129.82 10.33 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.223 2.616 . . . . 0.0 111.728 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.03 -173.7 43.68 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.918 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 11' ' ' LYS . 3.3 Cg_exo -78.66 10.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.542 2.828 . . . . 0.0 112.845 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 67.49 29.92 7.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.663 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -68.56 160.24 77.53 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.26 -45.32 22.4 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.697 2.931 . . . . 0.0 114.727 -174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.517 ' OE1' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -71.79 -30.46 65.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.571 -175.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HG2' ' OE1' ' A' ' 37' ' ' GLU . 85.2 mm-40 -68.01 -36.84 80.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 0.0 110.339 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -81.92 -0.61 44.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.037 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -108.32 -12.18 15.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.698 0.285 . . . . 0.0 111.001 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 10.1 ptm180 -95.36 -25.81 16.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.783 0.325 . . . . 0.0 110.576 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.0 -122.59 0.91 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.076 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 ' HG2' ' A' ' 71' ' ' GLN . 7.6 p -122.03 144.22 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 45.0 p -132.29 -168.27 2.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.456 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 36.6 m-85 -96.28 165.0 12.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.465 176.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.367 . . . . 0.0 111.446 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.35 168.92 19.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.05 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -67.85 -31.77 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.808 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -88.3 19.95 3.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.034 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 4.6 mm-40 -64.65 158.4 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.031 173.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.816 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 51.8 m -140.04 123.19 16.8 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.134 0.492 . . . . 0.0 111.737 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' CG1' ' A' ' 88' ' ' VAL . 30.6 mt -66.22 -26.75 67.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.271 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.55 -19.98 48.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.79 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.816 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 3.5 t70 -72.29 164.53 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.396 -172.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.61 ' HA ' ' HD2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.91 -31.19 61.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.054 -178.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.42 133.98 54.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.684 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.5 mt -133.47 121.7 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.925 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -110.09 107.8 17.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.263 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 121' ' ' LEU . 41.1 mt -94.55 111.81 26.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -105.71 123.31 47.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.561 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.477 ' HA3' HG23 ' A' ' 43' ' ' VAL . . . -150.58 175.52 29.57 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.088 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -142.11 156.38 45.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.733 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -71.73 140.96 49.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.361 0.413 . . . . 0.0 111.016 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -100.68 158.53 15.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.357 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.49 -38.14 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -87.9 -5.07 58.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 67' ' ' ARG . 8.6 mmt180 -113.25 115.36 47.62 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 0.0 110.665 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.82 -11.66 5.51 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.961 2.441 . . . . 0.0 113.359 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -160.58 89.07 0.81 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.562 0.696 . . . . 0.0 110.514 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.733 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 15.4 p90 -130.69 -151.83 0.48 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.809 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.697 ' HG2' HG12 ' A' ' 43' ' ' VAL . 25.8 mp0 -55.49 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 111.918 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.6 m-85 -94.88 82.07 3.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.154 0.502 . . . . 0.0 111.198 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 m -110.1 -60.96 1.73 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -95.96 28.12 3.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.656 -176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.8 tp -65.13 -19.0 65.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.418 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -9.61 58.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.62 11.75 23.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.939 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.28 161.39 14.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.349 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -135.27 -176.01 4.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.6 ptmm? -66.52 -13.86 61.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.336 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.66 45.91 1.11 Allowed Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 174.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.4 t -61.63 -25.33 67.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.09 -0.555 . . . . 0.0 112.117 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.52 89.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.698 0.761 . . . . 0.0 111.518 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.0 t -91.81 125.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.669 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -102.0 104.47 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -97.51 106.07 18.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 49.5 mttp -83.72 125.02 31.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.225 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -130.49 101.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.294 0.568 . . . . 0.0 110.144 -177.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.59 -81.72 0.4 Allowed Glycine 0 C--N 1.317 -0.482 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.421 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 -18.62 4.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.349 . . . . 0.0 111.242 -176.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -97.52 152.04 19.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -123.53 99.59 6.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.61 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -93.83 166.35 12.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.734 0.302 . . . . 0.0 110.761 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.564 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -127.55 126.64 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.454 0.645 . . . . 0.0 111.894 -170.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.6 m-85 -116.05 148.22 40.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.454 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.614 ' HB2' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -117.16 129.47 55.98 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 59.5 mtt -79.86 70.33 6.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.402 0.62 . . . . 0.0 110.703 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 t -80.04 -24.93 40.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.587 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 15.0 m -121.03 102.5 8.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.011 0.434 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.7 mt -113.11 129.98 67.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.17 173.94 11.5 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.909 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 140' ' ' LYS . 1.2 p30 -149.36 125.53 10.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.865 168.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 110' ' ' VAL . 19.0 m -131.38 -177.16 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.398 -169.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.3 mppt? -103.07 145.19 30.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.762 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 136' ' ' TRP . 25.3 Cg_exo -65.62 -12.99 37.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.95 2.433 . . . . 0.0 111.95 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -109.02 16.89 22.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.518 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.09 168.27 19.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.43 -20.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.691 0.281 . . . . 0.0 111.033 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.83 4.84 38.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.265 0.555 . . . . 0.0 110.777 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.461 HG23 HG21 ' A' ' 103' ' ' VAL . 11.3 p -80.12 -20.16 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -104.24 12.48 33.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.355 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 157.32 34.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 0.0 110.251 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.571 ' OE1' ' HE2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -92.9 82.73 4.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.541 0.686 . . . . 0.0 112.022 -174.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -77.02 74.23 3.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.571 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.64 174.27 5.95 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.25 -23.1 27.84 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -72.3 158.97 34.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.435 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.462 ' OD1' HG22 ' A' ' 145' ' ' THR . 3.1 p-10 -83.43 -161.71 0.54 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 55' ' ' GLN . 2.4 tptp -46.86 106.31 0.08 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.188 0.305 . . . . 0.0 110.244 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 10.0 pt20 -116.4 135.34 53.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.371 0.605 . . . . 0.0 110.861 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 59' ' ' ILE . 20.7 tp -101.47 109.86 21.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 m -94.37 101.27 13.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.49 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.9 mm? -80.49 104.55 11.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.727 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.473 HG23 ' HD3' ' A' ' 139' ' ' ARG . 53.3 mt -98.84 100.72 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.6 m -115.6 105.18 12.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.125 0.488 . . . . 0.0 110.833 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.5 m -90.99 94.31 9.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.453 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 9.6 p-10 -105.05 2.45 29.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.672 -166.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.5 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 20.8 t70 -127.66 99.18 5.47 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.246 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 87.2 t80 -97.36 127.19 43.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 133' ' ' THR . 22.1 t-20 -91.28 111.13 22.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.68 -14.43 62.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -85.7 -29.64 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 135' ' ' VAL . 10.1 t -124.07 -9.45 7.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.366 0.603 . . . . 0.0 110.663 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.78 54.6 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.727 -0.669 . . . . 0.0 113.062 175.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.474 HG12 HG23 ' A' ' 133' ' ' THR . 4.7 p -149.23 157.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 67.8 m95 -88.57 117.9 27.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.2 -24.97 25.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 128' ' ' ASP . 21.2 pttp -142.78 154.83 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.548 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HD3' HG23 ' A' ' 124' ' ' ILE . 11.8 ttm180 -121.87 112.99 19.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.529 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.515 ' CD ' ' HB3' ' A' ' 102' ' ' ASP . 51.7 tptt -77.14 123.67 26.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.41 HD12 HH11 ' A' ' 139' ' ' ARG . 11.5 tt -127.52 126.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.765 0.793 . . . . 0.0 111.212 -172.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.9 m-85 -117.07 112.95 21.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.8 t -94.23 94.68 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -95.96 104.05 15.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.368 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 0.4 OUTLIER -85.1 151.68 23.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 7.4 tp10 -55.58 142.4 33.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 110.865 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 96' ' ' LYS . 21.8 t -90.4 144.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.182 -0.913 . . . . 0.0 112.402 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 8.8 mmmm . . . . . 0 C--O 1.232 0.177 0 CA-C-O 121.476 0.655 . . . . 0.0 112.349 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 88' ' ' VAL . 55.7 Cg_endo -71.66 146.45 48.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.297 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.31 -175.75 5.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.135 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.597 HG13 ' HG ' ' A' ' 52' ' ' LEU . 25.4 mt -102.08 117.95 60.25 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.716 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.78 168.29 21.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 112.109 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 4.2 mptp? -84.93 -17.11 38.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.379 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.83 125.66 30.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.783 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.643 ' HB2' HE22 ' A' ' 38' ' ' GLN . 63.4 pttt -105.88 18.86 21.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -94.22 -7.58 41.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.762 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -170.03 1.78 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.225 0.536 . . . . 0.0 111.108 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.04 137.7 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.921 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.26 -34.55 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.359 0.599 . . . . 0.0 110.567 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 166.01 39.22 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 75.8 m-85 -107.86 139.3 42.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.266 0.533 . . . . 0.0 110.053 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 25' ' ' ILE . 8.4 tp -101.94 117.48 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 34.9 mt-10 -120.78 113.33 20.01 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.477 0.656 . . . . 0.0 110.907 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 47.9 mt -127.32 94.12 39.34 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.492 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 10.1 Cg_endo -53.19 -42.96 61.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.279 2.653 . . . . 0.0 113.3 -172.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -13.71 61.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.678 0.275 . . . . 0.0 111.737 -176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.51 9.5 23.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.347 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.72 27.77 16.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.203 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.3 mt -96.92 119.99 45.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.329 -175.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 26' ' ' LYS . 24.4 mmmt -141.02 42.7 1.81 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.607 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 11.6 mm-40 -102.66 149.7 37.0 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.338 -165.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.39 135.68 13.53 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.771 2.314 . . . . 0.0 112.54 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.45 123.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.206 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.86 121.82 61.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.585 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -79.94 161.13 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.917 2.412 . . . . 0.0 112.256 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.2 -164.35 26.21 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.128 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.93 2.64 8.12 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.682 2.921 . . . . 0.0 113.103 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.96 89.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.882 0.738 . . . . 0.0 110.829 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 p -119.14 157.46 50.81 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.801 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.72 -52.87 6.9 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.695 2.93 . . . . 0.0 114.529 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.43 75.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 111.598 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.643 HE22 ' HB2' ' A' ' 11' ' ' LYS . 37.1 tt0 -72.2 -37.68 69.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.93 0.395 . . . . 0.0 110.472 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.35 -18.06 60.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.98 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -81.7 -28.98 33.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -93.13 -35.79 13.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.673 0.273 . . . . 0.0 111.035 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' HG3' ' A' ' 71' ' ' GLN . . . -151.39 -137.86 2.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.208 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.25 162.32 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.2 m -131.43 172.32 12.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.905 0.383 . . . . 0.0 111.45 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.8 166.92 21.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.098 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.34 76.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.426 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -144.94 170.05 16.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.034 0.445 . . . . 0.0 110.962 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.09 -25.25 66.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.466 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.93 7.39 18.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 110.999 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.14 148.05 32.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -139.81 123.5 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.946 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.597 ' HG ' HG13 ' A' ' 7' ' ' ILE . 85.4 mt -74.26 -17.39 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.448 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.28 13.59 25.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.45 0.643 . . . . 0.0 110.529 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.45 178.08 4.69 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.5 pt20 -95.72 -22.21 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.705 0.288 . . . . 0.0 110.667 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.422 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -106.8 105.63 15.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.724 0.773 . . . . 0.0 110.355 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.69 133.92 68.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.746 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 3.0 p -124.69 121.87 35.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.149 0.5 . . . . 0.0 112.06 -173.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -114.07 132.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.1 130.84 45.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.68 126.95 6.82 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.897 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -111.81 76.23 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 m -60.82 134.36 57.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.79 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -145.09 150.75 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.137 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -53.02 -43.24 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 123.713 0.633 . . . . 0.0 112.402 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.84 10.76 3.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.162 -174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -131.21 76.41 76.3 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.15 -28.04 11.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.791 2.327 . . . . 0.0 113.527 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -140.2 73.5 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.475 0.655 . . . . 0.0 110.729 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.463 ' CE1' ' HB ' ' A' ' 73' ' ' THR . 1.4 p90 -132.39 155.09 49.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.538 -0.756 . . . . 0.0 108.972 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.607 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 10.3 mm100 16.49 -92.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.735 1.214 . . . . 0.0 114.226 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -116.7 97.11 5.81 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.677 0.275 . . . . 0.0 110.676 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.463 ' HB ' ' CE1' ' A' ' 70' ' ' TYR . 9.1 t -145.49 -39.34 0.24 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.219 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -91.58 26.67 2.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.706 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 125' ' ' THR . 19.6 mt -76.22 3.09 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.619 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -76.12 -21.08 57.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.189 0.518 . . . . 0.0 110.191 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.87 9.69 34.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.133 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.32 23.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.821 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 82' ' ' SER . 38.6 pttt -139.43 179.36 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.919 0.39 . . . . 0.0 111.109 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -66.77 -11.55 55.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.102 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.88 59.85 0.55 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 79' ' ' LYS . 6.0 p -74.77 -15.12 60.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.52 88.64 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.866 0.729 . . . . 0.0 111.407 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 56.1 t -88.81 124.56 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.909 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.1 m-85 -107.04 108.54 20.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.647 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 17.0 t80 -93.5 101.39 13.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.6 tptm -84.48 85.51 7.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.668 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 5' ' ' PRO . 7.8 p -109.85 125.6 67.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.441 0.638 . . . . 0.0 111.064 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 5' ' ' PRO . . . 63.45 -94.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.494 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.61 11.82 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.668 0.27 . . . . 0.0 111.146 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.8 160.42 26.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.894 0.378 . . . . 0.0 111.005 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 m -124.01 98.01 5.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.081 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.647 ' HG3' ' HB3' ' A' ' 86' ' ' PHE . 10.4 ptp180 -95.3 132.05 40.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.301 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -100.57 140.22 35.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.878 0.371 . . . . 0.0 110.793 -174.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.617 ' OH ' ' HD3' ' A' ' 93' ' ' ARG . 74.5 m-85 -129.31 147.93 51.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.77 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HD3' HG11 ' A' ' 147' ' ' VAL . 1.6 tptm -109.54 121.41 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 51.3 mtt -77.75 68.92 3.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 110.238 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -81.43 -11.74 59.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.924 -172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.7 m -135.43 99.4 4.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.991 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.97 128.01 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.4 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -167.75 179.2 4.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.203 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 4.5 p30 -125.12 153.25 43.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.05 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 110' ' ' VAL . 6.1 m -142.61 173.39 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.712 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.767 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -98.43 154.22 37.66 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.069 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.62 -15.5 49.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.623 2.215 . . . . 0.0 111.936 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.7 t -103.76 9.57 37.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.767 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 10.4 t70 -77.21 122.18 24.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.333 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.79 11.38 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.084 0.469 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -81.53 -46.91 13.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 103' ' ' VAL . 33.8 m -86.62 -8.33 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.211 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.0 mt -88.35 -3.78 58.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.103 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.05 160.89 25.66 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.83 106.89 3.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.025 0.441 . . . . 0.0 110.709 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.95 101.96 13.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.979 0.418 . . . . 0.0 111.347 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -169.76 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 173.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.74 -40.56 2.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.326 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -73.86 171.6 13.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.077 0.465 . . . . 0.0 110.766 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.16 -152.58 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.567 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -60.51 113.3 2.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -110.69 126.59 54.69 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.133 0.492 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 121' ' ' LEU . 23.9 mt -90.47 116.57 28.5 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.579 HG23 HD11 ' A' ' 141' ' ' ILE . 25.4 m -98.01 102.77 14.62 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.1 mm? -95.78 101.8 13.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.8 97.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.005 0.431 . . . . 0.0 109.885 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.651 HG21 HD12 ' A' ' 75' ' ' LEU . 21.1 p -105.25 107.39 18.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.424 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 m -94.2 92.83 7.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.3 33.72 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.077 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 26.9 t70 -137.47 103.86 5.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -100.08 123.86 44.81 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.833 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -97.86 112.54 24.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.392 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.3 -31.06 70.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.087 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mmmp? -70.8 -22.32 62.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.588 HG23 HG12 ' A' ' 135' ' ' VAL . 8.6 t -130.64 2.06 4.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 58.0 54.66 35.67 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.238 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 133' ' ' THR . 3.3 p -149.95 159.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.472 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 70.6 m95 -97.66 101.16 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.87 -66.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.428 -169.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -69.97 88.53 0.58 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.464 0.65 . . . . 0.0 110.568 -176.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.54 ' HG3' HG23 ' A' ' 103' ' ' VAL . 21.2 ptt180 -76.94 73.06 3.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.752 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HE2' ' CZ ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -62.67 124.25 20.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.348 -174.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.579 HD11 HG23 ' A' ' 122' ' ' THR . 8.7 tt -114.21 137.88 46.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.592 -168.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.614 ' CZ ' ' HE2' ' A' ' 140' ' ' LYS . 43.7 m-85 -110.44 119.23 38.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.8 t -102.57 102.86 14.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.254 0.549 . . . . 0.0 109.649 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -101.79 111.95 24.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.8 m -86.47 136.47 33.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.023 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.07 120.33 7.31 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.507 0.504 . . . . 0.0 110.833 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.509 HG11 ' HD3' ' A' ' 96' ' ' LYS . 7.1 p -111.19 122.26 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.543 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.298 -173.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt . . . . . 0 C--O 1.233 0.188 0 CA-C-O 121.287 0.565 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.68 135.81 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.634 2.223 . . . . 0.0 111.933 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.542 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 4.1 pt20 -153.16 161.36 42.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.255 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.477 HG23 ' CB ' ' A' ' 31' ' ' PRO . 4.6 mp -93.56 102.46 7.71 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.7 Cg_exo -66.85 165.18 26.79 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 122.805 2.337 . . . . 0.0 112.878 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.966 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -81.33 -22.36 38.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.391 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -74.95 109.95 8.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 41.7 mttp -86.67 9.4 18.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.333 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -110.65 5.73 21.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.24 0.543 . . . . 0.0 110.139 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.634 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 66.1 mttm -92.89 173.0 7.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.766 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.9 t -109.7 117.29 54.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.043 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.63 -26.08 23.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.184 0.516 . . . . 0.0 110.343 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.83 -175.3 43.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.418 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 90.0 m-85 -126.53 140.13 52.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.089 0.444 . . . . 0.0 110.273 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.2 tp -100.69 110.02 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.571 0.7 . . . . 0.0 109.539 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 42.5 mt-10 -113.34 113.14 24.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.195 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.57 92.07 48.49 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.43 -30.08 91.71 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.953 2.436 . . . . 0.0 112.221 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -70.06 -25.97 63.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.45 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.76 5.71 26.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.3 t0 61.86 20.7 11.68 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.911 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.428 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 68.4 mt -96.71 124.08 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.711 -173.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 3.9 mppt? -141.16 83.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.571 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 25.2 mm-40 -117.72 151.36 48.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.045 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.19 133.39 14.81 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.939 2.426 . . . . 0.0 111.911 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HA ' HG23 ' A' ' 43' ' ' VAL . 56.1 t -92.17 118.37 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.842 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.427 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 92.6 m-85 -95.54 114.28 63.6 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 38.2 Cg_endo -64.94 129.58 23.59 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.11 2.54 . . . . 0.0 112.179 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.24 179.43 43.91 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.648 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HG2' HG23 ' A' ' 35' ' ' THR . 62.5 Cg_endo -87.69 33.55 0.41 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.96 3.107 . . . . 0.0 112.451 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.55 32.04 11.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -62.26 138.14 96.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.341 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 85.4 Cg_exo -46.95 -48.71 13.85 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.788 2.992 . . . . 0.0 114.109 -172.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.48 -30.06 68.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.821 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.53 -41.49 79.84 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.6 mm? -77.51 -6.08 52.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -83.6 -14.36 52.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -126.32 -36.24 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -154.62 -167.67 16.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.388 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 ' HG2' ' A' ' 71' ' ' GLN . 10.8 m -88.97 153.4 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -139.51 169.01 18.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.62 151.79 26.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.371 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.47 62.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.36 156.93 20.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.0 111.862 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -97.18 -20.95 17.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -72.26 -12.27 61.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -75.08 150.2 38.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.837 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 m -130.86 159.62 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 88' ' ' VAL . 84.8 mt -76.3 -20.97 56.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.812 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.92 3.72 36.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 110.246 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.88 156.79 38.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -68.87 -27.24 65.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.242 0.544 . . . . 0.0 110.685 -176.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' HA ' HD22 ' A' ' 56' ' ' ASN . 2.5 t-20 -120.5 110.96 17.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.039 -174.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.48 123.95 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -117.67 116.8 27.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.0 0.428 . . . . 0.0 110.84 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -104.77 122.35 57.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.48 139.28 30.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.37 163.76 32.64 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.378 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -142.75 150.91 40.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.698 0.285 . . . . 0.0 110.36 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 ' HA ' ' A' ' 73' ' ' THR . 17.1 m -84.06 150.84 25.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.596 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 9.3 t80 -142.65 151.52 41.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.8 mt -81.82 -47.01 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 111.605 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.81 -43.69 97.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.978 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 70' ' ' TYR . 1.5 mmt180 -89.35 109.1 28.95 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.34 -11.08 17.54 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.584 2.189 . . . . 0.0 111.524 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -148.13 77.21 1.4 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.823 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.596 ' OH ' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -156.15 158.23 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.571 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 80.0 mt-30 41.44 -107.59 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.705 0.628 . . . . 0.0 112.463 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 75' ' ' LEU . 50.6 m-85 -131.69 91.09 2.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 63' ' ' THR . 2.7 t -120.71 -53.82 2.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.331 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 73' ' ' THR . 63.9 t30 -87.01 18.47 3.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.53 0.681 . . . . 0.0 109.919 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 72' ' ' PHE . 28.8 tp -70.06 -7.84 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.671 -178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -8.29 56.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.91 -0.98 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.822 173.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.79 160.61 20.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.283 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -163.5 -169.78 2.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.695 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.5 ptmt -51.1 -36.69 41.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -170.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.56 58.53 0.7 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.314 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.3 m -81.96 -7.95 59.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.33 89.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.567 0.699 . . . . 0.0 111.439 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -90.6 118.36 35.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 90.0 m-85 -103.9 121.26 42.74 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.009 0.433 . . . . 0.0 110.51 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 27.7 t80 -100.68 104.53 15.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.6 tptm -85.73 97.43 10.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.562 HG21 HD13 ' A' ' 52' ' ' LEU . 4.4 p -124.36 120.93 60.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -173.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.02 1.84 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.714 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -172.86 -28.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.979 0.512 . . . . 0.0 110.499 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 9.4 pt-20 -87.2 165.68 15.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.158 0.504 . . . . 0.0 111.565 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 m -123.57 110.74 15.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.616 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 9.1 mmm180 -87.1 132.19 33.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.408 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -107.22 123.16 47.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.57 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 87.5 m-85 -118.46 145.39 45.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.485 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.647 ' HE3' HG11 ' A' ' 147' ' ' VAL . 1.3 tppp? -114.43 128.61 56.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 56.3 mtt -78.22 70.86 4.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.632 0.73 . . . . 0.0 110.636 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -87.09 -6.74 58.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.039 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.596 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 49.0 m -140.04 103.86 4.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.347 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 97' ' ' MET . 84.3 mt -122.6 130.06 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -158.95 173.31 16.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.883 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.929 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 1.5 p30 -133.03 124.06 26.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.254 0.549 . . . . 0.0 109.9 175.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.79 -172.2 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.953 -171.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.558 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -124.63 152.6 69.27 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.051 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.25 -13.01 33.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.487 2.125 . . . . 0.0 110.974 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -13.13 59.97 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.389 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.55 ' HB2' ' HE3' ' A' ' 104' ' ' LYS . 12.7 t70 -108.99 121.69 45.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.875 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.96 32.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -102.17 -18.47 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.137 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.07 -16.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.239 0.542 . . . . 0.0 111.533 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.508 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -98.65 22.04 10.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 111.242 -175.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 10.1 t70 -79.25 -154.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.954 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 39.0 mt-10 -65.52 92.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.05 30.14 4.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.637 0.732 . . . . 0.0 111.492 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.79 153.44 21.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 176.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.33 -21.23 7.32 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -90.12 -170.29 2.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.282 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.49 -164.67 1.21 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -65.03 104.89 0.94 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 110.11 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 13.1 pt20 -100.22 120.18 39.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.296 0.57 . . . . 0.0 110.526 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -85.61 110.32 19.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -94.65 99.64 11.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.555 -175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.1 mt -85.69 108.25 17.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.8 mt -91.46 99.34 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 m -96.52 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.262 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 80.0 m -94.9 93.95 7.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.499 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -113.73 9.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 23.4 t70 -78.95 -79.81 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.619 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 1.0 OUTLIER 62.48 88.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.779 -177.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 48.4 t-20 -85.81 98.04 10.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.4 ' HG2' ' CE2' ' A' ' 129' ' ' TYR . 44.1 mt-10 -68.0 -3.13 9.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 93.5 mttt -72.95 -33.02 65.64 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.126 0.489 . . . . 0.0 110.489 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.6 t -128.13 -15.96 4.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.542 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 26.26 45.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.375 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.35 138.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 25.0 m95 -85.09 105.02 15.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.99 -67.75 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 17.9 tppt? -65.25 117.03 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.411 0.624 . . . . 0.0 110.173 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -124.15 106.22 10.15 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.691 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 30.4 tttp -86.22 132.98 33.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.628 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.84 123.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.774 0.797 . . . . 0.0 110.607 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 89.4 m-85 -110.56 107.11 16.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.632 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 60.3 t -91.74 98.68 8.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.43 0.633 . . . . 0.0 109.534 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -97.5 97.58 9.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.813 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 7.3 m -73.96 140.67 45.7 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.52 114.77 2.62 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.676 0.75 . . . . 0.0 110.235 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.647 HG11 ' HE3' ' A' ' 96' ' ' LYS . 7.7 p -101.73 125.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.927 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 148' ' ' LYS . 10.3 ptpt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.732 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 31.4 mttp . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 31.9 Cg_endo -64.48 115.29 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.291 1.994 . . . . 0.0 109.264 165.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.421 ' HA ' HD23 ' A' ' 52' ' ' LEU . 3.4 pt20 -124.62 143.64 50.61 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.398 0.618 . . . . 0.0 110.98 -172.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.626 HG23 ' HB2' ' A' ' 31' ' ' PRO . 9.6 mt -69.12 118.11 58.51 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.245 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.66 174.25 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.381 2.054 . . . . 0.0 111.721 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 36.4 mmtm -92.07 36.83 0.98 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.694 0.759 . . . . 0.0 109.997 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 13' ' ' LYS . 9.9 t70 -127.2 105.69 8.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.454 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.659 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 32.0 mttp -73.92 -6.86 49.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.324 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.0 t -95.57 -19.56 19.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.995 0.426 . . . . 0.0 110.265 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HG3' ' CG ' ' A' ' 10' ' ' ASP . 56.6 mttp -81.82 176.19 9.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.7 p -112.63 136.63 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.07 -31.29 14.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.372 0.606 . . . . 0.0 110.21 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.15 158.5 31.48 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.093 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -102.87 138.49 39.69 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.872 0.336 . . . . 0.0 110.122 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 84' ' ' VAL . 9.3 tp -104.03 120.25 53.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 36.8 mt-10 -128.07 112.06 14.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.548 0.689 . . . . 0.0 110.911 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.597 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 43.6 mt -120.91 95.49 48.91 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.446 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.35 -27.07 71.29 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 123.244 2.629 . . . . 0.0 112.402 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 35.2 t70 -67.3 -32.09 72.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.252 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -109.86 5.02 22.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.914 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t0 63.54 22.37 13.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.81 0.814 . . . . 0.0 110.71 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.597 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 59.4 mt -79.32 113.48 18.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.291 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -150.69 98.25 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.962 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.683 ' OE2' ' HA ' ' A' ' 70' ' ' TYR . 2.4 mt-10 -169.29 164.47 6.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 O-C-N 123.16 0.287 . . . . 0.0 110.989 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HB3' HG21 ' A' ' 14' ' ' VAL . 21.6 Cg_exo -66.58 148.91 84.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.1 2.534 . . . . 0.0 112.99 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.15 121.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.308 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 44' ' ' SER . 50.6 m-85 -93.44 137.76 23.29 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.26 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -92.15 153.52 3.18 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.71 2.273 . . . . 0.0 113.077 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.11 -174.48 25.15 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.861 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.659 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 94.7 Cg_endo -79.98 8.97 3.76 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.574 2.849 . . . . 0.0 113.142 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 61.71 68.82 0.68 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.614 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 33' ' ' PRO . 37.6 p -92.07 161.15 34.03 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.173 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -30.66 26.2 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.086 2.524 . . . . 0.0 112.589 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.43 -43.78 93.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.152 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.504 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 39.0 mm-40 -82.16 -40.14 22.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.259 -170.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.2 mm? -70.73 -7.73 46.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.36 0.6 . . . . 0.0 110.577 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -22.75 23.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.487 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 38' ' ' GLN . 7.0 ptm85 -105.14 -13.8 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.221 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . 162.84 -157.18 29.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.386 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 72' ' ' PHE . 70.2 t -95.44 135.88 28.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.924 0.392 . . . . 0.0 110.05 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.1 m -124.65 170.34 11.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HD1' ' HA ' ' A' ' 31' ' ' PRO . 26.8 m-85 -68.66 161.9 27.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.223 174.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.12 -27.87 21.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.577 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 2.2 mm-40 -117.83 145.04 44.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.516 0.674 . . . . 0.0 112.344 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.98 -6.98 59.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -90.27 -5.2 56.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.833 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.554 ' HB3' HD13 ' A' ' 7' ' ' ILE . 2.2 tp10 -48.8 139.44 9.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -143.65 132.42 22.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.68 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.434 HD21 HG13 ' A' ' 7' ' ' ILE . 2.6 mm? -75.98 -11.51 59.97 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.029 0.442 . . . . 0.0 110.813 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -89.17 -9.79 49.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.422 0.63 . . . . 0.0 110.218 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -89.14 170.71 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.495 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.554 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 4.7 pt20 -104.13 -0.87 28.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.74 0.305 . . . . 0.0 111.016 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.88 115.65 16.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.43 0.633 . . . . 0.0 109.92 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.21 129.27 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.275 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -108.11 120.78 43.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.344 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.5 mt -111.53 115.77 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.74 116.49 30.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 110.871 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' HA2' HG13 ' A' ' 43' ' ' VAL . . . -110.77 159.99 13.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.929 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -154.76 131.19 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 2.4 m -65.56 113.01 3.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 41.4 t80 -90.22 128.3 36.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.3 mt -58.97 -37.75 69.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.228 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.465 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 9.3 m-20 -91.95 8.28 38.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.908 0.385 . . . . 0.0 111.372 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 34.2 mtt180 -121.4 97.2 47.4 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.776 0.322 . . . . 0.0 110.985 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.17 -8.35 20.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.614 2.209 . . . . 0.0 111.694 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -154.26 82.3 1.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.683 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.3 p90 -118.37 -164.2 1.01 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.171 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 27' ' ' GLU . 24.6 mp0 -48.96 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.297 0.373 . . . . 0.0 111.765 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.521 ' CE2' HG11 ' A' ' 43' ' ' VAL . 18.8 m-85 -103.21 68.48 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.694 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -92.6 -42.17 9.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.338 0.589 . . . . 0.0 110.355 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.7 t30 -114.24 33.31 5.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.42 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -59.2 -27.21 65.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -177.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -9.92 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.78 -4.74 58.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.124 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.539 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -72.18 -174.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 5.9 ptpp? -167.02 -179.0 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.979 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.6 ptpt -53.99 -48.76 70.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.139 -176.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.5 54.99 0.57 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.438 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -73.64 -11.59 60.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.327 -0.436 . . . . 0.0 111.203 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 54.36 83.84 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.433 0.635 . . . . 0.0 111.801 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.5 t -85.41 111.42 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.827 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -99.8 113.67 26.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.519 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 2.1 t80 -102.4 108.21 19.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.593 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.43 92.68 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.974 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 91' ' ' GLU . 4.8 m -104.71 117.56 50.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.44 -83.16 0.2 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.572 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -152.74 12.17 0.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.722 0.296 . . . . 0.0 110.823 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.422 ' CG ' HG23 ' A' ' 88' ' ' VAL . 12.6 pt-20 -109.43 140.11 43.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.059 0.456 . . . . 0.0 110.291 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.6 m -100.62 109.71 21.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 16.5 mmt85 -88.7 142.03 28.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.54 173.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -118.67 130.73 56.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.9 0.381 . . . . 0.0 110.542 177.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 81.3 m-85 -127.83 143.85 51.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -107.07 137.32 45.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.743 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.0 mmt -83.87 81.95 8.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 110.14 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -92.2 -36.7 13.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.63 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.61 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 6.9 m -109.26 97.04 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 97' ' ' MET . 75.9 mt -117.68 117.16 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.896 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -168.99 -159.81 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 112.068 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -109.89 153.32 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.818 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 139' ' ' ARG . 10.6 m -135.38 166.48 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 167.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 106' ' ' THR . 0.0 OUTLIER -147.62 161.21 36.38 Favored Pre-proline 0 C--O 1.22 -0.45 0 O-C-N 122.334 -0.229 . . . . 0.0 111.32 -169.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 34.8 Cg_endo -65.08 11.75 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.717 2.278 . . . . 0.0 113.05 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.456 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.7 t -129.8 8.79 5.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.599 ' OD2' ' HB ' ' A' ' 103' ' ' VAL . 1.1 p30 -84.2 158.23 21.37 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 111' ' ' LEU . 29.1 m -112.58 18.73 7.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.198 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 -45.36 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.924 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.81 -11.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.654 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -106.39 12.3 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.703 0.287 . . . . 0.0 111.27 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.6 169.27 9.82 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.534 ' CG ' ' HE3' ' A' ' 115' ' ' LYS . 11.2 pt-20 -92.41 20.25 6.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 52.13 119.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.617 1.167 . . . . 0.0 113.724 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HE3' ' CG ' ' A' ' 113' ' ' GLU . 18.9 mmtp -109.48 147.31 33.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.586 -171.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.92 34.27 11.13 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.896 -1.502 . . . . 0.0 115.23 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -122.59 161.89 22.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.837 0.818 . . . . 0.0 112.016 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -93.98 -158.14 0.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -62.09 110.04 1.47 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -116.67 138.81 51.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.26 0.552 . . . . 0.0 112.124 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 121' ' ' LEU . 22.4 mt -97.73 112.26 24.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 169.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.42 HG23 HG22 ' A' ' 143' ' ' VAL . 13.3 m -96.26 103.85 15.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.287 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.7 mt -91.11 106.03 18.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.79 100.01 9.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 6.9 m -91.0 107.09 18.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.138 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.8 m -103.89 86.12 2.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -111.18 -2.15 15.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.574 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 36.4 t70 -104.8 94.37 5.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.488 0.661 . . . . 0.0 109.899 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 92.0 t80 -101.01 124.05 46.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.188 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -91.37 110.28 21.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.438 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.7 mt-10 -72.39 -21.65 61.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.847 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -72.51 -24.57 61.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.456 HG23 HG12 ' A' ' 135' ' ' VAL . 9.6 t -136.62 4.01 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.304 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.53 48.79 79.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.17 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 133' ' ' THR . 4.4 p -137.77 159.22 34.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.543 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 37.6 m95 -100.64 112.74 25.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 55.8 mt-10 -80.88 -60.02 2.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.932 0.396 . . . . 0.0 111.04 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 47.4 mmtm -88.94 101.52 14.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.177 0.513 . . . . 0.0 110.262 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -100.63 105.52 16.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 18.7 tptm -76.63 120.62 22.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.6 tt -118.98 122.55 69.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 122.037 0.922 . . . . 0.0 111.66 -172.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 24.5 m-85 -116.95 106.75 13.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.135 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.0 t -100.76 103.98 15.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.234 0.54 . . . . 0.0 110.259 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.494 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.995 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.7 m -93.59 138.81 31.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -57.83 125.03 21.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.042 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.519 HG21 ' HD3' ' A' ' 96' ' ' LYS . 2.7 t -85.75 146.38 6.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.775 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.68 179.024 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.51 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 36.9 Cg_endo -63.09 106.64 0.56 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.15 2.567 . . . . 0.0 112.878 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -120.64 137.9 54.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.776 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 52' ' ' LEU . 4.1 mp -76.5 125.24 87.71 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.71 153.51 54.0 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.116 1.877 . . . . 0.0 110.369 170.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -86.39 14.11 7.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.476 0.655 . . . . 0.0 111.215 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 27.4 t0 -100.71 102.43 13.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.549 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 24.5 pttm -81.27 0.13 38.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.446 -172.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.2 m -90.32 3.91 52.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 87.5 mttt -103.83 -176.53 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.348 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.79 129.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.049 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.45 -29.93 17.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.78 36.57 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.56 143.32 34.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 117.128 0.464 . . . . 0.0 109.758 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.545 0.688 . . . . 0.0 110.265 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 38.4 mt-10 -115.78 116.54 28.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.922 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.591 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 46.0 mt -133.87 91.62 24.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.52 -34.51 92.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.951 2.434 . . . . 0.0 111.871 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.77 -25.62 68.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.292 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -114.83 11.37 16.68 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.011 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 58.41 29.67 18.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.773 0.797 . . . . 0.0 110.754 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.632 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 58.9 mt -98.37 118.49 44.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.232 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 5.5 mtmt -150.19 81.91 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.282 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.424 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 40.9 mt-10 -149.21 162.47 28.84 Favored Pre-proline 0 N--CA 1.465 0.316 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 60.3 Cg_endo -72.43 148.16 48.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.072 2.515 . . . . 0.0 113.493 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.47 130.59 62.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.016 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 44' ' ' SER . 33.5 m-85 -97.11 137.96 21.25 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 73.0 Cg_endo -90.15 -172.31 0.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.962 2.441 . . . . 0.0 112.533 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.06 -174.27 16.83 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.453 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.84 12.39 3.02 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.926 3.084 . . . . 0.0 113.081 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.55 74.67 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.193 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.705 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -95.83 147.44 33.0 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.087 -176.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.705 ' HD2' HG22 ' A' ' 35' ' ' THR . 81.6 Cg_exo -40.65 -66.83 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.751 2.967 . . . . 0.0 114.46 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -26.63 55.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.762 0.315 . . . . 0.0 111.663 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.549 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 24.8 tp60 -66.54 -37.89 85.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.118 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.6 tp -74.3 -38.7 63.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.772 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -67.93 -9.8 48.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.19 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.59 -28.48 62.82 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 110.415 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.29 -88.7 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.257 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.443 HG12 ' HA3' ' A' ' 61' ' ' GLY . 34.0 m -137.02 157.84 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 21.9 p -150.72 156.07 40.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.013 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 21.2 m-85 -70.18 155.13 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.784 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.09 73.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.302 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -152.24 177.7 10.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.434 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.59 -28.2 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 -172.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -76.87 -11.06 59.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.083 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 50' ' ' GLU . 5.1 tp10 -61.24 126.26 26.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.747 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 23.5 m -112.39 138.24 49.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.791 0.329 . . . . 0.0 111.441 -173.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.661 ' HG ' HD11 ' A' ' 7' ' ' ILE . 77.6 mt -67.96 -25.52 65.48 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.57 17.47 23.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.464 0.65 . . . . 0.0 110.355 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -88.96 -177.21 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.464 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -16.93 58.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.197 0.522 . . . . 0.0 110.08 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.94 142.61 29.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.18 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.3 mp -129.07 105.29 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.727 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.562 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 4.5 m -89.94 113.1 24.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.464 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 ' CE1' ' A' ' 45' ' ' PHE . 57.0 mt -107.13 111.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.991 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -96.52 121.93 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.443 ' HA3' HG12 ' A' ' 43' ' ' VAL . . . -121.11 161.22 15.22 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.359 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -123.18 130.32 52.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.608 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 12.0 m -71.15 136.95 48.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.138 -177.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.16 136.63 37.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.328 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.1 mt -90.99 -46.77 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.114 0.483 . . . . 0.0 110.21 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.455 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 17.7 t70 -75.18 -39.69 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.399 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -92.34 109.04 35.44 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.92 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 94.1 Cg_endo -83.93 -0.35 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.878 2.385 . . . . 0.0 111.476 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -129.96 71.73 1.46 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.977 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.608 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 10.4 p90 -119.38 -175.41 2.93 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 1.4 mp0 -48.82 -66.69 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -173.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CZ ' HD22 ' A' ' 123' ' ' LEU . 23.1 m-30 -103.1 31.59 4.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -170.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -49.97 74.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.268 0.556 . . . . 0.0 111.429 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 67.0 t30 -102.51 25.52 8.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.231 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.11 -19.01 64.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.209 0.528 . . . . 0.0 110.901 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -68.87 -20.47 64.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.515 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.52 9.24 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.108 0.48 . . . . 0.0 110.308 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . . . -89.3 122.71 32.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.066 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 6.3 mmmm -101.58 -164.41 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.283 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -68.5 -21.94 64.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.22 50.88 0.87 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.574 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -70.3 -7.62 43.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.8 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 87.1 mmm 44.66 88.38 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.665 0.745 . . . . 0.0 112.029 -170.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -85.58 124.55 40.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.2 m-85 -109.13 112.99 25.46 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.27 109.56 21.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 5.3 tptp -91.28 85.51 5.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.706 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.652 ' O ' ' HG2' ' A' ' 91' ' ' GLU . 11.1 m -111.54 131.04 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.877 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 90' ' ' ASN . . . 59.14 22.1 54.77 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.035 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 29.3 m-80 73.53 14.48 4.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.479 0.711 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 6.2 pt-20 -97.14 179.4 4.93 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -135.28 117.62 15.66 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 94.5 mtt180 -116.01 133.42 56.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -101.35 131.27 47.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.293 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 84.2 m-85 -130.76 146.67 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.869 -178.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.8 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.55 132.42 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 21.2 mmt -75.53 68.15 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 110.226 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -84.46 -9.58 58.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.431 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 67.4 m -136.84 93.97 2.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.36 0.6 . . . . 0.0 111.183 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.16 118.21 56.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.562 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.9 ptt180 -149.35 165.19 32.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.244 0.545 . . . . 0.0 111.683 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.02 109.12 15.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.933 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.658 HG21 HG11 ' A' ' 110' ' ' VAL . 19.4 m -108.24 168.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.49 0.662 . . . . 0.0 111.683 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HD3' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -138.52 170.38 10.42 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.934 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.77 -26.81 58.77 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.065 1.843 . . . . 0.0 110.175 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -72.64 -12.42 61.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.878 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -91.67 128.8 37.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HA ' HD11 ' A' ' 111' ' ' LEU . 17.5 m -113.28 26.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.805 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -109.2 -9.87 15.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.684 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.658 HG11 HG21 ' A' ' 103' ' ' VAL . 15.9 m -91.62 -8.74 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -112.58 9.94 19.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.666 0.746 . . . . 0.0 109.381 175.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -89.2 160.81 16.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.298 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -50.45 125.93 13.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.489 . . . . 0.0 111.635 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -75.65 129.31 36.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.6 mptt -69.69 157.77 36.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.932 -172.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.04 56.81 1.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.441 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -79.26 -174.35 4.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.023 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.09 -163.78 0.84 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.27 121.63 11.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.92 135.07 54.36 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.158 0.504 . . . . 0.0 110.801 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -92.73 113.98 26.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.536 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.7 m -94.41 92.23 7.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.901 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 27.5 mt -83.47 104.56 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 110.044 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 60' ' ' ALA . 24.3 mt -94.52 101.04 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.074 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -97.11 96.4 8.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.082 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.482 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 62.5 m -96.01 89.25 5.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.93 -14.11 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.17 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.516 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 21.1 t70 -110.6 94.77 5.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.561 0.696 . . . . 0.0 109.832 -176.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 134' ' ' GLY . 94.1 t80 -107.55 124.5 50.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.485 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -90.88 101.96 14.72 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.22 -5.38 17.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.429 -174.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -38.76 68.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.874 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 135' ' ' VAL . 6.9 t -149.81 -26.48 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 129' ' ' TYR . . . 120.83 36.8 0.75 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.824 -1.179 . . . . 0.0 112.858 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.532 HG23 HG23 ' A' ' 133' ' ' THR . 93.0 t -104.39 124.05 58.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CE3' ' HB3' ' A' ' 126' ' ' CYS . 33.3 m95 -84.86 93.31 8.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.516 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 16.2 mm-40 -60.22 -68.26 0.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.863 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -91.76 103.86 16.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 -177.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.46 ' O ' HG22 ' A' ' 103' ' ' VAL . 84.1 mtm180 -105.44 95.65 5.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.925 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.836 ' HD3' ' HE1' ' A' ' 142' ' ' PHE . 2.4 ttmp? -74.54 130.39 39.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.959 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.562 ' CG2' ' HG3' ' A' ' 101' ' ' ARG . 12.8 tt -123.44 120.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.932 0.872 . . . . 0.0 111.025 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.836 ' HE1' ' HD3' ' A' ' 140' ' ' LYS . 8.4 m-85 -106.33 104.07 13.69 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.522 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 61.9 t -98.72 109.61 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.485 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.545 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.7 103.34 12.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.524 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -83.85 142.62 30.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.684 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -55.73 133.1 50.65 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.251 -175.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 7.3 p -111.85 160.91 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.259 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 147' ' ' VAL . 21.9 mmmt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.776 -0.63 . . . . 0.0 110.008 -177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 56.5 mtpt . . . . . 0 C--O 1.236 0.353 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 32.5 Cg_endo -62.71 125.19 15.53 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.695 2.263 . . . . 0.0 112.145 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -147.24 162.2 39.4 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' CD1' ' HG ' ' A' ' 52' ' ' LEU . 3.4 mp -86.78 127.47 59.98 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 0.0 110.486 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.44 -178.76 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.75 2.3 . . . . 0.0 112.666 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.711 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.4 103.8 7.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.46 -174.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.575 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 36.1 mtmm -88.7 13.38 12.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.623 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.8 t -98.26 -11.79 22.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.744 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -105.03 178.18 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 -178.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.99 131.55 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.66 16.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.235 0.541 . . . . 0.0 110.443 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.91 38.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 90.9 m-85 -112.62 138.47 49.36 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.392 0.596 . . . . 0.0 110.858 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.5 tp -106.78 105.17 18.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 122.167 0.984 . . . . 0.0 109.814 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -111.96 113.5 25.84 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.965 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.3 mt -125.61 95.94 39.41 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.788 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.66 -28.78 77.05 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.796 2.331 . . . . 0.0 111.688 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.469 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 27.4 t0 -71.27 -22.24 61.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.039 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.76 5.29 17.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.936 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.8 t70 64.62 24.24 12.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.455 0.645 . . . . 0.0 110.535 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.5 mt -96.23 126.29 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.928 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.4 mppt? -138.77 43.77 2.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 15.9 mm-40 -98.58 154.09 37.66 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.0 Cg_exo -78.5 145.0 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.269 2.646 . . . . 0.0 112.083 175.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.68 115.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -97.29 116.69 65.99 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.881 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 30.1 Cg_endo -63.37 140.67 77.86 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.416 2.077 . . . . 0.0 111.744 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.38 -179.47 41.41 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.356 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.575 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 12.9 Cg_endo -91.82 29.02 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.774 2.983 . . . . 0.0 112.439 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 58.47 50.0 9.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.557 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 p -68.43 150.6 97.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.93 -55.05 4.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.211 2.607 . . . . 0.0 113.099 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.89 -27.06 67.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.377 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -65.97 -46.05 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.327 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -78.53 -4.32 48.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.391 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.58 -18.82 16.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.141 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -102.08 -26.07 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 110.813 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -171.18 35.4 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.08 148.07 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.08 0.44 . . . . 0.0 110.005 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -137.04 -171.95 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 110.693 -174.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 33.3 m-85 -94.94 169.72 9.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.13 84.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 110.436 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -141.82 170.43 15.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.561 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.57 -7.61 54.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.398 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.75 13.54 30.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.644 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 8.0 mm-40 -74.3 169.34 17.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.355 0.598 . . . . 0.0 111.578 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.3 m -138.37 139.9 39.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 96.2 mt -77.45 -13.44 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.632 -176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.77 14.89 23.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.715 0.769 . . . . 0.0 110.103 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HB3' HG12 ' A' ' 57' ' ' ILE . 11.3 t70 -69.29 171.68 8.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.962 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 120' ' ' GLN . 1.1 tm0? -95.62 -26.0 15.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.441 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.495 ' HA ' ' HG3' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -134.09 56.39 1.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.144 0.973 . . . . 0.0 111.106 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 54' ' ' ASP . 49.9 mt -62.1 127.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.105 -173.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -105.75 109.43 21.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.288 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.01 118.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.034 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.1 133.07 36.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.735 0.302 . . . . 0.0 111.002 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.12 163.91 26.96 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.162 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -139.56 158.77 43.57 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 73' ' ' THR . 21.5 p -102.78 158.58 16.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.899 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.626 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -134.57 135.39 42.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.12 -39.92 81.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.154 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.19 -4.31 52.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 51.1 mtt85 -132.72 90.58 32.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.247 0.546 . . . . 0.0 111.422 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.644 ' O ' ' HB ' ' A' ' 73' ' ' THR . 7.6 Cg_exo -73.64 -23.7 16.68 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.624 2.883 . . . . 0.0 113.244 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -124.64 27.1 6.99 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.626 ' CE2' ' HB2' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -92.18 -16.03 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.155 0.979 . . . . 0.0 109.075 177.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HB3' ' H ' ' A' ' 72' ' ' PHE . 2.2 mt-30 -164.21 -154.54 0.25 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.292 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CE2' HD13 ' A' ' 123' ' ' LEU . 19.6 m-85 -74.22 26.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 68' ' ' PRO . 21.7 m -60.26 -45.9 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.488 . . . . 0.0 111.028 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -96.43 12.62 30.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.181 0.515 . . . . 0.0 110.675 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.27 -12.6 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.224 0.535 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.28 -12.86 61.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.452 176.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -89.79 -4.6 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.676 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -75.21 149.64 38.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.234 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 2.6 mppt? -111.12 -169.37 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 174.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.5 ptmm? -76.43 -11.8 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.297 0.57 . . . . 0.0 111.289 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.19 62.18 0.64 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.906 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -81.06 -9.63 59.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 51.01 83.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.489 0.662 . . . . 0.0 111.82 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 80.8 t -85.57 128.8 38.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.939 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -113.57 107.51 15.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -97.54 115.12 27.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.855 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.8 mmtp -93.39 97.33 10.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.237 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.05 130.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.849 0.357 . . . . 0.0 110.547 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.83 30.24 74.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.994 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 68.35 4.49 4.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.313 0.645 . . . . 0.0 111.351 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -92.34 150.63 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.869 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.3 m -109.79 112.64 24.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.829 0.347 . . . . 0.0 110.332 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 146' ' ' GLU . 21.7 mmm180 -105.03 133.22 50.18 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 3.5 mptt -102.35 130.74 49.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 95.8 m-85 -123.35 144.01 49.73 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.793 0.33 . . . . 0.0 110.407 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.55 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -113.27 131.56 55.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.8 mmt -74.75 64.38 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.097 0.475 . . . . 0.0 110.663 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -80.22 -13.84 58.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.709 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.612 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.8 m -134.1 99.13 4.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.012 0.434 . . . . 0.0 110.258 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 97' ' ' MET . 70.0 mt -117.71 131.42 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.743 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.413 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 15.0 ptm180 -167.95 -175.29 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 171.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.93 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 8.6 p-10 -141.89 125.6 16.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' A' ' 139' ' ' ARG . 24.5 m -112.07 173.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.137 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.857 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -122.68 165.04 23.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.68 -16.08 46.17 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.498 2.132 . . . . 0.0 111.746 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 t -109.65 12.94 24.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.342 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.857 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 11.8 t70 -93.65 148.47 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 34.0 m -111.41 0.43 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -170.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.413 ' HG3' ' NH2' ' A' ' 101' ' ' ARG . 26.8 mm-40 -72.7 -12.79 61.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 110.689 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 103' ' ' VAL . 22.7 m -94.78 -8.93 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.163 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 4.2 pp -99.15 -9.57 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.758 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -82.67 161.5 22.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.89 128.15 34.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.351 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -85.83 133.97 33.95 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -69.53 160.63 31.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.199 0.523 . . . . 0.0 112.411 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.81 59.93 0.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.327 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.39 176.73 0.76 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.238 0.542 . . . . 0.0 111.016 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -78.76 -155.8 0.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -63.47 103.47 0.52 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.495 ' HG3' ' HA ' ' A' ' 56' ' ' ASN . 18.6 pt20 -101.4 116.6 33.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.33 0.586 . . . . 0.0 109.854 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 tp -84.41 100.91 11.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.2 m -88.95 100.37 13.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.5 mt -87.25 109.04 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.7 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.8 mt -97.84 104.7 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 22.1 m -95.27 97.37 9.81 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.036 0.446 . . . . 0.0 110.185 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 47.9 m -86.96 102.17 14.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.33 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.53 -170.24 3.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.172 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 31.1 t70 57.4 83.95 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.797 0.808 . . . . 0.0 110.637 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 80.8 t80 -94.65 124.52 38.74 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.081 -174.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -95.67 99.94 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.506 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.0 mt-10 -58.84 -39.92 82.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.819 -171.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -70.52 -14.06 62.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.635 HG23 HG22 ' A' ' 135' ' ' VAL . 2.1 t -130.98 -7.04 3.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.292 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.82 35.16 72.63 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.623 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 133' ' ' THR . 33.3 m -116.8 155.03 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 117.315 0.557 . . . . 0.0 111.147 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -96.6 100.28 11.86 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.24 -16.93 60.94 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 23.6 ttmm -124.91 86.62 2.58 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.081 0.943 . . . . 0.0 110.928 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.726 ' HG3' HG23 ' A' ' 103' ' ' VAL . 30.1 ptt180 -92.98 86.92 5.58 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.218 172.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.93 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 36.2 tttp -70.25 139.32 52.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.773 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.53 124.5 59.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.932 0.873 . . . . 0.0 111.144 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.585 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 27.4 m-85 -114.48 103.75 11.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.601 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 47.3 t -94.3 96.74 6.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.414 0.626 . . . . 0.0 109.804 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.548 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -93.05 105.91 17.94 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.06 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.7 m -81.35 140.44 34.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.096 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 93' ' ' ARG . 36.4 tt0 -61.27 132.31 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.406 0.622 . . . . 0.0 111.879 -175.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 2.2 t -104.61 170.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.687 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 147' ' ' VAL . 40.5 mtpt . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.829 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.601 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 77.8 Cg_exo -51.36 118.09 4.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.455 2.77 . . . . 0.0 113.258 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.14 168.01 25.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.339 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.557 HG23 ' HB3' ' A' ' 31' ' ' PRO . 3.9 mp -91.66 112.33 53.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.44 165.01 18.72 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.532 2.155 . . . . 0.0 111.818 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.647 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -95.97 1.29 52.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.359 0.599 . . . . 0.0 109.835 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.88 109.88 14.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.439 173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 22.7 mttm -84.66 62.31 7.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.051 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 -29.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.576 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 2.8 mmpt? -54.24 154.59 4.31 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.537 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.37 111.93 32.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 164.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -76.39 -38.23 56.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.62 165.84 32.63 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.511 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 64.5 m-85 -112.87 132.57 55.24 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -96.74 107.92 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.876 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -112.9 108.15 16.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.887 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG12 HG13 ' A' ' 84' ' ' VAL . 23.0 mt -125.4 95.4 41.06 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.233 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.39 -16.2 53.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.797 2.331 . . . . 0.0 112.319 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 38.9 t70 -83.63 -21.67 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.443 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.12 11.24 15.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.329 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.69 19.6 11.88 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.078 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 20' ' ' ILE . 74.2 mt -93.57 122.09 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.342 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -139.48 49.2 1.82 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.897 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 12.3 mm-40 -116.55 162.52 26.36 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.066 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 90.9 Cg_endo -83.34 164.19 14.8 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.903 2.402 . . . . 0.0 113.269 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.14 136.73 59.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.199 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.29 133.49 20.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.793 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 23.9 Cg_exo -67.76 134.17 31.72 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.186 2.591 . . . . 0.0 111.808 168.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.13 144.08 4.1 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.029 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 60.3 Cg_endo -73.96 54.44 3.12 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.297 2.665 . . . . 0.0 112.241 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 58.25 42.39 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.776 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -69.12 127.01 93.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.251 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 65.1 Cg_exo -52.53 -39.64 74.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.289 2.659 . . . . 0.0 113.299 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.43 -12.52 61.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -101.21 -29.51 12.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.79 -18.24 48.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.123 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -81.96 -15.41 53.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.025 0.44 . . . . 0.0 110.379 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -114.01 -25.02 8.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.875 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.46 -138.05 2.35 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.635 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 72' ' ' PHE . 52.4 t -121.18 138.83 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.815 0.341 . . . . 0.0 110.649 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 t -119.52 169.3 10.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.917 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.793 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 54.7 m-85 -71.84 173.01 8.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.779 0.323 . . . . 0.0 110.361 173.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.14 -61.07 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.517 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.48 115.74 18.63 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 68.32 0.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.742 1.276 . . . . 0.0 111.092 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -146.07 2.6 0.9 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.268 171.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -76.66 160.52 29.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.146 -175.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 41.5 m -141.86 159.45 42.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.506 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' A' ' 7' ' ' ILE . 96.5 mt -85.76 -17.11 36.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.406 0.622 . . . . 0.0 109.895 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -86.25 -1.98 57.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.213 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 21.4 t0 -89.57 157.91 17.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.54 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.72 -25.51 26.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.963 0.411 . . . . 0.0 110.292 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.94 115.0 26.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.486 0.66 . . . . 0.0 111.657 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.81 127.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 m -121.95 120.52 34.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.56 126.69 68.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.4 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -94.63 104.48 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.017 0.437 . . . . 0.0 110.68 -176.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' HG13 ' A' ' 43' ' ' VAL . . . -101.53 166.75 18.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.462 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -155.94 -179.6 8.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 p -117.8 166.98 11.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.303 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 5.1 m-85 -124.16 144.52 49.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.221 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.68 -32.06 28.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.193 0.52 . . . . 0.0 111.206 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -96.97 -6.03 36.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.75 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 10.5 mmt180 -112.8 95.43 33.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.24 -8.36 19.72 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.397 2.065 . . . . 0.0 111.58 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -153.41 83.66 1.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.092 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CE2' ' HB ' ' A' ' 73' ' ' THR . 4.7 p90 -142.7 -170.16 3.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.897 ' HG2' ' HB3' ' A' ' 27' ' ' GLU . 77.5 mt-30 -32.81 -69.78 0.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.251 1.02 . . . . 0.0 113.621 -175.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 43' ' ' VAL . 4.9 m-30 -124.13 111.87 16.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.453 ' HB ' ' CE2' ' A' ' 70' ' ' TYR . 14.9 t -164.59 -40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.379 0.609 . . . . 0.0 110.236 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -96.75 21.08 9.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.712 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.9 tp -65.98 -18.79 65.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -8.71 56.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.893 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.27 -10.64 51.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.94 0.4 . . . . 0.0 110.704 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.537 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -73.29 156.18 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.109 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 97' ' ' MET . 32.8 mttp -129.79 -179.79 5.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.434 -176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -61.71 -28.84 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.114 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.21 42.85 1.72 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.466 -0.873 . . . . 0.0 110.993 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.516 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.9 t -57.25 -22.04 38.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.313 0.645 . . . . 0.0 112.048 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.23 87.13 0.06 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.747 0.784 . . . . 0.0 111.49 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.2 t -90.1 136.58 23.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.035 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.8 107.27 14.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.101 0.477 . . . . 0.0 109.926 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -94.7 105.3 17.23 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppp? -84.03 106.65 15.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.604 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 10.6 m -125.4 112.43 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 0.0 111.481 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.08 -94.71 0.18 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.838 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -129.94 8.31 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 110.238 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.87 138.56 40.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.427 ' OG1' ' HE2' ' A' ' 87' ' ' LYS . 43.7 m -107.25 93.19 4.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.578 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 146' ' ' GLU . 12.8 mmt180 -83.07 118.28 23.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.015 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.644 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 3.4 mptt -91.82 132.58 36.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 96.1 m-85 -124.7 144.81 50.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.099 0.476 . . . . 0.0 110.961 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.1 OUTLIER -113.52 128.05 56.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.061 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.632 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.1 mmt -78.7 60.43 2.75 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -77.05 -23.71 52.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.441 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.579 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 71.1 m -121.02 102.05 8.08 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 110.874 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.82 121.86 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.524 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -142.71 -172.35 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.471 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.96 141.14 46.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 139' ' ' ARG . 20.8 m -124.14 167.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.045 0.45 . . . . 0.0 111.003 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.959 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.13 163.09 53.68 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.281 -171.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 137' ' ' GLU . 60.2 Cg_endo -72.33 20.94 0.29 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.434 2.089 . . . . 0.0 112.124 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.9 t -156.47 8.87 0.22 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.959 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 2.3 p30 -78.98 176.92 9.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.157 0.503 . . . . 0.0 111.206 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.521 ' HA ' HD11 ' A' ' 111' ' ' LEU . 23.1 m -123.69 24.31 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.235 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.22 5.11 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.82 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.7 m -108.56 -13.95 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.974 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -108.06 1.85 22.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -89.94 174.33 7.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.19 107.3 8.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.608 ' HB3' HE22 ' A' ' 120' ' ' GLN . 56.0 mm-40 -81.83 69.37 8.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.649 0.738 . . . . 0.0 110.564 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -115.04 -165.6 1.04 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.468 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.49 -26.26 24.77 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.275 -0.488 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -125.13 -173.2 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -153.85 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 17.1 mmtm -54.56 123.1 12.07 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.608 HE22 ' HB3' ' A' ' 114' ' ' GLN . 12.6 pt20 -117.29 120.09 37.16 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 121' ' ' LEU . 28.1 mt -78.18 99.19 6.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.6 m -85.78 96.9 9.89 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.71 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 26.5 mt -94.92 101.37 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.943 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.36 93.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.0 m -93.9 111.27 22.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.144 0.497 . . . . 0.0 110.138 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 58.2 m -95.45 109.5 21.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -136.94 89.22 2.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.994 0.902 . . . . 0.0 110.594 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 9.1 p-10 -153.9 -51.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.194 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.5 83.52 0.1 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.023 0.827 . . . . 0.0 110.772 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 38.4 t-20 -77.84 94.13 4.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.25 -20.76 63.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.144 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 30.6 mmmt -63.3 -30.47 71.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.492 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 135' ' ' VAL . 4.9 t -129.68 -23.77 2.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 60.75 1.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.6 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 133' ' ' THR . 9.5 p -159.05 159.67 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -99.05 110.75 23.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 41.8 mt-10 -90.9 -59.83 2.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.709 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 53.2 mmtt -80.81 102.26 9.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.885 0.85 . . . . 0.0 110.987 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.549 ' HB2' HG23 ' A' ' 103' ' ' VAL . 74.1 mtt180 -114.11 102.07 9.82 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.598 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -83.2 122.29 28.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 5.0 tt -118.92 125.36 74.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.59 -172.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.632 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.2 m-85 -109.15 124.54 50.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.534 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.7 t -110.97 109.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.085 0.469 . . . . 0.0 110.318 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.62 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -107.65 120.03 41.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.351 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.6 m -89.86 143.1 27.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.122 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.496 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 31.9 tt0 -61.59 128.59 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.321 0.582 . . . . 0.0 111.239 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 148' ' ' LYS . 2.3 t -110.92 170.14 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.422 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.48 ' H ' HG12 ' A' ' 147' ' ' VAL . 37.1 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.263 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.1 mtmt . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.878 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 19.0 Cg_endo -58.38 124.12 15.13 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.975 2.45 . . . . 0.0 111.234 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -151.98 175.31 12.64 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.623 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.527 HG23 ' CB ' ' A' ' 31' ' ' PRO . 53.4 mt -113.12 95.23 33.98 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.212 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 23.9 Cg_exo -65.14 164.37 25.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.289 2.659 . . . . 0.0 113.565 -174.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -65.3 -34.1 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.779 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.09 129.44 34.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.368 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -96.88 6.1 49.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.088 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.4 m -101.12 8.45 42.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 65.8 mttm -107.84 175.9 5.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.83 120.49 59.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.614 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.92 -29.37 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.548 . . . . 0.0 110.913 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.99 168.95 42.1 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.238 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 80.0 m-85 -118.05 131.16 56.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -100.63 115.41 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.662 0.744 . . . . 0.0 110.003 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 47.7 mt-10 -123.63 112.39 17.36 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.83 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 25' ' ' ILE . 46.3 mt -126.27 94.78 40.26 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.903 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.75 -33.28 96.59 Favored 'Trans proline' 0 CA--C 1.518 -0.314 0 C-N-CA 122.77 2.313 . . . . 0.0 111.505 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.28 -34.45 70.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.37 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -112.35 10.35 19.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.49 30.58 15.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.858 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 20' ' ' ILE . 63.1 mt -86.86 133.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -156.14 57.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.14 0.495 . . . . 0.0 109.745 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -117.81 153.81 50.95 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.656 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -80.16 138.67 12.89 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.818 2.345 . . . . 0.0 112.635 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.93 131.38 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 110.316 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.3 m-85 -101.41 129.22 27.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.795 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 58.8 Cg_endo -71.5 149.81 56.55 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.887 2.391 . . . . 0.0 112.161 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.18 177.89 25.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.047 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 84.4 Cg_endo -84.63 29.95 0.53 Allowed 'Trans proline' 0 CA--C 1.52 -0.199 0 C-N-CA 123.813 3.009 . . . . 0.0 112.671 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . 60.8 56.34 2.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.042 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.52 HG23 ' HG2' ' A' ' 33' ' ' PRO . 1.4 p -76.55 138.22 67.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.67 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -38.47 -66.34 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.49 3.46 . . . . 0.0 114.655 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.59 -35.49 81.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -68.83 -34.4 75.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.731 -174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 pp -87.4 -0.43 56.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.44 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -98.67 -31.57 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.114 175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -70.51 -29.99 66.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.4 -97.48 0.16 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.031 ' HB ' ' HG3' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -170.28 153.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 8.4 t -133.37 176.19 8.74 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.362 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 73.5 m-85 -89.16 173.62 8.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.96 85.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.767 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.5 mt-10 -134.21 167.41 20.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.153 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 1.4 tm-20 -72.97 -40.08 65.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.141 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -80.49 11.11 3.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.117 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -62.34 146.58 50.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.932 176.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.3 m -141.81 133.27 26.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 111.775 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.25 -2.87 36.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.748 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.03 -13.47 53.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.686 0.755 . . . . 0.0 109.487 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.26 -168.82 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.59 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.69 0.94 9.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.602 0.239 . . . . 0.0 110.452 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -113.16 49.69 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.03 118.27 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.305 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' HD11 ' A' ' 124' ' ' ILE . 15.5 m -120.36 124.87 46.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.559 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.2 mt -108.92 136.26 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.38 113.37 26.92 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.942 0.151 . . . . 0.0 110.8 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -105.76 148.21 16.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.678 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -117.16 107.57 14.63 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.173 0.189 . . . . 0.0 110.622 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -65.18 126.63 28.73 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 8.3 t80 -130.97 152.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.65 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.3 mt -90.6 -43.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 4.4 m-20 -76.39 -1.58 27.63 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -122.92 115.58 29.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.67 0.271 . . . . 0.0 110.561 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -90.34 0.57 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.746 2.297 . . . . 0.0 112.032 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -141.74 79.21 1.67 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.564 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.55 -166.62 2.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.364 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 1.031 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 68.8 mm-40 -47.29 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -101.27 28.47 5.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -40.13 85.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.354 0.597 . . . . 0.0 111.053 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.55 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 67.0 t30 -111.07 22.99 14.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.25 -5.53 23.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.135 0.493 . . . . 0.0 110.998 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.55 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -75.37 -8.23 56.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 110.683 176.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.77 6.57 45.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.347 0.594 . . . . 0.0 110.48 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.95 152.53 21.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.503 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 -171.5 3.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -51.96 -22.05 3.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.96 44.83 1.12 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 119.578 -1.296 . . . . 0.0 113.337 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -67.88 142.2 56.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.647 ' HE1' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -91.19 89.85 7.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.101 176.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 57.2 t -85.95 107.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.493 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -100.52 118.85 37.56 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -110.51 104.16 12.86 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 1.4 mptm? -81.18 123.1 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.751 -177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.878 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 6.6 m -136.95 116.53 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.167 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.05 -95.58 0.2 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.454 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -120.85 -3.41 9.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.537 0.208 . . . . 0.0 110.897 -177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.42 178.95 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.957 -173.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -142.4 141.55 32.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 146' ' ' GLU . 18.3 mmm180 -108.53 132.65 53.62 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.647 ' HD3' ' HE1' ' A' ' 83' ' ' MET . 12.1 ptpt -99.3 135.62 40.44 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 86.4 m-85 -122.03 144.36 48.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.703 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.2 tptm -110.04 126.07 53.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.049 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.486 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 59.6 mtt -82.07 80.73 8.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.428 0.633 . . . . 0.0 110.588 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 98' ' ' THR . 2.0 t -89.25 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.153 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.0 t -144.83 129.17 17.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -141.19 125.47 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.181 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -170.74 -176.62 2.1 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.048 0.218 . . . . 0.0 110.832 172.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.731 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 2.9 p30 -130.24 138.88 50.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.417 . . . . 0.0 110.435 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.8 -179.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.93 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -93.19 154.19 41.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HD3' ' A' ' 139' ' ' ARG . 61.0 Cg_endo -72.09 -18.42 27.36 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.317 2.011 . . . . 0.0 111.736 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.7 t -106.63 15.74 25.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.85 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.415 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 6.0 t0 -72.58 162.05 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.517 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 -7.25 10.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.71 -29.53 64.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.629 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.22 -9.31 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.915 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 94.1 mt -90.98 10.29 27.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.2 -176.11 3.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.94 132.16 50.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.35 0.595 . . . . 0.0 111.298 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -82.78 120.97 26.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.616 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -84.19 -152.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.693 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.34 55.62 1.16 Allowed Glycine 0 C--N 1.336 0.583 0 O-C-N 123.267 0.354 . . . . 0.0 113.593 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -83.59 147.43 27.74 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -87.36 -157.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -67.06 103.67 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.842 0.353 . . . . 0.0 110.418 -178.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 2.8 pt20 -104.56 136.37 44.24 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.394 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.75 105.8 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.5 m -85.33 100.86 12.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.729 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.6 mt -83.64 99.39 10.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 58' ' ' SER . 18.9 mt -91.54 97.22 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 17.4 m -106.9 121.94 45.42 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.804 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 94.2 m -73.54 96.16 2.38 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.201 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 6.4 t70 -110.53 98.36 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.887 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -178.59 -82.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.51 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.63 ' CE1' ' HG2' ' A' ' 131' ' ' GLU . 1.2 t80 58.58 77.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.016 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -83.25 86.28 7.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.269 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.63 ' HG2' ' CE1' ' A' ' 129' ' ' TYR . 27.8 mt-10 -58.79 -22.95 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.764 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -64.83 -27.53 68.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.485 HG23 HG12 ' A' ' 135' ' ' VAL . 4.8 t -121.66 -17.5 7.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.84 0.352 . . . . 0.0 110.445 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 48.64 5.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.239 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.485 HG12 HG23 ' A' ' 133' ' ' THR . 4.0 p -146.14 158.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 46.5 m95 -105.34 98.69 8.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.65 -58.51 3.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -85.3 137.12 33.18 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.459 0.647 . . . . 0.0 112.316 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HD3' ' HD3' ' A' ' 105' ' ' PRO . 6.5 mpt_? -100.12 111.03 23.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.76 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -79.03 117.86 20.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.0 tt -120.48 123.48 70.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.913 0.863 . . . . 0.0 111.052 -174.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 11.5 m-85 -108.14 114.65 28.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.048 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 40.2 t -93.95 99.62 9.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.302 0.572 . . . . 0.0 110.02 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -103.83 109.34 21.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.291 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 5.7 m -93.53 143.56 26.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.468 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 93' ' ' ARG . 34.0 tt0 -54.01 124.02 14.3 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.685 0.615 . . . . 0.0 111.303 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.525 HG11 ' HD3' ' A' ' 96' ' ' LYS . 6.5 p -111.05 151.6 13.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.585 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 4.5 ptmm? . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.464 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 53' ' ' ASP . 16.6 mttt . . . . . 0 C--O 1.233 0.222 0 CA-C-O 121.192 0.52 . . . . 0.0 111.51 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 88' ' ' VAL . 11.1 Cg_exo -70.25 164.44 35.02 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.7 2.267 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -140.3 130.15 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.009 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.702 HG13 HD21 ' A' ' 52' ' ' LEU . 12.0 mt -63.6 121.98 73.64 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.124 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.33 -179.07 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.965 2.443 . . . . 0.0 112.575 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -81.16 -12.62 59.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.3 0.572 . . . . 0.0 110.554 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.03 113.16 21.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.139 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -91.53 1.46 57.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.223 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 t -98.97 -6.04 29.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.879 0.371 . . . . 0.0 111.377 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -106.3 172.92 6.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.066 0.46 . . . . 0.0 110.884 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.34 125.38 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.609 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.35 -44.98 13.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.381 0.61 . . . . 0.0 109.696 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.88 168.34 36.22 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 68.2 m-85 -107.77 140.84 40.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.138 0.469 . . . . 0.0 110.439 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -105.33 112.71 39.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.855 0.836 . . . . 0.0 109.446 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HB3' ' HD2' ' A' ' 26' ' ' LYS . 33.5 mt-10 -122.29 112.58 18.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.528 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 25' ' ' ILE . 38.7 mt -127.28 93.95 39.85 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.791 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.51 -28.47 86.72 Favored 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 123.117 2.545 . . . . 0.0 111.808 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 26.9 t70 -67.22 -28.03 67.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.174 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -114.66 12.41 17.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.148 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.5 t70 61.78 26.91 16.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.492 0.663 . . . . 0.0 111.128 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 20' ' ' ILE . 80.5 mt -95.99 129.67 45.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.206 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.596 ' HD2' ' HB3' ' A' ' 19' ' ' GLU . 9.2 mmmm -155.26 42.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.468 0.307 . . . . 0.0 111.498 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -124.46 157.47 64.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 36.4 Cg_endo -66.47 149.17 84.62 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.426 2.75 . . . . 0.0 113.52 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.81 138.1 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.214 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -100.33 135.57 20.23 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 121.0 0.428 . . . . 0.0 110.83 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.0 Cg_endo -79.89 128.93 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.729 2.286 . . . . 0.0 111.348 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.673 ' HA3' ' HG2' ' A' ' 38' ' ' GLN . . . -175.82 149.42 9.99 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.676 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.483 ' HG2' HG23 ' A' ' 35' ' ' THR . 68.8 Cg_endo -74.46 38.02 0.48 Allowed 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.966 3.111 . . . . 0.0 113.476 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 54.91 36.23 26.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.074 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 33' ' ' PRO . 6.1 p -76.46 154.16 83.85 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.784 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 77.3 Cg_exo -50.92 -46.71 29.14 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.607 2.871 . . . . 0.0 114.091 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -75.9 -17.83 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 111.349 -177.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.673 ' HG2' ' HA3' ' A' ' 32' ' ' GLY . 42.4 tp60 -81.41 -46.82 14.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.913 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 96.7 mt -77.89 -1.52 32.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.441 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 65.6 t30 -84.55 -44.19 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.747 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 7.0 ptm180 -75.52 -30.32 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.574 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -179.51 -162.9 29.42 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -85.39 155.73 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 117.491 0.646 . . . . 0.0 110.114 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.562 ' OG ' ' HG3' ' A' ' 38' ' ' GLN . 59.9 m -150.58 179.72 7.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.146 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -73.27 157.85 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.17 76.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.632 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.19 175.99 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.513 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.6 1.9 27.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.88 -17.32 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.49 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 58' ' ' SER . 1.3 mp0 -61.13 154.26 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.733 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m -141.56 157.95 44.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.88 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.5 mm? -77.08 -23.21 51.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.606 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 15.2 t70 -135.34 70.08 1.44 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.639 1.209 . . . . 0.0 109.108 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.895 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.3 t70 -124.78 162.4 24.37 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.709 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.89 -35.93 82.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.36 131.74 54.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.41 0.624 . . . . 0.0 111.21 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 121' ' ' LEU . 47.1 mt -129.2 123.06 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.417 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 1.1 m -113.17 109.2 18.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -107.99 124.35 64.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.09 120.02 33.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.003 0.43 . . . . 0.0 111.08 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.62 118.28 5.54 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.817 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -68.42 -38.62 81.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m 73.01 126.92 0.04 OUTLIER 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.552 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -137.43 142.51 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.22 -39.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.875 173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.63 -46.74 63.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.292 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -107.9 107.12 59.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.711 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.558 ' HA ' HG21 ' A' ' 73' ' ' THR . 96.4 Cg_endo -80.25 -18.89 9.58 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.551 2.168 . . . . 0.0 111.682 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -124.61 70.79 1.13 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.464 0.649 . . . . 0.0 110.896 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.444 ' HE1' ' HG1' ' A' ' 73' ' ' THR . 3.7 p90 -138.48 -177.5 4.88 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 166.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -41.06 -68.41 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -168.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -114.28 96.22 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.24 -174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 68' ' ' PRO . 1.3 m -156.49 -45.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.641 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -97.91 23.36 8.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.542 0.687 . . . . 0.0 110.247 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -11.5 59.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -71.11 -11.16 60.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.344 . . . . 0.0 111.545 -178.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -89.65 6.86 39.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -94.05 135.05 35.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.796 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 7.4 mptt -108.51 -170.87 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.617 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 97' ' ' MET . 6.2 ptpp? -65.87 -33.9 76.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.43 54.01 0.57 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.469 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 p -75.02 -15.97 60.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.425 ' HG2' ' HE3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 54.31 85.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.556 0.693 . . . . 0.0 111.639 -174.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 48.4 t -86.11 113.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.062 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.452 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 89.4 m-85 -98.73 110.43 23.03 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 34.9 t80 -99.21 102.59 14.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 35.7 mmtp -92.02 81.27 5.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.387 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.88 HG21 ' HG ' ' A' ' 52' ' ' LEU . 5.4 p -93.54 121.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.178 0.513 . . . . 0.0 110.489 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.12 -104.1 0.63 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.731 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 90' ' ' ASN . 6.6 m120 -124.64 9.25 8.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.312 . . . . 0.0 110.718 177.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -100.11 148.58 24.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 110.57 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 93.1 m -117.7 104.34 10.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.188 0.518 . . . . 0.0 111.023 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 58.2 mmt-85 -92.11 135.36 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.986 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -115.02 130.1 56.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.036 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -130.23 146.88 51.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.72 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -112.95 135.99 53.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 20.8 mmt -79.35 65.44 4.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.528 0.68 . . . . 0.0 110.359 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 t -80.44 -13.75 58.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.551 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.4 m -135.18 90.88 2.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.546 0.689 . . . . 0.0 111.1 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 97' ' ' MET . 73.1 mt -109.07 129.7 63.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.429 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -164.62 -169.64 1.8 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.83 0.347 . . . . 0.0 110.255 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.819 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 3.3 p-10 -145.68 137.37 25.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.56 HG23 ' HD2' ' A' ' 139' ' ' ARG . 21.5 m -120.29 174.13 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.323 -173.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.526 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.2 mppt? -91.6 158.05 41.03 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.827 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.737 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 19.9 Cg_endo -61.7 -24.2 77.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.358 2.039 . . . . 0.0 111.293 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -114.71 29.93 7.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.789 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 17.9 t70 -63.29 139.71 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.257 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.1 m -110.87 2.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.738 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -85.92 -36.24 20.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.197 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.1 -10.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.906 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 pp -111.13 -0.13 16.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 111.192 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.84 -159.15 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 9.5 pt-20 -60.98 112.91 2.26 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.458 0.646 . . . . 0.0 111.672 -177.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -85.6 134.18 34.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.518 174.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 12.1 mptt -74.16 174.98 7.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.278 -170.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.81 55.05 1.34 Allowed Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.884 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -69.41 173.54 5.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.329 0.585 . . . . 0.0 110.972 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.411 ' OD1' ' HD3' ' A' ' 119' ' ' LYS . 5.1 t70 -104.54 -149.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -58.69 114.85 2.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.83 119.84 38.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.259 0.552 . . . . 0.0 111.957 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 57' ' ' ILE . 14.0 mt -82.38 104.97 13.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -92.63 92.21 7.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.565 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 16.7 mt -87.78 101.12 13.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 mt -90.92 97.8 7.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.29 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -103.09 101.97 11.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.328 0.585 . . . . 0.0 110.362 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 86.3 m -92.56 101.87 14.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.689 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -120.36 68.44 0.85 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.495 0.664 . . . . 0.0 110.052 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 34.6 t70 -176.26 95.23 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.681 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -102.56 115.94 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -86.69 103.05 14.78 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.89 -27.07 68.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.017 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -77.53 -18.57 56.86 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.518 -173.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 135' ' ' VAL . 21.9 p -120.82 -32.3 4.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.62 16.24 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.505 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.535 HG12 ' OG1' ' A' ' 133' ' ' THR . 9.8 p -132.64 154.46 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.578 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.499 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 55.4 m95 -97.71 109.21 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.737 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 44.2 mt-10 -87.93 -63.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -172.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 48.1 tptt -75.57 80.7 2.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.134 0.969 . . . . 0.0 110.348 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HD2' HG23 ' A' ' 103' ' ' VAL . 1.5 ptp180 -93.57 108.63 20.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.355 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.819 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 45.6 tptt -80.66 132.77 35.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.334 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -122.71 122.72 66.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.923 0.868 . . . . 0.0 111.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.459 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 13.2 m-85 -110.69 105.32 14.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.687 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 26.2 t -99.35 104.23 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.349 0.595 . . . . 0.0 110.371 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.536 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -100.38 117.76 35.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.368 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.1 m -95.78 144.51 26.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 29.8 tt0 -56.67 135.91 54.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 111.725 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.626 HG21 ' HD3' ' A' ' 96' ' ' LYS . 1.1 t -106.94 172.26 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.55 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 147' ' ' VAL . 30.4 mmmt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.607 176.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 7.8 mtmp? . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 18.3 Cg_endo -58.58 134.56 61.71 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.547 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 8.8 pt20 -158.05 176.2 12.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.863 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 31' ' ' PRO . 5.4 mp -96.99 108.88 46.3 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.034 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.4 Cg_exo -68.11 165.03 29.79 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.811 2.341 . . . . 0.0 110.88 170.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -97.02 18.73 14.12 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.909 -171.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 18.3 t70 -86.84 150.07 24.38 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' GLN . 34.8 mmtp -80.4 -39.72 27.82 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 m -93.49 -22.34 18.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -59.72 150.02 29.07 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.599 0.714 . . . . 0.0 112.443 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -105.9 139.2 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.634 172.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.86 -32.53 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.448 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.16 161.87 26.82 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.485 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 35.7 m-85 -122.88 143.43 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -104.44 118.41 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.252 0.549 . . . . 0.0 109.79 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 26.0 mt-10 -125.81 111.62 15.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 62.1 mt -132.24 109.09 13.75 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 -47.18 15.3 Favored 'Trans proline' 0 N--CA 1.473 0.273 0 C-N-CA 123.157 2.571 . . . . 0.0 113.365 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -62.54 -30.19 71.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -98.18 2.4 48.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.224 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t70 61.55 27.76 17.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.969 0.89 . . . . 0.0 109.887 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 61.0 mt -97.24 129.29 47.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.235 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 32.5 ttpt -159.86 79.11 0.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 168.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.403 ' HB3' HE21 ' A' ' 71' ' ' GLN . 62.2 mm-40 -133.5 157.14 78.75 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.826 -173.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.2 146.88 71.35 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.848 2.365 . . . . 0.0 113.03 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.531 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 76.2 t -106.12 125.44 61.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.712 176.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 61.1 m-85 -93.54 103.44 9.86 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.627 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 3.0 Cg_endo -86.86 155.0 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.355 2.703 . . . . 0.0 112.298 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.77 -151.75 21.04 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.952 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.582 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 78.7 Cg_endo -76.3 19.21 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.249 2.633 . . . . 0.0 113.092 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 56.87 46.24 20.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.324 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.72 119.7 23.2 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.092 -174.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.32 -38.64 42.81 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.238 2.625 . . . . 0.0 113.066 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.95 -38.4 82.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.311 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 75.9 mm-40 -90.65 -30.73 16.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.089 0.471 . . . . 0.0 110.4 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.43 -27.99 63.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.975 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -68.28 -24.8 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 41' ' ' ARG . 15.9 mtp-105 -80.96 -52.71 7.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.738 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.72 -117.23 1.49 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.06 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.56 142.42 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -128.59 -179.59 5.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.385 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 31' ' ' PRO . 11.9 m-85 -74.61 178.09 5.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.7 -46.79 20.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.68 167.14 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.699 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -80.82 -10.31 59.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.522 0.677 . . . . 0.0 109.951 175.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.83 -23.0 58.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.854 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 9.5 pt-20 -84.03 177.86 8.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 112.161 -172.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.509 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 70.8 m -137.38 175.13 9.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -172.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.14 -15.95 34.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.432 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -134.9 70.34 1.44 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.283 1.04 . . . . 0.0 109.589 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 14.7 t70 -126.37 160.88 29.18 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.747 171.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -63.84 -31.54 72.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.64 125.86 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.588 0.708 . . . . 0.0 111.012 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.33 139.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -131.15 116.23 17.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.195 0.521 . . . . 0.0 111.659 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.4 mt -101.09 116.41 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.64 105.07 17.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 111.309 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.64 144.49 15.95 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.301 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -122.81 133.81 54.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.552 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -81.86 113.27 19.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -113.67 109.3 18.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.505 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.7 mm -54.96 -33.98 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.741 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.87 -40.46 76.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 61.1 mtt180 -106.98 108.91 62.74 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.914 0.388 . . . . 0.0 111.068 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 3.3 Cg_exo -77.77 -10.77 16.95 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.196 2.597 . . . . 0.0 112.737 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.68 80.53 1.7 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.425 0.631 . . . . 0.0 111.716 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.552 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -132.62 -161.82 1.17 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.751 168.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 27' ' ' GLU . 25.6 mp0 -49.63 -72.37 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -105.57 31.77 4.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -169.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 m -73.74 -34.86 64.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.04 0.448 . . . . 0.0 111.223 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -116.72 28.0 8.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.277 0.56 . . . . 0.0 110.484 -173.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.22 -21.45 65.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -74.03 -2.05 22.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.302 . . . . 0.0 111.622 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.42 8.2 37.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.62 153.92 20.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -125.82 176.41 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.295 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -61.2 -19.67 61.88 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.89 51.62 0.85 Allowed Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.174 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 m -79.28 -4.47 50.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 53.93 82.93 0.08 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.447 0.641 . . . . 0.0 111.244 -175.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.9 t -85.0 113.94 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.967 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.577 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 84.3 m-85 -94.26 117.64 30.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.884 0.373 . . . . 0.0 110.052 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.408 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 10.6 t80 -100.44 101.11 11.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 32.4 tptt -83.89 99.14 10.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.864 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.871 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.1 m -116.7 86.96 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.87 -107.04 1.69 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.231 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.14 -11.36 30.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 0.0 110.829 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.871 ' HB2' HG23 ' A' ' 88' ' ' VAL . 38.8 mt-10 -95.11 109.2 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.755 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.0 m -100.57 85.68 2.99 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 93' ' ' ARG . 11.3 ptp180 -93.39 133.73 36.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.525 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -102.86 139.38 38.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.771 -175.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.6 m-85 -120.91 148.99 43.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 1.2 tptm -110.49 131.96 54.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.9 mmt -76.68 70.58 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -77.05 -20.62 55.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.669 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 52.5 m -133.53 101.37 5.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 97' ' ' MET . 74.9 mt -116.49 116.54 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.688 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -161.66 -174.39 4.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.53 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.799 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 1.2 p-10 -144.09 134.92 25.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.19 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.7 m -133.77 -175.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.458 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -92.16 160.29 35.7 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.635 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.35 -20.71 31.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 111.445 175.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -98.83 10.54 41.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.882 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.21 115.86 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.802 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.95 2.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 0.0 110.996 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.12 -34.88 18.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.379 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.5 m -77.26 -26.25 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -91.83 20.29 5.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.9 169.37 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.516 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 5.6 pt-20 -66.61 84.8 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.328 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -87.45 37.78 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.652 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -82.52 172.12 13.35 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.639 176.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.91 -7.64 59.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.808 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -91.08 -168.25 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.133 0.492 . . . . 0.0 110.557 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -104.6 -157.78 0.63 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.9 OUTLIER -65.54 107.37 1.68 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -104.97 124.38 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.237 0.541 . . . . 0.0 110.282 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -92.95 98.26 11.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.1 m -84.41 99.11 10.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.258 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 20.0 mt -85.25 106.08 16.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.1 mt -93.52 127.24 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.578 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 30.5 m -136.67 105.21 5.78 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.256 0.551 . . . . 0.0 110.501 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.4 m -99.52 107.39 19.56 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -118.08 -1.46 11.41 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -172.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 137' ' ' GLU . 37.1 t70 -105.71 89.64 3.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.524 0.678 . . . . 0.0 109.919 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' A' ' 131' ' ' GLU . 92.3 t80 -82.58 124.91 30.59 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.172 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.514 ' OD1' HG22 ' A' ' 133' ' ' THR . 23.1 t-20 -89.29 103.62 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.595 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 40.2 mt-10 -64.09 -23.24 67.25 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -171.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 1.011 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 5.9 mmpt? -78.49 -23.43 46.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.514 HG22 ' OD1' ' A' ' 130' ' ' ASN . 7.7 t -130.06 -30.0 2.03 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.596 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.88 35.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.281 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.511 ' H ' HG23 ' A' ' 133' ' ' THR . 12.8 m -82.8 172.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 41.9 m95 -117.37 112.11 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.465 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 41.9 mt-10 -77.83 -21.38 51.59 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.799 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -114.98 118.35 33.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.296 0.57 . . . . 0.0 111.036 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -107.13 98.67 8.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.483 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 47.7 tptt -69.1 128.52 36.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.91 118.49 50.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.989 0.899 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 15.8 m-85 -109.08 101.59 10.64 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.305 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 38.3 t -95.42 97.09 6.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.403 0.62 . . . . 0.0 110.121 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.557 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -95.91 112.23 24.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.9 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.8 m -90.45 139.34 30.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.88 123.75 15.33 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.564 0.54 . . . . 0.0 110.798 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.553 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 4.0 t -76.8 147.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.644 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt . . . . . 0 C--O 1.248 1.024 0 O-C-N 124.324 1.015 . . . . 0.0 111.236 178.73 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 68.8 mmtt . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.84 118.33 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.874 2.383 . . . . 0.0 112.126 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -118.96 147.37 44.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.668 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.405 HG23 ' HB3' ' A' ' 31' ' ' PRO . 22.4 mt -84.57 121.82 74.91 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.453 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.79 -175.66 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.513 2.142 . . . . 0.0 112.206 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.667 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.73 6.35 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.167 178.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -95.92 103.95 15.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.052 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' CD ' ' HD3' ' A' ' 33' ' ' PRO . 35.3 mtmm -85.63 12.81 7.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.139 -176.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -106.72 -5.86 18.24 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.203 0.525 . . . . 0.0 109.678 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 99.3 mttt -91.37 -177.14 4.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -112.77 138.21 42.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.37 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.72 -29.4 12.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.244 0.545 . . . . 0.0 110.798 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.71 163.51 36.73 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 63.9 m-85 -109.44 135.79 49.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.483 0.642 . . . . 0.0 109.91 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.1 tp -97.86 108.53 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.772 0.796 . . . . 0.0 109.612 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -114.18 103.7 11.37 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.907 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mt -121.25 92.88 48.76 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.539 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.91 -21.18 68.9 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.052 2.502 . . . . 0.0 111.311 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.99 -30.14 63.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.888 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.52 10.9 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 63.14 29.25 16.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.769 0.795 . . . . 0.0 110.758 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.53 HG23 ' HG2' ' A' ' 27' ' ' GLU . 78.2 mt -102.22 118.74 49.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.5 mppt? -135.82 41.51 2.69 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.727 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 13.1 mm-40 -102.55 154.19 37.64 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.429 -163.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.79 143.45 13.25 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.473 2.116 . . . . 0.0 112.151 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.88 127.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 44' ' ' SER . 57.6 m-85 -100.76 133.71 20.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.493 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -69.26 145.34 59.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.498 2.132 . . . . 0.0 111.841 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . 164.8 162.07 15.08 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.31 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.743 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 Cg_endo -88.01 39.86 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.997 3.132 . . . . 0.0 111.545 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.71 35.98 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.47 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.403 ' OG1' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -76.0 152.48 84.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.824 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.53 -57.19 2.49 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.971 3.114 . . . . 0.0 113.818 -175.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.4 mm-40 -59.61 -34.76 73.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.8 mp0 -64.99 -44.21 90.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.287 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.3 -30.92 65.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.44 0.638 . . . . 0.0 110.109 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.08 -39.87 95.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.673 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 28.2 mtp-105 -75.67 -51.61 12.38 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.619 175.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' C ' ' HG3' ' A' ' 71' ' ' GLN . . . -156.47 -104.91 0.22 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.957 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.92 149.99 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 41.3 t -124.21 157.27 35.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.682 0.277 . . . . 0.0 110.901 -174.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -70.5 178.25 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 58' ' ' SER . . . -66.2 -46.58 76.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.743 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 12.8 pt-20 -149.15 -176.47 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.545 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -94.86 -27.37 15.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.151 -171.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -82.8 -9.86 59.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.038 0.447 . . . . 0.0 110.922 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.11 143.04 49.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.042 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 m -121.16 145.13 48.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.752 -171.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -81.84 -10.23 59.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.818 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -100.78 4.02 42.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 110.558 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -95.93 178.41 5.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.519 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.55 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.26 -8.8 28.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.708 0.29 . . . . 0.0 111.301 -177.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.424 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -119.58 107.1 12.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.745 0.783 . . . . 0.0 110.754 177.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.8 mt -127.58 136.11 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.872 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 36.6 t -132.02 132.71 43.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.382 0.611 . . . . 0.0 110.962 -172.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -115.56 127.97 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.296 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.24 111.61 22.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.042 0.448 . . . . 0.0 111.063 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.99 137.92 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.666 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -148.21 102.09 3.33 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 m -56.37 147.47 21.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.594 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.48 ' HB3' ' CG ' ' A' ' 67' ' ' ARG . 69.7 t80 -139.25 148.3 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.3 mt -54.57 -51.52 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.308 -174.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -87.77 40.54 0.94 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.608 -172.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.48 ' CG ' ' HB3' ' A' ' 64' ' ' PHE . 12.8 ptp180 -166.21 88.76 0.86 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.267 0.556 . . . . 0.0 111.416 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.85 -4.53 14.06 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.189 2.593 . . . . 0.0 112.038 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -154.73 83.58 1.1 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.025 -170.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -139.12 -168.19 2.39 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.31 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.727 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 9.2 mm100 -24.1 -75.73 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.882 1.273 . . . . 0.0 113.263 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -117.44 96.47 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 110.786 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.54 -49.74 0.78 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.327 0.584 . . . . 0.0 110.68 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.467 ' OD1' ' HE2' ' A' ' 76' ' ' LYS . 64.2 t30 -87.75 32.74 0.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.489 0.662 . . . . 0.0 110.952 -174.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.29 -7.48 49.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.392 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.467 ' HE2' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -78.4 -11.66 59.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.982 0.42 . . . . 0.0 111.017 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -12.22 49.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.755 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.15 22.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.772 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -157.13 -168.77 2.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.187 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.5 ptmt -46.2 -39.52 9.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.633 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -124.54 57.19 0.68 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.34 -1.409 . . . . 0.0 113.174 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -81.22 -6.94 59.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.736 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 84.2 mmm 47.68 91.63 0.01 OUTLIER 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.838 0.828 . . . . 0.0 112.744 -174.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -85.76 119.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -99.75 107.75 19.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.569 ' HD2' ' HD2' ' A' ' 93' ' ' ARG . 28.8 t80 -90.28 100.51 13.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.8 tppp? -82.86 93.75 7.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.212 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.09 122.03 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.268 0.556 . . . . 0.0 111.011 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.81 -90.48 0.13 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.962 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.455 HD22 ' HA ' ' A' ' 90' ' ' ASN . 1.8 t-20 -139.81 8.47 2.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.0 109.448 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -100.76 131.47 46.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.542 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.8 m -103.67 97.55 7.55 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.569 ' HD2' ' HD2' ' A' ' 86' ' ' PHE . 9.9 ptp180 -97.35 153.41 18.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.895 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.05 122.29 44.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.186 0.517 . . . . 0.0 111.754 -166.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.9 m-85 -122.17 138.27 54.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.736 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.88 132.25 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.665 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 53.8 mtt -80.9 62.79 5.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.633 0.73 . . . . 0.0 110.175 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -75.93 -12.66 60.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.723 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 37.4 m -132.94 97.84 4.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.311 0.577 . . . . 0.0 110.34 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.92 128.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.341 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' A' ' 140' ' ' LYS . 6.1 ptp180 -161.05 -178.63 6.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.989 0.423 . . . . 0.0 110.536 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.51 143.63 46.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.795 HG23 ' HG3' ' A' ' 139' ' ' ARG . 11.8 m -131.17 170.84 18.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.624 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -100.28 146.39 31.9 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.819 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 139' ' ' ARG . 38.3 Cg_exo -61.6 -2.31 2.57 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.938 2.425 . . . . 0.0 112.907 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -126.62 19.49 7.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.624 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 1.6 p30 -68.59 166.8 16.37 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.332 0.587 . . . . 0.0 111.143 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.474 ' HA ' HD11 ' A' ' 111' ' ' LEU . 29.0 m -120.54 23.97 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -97.98 -41.82 7.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.158 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -87.25 -7.8 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.908 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 108' ' ' VAL . 2.5 pp -120.0 18.19 12.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.492 . . . . 0.0 110.929 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 32.3 t70 -152.15 138.47 18.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.174 -175.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.415 ' HB3' ' CE ' ' A' ' 115' ' ' LYS . 95.4 mt-10 53.4 65.76 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.795 0.684 . . . . 0.0 111.652 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -88.9 93.28 9.54 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' CE ' ' HB3' ' A' ' 113' ' ' GLU . 8.0 mptt -67.43 163.1 21.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.213 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.38 54.03 2.77 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.806 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -66.21 172.03 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.076 0.465 . . . . 0.0 110.788 172.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 3.2 t70 -81.03 -161.07 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 2.3 mppt? -64.72 119.02 9.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.989 0.423 . . . . 0.0 110.057 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.16 138.26 53.12 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.669 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.9 108.33 19.61 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m -92.59 106.12 18.16 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.758 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.7 mt -92.95 103.19 15.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.01 94.26 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -105.25 98.91 8.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.408 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.725 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 6.1 p -76.34 96.83 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.319 0.58 . . . . 0.0 109.882 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -125.28 79.26 1.79 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.396 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.784 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 31.5 t70 -168.89 85.72 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.492 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 70.8 t80 -91.91 125.9 36.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.132 -167.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -97.26 108.55 21.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.486 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 34.6 mt-10 -58.27 -33.72 69.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -71.21 -25.71 62.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 135' ' ' VAL . 2.6 t -125.03 -31.0 3.16 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.837 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.492 ' HA2' ' CE2' ' A' ' 129' ' ' TYR . . . 96.46 4.23 59.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.113 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.647 ' H ' HG23 ' A' ' 133' ' ' THR . 98.5 t -84.67 138.51 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.774 0.321 . . . . 0.0 110.158 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.784 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 45.0 m95 -95.68 105.04 16.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.37 -16.39 56.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.715 -165.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 128' ' ' ASP . 4.6 tppp? -133.17 130.46 39.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.806 0.336 . . . . 0.0 110.464 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.795 ' HG3' HG23 ' A' ' 103' ' ' VAL . 27.9 ptt180 -111.09 113.6 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.456 0.646 . . . . 0.0 110.181 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 16.2 tptm -76.33 127.51 33.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.841 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -121.04 127.16 75.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.728 0.775 . . . . 0.0 111.42 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 93.1 m-85 -114.64 108.76 17.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.488 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.6 t -96.68 102.53 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.265 0.555 . . . . 0.0 110.007 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.65 107.97 19.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.336 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.4 m -90.76 144.02 26.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.71 138.44 18.26 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.555 0.534 . . . . 0.0 111.186 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 96' ' ' LYS . 21.5 t -97.05 153.71 3.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.548 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.06 179.394 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.53 130.76 22.53 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.5 2.8 . . . . 0.0 113.524 -174.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.08 169.07 18.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.875 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.433 HG23 ' HB3' ' A' ' 31' ' ' PRO . 2.4 mp -70.86 122.78 87.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 17.3 Cg_exo -67.52 170.54 13.47 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.747 2.298 . . . . 0.0 112.978 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -79.26 -21.96 45.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.82 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.23 108.56 21.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.022 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 52.6 mtmt -90.63 31.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.745 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -117.17 -20.92 9.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.367 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 19.2 ptpt -90.43 -175.44 4.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.479 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.8 p -100.94 137.52 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.874 0.369 . . . . 0.0 110.509 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -100.81 -40.19 7.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.373 0.606 . . . . 0.0 110.324 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.14 165.45 30.31 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.607 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 47.7 m-85 -115.37 139.25 50.17 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -103.61 115.36 45.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.608 0.718 . . . . 0.0 109.949 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.19 112.67 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.571 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.466 HG12 HG13 ' A' ' 84' ' ' VAL . 43.5 mt -127.93 95.41 34.47 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.142 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.4 -29.61 89.13 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 123.114 2.543 . . . . 0.0 112.047 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.98 -33.19 74.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.47 8.8 21.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 66.68 12.55 8.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.26 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.479 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 62.7 mt -78.21 123.54 35.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.244 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 14.3 mtmm -153.6 84.71 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 119.364 -0.351 . . . . 0.0 110.594 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.1 mm-40 -155.93 163.83 23.42 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 118.0 0.364 . . . . 0.0 111.725 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 14' ' ' VAL . 8.2 Cg_exo -72.4 156.89 54.1 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.08 2.52 . . . . 0.0 113.387 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.52 123.6 71.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.623 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.9 123.88 45.79 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.739 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 19.0 Cg_endo -58.28 129.41 32.73 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.968 2.445 . . . . 0.0 112.228 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . -172.27 135.12 3.24 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.445 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.486 ' HD3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 Cg_endo -80.68 61.43 8.22 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.309 2.673 . . . . 0.0 112.069 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.02 27.97 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.525 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 7.8 p -79.81 136.62 54.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.187 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 64.1 Cg_exo -52.51 -48.57 21.22 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.471 2.78 . . . . 0.0 113.829 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.628 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 2.2 mp0 -67.42 -23.19 65.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 111.653 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.565 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.9 mp0 -83.06 -26.01 31.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.044 0.45 . . . . 0.0 110.013 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.56 -5.66 55.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.457 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' A' ' 37' ' ' GLU . 28.4 p30 -97.11 -23.68 16.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -96.0 -20.74 18.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA2' ' NE2' ' A' ' 71' ' ' GLN . . . -168.95 -150.22 6.59 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.84 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.91 142.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.565 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 70.8 m -127.55 -175.58 3.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.246 0.546 . . . . 0.0 112.001 -172.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.79 -178.86 6.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.662 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.71 -50.93 5.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.101 0.477 . . . . 0.0 109.941 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HB2' ' OE2' ' A' ' 50' ' ' GLU . 35.7 mt-10 -119.59 -167.58 1.44 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.018 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.47 27.23 9.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -105.41 -28.66 10.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.533 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 58' ' ' SER . 3.0 mp0 -63.79 168.99 4.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.033 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.878 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 56.3 m -147.84 160.14 43.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.396 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HB3' HG11 ' A' ' 88' ' ' VAL . 81.9 mt -78.67 2.33 19.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -137.34 11.06 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.916 0.865 . . . . 0.0 109.311 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.878 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 11.9 t70 -79.85 162.26 25.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.605 -175.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.584 ' HA ' ' HD3' ' A' ' 119' ' ' LYS . 1.3 tm0? -63.23 -38.23 90.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.701 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.0 129.64 55.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 110.796 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.43 ' HB ' HD23 ' A' ' 121' ' ' LEU . 36.7 mt -136.83 116.59 16.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.518 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 17.2 m -113.97 122.13 46.0 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.9 123.92 72.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.19 112.2 23.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.32 159.39 13.73 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.047 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -146.11 136.62 24.05 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.747 ' OG1' ' HA ' ' A' ' 127' ' ' ASP . 2.6 m -51.93 -65.82 0.49 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.374 0.421 . . . . 0.0 111.86 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 52.7 p90 -170.62 157.83 5.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.909 0.385 . . . . 0.0 110.951 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.2 mm -98.43 -50.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.93 22.61 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.906 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 11.8 mmm180 -115.88 119.54 37.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.365 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.85 -11.26 13.93 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.968 2.445 . . . . 0.0 113.696 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -157.43 90.33 1.1 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.154 0.502 . . . . 0.0 110.783 -169.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.577 ' OH ' ' HA ' ' A' ' 64' ' ' PHE . 11.9 p90 -148.46 -160.27 1.15 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.514 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.606 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -41.66 -79.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.769 0.828 . . . . 0.0 112.739 -175.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -106.48 106.05 16.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 m -147.62 -50.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.26 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -91.99 25.29 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.609 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.479 ' HG ' ' CD1' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -67.24 -17.96 65.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.431 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -75.84 -10.34 59.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.731 0.3 . . . . 0.0 110.808 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.01 -6.3 58.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 110.674 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.85 169.4 18.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.556 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -162.95 -171.29 2.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.731 -178.098 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -49.15 -47.21 45.82 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -113.61 62.08 0.32 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -82.14 -15.94 51.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.472 ' CE ' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 55.15 90.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.675 0.75 . . . . 0.0 111.595 -176.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 20' ' ' ILE . 39.7 t -87.98 119.9 36.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.417 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -95.91 106.85 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 121' ' ' LEU . 3.1 t80 -91.23 94.89 9.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.1 tppp? -81.23 86.39 6.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.452 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 91' ' ' GLU . 5.7 m -90.16 90.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.722 0.772 . . . . 0.0 111.006 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.89 -91.96 0.36 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.032 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.09 -4.84 10.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.659 0.266 . . . . 0.0 111.053 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.69 ' HB2' HG23 ' A' ' 88' ' ' VAL . 32.6 mt-10 -97.66 147.63 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.331 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.2 m -124.81 103.66 8.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.118 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.692 ' HG3' ' HE2' ' A' ' 95' ' ' TYR . 6.6 ptm180 -109.81 139.09 45.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.165 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HB2' ' CE ' ' A' ' 83' ' ' MET . 3.5 ptmm? -108.34 130.57 55.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 111.962 -172.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.692 ' HE2' ' HG3' ' A' ' 93' ' ' ARG . 61.2 m-85 -116.74 152.24 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.427 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.566 ' HE3' HG11 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -115.73 134.36 55.1 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.639 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 20.2 mmt -79.27 63.65 3.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.519 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 t -74.6 -23.81 58.78 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.603 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.5 m -129.83 96.12 4.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 111.329 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.47 124.48 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.599 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -137.87 159.98 40.52 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.835 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.39 124.67 51.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.64 HG11 HG13 ' A' ' 110' ' ' VAL . 21.6 m -119.32 131.62 71.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.788 0.804 . . . . 0.0 111.473 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.618 ' HG3' ' HG2' ' A' ' 138' ' ' LYS . 3.2 mppt? -98.35 168.43 9.89 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.03 -11.55 27.87 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.43 2.087 . . . . 0.0 112.266 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t -107.88 8.4 28.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.326 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 12.7 t0 -94.03 134.45 36.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.317 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.39 4.75 8.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.29 -30.79 71.68 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 110.98 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.64 HG13 HG11 ' A' ' 103' ' ' VAL . 17.0 m -84.67 -6.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.165 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.68 -7.46 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.49 157.96 17.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.69 123.36 18.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -77.18 139.47 39.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.98 -154.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -168.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.8 52.82 1.63 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 123.491 0.494 . . . . 0.0 114.235 -169.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -75.7 150.39 37.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 172.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -90.98 -149.4 0.22 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.637 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 32.5 mmtp -60.97 124.38 20.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -137.98 138.85 39.32 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.334 0.588 . . . . 0.0 111.911 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 86' ' ' PHE . 36.8 mt -94.1 103.76 15.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.1 m -88.1 91.1 8.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.793 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 26.1 mt -84.4 99.91 10.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.737 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.7 mt -83.05 78.26 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.9 m -87.81 99.61 12.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.975 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 57.1 m -74.23 94.89 2.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.747 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 35.7 t70 -101.69 1.5 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.346 -172.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.727 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 17.7 t0 -112.5 94.46 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.853 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 32.8 t80 -77.43 -26.98 52.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.155 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.5 t30 49.4 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.743 0.783 . . . . 0.0 111.457 -173.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.472 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 20.4 mt-10 -62.71 -8.63 7.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.808 -174.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 57.1 mmtt -60.37 -35.09 74.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 t -159.41 -3.26 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.19 40.07 7.63 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.424 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.44 117.18 53.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.182 0.515 . . . . 0.0 110.032 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.727 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 27.7 m95 -78.51 96.55 5.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 46.1 mt-10 -86.29 -61.98 1.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.18 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.618 ' HG2' ' HG3' ' A' ' 104' ' ' LYS . 33.8 mtmm -89.31 119.06 29.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.475 ' HB2' HG23 ' A' ' 103' ' ' VAL . 40.8 mtt85 -100.56 114.71 28.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.494 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -89.01 111.0 21.62 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.3 tt -102.42 127.33 56.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.615 0.721 . . . . 0.0 110.694 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.639 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 89.5 m-85 -108.51 112.73 25.27 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.438 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 44.3 t -101.43 97.33 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.428 0.633 . . . . 0.0 109.776 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.616 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -94.7 113.3 25.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.148 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 m -89.01 141.1 28.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.296 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 5.3 tt0 -61.0 115.38 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.566 HG11 ' HE3' ' A' ' 96' ' ' LYS . 5.1 p -117.19 124.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.573 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.4 -0.809 . . . . 0.0 111.223 -176.487 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 39.4 mtmt . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.888 0.375 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 13.8 Cg_endo -55.64 124.26 15.84 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.862 2.375 . . . . 0.0 111.277 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -141.1 146.79 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.72 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.5 mp -78.62 129.18 74.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.701 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 163.28 39.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.749 2.299 . . . . 0.0 112.863 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.934 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -70.83 -15.68 62.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.695 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.59 121.88 28.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.753 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 37.7 mmtm -95.2 16.62 16.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.417 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -127.04 26.54 6.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.542 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 64.4 mttm -118.06 176.03 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.409 0.623 . . . . 0.0 112.045 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.0 t -109.54 111.87 38.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.614 173.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -91.04 -21.42 21.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.02 159.41 31.88 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.901 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 57.9 m-85 -114.81 135.68 53.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -101.86 121.22 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.527 0.68 . . . . 0.0 109.791 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.648 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 37.7 mt-10 -124.26 118.75 27.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.449 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -134.21 96.9 15.32 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -54.01 -35.89 82.47 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.324 2.683 . . . . 0.0 112.999 -176.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.8 -29.84 69.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.796 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.71 2.36 27.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.628 0.251 . . . . 0.0 110.976 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HB3' HD21 ' A' ' 69' ' ' ASN . 30.9 t70 65.56 25.97 11.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.836 0.827 . . . . 0.0 110.084 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 20' ' ' ILE . 77.1 mt -91.47 125.4 44.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.954 -177.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.648 ' HD2' ' HG2' ' A' ' 19' ' ' GLU . 7.0 mmmt -151.27 54.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 5.5 mm-40 -121.82 153.66 60.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.611 -166.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.89 134.23 10.6 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.966 2.444 . . . . 0.0 112.807 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.07 135.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.329 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.41 ' HD2' ' HA3' ' A' ' 42' ' ' GLY . 51.2 m-85 -101.46 102.71 23.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.036 0.446 . . . . 0.0 109.857 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.2 Cg_endo -71.14 140.93 38.56 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.972 2.448 . . . . 0.0 112.112 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.15 -171.4 43.37 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.79 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.753 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 27.0 Cg_endo -93.73 34.52 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.012 3.141 . . . . 0.0 112.566 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 60.55 27.73 17.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.431 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.729 HG23 ' HB2' ' A' ' 38' ' ' GLN . 2.6 t -62.67 128.58 91.92 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.894 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.57 -44.89 24.73 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 124.093 3.195 . . . . 0.0 113.928 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 39.4 mt-10 -61.07 -49.37 77.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.729 ' HB2' HG23 ' A' ' 35' ' ' THR . 2.8 mp0 -70.69 -26.37 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 39' ' ' LEU . 6.5 mt -75.33 -10.15 59.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 176.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -99.48 -5.68 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.362 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' GLN . 57.4 mtp180 -102.03 -30.7 11.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 30' ' ' TYR . . . -170.05 -170.58 34.61 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.797 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -89.95 150.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 117.63 0.715 . . . . 0.0 109.715 176.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.8 t -137.79 178.91 6.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CD2' ' HG2' ' A' ' 50' ' ' GLU . 58.3 m-85 -84.61 172.65 11.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.81 82.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 0.0 110.775 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -157.31 -179.48 8.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.231 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 14.5 tt0 -76.77 -15.56 59.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.616 -174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -87.56 4.46 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.023 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 6.3 tp10 -56.63 127.56 32.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.909 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.9 m -120.02 121.64 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.895 0.379 . . . . 0.0 110.767 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 52.0 mt -72.73 -16.59 61.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.432 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -98.68 2.63 47.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.218 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.909 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 14.0 t70 -86.77 -178.55 6.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.73 -18.46 23.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -116.8 108.33 15.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.777 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.48 105.49 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.406 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 1.1 m -101.17 120.86 40.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.209 -175.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mt -112.98 127.74 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 124.1 39.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.974 0.416 . . . . 0.0 110.937 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.62 173.15 18.2 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.093 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -163.45 179.57 7.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 150.38 20.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.679 0.276 . . . . 0.0 110.967 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.477 ' HE2' ' HB3' ' A' ' 66' ' ' ASP . 40.6 t80 -134.37 152.12 51.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.2 mt -81.45 -53.86 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' HE2' ' A' ' 64' ' ' PHE . 23.0 t70 -64.86 -42.52 94.81 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' A' ' 70' ' ' TYR . 22.8 mtp180 -106.98 110.18 63.46 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.605 -175.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.59 -8.73 20.82 Favored 'Trans proline' 0 CA--C 1.516 -0.379 0 C-N-CA 123.188 2.592 . . . . 0.0 112.222 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.443 HD21 ' HB3' ' A' ' 24' ' ' ASP . 17.3 t-20 -161.77 86.29 0.64 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.236 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.475 ' HB3' ' HE ' ' A' ' 67' ' ' ARG . 20.7 p90 -113.16 -150.29 0.46 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 22.0 mp0 -44.48 -56.29 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.358 0.411 . . . . 0.0 111.561 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' HD2' ' C ' ' A' ' 71' ' ' GLN . 2.5 m-85 -128.12 106.77 9.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.91 -64.04 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.974 0.416 . . . . 0.0 110.597 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -83.58 21.27 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.53 0.681 . . . . 0.0 110.13 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 75' ' ' LEU . 6.9 tt -60.87 -21.56 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.886 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -9.63 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.129 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.44 -3.28 52.47 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 111.299 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.45 162.47 25.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -135.98 -173.52 3.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.291 -178.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 ptpp? -72.93 11.41 0.69 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.27 46.96 0.43 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 m -83.47 132.41 34.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.853 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 73.2 mmm -79.89 102.48 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.121 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 39.2 t -90.25 132.32 35.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.054 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 72.4 m-85 -114.28 121.65 44.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -111.17 109.91 20.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.075 0.464 . . . . 0.0 110.14 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 30.3 mmtm -81.43 106.44 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.833 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 52' ' ' LEU . 9.2 p -142.04 132.99 25.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 111.264 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.32 -91.92 0.14 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.405 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -140.46 4.03 1.95 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.43 0.634 . . . . 0.0 109.812 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -110.51 164.57 12.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.391 0.615 . . . . 0.0 111.397 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 m -122.89 92.17 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.995 171.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 19.5 mmt180 -74.36 121.42 21.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.065 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.26 131.36 41.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.697 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 89.1 m-85 -127.08 149.08 50.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.853 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -117.53 123.52 46.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.4 mtt -81.82 71.13 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.26 0.552 . . . . 0.0 110.588 -176.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.8 t -83.52 -21.92 32.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.911 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.6 m -118.62 110.37 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -129.93 128.85 65.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.531 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.582 HH21 HG13 ' A' ' 110' ' ' VAL . 28.2 ptt180 -170.42 -175.06 1.81 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . 2.7 p30 -126.87 152.2 47.36 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 170.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 110' ' ' VAL . 12.3 m -127.44 126.15 66.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -174.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.563 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -73.04 158.32 87.28 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.008 171.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.36 -14.06 18.9 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.729 2.286 . . . . 0.0 112.639 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 104' ' ' LYS . 68.6 p -87.88 -3.41 58.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.039 0.447 . . . . 0.0 111.053 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.563 ' HB2' ' HD2' ' A' ' 104' ' ' LYS . 14.2 t70 -82.74 116.77 22.24 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.87 8.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.09 -39.13 23.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.067 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG13 HH21 ' A' ' 101' ' ' ARG . 19.6 m -77.84 -23.04 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.373 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.39 -27.1 63.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.784 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.46 97.58 10.55 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.194 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -18.38 109.47 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.896 -1.956 . . . . 0.0 114.448 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.455 ' HB2' HE22 ' A' ' 120' ' ' GLN . 1.7 mp0 -78.52 115.6 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.053 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.57 179.52 5.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.267 173.518 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.27 -16.91 48.66 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.24 178.85 4.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.162 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -89.07 -148.44 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.52 109.01 0.55 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.455 HE22 ' HB2' ' A' ' 114' ' ' GLN . 13.1 pt20 -101.79 118.07 36.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.496 0.665 . . . . 0.0 110.019 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HG ' HD21 ' A' ' 123' ' ' LEU . 20.9 tp -83.5 102.11 11.88 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.1 m -90.7 96.83 10.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.256 -174.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.59 HD21 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mt -90.64 102.67 15.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.814 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.1 mt -95.53 97.15 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.252 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.7 m -96.53 98.26 10.08 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.82 100.68 7.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 128' ' ' ASP . 23.7 t70 -136.0 83.23 2.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.725 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 11.3 t70 166.94 99.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.065 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -87.66 132.42 34.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 22.7 t-20 -103.94 114.19 28.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.573 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.52 -19.2 46.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 0.0 111.332 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -63.15 -38.14 90.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.166 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.485 HG22 ' OD1' ' A' ' 130' ' ' ASN . 14.2 t -131.85 -11.28 3.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 0.0 111.611 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.43 26.95 26.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.743 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.54 -177.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 117.09 0.445 . . . . 0.0 110.905 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.725 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 58.3 m95 -115.78 104.49 11.71 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 130' ' ' ASN . 43.2 mt-10 -67.86 -58.91 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.953 -172.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 128' ' ' ASP . 26.7 ttpp -80.97 91.34 6.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.184 0.992 . . . . 0.0 110.582 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -93.99 100.85 12.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.335 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -74.82 125.59 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.981 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.93 119.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.987 0.899 . . . . 0.0 111.191 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HD2' ' SD ' ' A' ' 97' ' ' MET . 10.4 m-85 -108.67 108.9 19.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.314 175.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 72.0 t -94.22 106.63 18.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.282 0.563 . . . . 0.0 109.956 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.509 ' HB2' ' HG2' ' A' ' 97' ' ' MET . . . -105.14 108.5 20.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.76 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.5 m -79.47 137.26 37.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.433 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 38.0 tt0 -55.6 123.59 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 96' ' ' LYS . 5.7 t -80.81 154.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.41 ' HG2' HG12 ' A' ' 147' ' ' VAL . 10.6 ptpt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.525 -0.75 . . . . 0.0 112.189 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 92.9 mttt . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.752 0.311 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.519 ' CB ' ' HB ' ' A' ' 88' ' ' VAL . 36.7 Cg_endo -64.66 124.8 13.77 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.755 2.304 . . . . 0.0 111.532 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -153.18 177.12 11.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.589 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 31' ' ' PRO . 45.9 mt -106.37 105.3 53.82 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.131 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.21 169.68 12.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.675 2.25 . . . . 0.0 112.674 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 17.4 mtpp -84.96 -21.21 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.787 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.44 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 25.5 t70 -68.89 108.46 3.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.062 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 29.9 mttp -90.5 19.05 5.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.877 -168.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -112.11 8.35 19.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 35.8 mttp -111.87 178.67 4.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.531 0.681 . . . . 0.0 112.146 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.703 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -82.58 -41.85 19.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.286 0.565 . . . . 0.0 110.189 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.97 160.76 33.28 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 38.2 m-85 -102.06 133.47 46.83 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -101.82 114.19 40.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.59 0.709 . . . . 0.0 110.269 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.6 mt-10 -114.95 117.09 29.64 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.042 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 65.0 mt -131.15 94.03 28.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.01 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.36 -16.12 52.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.259 2.64 . . . . 0.0 112.794 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB3' ' OG ' ' A' ' 82' ' ' SER . 33.7 t70 -81.91 -28.43 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.557 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.81 20.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.998 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.41 20.26 10.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.585 0.707 . . . . 0.0 111.21 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 72.0 mt -91.09 114.7 28.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.437 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.8 mppt? -142.79 84.9 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.637 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 4.4 mt-10 -146.41 158.65 46.84 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.782 0.325 . . . . 0.0 111.581 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 73.6 Cg_endo -77.0 136.61 16.63 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.907 2.404 . . . . 0.0 112.627 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.64 134.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.146 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' SER . 35.1 m-85 -97.32 121.49 58.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.581 . . . . 0.0 111.13 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.584 ' HB2' HG23 ' A' ' 7' ' ' ILE . 86.0 Cg_endo -85.92 148.37 9.46 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.334 2.689 . . . . 0.0 112.705 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.91 -169.52 36.56 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.891 172.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 35' ' ' THR . 81.7 Cg_endo -76.85 13.18 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 123.808 3.006 . . . . 0.0 112.77 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.83 75.57 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.164 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 33' ' ' PRO . 72.8 p -97.33 164.53 17.51 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.664 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.34 -37.93 81.78 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.203 1.935 . . . . 0.0 111.339 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.4 mm-40 -59.14 -44.25 92.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.777 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.817 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.2 mp0 -59.68 -42.95 94.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.49 -9.58 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.811 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.56 -31.76 12.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.735 0.303 . . . . 0.0 111.155 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.7 ptp180 -87.24 -19.84 27.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.989 0.423 . . . . 0.0 110.614 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.76 -127.26 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.287 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 60' ' ' ALA . 93.9 t -126.92 141.66 45.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.817 ' HB2' ' HB3' ' A' ' 38' ' ' GLN . 41.8 t -119.74 163.65 17.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.214 0.53 . . . . 0.0 110.775 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 7' ' ' ILE . 55.6 m-85 -71.87 159.66 33.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.754 172.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.46 -49.12 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -140.07 166.32 24.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.14 -19.83 46.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.28 0.562 . . . . 0.0 110.043 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.04 4.8 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.068 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.24 163.47 23.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.992 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 23.2 t -122.36 177.1 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 15' ' ' ALA . 85.0 mt -110.17 -16.08 13.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.641 0.257 . . . . 0.0 111.171 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.09 12.11 16.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.893 0.854 . . . . 0.0 109.374 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.992 ' HB2' ' HB3' ' A' ' 51' ' ' SER . 3.1 t70 -79.31 179.18 7.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.413 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -21.85 46.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -131.3 129.24 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.638 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.3 mp -129.68 101.75 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.549 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 5.4 m -93.04 125.33 37.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.5 mt -119.13 138.88 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.527 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.91 122.35 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.51 166.7 14.32 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.852 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.57 38.02 0.68 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.326 0.563 . . . . 0.0 111.431 -174.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 56.03 -158.75 0.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 -174.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.453 ' H ' HG22 ' A' ' 63' ' ' THR . 47.5 p90 -120.47 178.61 4.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.442 0.639 . . . . 0.0 112.344 -170.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 62.2 mt -128.27 -53.68 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.011 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.42 49.02 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.196 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 16.9 mmt180 -142.76 105.49 5.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.161 -175.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.62 -16.5 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.971 1.781 . . . . 0.0 111.601 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -154.78 82.31 1.09 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.749 -176.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -122.17 -176.97 3.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.637 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -38.24 -71.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 2.5 m-30 -105.66 76.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.765 -0.584 . . . . 0.0 111.446 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.89 -58.36 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.674 0.749 . . . . 0.0 110.259 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -100.34 21.05 13.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.407 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.475 HD23 ' OG1' ' A' ' 125' ' ' THR . 40.8 tp -63.75 -23.18 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.786 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -13.54 62.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.976 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.05 9.72 26.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.662 0.268 . . . . 0.0 111.299 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.491 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -91.67 141.39 28.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.45 . . . . 0.0 111.333 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 82' ' ' SER . 10.6 mptt -109.71 -179.0 3.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.805 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.8 ptpt -57.3 -41.37 79.72 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.49 47.65 1.32 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.719 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.552 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -66.82 -17.21 64.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.596 0.358 . . . . 0.0 111.895 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.66 86.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.52 0.676 . . . . 0.0 111.727 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -88.37 114.81 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.251 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 76.1 m-85 -101.43 105.4 16.42 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.79 106.93 19.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.7 mmtp -90.91 92.57 8.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.11 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.8 m -90.67 92.37 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.672 0.748 . . . . 0.0 110.179 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.58 -88.99 0.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.51 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.05 0.28 5.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.151 0.501 . . . . 0.0 110.083 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.864 ' HB2' HG23 ' A' ' 88' ' ' VAL . 9.5 mm-40 -92.18 119.03 31.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.495 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 m -92.54 106.04 18.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.576 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -94.96 136.57 35.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -114.55 118.85 34.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -177.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.583 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 71.9 m-85 -118.03 145.7 44.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.398 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -110.23 138.76 46.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.8 mmt -81.0 68.06 7.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.141 0.496 . . . . 0.0 110.15 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -75.73 -20.9 58.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.859 -172.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 51.0 m -133.03 101.59 5.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.175 0.512 . . . . 0.0 111.17 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 97' ' ' MET . 78.5 mt -119.03 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.266 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -157.97 176.2 12.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.355 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 10.6 p-10 -134.98 128.39 32.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.976 0.417 . . . . 0.0 110.135 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.902 HG11 HG11 ' A' ' 110' ' ' VAL . 31.6 m -129.05 179.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.39 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.422 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -102.99 158.0 32.62 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.075 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 139' ' ' ARG . 19.8 Cg_endo -61.75 -15.19 40.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.929 2.419 . . . . 0.0 112.585 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.3 t -96.26 -7.13 36.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.905 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.78 97.94 9.98 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.635 ' HA ' HD21 ' A' ' 111' ' ' LEU . 29.6 m -100.06 8.25 8.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.821 0.343 . . . . 0.0 111.715 -170.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -93.43 -15.47 25.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.902 HG11 HG11 ' A' ' 103' ' ' VAL . 22.5 m -76.44 -23.71 15.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.547 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -97.41 34.54 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.09 0.471 . . . . 0.0 111.064 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -70.16 169.66 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.25 105.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.459 0.647 . . . . 0.0 110.789 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -82.21 45.33 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.466 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -77.48 174.57 10.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.33 175.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.86 13.25 78.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.744 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -110.44 -170.69 1.69 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.082 0.468 . . . . 0.0 110.193 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.73 -163.58 0.86 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -62.35 110.02 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.11 143.22 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.237 0.541 . . . . 0.0 111.446 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.494 HD23 ' HB ' ' A' ' 57' ' ' ILE . 70.6 mt -96.27 125.22 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.316 174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 12.0 m -97.69 92.43 5.88 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.3 mm? -87.45 100.69 12.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.236 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.98 97.84 7.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.475 ' OG1' HD23 ' A' ' 75' ' ' LEU . 2.4 m -102.91 102.11 12.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.963 0.411 . . . . 0.0 109.925 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 20.6 m -85.89 100.4 12.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -115.5 177.55 4.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.342 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.26 83.34 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.739 0.649 . . . . 0.0 111.003 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.697 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -102.91 170.67 7.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.413 0.625 . . . . 0.0 111.919 -172.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -104.9 92.34 4.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.058 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 38.2 mt-10 -44.56 -37.9 3.86 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.36 -29.01 70.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 135' ' ' VAL . 8.6 t -126.44 -14.84 5.76 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.509 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.687 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 133' ' ' THR . 16.3 m -75.15 146.48 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 117.437 0.618 . . . . 0.0 110.251 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.697 ' CE3' ' HB3' ' A' ' 129' ' ' TYR . 85.1 m95 -94.14 111.91 23.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -70.6 -53.73 14.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.382 -172.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -90.71 85.09 5.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 0.0 111.405 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 35.7 ptt180 -80.64 79.94 7.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 85.0 tttt -70.15 123.23 21.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.067 -174.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -107.8 125.52 64.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.687 0.756 . . . . 0.0 110.741 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.2 m-85 -109.05 110.83 22.2 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 84.3 t -96.91 103.33 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.405 0.621 . . . . 0.0 109.556 176.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -101.75 102.37 13.0 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.35 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -87.62 139.5 30.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 7.3 tt0 -55.21 128.61 34.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.941 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 5.9 p -96.48 155.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.128 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.089 -175.263 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' HE2' ' A' ' 17' ' ' TYR . 83.6 mtp . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.528 0.204 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' NE2' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -156.96 -171.8 3.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.733 177.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.41 136.86 38.44 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.6 mtmt 54.6 94.69 0.05 OUTLIER Pre-proline 0 C--O 1.233 0.197 0 O-C-N 123.729 0.643 . . . . 0.0 110.674 -169.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' LEU . 29.2 Cg_endo -57.78 115.02 2.22 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.899 2.399 . . . . 0.0 112.954 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.515 ' HG2' ' NE2' ' A' ' 2' ' ' GLN . 2.6 pt20 -146.84 168.22 21.97 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.752 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.735 HG23 ' HB2' ' A' ' 31' ' ' PRO . 46.6 mt -104.18 120.88 49.49 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.39 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 7' ' ' ILE . 2.4 Cg_endo -83.88 179.68 4.62 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.122 2.548 . . . . 0.0 112.321 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -79.1 -25.24 43.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.05 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.38 116.21 8.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 110.259 177.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -92.89 16.33 12.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.735 -176.573 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 t -108.54 -29.09 8.95 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -89.3 174.37 7.87 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.207 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.63 128.67 52.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.057 -175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.446 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -80.77 -41.24 23.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.09 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.77 164.09 35.61 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.443 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 72.7 m-85 -107.36 140.88 39.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.899 0.35 . . . . 0.0 110.267 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.4 tp -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.364 0.602 . . . . 0.0 110.113 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.1 mt-10 -120.76 111.88 18.15 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.638 0.732 . . . . 0.0 111.262 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.8 mt -124.86 93.91 45.1 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.002 -0.999 . . . . 0.0 108.75 176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.71 -28.71 87.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.006 2.471 . . . . 0.0 112.283 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -71.0 -23.19 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.934 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.75 7.3 18.5 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.905 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.7 t70 64.68 27.21 13.17 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.703 0.763 . . . . 0.0 110.458 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 84.6 mt -106.64 122.28 60.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.0 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.27 75.2 1.47 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 167.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 67.8 mm-40 -122.0 162.02 39.43 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.68 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 69.0 Cg_endo -77.09 128.05 9.64 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.793 2.328 . . . . 0.0 113.321 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.5 t -92.15 124.93 44.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.83 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 44' ' ' SER . 62.8 m-85 -93.76 123.26 60.26 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.246 0.545 . . . . 0.0 110.966 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.735 ' HB2' HG23 ' A' ' 7' ' ' ILE . 68.6 Cg_endo -76.14 107.92 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.64 2.227 . . . . 0.0 111.289 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -155.9 167.22 33.18 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 119.734 -1.222 . . . . 0.0 112.8 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 88.5 Cg_endo -87.58 31.75 0.43 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.889 3.059 . . . . 0.0 112.544 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 62.25 26.88 16.12 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.202 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 t -70.32 142.61 89.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.722 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -39.44 -55.52 1.55 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.861 3.04 . . . . 0.0 114.852 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -64.41 -24.06 67.5 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.8 tp60 -69.4 -39.63 77.84 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.14 0.495 . . . . 0.0 109.698 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 94.0 mt -80.96 -23.41 38.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -70.19 -24.52 63.14 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.403 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -103.86 -22.65 13.47 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.049 -0.261 . . . . 0.0 111.674 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -175.3 -156.68 14.95 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.161 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.465 HG11 ' CE1' ' A' ' 72' ' ' PHE . 28.5 m -92.27 154.58 3.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.808 0.337 . . . . 0.0 110.262 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 29.6 t -135.51 163.37 30.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.993 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 58' ' ' SER . 31.1 m-85 -74.67 162.34 28.82 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.82 -38.49 70.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.931 0.396 . . . . 0.0 110.689 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -137.9 176.14 8.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.666 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.745 0.783 . . . . 0.0 109.305 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -88.33 -22.08 24.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.855 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -76.58 171.97 13.78 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.941 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 66.5 m -154.1 165.32 36.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.948 0.404 . . . . 0.0 110.543 -177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.521 HD13 ' CG2' ' A' ' 88' ' ' VAL . 15.7 mt -79.43 -13.46 59.57 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.971 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -101.29 -3.06 29.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.584 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -82.66 170.92 14.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.228 -0.897 . . . . 0.0 108.97 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -85.94 -20.76 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -107.69 108.01 19.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.644 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.98 111.66 30.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 171.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 12.2 m -117.31 116.6 27.54 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.877 0.37 . . . . 0.0 111.014 -174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.0 mt -102.71 121.12 53.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.227 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -84.04 116.44 22.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.338 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.6 114.31 3.81 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.188 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -87.9 84.62 6.98 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.3 m -68.85 140.37 55.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.534 175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.83 150.88 40.52 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 110.308 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 88.4 mt -91.98 -43.34 13.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -50.72 -43.52 57.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.353 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' A' ' 67' ' ' ARG . 24.5 mtp85 -100.18 124.29 43.79 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.856 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -87.42 -16.62 3.1 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.788 2.326 . . . . 0.0 113.012 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -138.84 73.41 1.43 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.184 0.516 . . . . 0.0 110.888 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -119.33 -161.16 0.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' HG2' ' HG3' ' A' ' 27' ' ' GLU . 43.8 mt-30 -60.21 -77.76 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' CE1' HG11 ' A' ' 43' ' ' VAL . 3.1 m-85 -84.59 19.02 2.09 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -168.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.23 -47.63 78.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.347 0.594 . . . . 0.0 111.04 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -101.96 12.03 37.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -172.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.0 tt -66.94 -16.73 64.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.365 0.602 . . . . 0.0 110.337 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -8.88 56.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.787 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.35 1.72 56.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.93 0.395 . . . . 0.0 110.933 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.1 165.56 23.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.111 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 97' ' ' MET . 11.2 pttm -158.08 -170.92 3.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.896 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.1 ptpt -54.4 -39.14 66.97 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -169.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -117.68 59.78 0.47 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 119.602 -1.285 . . . . 0.0 112.443 -178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.4 m -84.22 -5.22 59.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.56 85.34 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.638 0.586 . . . . 0.0 111.694 -177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 45.5 t -86.66 112.31 22.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.96 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.56 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 65.2 m-85 -100.84 107.93 19.6 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.269 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.551 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 12.6 t80 -99.11 102.1 13.68 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -82.7 88.97 6.71 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.361 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG2' HD13 ' A' ' 52' ' ' LEU . 7.5 p -117.44 124.43 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.087 0.47 . . . . 0.0 111.589 -170.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.24 -57.1 1.13 Allowed Glycine 0 CA--C 1.509 -0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.718 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -169.11 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.427 0.632 . . . . 0.0 110.223 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -88.06 154.94 20.07 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.252 -172.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 m -98.0 100.92 12.28 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.33 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 51.1 mmt-85 -82.27 112.43 19.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.116 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.803 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.09 128.78 42.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.376 0.607 . . . . 0.0 110.56 177.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 72.1 m-85 -121.92 151.43 40.73 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.395 177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.601 ' HE3' HG21 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -117.67 138.28 52.09 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 176.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.673 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 19.3 mmt -80.61 68.35 6.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.263 0.554 . . . . 0.0 110.311 -175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -78.92 -38.8 36.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.713 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.616 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 33.4 m -110.27 103.68 12.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.053 0.454 . . . . 0.0 110.546 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.8 mt -123.49 126.06 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.117 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.426 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 7.1 ptm180 -159.77 -175.59 5.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 172.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.517 ' HB3' ' HD3' ' A' ' 140' ' ' LYS . 3.3 p30 -136.4 144.79 44.71 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.811 HG11 HG11 ' A' ' 110' ' ' VAL . 28.7 m -126.41 -169.16 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.787 -177.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.615 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -136.89 160.39 66.48 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.422 -176.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.87 -20.82 30.65 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.645 2.23 . . . . 0.0 112.307 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.1 p -91.7 8.21 38.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.037 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.429 ' HB2' ' HE2' ' A' ' 104' ' ' LYS . 24.7 t0 -107.71 97.3 7.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.6 m -104.99 16.2 6.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.222 0.534 . . . . 0.0 110.591 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -104.74 -2.32 25.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.328 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.811 HG11 HG11 ' A' ' 103' ' ' VAL . 13.5 m -96.83 -39.77 9.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.979 0.419 . . . . 0.0 110.899 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.525 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -86.35 86.96 7.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 122.462 1.125 . . . . 0.0 108.743 173.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -155.7 -164.39 1.72 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.991 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.509 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 7.1 pt-20 -77.7 71.26 4.17 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 111.344 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -86.3 47.88 1.54 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.509 ' HE2' ' HB2' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -71.64 172.57 9.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.203 -176.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 108.14 -14.21 36.99 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -92.6 175.21 6.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 110.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -89.62 -157.32 0.45 Allowed 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 108.49 1.09 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -104.4 130.62 52.27 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 110.498 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -96.09 104.02 15.94 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.0 m -88.67 98.22 11.56 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.469 -176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -83.13 103.06 12.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 38.8 mt -96.71 89.51 2.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.876 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 m -95.48 101.8 13.55 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.228 -175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 37.8 m -84.06 115.58 22.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.693 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -120.33 158.56 26.84 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.131 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 t70 70.14 98.97 0.06 Allowed 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.91 0.757 . . . . 0.0 110.986 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -86.58 130.02 34.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.619 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -97.16 101.51 13.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.5 -17.16 64.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.573 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -71.16 -27.73 63.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 7.2 t -133.9 -23.44 1.77 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.79 26.73 8.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.641 175.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.88 174.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 117.027 0.413 . . . . 0.0 110.963 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -110.83 116.95 32.14 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -70.7 -50.95 30.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.149 -170.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.748 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 11.0 mmpt? -95.07 100.41 12.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.158 0.504 . . . . 0.0 111.243 -174.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.503 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 68.7 mtm180 -91.9 83.59 5.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.517 ' HD3' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -64.58 129.69 40.81 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.293 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.67 114.57 38.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 122.234 1.016 . . . . 0.0 110.851 -173.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.647 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 67.4 m-85 -108.12 104.7 14.17 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.01 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 37.8 t -90.97 93.25 4.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.703 0.763 . . . . 0.0 109.671 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.626 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -88.39 105.14 17.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.661 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.3 m -84.37 142.61 30.03 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.803 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -53.38 114.45 1.5 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.052 0.453 . . . . 0.0 109.873 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.601 HG21 ' HE3' ' A' ' 96' ' ' LYS . 7.3 p -94.28 148.63 4.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.351 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.444 -179.745 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.503 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -104.62 172.64 6.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.022 0.439 . . . . 0.0 110.848 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.75 90.65 8.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.172 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 55.2 mtmt -105.43 101.93 34.41 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.843 175.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.697 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 18.9 Cg_endo -57.38 126.67 22.74 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.31 2.673 . . . . 0.0 112.349 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -158.06 162.39 38.08 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.944 -175.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.474 HG23 ' HB2' ' A' ' 31' ' ' PRO . 22.6 mt -99.36 123.32 48.87 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.807 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.77 -172.75 1.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.864 2.376 . . . . 0.0 113.008 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -90.92 -14.45 31.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.546 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -95.45 145.56 25.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.85 0.357 . . . . 0.0 110.628 -177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mtmm -99.55 5.34 46.06 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.039 -174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 m -111.34 9.75 21.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.573 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -110.34 171.96 7.15 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.268 0.556 . . . . 0.0 111.644 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 68.7 t -101.51 118.0 47.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.81 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -92.32 -25.07 18.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.285 0.564 . . . . 0.0 110.233 176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.96 177.92 45.21 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.292 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 69.1 m-85 -123.78 136.5 54.45 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -109.99 103.88 16.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 122.256 1.027 . . . . 0.0 110.085 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -115.2 108.66 16.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.71 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.487 HG12 HG13 ' A' ' 84' ' ' VAL . 25.4 mt -121.34 94.88 48.66 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.212 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.48 -28.02 70.53 Favored 'Trans proline' 0 CA--C 1.517 -0.359 0 C-N-CA 122.745 2.297 . . . . 0.0 111.225 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 34.2 t70 -67.45 -24.94 65.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.572 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -118.01 11.81 13.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.321 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.1 t0 59.39 30.01 19.65 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.657 0.741 . . . . 0.0 111.063 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.466 HD12 HD12 ' A' ' 20' ' ' ILE . 84.5 mt -97.78 121.96 48.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.085 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 2.4 mppt? -145.03 80.73 1.62 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' HB3' HE22 ' A' ' 71' ' ' GLN . 14.4 mm-40 -154.01 158.82 32.49 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-O 120.644 0.259 . . . . 0.0 111.517 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 71.1 Cg_endo -75.06 163.52 35.07 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.922 2.414 . . . . 0.0 113.054 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -107.82 133.41 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.809 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -106.45 118.87 53.55 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.325 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 75.1 Cg_endo -85.69 162.8 10.72 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.924 2.416 . . . . 0.0 113.224 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 157.01 -173.75 34.62 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.457 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -76.75 6.52 4.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.233 2.622 . . . . 0.0 112.517 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 65.15 75.44 0.36 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.956 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.674 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 71.1 p -111.61 163.95 16.27 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.414 172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.674 ' HD2' ' HB ' ' A' ' 35' ' ' THR . 53.8 Cg_exo -38.28 -48.04 2.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 124.092 3.195 . . . . 0.0 115.361 -173.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -71.08 -30.14 66.18 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.687 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.5 mp0 -64.93 -43.59 92.25 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.837 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.0 12.08 6.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.91 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.501 ' HA ' ' HZ ' ' A' ' 64' ' ' PHE . 55.2 t-20 -107.77 -47.44 3.6 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.449 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 41' ' ' ARG . 13.3 ptm180 -83.58 -26.0 30.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.278 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.4 -139.86 2.75 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.339 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.554 HG12 HE21 ' A' ' 71' ' ' GLN . 11.6 p -124.57 145.28 32.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.687 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 62.4 m -133.31 -177.39 4.5 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -170.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -95.82 166.79 11.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.477 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -40.36 96.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.042 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -149.2 170.48 18.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.141 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -78.18 -23.49 47.58 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -84.62 -1.47 56.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -61.34 145.37 51.72 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.2 m -128.04 150.67 49.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.753 0.311 . . . . 0.0 111.032 -177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.8 mt -80.8 -16.57 53.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.388 0.613 . . . . 0.0 110.221 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.27 -4.33 58.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.632 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.83 164.3 22.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.229 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.36 -21.85 59.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.114 177.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.77 145.55 44.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.884 0.373 . . . . 0.0 110.16 176.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' HB ' HD23 ' A' ' 121' ' ' LEU . 4.0 mp -125.99 115.05 41.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.839 178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 m -88.99 107.2 18.9 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.611 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.1 mt -105.02 122.9 58.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.72 126.71 42.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.192 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -98.7 158.98 20.31 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.07 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -149.39 93.95 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.423 ' HA ' ' CE2' ' A' ' 70' ' ' TYR . 2.8 m -62.09 148.51 43.99 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.651 -176.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.501 ' HZ ' ' HA ' ' A' ' 40' ' ' ASN . 88.5 m-85 -118.19 172.21 7.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.662 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 64.0 mt -105.01 -42.12 6.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.852 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -86.89 -4.99 59.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.724 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -117.72 111.14 39.65 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 121.17 -0.212 . . . . 0.0 110.737 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -75.58 -10.01 20.15 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.812 2.341 . . . . 0.0 112.347 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -155.64 84.49 1.04 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.312 0.577 . . . . 0.0 110.966 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 63' ' ' THR . 10.2 p90 -108.56 -168.87 1.41 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 169.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.554 HE21 HG12 ' A' ' 43' ' ' VAL . 10.0 mm100 -38.33 -69.79 0.11 Allowed 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.464 ' CE1' HG21 ' A' ' 43' ' ' VAL . 19.5 m-30 -114.41 78.81 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.233 -0.292 . . . . 0.0 111.625 -176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.02 -50.86 2.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.566 0.698 . . . . 0.0 110.508 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 64.0 t30 -87.17 30.62 0.76 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.157 -172.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.77 -9.54 54.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.915 0.388 . . . . 0.0 111.371 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.36 -9.62 59.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.033 0.444 . . . . 0.0 111.003 177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -94.16 -6.86 43.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.1 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.572 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -79.77 127.14 31.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.58 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -111.54 -169.08 1.39 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.465 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -63.04 -44.62 95.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.641 -176.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -99.92 52.94 0.99 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.678 -1.249 . . . . 0.0 110.892 177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.4 t -62.96 -21.64 66.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.167 -0.516 . . . . 0.0 111.404 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.409 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 50.17 76.01 0.16 Allowed 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.513 -174.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.8 t -81.46 122.68 36.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.24 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -100.11 99.69 10.44 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.188 0.518 . . . . 0.0 109.753 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -101.52 109.58 21.41 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 92' ' ' THR . 94.5 mttt -97.21 135.5 39.06 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.081 -174.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 5.2 m -141.36 107.95 2.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.032 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.85 -102.2 0.55 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.352 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.525 HD22 ' H ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -115.26 5.65 14.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.809 0.338 . . . . 0.0 110.868 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 88' ' ' VAL . 40.9 mt-10 -102.43 113.63 27.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.451 HG23 ' HG2' ' A' ' 87' ' ' LYS . 19.0 m -95.57 97.5 9.8 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 171.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 93' ' ' ARG . 16.9 mtp85 -93.27 135.88 34.06 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.192 -172.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -98.68 130.56 45.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.538 ' HB3' ' HB1' ' A' ' 144' ' ' ALA . 92.7 m-85 -122.63 137.26 54.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.93 0.395 . . . . 0.0 110.611 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.615 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -109.69 131.3 55.19 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -178.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 22.4 mmt -80.73 76.1 7.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.389 0.614 . . . . 0.0 110.379 -175.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 t -86.97 -12.05 48.71 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.789 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 41.7 m -137.11 100.62 4.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.148 0.499 . . . . 0.0 110.504 177.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.485 HD11 ' HB3' ' A' ' 97' ' ' MET . 74.4 mt -119.5 122.27 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.353 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -161.2 -176.73 5.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.905 0.383 . . . . 0.0 110.653 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.653 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 1.1 p30 -131.52 141.02 49.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 110' ' ' VAL . 35.3 m -121.17 -176.0 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.143 0.497 . . . . 0.0 111.226 -176.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.502 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -111.48 157.2 39.85 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.644 -176.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 17.8 Cg_endo -60.21 -10.89 14.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.681 2.254 . . . . 0.0 112.643 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -117.16 17.89 14.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.26 129.91 39.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.795 0.331 . . . . 0.0 110.228 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.6 m -123.89 30.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.63 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.96 -7.15 9.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.688 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.555 HG11 HG11 ' A' ' 103' ' ' VAL . 16.0 m -92.39 -19.11 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.3 0.571 . . . . 0.0 110.323 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.519 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -101.2 19.97 16.61 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 173.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -116.19 145.14 43.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.388 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 49.34 67.53 0.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.536 0.522 . . . . 0.0 111.375 -174.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.39 89.51 7.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.619 0.724 . . . . 0.0 109.369 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.07 160.6 28.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.587 -1.188 . . . . 0.0 112.297 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.27 62.08 0.8 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.103 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -59.84 176.64 0.28 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.331 0.586 . . . . 0.0 111.178 172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -83.04 -170.12 2.87 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 167.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 55' ' ' GLN . 4.4 mptp? -64.09 112.69 3.11 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -117.12 131.79 56.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.311 0.577 . . . . 0.0 111.204 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.435 HD23 ' HB ' ' A' ' 57' ' ' ILE . 67.4 mt -86.01 121.22 28.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.991 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.8 m -102.88 94.78 5.76 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 24.9 mt -83.84 100.33 10.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.923 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.3 mt -90.54 93.47 4.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.747 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.3 m -98.25 95.78 7.62 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.111 -175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.2 m -78.82 111.92 15.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.606 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.17 178.41 6.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.708 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.21 82.28 0.18 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.566 0.698 . . . . 0.0 110.233 -175.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -83.54 126.45 32.82 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.529 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -95.48 100.85 12.55 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.34 -18.07 65.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.481 -174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -74.53 -27.21 60.43 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 135' ' ' VAL . 8.1 t -124.58 -20.33 5.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.783 0.325 . . . . 0.0 111.191 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.67 46.39 6.39 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.538 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 133' ' ' THR . 5.6 p -139.76 156.7 26.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.669 0.271 . . . . 0.0 110.355 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -93.76 115.28 27.7 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -76.05 -40.32 53.56 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -170.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -104.26 126.9 51.76 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.458 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -103.73 89.2 3.26 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.653 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 51.6 tptt -71.86 123.21 22.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.1 tt -121.01 124.01 71.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.869 0.842 . . . . 0.0 111.03 -174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.583 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 21.0 m-85 -113.99 108.11 16.58 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.837 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.9 t -99.52 106.06 18.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.431 0.634 . . . . 0.0 110.088 178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.66 112.08 25.03 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.268 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.6 m -87.06 139.23 30.78 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.085 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -61.82 117.82 6.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.441 0.639 . . . . 0.0 111.291 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.6 HG11 ' HE3' ' A' ' 96' ' ' LYS . 3.3 p -114.11 134.35 57.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.5 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.409 ' H ' ' HG2' ' A' ' 148' ' ' LYS . 4.6 ptpp? . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.392 -0.813 . . . . 0.0 111.106 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -69.84 -170.25 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.428 0.632 . . . . 0.0 110.742 175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.35 99.62 7.13 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.118 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HE3' ' OD1' ' A' ' 53' ' ' ASP . 40.4 mtpt -133.12 88.5 36.17 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.571 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HG2' HG22 ' A' ' 88' ' ' VAL . 20.0 Cg_exo -66.21 145.37 78.19 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.004 2.47 . . . . 0.0 112.442 -178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -123.99 154.21 40.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.097 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.544 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.8 mp -73.64 122.77 88.4 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -65.81 167.36 17.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.917 2.411 . . . . 0.0 112.752 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -78.85 -12.55 60.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.29 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -99.15 118.82 36.72 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.673 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -95.53 21.86 7.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.385 -173.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.8 m -108.33 4.23 24.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.292 0.568 . . . . 0.0 110.322 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.525 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 98.5 mttt -102.94 -176.56 3.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.099 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.49 135.22 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.222 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.634 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -97.53 -35.43 10.64 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 110.493 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.07 163.29 34.22 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 49.8 m-85 -106.24 134.93 48.59 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.0 tp -100.33 108.1 22.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.834 0.825 . . . . 0.0 109.782 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 26' ' ' LYS . 59.0 mt-10 -115.8 111.02 19.88 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.232 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG12 HG13 ' A' ' 84' ' ' VAL . 46.2 mt -124.42 92.33 48.21 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.722 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -52.82 -34.62 66.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.317 2.678 . . . . 0.0 112.957 -175.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.602 ' OD1' ' HE2' ' A' ' 79' ' ' LYS . 5.4 m-20 -58.6 -38.38 77.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.659 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -103.53 8.92 37.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.307 -175.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.8 t70 54.72 38.72 30.58 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.239 -175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.537 HG23 ' HG2' ' A' ' 27' ' ' GLU . 65.5 mt -100.75 127.67 53.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.257 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.559 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -143.57 29.77 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.843 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 7.0 mm-40 -88.74 149.05 43.09 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.965 -163.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.76 141.58 24.69 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.293 1.996 . . . . 0.0 111.795 173.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.87 124.75 55.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.515 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -95.77 108.92 43.36 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.791 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.58 ' HG3' ' HB2' ' A' ' 15' ' ' ALA . 87.9 Cg_endo -76.69 152.0 32.66 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.851 2.367 . . . . 0.0 112.744 -174.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.66 -167.78 33.16 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.421 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.44 30.63 0.53 Allowed 'Trans proline' 0 CA--C 1.519 -0.253 0 C-N-CA 123.494 2.796 . . . . 0.0 112.445 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.85 82.9 0.16 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.528 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.21 137.51 24.84 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.048 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.586 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 18.9 Cg_endo -58.7 -27.42 83.28 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.935 2.423 . . . . 0.0 113.381 -175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.445 ' O ' ' HB3' ' A' ' 40' ' ' ASN . 41.8 mt-10 -90.87 -33.62 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -76.63 -30.91 57.08 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.004 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.0 tp -84.89 -5.05 59.34 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.94 0.876 . . . . 0.0 109.367 175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 48.3 t-20 -81.47 -56.05 4.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.283 174.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -82.8 -26.4 31.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.224 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.89 -136.47 3.31 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.339 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG12 HE21 ' A' ' 71' ' ' GLN . 14.8 p -140.33 147.35 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.6 t -130.26 -171.79 2.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.852 0.358 . . . . 0.0 110.181 -175.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -93.1 174.46 7.22 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.329 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.87 -52.82 8.79 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -127.99 177.02 7.16 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.124 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -79.47 -18.04 52.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -82.43 -2.16 52.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.934 0.397 . . . . 0.0 110.755 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.26 138.43 57.61 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 38.4 m -122.38 -172.83 2.54 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.634 HD11 ' HB1' ' A' ' 15' ' ' ALA . 65.7 mt -111.95 -18.71 12.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.632 -179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' OD1' ' HE3' ' A' ' 4' ' ' LYS . 36.7 t70 -126.52 13.1 7.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.801 0.81 . . . . 0.0 110.184 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 18.8 t70 -81.17 160.83 24.26 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.239 176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -66.34 -25.53 66.87 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.826 0.346 . . . . 0.0 110.293 -179.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -108.72 110.71 22.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.789 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.9 mm -119.2 90.19 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.0 m -92.83 108.73 20.22 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.158 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.9 mt -102.58 121.47 53.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.36 115.46 27.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA3' ' CD2' ' A' ' 72' ' ' PHE . . . -123.63 167.04 15.95 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.403 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -154.16 153.66 32.21 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.463 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 20.0 m -84.91 141.71 30.2 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CE2' ' HB3' ' A' ' 66' ' ' ASP . 45.3 t80 -125.23 107.92 11.22 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -51.39 -39.27 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.143 -0.935 . . . . 0.0 113.27 -171.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.464 ' HB3' ' CE2' ' A' ' 64' ' ' PHE . 18.8 t70 -73.23 -22.06 60.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -169.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -109.45 129.74 23.56 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.96 -0.462 . . . . 0.0 111.069 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -94.72 -5.0 2.27 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.976 2.451 . . . . 0.0 113.152 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -143.91 77.44 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.287 0.565 . . . . 0.0 110.67 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 30.6 p90 -140.54 -166.97 2.24 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.804 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.843 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 5.7 mm100 -43.55 -77.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.075 0.859 . . . . 0.0 112.738 -174.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.402 ' CD2' ' HA3' ' A' ' 61' ' ' GLY . 23.8 m-85 -106.2 79.66 1.42 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.065 0.46 . . . . 0.0 111.002 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 m -111.48 -52.18 2.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.658 0.742 . . . . 0.0 109.862 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 63.5 t30 -97.5 19.92 12.58 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.211 -177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.1 tp -64.21 -16.47 62.05 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.206 -177.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -9.73 50.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.717 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.26 16.32 11.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.83 147.69 22.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.944 0.402 . . . . 0.0 111.167 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.602 ' HE2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -150.59 -172.66 4.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.407 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 97' ' ' MET . 20.1 ptmt -47.05 -49.78 20.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.388 0.885 . . . . 0.0 113.388 -171.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -115.59 59.96 0.42 Allowed Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 119.71 -1.233 . . . . 0.0 112.294 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . 30.5 m -79.61 -2.44 42.57 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.886 -0.185 . . . . 0.0 111.43 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 49.7 78.01 0.1 Allowed 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.587 0.554 . . . . 0.0 111.453 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 41.5 t -79.69 112.3 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.722 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -97.86 109.15 21.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.852 0.358 . . . . 0.0 110.084 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -94.07 101.89 13.93 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.8 tptm -85.63 92.22 8.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.768 -176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.483 HG22 ' HG2' ' A' ' 5' ' ' PRO . 7.3 p -119.47 126.6 75.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.18 0.514 . . . . 0.0 111.091 -174.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.03 -101.02 0.27 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.942 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -125.22 1.85 7.84 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 0.0 110.273 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -104.23 132.39 50.53 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.18 -174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m -101.7 87.16 3.08 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -92.85 128.93 38.89 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.137 0.494 . . . . 0.0 110.456 -176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.586 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -96.44 139.16 32.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.741 -173.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 77.8 m-85 -122.67 148.88 44.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.784 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.599 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -119.16 132.26 55.95 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.66 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 61.6 mtt -82.53 69.67 9.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.379 0.609 . . . . 0.0 110.562 -176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.8 t -75.7 -26.97 58.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.224 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.613 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 16.2 m -120.19 108.77 14.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.567 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -125.31 126.77 71.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.728 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.565 HH22 ' HB2' ' A' ' 109' ' ' GLU . 25.5 ptt180 -168.1 -177.07 3.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.245 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -120.66 139.96 52.28 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 110' ' ' VAL . 31.3 m -129.43 -178.01 2.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.824 -177.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -105.55 157.64 34.07 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.271 177.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -21.49 72.06 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.447 2.098 . . . . 0.0 111.637 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.6 t -118.8 26.9 9.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.6 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.545 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 19.3 t70 -63.04 152.84 35.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.934 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 25.5 m -95.16 -14.11 8.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.926 0.393 . . . . 0.0 111.376 -170.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.565 ' HB2' HH22 ' A' ' 101' ' ' ARG . 43.4 mt-10 -88.44 -29.55 20.11 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.124 0.488 . . . . 0.0 109.749 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 103' ' ' VAL . 22.9 m -79.34 -6.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.391 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 86.0 mt -88.32 3.29 50.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.287 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -109.63 -172.51 2.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.349 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -130.45 112.26 13.06 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -74.14 74.13 1.76 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 111.277 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.75 161.29 30.38 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.282 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.01 6.09 63.6 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -114.43 -179.49 3.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.265 0.555 . . . . 0.0 110.691 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -94.56 -154.74 0.43 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.464 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 9.6 mmtm -64.45 123.91 20.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.88 104.6 16.54 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.719 177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 144' ' ' ALA . 25.3 tp -78.32 100.76 6.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -93.71 99.48 11.88 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.002 -172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.3 mm? -80.5 99.72 8.19 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.7 mt -91.41 110.74 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.146 -178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 7.1 m -110.42 95.3 5.48 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.115 0.483 . . . . 0.0 111.247 -176.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.505 ' HB3' ' CB ' ' A' ' 136' ' ' TRP . 69.2 m -89.7 101.23 13.92 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 175.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -121.8 2.63 10.03 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.665 ' HB2' ' HG2' ' A' ' 138' ' ' LYS . 7.1 t70 -119.86 96.38 5.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -70.58 130.57 42.17 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.294 -178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.456 ' HB2' ' HG2' ' A' ' 137' ' ' GLU . 50.1 t-20 -97.62 116.87 30.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.321 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.65 -24.73 62.76 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -72.22 -21.22 61.43 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.522 HG23 HG22 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -141.2 -34.81 0.48 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -174.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.86 2.51 34.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.817 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 133' ' ' THR . 17.2 m -86.73 -174.58 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.754 0.311 . . . . 0.0 110.89 178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.505 ' CB ' ' HB3' ' A' ' 126' ' ' CYS . 54.5 m95 -114.68 126.65 55.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 130' ' ' ASN . 34.7 mm-40 -77.6 -74.72 0.24 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -175.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.665 ' HG2' ' HB2' ' A' ' 128' ' ' ASP . 22.8 pttm -85.13 131.03 34.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.446 0.641 . . . . 0.0 110.432 -175.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -116.48 97.96 6.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.927 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -66.18 126.7 29.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 174.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.4 tt -126.21 122.71 62.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.656 0.741 . . . . 0.0 110.812 -175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.574 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.5 m-85 -108.82 112.13 24.23 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 174.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.613 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 33.8 t -95.55 96.32 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.473 0.654 . . . . 0.0 109.723 177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -96.93 109.89 22.53 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.332 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.7 m -81.75 140.38 34.3 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.961 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -59.59 119.8 8.25 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.455 0.472 . . . . 0.0 110.566 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.599 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 10.0 t -85.89 137.8 20.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.94 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 8.5 mmpt? . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.915 -176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtm . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 120.528 0.204 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -92.27 13.07 20.33 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 120.951 0.405 . . . . 0.0 110.812 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.87 108.66 5.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.338 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -122.21 94.62 47.85 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.944 171.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.4 127.31 17.91 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.691 2.261 . . . . 0.0 111.399 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -140.73 127.68 20.64 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.65 0.738 . . . . 0.0 110.967 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.615 HG13 HD21 ' A' ' 52' ' ' LEU . 7.0 mt -59.95 131.01 89.14 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.14 178.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.28 160.8 26.1 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.722 2.282 . . . . 0.0 111.407 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 9' ' ' LYS . 20.1 ptmt -79.23 -15.78 57.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.76 0.314 . . . . 0.0 111.196 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.416 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 33.7 t70 -79.99 122.17 26.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.107 0.48 . . . . 0.0 110.727 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -85.12 20.04 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.669 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.0 t -126.79 10.26 7.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.744 0.307 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.565 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 93.8 mttt -105.74 174.78 5.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.947 0.403 . . . . 0.0 110.76 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -105.88 117.87 52.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.881 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.64 -31.99 23.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.202 0.525 . . . . 0.0 110.409 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.05 173.21 45.12 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.259 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 80.8 m-85 -117.13 137.55 52.23 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.39 114.8 38.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.253 0.549 . . . . 0.0 109.574 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 66.1 mt-10 -117.93 106.16 12.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.426 0.632 . . . . 0.0 111.28 -176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.0 mt -120.94 95.3 48.95 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.93 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HG3' ' HE2' ' A' ' 85' ' ' TYR . 18.6 Cg_endo -59.95 -30.36 91.53 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.946 2.431 . . . . 0.0 112.212 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.473 ' OD1' ' HD2' ' A' ' 79' ' ' LYS . 30.4 t0 -66.28 -30.86 71.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.57 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 74' ' ' ASN . . . -107.2 3.53 25.72 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.468 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.7 t0 61.73 23.08 13.48 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.99 0.9 . . . . 0.0 110.583 -178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 65.2 mt -90.35 106.88 17.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.124 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -133.04 83.43 2.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.554 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 31.9 mm-40 -133.8 159.37 72.7 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.925 -173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.49 148.22 18.24 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.669 2.246 . . . . 0.0 113.337 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.85 128.09 61.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.075 176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' SER . 65.2 m-85 -100.58 117.97 61.81 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.606 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.565 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 52.3 Cg_endo -68.19 150.16 76.67 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.866 2.377 . . . . 0.0 112.575 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 154.07 177.7 27.76 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.427 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 48' ' ' GLU . 94.6 Cg_endo -79.19 30.99 0.46 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.323 2.682 . . . . 0.0 112.757 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HB1' HD22 ' A' ' 39' ' ' LEU . . . 60.22 38.8 19.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.721 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.414 ' HB ' ' OE1' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -53.73 127.21 51.32 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.328 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -41.36 -59.54 0.81 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.994 3.129 . . . . 0.0 114.555 -170.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 41.3 mt-10 -74.42 -35.99 63.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.414 ' OE1' ' HB ' ' A' ' 35' ' ' THR . 23.3 mp0 -69.77 -35.24 74.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.275 0.56 . . . . 0.0 110.361 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.427 HD22 ' HB1' ' A' ' 34' ' ' ALA . 17.2 tp -84.18 -10.97 57.31 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.839 0.828 . . . . 0.0 109.453 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 37' ' ' GLU . 52.3 t30 -66.63 -49.69 65.42 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.778 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -90.79 -23.25 20.68 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.386 -175.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.34 -147.07 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.701 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.613 HG22 ' HG2' ' A' ' 71' ' ' GLN . 16.0 m -132.65 152.56 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 5.5 t -137.05 -171.75 3.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.688 0.28 . . . . 0.0 110.402 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -103.09 171.75 7.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.442 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.475 ' HB2' ' HB2' ' A' ' 58' ' ' SER . . . -63.68 -47.63 80.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 110.173 177.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -127.29 162.34 26.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.681 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 9.6 pt-20 -74.26 -17.48 60.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.021 178.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -109.9 30.44 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.623 0.725 . . . . 0.0 109.857 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' O ' HD12 ' A' ' 7' ' ' ILE . 4.9 tp10 -62.83 146.36 52.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.153 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 37.7 m -120.05 120.14 35.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.102 0.477 . . . . 0.0 111.506 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.917 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.7 mm? -71.22 -17.56 62.5 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.702 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -92.72 0.88 57.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.524 0.678 . . . . 0.0 110.322 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.9 t70 -83.05 -172.48 4.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.692 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.98 -30.19 18.95 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.84 132.55 56.61 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.109 -176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.464 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.4 mp -135.56 108.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 173.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 20.2 m -101.02 124.69 47.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.998 0.427 . . . . 0.0 111.175 -174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -109.57 125.31 66.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.818 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.05 127.43 37.51 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.149 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 72' ' ' PHE . . . -139.89 170.71 24.16 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.586 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -169.07 165.28 11.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.583 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.7 m -75.1 143.16 43.51 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 6.0 t80 -122.06 152.8 39.43 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.78 0.324 . . . . 0.0 110.635 -173.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.3 mt -99.43 -47.28 12.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.027 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.545 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -58.98 -46.03 89.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.965 -174.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -101.77 124.43 40.51 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.835 0.35 . . . . 0.0 111.328 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.6 5.76 6.19 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.805 2.337 . . . . 0.0 110.763 170.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -149.86 80.3 1.38 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.707 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -126.76 -160.25 0.98 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.009 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.613 ' HG2' HG22 ' A' ' 43' ' ' VAL . 1.5 mp0 -59.44 -78.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.478 ' CD1' ' HA3' ' A' ' 61' ' ' GLY . 22.5 m-30 -91.09 31.66 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -169.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.526 HG23 ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -63.82 -24.41 67.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.269 -179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.4 ' O ' ' HB1' ' A' ' 23' ' ' ALA . 64.7 t30 -134.95 36.0 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 111.723 -173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.89 13.78 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.589 -0.695 . . . . 0.0 111.271 177.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.9 pttp -89.97 -22.09 22.1 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.227 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.53 21.64 8.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.982 -174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -95.85 153.94 17.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.482 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' HD2' ' OD1' ' A' ' 22' ' ' ASP . 4.6 mptt -132.6 -168.16 2.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.0 ptpp? -69.67 -23.94 63.53 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.855 0.359 . . . . 0.0 111.67 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -121.88 56.34 0.64 Allowed Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 119.855 -1.165 . . . . 0.0 112.709 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.9 m -81.42 -10.45 59.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 57.01 90.43 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.451 0.643 . . . . 0.0 111.344 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.3 t -95.06 109.53 22.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.25 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.455 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 73.1 m-85 -94.56 114.35 26.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.44 ' HB2' HD11 ' A' ' 121' ' ' LEU . 9.2 t80 -98.95 104.81 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 18.8 tptp -87.3 83.89 7.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.469 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.917 HG21 ' HG ' ' A' ' 52' ' ' LEU . 7.1 p -113.85 131.85 64.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.926 0.393 . . . . 0.0 110.678 -173.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.55 -103.02 0.55 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.61 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -127.54 8.81 6.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.393 0.139 . . . . 0.0 111.227 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -124.41 158.52 32.55 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 112.159 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.5 m -124.63 108.89 12.51 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.857 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 85' ' ' TYR . 97.9 mtt180 -100.14 146.6 26.63 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.186 -0.205 . . . . 0.0 110.591 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.85 120.14 39.69 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.571 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 94.6 m-85 -112.67 141.28 46.64 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.582 ' HD2' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -111.42 133.21 53.89 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.586 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.3 mtt -81.4 63.61 5.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.527 0.679 . . . . 0.0 110.465 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -71.26 -32.27 68.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.462 -174.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.584 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 65.3 m -114.26 97.69 6.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.6 mt -114.51 138.7 43.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.844 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -162.22 -178.45 6.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.515 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -126.48 140.01 52.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.888 HG23 ' HG3' ' A' ' 139' ' ' ARG . 7.7 m -114.2 147.5 17.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.259 0.552 . . . . 0.0 111.073 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -85.77 159.08 55.71 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.623 -176.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 137' ' ' GLU . 31.2 Cg_endo -64.79 -22.83 63.35 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.604 2.203 . . . . 0.0 111.596 177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -106.66 8.5 31.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.145 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.543 ' HB2' ' HB2' ' A' ' 104' ' ' LYS . 11.7 t70 -85.13 142.22 29.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.277 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.75 11.07 8.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.951 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -83.49 -28.27 28.83 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.291 0.567 . . . . 0.0 109.505 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.52 -26.42 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.844 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.03 9.91 37.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.872 0.368 . . . . 0.0 111.516 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 7.9 t70 -100.93 -175.09 2.78 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.036 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.406 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 4.2 pt-20 -115.22 102.74 10.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.18 0.514 . . . . 0.0 110.477 -174.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -79.52 95.27 5.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.869 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.502 ' H ' ' HD2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -99.08 -175.96 3.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.413 178.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.07 -4.83 84.74 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.192 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -98.47 -174.31 2.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.81 -158.62 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -64.5 111.82 2.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 171.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.71 151.75 47.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.328 0.585 . . . . 0.0 112.209 -173.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.464 HD23 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -106.98 121.59 44.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.433 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 27.5 m -95.78 98.93 10.82 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.062 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 8.7 mt -85.03 101.07 12.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.131 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 53.1 mt -92.01 92.64 3.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -101.62 101.17 11.67 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.317 0.579 . . . . 0.0 111.183 -172.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 76.9 m -84.06 105.07 14.65 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.874 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -98.8 -27.27 14.01 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.485 ' CG ' ' HD3' ' A' ' 138' ' ' LYS . 16.0 t70 -114.71 100.29 8.14 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.276 0.56 . . . . 0.0 111.14 -170.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -87.14 122.76 31.39 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.441 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -91.04 107.3 19.11 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.23 -27.15 67.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.986 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -65.13 -34.74 79.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -173.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.506 HG23 HG12 ' A' ' 135' ' ' VAL . 9.9 t -126.16 -5.6 6.68 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.32 0.581 . . . . 0.0 110.625 -177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 70.93 52.52 14.06 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.931 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.506 HG12 HG23 ' A' ' 133' ' ' THR . 9.0 p -142.23 150.17 18.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.433 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 46.6 m95 -92.69 98.0 11.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.741 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 42.7 mt-10 -72.42 -64.87 0.86 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.16 0.505 . . . . 0.0 111.101 -175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.741 ' HD2' ' HB2' ' A' ' 137' ' ' GLU . 8.4 mptt -81.58 109.23 15.82 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.597 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.888 ' HG3' HG23 ' A' ' 103' ' ' VAL . 11.9 ptt180 -121.38 114.75 21.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.451 -178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.414 ' HE2' ' CE2' ' A' ' 142' ' ' PHE . 19.9 tptm -83.79 127.35 33.75 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.671 -178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.404 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 15.2 tt -120.1 128.44 75.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.578 0.704 . . . . 0.0 110.975 -175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.8 m-85 -115.84 116.09 27.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.026 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 41.3 t -98.86 96.43 5.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -95.73 116.04 28.3 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.775 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 m -96.34 145.17 25.84 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.696 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -53.04 122.56 9.61 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.58 0.55 . . . . 0.0 110.691 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.542 HG21 ' HE3' ' A' ' 96' ' ' LYS . 15.0 p -122.99 150.78 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.498 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.433 ' HG2' ' H ' ' A' ' 148' ' ' LYS . 14.9 ptpt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.326 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.608 ' SD ' ' HA2' ' A' ' 89' ' ' GLY . 60.9 mtt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -83.01 -177.23 6.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.154 0.502 . . . . 0.0 111.323 -178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.75 165.48 17.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.574 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt 53.94 93.77 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 123.709 0.631 . . . . 0.0 111.155 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.66 130.44 24.87 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 123.051 2.501 . . . . 0.0 113.612 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -143.55 161.33 38.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.088 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 31' ' ' PRO . 3.5 mp -90.89 126.82 54.26 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.597 0.237 . . . . 0.0 110.676 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.71 -175.31 2.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.117 2.545 . . . . 0.0 111.701 175.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -82.24 -17.77 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.663 -178.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -90.07 121.51 32.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.266 0.555 . . . . 0.0 110.517 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -106.5 16.54 24.53 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.136 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 m -102.46 3.48 37.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.728 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -122.35 168.6 11.87 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.846 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.8 t -93.89 119.4 41.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.221 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -94.19 -21.62 18.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.944 0.402 . . . . 0.0 110.532 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.29 164.41 37.17 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.318 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 79.7 m-85 -119.87 144.77 47.2 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.5 tp -101.71 108.49 23.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.812 0.815 . . . . 0.0 109.564 175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.78 108.62 17.68 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.193 -175.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.431 HG12 HG13 ' A' ' 84' ' ' VAL . 41.7 mt -126.42 91.24 48.09 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.096 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 21.5 Cg_endo -61.55 -25.75 79.81 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.942 2.428 . . . . 0.0 112.164 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.562 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 33.8 t70 -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.028 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -110.29 8.31 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.57 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.3 t70 63.47 27.62 15.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.747 0.784 . . . . 0.0 110.652 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 88.6 mt -104.2 114.62 44.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.298 -175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.2 mppt? -142.37 82.1 1.77 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.514 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 11.2 mm-40 -134.02 159.99 70.26 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.054 -173.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 67.4 Cg_endo -75.17 144.91 30.24 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.918 2.412 . . . . 0.0 113.442 -178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.6 t -107.81 128.37 63.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.623 173.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -97.63 114.6 65.15 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.557 ' HB2' HG23 ' A' ' 7' ' ' ILE . 86.1 Cg_endo -78.67 142.22 17.93 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.757 2.305 . . . . 0.0 112.431 -174.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.42 -161.43 28.19 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.912 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 59.8 Cg_endo -88.18 30.02 0.45 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.911 3.074 . . . . 0.0 113.312 -175.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.22 56.84 4.88 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.63 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.38 138.02 95.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.671 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.37 -58.62 1.3 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.252 3.302 . . . . 0.0 114.076 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.49 -34.44 76.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.648 0.261 . . . . 0.0 111.696 -176.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -81.2 -36.34 30.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.426 . . . . 0.0 110.847 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.41 -14.72 59.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.621 0.724 . . . . 0.0 109.575 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -73.91 -42.66 60.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.168 176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 41' ' ' ARG . 12.9 ptm180 -86.13 -40.39 15.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.521 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.88 -157.11 8.15 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.603 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.445 HG23 HE21 ' A' ' 71' ' ' GLN . 40.2 t -113.26 142.67 24.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.0 t -130.64 -174.73 3.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -93.67 160.05 14.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.886 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.22 -29.26 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.445 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -135.78 165.55 25.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.004 0.431 . . . . 0.0 110.946 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 37.6 tt0 -82.8 -32.12 27.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.748 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -85.47 31.05 0.59 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.119 0.485 . . . . 0.0 111.167 -176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -85.68 151.41 23.9 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.838 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 47.1 m -122.93 150.21 43.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.752 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 93.6 mt -93.02 6.8 46.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.785 0.326 . . . . 0.0 111.746 -177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -132.68 8.34 4.18 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.706 0.765 . . . . 0.0 109.547 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.838 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 15.6 t70 -81.71 164.26 21.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.288 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 119' ' ' LYS . 1.2 tm0? -67.78 -29.05 68.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.035 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -119.48 138.37 53.19 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.794 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 64.5 mt -140.0 117.82 10.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.858 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 m -100.23 103.4 14.85 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.045 -175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.5 mt -98.31 114.81 36.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.41 123.77 48.58 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.1 167.63 21.71 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.196 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 -139.74 128.86 23.74 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.491 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 4.3 m -52.71 110.43 0.51 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.342 0.591 . . . . 0.0 111.282 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 66' ' ' ASP . 13.8 t80 -80.88 129.48 34.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.93 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.4 mm -75.0 -49.65 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.403 -175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.43 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . 3.1 m-20 -74.19 -1.35 20.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.23 -175.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 85.0 mtm180 -130.24 94.38 30.54 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.86 -13.5 34.5 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.812 2.341 . . . . 0.0 112.515 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -147.33 63.27 1.16 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.445 0.641 . . . . 0.0 110.167 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 9.7 p90 -99.12 -157.79 0.63 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.514 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.4 OUTLIER -43.57 -75.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.506 0.504 . . . . 0.0 112.123 178.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.541 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 22.2 m-30 -100.03 77.17 1.98 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.044 0.45 . . . . 0.0 111.971 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.84 -52.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.808 173.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.554 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 10.7 t30 -88.62 11.94 16.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.047 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.83 -23.16 64.89 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.958 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -70.1 -8.29 48.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.944 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.72 5.12 41.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.777 175.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.634 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . . . -96.16 135.15 38.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.438 0.637 . . . . 0.0 111.23 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 82' ' ' SER . 3.5 mppt? -108.86 -172.94 2.15 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.015 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -64.21 -30.62 71.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.827 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.82 49.69 0.83 Allowed Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.108 -1.044 . . . . 0.0 111.246 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.522 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 6.7 t -66.07 -21.09 66.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.112 -0.544 . . . . 0.0 111.53 -177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.413 ' CE ' ' HB3' ' A' ' 94' ' ' LYS . 0.1 OUTLIER 53.91 83.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.518 0.675 . . . . 0.0 111.547 -175.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 74.4 t -85.2 125.15 40.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.185 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -106.03 108.42 19.93 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.276 0.56 . . . . 0.0 110.337 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.75 103.07 15.76 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.0 tppp? -86.86 90.69 8.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.983 -176.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.0 m -117.42 129.12 74.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -175.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.608 ' HA2' ' SD ' ' A' ' 1' ' ' MET . . . 63.78 -88.17 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.494 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -148.18 11.07 0.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.89 0.376 . . . . 0.0 110.155 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 145.57 41.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.206 0.527 . . . . 0.0 111.33 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.9 m -109.18 107.11 17.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.372 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -99.74 137.0 38.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.938 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.413 ' HB3' ' CE ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -102.89 139.01 39.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.85 0.357 . . . . 0.0 110.519 -177.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -133.27 142.52 48.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.023 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -107.63 136.76 46.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.9 mmt -80.64 70.37 7.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.4 0.619 . . . . 0.0 110.108 -178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -83.64 -4.69 58.8 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.895 -172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 20.2 m -144.02 105.82 4.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.093 0.473 . . . . 0.0 110.587 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.43 HD11 ' HB3' ' A' ' 97' ' ' MET . 77.3 mt -122.08 123.27 68.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.924 -177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -165.23 -166.58 1.02 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.213 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.666 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 4.5 p-10 -142.98 144.97 32.54 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 173.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.691 HG23 ' HE ' ' A' ' 139' ' ' ARG . 11.3 m -132.07 154.17 39.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.269 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.46 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -97.09 164.86 16.94 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.785 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -67.19 -18.35 50.77 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.473 2.115 . . . . 0.0 111.229 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.8 t -103.91 12.86 33.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' HG13 ' A' ' 110' ' ' VAL . 7.6 t70 -74.63 154.76 38.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.432 ' HA ' HD21 ' A' ' 111' ' ' LEU . 28.5 m -96.11 -15.26 7.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.04 0.448 . . . . 0.0 110.857 -172.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -91.15 -5.06 55.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.332 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG13 ' HB3' ' A' ' 107' ' ' ASP . 21.8 m -83.6 -17.93 10.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.818 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -112.49 18.5 18.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.032 178.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -86.91 167.58 14.17 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.388 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -67.34 139.44 57.22 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.804 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -83.63 143.29 30.2 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.38 170.0 13.15 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.588 -166.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.13 51.78 2.87 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.254 -177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -83.1 177.0 8.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.508 -0.346 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.13 -156.25 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 170.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.516 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 19.1 mmtm -60.7 115.45 3.66 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -106.34 112.04 24.89 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.979 -177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.7 mt -78.55 105.38 9.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.9 m -91.57 93.73 9.09 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.683 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 3.2 mm? -77.65 99.1 5.67 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.578 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.51 103.11 14.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.043 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.0 m -117.67 89.72 3.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.007 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 64.0 m -73.97 104.82 4.96 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -110.54 76.73 1.0 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.569 0.7 . . . . 0.0 110.75 -175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.603 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 16.6 t70 -162.88 -80.38 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.707 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.484 ' CZ ' ' HG2' ' A' ' 131' ' ' GLU . 1.6 t80 61.03 86.67 0.1 Allowed 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.628 0.58 . . . . 0.0 110.384 -172.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -92.79 97.36 10.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.696 175.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.484 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 36.4 mt-10 -60.87 -15.74 33.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.278 -177.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -66.24 -34.79 78.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.938 0.399 . . . . 0.0 110.903 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.9 t -115.55 -14.99 11.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.436 0.636 . . . . 0.0 109.844 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.11 31.89 50.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.029 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 50.5 t -134.86 139.33 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 126' ' ' CYS . 44.1 m95 -78.14 92.26 4.4 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 172.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -80.55 -8.46 59.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.603 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 62.9 tttm -121.13 131.15 54.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 126' ' ' CYS . 19.9 ttp180 -136.57 100.92 4.48 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.34 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.666 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 48.7 tptt -69.1 126.68 30.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.12 124.88 68.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.772 0.796 . . . . 0.0 111.033 -174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.601 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 14.6 m-85 -115.66 116.36 27.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.395 176.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 45.6 t -104.02 103.83 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.322 0.582 . . . . 0.0 110.103 178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.63 114.48 28.2 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.747 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 20.9 m -89.75 140.14 29.88 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.351 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -56.07 126.57 26.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.202 0.525 . . . . 0.0 111.255 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.461 HG11 ' HD3' ' A' ' 96' ' ' LYS . 13.1 p -130.09 160.53 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.229 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.491 -178.13 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -98.42 173.42 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.131 0.491 . . . . 0.0 110.345 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.48 86.66 7.07 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.629 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 87.8 mttt -137.78 103.85 8.33 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.95 177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 35.9 Cg_endo -64.19 135.87 49.05 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.974 2.449 . . . . 0.0 112.181 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -134.41 167.1 21.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.197 0.522 . . . . 0.0 110.519 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 51' ' ' SER . 43.1 mt -107.02 113.78 62.15 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -87.73 177.35 3.65 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.92 2.413 . . . . 0.0 112.292 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -74.65 -24.25 58.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.231 0.539 . . . . 0.0 110.134 177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.21 100.26 0.77 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.015 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -98.68 20.84 12.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 110.608 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.6 m -100.23 -11.86 20.03 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.284 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HB3' ' NZ ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -107.33 176.69 5.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.097 -178.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.97 129.53 41.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.727 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.24 -41.5 9.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.184 0.516 . . . . 0.0 110.301 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 87' ' ' LYS . . . -155.3 176.08 33.04 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.668 179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 71.9 m-85 -122.7 135.98 54.74 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.6 tp -98.63 110.05 25.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.807 0.813 . . . . 0.0 109.776 178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 85.9 mt-10 -119.17 109.62 16.08 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.92 89.6 38.15 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.67 -32.73 76.81 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 123.112 2.541 . . . . 0.0 112.481 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -68.63 -23.78 64.48 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.454 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -107.89 8.12 28.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.137 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.2 t70 65.4 17.65 11.04 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.844 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.556 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 91.2 mt -97.38 131.27 44.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.985 -175.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 37.0 mtpt -156.41 45.73 0.43 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.486 0.66 . . . . 0.0 109.834 175.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HB2' ' HG3' ' A' ' 71' ' ' GLN . 0.8 OUTLIER -106.63 156.87 36.38 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.158 -169.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 57.4 Cg_endo -73.43 148.63 43.28 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 121.91 1.74 . . . . 0.0 112.896 176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.3 t -113.82 134.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 44' ' ' SER . 46.5 m-85 -101.08 144.22 28.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.318 -177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.13 162.52 20.31 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.411 2.074 . . . . 0.0 110.894 175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 153.24 165.2 13.24 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 119.456 -1.354 . . . . 0.0 113.093 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.66 30.24 0.41 Allowed 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 124.041 3.161 . . . . 0.0 113.221 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 57.36 43.39 23.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.763 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.759 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.65 147.24 96.45 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.15 -177.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.637 ' HD2' HG22 ' A' ' 35' ' ' THR . 89.2 Cg_exo -49.04 -53.3 7.23 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.291 2.66 . . . . 0.0 113.965 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.759 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -71.82 -27.08 62.67 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.761 -178.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' A' ' 44' ' ' SER . 42.6 tp60 -62.49 -51.91 65.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.995 175.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.74 -16.83 61.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.445 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -72.62 -40.3 66.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.266 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -68.97 -45.12 71.49 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.051 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.0 -110.19 0.23 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.598 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.3 m -130.71 152.68 37.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.58 0.229 . . . . 0.0 110.679 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 36.9 t -148.18 165.81 29.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.001 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -68.56 162.01 26.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.32 -37.44 25.75 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.858 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HB3' ' H ' ' A' ' 49' ' ' ASN . 21.2 mm-40 -125.61 156.33 39.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.507 0.67 . . . . 0.0 111.562 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.33 -1.65 58.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.856 0.836 . . . . 0.0 108.772 172.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.436 ' H ' ' HB3' ' A' ' 47' ' ' GLU . 27.0 t-20 -91.14 -19.72 22.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.058 -175.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.71 170.51 16.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.991 0.424 . . . . 0.0 110.532 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.535 ' HA ' HD12 ' A' ' 7' ' ' ILE . 56.1 m -146.94 157.63 43.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.525 -176.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HG ' HG13 ' A' ' 7' ' ' ILE . 96.0 mt -73.79 -12.09 60.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 111.939 -175.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -113.5 11.16 18.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.879 0.847 . . . . 0.0 109.844 177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 4.3 t0 -83.21 156.78 23.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.652 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 115' ' ' LYS . 1.1 tm0? -68.15 -32.75 73.24 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.15 120.33 40.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.409 0.623 . . . . 0.0 111.56 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.1 mt -125.75 134.16 67.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.1 p -132.45 121.14 22.93 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.06 0.457 . . . . 0.0 112.022 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mt -108.69 128.45 64.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -89.02 123.57 33.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.033 0.444 . . . . 0.0 111.283 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.34 123.94 7.7 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.762 178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.47 ' HA ' ' C12' ' A' ' 201' ' ' JPT . 3.5 t-160 -70.51 -61.85 1.61 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.505 0.193 . . . . 0.0 110.687 -176.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.1 m 69.09 122.46 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 O-C-N 124.099 0.875 . . . . 0.0 110.693 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -152.63 138.75 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.3 -37.02 76.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.721 -176.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.94 6.94 16.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.339 -176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -136.39 77.47 47.22 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.64 3.65 7.66 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.827 2.351 . . . . 0.0 113.338 -171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -153.19 47.44 0.69 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.973 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -101.5 -175.21 2.79 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 170.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.487 ' HG3' ' HB2' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -34.69 -74.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -177.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.45 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 21.3 m-30 -96.96 81.33 3.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.485 0.66 . . . . 0.0 111.245 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.7 m -150.4 -41.28 0.13 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.174 172.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -91.08 11.9 21.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.462 0.649 . . . . 0.0 109.388 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.5 tp -66.01 -12.53 55.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.948 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -10.13 58.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.069 0.462 . . . . 0.0 111.257 176.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -82.13 -9.77 59.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.496 175.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.17 132.06 35.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.068 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 97' ' ' MET . 26.4 mmtp -120.53 -177.74 3.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.086 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -61.12 -13.77 19.82 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -169.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -132.42 34.23 2.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.547 177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.0 m -82.77 121.86 27.45 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.9 mtp -71.8 108.17 4.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.2 0.524 . . . . 0.0 110.526 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 63.3 t -89.56 115.94 30.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.668 177.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 82.6 m-85 -102.57 121.42 42.35 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.072 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 17' ' ' TYR . 12.0 t80 -112.81 99.06 7.61 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 5.4 mptt -75.25 102.22 4.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.013 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.7 m -96.85 86.73 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.168 0.509 . . . . 0.0 111.561 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.38 -59.25 3.26 Favored Glycine 0 N--CA 1.453 -0.206 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.308 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -137.35 -37.46 0.63 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.844 0.354 . . . . 0.0 111.392 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -107.97 -179.73 3.98 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 6.6 t -132.23 142.57 49.47 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-O 121.397 0.618 . . . . 0.0 109.905 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.7 mmm180 -100.24 132.2 45.75 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.296 -0.865 . . . . 0.0 108.942 177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -99.76 126.48 45.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.942 0.401 . . . . 0.0 110.462 -177.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 83.9 m-85 -125.13 149.94 47.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.38 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.8 tptm -113.17 135.18 54.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.604 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 16.7 mmt -79.9 62.62 4.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.081 0.467 . . . . 0.0 110.396 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -75.62 -8.95 58.07 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.126 -171.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.573 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 55.9 m -145.21 103.3 3.84 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.966 -0.459 . . . . 0.0 110.998 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 97' ' ' MET . 82.6 mt -120.59 128.34 76.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.458 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -161.24 177.42 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.875 0.369 . . . . 0.0 110.345 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -132.16 120.55 22.42 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 34.4 m -75.24 151.28 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.51 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -86.51 148.39 46.51 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.73 -179.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.628 ' HB3' ' HB3' ' A' ' 137' ' ' GLU . 32.8 Cg_exo -62.06 -15.68 45.29 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.697 2.265 . . . . 0.0 112.284 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -99.76 -5.66 28.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.84 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -91.81 133.22 35.83 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.966 0.412 . . . . 0.0 110.415 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.5 m -133.57 24.26 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.112 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -115.89 -28.14 6.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.562 -172.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.6 t -79.18 -22.59 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.475 0.655 . . . . 0.0 110.79 -174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.499 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -99.5 25.53 6.96 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.467 -173.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.91 175.35 7.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.552 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 8.7 pt-20 -72.21 70.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.397 0.618 . . . . 0.0 112.033 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -86.72 75.46 9.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.569 178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -100.11 -179.36 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.838 178.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.31 -2.38 16.29 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -85.44 -170.71 3.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.34 -0.43 . . . . 0.0 109.946 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.75 -158.51 0.4 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 168.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 1.3 mptm? -61.77 104.82 0.48 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -103.05 125.4 49.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.327 0.584 . . . . 0.0 110.54 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.4 tp -91.92 109.72 21.06 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m -96.28 102.26 14.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.572 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.618 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.6 mm? -87.38 100.7 12.93 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.8 mt -91.72 89.18 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.6 m -100.56 99.73 10.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.125 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 83.4 m -60.7 125.26 23.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.745 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.425 ' H ' ' HA ' ' A' ' 139' ' ' ARG . 8.8 t70 -112.08 -21.57 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.041 -160.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.604 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 13.6 t70 -140.85 108.57 5.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.389 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -101.38 130.08 47.51 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.57 0.7 . . . . 0.0 109.924 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -80.67 103.27 10.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.794 -1.093 . . . . 0.0 109.274 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -54.95 -26.07 33.91 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.554 0.575 . . . . 0.0 112.554 -175.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -77.08 -17.45 58.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.554 ' OG1' HG22 ' A' ' 135' ' ' VAL . 16.5 p -126.68 -37.69 2.13 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.536 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 99.85 8.54 51.24 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.939 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.554 HG22 ' OG1' ' A' ' 133' ' ' THR . 30.2 m -98.34 141.51 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-O 120.8 0.333 . . . . 0.0 111.34 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 129' ' ' TYR . 60.4 m95 -87.97 86.65 7.16 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 105' ' ' PRO . 51.2 mt-10 -65.0 -64.19 0.93 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.961 -175.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 35.6 tttm -85.5 126.48 33.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.425 ' HA ' ' H ' ' A' ' 127' ' ' ASP . 0.0 OUTLIER -129.09 139.95 51.78 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.543 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.64 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 27.0 tttp -87.57 145.08 26.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.126 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.25 125.95 48.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.672 0.748 . . . . 0.0 110.936 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.618 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.7 m-85 -111.91 112.71 24.56 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.891 175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 59.3 t -98.15 98.97 7.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.372 0.606 . . . . 0.0 109.649 176.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -98.4 102.87 14.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.201 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.9 m -82.07 139.64 34.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.871 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -57.58 126.01 25.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.492 0.663 . . . . 0.0 110.8 -177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.42 HG22 ' N ' ' A' ' 148' ' ' LYS . 11.9 p -114.05 170.82 4.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.935 -176.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 147' ' ' VAL . 3.2 ptmm? . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.865 -0.588 . . . . 0.0 110.715 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.47 ' C12' ' HA ' ' A' ' 62' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 120.705 0.288 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.5 mp0 -88.13 -14.87 37.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.333 0.587 . . . . 0.0 110.693 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.11 135.72 31.21 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.058 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp 43.3 79.76 0.32 Allowed Pre-proline 0 C--O 1.233 0.211 0 O-C-N 123.859 0.724 . . . . 0.0 111.913 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.33 144.92 69.96 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.6 2.2 . . . . 0.0 112.169 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.79 156.84 47.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.733 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.421 HG23 ' CB ' ' A' ' 31' ' ' PRO . 28.3 mt -107.8 109.6 62.28 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.364 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.689 ' HG2' ' HE3' ' A' ' 13' ' ' LYS . 49.9 Cg_endo -73.35 164.09 36.09 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.418 2.078 . . . . 0.0 111.579 175.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -71.19 -3.22 19.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 -177.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.714 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 19.3 t70 -69.24 145.63 52.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.272 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 22.5 pttp -118.63 9.73 12.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.952 0.406 . . . . 0.0 111.525 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.7 m -95.01 -50.46 5.09 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.056 -0.402 . . . . 0.0 111.35 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.714 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -76.83 162.04 27.96 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 29' ' ' VAL . 14.5 p -96.85 151.6 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.105 174.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.36 -32.12 3.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -137.66 164.27 25.45 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.994 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 59.1 m-85 -129.73 135.17 48.15 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.4 tp -104.98 115.23 46.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.532 0.682 . . . . 0.0 110.154 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -125.17 119.91 29.86 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.891 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 52.1 mt -133.4 95.03 18.57 Favored Pre-proline 0 C--N 1.315 -0.914 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.071 178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.93 -22.55 68.51 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.715 2.277 . . . . 0.0 112.115 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.454 ' HB3' ' OG ' ' A' ' 82' ' ' SER . 27.0 t0 -68.5 -33.02 73.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.392 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.56 2.5 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.584 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.7 t0 57.7 36.56 26.73 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.874 0.845 . . . . 0.0 110.313 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 55.0 mt -102.45 121.49 53.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.624 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -147.06 86.59 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.4 mm-40 -145.26 159.8 47.75 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.617 0.246 . . . . 0.0 111.099 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.2 157.7 45.88 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.837 2.358 . . . . 0.0 113.447 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 14' ' ' VAL . 93.4 t -110.88 123.34 66.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.716 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 44' ' ' SER . 60.0 m-85 -92.42 110.97 48.3 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 121.312 0.577 . . . . 0.0 111.467 -175.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 11' ' ' LYS . 4.7 Cg_exo -77.61 129.82 10.33 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.223 2.616 . . . . 0.0 111.728 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.03 -173.7 43.68 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.918 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 11' ' ' LYS . 3.3 Cg_exo -78.66 10.17 2.94 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 123.542 2.828 . . . . 0.0 112.845 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 67.49 29.92 7.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.663 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -68.56 160.24 77.53 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.454 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.26 -45.32 22.4 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.697 2.931 . . . . 0.0 114.727 -174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.517 ' OE1' ' HG2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -71.79 -30.46 65.56 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.571 -175.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.517 ' HG2' ' OE1' ' A' ' 37' ' ' GLU . 85.2 mm-40 -68.01 -36.84 80.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 0.0 110.339 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 61.6 mt -81.92 -0.61 44.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.037 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -108.32 -12.18 15.09 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.698 0.285 . . . . 0.0 111.001 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.481 ' HD3' ' OE1' ' A' ' 38' ' ' GLN . 10.1 ptm180 -95.36 -25.81 16.14 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.783 0.325 . . . . 0.0 110.576 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 174.0 -122.59 0.91 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.076 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.697 HG12 ' HG2' ' A' ' 71' ' ' GLN . 7.6 p -122.03 144.22 32.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 45.0 p -132.29 -168.27 2.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.456 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 36.6 m-85 -96.28 165.0 12.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.465 176.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.36 95.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.872 0.367 . . . . 0.0 111.446 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -146.35 168.92 19.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.05 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -67.85 -31.77 71.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.808 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -88.3 19.95 3.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.034 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 4.6 mm-40 -64.65 158.4 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.031 173.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.816 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 51.8 m -140.04 123.19 16.8 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.134 0.492 . . . . 0.0 111.737 -174.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD13 ' CG1' ' A' ' 88' ' ' VAL . 30.6 mt -66.22 -26.75 67.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.271 177.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -79.55 -19.98 48.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.79 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.816 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 3.5 t70 -72.29 164.53 26.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.396 -172.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.61 ' HA ' ' HD2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -74.91 -31.19 61.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.054 -178.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.42 133.98 54.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.684 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.5 mt -133.47 121.7 42.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.145 -0.479 . . . . 0.0 109.925 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.3 m -110.09 107.8 17.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.263 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 121' ' ' LEU . 41.1 mt -94.55 111.81 26.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -105.71 123.31 47.72 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.561 -173.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.477 ' HA3' HG23 ' A' ' 43' ' ' VAL . . . -150.58 175.52 29.57 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.088 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -142.11 156.38 45.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.733 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -71.73 140.96 49.79 Favored 'General case' 0 C--N 1.318 -0.763 0 O-C-N 123.361 0.413 . . . . 0.0 111.016 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -100.68 158.53 15.88 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.357 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 63.3 mt -100.49 -38.14 6.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -87.9 -5.07 58.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 67' ' ' ARG . 8.6 mmt180 -113.25 115.36 47.62 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.645 0.259 . . . . 0.0 110.665 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -86.82 -11.66 5.51 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.961 2.441 . . . . 0.0 113.359 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -160.58 89.07 0.81 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.562 0.696 . . . . 0.0 110.514 -173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.733 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 15.4 p90 -130.69 -151.83 0.48 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.809 177.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.697 ' HG2' HG12 ' A' ' 43' ' ' VAL . 25.8 mp0 -55.49 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.83 0.348 . . . . 0.0 111.918 -178.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.539 ' CE1' HG21 ' A' ' 43' ' ' VAL . 21.6 m-85 -94.88 82.07 3.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.154 0.502 . . . . 0.0 111.198 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 m -110.1 -60.96 1.73 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.504 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -95.96 28.12 3.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.239 0.542 . . . . 0.0 110.656 -176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.8 tp -65.13 -19.0 65.77 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.418 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -9.61 58.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.954 0.407 . . . . 0.0 111.518 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.62 11.75 23.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.939 176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -92.28 161.39 14.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.349 177.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -135.27 -176.01 4.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.6 ptmm? -66.52 -13.86 61.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.336 -174.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.66 45.91 1.11 Allowed Glycine 0 C--N 1.318 -0.43 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 174.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.4 t -61.63 -25.33 67.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.09 -0.555 . . . . 0.0 112.117 -175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.52 89.53 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.698 0.761 . . . . 0.0 111.518 -175.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 60.0 t -91.81 125.7 44.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.669 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -102.0 104.47 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 176.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -97.51 106.07 18.32 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 49.5 mttp -83.72 125.02 31.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.225 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG1' HD13 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -130.49 101.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.294 0.568 . . . . 0.0 110.144 -177.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.59 -81.72 0.4 Allowed Glycine 0 C--N 1.317 -0.482 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.421 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 -18.62 4.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.834 0.349 . . . . 0.0 111.242 -176.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -97.52 152.04 19.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.165 0.507 . . . . 0.0 111.483 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -123.53 99.59 6.38 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.61 173.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -93.83 166.35 12.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.734 0.302 . . . . 0.0 110.761 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.564 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -127.55 126.64 42.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.454 0.645 . . . . 0.0 111.894 -170.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.554 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.6 m-85 -116.05 148.22 40.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.454 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.614 ' HB2' HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -117.16 129.47 55.98 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 59.5 mtt -79.86 70.33 6.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.402 0.62 . . . . 0.0 110.703 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 t -80.04 -24.93 40.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.833 -175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.587 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 15.0 m -121.03 102.5 8.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.011 0.434 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.7 mt -113.11 129.98 67.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.17 173.94 11.5 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 121.265 0.555 . . . . 0.0 110.909 177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.515 ' HB3' ' CD ' ' A' ' 140' ' ' LYS . 1.2 p30 -149.36 125.53 10.73 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.865 168.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 110' ' ' VAL . 19.0 m -131.38 -177.16 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.398 -169.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.3 mppt? -103.07 145.19 30.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.762 176.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 136' ' ' TRP . 25.3 Cg_exo -65.62 -12.99 37.58 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.95 2.433 . . . . 0.0 111.95 176.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.1 t -109.02 16.89 22.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.518 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -74.09 168.27 19.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.8 m -113.43 -20.97 5.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.691 0.281 . . . . 0.0 111.033 -175.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -102.83 4.84 38.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.265 0.555 . . . . 0.0 110.777 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.461 HG23 HG21 ' A' ' 103' ' ' VAL . 11.3 p -80.12 -20.16 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.847 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -104.24 12.48 33.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.355 -176.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -67.63 157.32 34.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 0.0 110.251 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.571 ' OE1' ' HE2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -92.9 82.73 4.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.541 0.686 . . . . 0.0 112.022 -174.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -77.02 74.23 3.59 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.482 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.571 ' HE2' ' OE1' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -105.64 174.27 5.95 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 171.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 107.25 -23.1 27.84 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -72.3 158.97 34.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.435 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.462 ' OD1' HG22 ' A' ' 145' ' ' THR . 3.1 p-10 -83.43 -161.71 0.54 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 174.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 55' ' ' GLN . 2.4 tptp -46.86 106.31 0.08 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 123.188 0.305 . . . . 0.0 110.244 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 10.0 pt20 -116.4 135.34 53.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.371 0.605 . . . . 0.0 110.861 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 59' ' ' ILE . 20.7 tp -101.47 109.86 21.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.6 m -94.37 101.27 13.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.49 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.9 mm? -80.49 104.55 11.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.727 177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.473 HG23 ' HD3' ' A' ' 139' ' ' ARG . 53.3 mt -98.84 100.72 11.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 24.6 m -115.6 105.18 12.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.125 0.488 . . . . 0.0 110.833 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 4.5 m -90.99 94.31 9.58 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.453 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 9.6 p-10 -105.05 2.45 29.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.672 -166.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.5 ' HB2' ' HE3' ' A' ' 138' ' ' LYS . 20.8 t70 -127.66 99.18 5.47 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.246 -174.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 87.2 t80 -97.36 127.19 43.11 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.537 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.463 ' OD1' HG22 ' A' ' 133' ' ' THR . 22.1 t-20 -91.28 111.13 22.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.68 -14.43 62.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.4 mttm -85.7 -29.64 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.474 HG23 HG12 ' A' ' 135' ' ' VAL . 10.1 t -124.07 -9.45 7.66 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.366 0.603 . . . . 0.0 110.663 -176.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.78 54.6 11.64 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.727 -0.669 . . . . 0.0 113.062 175.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.474 HG12 HG23 ' A' ' 133' ' ' THR . 4.7 p -149.23 157.52 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 67.8 m95 -88.57 117.9 27.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.2 -24.97 25.89 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' A' ' 128' ' ' ASP . 21.2 pttp -142.78 154.83 44.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.548 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.473 ' HD3' HG23 ' A' ' 124' ' ' ILE . 11.8 ttm180 -121.87 112.99 19.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.529 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.515 ' CD ' ' HB3' ' A' ' 102' ' ' ASP . 51.7 tptt -77.14 123.67 26.73 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.41 HD12 HH11 ' A' ' 139' ' ' ARG . 11.5 tt -127.52 126.96 68.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.765 0.793 . . . . 0.0 111.212 -172.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 83.9 m-85 -117.07 112.95 21.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.8 t -94.23 94.68 4.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 109.302 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -95.96 104.05 15.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.368 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.498 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 0.4 OUTLIER -85.1 151.68 23.96 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.41 ' HB2' ' HB3' ' A' ' 119' ' ' LYS . 7.4 tp10 -55.58 142.4 33.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 110.865 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 96' ' ' LYS . 21.8 t -90.4 144.04 9.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.182 -0.913 . . . . 0.0 112.402 -174.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.941 0.4 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -100.33 4.71 44.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.097 0.475 . . . . 0.0 110.797 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.18 143.53 9.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.192 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 8.8 mmmm 51.22 91.93 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.231 0 O-C-N 123.968 0.792 . . . . 0.0 112.349 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' HB2' HG22 ' A' ' 88' ' ' VAL . 55.7 Cg_endo -71.66 146.45 48.94 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.493 2.128 . . . . 0.0 112.297 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -153.31 -175.75 5.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.135 -175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.597 HG13 ' HG ' ' A' ' 52' ' ' LEU . 25.4 mt -102.08 117.95 60.25 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.716 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.78 168.29 21.19 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.594 2.196 . . . . 0.0 112.109 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HD2' ' N ' ' A' ' 9' ' ' LYS . 4.2 mptp? -84.93 -17.11 38.79 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.379 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.83 125.66 30.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.783 171.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.643 ' HB2' HE22 ' A' ' 38' ' ' GLN . 63.4 pttt -105.88 18.86 21.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 m -94.22 -7.58 41.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.762 -177.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.43 -170.03 1.78 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.225 0.536 . . . . 0.0 111.108 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.04 137.7 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.921 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.26 -34.55 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.359 0.599 . . . . 0.0 110.567 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.68 166.01 39.22 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.569 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 75.8 m-85 -107.86 139.3 42.66 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.266 0.533 . . . . 0.0 110.053 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.408 ' O ' HG22 ' A' ' 25' ' ' ILE . 8.4 tp -101.94 117.48 47.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 34.9 mt-10 -120.78 113.33 20.01 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.477 0.656 . . . . 0.0 110.907 -176.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.428 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 47.9 mt -127.32 94.12 39.34 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.492 176.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 10.1 Cg_endo -53.19 -42.96 61.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.279 2.653 . . . . 0.0 113.3 -172.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -13.71 61.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.678 0.275 . . . . 0.0 111.737 -176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.51 9.5 23.21 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.347 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.72 27.77 16.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.203 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 59.3 mt -96.92 119.99 45.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.329 -175.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 26' ' ' LYS . 24.4 mmmt -141.02 42.7 1.81 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.607 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 11.6 mm-40 -102.66 149.7 37.0 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.338 -165.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.39 135.68 13.53 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.771 2.314 . . . . 0.0 112.54 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.45 123.38 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.808 0.337 . . . . 0.0 110.206 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -94.86 121.82 61.85 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.585 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -79.94 161.13 24.03 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.917 2.412 . . . . 0.0 112.256 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.2 -164.35 26.21 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 119.986 -1.102 . . . . 0.0 113.128 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.93 2.64 8.12 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 123.682 2.921 . . . . 0.0 113.103 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.96 89.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.882 0.738 . . . . 0.0 110.829 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.9 p -119.14 157.46 50.81 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.801 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -46.72 -52.87 6.9 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.695 2.93 . . . . 0.0 114.529 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -33.43 75.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.653 0.263 . . . . 0.0 111.598 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.643 HE22 ' HB2' ' A' ' 11' ' ' LYS . 37.1 tt0 -72.2 -37.68 69.21 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.93 0.395 . . . . 0.0 110.472 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.3 mt -74.35 -18.06 60.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.984 0.421 . . . . 0.0 110.98 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -81.7 -28.98 33.19 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -93.13 -35.79 13.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.673 0.273 . . . . 0.0 111.035 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.448 ' HA2' ' HG3' ' A' ' 71' ' ' GLN . . . -151.39 -137.86 2.71 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.208 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.25 162.32 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.2 m -131.43 172.32 12.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.905 0.383 . . . . 0.0 111.45 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -79.8 166.92 21.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.098 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.34 76.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.426 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -144.94 170.05 16.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.034 0.445 . . . . 0.0 110.962 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -66.09 -25.25 66.92 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.466 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.93 7.39 18.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.167 0.508 . . . . 0.0 110.999 -175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -59.14 148.05 32.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.4 m -139.81 123.5 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.795 0.331 . . . . 0.0 110.946 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.597 ' HG ' HG13 ' A' ' 7' ' ' ILE . 85.4 mt -74.26 -17.39 60.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.448 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.28 13.59 25.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.45 0.643 . . . . 0.0 110.529 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.45 178.08 4.69 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 173.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.567 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 1.5 pt20 -95.72 -22.21 17.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.705 0.288 . . . . 0.0 110.667 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.422 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -106.8 105.63 15.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.724 0.773 . . . . 0.0 110.355 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.8 mt -124.69 133.92 68.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.746 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 3.0 p -124.69 121.87 35.89 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.149 0.5 . . . . 0.0 112.06 -173.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.5 mt -114.07 132.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.528 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.1 130.84 45.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 0.0 111.261 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.68 126.95 6.82 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.897 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -111.81 76.23 0.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.971 0.415 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 m -60.82 134.36 57.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.79 -178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -145.09 150.75 37.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.137 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.4 mt -53.02 -43.24 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 123.713 0.633 . . . . 0.0 112.402 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -79.84 10.76 3.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.162 -174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -131.21 76.41 76.3 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.15 -28.04 11.17 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.791 2.327 . . . . 0.0 113.527 -172.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -140.2 73.5 1.43 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.475 0.655 . . . . 0.0 110.729 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.463 ' CE1' ' HB ' ' A' ' 73' ' ' THR . 1.4 p90 -132.39 155.09 49.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.538 -0.756 . . . . 0.0 108.972 175.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.607 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 10.3 mm100 16.49 -92.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.735 1.214 . . . . 0.0 114.226 169.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -116.7 97.11 5.81 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.677 0.275 . . . . 0.0 110.676 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.463 ' HB ' ' CE1' ' A' ' 70' ' ' TYR . 9.1 t -145.49 -39.34 0.24 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.333 0.587 . . . . 0.0 110.219 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -91.58 26.67 2.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.706 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.651 HD12 HG21 ' A' ' 125' ' ' THR . 19.6 mt -76.22 3.09 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.619 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -76.12 -21.08 57.05 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.189 0.518 . . . . 0.0 110.191 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -92.87 9.69 34.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.133 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.18 154.32 23.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.821 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' H ' ' HB3' ' A' ' 82' ' ' SER . 38.6 pttt -139.43 179.36 6.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.919 0.39 . . . . 0.0 111.109 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 97' ' ' MET . 12.5 ptmm? -66.77 -11.55 55.38 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.102 -175.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.88 59.85 0.55 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 79' ' ' LYS . 6.0 p -74.77 -15.12 60.77 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.52 88.64 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.866 0.729 . . . . 0.0 111.407 -172.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 56.1 t -88.81 124.56 41.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.909 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 88.1 m-85 -107.04 108.54 20.08 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.647 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 17.0 t80 -93.5 101.39 13.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.569 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 17.6 tptm -84.48 85.51 7.4 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.668 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 5' ' ' PRO . 7.8 p -109.85 125.6 67.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.441 0.638 . . . . 0.0 111.064 -173.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 5' ' ' PRO . . . 63.45 -94.47 0.13 Allowed Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.494 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.61 11.82 3.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.668 0.27 . . . . 0.0 111.146 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.8 160.42 26.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.894 0.378 . . . . 0.0 111.005 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 m -124.01 98.01 5.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.081 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.647 ' HG3' ' HB3' ' A' ' 86' ' ' PHE . 10.4 ptp180 -95.3 132.05 40.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.301 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -100.57 140.22 35.14 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.878 0.371 . . . . 0.0 110.793 -174.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.617 ' OH ' ' HD3' ' A' ' 93' ' ' ARG . 74.5 m-85 -129.31 147.93 51.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.77 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HD3' HG11 ' A' ' 147' ' ' VAL . 1.6 tptm -109.54 121.41 45.14 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 51.3 mtt -77.75 68.92 3.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.244 0.545 . . . . 0.0 110.238 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 t -81.43 -11.74 59.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.924 -172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.7 m -135.43 99.4 4.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.284 0.564 . . . . 0.0 110.991 178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.97 128.01 73.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.4 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -167.75 179.2 4.9 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.203 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 4.5 p30 -125.12 153.25 43.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.05 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 110' ' ' VAL . 6.1 m -142.61 173.39 6.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.712 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.767 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -98.43 154.22 37.66 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.069 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.62 -15.5 49.66 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.623 2.215 . . . . 0.0 111.936 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.7 t -103.76 9.57 37.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.355 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.767 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 10.4 t70 -77.21 122.18 24.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.333 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.79 11.38 8.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.084 0.469 . . . . 0.0 110.665 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -81.53 -46.91 13.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.575 HG21 HG21 ' A' ' 103' ' ' VAL . 33.8 m -86.62 -8.33 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.211 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.0 mt -88.35 -3.78 58.78 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.103 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.05 160.89 25.66 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.83 106.89 3.76 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.025 0.441 . . . . 0.0 110.709 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.95 101.96 13.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.979 0.418 . . . . 0.0 111.347 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -169.76 1.8 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 173.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.74 -40.56 2.48 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.326 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -73.86 171.6 13.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.077 0.465 . . . . 0.0 110.766 177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -83.16 -152.58 0.12 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.567 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -60.51 113.3 2.36 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -110.69 126.59 54.69 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.133 0.492 . . . . 0.0 111.073 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 121' ' ' LEU . 23.9 mt -90.47 116.57 28.5 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.579 HG23 HD11 ' A' ' 141' ' ' ILE . 25.4 m -98.01 102.77 14.62 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.608 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.1 mm? -95.78 101.8 13.53 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.8 97.25 6.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.005 0.431 . . . . 0.0 109.885 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.651 HG21 HD12 ' A' ' 75' ' ' LEU . 21.1 p -105.25 107.39 18.34 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.424 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 9.7 m -94.2 92.83 7.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -113.3 33.72 4.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.077 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 26.9 t70 -137.47 103.86 5.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -100.08 123.86 44.81 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.833 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -97.86 112.54 24.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.392 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.3 -31.06 70.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.087 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.3 mmmp? -70.8 -22.32 62.37 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.588 HG23 HG12 ' A' ' 135' ' ' VAL . 8.6 t -130.64 2.06 4.49 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.95 0.405 . . . . 0.0 110.755 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 58.0 54.66 35.67 Favored Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.238 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.588 HG12 HG23 ' A' ' 133' ' ' THR . 3.3 p -149.95 159.19 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.472 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 70.6 m95 -97.66 101.16 12.6 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.87 -66.33 0.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.428 -169.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -69.97 88.53 0.58 Allowed 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.464 0.65 . . . . 0.0 110.568 -176.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.54 ' HG3' HG23 ' A' ' 103' ' ' VAL . 21.2 ptt180 -76.94 73.06 3.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.752 172.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HE2' ' CZ ' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -62.67 124.25 20.51 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.348 -174.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.579 HD11 HG23 ' A' ' 122' ' ' THR . 8.7 tt -114.21 137.88 46.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.592 -168.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.614 ' CZ ' ' HE2' ' A' ' 140' ' ' LYS . 43.7 m-85 -110.44 119.23 38.51 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 170.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.591 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 42.8 t -102.57 102.86 14.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.254 0.549 . . . . 0.0 109.649 175.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 95' ' ' TYR . . . -101.79 111.95 24.38 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.406 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.8 m -86.47 136.47 33.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.023 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -56.07 120.33 7.31 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 123.507 0.504 . . . . 0.0 110.833 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.509 HG11 ' HD3' ' A' ' 96' ' ' LYS . 7.1 p -111.19 122.26 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.543 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt . . . . . 0 C--O 1.245 0.859 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.298 -173.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.516 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 70.6 -61.03 0.48 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.706 0.765 . . . . 0.0 110.487 -173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.98 161.99 13.59 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.221 172.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt 54.22 87.55 0.14 Allowed Pre-proline 0 C--N 1.33 -0.262 0 O-C-N 123.931 0.77 . . . . 0.0 112.197 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.68 135.81 14.78 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.634 2.223 . . . . 0.0 111.933 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.542 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 4.1 pt20 -153.16 161.36 42.53 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.255 -176.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.477 HG23 ' CB ' ' A' ' 31' ' ' PRO . 4.6 mp -93.56 102.46 7.71 Favored Pre-proline 0 C--N 1.331 -0.237 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 169.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.7 Cg_exo -66.85 165.18 26.79 Favored 'Trans proline' 0 CA--C 1.517 -0.326 0 C-N-CA 122.805 2.337 . . . . 0.0 112.878 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.966 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -81.33 -22.36 38.55 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.391 178.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -74.95 109.95 8.83 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' PRO . 41.7 mttp -86.67 9.4 18.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.333 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.6 t -110.65 5.73 21.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.24 0.543 . . . . 0.0 110.139 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.634 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 66.1 mttm -92.89 173.0 7.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.766 177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.9 t -109.7 117.29 54.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.043 176.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.63 -26.08 23.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.184 0.516 . . . . 0.0 110.343 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.83 -175.3 43.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.418 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 90.0 m-85 -126.53 140.13 52.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.089 0.444 . . . . 0.0 110.273 178.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.2 tp -100.69 110.02 26.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.571 0.7 . . . . 0.0 109.539 177.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 42.5 mt-10 -113.34 113.14 24.83 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.195 -176.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.8 mt -124.57 92.07 48.49 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.43 -30.08 91.71 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.953 2.436 . . . . 0.0 112.221 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -70.06 -25.97 63.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.45 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.76 5.71 26.89 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.412 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.3 t0 61.86 20.7 11.68 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.911 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.428 ' C ' ' HD3' ' A' ' 26' ' ' LYS . 68.4 mt -96.71 124.08 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.711 -173.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.428 ' HD3' ' C ' ' A' ' 25' ' ' ILE . 3.9 mppt? -141.16 83.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.571 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 25.2 mm-40 -117.72 151.36 48.44 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.045 -171.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.19 133.39 14.81 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.939 2.426 . . . . 0.0 111.911 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HA ' HG23 ' A' ' 43' ' ' VAL . 56.1 t -92.17 118.37 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.842 176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.427 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 92.6 m-85 -95.54 114.28 63.6 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.234 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.634 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 38.2 Cg_endo -64.94 129.58 23.59 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.11 2.54 . . . . 0.0 112.179 -177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 173.24 179.43 43.91 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 119.952 -1.118 . . . . 0.0 112.648 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.433 ' HG2' HG23 ' A' ' 35' ' ' THR . 62.5 Cg_endo -87.69 33.55 0.41 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 123.96 3.107 . . . . 0.0 112.451 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.55 32.04 11.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.775 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.433 HG23 ' HG2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -62.26 138.14 96.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.341 178.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 85.4 Cg_exo -46.95 -48.71 13.85 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.788 2.992 . . . . 0.0 114.109 -172.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -59.48 -30.06 68.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.821 -174.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -68.53 -41.49 79.84 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 3.6 mm? -77.51 -6.08 52.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.922 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -83.6 -14.36 52.23 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.541 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -126.32 -36.24 2.32 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -154.62 -167.67 16.83 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.388 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG13 ' HG2' ' A' ' 71' ' ' GLN . 10.8 m -88.97 153.4 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -139.51 169.01 18.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -82.62 151.79 26.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.371 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.55 -45.47 62.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.723 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -111.36 156.93 20.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.279 0.562 . . . . 0.0 111.862 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -97.18 -20.95 17.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 172.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -72.26 -12.27 61.08 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.999 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -75.08 150.2 38.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.837 -173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 m -130.86 159.62 36.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.795 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 88' ' ' VAL . 84.8 mt -76.3 -20.97 56.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.812 -176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.92 3.72 36.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.332 0.587 . . . . 0.0 110.246 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.88 156.79 38.55 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -68.87 -27.24 65.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.242 0.544 . . . . 0.0 110.685 -176.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' HA ' HD22 ' A' ' 56' ' ' ASN . 2.5 t-20 -120.5 110.96 17.09 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.039 -174.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.48 123.95 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.5 m -117.67 116.8 27.77 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.0 0.428 . . . . 0.0 110.84 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 64.2 mt -104.77 122.35 57.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.176 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.48 139.28 30.9 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.379 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.37 163.76 32.64 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.378 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.8 p80 -142.75 150.91 40.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.698 0.285 . . . . 0.0 110.36 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.508 HG23 ' HA ' ' A' ' 73' ' ' THR . 17.1 m -84.06 150.84 25.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.596 ' HB2' ' OH ' ' A' ' 70' ' ' TYR . 9.3 t80 -142.65 151.52 41.51 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.8 mt -81.82 -47.01 19.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.779 0.323 . . . . 0.0 111.605 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.81 -43.69 97.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.978 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HD2' ' HB3' ' A' ' 70' ' ' TYR . 1.5 mmt180 -89.35 109.1 28.95 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.34 -11.08 17.54 Favored 'Trans proline' 0 CA--C 1.515 -0.431 0 C-N-CA 122.584 2.189 . . . . 0.0 111.524 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -148.13 77.21 1.4 Allowed 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.823 -172.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.596 ' OH ' ' HB2' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -156.15 158.23 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 172.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.571 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 80.0 mt-30 41.44 -107.59 0.08 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.705 0.628 . . . . 0.0 112.463 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.467 ' CD1' HD22 ' A' ' 75' ' ' LEU . 50.6 m-85 -131.69 91.09 2.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.852 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 63' ' ' THR . 2.7 t -120.71 -53.82 2.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.331 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 73' ' ' THR . 63.9 t30 -87.01 18.47 3.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.53 0.681 . . . . 0.0 109.919 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.467 HD22 ' CD1' ' A' ' 72' ' ' PHE . 28.8 tp -70.06 -7.84 44.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.671 -178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.67 -8.29 56.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.91 -0.98 57.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.822 173.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.79 160.61 20.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.283 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -163.5 -169.78 2.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.695 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.5 ptmt -51.1 -36.69 41.7 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -170.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.5 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.56 58.53 0.7 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.314 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.3 m -81.96 -7.95 59.64 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.33 89.85 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.567 0.699 . . . . 0.0 111.439 -175.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -90.6 118.36 35.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 90.0 m-85 -103.9 121.26 42.74 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.009 0.433 . . . . 0.0 110.51 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 27.7 t80 -100.68 104.53 15.84 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.6 tptm -85.73 97.43 10.14 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG21 HD13 ' A' ' 52' ' ' LEU . 4.4 p -124.36 120.93 60.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.248 0.547 . . . . 0.0 111.925 -173.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.07 -56.02 1.84 Allowed Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.714 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -172.86 -28.53 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 122.979 0.512 . . . . 0.0 110.499 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' OE1' ' HD3' ' A' ' 93' ' ' ARG . 9.4 pt-20 -87.2 165.68 15.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.158 0.504 . . . . 0.0 111.565 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 m -123.57 110.74 15.41 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.616 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 9.1 mmm180 -87.1 132.19 33.91 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.408 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -107.22 123.16 47.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.57 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 87.5 m-85 -118.46 145.39 45.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.485 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.647 ' HE3' HG11 ' A' ' 147' ' ' VAL . 1.3 tppp? -114.43 128.61 56.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 56.3 mtt -78.22 70.86 4.64 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.632 0.73 . . . . 0.0 110.636 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -87.09 -6.74 58.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.201 -0.908 . . . . 0.0 112.039 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.596 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 49.0 m -140.04 103.86 4.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.07 0.462 . . . . 0.0 110.347 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 97' ' ' MET . 84.3 mt -122.6 130.06 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.027 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -158.95 173.31 16.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.883 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.929 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 1.5 p30 -133.03 124.06 26.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.254 0.549 . . . . 0.0 109.9 175.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.8 m -99.79 -172.2 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.953 -171.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.558 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 0.1 OUTLIER -124.63 152.6 69.27 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.051 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.25 -13.01 33.15 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.487 2.125 . . . . 0.0 110.974 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -13.13 59.97 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.389 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.55 ' HB2' ' HE3' ' A' ' 104' ' ' LYS . 12.7 t70 -108.99 121.69 45.67 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.875 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.4 m -125.96 32.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -102.17 -18.47 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.137 -175.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.4 p -83.07 -16.46 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.239 0.542 . . . . 0.0 111.533 -168.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.508 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -98.65 22.04 10.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.142 0.496 . . . . 0.0 111.242 -175.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 113' ' ' GLU . 10.1 t70 -79.25 -154.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.954 178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.656 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 39.0 mt-10 -65.52 92.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -101.05 30.14 4.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.637 0.732 . . . . 0.0 111.492 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.656 ' HE2' ' HB3' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.79 153.44 21.67 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.64 176.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.33 -21.23 7.32 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -177.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.0 mttp -90.12 -170.29 2.72 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.282 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.49 -164.67 1.21 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -65.03 104.89 0.94 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.843 0.354 . . . . 0.0 110.11 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 13.1 pt20 -100.22 120.18 39.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.296 0.57 . . . . 0.0 110.526 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.0 tp -85.61 110.32 19.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.7 m -94.65 99.64 11.72 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.555 -175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.1 mt -85.69 108.25 17.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 33.8 mt -91.46 99.34 9.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.0 m -96.52 106.5 18.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.262 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 80.0 m -94.9 93.95 7.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.499 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -113.73 9.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.871 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 23.4 t70 -78.95 -79.81 0.13 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.619 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 1.0 OUTLIER 62.48 88.78 0.09 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.779 -177.471 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 48.4 t-20 -85.81 98.04 10.52 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.4 ' HG2' ' CE2' ' A' ' 129' ' ' TYR . 44.1 mt-10 -68.0 -3.13 9.07 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 93.5 mttt -72.95 -33.02 65.64 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.126 0.489 . . . . 0.0 110.489 174.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.6 t -128.13 -15.96 4.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.542 -175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 26.26 45.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.375 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.35 138.95 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.594 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 25.0 m95 -85.09 105.02 15.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.99 -67.75 0.75 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.763 0.316 . . . . 0.0 111.08 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 17.9 tppt? -65.25 117.03 7.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.411 0.624 . . . . 0.0 110.173 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -124.15 106.22 10.15 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.691 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.929 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 30.4 tttp -86.22 132.98 33.87 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.628 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 10.4 tt -118.84 123.58 71.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.774 0.797 . . . . 0.0 110.607 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 89.4 m-85 -110.56 107.11 16.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.632 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 60.3 t -91.74 98.68 8.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.43 0.633 . . . . 0.0 109.534 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -97.5 97.58 9.2 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.813 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 7.3 m -73.96 140.67 45.7 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -58.52 114.77 2.62 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.676 0.75 . . . . 0.0 110.235 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.647 HG11 ' HE3' ' A' ' 96' ' ' LYS . 7.7 p -101.73 125.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.927 -175.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 148' ' ' LYS . 10.3 ptpt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.141 -0.933 . . . . 0.0 110.732 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.66 -65.03 0.37 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.8 0.809 . . . . 0.0 109.994 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.19 140.37 29.74 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.934 172.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 31.4 mttp -108.49 97.4 22.83 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 31.9 Cg_endo -64.48 115.29 3.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.291 1.994 . . . . 0.0 109.264 165.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.421 ' HA ' HD23 ' A' ' 52' ' ' LEU . 3.4 pt20 -124.62 143.64 50.61 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.398 0.618 . . . . 0.0 110.98 -172.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.626 HG23 ' HB2' ' A' ' 31' ' ' PRO . 9.6 mt -69.12 118.11 58.51 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.245 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.66 174.25 12.55 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.381 2.054 . . . . 0.0 111.721 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 36.4 mmtm -92.07 36.83 0.98 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.694 0.759 . . . . 0.0 109.997 175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.466 ' CG ' ' HG3' ' A' ' 13' ' ' LYS . 9.9 t70 -127.2 105.69 8.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.454 176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.659 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 32.0 mttp -73.92 -6.86 49.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.942 0.401 . . . . 0.0 111.324 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.0 t -95.57 -19.56 19.69 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.995 0.426 . . . . 0.0 110.265 -176.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HG3' ' CG ' ' A' ' 10' ' ' ASP . 56.6 mttp -81.82 176.19 9.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.7 p -112.63 136.63 48.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.813 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -94.07 -31.29 14.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.372 0.606 . . . . 0.0 110.21 176.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.15 158.5 31.48 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.093 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -102.87 138.49 39.69 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.872 0.336 . . . . 0.0 110.122 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.42 HD11 HG13 ' A' ' 84' ' ' VAL . 9.3 tp -104.03 120.25 53.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 36.8 mt-10 -128.07 112.06 14.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.548 0.689 . . . . 0.0 110.911 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.597 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 43.6 mt -120.91 95.49 48.91 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.446 175.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.35 -27.07 71.29 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 123.244 2.629 . . . . 0.0 112.402 -171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 35.2 t70 -67.3 -32.09 72.84 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.252 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 74' ' ' ASN . . . -109.86 5.02 22.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.914 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.2 t0 63.54 22.37 13.16 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.81 0.814 . . . . 0.0 110.71 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.597 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 59.4 mt -79.32 113.48 18.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.291 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -150.69 98.25 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.962 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.683 ' OE2' ' HA ' ' A' ' 70' ' ' TYR . 2.4 mt-10 -169.29 164.47 6.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 O-C-N 123.16 0.287 . . . . 0.0 110.989 176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' HB3' HG21 ' A' ' 14' ' ' VAL . 21.6 Cg_exo -66.58 148.91 84.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.1 2.534 . . . . 0.0 112.99 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.9 t -105.15 121.13 56.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.308 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 44' ' ' SER . 50.6 m-85 -93.44 137.76 23.29 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.26 -176.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HB2' HG23 ' A' ' 7' ' ' ILE . 89.5 Cg_endo -92.15 153.52 3.18 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.71 2.273 . . . . 0.0 113.077 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 145.11 -174.48 25.15 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.861 176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.659 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 94.7 Cg_endo -79.98 8.97 3.76 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.574 2.849 . . . . 0.0 113.142 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 61.71 68.82 0.68 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.614 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 33' ' ' PRO . 37.6 p -92.07 161.15 34.03 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.173 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.17 -30.66 26.2 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.086 2.524 . . . . 0.0 112.589 177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -59.43 -43.78 93.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.152 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.504 ' HA ' ' HG2' ' A' ' 41' ' ' ARG . 39.0 mm-40 -82.16 -40.14 22.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.259 -170.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.2 mm? -70.73 -7.73 46.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.36 0.6 . . . . 0.0 110.577 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.86 -22.75 23.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.487 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 38' ' ' GLN . 7.0 ptm85 -105.14 -13.8 15.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.221 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . 162.84 -157.18 29.16 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.386 175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 72' ' ' PHE . 70.2 t -95.44 135.88 28.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.924 0.392 . . . . 0.0 110.05 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 19.1 m -124.65 170.34 11.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HD1' ' HA ' ' A' ' 31' ' ' PRO . 26.8 m-85 -68.66 161.9 27.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.223 174.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -88.12 -27.87 21.64 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.909 0.385 . . . . 0.0 110.577 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 2.2 mm-40 -117.83 145.04 44.85 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.516 0.674 . . . . 0.0 112.344 -178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.98 -6.98 59.52 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -90.27 -5.2 56.58 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.833 176.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.554 ' HB3' HD13 ' A' ' 7' ' ' ILE . 2.2 tp10 -48.8 139.44 9.85 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.013 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.1 m -143.65 132.42 22.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.68 -177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.434 HD21 HG13 ' A' ' 7' ' ' ILE . 2.6 mm? -75.98 -11.51 59.97 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.029 0.442 . . . . 0.0 110.813 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -89.17 -9.79 49.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.422 0.63 . . . . 0.0 110.218 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -89.14 170.71 10.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.495 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.554 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 4.7 pt20 -104.13 -0.87 28.07 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.74 0.305 . . . . 0.0 111.016 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.88 115.65 16.17 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.43 0.633 . . . . 0.0 109.92 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.9 mt -128.21 129.27 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.275 -176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.0 m -108.11 120.78 43.31 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.344 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.5 mt -111.53 115.77 50.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.414 ' HB1' ' C13' ' A' ' 201' ' ' JPT . . . -97.74 116.49 30.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 110.871 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' HA2' HG13 ' A' ' 43' ' ' VAL . . . -110.77 159.99 13.52 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.929 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -154.76 131.19 10.49 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 70' ' ' TYR . 2.4 m -65.56 113.01 3.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.993 0.425 . . . . 0.0 110.719 178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 67' ' ' ARG . 41.4 t80 -90.22 128.3 36.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.847 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 66.3 mt -58.97 -37.75 69.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.228 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.465 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 9.3 m-20 -91.95 8.28 38.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.908 0.385 . . . . 0.0 111.372 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.516 ' HD3' ' HB3' ' A' ' 70' ' ' TYR . 34.2 mtt180 -121.4 97.2 47.4 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-O 120.776 0.322 . . . . 0.0 110.985 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.17 -8.35 20.87 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.614 2.209 . . . . 0.0 111.694 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -154.26 82.3 1.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.035 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.683 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 15.3 p90 -118.37 -164.2 1.01 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.171 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 27' ' ' GLU . 24.6 mp0 -48.96 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.297 0.373 . . . . 0.0 111.765 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.521 ' CE2' HG11 ' A' ' 43' ' ' VAL . 18.8 m-85 -103.21 68.48 0.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.877 0.37 . . . . 0.0 111.694 -174.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -92.6 -42.17 9.81 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.338 0.589 . . . . 0.0 110.355 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 65.7 t30 -114.24 33.31 5.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.42 -175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -59.2 -27.21 65.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.236 -177.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.49 -9.92 59.19 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.78 -4.74 58.86 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.124 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.539 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -72.18 -174.53 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.19 0.519 . . . . 0.0 110.91 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HG2' ' OD2' ' A' ' 22' ' ' ASP . 5.9 ptpp? -167.02 -179.0 4.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.979 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.6 ptpt -53.99 -48.76 70.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.532 0.52 . . . . 0.0 112.139 -176.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.5 54.99 0.57 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 119.849 -1.167 . . . . 0.0 111.438 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -73.64 -11.59 60.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.327 -0.436 . . . . 0.0 111.203 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 54.36 83.84 0.07 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.433 0.635 . . . . 0.0 111.801 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 61.5 t -85.41 111.42 20.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.827 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -99.8 113.67 26.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.996 0.427 . . . . 0.0 110.277 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.519 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 2.1 t80 -102.4 108.21 19.46 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.593 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -89.43 92.68 9.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.974 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 91' ' ' GLU . 4.8 m -104.71 117.56 50.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.44 -83.16 0.2 Allowed Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.572 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -152.74 12.17 0.51 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.722 0.296 . . . . 0.0 110.823 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.422 ' CG ' HG23 ' A' ' 88' ' ' VAL . 12.6 pt-20 -109.43 140.11 43.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.059 0.456 . . . . 0.0 110.291 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.6 m -100.62 109.71 21.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.237 -177.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 16.5 mmt85 -88.7 142.03 28.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.54 173.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -118.67 130.73 56.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.9 0.381 . . . . 0.0 110.542 177.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 81.3 m-85 -127.83 143.85 51.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.713 -178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.519 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.9 OUTLIER -107.07 137.32 45.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.743 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.0 mmt -83.87 81.95 8.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 110.14 -176.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -92.2 -36.7 13.12 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.63 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.61 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 6.9 m -109.26 97.04 6.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.487 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 97' ' ' MET . 75.9 mt -117.68 117.16 54.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.896 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -168.99 -159.81 0.25 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.062 0.458 . . . . 0.0 112.068 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -109.89 153.32 24.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.818 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 139' ' ' ARG . 10.6 m -135.38 166.48 27.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 167.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.456 ' C ' ' H ' ' A' ' 106' ' ' THR . 0.0 OUTLIER -147.62 161.21 36.38 Favored Pre-proline 0 C--O 1.22 -0.45 0 O-C-N 122.334 -0.229 . . . . 0.0 111.32 -169.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 104' ' ' LYS . 34.8 Cg_endo -65.08 11.75 0.12 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.717 2.278 . . . . 0.0 113.05 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.456 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.7 t -129.8 8.79 5.33 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.538 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.599 ' OD2' ' HB ' ' A' ' 103' ' ' VAL . 1.1 p30 -84.2 158.23 21.37 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.558 ' HA ' HD21 ' A' ' 111' ' ' LEU . 29.1 m -112.58 18.73 7.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.198 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.7 -45.36 11.74 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.924 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.0 m -76.81 -11.44 13.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.654 -172.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.2 OUTLIER -106.39 12.3 29.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.703 0.287 . . . . 0.0 111.27 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -97.6 169.27 9.82 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.534 ' CG ' ' HE3' ' A' ' 115' ' ' LYS . 11.2 pt-20 -92.41 20.25 6.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -175.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 52.13 119.7 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.617 1.167 . . . . 0.0 113.724 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HE3' ' CG ' ' A' ' 113' ' ' GLU . 18.9 mmtp -109.48 147.31 33.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.586 -171.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 47.92 34.27 11.13 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.896 -1.502 . . . . 0.0 115.23 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -122.59 161.89 22.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.837 0.818 . . . . 0.0 112.016 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -93.98 -158.14 0.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.554 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -62.09 110.04 1.47 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -116.67 138.81 51.18 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.26 0.552 . . . . 0.0 112.124 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 121' ' ' LEU . 22.4 mt -97.73 112.26 24.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 169.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.42 HG23 HG22 ' A' ' 143' ' ' VAL . 13.3 m -96.26 103.85 15.77 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.287 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.7 mt -91.11 106.03 18.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.79 100.01 9.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 6.9 m -91.0 107.09 18.97 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.138 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 57.8 m -103.89 86.12 2.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.139 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -111.18 -2.15 15.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.043 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.574 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 36.4 t70 -104.8 94.37 5.24 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.488 0.661 . . . . 0.0 109.899 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 92.0 t80 -101.01 124.05 46.14 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.188 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -91.37 110.28 21.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 173.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.438 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.7 mt-10 -72.39 -21.65 61.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.847 -173.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -72.51 -24.57 61.17 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.456 HG23 HG12 ' A' ' 135' ' ' VAL . 9.6 t -136.62 4.01 2.81 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.304 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 62.53 48.79 79.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.012 -0.613 . . . . 0.0 113.17 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 133' ' ' THR . 4.4 p -137.77 159.22 34.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.543 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 37.6 m95 -100.64 112.74 25.18 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 55.8 mt-10 -80.88 -60.02 2.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.932 0.396 . . . . 0.0 111.04 -174.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 47.4 mmtm -88.94 101.52 14.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.177 0.513 . . . . 0.0 110.262 178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.625 ' HB2' HG23 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -100.63 105.52 16.92 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 125' ' ' THR . 18.7 tptm -76.63 120.62 22.07 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.506 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 14.6 tt -118.98 122.55 69.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 122.037 0.922 . . . . 0.0 111.66 -172.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 24.5 m-85 -116.95 106.75 13.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.594 -1.185 . . . . 0.0 109.135 175.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.0 t -100.76 103.98 15.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.234 0.54 . . . . 0.0 110.259 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.494 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -96.62 118.85 33.98 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.995 179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.7 m -93.59 138.81 31.46 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.453 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -57.83 125.03 21.24 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.042 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.519 HG21 ' HD3' ' A' ' 96' ' ' LYS . 2.7 t -85.75 146.38 6.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.775 -176.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.68 179.024 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.414 ' C13' ' HB1' ' A' ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 121.135 0.493 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -116.98 -174.86 2.67 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.475 -176.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.56 94.41 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.321 0.581 . . . . 0.0 111.804 -176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.1 mtmt -127.64 103.34 22.02 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.106 171.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.51 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 36.9 Cg_endo -63.09 106.64 0.56 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.15 2.567 . . . . 0.0 112.878 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -120.64 137.9 54.2 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.776 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.661 HD11 ' HG ' ' A' ' 52' ' ' LEU . 4.1 mp -76.5 125.24 87.71 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.71 153.51 54.0 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.116 1.877 . . . . 0.0 110.369 170.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -86.39 14.11 7.16 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.476 0.655 . . . . 0.0 111.215 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 27.4 t0 -100.71 102.43 13.54 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.549 ' HD2' ' HG2' ' A' ' 38' ' ' GLN . 24.5 pttm -81.27 0.13 38.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.446 -172.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.2 m -90.32 3.91 52.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 87.5 mttt -103.83 -176.53 3.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.348 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -105.79 129.67 58.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.049 171.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.45 -29.93 17.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.368 0.604 . . . . 0.0 110.581 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.78 36.57 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.56 143.32 34.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 117.128 0.464 . . . . 0.0 109.758 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.8 tp -107.27 117.31 52.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.545 0.688 . . . . 0.0 110.265 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 38.4 mt-10 -115.78 116.54 28.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.922 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.591 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 46.0 mt -133.87 91.62 24.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.52 -34.51 92.64 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.951 2.434 . . . . 0.0 111.871 -175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -62.77 -25.62 68.31 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.292 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 78' ' ' ALA . . . -114.83 11.37 16.68 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.011 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.7 t70 58.41 29.67 18.57 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.773 0.797 . . . . 0.0 110.754 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.632 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 58.9 mt -98.37 118.49 44.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.232 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 25' ' ' ILE . 5.5 mtmt -150.19 81.91 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.282 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.424 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 40.9 mt-10 -149.21 162.47 28.84 Favored Pre-proline 0 N--CA 1.465 0.316 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 27' ' ' GLU . 60.3 Cg_endo -72.43 148.16 48.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.072 2.515 . . . . 0.0 113.493 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -109.47 130.59 62.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.016 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.557 ' O ' ' HA ' ' A' ' 44' ' ' SER . 33.5 m-85 -97.11 137.96 21.25 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 73.0 Cg_endo -90.15 -172.31 0.56 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.962 2.441 . . . . 0.0 112.533 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.06 -174.27 16.83 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.453 173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.84 12.39 3.02 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.926 3.084 . . . . 0.0 113.081 -177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.55 74.67 0.44 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.193 -174.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.705 HG22 ' HD2' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -95.83 147.44 33.0 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.087 -176.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.705 ' HD2' HG22 ' A' ' 35' ' ' THR . 81.6 Cg_exo -40.65 -66.83 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.751 2.967 . . . . 0.0 114.46 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.56 -26.63 55.32 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.762 0.315 . . . . 0.0 111.663 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.549 ' HG2' ' HD2' ' A' ' 11' ' ' LYS . 24.8 tp60 -66.54 -37.89 85.98 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.211 0.529 . . . . 0.0 110.118 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.6 tp -74.3 -38.7 63.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.772 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -67.93 -9.8 48.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.19 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -72.59 -28.48 62.82 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.06 0.457 . . . . 0.0 110.415 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.29 -88.7 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.257 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.443 HG12 ' HA3' ' A' ' 61' ' ' GLY . 34.0 m -137.02 157.84 35.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 21.9 p -150.72 156.07 40.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.013 178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 31' ' ' PRO . 21.2 m-85 -70.18 155.13 41.06 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.784 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.09 73.78 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.302 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -152.24 177.7 10.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.434 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.59 -28.2 45.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.946 -172.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -76.87 -11.06 59.77 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.083 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 50' ' ' GLU . 5.1 tp10 -61.24 126.26 26.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.747 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 23.5 m -112.39 138.24 49.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.791 0.329 . . . . 0.0 111.441 -173.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.661 ' HG ' HD11 ' A' ' 7' ' ' ILE . 77.6 mt -67.96 -25.52 65.48 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -105.57 17.47 23.79 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.464 0.65 . . . . 0.0 110.355 -175.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.747 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 7.5 t70 -88.96 -177.21 5.42 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.464 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.6 -16.93 58.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.197 0.522 . . . . 0.0 110.08 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.94 142.61 29.99 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.18 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.3 mp -129.07 105.29 12.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.727 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.562 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 4.5 m -89.94 113.1 24.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.464 -177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.4 HG12 ' CE1' ' A' ' 45' ' ' PHE . 57.0 mt -107.13 111.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.991 177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HA ' ' HB ' ' A' ' 124' ' ' ILE . . . -96.52 121.93 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.443 ' HA3' HG12 ' A' ' 43' ' ' VAL . . . -121.11 161.22 15.22 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.359 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -123.18 130.32 52.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.608 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 12.0 m -71.15 136.95 48.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.138 -177.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.16 136.63 37.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.328 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 56.1 mt -90.99 -46.77 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.114 0.483 . . . . 0.0 110.21 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.455 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 17.7 t70 -75.18 -39.69 60.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.399 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -92.34 109.04 35.44 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.92 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 66' ' ' ASP . 94.1 Cg_endo -83.93 -0.35 9.59 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.878 2.385 . . . . 0.0 111.476 178.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -129.96 71.73 1.46 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.977 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.608 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 10.4 p90 -119.38 -175.41 2.93 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 166.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' H ' ' NE2' ' A' ' 71' ' ' GLN . 1.4 mp0 -48.82 -66.69 0.36 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -173.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' CZ ' HD22 ' A' ' 123' ' ' LEU . 23.1 m-30 -103.1 31.59 4.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -170.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -49.97 74.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.268 0.556 . . . . 0.0 111.429 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 23' ' ' ALA . 67.0 t30 -102.51 25.52 8.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.231 -175.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.11 -19.01 64.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.209 0.528 . . . . 0.0 110.901 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.2 pttt -68.87 -20.47 64.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.515 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.52 9.24 32.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.108 0.48 . . . . 0.0 110.308 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . . . -89.3 122.71 32.81 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.066 176.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 6.3 mmmm -101.58 -164.41 1.1 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.283 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -68.5 -21.94 64.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -172.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.22 50.88 0.87 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.313 -0.946 . . . . 0.0 112.574 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.2 m -70.3 -7.62 43.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.8 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 87.1 mmm 44.66 88.38 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.665 0.745 . . . . 0.0 112.029 -170.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.8 t -85.58 124.55 40.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.742 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 74.2 m-85 -109.13 112.99 25.46 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -94.27 109.56 21.37 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' GLU . 5.3 tptp -91.28 85.51 5.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.706 -175.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.652 ' O ' ' HG2' ' A' ' 91' ' ' GLU . 11.1 m -111.54 131.04 63.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.877 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 90' ' ' ASN . . . 59.14 22.1 54.77 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.035 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 89' ' ' GLY . 29.3 m-80 73.53 14.48 4.31 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.479 0.711 . . . . 0.0 112.012 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 6.2 pt-20 -97.14 179.4 4.93 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 m -135.28 117.62 15.66 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.418 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 94.5 mtt180 -116.01 133.42 56.05 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -101.35 131.27 47.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.293 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 84.2 m-85 -130.76 146.67 52.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.869 -178.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.8 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.55 132.42 54.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 21.2 mmt -75.53 68.15 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.305 0.574 . . . . 0.0 110.226 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.2 t -84.46 -9.58 58.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.431 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.583 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 67.4 m -136.84 93.97 2.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.36 0.6 . . . . 0.0 111.183 175.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.16 118.21 56.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.407 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.562 ' HG3' ' CG2' ' A' ' 141' ' ' ILE . 18.9 ptt180 -149.35 165.19 32.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.244 0.545 . . . . 0.0 111.683 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -119.02 109.12 15.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.933 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.658 HG21 HG11 ' A' ' 110' ' ' VAL . 19.4 m -108.24 168.74 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.49 0.662 . . . . 0.0 111.683 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HD3' ' C ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -138.52 170.38 10.42 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.216 -0.902 . . . . 0.0 108.934 -175.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.77 -26.81 58.77 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.065 1.843 . . . . 0.0 110.175 169.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.4 m -72.64 -12.42 61.03 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.719 -1.582 . . . . 0.0 111.878 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -91.67 128.8 37.64 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HA ' HD11 ' A' ' 111' ' ' LEU . 17.5 m -113.28 26.59 3.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.805 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -109.2 -9.87 15.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.684 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.658 HG11 HG21 ' A' ' 103' ' ' VAL . 15.9 m -91.62 -8.74 10.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -112.58 9.94 19.48 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.666 0.746 . . . . 0.0 109.381 175.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -89.2 160.81 16.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.298 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -50.45 125.93 13.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.128 0.489 . . . . 0.0 111.635 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -75.65 129.31 36.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 10.6 mptt -69.69 157.77 36.65 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.932 -172.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.04 56.81 1.44 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.441 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -79.26 -174.35 4.1 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.352 -0.424 . . . . 0.0 110.023 173.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.09 -163.78 0.84 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -59.27 121.63 11.87 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -122.92 135.07 54.36 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.158 0.504 . . . . 0.0 110.801 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 57' ' ' ILE . 74.2 mt -92.73 113.98 26.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.536 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.7 m -94.41 92.23 7.05 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.901 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 27.5 mt -83.47 104.56 13.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.959 0.409 . . . . 0.0 110.044 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.456 ' HB ' ' HA ' ' A' ' 60' ' ' ALA . 24.3 mt -94.52 101.04 12.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.074 -177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.1 m -97.11 96.4 8.43 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.082 -177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.482 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 62.5 m -96.01 89.25 5.14 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.198 0.523 . . . . 0.0 109.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.93 -14.11 15.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.17 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.516 ' OD1' ' HB2' ' A' ' 137' ' ' GLU . 21.1 t70 -110.6 94.77 5.17 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.561 0.696 . . . . 0.0 109.832 -176.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 134' ' ' GLY . 94.1 t80 -107.55 124.5 50.01 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.485 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -90.88 101.96 14.72 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -68.22 -5.38 17.94 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.429 -174.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.96 -38.76 68.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.879 0.371 . . . . 0.0 110.874 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 135' ' ' VAL . 6.9 t -149.81 -26.48 0.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 129' ' ' TYR . . . 120.83 36.8 0.75 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.824 -1.179 . . . . 0.0 112.858 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.532 HG23 HG23 ' A' ' 133' ' ' THR . 93.0 t -104.39 124.05 58.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CE3' ' HB3' ' A' ' 126' ' ' CYS . 33.3 m95 -84.86 93.31 8.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.516 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 16.2 mm-40 -60.22 -68.26 0.31 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.863 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.423 ' HE3' ' C ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -91.76 103.86 16.37 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 -177.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.503 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 84.1 mtm180 -105.44 95.65 5.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.925 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.836 ' HD3' ' HE1' ' A' ' 142' ' ' PHE . 2.4 ttmp? -74.54 130.39 39.5 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.632 -0.427 . . . . 0.0 109.959 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.562 ' CG2' ' HG3' ' A' ' 101' ' ' ARG . 12.8 tt -123.44 120.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.932 0.872 . . . . 0.0 111.025 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.836 ' HE1' ' HD3' ' A' ' 140' ' ' LYS . 8.4 m-85 -106.33 104.07 13.69 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.522 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 61.9 t -98.72 109.61 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.254 0.549 . . . . 0.0 110.485 -179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.545 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -104.7 103.34 12.96 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.524 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -83.85 142.62 30.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.684 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -55.73 133.1 50.65 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.135 0.493 . . . . 0.0 111.251 -175.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 7.3 p -111.85 160.91 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.259 -176.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' N ' HG22 ' A' ' 147' ' ' VAL . 21.9 mmmt . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.776 -0.63 . . . . 0.0 110.008 -177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.503 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.674 ' SD ' ' HA ' ' A' ' 5' ' ' PRO . 48.5 ttm . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -113.25 5.27 16.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.236 0.541 . . . . 0.0 110.834 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.82 138.89 12.14 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.122 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 56.5 mtpt 45.97 93.53 0.05 OUTLIER Pre-proline 0 C--O 1.236 0.353 0 O-C-N 124.565 1.165 . . . . 0.0 113.547 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.674 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 32.5 Cg_endo -62.71 125.19 15.53 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.695 2.263 . . . . 0.0 112.145 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -147.24 162.2 39.4 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.318 -177.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' CD1' ' HG ' ' A' ' 52' ' ' LEU . 3.4 mp -86.78 127.47 59.98 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 0.0 110.486 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -82.44 -178.76 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.75 2.3 . . . . 0.0 112.666 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -69.88 -32.03 70.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.711 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.4 103.8 7.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.46 -174.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.575 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 36.1 mtmm -88.7 13.38 12.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.623 178.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.8 t -98.26 -11.79 22.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.744 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -105.03 178.18 4.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.988 0.423 . . . . 0.0 111.067 -178.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.99 131.55 49.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.422 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.82 -33.66 16.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.235 0.541 . . . . 0.0 110.443 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.85 168.91 38.6 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 90.9 m-85 -112.62 138.47 49.36 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 117.392 0.596 . . . . 0.0 110.858 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 18' ' ' ILE . 7.5 tp -106.78 105.17 18.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 122.167 0.984 . . . . 0.0 109.814 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -111.96 113.5 25.84 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.965 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 45.3 mt -125.61 95.94 39.41 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.788 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.66 -28.78 77.05 Favored 'Trans proline' 0 CA--C 1.52 -0.205 0 C-N-CA 122.796 2.331 . . . . 0.0 111.688 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.469 ' OD2' ' HA ' ' A' ' 78' ' ' ALA . 27.4 t0 -71.27 -22.24 61.99 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.039 -178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.76 5.29 17.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.936 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.8 t70 64.62 24.24 12.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.455 0.645 . . . . 0.0 110.535 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.5 mt -96.23 126.29 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.928 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.4 mppt? -138.77 43.77 2.09 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 15.9 mm-40 -98.58 154.09 37.66 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -166.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 27' ' ' GLU . 5.0 Cg_exo -78.5 145.0 20.53 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.269 2.646 . . . . 0.0 112.083 175.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.8 t -100.68 115.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.804 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -97.29 116.69 65.99 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.881 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 30.1 Cg_endo -63.37 140.67 77.86 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.416 2.077 . . . . 0.0 111.744 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 168.38 -179.47 41.41 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.356 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.575 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 12.9 Cg_endo -91.82 29.02 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.774 2.983 . . . . 0.0 112.439 -178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 45' ' ' PHE . . . 58.47 50.0 9.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.557 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 p -68.43 150.6 97.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -47.93 -55.05 4.36 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.211 2.607 . . . . 0.0 113.099 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.89 -27.06 67.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.377 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -65.97 -46.05 79.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.327 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.3 mt -78.53 -4.32 48.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.391 -174.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -100.58 -18.82 16.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.141 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -102.08 -26.07 13.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.959 0.409 . . . . 0.0 110.813 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.2 -171.18 35.4 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.08 148.07 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.08 0.44 . . . . 0.0 110.005 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -137.04 -171.95 3.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 110.693 -174.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . 33.3 m-85 -94.94 169.72 9.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.75 -47.13 84.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 110.436 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -141.82 170.43 15.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.561 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.57 -7.61 54.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.398 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -97.75 13.54 30.04 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.644 -174.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 45' ' ' PHE . 8.0 mm-40 -74.3 169.34 17.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.355 0.598 . . . . 0.0 111.578 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.3 m -138.37 139.9 39.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 7' ' ' ILE . 96.2 mt -77.45 -13.44 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.632 -176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -109.77 14.89 23.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.715 0.769 . . . . 0.0 110.103 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.505 ' HB3' HG12 ' A' ' 57' ' ' ILE . 11.3 t70 -69.29 171.68 8.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.962 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 120' ' ' GLN . 1.1 tm0? -95.62 -26.0 15.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.441 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.495 ' HA ' ' HG3' ' A' ' 120' ' ' GLN . 0.1 OUTLIER -134.09 56.39 1.85 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.144 0.973 . . . . 0.0 111.106 -175.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 54' ' ' ASP . 49.9 mt -62.1 127.53 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.105 -173.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -105.75 109.43 21.39 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.288 -173.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.01 118.62 51.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.034 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.1 133.07 36.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.735 0.302 . . . . 0.0 111.002 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -142.12 163.91 26.96 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.162 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -139.56 158.77 43.57 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 73' ' ' THR . 21.5 p -102.78 158.58 16.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.899 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.626 ' HB2' ' CE2' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -134.57 135.39 42.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.12 -39.92 81.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.154 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -93.19 -4.31 52.3 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 70' ' ' TYR . 51.1 mtt85 -132.72 90.58 32.19 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.247 0.546 . . . . 0.0 111.422 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.644 ' O ' ' HB ' ' A' ' 73' ' ' THR . 7.6 Cg_exo -73.64 -23.7 16.68 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.624 2.883 . . . . 0.0 113.244 -175.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -124.64 27.1 6.99 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -173.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.626 ' CE2' ' HB2' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -92.18 -16.03 26.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 122.155 0.979 . . . . 0.0 109.075 177.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HB3' ' H ' ' A' ' 72' ' ' PHE . 2.2 mt-30 -164.21 -154.54 0.25 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.431 -1.713 . . . . 0.0 109.292 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.455 ' CE2' HD13 ' A' ' 123' ' ' LEU . 19.6 m-85 -74.22 26.89 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 68' ' ' PRO . 21.7 m -60.26 -45.9 91.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.124 0.488 . . . . 0.0 111.028 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -96.43 12.62 30.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.181 0.515 . . . . 0.0 110.675 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.5 tp -68.27 -12.6 61.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.224 0.535 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.28 -12.86 61.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.452 176.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 76' ' ' LYS . . . -89.79 -4.6 57.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.676 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.469 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -75.21 149.64 38.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.234 -177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.453 ' HE2' ' HB2' ' A' ' 79' ' ' LYS . 2.6 mppt? -111.12 -169.37 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 174.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.5 ptmm? -76.43 -11.8 59.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.297 0.57 . . . . 0.0 111.289 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -128.19 62.18 0.64 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.906 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.1 m -81.06 -9.63 59.8 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 51.01 83.99 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.489 0.662 . . . . 0.0 111.82 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 80.8 t -85.57 128.8 38.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.939 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -113.57 107.51 15.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.909 0.385 . . . . 0.0 110.207 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -97.54 115.12 27.23 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.855 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.8 mmtp -93.39 97.33 10.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.237 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.05 130.66 66.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.849 0.357 . . . . 0.0 110.547 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.83 30.24 74.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.994 -177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 68.35 4.49 4.24 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.313 0.645 . . . . 0.0 111.351 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -92.34 150.63 20.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.869 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.3 m -109.79 112.64 24.81 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.829 0.347 . . . . 0.0 110.332 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 146' ' ' GLU . 21.7 mmm180 -105.03 133.22 50.18 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 3.5 mptt -102.35 130.74 49.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.578 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 95.8 m-85 -123.35 144.01 49.73 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.793 0.33 . . . . 0.0 110.407 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.55 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -113.27 131.56 55.87 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.585 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.8 mmt -74.75 64.38 1.24 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.097 0.475 . . . . 0.0 110.663 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 t -80.22 -13.84 58.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.709 -173.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.612 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.8 m -134.1 99.13 4.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.012 0.434 . . . . 0.0 110.258 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 97' ' ' MET . 70.0 mt -117.71 131.42 70.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.743 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.413 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 15.0 ptm180 -167.95 -175.29 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 171.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.93 ' HB3' ' HG3' ' A' ' 140' ' ' LYS . 8.6 p-10 -141.89 125.6 16.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' A' ' 139' ' ' ARG . 24.5 m -112.07 173.38 2.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.137 -175.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.857 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -122.68 165.04 23.1 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -177.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -61.68 -16.08 46.17 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.498 2.132 . . . . 0.0 111.746 175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.0 t -109.65 12.94 24.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.342 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.857 ' HB2' ' HG2' ' A' ' 104' ' ' LYS . 11.8 t70 -93.65 148.47 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.575 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 34.0 m -111.41 0.43 9.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -170.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.413 ' HG3' ' NH2' ' A' ' 101' ' ' ARG . 26.8 mm-40 -72.7 -12.79 61.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 0.0 110.689 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.481 HG11 HG21 ' A' ' 103' ' ' VAL . 22.7 m -94.78 -8.93 9.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.163 -178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 108' ' ' VAL . 4.2 pp -99.15 -9.57 23.61 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.758 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -82.67 161.5 22.13 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.89 128.15 34.56 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.351 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -85.83 133.97 33.95 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -69.53 160.63 31.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.199 0.523 . . . . 0.0 112.411 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.81 59.93 0.96 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 114.639 -1.164 . . . . 0.0 112.327 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -63.39 176.73 0.76 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.238 0.542 . . . . 0.0 111.016 173.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -78.76 -155.8 0.09 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -63.47 103.47 0.52 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.495 ' HG3' ' HA ' ' A' ' 56' ' ' ASN . 18.6 pt20 -101.4 116.6 33.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.33 0.586 . . . . 0.0 109.854 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 tp -84.41 100.91 11.62 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.2 m -88.95 100.37 13.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.717 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 18.5 mt -87.25 109.04 19.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.7 178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 22.8 mt -97.84 104.7 16.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 22.1 m -95.27 97.37 9.81 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.036 0.446 . . . . 0.0 110.185 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 47.9 m -86.96 102.17 14.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.33 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -142.53 -170.24 3.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.172 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 138' ' ' LYS . 31.1 t70 57.4 83.95 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.797 0.808 . . . . 0.0 110.637 -175.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.506 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 80.8 t80 -94.65 124.52 38.74 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.081 -174.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -95.67 99.94 11.72 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.506 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 34.0 mt-10 -58.84 -39.92 82.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.819 -171.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -70.52 -14.06 62.36 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -171.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.635 HG23 HG22 ' A' ' 135' ' ' VAL . 2.1 t -130.98 -7.04 3.93 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.807 -0.357 . . . . 0.0 111.292 176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.82 35.16 72.63 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.623 174.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 133' ' ' THR . 33.3 m -116.8 155.03 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 117.315 0.557 . . . . 0.0 111.147 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -96.6 100.28 11.86 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -74.24 -16.93 60.94 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 128' ' ' ASP . 23.6 ttmm -124.91 86.62 2.58 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.081 0.943 . . . . 0.0 110.928 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.726 ' HG3' HG23 ' A' ' 103' ' ' VAL . 30.1 ptt180 -92.98 86.92 5.58 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.218 172.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.93 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 36.2 tttp -70.25 139.32 52.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.773 -174.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.53 124.5 59.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.932 0.873 . . . . 0.0 111.144 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.585 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 27.4 m-85 -114.48 103.75 11.35 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.601 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.612 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 47.3 t -94.3 96.74 6.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.414 0.626 . . . . 0.0 109.804 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.548 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -93.05 105.91 17.94 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.06 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 16.7 m -81.35 140.44 34.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.096 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 93' ' ' ARG . 36.4 tt0 -61.27 132.31 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.406 0.622 . . . . 0.0 111.879 -175.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 96' ' ' LYS . 2.2 t -104.61 170.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.687 177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 147' ' ' VAL . 40.5 mtpt . . . . . 0 C--O 1.244 0.791 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.829 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.52 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.917 0.389 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -121.63 -171.3 2.2 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.314 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . -109.68 99.55 8.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.998 0.428 . . . . 0.0 110.543 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -106.24 98.62 19.98 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.792 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.601 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 77.8 Cg_exo -51.36 118.09 4.03 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 123.455 2.77 . . . . 0.0 113.258 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -150.14 168.01 25.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.339 176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.557 HG23 ' HB3' ' A' ' 31' ' ' PRO . 3.9 mp -91.66 112.33 53.9 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -63.44 165.01 18.72 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.532 2.155 . . . . 0.0 111.818 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.647 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -95.97 1.29 52.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.359 0.599 . . . . 0.0 109.835 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -79.88 109.88 14.72 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.439 173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 33' ' ' PRO . 22.7 mttm -84.66 62.31 7.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.051 -174.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 t -169.03 -29.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.576 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 2.8 mmpt? -54.24 154.59 4.31 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.537 170.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 p -101.37 111.93 32.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 164.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -76.39 -38.23 56.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.244 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.62 165.84 32.63 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.511 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 64.5 m-85 -112.87 132.57 55.24 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.1 tp -96.74 107.92 20.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 122.072 0.939 . . . . 0.0 109.876 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -112.9 108.15 16.99 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.887 -177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG12 HG13 ' A' ' 84' ' ' VAL . 23.0 mt -125.4 95.4 41.06 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.233 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.39 -16.2 53.24 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.797 2.331 . . . . 0.0 112.319 -176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.537 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 38.9 t70 -83.63 -21.67 32.44 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.443 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.12 11.24 15.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.792 0.329 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.69 19.6 11.88 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.078 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.42 HD12 HD12 ' A' ' 20' ' ' ILE . 74.2 mt -93.57 122.09 44.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.342 -174.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -139.48 49.2 1.82 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.897 ' HB3' ' HG2' ' A' ' 71' ' ' GLN . 12.3 mm-40 -116.55 162.52 26.36 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.066 -167.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 90.9 Cg_endo -83.34 164.19 14.8 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.903 2.402 . . . . 0.0 113.269 178.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.5 t -126.14 136.73 59.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.199 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -106.29 133.49 20.21 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.793 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 23.9 Cg_exo -67.76 134.17 31.72 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 123.186 2.591 . . . . 0.0 111.808 168.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.13 144.08 4.1 Favored Glycine 0 N--CA 1.439 -1.14 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.029 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 11' ' ' LYS . 60.3 Cg_endo -73.96 54.44 3.12 Favored 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.297 2.665 . . . . 0.0 112.241 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 58.25 42.39 21.91 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.776 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -69.12 127.01 93.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.251 -179.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 65.1 Cg_exo -52.53 -39.64 74.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 123.289 2.659 . . . . 0.0 113.299 -178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -69.43 -12.52 61.73 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -101.21 -29.51 12.06 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.892 0.377 . . . . 0.0 110.635 173.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.1 mt -80.79 -18.24 48.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.123 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -81.96 -15.41 53.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.025 0.44 . . . . 0.0 110.379 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -114.01 -25.02 8.74 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.875 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -166.46 -138.05 2.35 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.635 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 72' ' ' PHE . 52.4 t -121.18 138.83 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.815 0.341 . . . . 0.0 110.649 -176.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.8 t -119.52 169.3 10.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.917 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.793 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 54.7 m-85 -71.84 173.01 8.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.779 0.323 . . . . 0.0 110.361 173.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.14 -61.07 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.517 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -128.48 115.74 18.63 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.28 68.32 0.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.742 1.276 . . . . 0.0 111.092 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -146.07 2.6 0.9 Allowed 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.544 -1.207 . . . . 0.0 108.268 171.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -76.66 160.52 29.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.146 -175.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 41.5 m -141.86 159.45 42.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.506 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' A' ' 7' ' ' ILE . 96.5 mt -85.76 -17.11 36.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.406 0.622 . . . . 0.0 109.895 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -86.25 -1.98 57.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.213 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.626 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 21.4 t0 -89.57 157.91 17.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.54 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.72 -25.51 26.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.963 0.411 . . . . 0.0 110.292 -176.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.94 115.0 26.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.486 0.66 . . . . 0.0 111.657 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.8 mt -123.81 127.96 74.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 m -121.95 120.52 34.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.822 0.344 . . . . 0.0 111.449 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.9 mt -111.56 126.69 68.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.4 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -94.63 104.48 16.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.017 0.437 . . . . 0.0 110.68 -176.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' HG13 ' A' ' 43' ' ' VAL . . . -101.53 166.75 18.53 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.462 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -155.94 -179.6 8.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 p -117.8 166.98 11.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.809 0.338 . . . . 0.0 111.303 177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.542 ' HB2' ' HB2' ' A' ' 67' ' ' ARG . 5.1 m-85 -124.16 144.52 49.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.221 171.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 65.3 mt -74.68 -32.06 28.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.193 0.52 . . . . 0.0 111.206 -176.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -96.97 -6.03 36.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.75 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 10.5 mmt180 -112.8 95.43 33.36 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.24 -8.36 19.72 Favored 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.397 2.065 . . . . 0.0 111.58 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -153.41 83.66 1.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.092 -173.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.453 ' CE2' ' HB ' ' A' ' 73' ' ' THR . 4.7 p90 -142.7 -170.16 3.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.897 ' HG2' ' HB3' ' A' ' 27' ' ' GLU . 77.5 mt-30 -32.81 -69.78 0.08 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.251 1.02 . . . . 0.0 113.621 -175.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' CD2' HG11 ' A' ' 43' ' ' VAL . 4.9 m-30 -124.13 111.87 16.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.996 -0.44 . . . . 0.0 110.87 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.453 ' HB ' ' CE2' ' A' ' 70' ' ' TYR . 14.9 t -164.59 -40.85 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.379 0.609 . . . . 0.0 110.236 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -96.75 21.08 9.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.712 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.9 tp -65.98 -18.79 65.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -8.71 56.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.893 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.27 -10.64 51.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.94 0.4 . . . . 0.0 110.704 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.537 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -73.29 156.18 38.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.109 -177.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 97' ' ' MET . 32.8 mttp -129.79 -179.79 5.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.434 -176.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -61.71 -28.84 69.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 112.114 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -118.21 42.85 1.72 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.466 -0.873 . . . . 0.0 110.993 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.516 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 7.9 t -57.25 -22.04 38.45 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.313 0.645 . . . . 0.0 112.048 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.23 87.13 0.06 Allowed 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.747 0.784 . . . . 0.0 111.49 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 87.2 t -90.1 136.58 23.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.035 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.8 107.27 14.83 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.101 0.477 . . . . 0.0 109.926 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -94.7 105.3 17.23 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 2.3 tppp? -84.03 106.65 15.85 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.604 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 10.6 m -125.4 112.43 31.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.137 0.494 . . . . 0.0 111.481 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.08 -94.71 0.18 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.838 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.436 ' ND2' ' HB3' ' A' ' 3' ' ' ALA . 9.1 p30 -129.94 8.31 5.22 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.955 0.407 . . . . 0.0 110.238 177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -103.87 138.56 40.29 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.221 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.427 ' OG1' ' HE2' ' A' ' 87' ' ' LYS . 43.7 m -107.25 93.19 4.42 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.578 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 146' ' ' GLU . 12.8 mmt180 -83.07 118.28 23.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.015 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.644 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 3.4 mptt -91.82 132.58 36.33 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 96.1 m-85 -124.7 144.81 50.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.099 0.476 . . . . 0.0 110.961 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 0.1 OUTLIER -113.52 128.05 56.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.061 -178.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.632 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 21.1 mmt -78.7 60.43 2.75 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -77.05 -23.71 52.02 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.441 -174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.579 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 71.1 m -121.02 102.05 8.08 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.268 0.556 . . . . 0.0 110.874 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.5 mt -116.82 121.86 68.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.524 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -142.71 -172.35 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.471 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.96 141.14 46.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 177.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.549 HG23 ' HB2' ' A' ' 139' ' ' ARG . 20.8 m -124.14 167.38 18.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.045 0.45 . . . . 0.0 111.003 -179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.959 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.13 163.09 53.68 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.281 -171.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 137' ' ' GLU . 60.2 Cg_endo -72.33 20.94 0.29 Allowed 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.434 2.089 . . . . 0.0 112.124 177.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 104' ' ' LYS . 8.9 t -156.47 8.87 0.22 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.959 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 2.3 p30 -78.98 176.92 9.19 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.157 0.503 . . . . 0.0 111.206 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.521 ' HA ' HD11 ' A' ' 111' ' ' LEU . 23.1 m -123.69 24.31 3.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.235 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -113.22 5.11 16.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.82 -174.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.7 m -108.56 -13.95 10.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.974 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -108.06 1.85 22.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -176.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -89.94 174.33 7.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -76.19 107.3 8.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.882 0.372 . . . . 0.0 110.349 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.608 ' HB3' HE22 ' A' ' 120' ' ' GLN . 56.0 mm-40 -81.83 69.37 8.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.649 0.738 . . . . 0.0 110.564 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -115.04 -165.6 1.04 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.468 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.49 -26.26 24.77 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.275 -0.488 . . . . 0.0 111.894 176.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -125.13 -173.2 2.75 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -87.51 -153.85 0.24 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.425 ' HB2' ' HE2' ' A' ' 95' ' ' TYR . 17.1 mmtm -54.56 123.1 12.07 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.608 HE22 ' HB3' ' A' ' 114' ' ' GLN . 12.6 pt20 -117.29 120.09 37.16 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.735 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 121' ' ' LEU . 28.1 mt -78.18 99.19 6.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.6 m -85.78 96.9 9.89 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.71 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 26.5 mt -94.92 101.37 13.15 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.943 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.36 93.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.0 m -93.9 111.27 22.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.144 0.497 . . . . 0.0 110.138 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 58.2 m -95.45 109.5 21.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.297 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -136.94 89.22 2.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.994 0.902 . . . . 0.0 110.594 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 9.1 p-10 -153.9 -51.26 0.1 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.194 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 56.5 83.52 0.1 Allowed 'General case' 0 C--O 1.233 0.208 0 O-C-N 124.023 0.827 . . . . 0.0 110.772 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 132' ' ' LYS . 38.4 t-20 -77.84 94.13 4.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.25 -20.76 63.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.144 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 130' ' ' ASN . 30.6 mmmt -63.3 -30.47 71.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.492 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.425 HG23 HG12 ' A' ' 135' ' ' VAL . 4.9 t -129.68 -23.77 2.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.164 178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 60.75 1.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.6 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.425 HG12 HG23 ' A' ' 133' ' ' THR . 9.5 p -159.05 159.67 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -99.05 110.75 23.3 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 41.8 mt-10 -90.9 -59.83 2.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.709 -176.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 128' ' ' ASP . 53.2 mmtt -80.81 102.26 9.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.885 0.85 . . . . 0.0 110.987 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.549 ' HB2' HG23 ' A' ' 103' ' ' VAL . 74.1 mtt180 -114.11 102.07 9.82 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.598 -176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -83.2 122.29 28.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 5.0 tt -118.92 125.36 74.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.59 -172.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.632 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 16.2 m-85 -109.15 124.54 50.99 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.589 -1.187 . . . . 0.0 109.534 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 57.7 t -110.97 109.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.085 0.469 . . . . 0.0 110.318 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.62 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -107.65 120.03 41.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.351 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.6 m -89.86 143.1 27.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.122 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.496 ' OE1' ' HD2' ' A' ' 93' ' ' ARG . 31.9 tt0 -61.59 128.59 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.321 0.582 . . . . 0.0 111.239 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 148' ' ' LYS . 2.3 t -110.92 170.14 3.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.422 -178.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.48 ' H ' HG12 ' A' ' 147' ' ' VAL . 37.1 mtpt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.431 -0.795 . . . . 0.0 112.263 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HG3' ' HG2' ' A' ' 2' ' ' GLN . 24.9 ptt? . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 82.3 mm-40 73.04 5.07 5.11 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.764 0.826 . . . . 0.0 111.583 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.636 ' HB3' HD22 ' A' ' 90' ' ' ASN . . . -178.81 106.14 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.454 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.469 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 50.1 mtmt -102.41 100.44 15.79 Favored Pre-proline 0 C--N 1.32 -0.681 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.878 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 19.0 Cg_endo -58.38 124.12 15.13 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.975 2.45 . . . . 0.0 111.234 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -151.98 175.31 12.64 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.623 -173.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.527 HG23 ' CB ' ' A' ' 31' ' ' PRO . 53.4 mt -113.12 95.23 33.98 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.212 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.531 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 23.9 Cg_exo -65.14 164.37 25.52 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.289 2.659 . . . . 0.0 113.565 -174.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -65.3 -34.1 77.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.779 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.09 129.44 34.5 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.368 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm -96.88 6.1 49.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.088 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.4 m -101.12 8.45 42.77 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 65.8 mttm -107.84 175.9 5.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.687 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -107.83 120.49 59.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.614 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.92 -29.37 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.252 0.548 . . . . 0.0 110.913 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.99 168.95 42.1 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.238 -179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 80.0 m-85 -118.05 131.16 56.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tp -100.63 115.41 42.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.662 0.744 . . . . 0.0 110.003 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 47.7 mt-10 -123.63 112.39 17.36 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.83 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 25' ' ' ILE . 46.3 mt -126.27 94.78 40.26 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.903 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -57.75 -33.28 96.59 Favored 'Trans proline' 0 CA--C 1.518 -0.314 0 C-N-CA 122.77 2.313 . . . . 0.0 111.505 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -58.28 -34.45 70.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.37 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -112.35 10.35 19.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.845 0.355 . . . . 0.0 110.449 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 55.49 30.58 15.39 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.858 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.478 HD12 HD12 ' A' ' 20' ' ' ILE . 63.1 mt -86.86 133.3 30.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.26 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HG2' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -156.14 57.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.14 0.495 . . . . 0.0 109.745 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -117.81 153.81 50.95 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.656 -172.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -80.16 138.67 12.89 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.818 2.345 . . . . 0.0 112.635 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.7 t -100.93 131.38 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.936 0.398 . . . . 0.0 110.316 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' A' ' 44' ' ' SER . 84.3 m-85 -101.41 129.22 27.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.795 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.531 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 58.8 Cg_endo -71.5 149.81 56.55 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.887 2.391 . . . . 0.0 112.161 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.18 177.89 25.44 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.047 174.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB3' ' HB2' ' A' ' 48' ' ' GLU . 84.4 Cg_endo -84.63 29.95 0.53 Allowed 'Trans proline' 0 CA--C 1.52 -0.199 0 C-N-CA 123.813 3.009 . . . . 0.0 112.671 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.563 ' HA ' ' HB3' ' A' ' 44' ' ' SER . . . 60.8 56.34 2.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.042 -177.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.52 HG23 ' HG2' ' A' ' 33' ' ' PRO . 1.4 p -76.55 138.22 67.09 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.67 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -38.47 -66.34 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 124.49 3.46 . . . . 0.0 114.655 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.59 -35.49 81.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 -173.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -68.83 -34.4 75.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.731 -174.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.5 pp -87.4 -0.43 56.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.44 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -98.67 -31.57 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.114 175.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -70.51 -29.99 66.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.178 0.513 . . . . 0.0 109.641 174.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.4 -97.48 0.16 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.031 ' HB ' ' HG3' ' A' ' 71' ' ' GLN . 0.6 OUTLIER -170.28 153.22 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 8.4 t -133.37 176.19 8.74 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.362 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' HD2' ' HA ' ' A' ' 31' ' ' PRO . 73.5 m-85 -89.16 173.62 8.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.294 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.39 -44.96 85.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.767 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 50' ' ' GLU . 32.5 mt-10 -134.21 167.41 20.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 111.153 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 1.4 tm-20 -72.97 -40.08 65.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.141 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -80.49 11.11 3.92 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.117 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HB3' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -62.34 146.58 50.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.932 176.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 62.3 m -141.81 133.27 26.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 0.0 111.775 -175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.3 mt -77.25 -2.87 36.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.748 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -84.03 -13.47 53.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.686 0.755 . . . . 0.0 109.487 177.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -88.26 -168.82 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.59 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.69 0.94 9.95 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.602 0.239 . . . . 0.0 110.452 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -113.16 49.69 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.139 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -75.03 118.27 20.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.305 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' HD11 ' A' ' 124' ' ' ILE . 15.5 m -120.36 124.87 46.59 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.559 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.2 mt -108.92 136.26 45.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.863 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.38 113.37 26.92 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.942 0.151 . . . . 0.0 110.8 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -105.76 148.21 16.43 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.678 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.473 ' HB2' ' C12' ' A' ' 201' ' ' JPT . 10.7 t-160 -117.16 107.57 14.63 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.173 0.189 . . . . 0.0 110.622 178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -65.18 126.63 28.73 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 66' ' ' ASP . 8.3 t80 -130.97 152.82 49.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.65 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.3 mt -90.6 -43.56 14.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.613 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.526 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 4.4 m-20 -76.39 -1.58 27.63 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -122.92 115.58 29.21 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.67 0.271 . . . . 0.0 110.561 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -90.34 0.57 5.32 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.746 2.297 . . . . 0.0 112.032 173.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -141.74 79.21 1.67 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.564 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -141.55 -166.62 2.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.364 173.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 1.031 ' HG3' ' HB ' ' A' ' 43' ' ' VAL . 68.8 mm-40 -47.29 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -101.27 28.47 5.39 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -168.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -40.13 85.51 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.354 0.597 . . . . 0.0 111.053 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.55 ' OD1' ' HE3' ' A' ' 76' ' ' LYS . 67.0 t30 -111.07 22.99 14.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.718 -174.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -69.25 -5.53 23.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.135 0.493 . . . . 0.0 110.998 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.55 ' HE3' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -75.37 -8.23 56.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.898 0.38 . . . . 0.0 110.683 176.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.77 6.57 45.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.347 0.594 . . . . 0.0 110.48 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.95 152.53 21.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.503 178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 -171.5 3.78 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.117 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -51.96 -22.05 3.59 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -136.96 44.83 1.12 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 119.578 -1.296 . . . . 0.0 113.337 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 m -67.88 142.2 56.17 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.647 ' HE1' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -91.19 89.85 7.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.101 176.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 94' ' ' LYS . 57.2 t -85.95 107.55 16.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.493 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -100.52 118.85 37.56 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -110.51 104.16 12.86 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 1.4 mptm? -81.18 123.1 28.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.751 -177.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.878 ' HB ' ' HB3' ' A' ' 5' ' ' PRO . 6.6 m -136.95 116.53 15.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.167 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.05 -95.58 0.2 Allowed Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.454 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.636 HD22 ' HB3' ' A' ' 3' ' ' ALA . 8.0 p30 -120.85 -3.41 9.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.537 0.208 . . . . 0.0 110.897 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -129.42 178.95 6.08 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.957 -173.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 t -142.4 141.55 32.28 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.4 HH21 ' CD ' ' A' ' 146' ' ' GLU . 18.3 mmm180 -108.53 132.65 53.62 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.647 ' HD3' ' HE1' ' A' ' 83' ' ' MET . 12.1 ptpt -99.3 135.62 40.44 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 86.4 m-85 -122.03 144.36 48.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.703 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.547 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 2.2 tptm -110.04 126.07 53.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.049 178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.486 ' HG2' ' HB2' ' A' ' 144' ' ' ALA . 59.6 mtt -82.07 80.73 8.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.428 0.633 . . . . 0.0 110.588 -175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 98' ' ' THR . 2.0 t -89.25 -6.16 57.04 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.153 -173.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB3' ' HB ' ' A' ' 143' ' ' VAL . 8.0 t -144.83 129.17 17.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 176.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -141.19 125.47 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.181 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -170.74 -176.62 2.1 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.048 0.218 . . . . 0.0 110.832 172.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.731 ' HB3' ' HE3' ' A' ' 140' ' ' LYS . 2.9 p30 -130.24 138.88 50.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.417 . . . . 0.0 110.435 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.0 m -142.8 -179.77 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.93 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -93.19 154.19 41.58 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.495 ' HD3' ' HD3' ' A' ' 139' ' ' ARG . 61.0 Cg_endo -72.09 -18.42 27.36 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.317 2.011 . . . . 0.0 111.736 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.7 t -106.63 15.74 25.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.85 -179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.415 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 6.0 t0 -72.58 162.05 29.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.517 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 -7.25 10.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 121.477 0.656 . . . . 0.0 109.741 -176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -71.71 -29.53 64.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.629 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 m -97.22 -9.31 9.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.915 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 107' ' ' ASP . 94.1 mt -90.98 10.29 27.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.672 -178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -95.2 -176.11 3.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.225 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -103.94 132.16 50.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.35 0.595 . . . . 0.0 111.298 -177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -82.78 120.97 26.3 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.616 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -84.19 -152.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.693 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.34 55.62 1.16 Allowed Glycine 0 C--N 1.336 0.583 0 O-C-N 123.267 0.354 . . . . 0.0 113.593 -175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 25.2 mmtm -83.59 147.43 27.74 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 171.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -87.36 -157.45 0.39 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.432 ' HD3' ' N ' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -67.06 103.67 1.23 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.842 0.353 . . . . 0.0 110.418 -178.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 145' ' ' THR . 2.8 pt20 -104.56 136.37 44.24 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.394 178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.75 105.8 16.3 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.5 m -85.33 100.86 12.11 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.729 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.6 mt -83.64 99.39 10.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 176.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 58' ' ' SER . 18.9 mt -91.54 97.22 6.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 140' ' ' LYS . 17.4 m -106.9 121.94 45.42 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.804 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 94.2 m -73.54 96.16 2.38 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.0 -0.68 . . . . 0.0 110.201 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 140' ' ' LYS . 6.4 t70 -110.53 98.36 7.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.887 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -178.59 -82.35 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.51 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.63 ' CE1' ' HG2' ' A' ' 131' ' ' GLU . 1.2 t80 58.58 77.48 0.3 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.016 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -83.25 86.28 7.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.269 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.63 ' HG2' ' CE1' ' A' ' 129' ' ' TYR . 27.8 mt-10 -58.79 -22.95 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.764 -178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -64.83 -27.53 68.94 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.485 HG23 HG12 ' A' ' 135' ' ' VAL . 4.8 t -121.66 -17.5 7.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.84 0.352 . . . . 0.0 110.445 177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.09 48.64 5.33 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.239 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.485 HG12 HG23 ' A' ' 133' ' ' THR . 4.0 p -146.14 158.05 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.501 ' HB2' ' O4 ' ' A' ' 201' ' ' JPT . 46.5 m95 -105.34 98.69 8.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -72.65 -58.51 3.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.76 0.314 . . . . 0.0 111.782 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -85.3 137.12 33.18 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.459 0.647 . . . . 0.0 112.316 -171.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.495 ' HD3' ' HD3' ' A' ' 105' ' ' PRO . 6.5 mpt_? -100.12 111.03 23.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.76 172.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 127' ' ' ASP . 0.1 OUTLIER -79.03 117.86 20.48 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.183 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.0 tt -120.48 123.48 70.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.913 0.863 . . . . 0.0 111.052 -174.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.55 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 11.5 m-85 -108.14 114.65 28.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.048 175.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 99' ' ' SER . 40.2 t -93.95 99.62 9.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.302 0.572 . . . . 0.0 110.02 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -103.83 109.34 21.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.291 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 120' ' ' GLN . 5.7 m -93.53 143.56 26.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.468 -177.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 93' ' ' ARG . 34.0 tt0 -54.01 124.02 14.3 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 123.685 0.615 . . . . 0.0 111.303 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.525 HG11 ' HD3' ' A' ' 96' ' ' LYS . 6.5 p -111.05 151.6 13.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.585 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.45 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 4.5 ptmm? . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.59 -0.719 . . . . 0.0 111.464 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.501 ' O4 ' ' HB2' ' A' ' 136' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.558 0.218 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.02 169.19 9.99 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.0 98.94 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.982 0.801 . . . . 0.0 110.223 -172.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 53' ' ' ASP . 16.6 mttt 54.66 84.73 0.21 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.51 -171.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.498 ' HG2' HG22 ' A' ' 88' ' ' VAL . 11.1 Cg_exo -70.25 164.44 35.02 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.7 2.267 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -140.3 130.15 24.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.197 0.522 . . . . 0.0 111.009 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.702 HG13 HD21 ' A' ' 52' ' ' LEU . 12.0 mt -63.6 121.98 73.64 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.124 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -86.33 -179.07 2.98 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.965 2.443 . . . . 0.0 112.575 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -81.16 -12.62 59.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.3 0.572 . . . . 0.0 110.554 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -85.03 113.16 21.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.139 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -91.53 1.46 57.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.223 -176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 t -98.97 -6.04 29.43 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.879 0.371 . . . . 0.0 111.377 -171.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -106.3 172.92 6.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.066 0.46 . . . . 0.0 110.884 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.0 t -92.34 125.38 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.609 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.35 -44.98 13.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.381 0.61 . . . . 0.0 109.696 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.88 168.34 36.22 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' PRO . 68.2 m-85 -107.77 140.84 40.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 117.138 0.469 . . . . 0.0 110.439 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.0 tp -105.33 112.71 39.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.855 0.836 . . . . 0.0 109.446 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HB3' ' HD2' ' A' ' 26' ' ' LYS . 33.5 mt-10 -122.29 112.58 18.31 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.528 -176.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 25' ' ' ILE . 38.7 mt -127.28 93.95 39.85 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.791 177.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.51 -28.47 86.72 Favored 'Trans proline' 0 CA--C 1.518 -0.298 0 C-N-CA 123.117 2.545 . . . . 0.0 111.808 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 78' ' ' ALA . 26.9 t70 -67.22 -28.03 67.73 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.174 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -114.66 12.41 17.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.148 -176.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.5 t70 61.78 26.91 16.4 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.492 0.663 . . . . 0.0 111.128 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 20' ' ' ILE . 80.5 mt -95.99 129.67 45.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.206 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.596 ' HD2' ' HB3' ' A' ' 19' ' ' GLU . 9.2 mmmm -155.26 42.18 0.44 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.468 0.307 . . . . 0.0 111.498 -175.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -124.46 157.47 64.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 36.4 Cg_endo -66.47 149.17 84.62 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.426 2.75 . . . . 0.0 113.52 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.81 138.1 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.214 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -100.33 135.57 20.23 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 121.0 0.428 . . . . 0.0 110.83 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.498 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.0 Cg_endo -79.89 128.93 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.729 2.286 . . . . 0.0 111.348 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.673 ' HA3' ' HG2' ' A' ' 38' ' ' GLN . . . -175.82 149.42 9.99 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.794 -1.193 . . . . 0.0 112.676 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.483 ' HG2' HG23 ' A' ' 35' ' ' THR . 68.8 Cg_endo -74.46 38.02 0.48 Allowed 'Trans proline' 0 N--CA 1.477 0.519 0 C-N-CA 123.966 3.111 . . . . 0.0 113.476 177.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 54.91 36.23 26.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.074 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 33' ' ' PRO . 6.1 p -76.46 154.16 83.85 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.784 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 77.3 Cg_exo -50.92 -46.71 29.14 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.607 2.871 . . . . 0.0 114.091 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HG3' ' H ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -75.9 -17.83 59.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 111.349 -177.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.673 ' HG2' ' HA3' ' A' ' 32' ' ' GLY . 42.4 tp60 -81.41 -46.82 14.05 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.913 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 96.7 mt -77.89 -1.52 32.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.441 177.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 36' ' ' PRO . 65.6 t30 -84.55 -44.19 13.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.747 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 38' ' ' GLN . 7.0 ptm180 -75.52 -30.32 59.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.574 -178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -179.51 -162.9 29.42 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.6 m -85.39 155.73 3.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 117.491 0.646 . . . . 0.0 110.114 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.562 ' OG ' ' HG3' ' A' ' 38' ' ' GLN . 59.9 m -150.58 179.72 7.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.146 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -73.27 157.85 36.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.577 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -45.17 76.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.632 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.19 175.99 9.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.513 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -80.6 1.9 27.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.229 0.538 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -81.88 -17.32 47.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.49 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' HG3' ' H ' ' A' ' 58' ' ' SER . 1.3 mp0 -61.13 154.26 23.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.733 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.895 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m -141.56 157.95 44.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.88 ' HG ' HG21 ' A' ' 88' ' ' VAL . 2.5 mm? -77.08 -23.21 51.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.086 0.47 . . . . 0.0 110.606 -178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.478 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 15.2 t70 -135.34 70.08 1.44 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 122.639 1.209 . . . . 0.0 109.108 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.895 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 9.3 t70 -124.78 162.4 24.37 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 113.137 -1.847 . . . . 0.0 108.709 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -63.89 -35.93 82.26 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.36 131.74 54.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.41 0.624 . . . . 0.0 111.21 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.547 ' HB ' HD23 ' A' ' 121' ' ' LEU . 47.1 mt -129.2 123.06 57.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.417 ' H ' ' HG3' ' A' ' 50' ' ' GLU . 1.1 m -113.17 109.2 18.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -172.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.9 mt -107.99 124.35 64.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.09 120.02 33.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.003 0.43 . . . . 0.0 111.08 -176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.62 118.28 5.54 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.817 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -68.42 -38.62 81.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.6 m 73.01 126.92 0.04 OUTLIER 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.552 -174.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -137.43 142.51 41.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.118 178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 96.0 mt -91.22 -39.45 11.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.875 173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.63 -46.74 63.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.292 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -107.9 107.12 59.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.711 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.558 ' HA ' HG21 ' A' ' 73' ' ' THR . 96.4 Cg_endo -80.25 -18.89 9.58 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.551 2.168 . . . . 0.0 111.682 178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -124.61 70.79 1.13 Allowed 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.464 0.649 . . . . 0.0 110.896 -174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.444 ' HE1' ' HG1' ' A' ' 73' ' ' THR . 3.7 p90 -138.48 -177.5 4.88 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 166.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -41.06 -68.41 0.19 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -168.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -114.28 96.22 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.24 -174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 68' ' ' PRO . 1.3 m -156.49 -45.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.641 172.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -97.91 23.36 8.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.542 0.687 . . . . 0.0 110.247 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.21 -11.5 59.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.973 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -71.11 -11.16 60.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.823 0.344 . . . . 0.0 111.545 -178.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -89.65 6.86 39.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.516 ' HA ' ' OD1' ' A' ' 22' ' ' ASP . . . -94.05 135.05 35.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.796 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 7.4 mptt -108.51 -170.87 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.617 175.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 97' ' ' MET . 6.2 ptpp? -65.87 -33.9 76.9 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.43 54.01 0.57 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.469 177.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.3 p -75.02 -15.97 60.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.425 ' HG2' ' HE3' ' A' ' 96' ' ' LYS . 0.0 OUTLIER 54.31 85.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.556 0.693 . . . . 0.0 111.639 -174.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 48.4 t -86.11 113.44 24.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.062 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.452 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 89.4 m-85 -98.73 110.43 23.03 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.576 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 34.9 t80 -99.21 102.59 14.29 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 35.7 mmtp -92.02 81.27 5.1 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.387 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.88 HG21 ' HG ' ' A' ' 52' ' ' LEU . 5.4 p -93.54 121.05 43.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.178 0.513 . . . . 0.0 110.489 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 61.12 -104.1 0.63 Allowed Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.731 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 90' ' ' ASN . 6.6 m120 -124.64 9.25 8.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.756 0.312 . . . . 0.0 110.718 177.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -100.11 148.58 24.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.88 0.371 . . . . 0.0 110.57 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 93.1 m -117.7 104.34 10.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.188 0.518 . . . . 0.0 111.023 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' ' 86' ' ' PHE . 58.2 mmt-85 -92.11 135.36 34.04 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.986 176.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -115.02 130.1 56.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.036 179.111 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 76.4 m-85 -130.23 146.88 51.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.72 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.626 ' HD3' HG21 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -112.95 135.99 53.12 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.702 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.536 ' SD ' ' HB2' ' A' ' 144' ' ' ALA . 20.8 mmt -79.35 65.44 4.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.528 0.68 . . . . 0.0 110.359 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.2 t -80.44 -13.75 58.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.551 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 28.4 m -135.18 90.88 2.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.546 0.689 . . . . 0.0 111.1 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 97' ' ' MET . 73.1 mt -109.07 129.7 63.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.429 177.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -164.62 -169.64 1.8 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.83 0.347 . . . . 0.0 110.255 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.819 ' HB3' ' HD2' ' A' ' 140' ' ' LYS . 3.3 p-10 -145.68 137.37 25.18 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.56 HG23 ' HD2' ' A' ' 139' ' ' ARG . 21.5 m -120.29 174.13 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.323 -173.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.526 ' N ' ' HD3' ' A' ' 104' ' ' LYS . 3.2 mppt? -91.6 158.05 41.03 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.827 -176.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.737 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 19.9 Cg_endo -61.7 -24.2 77.31 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.358 2.039 . . . . 0.0 111.293 176.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -114.71 29.93 7.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.789 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 17.9 t70 -63.29 139.71 58.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.257 -178.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.1 m -110.87 2.57 8.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.738 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -85.92 -36.24 20.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.279 0.561 . . . . 0.0 110.197 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.1 -10.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.906 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 pp -111.13 -0.13 16.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.775 0.322 . . . . 0.0 111.192 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -99.84 -159.15 0.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 113' ' ' GLU . 9.5 pt-20 -60.98 112.91 2.26 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.458 0.646 . . . . 0.0 111.672 -177.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -85.6 134.18 34.02 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.518 174.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 12.1 mptt -74.16 174.98 7.96 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.278 -170.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.81 55.05 1.34 Allowed Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.884 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -69.41 173.54 5.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.329 0.585 . . . . 0.0 110.972 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.411 ' OD1' ' HD3' ' A' ' 119' ' ' LYS . 5.1 t70 -104.54 -149.72 0.42 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 171.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -58.69 114.85 2.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -113.83 119.84 38.71 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.259 0.552 . . . . 0.0 111.957 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.547 HD23 ' HB ' ' A' ' 57' ' ' ILE . 14.0 mt -82.38 104.97 13.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.6 m -92.63 92.21 7.9 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.565 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 16.7 mt -87.78 101.12 13.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.997 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 40.1 mt -90.92 97.8 7.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.29 -177.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.4 m -103.09 101.97 11.96 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.328 0.585 . . . . 0.0 110.362 -177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 86.3 m -92.56 101.87 14.31 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.689 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -120.36 68.44 0.85 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.495 0.664 . . . . 0.0 110.052 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 138' ' ' LYS . 34.6 t70 -176.26 95.23 0.05 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.681 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -102.56 115.94 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.233 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -86.69 103.05 14.78 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -63.89 -27.07 68.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.017 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.562 ' N ' ' HD3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -77.53 -18.57 56.86 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.518 -173.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 135' ' ' VAL . 21.9 p -120.82 -32.3 4.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.62 16.24 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.505 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.535 HG12 ' OG1' ' A' ' 133' ' ' THR . 9.8 p -132.64 154.46 39.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.804 0.335 . . . . 0.0 110.578 -177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.718 ' HB2' ' O4 ' ' A' ' 201' ' ' JPT . 55.4 m95 -97.71 109.21 22.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.737 ' HG2' ' HG3' ' A' ' 105' ' ' PRO . 44.2 mt-10 -87.93 -63.76 1.25 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -172.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 128' ' ' ASP . 48.1 tptt -75.57 80.7 2.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 122.134 0.969 . . . . 0.0 110.348 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.56 ' HD2' HG23 ' A' ' 103' ' ' VAL . 1.5 ptp180 -93.57 108.63 20.31 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.355 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.819 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 45.6 tptt -80.66 132.77 35.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.334 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -122.71 122.72 66.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.923 0.868 . . . . 0.0 111.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.459 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 13.2 m-85 -110.69 105.32 14.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.687 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 26.2 t -99.35 104.23 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.349 0.595 . . . . 0.0 110.371 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.536 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -100.38 117.76 35.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.368 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 5.1 m -95.78 144.51 26.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.404 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.765 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 29.8 tt0 -56.67 135.91 54.96 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.256 0.55 . . . . 0.0 111.725 -174.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.626 HG21 ' HD3' ' A' ' 96' ' ' LYS . 1.1 t -106.94 172.26 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.55 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.424 ' H ' HG12 ' A' ' 147' ' ' VAL . 30.4 mmmt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.541 -0.742 . . . . 0.0 110.607 176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.718 ' O4 ' ' HB2' ' A' ' 136' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptt? . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -89.24 -164.93 1.22 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.07 0.462 . . . . 0.0 110.863 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -138.92 90.02 2.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.308 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 7.8 mtmp? -128.92 101.02 20.23 Favored Pre-proline 0 C--N 1.317 -0.839 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.795 -178.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 4' ' ' LYS . 18.3 Cg_endo -58.58 134.56 61.71 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 123.248 2.632 . . . . 0.0 112.831 -177.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.547 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 8.8 pt20 -158.05 176.2 12.83 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.863 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 31' ' ' PRO . 5.4 mp -96.99 108.88 46.3 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.034 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 6' ' ' GLN . 22.4 Cg_exo -68.11 165.03 29.79 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.811 2.341 . . . . 0.0 110.88 170.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -97.02 18.73 14.12 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.909 -171.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 18.3 t70 -86.84 150.07 24.38 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 38' ' ' GLN . 34.8 mmtp -80.4 -39.72 27.82 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 m -93.49 -22.34 18.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -59.72 150.02 29.07 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.599 0.714 . . . . 0.0 112.443 -177.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 29' ' ' VAL . 7.3 p -105.9 139.2 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.634 172.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.86 -32.53 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.448 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -141.16 161.87 26.82 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.485 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 35.7 m-85 -122.88 143.43 49.88 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 tp -104.44 118.41 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.252 0.549 . . . . 0.0 109.79 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 26.0 mt-10 -125.81 111.62 15.08 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.611 -175.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 62.1 mt -132.24 109.09 13.75 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.921 -178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -60.28 -47.18 15.3 Favored 'Trans proline' 0 N--CA 1.473 0.273 0 C-N-CA 123.157 2.571 . . . . 0.0 113.365 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -62.54 -30.19 71.12 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -98.18 2.4 48.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.224 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.4 t70 61.55 27.76 17.17 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.969 0.89 . . . . 0.0 109.887 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 61.0 mt -97.24 129.29 47.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.235 -174.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 32.5 ttpt -159.86 79.11 0.7 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 168.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.403 ' HB3' HE21 ' A' ' 71' ' ' GLN . 62.2 mm-40 -133.5 157.14 78.75 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.826 -173.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -68.2 146.88 71.35 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.848 2.365 . . . . 0.0 113.03 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.531 ' O ' ' HD3' ' A' ' 31' ' ' PRO . 76.2 t -106.12 125.44 61.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.712 176.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 61.1 m-85 -93.54 103.44 9.86 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-O 121.188 0.518 . . . . 0.0 110.476 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.627 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 3.0 Cg_endo -86.86 155.0 8.66 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.355 2.703 . . . . 0.0 112.298 -177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.77 -151.75 21.04 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.952 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.582 ' HA ' ' HB2' ' A' ' 48' ' ' GLU . 78.7 Cg_endo -76.3 19.21 0.62 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 123.249 2.633 . . . . 0.0 113.092 -176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 56.87 46.24 20.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.324 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.72 119.7 23.2 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.092 -174.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.32 -38.64 42.81 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.238 2.625 . . . . 0.0 113.066 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -59.95 -38.4 82.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.311 . . . . 0.0 111.287 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 11' ' ' LYS . 75.9 mm-40 -90.65 -30.73 16.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.089 0.471 . . . . 0.0 110.4 -176.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.5 tp -71.43 -27.99 63.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.975 177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -68.28 -24.8 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.664 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 41' ' ' ARG . 15.9 mtp-105 -80.96 -52.71 7.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.738 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.72 -117.23 1.49 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.06 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.2 t -136.56 142.42 38.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.5 m -128.59 -179.59 5.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.385 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 31' ' ' PRO . 11.9 m-85 -74.61 178.09 5.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.925 0.393 . . . . 0.0 110.472 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.7 -46.79 20.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.139 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.68 167.14 21.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.699 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -80.82 -10.31 59.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.522 0.677 . . . . 0.0 109.951 175.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -74.83 -23.0 58.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.854 -173.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 9.5 pt-20 -84.03 177.86 8.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.158 0.504 . . . . 0.0 112.161 -172.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.509 ' HA ' ' CD1' ' A' ' 7' ' ' ILE . 70.8 m -137.38 175.13 9.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.286 -172.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.8 mt -88.14 -15.95 34.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.432 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -134.9 70.34 1.44 Allowed 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 122.283 1.04 . . . . 0.0 109.589 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 14.7 t70 -126.37 160.88 29.18 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 113.555 -1.657 . . . . 0.0 108.747 171.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -63.84 -31.54 72.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -124.64 125.86 44.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.588 0.708 . . . . 0.0 111.012 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.33 139.49 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -131.15 116.23 17.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.195 0.521 . . . . 0.0 111.659 -174.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.4 mt -101.09 116.41 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.64 105.07 17.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.054 0.454 . . . . 0.0 111.309 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.64 144.49 15.95 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.301 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -122.81 133.81 54.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.552 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 24.2 m -81.86 113.27 19.68 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.204 0.526 . . . . 0.0 111.058 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -113.67 109.3 18.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.505 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 33.7 mm -54.96 -33.98 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.741 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -56.87 -40.46 76.22 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 61.1 mtt180 -106.98 108.91 62.74 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.914 0.388 . . . . 0.0 111.068 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 3.3 Cg_exo -77.77 -10.77 16.95 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.196 2.597 . . . . 0.0 112.737 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.68 80.53 1.7 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.425 0.631 . . . . 0.0 111.716 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.552 ' OH ' ' HA ' ' A' ' 63' ' ' THR . 46.0 p90 -132.62 -161.82 1.17 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.751 168.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 27' ' ' GLU . 25.6 mp0 -49.63 -72.37 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -174.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -105.57 31.77 4.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -169.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 m -73.74 -34.86 64.93 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.04 0.448 . . . . 0.0 111.223 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -116.72 28.0 8.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.277 0.56 . . . . 0.0 110.484 -173.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.8 tp -67.22 -21.45 65.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.4 pptp? -74.03 -2.05 22.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.735 0.302 . . . . 0.0 111.622 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . . . -91.42 8.2 37.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -89.62 153.92 20.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.226 0.536 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -125.82 176.41 6.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.295 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 97' ' ' MET . 13.1 ptmm? -61.2 -19.67 61.88 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.89 51.62 0.85 Allowed Glycine 0 C--N 1.319 -0.38 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.174 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.0 m -79.28 -4.47 50.89 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 83' ' ' MET . 0.1 OUTLIER 53.93 82.93 0.08 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.447 0.641 . . . . 0.0 111.244 -175.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.577 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 50.9 t -85.0 113.94 24.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.967 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.577 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 84.3 m-85 -94.26 117.64 30.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.884 0.373 . . . . 0.0 110.052 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.408 ' HB3' ' HG3' ' A' ' 93' ' ' ARG . 10.6 t80 -100.44 101.11 11.98 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 175.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 32.4 tptt -83.89 99.14 10.16 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.864 -172.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.871 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.1 m -116.7 86.96 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.781 0.801 . . . . 0.0 111.098 177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 64.87 -107.04 1.69 Allowed Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.231 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -94.14 -11.36 30.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 0.0 110.829 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.871 ' HB2' HG23 ' A' ' 88' ' ' VAL . 38.8 mt-10 -95.11 109.2 21.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.016 0.436 . . . . 0.0 110.755 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.0 m -100.57 85.68 2.99 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 172.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 93' ' ' ARG . 11.3 ptp180 -93.39 133.73 36.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.525 -175.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' HD3' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -102.86 139.38 38.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.771 -175.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 73.6 m-85 -120.91 148.99 43.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.191 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 1.2 tptm -110.49 131.96 54.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 20.9 mmt -76.68 70.58 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.054 0.454 . . . . 0.0 110.686 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -77.05 -20.62 55.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.669 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 52.5 m -133.53 101.37 5.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.942 0.401 . . . . 0.0 111.008 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 97' ' ' MET . 74.9 mt -116.49 116.54 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.688 177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.8 ptt-85 -161.66 -174.39 4.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.53 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.799 ' HB2' ' HD2' ' A' ' 138' ' ' LYS . 1.2 p-10 -144.09 134.92 25.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.19 -179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.7 m -133.77 -175.73 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.458 -174.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -92.16 160.29 35.7 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.635 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.872 ' HA ' ' O2 ' ' A' ' 201' ' ' JPT . 45.5 Cg_endo -70.35 -20.71 31.71 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.486 2.124 . . . . 0.0 111.445 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.6 t -98.83 10.54 41.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.882 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -75.21 115.86 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.802 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.95 2.41 10.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.037 0.446 . . . . 0.0 110.996 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.12 -34.88 18.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.379 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.5 m -77.26 -26.25 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.682 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.4 pp -91.83 20.29 5.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.234 0.54 . . . . 0.0 110.947 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -67.9 169.37 9.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.516 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' HB2' ' HE2' ' A' ' 115' ' ' LYS . 5.6 pt-20 -66.61 84.8 0.11 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.383 0.611 . . . . 0.0 111.328 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -87.45 37.78 0.8 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.652 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.482 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -82.52 172.12 13.35 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.639 176.107 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 99.91 -7.64 59.11 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.808 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -91.08 -168.25 2.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.133 0.492 . . . . 0.0 110.557 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -104.6 -157.78 0.63 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 167.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.9 OUTLIER -65.54 107.37 1.68 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -104.97 124.38 49.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.237 0.541 . . . . 0.0 110.282 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.5 tp -92.95 98.26 11.25 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.1 m -84.41 99.11 10.44 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.258 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 20.0 mt -85.25 106.08 16.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.1 mt -93.52 127.24 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.578 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' A' ' 140' ' ' LYS . 30.5 m -136.67 105.21 5.78 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.256 0.551 . . . . 0.0 110.501 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 32.4 m -99.52 107.39 19.56 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -118.08 -1.46 11.41 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -172.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.465 ' OD2' ' HB2' ' A' ' 137' ' ' GLU . 37.1 t70 -105.71 89.64 3.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.524 0.678 . . . . 0.0 109.919 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' A' ' 131' ' ' GLU . 92.3 t80 -82.58 124.91 30.59 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.172 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.514 ' OD1' HG22 ' A' ' 133' ' ' THR . 23.1 t-20 -89.29 103.62 16.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.595 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 40.2 mt-10 -64.09 -23.24 67.25 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -171.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 1.011 ' HE2' ' HA ' ' A' ' 132' ' ' LYS . 5.9 mmpt? -78.49 -23.43 46.4 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.514 HG22 ' OD1' ' A' ' 130' ' ' ASN . 7.7 t -130.06 -30.0 2.03 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.596 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.88 35.4 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.281 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.511 ' H ' HG23 ' A' ' 133' ' ' THR . 12.8 m -82.8 172.38 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 120.889 0.376 . . . . 0.0 110.77 178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.479 ' CZ3' ' HB2' ' A' ' 129' ' ' TYR . 41.9 m95 -117.37 112.11 20.26 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.465 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 41.9 mt-10 -77.83 -21.38 51.59 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -172.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.799 ' HD2' ' HB2' ' A' ' 102' ' ' ASP . 0.1 OUTLIER -114.98 118.35 33.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.296 0.57 . . . . 0.0 111.036 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -107.13 98.67 8.29 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.483 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.799 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 47.7 tptt -69.1 128.52 36.96 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 174.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.8 tt -126.91 118.49 50.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 CA-C-O 121.989 0.899 . . . . 0.0 111.085 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 15.8 m-85 -109.08 101.59 10.64 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.305 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 38.3 t -95.42 97.09 6.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-O 121.403 0.62 . . . . 0.0 110.121 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.557 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -95.91 112.23 24.01 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.9 178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.8 m -90.45 139.34 30.77 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -55.88 123.75 15.33 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.564 0.54 . . . . 0.0 110.798 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.553 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 4.0 t -76.8 147.3 7.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.644 -174.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt . . . . . 0 C--O 1.248 1.024 0 O-C-N 124.324 1.015 . . . . 0.0 111.236 178.73 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.872 ' O2 ' ' HA ' ' A' ' 105' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 2' ' ' GLN . 17.4 tt0 70.1 6.97 6.01 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.925 0.766 . . . . 0.0 111.13 179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.58 142.06 15.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.51 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 68.8 mmtt -119.06 93.2 46.55 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.552 172.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.84 118.33 5.52 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.874 2.383 . . . . 0.0 112.126 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -118.96 147.37 44.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.668 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.405 HG23 ' HB3' ' A' ' 31' ' ' PRO . 22.4 mt -84.57 121.82 74.91 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.453 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.79 -175.66 1.98 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.513 2.142 . . . . 0.0 112.206 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.667 ' HD2' ' H ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -97.73 6.35 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.167 178.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -95.92 103.95 15.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.052 174.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' CD ' ' HD3' ' A' ' 33' ' ' PRO . 35.3 mtmm -85.63 12.81 7.99 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.158 -0.473 . . . . 0.0 112.139 -176.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.1 t -106.72 -5.86 18.24 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.203 0.525 . . . . 0.0 109.678 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 99.3 mttt -91.37 -177.14 4.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.516 176.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -112.77 138.21 42.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.37 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.72 -29.4 12.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.244 0.545 . . . . 0.0 110.798 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -165.71 163.51 36.73 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 63.9 m-85 -109.44 135.79 49.89 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 117.483 0.642 . . . . 0.0 109.91 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 18' ' ' ILE . 8.1 tp -97.86 108.53 21.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.772 0.796 . . . . 0.0 109.612 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -114.18 103.7 11.37 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.907 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 mt -121.25 92.88 48.76 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 114.669 -1.151 . . . . 0.0 108.539 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.91 -21.18 68.9 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.052 2.502 . . . . 0.0 111.311 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.99 -30.14 63.58 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.888 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.52 10.9 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 t70 63.14 29.25 16.15 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.769 0.795 . . . . 0.0 110.758 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.53 HG23 ' HG2' ' A' ' 27' ' ' GLU . 78.2 mt -102.22 118.74 49.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 2.5 mppt? -135.82 41.51 2.69 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.727 ' HG3' ' HA ' ' A' ' 71' ' ' GLN . 13.1 mm-40 -102.55 154.19 37.64 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.429 -163.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.79 143.45 13.25 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.473 2.116 . . . . 0.0 112.151 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.1 t -102.88 127.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.892 0.377 . . . . 0.0 110.265 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.533 ' O ' ' HA ' ' A' ' 44' ' ' SER . 57.6 m-85 -100.76 133.71 20.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.493 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 13' ' ' LYS . 46.4 Cg_endo -69.26 145.34 59.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.498 2.132 . . . . 0.0 111.841 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . 164.8 162.07 15.08 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.078 -1.058 . . . . 0.0 112.31 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.743 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 Cg_endo -88.01 39.86 0.56 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.997 3.132 . . . . 0.0 111.545 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 63.71 35.98 11.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.47 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.403 ' OG1' ' HD2' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -76.0 152.48 84.47 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.824 -178.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -49.53 -57.19 2.49 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.971 3.114 . . . . 0.0 113.818 -175.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.4 mm-40 -59.61 -34.76 73.17 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.8 mp0 -64.99 -44.21 90.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.931 0.396 . . . . 0.0 110.287 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.3 -30.92 65.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.44 0.638 . . . . 0.0 110.109 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.08 -39.87 95.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.673 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 28.2 mtp-105 -75.67 -51.61 12.38 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 120.986 0.422 . . . . 0.0 110.619 175.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' C ' ' HG3' ' A' ' 71' ' ' GLN . . . -156.47 -104.91 0.22 Allowed Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.957 -175.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -138.92 149.99 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' TYR . 41.3 t -124.21 157.27 35.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.682 0.277 . . . . 0.0 110.901 -174.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -70.5 178.25 3.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 58' ' ' SER . . . -66.2 -46.58 76.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.743 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 12.8 pt-20 -149.15 -176.47 5.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.545 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -94.86 -27.37 15.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.151 -171.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -82.8 -9.86 59.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.038 0.447 . . . . 0.0 110.922 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.11 143.04 49.92 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.042 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.7 m -121.16 145.13 48.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.788 0.328 . . . . 0.0 111.752 -171.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 77.7 mt -81.84 -10.23 59.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.818 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -100.78 4.02 42.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.479 0.657 . . . . 0.0 110.558 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -95.93 178.41 5.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.519 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.55 ' HA ' ' HG3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -97.26 -8.8 28.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.708 0.29 . . . . 0.0 111.301 -177.104 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.424 ' H ' HD22 ' A' ' 56' ' ' ASN . 0.1 OUTLIER -119.58 107.1 12.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.745 0.783 . . . . 0.0 110.754 177.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.8 mt -127.58 136.11 61.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.314 -0.857 . . . . 0.0 108.872 177.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.42 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 36.6 t -132.02 132.71 43.67 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.382 0.611 . . . . 0.0 110.962 -172.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.9 mt -115.56 127.97 72.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.296 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.24 111.61 22.85 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.042 0.448 . . . . 0.0 111.063 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.99 137.92 13.67 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.666 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -148.21 102.09 3.33 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 m -56.37 147.47 21.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.594 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.48 ' HB3' ' CG ' ' A' ' 67' ' ' ARG . 69.7 t80 -139.25 148.3 42.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -178.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.3 mt -54.57 -51.52 49.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.308 -174.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -87.77 40.54 0.94 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.608 -172.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' CG ' ' HB3' ' A' ' 64' ' ' PHE . 12.8 ptp180 -166.21 88.76 0.86 Allowed Pre-proline 0 C--N 1.324 -0.533 0 CA-C-O 121.267 0.556 . . . . 0.0 111.416 176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -78.85 -4.53 14.06 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 123.189 2.593 . . . . 0.0 112.038 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -154.73 83.58 1.1 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.025 -170.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -139.12 -168.19 2.39 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.31 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.727 ' HA ' ' HG3' ' A' ' 27' ' ' GLU . 9.2 mm100 -24.1 -75.73 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.882 1.273 . . . . 0.0 113.263 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -117.44 96.47 5.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.681 0.277 . . . . 0.0 110.786 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.54 -49.74 0.78 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.327 0.584 . . . . 0.0 110.68 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.467 ' OD1' ' HE2' ' A' ' 76' ' ' LYS . 64.2 t30 -87.75 32.74 0.72 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.489 0.662 . . . . 0.0 110.952 -174.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.4 mt -72.29 -7.48 49.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.392 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.467 ' HE2' ' OD1' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -78.4 -11.66 59.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.982 0.42 . . . . 0.0 111.017 178.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.49 -12.22 49.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.755 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.09 158.15 22.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.772 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' N ' ' HD3' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -157.13 -168.77 2.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.187 178.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 97' ' ' MET . 18.5 ptmt -46.2 -39.52 9.87 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.633 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -124.54 57.19 0.68 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 119.34 -1.409 . . . . 0.0 113.174 -176.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -81.22 -6.94 59.42 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.736 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 84.2 mmm 47.68 91.63 0.01 OUTLIER 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.838 0.828 . . . . 0.0 112.744 -174.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -85.76 119.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.997 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -99.75 107.75 19.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.569 ' HD2' ' HD2' ' A' ' 93' ' ' ARG . 28.8 t80 -90.28 100.51 13.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 3.8 tppp? -82.86 93.75 7.54 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.212 -177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.09 122.03 68.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.268 0.556 . . . . 0.0 111.011 -178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.81 -90.48 0.13 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.962 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.455 HD22 ' HA ' ' A' ' 90' ' ' ASN . 1.8 t-20 -139.81 8.47 2.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.414 0.626 . . . . 0.0 109.448 177.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -100.76 131.47 46.64 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.542 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 87.8 m -103.67 97.55 7.55 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 169.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.569 ' HD2' ' HD2' ' A' ' 86' ' ' PHE . 9.9 ptp180 -97.35 153.41 18.09 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.895 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -116.05 122.29 44.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.186 0.517 . . . . 0.0 111.754 -166.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.536 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 98.9 m-85 -122.17 138.27 54.53 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.84 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.736 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.3 OUTLIER -111.88 132.25 54.84 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.665 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 53.8 mtt -80.9 62.79 5.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.633 0.73 . . . . 0.0 110.175 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -75.93 -12.66 60.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.723 -173.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.576 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 37.4 m -132.94 97.84 4.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.311 0.577 . . . . 0.0 110.34 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 64.1 mt -115.92 128.1 73.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.341 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.468 ' O ' ' HD2' ' A' ' 140' ' ' LYS . 6.1 ptp180 -161.05 -178.63 6.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.989 0.423 . . . . 0.0 110.536 176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.51 143.63 46.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.795 HG23 ' HG3' ' A' ' 139' ' ' ARG . 11.8 m -131.17 170.84 18.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.059 0.457 . . . . 0.0 110.687 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.624 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -100.28 146.39 31.9 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.819 -177.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 139' ' ' ARG . 38.3 Cg_exo -61.6 -2.31 2.57 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.938 2.425 . . . . 0.0 112.907 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.9 t -126.62 19.49 7.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.624 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 1.6 p30 -68.59 166.8 16.37 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 121.332 0.587 . . . . 0.0 111.143 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.474 ' HA ' HD11 ' A' ' 111' ' ' LEU . 29.0 m -120.54 23.97 4.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.405 ' HG2' ' HB2' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -97.98 -41.82 7.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.158 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 20.5 m -87.25 -7.8 10.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.908 -174.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 108' ' ' VAL . 2.5 pp -120.0 18.19 12.46 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.132 0.492 . . . . 0.0 110.929 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 32.3 t70 -152.15 138.47 18.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.174 -175.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.415 ' HB3' ' CE ' ' A' ' 115' ' ' LYS . 95.4 mt-10 53.4 65.76 1.42 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.795 0.684 . . . . 0.0 111.652 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -88.9 93.28 9.54 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' CE ' ' HB3' ' A' ' 113' ' ' GLU . 8.0 mptt -67.43 163.1 21.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.213 -172.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.38 54.03 2.77 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.272 -0.877 . . . . 0.0 112.806 -176.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp -66.21 172.03 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.076 0.465 . . . . 0.0 110.788 172.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 55' ' ' GLN . 3.2 t70 -81.03 -161.07 0.37 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.55 ' HG3' ' HA ' ' A' ' 55' ' ' GLN . 2.3 mppt? -64.72 119.02 9.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.989 0.423 . . . . 0.0 110.057 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -127.16 138.26 53.12 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.669 178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.6 tp -103.9 108.33 19.61 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m -92.59 106.12 18.16 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.758 -176.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 9.7 mt -92.95 103.19 15.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.7 mt -98.01 94.26 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.7 m -105.25 98.91 8.55 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.944 0.402 . . . . 0.0 110.408 -177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.725 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 6.1 p -76.34 96.83 4.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.319 0.58 . . . . 0.0 109.882 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -125.28 79.26 1.79 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.396 -175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.784 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 31.5 t70 -168.89 85.72 0.16 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.492 ' CE2' ' HA2' ' A' ' 134' ' ' GLY . 70.8 t80 -91.91 125.9 36.79 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.132 -167.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -97.26 108.55 21.29 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 171.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.486 ' HA ' ' CE1' ' A' ' 129' ' ' TYR . 34.6 mt-10 -58.27 -33.72 69.73 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -173.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -71.21 -25.71 62.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.647 HG23 ' H ' ' A' ' 135' ' ' VAL . 2.6 t -125.03 -31.0 3.16 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.837 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' HA2' ' CE2' ' A' ' 129' ' ' TYR . . . 96.46 4.23 59.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.299 -0.953 . . . . 0.0 112.113 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.647 ' H ' HG23 ' A' ' 133' ' ' THR . 98.5 t -84.67 138.51 19.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.774 0.321 . . . . 0.0 110.158 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.784 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 45.0 m95 -95.68 105.04 16.99 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 176.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.37 -16.39 56.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.715 -165.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 128' ' ' ASP . 4.6 tppp? -133.17 130.46 39.19 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.806 0.336 . . . . 0.0 110.464 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.795 ' HG3' HG23 ' A' ' 103' ' ' VAL . 27.9 ptt180 -111.09 113.6 26.25 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.456 0.646 . . . . 0.0 110.181 176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 101' ' ' ARG . 16.2 tptm -76.33 127.51 33.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.841 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.9 tt -121.04 127.16 75.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.728 0.775 . . . . 0.0 111.42 -174.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 93.1 m-85 -114.64 108.76 17.25 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.488 177.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 43.6 t -96.68 102.53 13.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.265 0.555 . . . . 0.0 110.007 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 96' ' ' LYS . . . -100.65 107.97 19.74 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.336 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.4 m -90.76 144.02 26.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.104 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -50.71 138.44 18.26 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.555 0.534 . . . . 0.0 111.186 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.67 HG22 ' HB2' ' A' ' 96' ' ' LYS . 21.5 t -97.05 153.71 3.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.548 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.2 ptmt . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.06 179.394 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.665 ' O2 ' ' HD3' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.1 mm-40 -77.08 -171.25 1.95 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.261 0.553 . . . . 0.0 111.328 -176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.64 105.27 8.89 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.833 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -128.43 99.12 24.4 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.53 130.76 22.53 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.5 2.8 . . . . 0.0 113.524 -174.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.08 169.07 18.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.397 -0.82 . . . . 0.0 108.875 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.433 HG23 ' HB3' ' A' ' 31' ' ' PRO . 2.4 mp -70.86 122.78 87.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 176.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' HD2' ' HG3' ' A' ' 31' ' ' PRO . 17.3 Cg_exo -67.52 170.54 13.47 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.747 2.298 . . . . 0.0 112.978 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -79.26 -21.96 45.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.915 -1.038 . . . . 0.0 109.82 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -97.23 108.56 21.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.022 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 31' ' ' PRO . 52.6 mtmt -90.63 31.19 1.06 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.745 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -117.17 -20.92 9.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.367 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 19.2 ptpt -90.43 -175.44 4.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.479 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 28' ' ' PRO . 7.8 p -100.94 137.52 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.874 0.369 . . . . 0.0 110.509 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -100.81 -40.19 7.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.373 0.606 . . . . 0.0 110.324 177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.14 165.45 30.31 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.607 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 47.7 m-85 -115.37 139.25 50.17 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -103.61 115.36 45.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.608 0.718 . . . . 0.0 109.949 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.19 112.67 16.05 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.571 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.466 HG12 HG13 ' A' ' 84' ' ' VAL . 43.5 mt -127.93 95.41 34.47 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.142 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.4 -29.61 89.13 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 123.114 2.543 . . . . 0.0 112.047 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.98 -33.19 74.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.875 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.47 8.8 21.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 66.68 12.55 8.88 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.26 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.479 ' CD1' ' HG ' ' A' ' 75' ' ' LEU . 62.7 mt -78.21 123.54 35.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.244 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 14.3 mtmm -153.6 84.71 1.17 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 119.364 -0.351 . . . . 0.0 110.594 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.606 ' HB3' ' HG3' ' A' ' 71' ' ' GLN . 13.1 mm-40 -155.93 163.83 23.42 Favored Pre-proline 0 N--CA 1.469 0.518 0 CA-C-N 118.0 0.364 . . . . 0.0 111.725 -178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 14' ' ' VAL . 8.2 Cg_exo -72.4 156.89 54.1 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.08 2.52 . . . . 0.0 113.387 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -116.52 123.6 71.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.623 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.9 123.88 45.79 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.739 -178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 19.0 Cg_endo -58.28 129.41 32.73 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.968 2.445 . . . . 0.0 112.228 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.486 ' HA2' ' HD3' ' A' ' 33' ' ' PRO . . . -172.27 135.12 3.24 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.445 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.486 ' HD3' ' HA2' ' A' ' 32' ' ' GLY . 2.2 Cg_endo -80.68 61.43 8.22 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.309 2.673 . . . . 0.0 112.069 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.02 27.97 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.525 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 7.8 p -79.81 136.62 54.73 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.187 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 64.1 Cg_exo -52.51 -48.57 21.22 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.471 2.78 . . . . 0.0 113.829 -175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.628 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 2.2 mp0 -67.42 -23.19 65.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 111.653 -176.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.565 ' HB3' ' OG ' ' A' ' 44' ' ' SER . 1.9 mp0 -83.06 -26.01 31.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.044 0.45 . . . . 0.0 110.013 177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.8 mt -90.56 -5.66 55.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.457 -177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.628 ' ND2' ' HA ' ' A' ' 37' ' ' GLU . 28.4 p30 -97.11 -23.68 16.11 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.982 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -96.0 -20.74 18.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA2' ' NE2' ' A' ' 71' ' ' GLN . . . -168.95 -150.22 6.59 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.84 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.91 142.28 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.565 ' OG ' ' HB3' ' A' ' 38' ' ' GLN . 70.8 m -127.55 -175.58 3.5 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.246 0.546 . . . . 0.0 112.001 -172.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -85.79 -178.86 6.71 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.662 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.71 -50.93 5.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.101 0.477 . . . . 0.0 109.941 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HB2' ' OE2' ' A' ' 50' ' ' GLU . 35.7 mt-10 -119.59 -167.58 1.44 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.018 176.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -117.47 27.23 9.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -105.41 -28.66 10.72 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.533 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 58' ' ' SER . 3.0 mp0 -63.79 168.99 4.45 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.033 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.878 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 56.3 m -147.84 160.14 43.08 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.396 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HB3' HG11 ' A' ' 88' ' ' VAL . 81.9 mt -78.67 2.33 19.87 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -137.34 11.06 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.916 0.865 . . . . 0.0 109.311 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.878 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 11.9 t70 -79.85 162.26 25.15 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.605 -175.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.584 ' HA ' ' HD3' ' A' ' 119' ' ' LYS . 1.3 tm0? -63.23 -38.23 90.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.701 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.0 129.64 55.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.353 0.597 . . . . 0.0 110.796 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.43 ' HB ' HD23 ' A' ' 121' ' ' LEU . 36.7 mt -136.83 116.59 16.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.518 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 17.2 m -113.97 122.13 46.0 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 -173.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.9 123.92 72.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.19 112.2 23.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.644 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -112.32 159.39 13.73 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.047 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -146.11 136.62 24.05 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.747 ' OG1' ' HA ' ' A' ' 127' ' ' ASP . 2.6 m -51.93 -65.82 0.49 Allowed 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.374 0.421 . . . . 0.0 111.86 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' HA ' ' OH ' ' A' ' 70' ' ' TYR . 52.7 p90 -170.62 157.83 5.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.909 0.385 . . . . 0.0 110.951 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 51.2 mm -98.43 -50.21 11.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -159.93 22.61 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.906 176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.417 ' HB2' ' CD2' ' A' ' 70' ' ' TYR . 11.8 mmm180 -115.88 119.54 37.08 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.365 -175.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.85 -11.26 13.93 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.968 2.445 . . . . 0.0 113.696 -177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -157.43 90.33 1.1 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.154 0.502 . . . . 0.0 110.783 -169.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.577 ' OH ' ' HA ' ' A' ' 64' ' ' PHE . 11.9 p90 -148.46 -160.27 1.15 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.514 171.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.606 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -41.66 -79.05 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.769 0.828 . . . . 0.0 112.739 -175.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -106.48 106.05 16.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.017 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 m -147.62 -50.66 0.18 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.26 176.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -91.99 25.29 2.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.609 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.479 ' HG ' ' CD1' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -67.24 -17.96 65.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.431 -176.511 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -75.84 -10.34 59.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.731 0.3 . . . . 0.0 110.808 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.01 -6.3 58.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.148 0.499 . . . . 0.0 110.674 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.85 169.4 18.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.556 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 97' ' ' MET . 0.0 OUTLIER -162.95 -171.29 2.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.731 -178.098 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 97' ' ' MET . 19.7 ptmt -49.15 -47.21 45.82 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -170.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' HD2' ' A' ' 96' ' ' LYS . . . -113.61 62.08 0.32 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.527 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.9 m -82.14 -15.94 51.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.472 ' CE ' ' HB2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER 55.15 90.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.675 0.75 . . . . 0.0 111.595 -176.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.466 HG13 HG12 ' A' ' 20' ' ' ILE . 39.7 t -87.98 119.9 36.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.417 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -95.91 106.85 19.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 121' ' ' LEU . 3.1 t80 -91.23 94.89 9.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.607 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 4.1 tppp? -81.23 86.39 6.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.452 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.69 HG23 ' HB2' ' A' ' 91' ' ' GLU . 5.7 m -90.16 90.96 3.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.722 0.772 . . . . 0.0 111.006 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.89 -91.96 0.36 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.232 -0.894 . . . . 0.0 112.032 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -118.09 -4.84 10.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.659 0.266 . . . . 0.0 111.053 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.69 ' HB2' HG23 ' A' ' 88' ' ' VAL . 32.6 mt-10 -97.66 147.63 24.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.095 0.474 . . . . 0.0 111.331 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.2 m -124.81 103.66 8.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.118 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.692 ' HG3' ' HE2' ' A' ' 95' ' ' TYR . 6.6 ptm180 -109.81 139.09 45.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.165 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' HB2' ' CE ' ' A' ' 83' ' ' MET . 3.5 ptmm? -108.34 130.57 55.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.321 0.581 . . . . 0.0 111.962 -172.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.692 ' HE2' ' HG3' ' A' ' 93' ' ' ARG . 61.2 m-85 -116.74 152.24 34.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.427 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.566 ' HE3' HG11 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -115.73 134.36 55.1 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.639 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 20.2 mmt -79.27 63.65 3.96 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.316 0.579 . . . . 0.0 110.519 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.1 t -74.6 -23.81 58.78 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.542 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.603 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 19.5 m -129.83 96.12 4.14 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.176 0.512 . . . . 0.0 111.329 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.47 124.48 66.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.599 177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -137.87 159.98 40.52 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.835 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -115.39 124.67 51.8 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.64 HG11 HG13 ' A' ' 110' ' ' VAL . 21.6 m -119.32 131.62 71.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.788 0.804 . . . . 0.0 111.473 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.618 ' HG3' ' HG2' ' A' ' 138' ' ' LYS . 3.2 mppt? -98.35 168.43 9.89 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.337 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.03 -11.55 27.87 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.43 2.087 . . . . 0.0 112.266 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.1 t -107.88 8.4 28.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.326 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB2' ' H ' ' A' ' 104' ' ' LYS . 12.7 t0 -94.03 134.45 36.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.317 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.39 4.75 8.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.29 -30.79 71.68 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.228 0.537 . . . . 0.0 110.98 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.64 HG13 HG11 ' A' ' 103' ' ' VAL . 17.0 m -84.67 -6.23 10.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.165 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.6 mt -95.68 -7.46 37.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.75 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -90.49 157.96 17.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.074 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -62.69 123.36 18.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.773 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -77.18 139.47 39.92 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.98 -154.16 0.29 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -168.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.8 52.82 1.63 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 123.491 0.494 . . . . 0.0 114.235 -169.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -75.7 150.39 37.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.965 0.412 . . . . 0.0 110.784 172.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -90.98 -149.4 0.22 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.637 ' HB2' ' HB2' ' A' ' 146' ' ' GLU . 32.5 mmtp -60.97 124.38 20.32 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -137.98 138.85 39.32 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.334 0.588 . . . . 0.0 111.911 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 86' ' ' PHE . 36.8 mt -94.1 103.76 15.81 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.1 m -88.1 91.1 8.65 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.793 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 26.1 mt -84.4 99.91 10.96 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.737 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 37.7 mt -83.05 78.26 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.9 m -87.81 99.61 12.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.975 -173.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 136' ' ' TRP . 57.1 m -74.23 94.89 2.53 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 174.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.747 ' HA ' ' OG1' ' A' ' 63' ' ' THR . 35.7 t70 -101.69 1.5 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.346 -172.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.727 ' O ' ' HA ' ' A' ' 136' ' ' TRP . 17.7 t0 -112.5 94.46 4.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.853 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.472 ' CE2' ' HA ' ' A' ' 131' ' ' GLU . 32.8 t80 -77.43 -26.98 52.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.155 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.5 t30 49.4 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.743 0.783 . . . . 0.0 111.457 -173.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.472 ' HA ' ' CE2' ' A' ' 129' ' ' TYR . 20.4 mt-10 -62.71 -8.63 7.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.808 -174.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 132' ' ' LYS . 57.1 mmtt -60.37 -35.09 74.88 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 11.2 t -159.41 -3.26 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.19 40.07 7.63 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.424 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.44 117.18 53.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.182 0.515 . . . . 0.0 110.032 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.727 ' HA ' ' O ' ' A' ' 128' ' ' ASP . 27.7 m95 -78.51 96.55 5.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.837 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' OD2' ' A' ' 128' ' ' ASP . 46.1 mt-10 -86.29 -61.98 1.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.18 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.618 ' HG2' ' HG3' ' A' ' 104' ' ' LYS . 33.8 mtmm -89.31 119.06 29.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.599 0.714 . . . . 0.0 111.073 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.475 ' HB2' HG23 ' A' ' 103' ' ' VAL . 40.8 mtt85 -100.56 114.71 28.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.494 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -89.01 111.0 21.62 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.3 tt -102.42 127.33 56.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.615 0.721 . . . . 0.0 110.694 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.639 ' HB3' ' SD ' ' A' ' 97' ' ' MET . 89.5 m-85 -108.51 112.73 25.27 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.438 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 44.3 t -101.43 97.33 5.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.428 0.633 . . . . 0.0 109.776 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.616 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -94.7 113.3 25.06 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.148 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 m -89.01 141.1 28.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.296 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.637 ' HB2' ' HB2' ' A' ' 119' ' ' LYS . 5.3 tt0 -61.0 115.38 3.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.309 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.566 HG11 ' HE3' ' A' ' 96' ' ' LYS . 5.1 p -117.19 124.77 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.573 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.4 -0.809 . . . . 0.0 111.223 -176.487 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.432 ' C5 ' ' HE ' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.53 0.205 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -76.21 -177.35 3.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 171.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.03 105.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 O-C-N 123.438 0.461 . . . . 0.0 109.811 -170.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 39.4 mtmt 59.45 97.52 0.04 OUTLIER Pre-proline 0 N--CA 1.45 -0.449 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.867 -167.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 13.8 Cg_endo -55.64 124.26 15.84 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.862 2.375 . . . . 0.0 111.277 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -141.1 146.79 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.72 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 31' ' ' PRO . 2.5 mp -78.62 129.18 74.98 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.701 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.18 163.28 39.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.749 2.299 . . . . 0.0 112.863 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.934 ' H ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -70.83 -15.68 62.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.695 177.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -84.59 121.88 28.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.753 ' HD2' ' HD3' ' A' ' 33' ' ' PRO . 37.7 mmtm -95.2 16.62 16.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.417 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -127.04 26.54 6.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.005 0.431 . . . . 0.0 110.542 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.475 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 64.4 mttm -118.06 176.03 5.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.409 0.623 . . . . 0.0 112.045 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.0 t -109.54 111.87 38.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.614 173.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 31' ' ' PRO . . . -91.04 -21.42 21.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 110.963 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.02 159.41 31.88 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.901 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 57.9 m-85 -114.81 135.68 53.92 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.5 tp -101.86 121.22 52.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.527 0.68 . . . . 0.0 109.791 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.648 ' HG2' ' HD2' ' A' ' 26' ' ' LYS . 37.7 mt-10 -124.26 118.75 27.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.449 -177.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 25' ' ' ILE . 55.9 mt -134.21 96.9 15.32 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 20' ' ' ILE . 9.5 Cg_endo -54.01 -35.89 82.47 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.324 2.683 . . . . 0.0 112.999 -176.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -66.8 -29.84 69.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.796 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.71 2.36 27.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.628 0.251 . . . . 0.0 110.976 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HB3' HD21 ' A' ' 69' ' ' ASN . 30.9 t70 65.56 25.97 11.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.836 0.827 . . . . 0.0 110.084 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 20' ' ' ILE . 77.1 mt -91.47 125.4 44.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.954 -177.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.648 ' HD2' ' HG2' ' A' ' 19' ' ' GLU . 7.0 mmmt -151.27 54.24 0.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 5.5 mm-40 -121.82 153.66 60.32 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.611 -166.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -79.89 134.23 10.6 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.966 2.444 . . . . 0.0 112.807 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.9 t -90.07 135.05 27.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.329 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.41 ' HD2' ' HA3' ' A' ' 42' ' ' GLY . 51.2 m-85 -101.46 102.71 23.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.036 0.446 . . . . 0.0 109.857 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB2' HG23 ' A' ' 7' ' ' ILE . 73.2 Cg_endo -71.14 140.93 38.56 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.972 2.448 . . . . 0.0 112.112 -176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.15 -171.4 43.37 Favored Glycine 0 N--CA 1.439 -1.125 0 C-N-CA 119.752 -1.213 . . . . 0.0 112.79 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.753 ' HD3' ' HD2' ' A' ' 11' ' ' LYS . 27.0 Cg_endo -93.73 34.52 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.012 3.141 . . . . 0.0 112.566 -177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 60.55 27.73 17.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.844 -1.071 . . . . 0.0 111.431 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.729 HG23 ' HB2' ' A' ' 38' ' ' GLN . 2.6 t -62.67 128.58 91.92 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.894 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -47.57 -44.89 24.73 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 124.093 3.195 . . . . 0.0 113.928 -174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 39.4 mt-10 -61.07 -49.37 77.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.997 0.427 . . . . 0.0 110.743 -176.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.729 ' HB2' HG23 ' A' ' 35' ' ' THR . 2.8 mp0 -70.69 -26.37 63.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.891 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 39' ' ' LEU . 6.5 mt -75.33 -10.15 59.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 176.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -99.48 -5.68 28.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.362 176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD3' ' HA ' ' A' ' 38' ' ' GLN . 57.4 mtp180 -102.03 -30.7 11.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 30' ' ' TYR . . . -170.05 -170.58 34.61 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.482 -1.235 . . . . 0.0 110.797 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.8 m -89.95 150.65 3.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 117.63 0.715 . . . . 0.0 109.715 176.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.8 t -137.79 178.91 6.76 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.019 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CD2' ' HG2' ' A' ' 50' ' ' GLU . 58.3 m-85 -84.61 172.65 11.41 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.123 -178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.81 82.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.918 0.39 . . . . 0.0 110.775 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -157.31 -179.48 8.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.231 174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 33' ' ' PRO . 14.5 tt0 -76.77 -15.56 59.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.616 -174.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -87.56 4.46 43.58 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.023 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 6.3 tp10 -56.63 127.56 32.01 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 176.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.909 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 19.9 m -120.02 121.64 39.37 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.895 0.379 . . . . 0.0 110.767 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 5' ' ' PRO . 52.0 mt -72.73 -16.59 61.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.432 -178.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -98.68 2.63 47.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.218 178.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.909 ' HB2' ' HB2' ' A' ' 51' ' ' SER . 14.0 t70 -86.77 -178.55 6.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -91.73 -18.46 23.89 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -116.8 108.33 15.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.777 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.48 105.49 18.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.406 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 1.1 m -101.17 120.86 40.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.209 -175.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.2 mt -112.98 127.74 70.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.34 124.1 39.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.974 0.416 . . . . 0.0 110.937 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -126.62 173.15 18.2 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.093 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -163.45 179.57 7.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.3 150.38 20.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.679 0.276 . . . . 0.0 110.967 173.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.477 ' HE2' ' HB3' ' A' ' 66' ' ' ASP . 40.6 t80 -134.37 152.12 51.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.2 mt -81.45 -53.86 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -172.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.477 ' HB3' ' HE2' ' A' ' 64' ' ' PHE . 23.0 t70 -64.86 -42.52 94.81 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -174.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.475 ' HE ' ' HB3' ' A' ' 70' ' ' TYR . 22.8 mtp180 -106.98 110.18 63.46 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.605 -175.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.59 -8.73 20.82 Favored 'Trans proline' 0 CA--C 1.516 -0.379 0 C-N-CA 123.188 2.592 . . . . 0.0 112.222 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.443 HD21 ' HB3' ' A' ' 24' ' ' ASP . 17.3 t-20 -161.77 86.29 0.64 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.236 -175.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.475 ' HB3' ' HE ' ' A' ' 67' ' ' ARG . 20.7 p90 -113.16 -150.29 0.46 Allowed 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.526 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 22.0 mp0 -44.48 -56.29 4.41 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.358 0.411 . . . . 0.0 111.561 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.474 ' HD2' ' C ' ' A' ' 71' ' ' GLN . 2.5 m-85 -128.12 106.77 9.28 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 178.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.91 -64.04 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.974 0.416 . . . . 0.0 110.597 175.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -83.58 21.27 1.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.53 0.681 . . . . 0.0 110.13 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 75' ' ' LEU . 6.9 tt -60.87 -21.56 63.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.886 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -9.63 40.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.129 -178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.44 -3.28 52.47 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.848 0.356 . . . . 0.0 111.299 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.45 162.47 25.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.058 0.456 . . . . 0.0 110.734 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -135.98 -173.52 3.4 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.291 -178.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 ptpp? -72.93 11.41 0.69 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -172.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.27 46.96 0.43 Allowed Glycine 0 C--N 1.31 -0.892 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.427 176.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 m -83.47 132.41 34.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.853 ' SD ' ' HE2' ' A' ' 96' ' ' LYS . 73.2 mmm -79.89 102.48 9.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.121 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 39.2 t -90.25 132.32 35.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.054 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 72.4 m-85 -114.28 121.65 44.33 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -111.17 109.91 20.18 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.075 0.464 . . . . 0.0 110.14 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 30.3 mmtm -81.43 106.44 13.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.833 178.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 52' ' ' LEU . 9.2 p -142.04 132.99 25.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.085 0.469 . . . . 0.0 111.264 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.32 -91.92 0.14 Allowed Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.405 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -140.46 4.03 1.95 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.43 0.634 . . . . 0.0 109.812 178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -110.51 164.57 12.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.391 0.615 . . . . 0.0 111.397 -174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.9 m -122.89 92.17 3.65 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.995 171.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.433 ' HD2' ' OE2' ' A' ' 146' ' ' GLU . 19.5 mmt180 -74.36 121.42 21.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.065 -174.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.628 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -95.26 131.36 41.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.697 179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 89.1 m-85 -127.08 149.08 50.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.853 ' HE2' ' SD ' ' A' ' 83' ' ' MET . 0.0 OUTLIER -117.53 123.52 46.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.54 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 54.4 mtt -81.82 71.13 8.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.26 0.552 . . . . 0.0 110.588 -176.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.8 t -83.52 -21.92 32.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.911 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 42.6 m -118.62 110.37 17.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.352 . . . . 0.0 110.286 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 77.8 mt -129.93 128.85 65.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.531 -174.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.582 HH21 HG13 ' A' ' 110' ' ' VAL . 28.2 ptt180 -170.42 -175.06 1.81 Allowed 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . 2.7 p30 -126.87 152.2 47.36 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 170.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.547 HG21 HG21 ' A' ' 110' ' ' VAL . 12.3 m -127.44 126.15 66.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -174.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.563 ' HD2' ' HB2' ' A' ' 107' ' ' ASP . 0.1 OUTLIER -73.04 158.32 87.28 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.008 171.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -58.36 -14.06 18.9 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.729 2.286 . . . . 0.0 112.639 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.43 ' OG1' ' HD3' ' A' ' 104' ' ' LYS . 68.6 p -87.88 -3.41 58.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.039 0.447 . . . . 0.0 111.053 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.563 ' HB2' ' HD2' ' A' ' 104' ' ' LYS . 14.2 t70 -82.74 116.77 22.24 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.618 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.87 8.23 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.643 179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -82.09 -39.13 23.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.067 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.582 HG13 HH21 ' A' ' 101' ' ' ARG . 19.6 m -77.84 -23.04 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.373 174.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.39 -27.1 63.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.784 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.46 97.58 10.55 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.194 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -18.38 109.47 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 112.896 -1.956 . . . . 0.0 114.448 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.455 ' HB2' HE22 ' A' ' 120' ' ' GLN . 1.7 mp0 -78.52 115.6 18.34 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.053 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -126.57 179.52 5.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.267 173.518 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 104.27 -16.91 48.66 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -101.24 178.85 4.53 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.426 -0.387 . . . . 0.0 110.162 177.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -89.07 -148.44 0.18 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -56.52 109.01 0.55 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 173.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.455 HE22 ' HB2' ' A' ' 114' ' ' GLN . 13.1 pt20 -101.79 118.07 36.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.496 0.665 . . . . 0.0 110.019 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.59 ' HG ' HD21 ' A' ' 123' ' ' LEU . 20.9 tp -83.5 102.11 11.88 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.406 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 13.1 m -90.7 96.83 10.83 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.256 -174.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.59 HD21 ' HG ' ' A' ' 121' ' ' LEU . 8.4 mt -90.64 102.67 15.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.814 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 30.1 mt -95.53 97.15 6.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.252 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.7 m -96.53 98.26 10.08 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.069 0.461 . . . . 0.0 110.335 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 61.2 m -78.82 100.68 7.26 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 128' ' ' ASP . 23.7 t70 -136.0 83.23 2.0 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.66 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.725 ' H ' ' HE3' ' A' ' 136' ' ' TRP . 11.3 t70 166.94 99.5 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.065 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -87.66 132.42 34.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.16 0.505 . . . . 0.0 111.574 -170.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 22.7 t-20 -103.94 114.19 28.26 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.573 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -80.52 -19.2 46.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.81 0.338 . . . . 0.0 111.332 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -63.15 -38.14 90.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.166 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.485 HG22 ' OD1' ' A' ' 130' ' ' ASN . 14.2 t -131.85 -11.28 3.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 0.0 111.611 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.43 26.95 26.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.743 173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 34.7 m -111.54 -177.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 117.09 0.445 . . . . 0.0 110.905 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.725 ' HE3' ' H ' ' A' ' 128' ' ' ASP . 58.3 m95 -115.78 104.49 11.71 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 173.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 130' ' ' ASN . 43.2 mt-10 -67.86 -58.91 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.953 -172.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.509 ' HB3' ' CB ' ' A' ' 128' ' ' ASP . 26.7 ttpp -80.97 91.34 6.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.184 0.992 . . . . 0.0 110.582 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -93.99 100.85 12.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.335 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -74.82 125.59 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.981 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.93 119.49 59.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.987 0.899 . . . . 0.0 111.191 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.481 ' HD2' ' SD ' ' A' ' 97' ' ' MET . 10.4 m-85 -108.67 108.9 19.94 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.314 175.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 72.0 t -94.22 106.63 18.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.282 0.563 . . . . 0.0 109.956 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.509 ' HB2' ' HG2' ' A' ' 97' ' ' MET . . . -105.14 108.5 20.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.76 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.5 m -79.47 137.26 37.16 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.248 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.433 ' OE2' ' HD2' ' A' ' 93' ' ' ARG . 38.0 tt0 -55.6 123.59 14.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 96' ' ' LYS . 5.7 t -80.81 154.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.41 ' HG2' HG12 ' A' ' 147' ' ' VAL . 10.6 ptpt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.525 -0.75 . . . . 0.0 112.189 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -98.55 -174.21 2.75 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.982 0.42 . . . . 0.0 110.822 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.64 132.96 56.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.192 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 92.9 mttt -126.73 92.02 45.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.267 174.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.519 ' CB ' ' HB ' ' A' ' 88' ' ' VAL . 36.7 Cg_endo -64.66 124.8 13.77 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.755 2.304 . . . . 0.0 111.532 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -153.18 177.12 11.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.589 -174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 31' ' ' PRO . 45.9 mt -106.37 105.3 53.82 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.131 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.21 169.68 12.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.675 2.25 . . . . 0.0 112.674 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 17.4 mtpp -84.96 -21.21 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.787 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.44 ' OD2' ' HG3' ' A' ' 13' ' ' LYS . 25.5 t70 -68.89 108.46 3.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.062 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 9' ' ' LYS . 29.9 mttp -90.5 19.05 5.57 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.877 -168.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -112.11 8.35 19.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.791 0.329 . . . . 0.0 110.816 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' HG3' ' OD2' ' A' ' 10' ' ' ASP . 35.8 mttp -111.87 178.67 4.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.531 0.681 . . . . 0.0 112.146 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.73 126.06 72.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.703 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 52' ' ' LEU . . . -82.58 -41.85 19.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.286 0.565 . . . . 0.0 110.189 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -162.97 160.76 33.28 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 87' ' ' LYS . 38.2 m-85 -102.06 133.47 46.83 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.9 tp -101.82 114.19 40.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.59 0.709 . . . . 0.0 110.269 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 85' ' ' TYR . 43.6 mt-10 -114.95 117.09 29.64 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.042 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 25' ' ' ILE . 65.0 mt -131.15 94.03 28.62 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.01 177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.36 -16.12 52.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.259 2.64 . . . . 0.0 112.794 -174.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB3' ' OG ' ' A' ' 82' ' ' SER . 33.7 t70 -81.91 -28.43 32.86 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.557 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.81 20.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.998 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.41 20.26 10.94 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.585 0.707 . . . . 0.0 111.21 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 20' ' ' ILE . 72.0 mt -91.09 114.7 28.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.437 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.414 ' HE2' ' HB2' ' A' ' 26' ' ' LYS . 2.8 mppt? -142.79 84.9 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.637 ' CB ' ' HG3' ' A' ' 71' ' ' GLN . 4.4 mt-10 -146.41 158.65 46.84 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.782 0.325 . . . . 0.0 111.581 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 17' ' ' TYR . 73.6 Cg_endo -77.0 136.61 16.63 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.907 2.404 . . . . 0.0 112.627 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -91.64 134.4 30.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.146 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' SER . 35.1 m-85 -97.32 121.49 58.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.321 0.581 . . . . 0.0 111.13 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.584 ' HB2' HG23 ' A' ' 7' ' ' ILE . 86.0 Cg_endo -85.92 148.37 9.46 Favored 'Trans proline' 0 N--CA 1.455 -0.735 0 C-N-CA 123.334 2.689 . . . . 0.0 112.705 -178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 160.91 -169.52 36.56 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.893 -1.146 . . . . 0.0 112.891 172.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 35' ' ' THR . 81.7 Cg_endo -76.85 13.18 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 123.808 3.006 . . . . 0.0 112.77 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 61.83 75.57 0.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.164 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 33' ' ' PRO . 72.8 p -97.33 164.53 17.51 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.664 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.34 -37.93 81.78 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.203 1.935 . . . . 0.0 111.339 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 41' ' ' ARG . 26.4 mm-40 -59.14 -44.25 92.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.777 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.817 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 1.2 mp0 -59.68 -42.95 94.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.3 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -80.49 -9.58 59.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.811 -173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.56 -31.76 12.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.735 0.303 . . . . 0.0 111.155 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 37' ' ' GLU . 17.7 ptp180 -87.24 -19.84 27.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.989 0.423 . . . . 0.0 110.614 177.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.76 -127.26 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.287 177.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 60' ' ' ALA . 93.9 t -126.92 141.66 45.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.817 ' HB2' ' HB3' ' A' ' 38' ' ' GLN . 41.8 t -119.74 163.65 17.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.214 0.53 . . . . 0.0 110.775 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 7' ' ' ILE . 55.6 m-85 -71.87 159.66 33.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.754 172.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.46 -49.12 79.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -140.07 166.32 24.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -80.14 -19.83 46.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.28 0.562 . . . . 0.0 110.043 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -80.04 4.8 15.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.068 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.24 163.47 23.97 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.992 ' HB3' ' HB2' ' A' ' 54' ' ' ASP . 23.2 t -122.36 177.1 5.53 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 15' ' ' ALA . 85.0 mt -110.17 -16.08 13.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.641 0.257 . . . . 0.0 111.171 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -115.09 12.11 16.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.893 0.854 . . . . 0.0 109.374 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.992 ' HB2' ' HB3' ' A' ' 51' ' ' SER . 3.1 t70 -79.31 179.18 7.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.413 179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.12 -21.85 46.02 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -131.3 129.24 41.24 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.638 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' HB ' HD23 ' A' ' 121' ' ' LEU . 5.3 mp -129.68 101.75 6.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.549 ' HA ' ' HB ' ' A' ' 122' ' ' THR . 5.4 m -93.04 125.33 37.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -175.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.5 mt -119.13 138.88 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.527 ' O ' HG13 ' A' ' 43' ' ' VAL . . . -117.91 122.35 43.08 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -173.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -121.51 166.7 14.32 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.852 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.564 ' HB3' ' C12' ' A' ' 201' ' ' JPT . 0.3 OUTLIER -150.57 38.02 0.68 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 117.326 0.563 . . . . 0.0 111.431 -174.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER 56.03 -158.75 0.23 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.186 -174.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.453 ' H ' HG22 ' A' ' 63' ' ' THR . 47.5 p90 -120.47 178.61 4.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.442 0.639 . . . . 0.0 112.344 -170.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 62.2 mt -128.27 -53.68 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.011 172.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.42 49.02 2.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.443 -0.798 . . . . 0.0 109.196 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 64' ' ' PHE . 16.9 mmt180 -142.76 105.49 5.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.161 -175.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.62 -16.5 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 121.971 1.781 . . . . 0.0 111.601 177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -154.78 82.31 1.09 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.749 -176.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -122.17 -176.97 3.48 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 170.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.637 ' HG3' ' CB ' ' A' ' 27' ' ' GLU . 0.9 OUTLIER -38.24 -71.07 0.08 Allowed 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.503 ' CZ ' HD12 ' A' ' 123' ' ' LEU . 2.5 m-30 -105.66 76.04 1.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.765 -0.584 . . . . 0.0 111.446 -175.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.89 -58.36 2.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.674 0.749 . . . . 0.0 110.259 177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -100.34 21.05 13.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.407 -173.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.475 HD23 ' OG1' ' A' ' 125' ' ' THR . 40.8 tp -63.75 -23.18 67.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.786 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -13.54 62.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.976 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.05 9.72 26.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.662 0.268 . . . . 0.0 111.299 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.491 ' HA ' ' OD2' ' A' ' 22' ' ' ASP . . . -91.67 141.39 28.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.046 0.45 . . . . 0.0 111.333 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 82' ' ' SER . 10.6 mptt -109.71 -179.0 3.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.805 177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.8 ptpt -57.3 -41.37 79.72 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.735 0.642 . . . . 0.0 112.735 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.49 47.65 1.32 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.699 -1.239 . . . . 0.0 111.719 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.552 ' OG ' ' HB3' ' A' ' 22' ' ' ASP . 4.7 t -66.82 -17.21 64.77 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 122.596 0.358 . . . . 0.0 111.895 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.66 86.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.52 0.676 . . . . 0.0 111.727 -174.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 95' ' ' TYR . 58.8 t -88.37 114.81 27.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.251 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB2' ' HB2' ' A' ' 19' ' ' GLU . 76.1 m-85 -101.43 105.4 16.42 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -97.79 106.93 19.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . 34.7 mmtp -90.91 92.57 8.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.11 -175.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.864 HG23 ' HB2' ' A' ' 91' ' ' GLU . 4.8 m -90.67 92.37 3.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 121.672 0.748 . . . . 0.0 110.179 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.58 -88.99 0.83 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.51 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.05 0.28 5.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.151 0.501 . . . . 0.0 110.083 176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.864 ' HB2' HG23 ' A' ' 88' ' ' VAL . 9.5 mm-40 -92.18 119.03 31.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.495 -175.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 m -92.54 106.04 18.1 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.576 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -94.96 136.57 35.12 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.674 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -114.55 118.85 34.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -177.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.583 ' HB2' ' HB ' ' A' ' 84' ' ' VAL . 71.9 m-85 -118.03 145.7 44.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.398 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -110.23 138.76 46.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 177.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 142' ' ' PHE . 19.8 mmt -81.0 68.06 7.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.141 0.496 . . . . 0.0 110.15 -177.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 t -75.73 -20.9 58.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.859 -172.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HB2' ' HB ' ' A' ' 143' ' ' VAL . 51.0 m -133.03 101.59 5.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.175 0.512 . . . . 0.0 111.17 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 97' ' ' MET . 78.5 mt -119.03 124.36 73.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.266 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -157.97 176.2 12.85 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.355 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.582 ' HA ' ' HA ' ' A' ' 140' ' ' LYS . 10.6 p-10 -134.98 128.39 32.34 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.976 0.417 . . . . 0.0 110.135 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.902 HG11 HG11 ' A' ' 110' ' ' VAL . 31.6 m -129.05 179.29 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.39 -174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.422 ' H ' ' HD3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -102.99 158.0 32.62 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.075 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 139' ' ' ARG . 19.8 Cg_endo -61.75 -15.19 40.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.929 2.419 . . . . 0.0 112.585 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.3 t -96.26 -7.13 36.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.905 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -84.78 97.94 9.98 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.635 ' HA ' HD21 ' A' ' 111' ' ' LEU . 29.6 m -100.06 8.25 8.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.821 0.343 . . . . 0.0 111.715 -170.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -93.43 -15.47 25.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.316 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.902 HG11 HG11 ' A' ' 103' ' ' VAL . 22.5 m -76.44 -23.71 15.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.547 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.635 HD21 ' HA ' ' A' ' 108' ' ' VAL . 0.3 OUTLIER -97.41 34.54 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.09 0.471 . . . . 0.0 111.064 -179.341 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -70.16 169.66 13.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 173.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -66.25 105.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.459 0.647 . . . . 0.0 110.789 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -82.21 45.33 0.93 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.466 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -77.48 174.57 10.71 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.33 175.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.86 13.25 78.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.744 -176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -110.44 -170.69 1.69 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.082 0.468 . . . . 0.0 110.193 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.73 -163.58 0.86 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.563 ' HG3' ' O ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -62.35 110.02 1.52 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -124.11 143.22 50.6 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.237 0.541 . . . . 0.0 111.446 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.494 HD23 ' HB ' ' A' ' 57' ' ' ILE . 70.6 mt -96.27 125.22 40.63 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.316 174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.549 ' HB ' ' HA ' ' A' ' 58' ' ' SER . 12.0 m -97.69 92.43 5.88 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 142' ' ' PHE . 2.3 mm? -87.45 100.69 12.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.236 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.98 97.84 7.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.475 ' OG1' HD23 ' A' ' 75' ' ' LEU . 2.4 m -102.91 102.11 12.18 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.963 0.411 . . . . 0.0 109.925 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 139' ' ' ARG . 20.6 m -85.89 100.4 12.06 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.975 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -115.5 177.55 4.62 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.342 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 52.26 83.34 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.739 0.649 . . . . 0.0 111.003 175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.697 ' HB3' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -102.91 170.67 7.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.413 0.625 . . . . 0.0 111.919 -172.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -104.9 92.34 4.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.058 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 129' ' ' TYR . 38.2 mt-10 -44.56 -37.9 3.86 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -64.36 -29.01 70.09 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.416 HG23 ' H ' ' A' ' 135' ' ' VAL . 8.6 t -126.44 -14.84 5.76 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.509 -176.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.58 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.687 173.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.416 ' H ' HG23 ' A' ' 133' ' ' THR . 16.3 m -75.15 146.48 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 117.437 0.618 . . . . 0.0 110.251 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.697 ' CE3' ' HB3' ' A' ' 129' ' ' TYR . 85.1 m95 -94.14 111.91 23.67 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -70.6 -53.73 14.8 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.382 -172.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -90.71 85.09 5.96 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.11 0.481 . . . . 0.0 111.405 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.612 ' NH1' ' O2 ' ' A' ' 201' ' ' JPT . 35.7 ptt180 -80.64 79.94 7.18 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 170.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 102' ' ' ASP . 85.0 tttt -70.15 123.23 21.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.067 -174.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 13.7 tt -107.8 125.52 64.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.687 0.756 . . . . 0.0 110.741 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.645 ' HB2' ' HB2' ' A' ' 123' ' ' LEU . 37.2 m-85 -109.05 110.83 22.2 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 173.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 99' ' ' SER . 84.3 t -96.91 103.33 14.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.405 0.621 . . . . 0.0 109.556 176.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.594 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -101.75 102.37 13.0 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.35 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.5 m -87.62 139.5 30.47 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 95' ' ' TYR . 7.3 tt0 -55.21 128.61 34.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.601 0.715 . . . . 0.0 110.941 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 96' ' ' LYS . 5.9 p -96.48 155.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.128 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.433 -0.794 . . . . 0.0 112.089 -175.263 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' JPT . . . . . 0.612 ' O2 ' ' NH1' ' A' ' 139' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_